<SEC-DOCUMENT>0000355019-24-000038.txt : 20240927
<SEC-HEADER>0000355019-24-000038.hdr.sgml : 20240927
<ACCEPTANCE-DATETIME>20240927163047
ACCESSION NUMBER:		0000355019-24-000038
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		96
CONFORMED PERIOD OF REPORT:	20240630
FILED AS OF DATE:		20240927
DATE AS OF CHANGE:		20240927

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FONAR CORP
		CENTRAL INDEX KEY:			0000355019
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				112464137
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-10248
		FILM NUMBER:		241335352

	BUSINESS ADDRESS:	
		STREET 1:		110 MARCUS DR
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
		BUSINESS PHONE:		6316942929

	MAIL ADDRESS:	
		STREET 1:		110 MARCUS DRIVE
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>fonar_10-k.htm
<DESCRIPTION>FONAR CORPORATION FORM 10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:FONR="http://fonar.com/20240630">
<head>
     <title>Form 10-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02F_US%2DGAAP%2D2024%2D(with%2DECD)_rempres -->
<!-- Field: Set; Name: xdx; ID: xdx_03C_FONR_fonar.com_20240630 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20230701_20240630 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_052_edei%2D%2DDocumentFiscalYearFocus_2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0000355019 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_064_Integer_5_Integer -->
<body style="font: 11pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000004" name="dei:DocumentFiscalYearFocus">2024</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000005" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000006" name="dei:EntityCentralIndexKey">0000355019</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2023-06-30" id="xdx2ixbrl0195" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30_custom_ClassANonVotingPreferredMember" id="xdx2ixbrl0465" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0466" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0467" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012023-06-30_custom_ClassANonVotingPreferredMember" id="xdx2ixbrl0469" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0470" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012023-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0471" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2022-07-012023-06-30_custom_ClassANonVotingPreferredMember" id="xdx2ixbrl0473" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2022-07-012023-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0475" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012023-06-30_custom_ClassANonVotingPreferredMember" id="xdx2ixbrl0479" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0480" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012023-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0481" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012024-06-30_custom_ClassANonVotingPreferredMember" id="xdx2ixbrl0489" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0490" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0491" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012024-06-30_custom_ClassANonVotingPreferredMember" id="xdx2ixbrl0493" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0494" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0495" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-07-012024-06-30_custom_ClassANonVotingPreferredMember" id="xdx2ixbrl0497" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0499" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012024-06-30_custom_ClassANonVotingPreferredMember" id="xdx2ixbrl0503" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0504" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0505" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0516" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0519" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0520" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0523" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0525" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0526" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0531" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0534" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0535" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0538" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0540" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0541" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0550" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012023-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0555" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2022-07-012023-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0559" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0560" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012023-06-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0562" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0570" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012024-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0575" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-07-012024-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0579" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0580" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0582" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="FONR:GainOnSaleOfEquipmentRelatedParty" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0612" unitRef="USD" xs:nil="true"/>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="fonr-20240630.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-07-01to2024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-18_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-18_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-18_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-18_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_CommonStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:CommonStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_CommonStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:CommonStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ClassANonVotingPreferredStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ClassANonVotingPreferredStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ClassANonVotingPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ClassANonVotingPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonStockMember958664140">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ClassANonVotingPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ClassANonVotingPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ClassANonVotingPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonStockMember958664218">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-07-01_us-gaap_OtherInvesteesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-07-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-07-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_OtherInvesteesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_OtherInvesteesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_IntellectualPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_DiagnosticImagingFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">FONR:DiagnosticImagingFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-07-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-07-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FONR:RelatedPartiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FONR:RelatedPartiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FONR:RelatedPartiesMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FONR:RelatedPartiesMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_srt_MinimumMember_custom_DiagnosticEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_srt_MaximumMember_custom_DiagnosticEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_srt_MinimumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDeveopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_srt_MaximumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDeveopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_srt_MinimumMember_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_srt_MaximumMember_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_srt_MinimumMember_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_srt_MaximumMember_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_srt_MinimumMember_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_srt_MaximumMember_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_srt_WeightedAverageMember_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_CommonStockMember958666312">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_CommonStockMember958666343">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_NotesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_NotesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_NotesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_NotesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_NotesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_DiagnosticEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_DiagnosticEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ResearchDevelopmentAndDemonstrationEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDevelopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ResearchDevelopmentAndDemonstrationEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDevelopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_PropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_PropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_OperatingLeasePaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:OperatingLeasePaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_FinancingLeasePaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:FinancingLeasePaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_PreferredClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-04-23_custom_N2010StockBonusPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-04-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-08-10_custom_N2010StockBonusPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-08-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_N2010StockBonusPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_N2010StockBonusPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_N2010StockBonusPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-252022-09-26_srt_BoardOfDirectorsChairmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-25</xbrli:startDate>
        <xbrli:endDate>2022-09-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-02-13_custom_HDMMember_custom_ClassAControllingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-02-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-02-13_custom_HDMMember_custom_ClassBControllingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassBControllingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-02-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-02-122013-02-13_custom_HDMMember_custom_ClassBControllingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassBControllingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-02-12</xbrli:startDate>
        <xbrli:endDate>2013-02-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-02-122013-02-13_custom_HDMMember_custom_ClassAControllingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-02-12</xbrli:startDate>
        <xbrli:endDate>2013-02-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-03-05_custom_HDMMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-03-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-01-08_custom_ClassAControllingInterestsMember_custom_HDMMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-01-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-072015-01-08_custom_ClassAControllingInterestsMember_custom_HDMMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-07</xbrli:startDate>
        <xbrli:endDate>2015-01-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ClassAControllingInterestsMember_custom_HDMMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ClassAControllingInterestsMember_custom_HDMMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_HDMMember_custom_ClassAControllingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_NotePayable1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_NotePayable1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_NotePayable2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_NotePayable1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_NotePayable2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_NotePayable2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-02-282016-02-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-02-28</xbrli:startDate>
        <xbrli:endDate>2016-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_MagneticResonanceManagementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">FONR:MagneticResonanceManagementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_BensonhurstMRILimitedPartnershipMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:BensonhurstMRILimitedPartnershipMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-05-302017-06-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-05-30</xbrli:startDate>
        <xbrli:endDate>2017-06-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_RadianHealthcareManagementLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:RadianHealthcareManagementLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_HealthCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_HealthCareOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_HealthCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_HealthCareOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_HealthCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_HealthCareOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_HealthCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_HealthCareOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_country_DE">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_country_DE">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_country_AE">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AE</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_country_AE">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AE</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_country_PR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_country_PR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_country_CH">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_country_CH">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_country_GB">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_country_GB">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_country_DO">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DO</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_country_DO">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DO</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_country_GR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_country_GR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_country_AU">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_country_AU">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-18_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Integer">
      <xbrli:measure>FONR:Integer</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact001026" toRefs="Footnote001059"/>
  <ix:relationship fromRefs="Fact001032" toRefs="Footnote001059"/>
  <ix:relationship fromRefs="Fact001036" toRefs="Footnote001059"/>
  <ix:relationship fromRefs="Fact001040" toRefs="Footnote001059"/>
  <ix:relationship fromRefs="Fact001044" toRefs="Footnote001059"/>
  <ix:relationship fromRefs="Fact001048" toRefs="Footnote001059"/>
  <ix:relationship fromRefs="Fact001052" toRefs="Footnote001059"/>
  <ix:relationship fromRefs="Fact001056" toRefs="Footnote001059"/>
  <ix:relationship fromRefs="Fact001829" toRefs="Footnote001894"/>
  <ix:relationship fromRefs="Fact001831" toRefs="Footnote001894"/>
  <ix:relationship fromRefs="Fact001833" toRefs="Footnote001894"/>
  <ix:relationship fromRefs="Fact001865" toRefs="Footnote001894"/>
  <ix:relationship fromRefs="Fact001867" toRefs="Footnote001894"/>
  <ix:relationship fromRefs="Fact001869" toRefs="Footnote001894"/>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 11pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="margin: 0pt; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt">SECURITIES
AND EXCHANGE COMMISSION</span><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><br/>
</span><span style="font-size: 12pt">&#160; <span style="font-family: Times New Roman, Times, Serif">WASHINGTON, D.C. 20549</span></span></p>

<p style="margin: 0pt; text-align: center; text-indent: 0pt"><span style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></p>

<p style="margin: 0pt; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90B_edei--DocumentType_c20230701__20240630_zjUJgCZdfiLj"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000013" name="dei:DocumentType">10-K</ix:nonNumeric></span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 12pt"><span id="xdx_902_edei--DocumentAnnualReport_c20230701__20240630_zx8VtnagTqu5"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleantrue" id="Fact000014" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span>
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>For the fiscal year ended <span id="xdx_90E_edei--DocumentPeriodEndDate_c20230701__20240630_zndKRVKOKTJ6"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:datemonthdayyearen" id="Fact000015" name="dei:DocumentPeriodEndDate"><span id="xdx_90E_edei--CurrentFiscalYearEndDate_c20230701__20240630_z6WUrOUwBNm"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:datemonthdayen" id="Fact000016" name="dei:CurrentFiscalYearEndDate">June 30</ix:nonNumeric></span>, 2024</ix:nonNumeric></span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">OR</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 12pt"><span id="xdx_901_edei--DocumentTransitionReport_c20230701__20240630_zlULBXCy7oB7"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleanfalse" id="Fact000017" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt">&#160;TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">For the transition period from _____________ to _____________</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">Commission File No. <span id="xdx_90B_edei--EntityFileNumber_c20230701__20240630_z6o3Ca43GDBf"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000018" name="dei:EntityFileNumber">0-10248</ix:nonNumeric></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><img src="fonar_logo.jpg" alt="" style="height: 38px; width: 250px"/>&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 5%">&#160;</td>
    <td style="border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom; width: 90%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 24pt"><b><span id="xdx_90F_edei--EntityRegistrantName_c20230701__20240630_zGrgFhugr7qk"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000019" name="dei:EntityRegistrantName">FONAR CORPORATION</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: top; width: 5%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="font: 11pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(Exact name of registrant as specified in its charter)</span></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="border-bottom: Black 1pt solid; text-align: center; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="text-transform: uppercase"><span id="xdx_905_edei--EntityIncorporationStateCountryCode_c20230701__20240630" title="Entity Incorporation, State or Country Code"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt-sec:stateprovnameen" id="Fact000021" name="dei:EntityIncorporationStateCountryCode">delaware</ix:nonNumeric></span></span></span></td>
<td style="padding-bottom: 1pt; text-align: center; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: center; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_907_edei--EntityTaxIdentificationNumber_c20230701__20240630" title="Entity Tax Identification Number"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000023" name="dei:EntityTaxIdentificationNumber">11-2464137</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(State of incorporation)</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(IRS Employer Identification Number)</span></td></tr>
<tr style="vertical-align: top">
<td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_90A_edei--EntityAddressAddressLine1_c20230701__20240630" title="Entity Address, Address Line One"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000025" name="dei:EntityAddressAddressLine1">110 Marcus Drive</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressCityOrTown_c20230701__20240630" title="Entity Address, City or Town"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000027" name="dei:EntityAddressCityOrTown">Melville</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressStateOrProvince_c20230701__20240630" title="Entity Address, State or Province"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt-sec:stateprovnameen" id="Fact000029" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span></span></td>
<td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_902_edei--EntityAddressPostalZipCode_c20230701__20240630" title="Entity Address, Postal Zip Code"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000031" name="dei:EntityAddressPostalZipCode">11747</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(Address of principal executive offices)</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(Zip Code)</span></td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(<span id="xdx_908_edei--CityAreaCode_c20230701__20240630" title="City Area Code"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000033" name="dei:CityAreaCode">631</ix:nonNumeric></span>)
    <span id="xdx_90A_edei--LocalPhoneNumber_c20230701__20240630" title="Local Phone Number"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000035" name="dei:LocalPhoneNumber">694-2929</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(Registrant's
    Telephone Number, including area code)</span></td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Securities Registered pursuant to Section 12(b) of the Act</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: center; width: 34%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="text-decoration: underline">Title of
    Each Class</span></span></td>
    <td style="text-align: center; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: center; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="text-decoration: underline">Trading Symbol(s)</span></span></td>
    <td style="text-align: center; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: center; width: 34%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="text-decoration: underline">Exchange
    Registered</span></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_90D_edei--Security12bTitle_c20230701__20240630_z5cLtcyBw3U3"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000036" name="dei:Security12bTitle">Common Stock, $.0001 par
    value</ix:nonNumeric></span></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_90B_edei--TradingSymbol_c20230701__20240630_zhYfOYDRPun5"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000037" name="dei:TradingSymbol">FONR</ix:nonNumeric></span></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_904_edei--SecurityExchangeName_c20230701__20240630_zpH0wHfBkbPg"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt-sec:exchnameen" id="Fact000038" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span> Capital Market</span></td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Securities
Registered pursuant to Section 12(g) of the Act</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">None</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes </span><span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span><span style="font-family: Times New Roman, Times, Serif">&#160;<span id="xdx_904_edei--EntityWellKnownSeasonedIssuer_c20230701__20240630" title="Entity Well-known Seasoned Issuer"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000040" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span>
</span><span style="font-family: Segoe UI Symbol,sans-serif">&#9746;</span> <span style="font-family: Times New Roman, Times, Serif">.
</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes </span><span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span><span style="font-family: Times New Roman, Times, Serif">&#160;<span id="xdx_907_edei--EntityVoluntaryFilers_c20230701__20240630" title="Entity Voluntary Filers"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000042" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span>
</span><span style="font-family: Segoe UI Symbol,sans-serif">&#9746;</span> <span style="font-family: Times New Roman, Times, Serif">.<br/>
</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. <span id="xdx_901_edei--EntityCurrentReportingStatus_c20230701__20240630_zShJqZZ5jR7c"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000043" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span>&#160;</span><span style="font-family: Segoe UI Symbol,sans-serif">&#9746;</span>
<span style="font-family: Times New Roman, Times, Serif">No </span><span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span>
<span style="font-family: Times New Roman, Times, Serif">.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant (1) has submitted electronically and posted on its corporate website, if any, every Interactive Data
File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding
12 months (or for such shorter period that the registrant was required to submit and post such files). <span id="xdx_901_edei--EntityInteractiveDataCurrent_c20230701__20240630_zZC1bdwW25O6"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000044" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span>&#160;</span><span style="font-family: Segoe UI Symbol,sans-serif">&#9746;</span>
<span style="font-family: Times New Roman, Times, Serif">No </span><span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by check mark whether the registrant is a
large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of &#8220;large
accelerated filer&#8221;, &#8220;accelerated filer and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act. (Check
one):</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font: 11pt Times New Roman, Times, Serif; width: 33%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Large accelerated filer&#160;</span><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 11pt">&#9744;</span></td>
    <td style="font: 11pt Times New Roman, Times, Serif; width: 34%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Accelerated filer </span><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 11pt">&#9744;</span></td>
    <td style="font: 11pt Times New Roman, Times, Serif; width: 33%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_904_edei--EntityFilerCategory_c20230701__20240630_z0x3OlMPT0Pe"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt-sec:entityfilercategoryen" id="Fact000045" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric></span> </span><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 11pt">&#9746;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 11pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Smaller reporting company </span><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 11pt"><span id="xdx_90B_edei--EntitySmallBusiness_c20230701__20240630_zUQ2J9BhPo7g"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleantrue" id="Fact000046" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td>
    <td style="font: 11pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Emerging Growth Company </span><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 11pt"><span id="xdx_904_edei--EntityEmergingGrowthCompany_c20230701__20240630_zIaKybloGo1"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleanfalse" id="Fact000047" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 11pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">If
securities are registers pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant
included in the filing reflect the correction of an error to previously issued financial statements. Yes&#160;</span><span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span>
<span style="font-family: Times New Roman, Times, Serif">No </span><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_90A_edei--DocumentFinStmtErrorCorrectionFlag_dbF_c20230701__20240630_zs5SQlbAorDe"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleanfalse" id="Fact000048" name="dei:DocumentFinStmtErrorCorrectionFlag">&#9746;</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif">&#160;.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation
received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). Yes&#160;</span><span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span>
<span style="font-family: Times New Roman, Times, Serif">No </span><span style="font-family: Segoe UI Symbol,sans-serif">&#9746;</span><span style="font-family: Times New Roman, Times, Serif">&#160;.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes&#160;</span><span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span>
<span style="font-family: Times New Roman, Times, Serif">No </span><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_90E_edei--EntityShellCompany_dbF_c20230701__20240630_zpvFpPX8B1id"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleanfalse" id="Fact000049" name="dei:EntityShellCompany">&#9746;</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif">&#160;.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The aggregate market value of the shares of Common
Stock held by non-affiliates as of December 29, 2023 based on the closing price of $19.56 per share on such date as reported on the NASDAQ
System, was approximately $<span id="xdx_90F_edei--EntityPublicFloat_iI_pn5n6_c20231229_z1kc7ZYe9ZTh" title="Entity Public Float"><ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2023-12-29" id="Fact000051" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">121.0</ix:nonFraction></span> million. The other outstanding classes do not have a readily determinable market value.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 18, 2024, <span id="xdx_90A_edei--EntityCommonStockSharesOutstanding_iI_c20240918__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zqleA5sQxtj3" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2024-09-18_us-gaap_CommonStockMember" id="Fact000053" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,328,294</ix:nonFraction></span> shares of Common
Stock, <span id="xdx_90B_edei--EntityCommonStockSharesOutstanding_iI_c20240918__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zXqFZyyVesuh" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2024-09-18_us-gaap_CommonClassBMember" id="Fact000055" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">146</ix:nonFraction></span> shares of Class B Common Stock, <span id="xdx_901_edei--EntityCommonStockSharesOutstanding_iI_c20240918__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zZaPK9YGgink" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2024-09-18_us-gaap_CommonClassCMember" id="Fact000057" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span> shares of Class C Common Stock and <span id="xdx_90F_edei--EntityCommonStockSharesOutstanding_iI_c20240918__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zONeNDGWBw" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2024-09-18_custom_ClassANonVotingPreferredStockMember" id="Fact000059" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">313,438</ix:nonFraction></span> shares of Class A Non-voting Preferred Stock
of the registrant were outstanding.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;<span id="xdx_906_edei--DocumentFinStmtErrorCorrectionFlag_c20230701__20240630_zExicQyV1xei" style="display: none"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleanfalse" id="Fact000060" name="dei:DocumentFinStmtErrorCorrectionFlag">No</ix:nonNumeric></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">DOCUMENTS INCORPORATED BY REFERENCE</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NONE<br/></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">TABLE OF CONTENTS</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 11%">&#160;</td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: bottom; width: 10%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 67%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">FORM
    10-K ITEMS</span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: top; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">PAGE</span></td></tr>
  <tr>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">PART I</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 1.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="text-decoration: underline">Business</span></span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">4</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 1A.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Risk Factors</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">24</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 1B.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Unresolved Staff Comments</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">27</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 1C.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="text-decoration: underline">Cybersecurity </span></span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">27</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 2.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Properties</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">28</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 3.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Legal Proceedings</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">28</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 4.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Mine Safety Disclosures</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">28</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">PART II</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 5.</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><a href="#a_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases <span style="text-decoration: underline">of Equity Securities</span></span></a></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">28</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 6.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="text-decoration: underline">[Reserved[</span></span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">30</span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 7.</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><a href="#a_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">30</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 7A.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="text-decoration: underline">Quantitative and Qualitative Disclosures About Market Risk.</span></span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">38</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 8.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Financial Statements <span style="text-decoration: underline">and Supplementary Data</span></span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">38</span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 9.</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><a href="#a_013"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></a></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">80</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 9A.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_014"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Controls and Procedures</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">80</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 9B.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_015"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Other Information</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">81</span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 9C.</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><a href="#a_016"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="text-decoration: underline">Disclosures Regarding Foreign Jurisdictions that Prevent Inspections</span></span></a></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">81</span></td></tr>
  <tr>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">PART III</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 10.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_017"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Directors, Executive Officers <span style="text-decoration: underline">and Corporate Governance</span></span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">81</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 11.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_018"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Executive Compensation</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">84</span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 12.</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><a href="#a_019"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="text-decoration: underline">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></span></a></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">87</span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 13.</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><a href="#a_020"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Certain Relationships and Related Transactions, and Director Independence</span></a></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">89</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 14.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_021"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Principal Accountant Fees and Services</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">90</span></td></tr>
  <tr>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">PART IV</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 15.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_022"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Exhibits <span style="text-decoration: underline">and Financial Statement Schedules</span></span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">91</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>PART I</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_001"></span>ITEM 1. BUSINESS	</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>GENERAL</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR Corporation, sometimes referred to as the &#8220;Company&#8221;
or &#8220;FONAR&#8221;, is a Delaware corporation which was incorporated on July 17, 1978. Our address is 110 Marcus Drive, Melville,
New York 11747 and our telephone number is 631-694-2929. FONAR also maintains a website at www.fonar.com. FONAR provides copies of its
filings with the Securities and Exchange Commission on Forms 10-K, 10-Q and 8-K and amendments to these reports to stockholders on request.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We conduct our business in two segments. Our medical
equipment segment is conducted directly through FONAR. Our physician management and diagnostic services segment is conducted through our
subsidiary Health Management Corporation of America (&#8220;HMCA&#8221;). HMCA provides management services, administrative services,
billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing, IT services, hiring,
conducting interviews and managing personnel, storage of medical records, office space, equipment, repair, maintenance service, and clerical
and other non-medical personnel to medical providers engaged in diagnostic imaging. In addition to acting as a management company, HMCA
owns and operates six diagnostic imaging facilities in Florida, where the corporate practice of medicine is permitted.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR is engaged in the business of designing, manufacturing,
selling and servicing magnetic resonance imaging scanners, also referred to as &#8220;MRI&#8221; or &#8220;MR&#8221; scanners, which utilize
MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions and injuries. FONAR&#8217;s founders
built the first MRI scanner in 1977 and FONAR introduced the first commercial MRI scanner in 1980. FONAR is also the originator of the
iron-core non-superconductive and permanent magnet MRI technology.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR&#8217;s iron frame technology made FONAR the
originator of &#8220;open&#8221; MRI scanners. We introduced the first &#8220;open&#8221; MRI in 1980. Since that time we have concentrated
on further application of our &#8220;open&#8221; MRI, introducing most recently the Upright&#174; Multi-Position&#8482;&#8221; MRI scanner
(also referred to as the &#8220;Upright&#174;&#8221; or &#8220;Stand-Up&#174;&#8221; MRI scanner) and the FONAR 360&#8482; MRI scanner.
The FONAR 360&#8482; MRI is not presently being marketed.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">See Note 16 to the Consolidated Financial Statements
for separate financial information regarding our medical equipment and physician and diagnostic management services segments.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS</b>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain statements made in this Annual Report on Form
10-K are &#8220;forward-looking statements&#8221;, within the meaning of the Private Securities Litigation Reform Act of 1995, regarding
the plans and objectives of Management for future operations. These statements involve known and unknown risks, uncertainties and other
factors that may cause our actual results, performance or achievements to be materially different from any future results, performance
or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on current expectations
that involve numerous risks and uncertainties. Our plans and objectives are based, in part, on assumptions involving the expansion of
business. These assumptions involve judgments with respect to future economic, competitive and market conditions and future business decisions,
all of which are difficult or impossible to predict accurately and many of which are beyond our control. Although we believe that our
assumptions underlying the forward-looking statements are reasonable, any of the assumptions could prove inaccurate and, therefore, there
can be no assurance that the forward-looking statements included in this Annual Report will prove to be accurate. In light of the significant
uncertainties inherent in our forward-looking statements, the inclusion of such information should not be regarded as a representation
by us or any other person that our objectives and plans will be achieved. These statements are not guarantees of future performance and
undue reliance should not be placed on them.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>MEDICAL EQUIPMENT SEGMENT</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline">PRODUCTS</span></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">The Upright&#174; MRI scanner is our primary product.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Upright&#174; MRI is a &#8220;whole-body&#8221;
MRI, meaning that it can be used to scan virtually any part of the body. The Upright&#174; MRI differs from conventional MRI scanners in
that it is not limited to scanning patients in the recumbent posture. For example, patients can be scanned while sitting, standing, bending,
or lying down.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fact that the patient space is unobstructed permits
scanning in a variety of postures that cannot be duplicated in conventional MRI scanners. Most conventional MRI scanners in use today
employ solenoidal super-conducting magnets whose magnetic field orientation is along the axis of the patient&#8217;s body, which must
be placed into the bore of the scanner in either a supine or prone posture. Our experience is that when presented with a choice between
being scanned lying down in a tunnel-like enclosure or seated in an open MRI, most patients will choose the latter.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Upright&#174; MRI is also, by design, a non-claustrophobic
MRI scanner. The Upright&#174; MRI employs a dipole magnet whose magnetic field orientation is transverse to the axis of the patient&#8217;s
body. The gap between the poles of the magnet is the space into which the patient is placed. Because the magnetic field direction is horizontal
and transverse to the body, a patient who is scanned seated or standing has an unobstructed view out of the gap of the magnet. In typical
installations, patients watch television while being scanned, without the aid of special glasses with mirrors.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Upright&#174; MRI facilitates patient scanning
in a variety of postures thanks to a unique, three-axis patient handling system. The motorized patient table, or bed, can be rotated to
any angle between 0 (horizontal) and 84 degrees (nearly vertical). Unlike a conventional recumbent MRI patient table, which can only move
into or out of the scanner&#8217;s bore, the Upright&#174; MRI bed can be translated with two degrees of freedom, in/out and up/down. User-friendly
software allows the scanner operator to move the anatomical region of interest precisely to the center of the magnet using a cursor placed
on a localizer image. Anatomically true image orientation is assured, regardless of the rotation angle of the bed, via computer read-back
of the table&#8217;s position. A seat can be hooked onto the bed in a variety of locations, or removed, as needed. Transpolar VersaRests&#8482;
and other devices can be used to keep the patient comfortable and motionless throughout the scanning process.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>IMAGE QUALITY AND FIELD STRENGTH</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Most commercially available MRI scanners range in
magnetic field strength from about 0.2 T (Tesla) to 7.0 T, and open MRI scanners range from about 0.2 T to 1.2 T.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Field strength is an important characteristic of MRI
scanners, but not the only one. Higher field strengths generally provide higher signal-to-noise ratios (SNR) on account of the Boltzmann
distribution, but SNR is not the only determinant of image quality. For example, the spin-lattice relaxation time T<sub>1</sub> that characterizes
the nuclear magnetic resonance (NMR) signal increases with field strength, decreasing the difference in T<sub>1</sub> values between tissues
that is an essential contributor to contrast in images. For example, grey/white matter contrast in the brain falls off rapidly above about
1.0 T, and some studies have shown that optimal tissue contrast occurs in the mid-field region, down to 0.2 T. Imaging bandwidth, receiver
coil design, pulse sequence design, and scan parameters significantly affect image quality. Indeed, researchers and MRI vendors are pushing
the boundaries of MRI technology in both directions, that is, to very low (1 &#8211; 199 mT) and very high (7.0 T and above) field strengths
for a variety of technical and diagnostic reasons. For instance, one advantage of lower field strengths is that image artifacts arising
from metallic implants such as surgical screws diminish as field strength decreases. This is particularly important for surgeons referring
their postoperative patients for diagnostic imaging studies.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Upright&#174; MRI operates at a mid-field strength
of 0.6 T and enjoys wide acceptance in the radiological community. The scanner is diagnostically versatile and equipped with a broad range
of clinically proven imaging protocols that produce images of exceptional quality, and a fully-featured, robust, and user-friendly software
interface.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>DIAGNOSTIC ADVANTAGES OF POSITIONAL MRI</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Apart from its attractiveness as an open, non-claustrophobic,
general-purpose MRI, the Upright&#174; MRI can deliver diagnostically relevant information that correlates with patient posture.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For example, a variety of injuries to and pathologies
of the spine, such as spondylolisthesis (&#8220;slipped disc&#8221;), may go undetected in the recumbent posture, but manifest themselves
when the patient is scanned in a normal, weight-bearing (&#8220;physiological&#8221;) position, such as seated, or seated in forward flexion,
extension, or standing.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Upright&#174; MRI has demonstrated its value for
patients suffering from scoliosis, who typically undergo regular x-ray exams over a course of years. A study by the National Cancer Institute
(2000) of 5,466 women with scoliosis reported a 70% increase in breast cancer resulting from 24.7 chest x-rays received on average over
the course of their treatment. Prior to the advent of the Upright&#174; MRI, the x-ray machine was the only imaging modality that could
evaluate the condition because the patient must be imaged standing. FONAR has developed an RF receiver coil and a 3D scanning protocol
that for the first time allows scoliosis patients to obtain diagnostic, multi-slice images of their spines while standing, without the
risks associated with radiation, and with the soft-tissue-contrast benefits of MRI over x-ray.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The utility of upright, weight-bearing MRI is not
limited to the spine. For example, approximately one in a thousand people (some 200,000 to 500,000 in the US) have a congenital condition
known as Chiari malformation, an abnormality of the brain at the junction with the spine at the base of the skull. In people with Chiari
malformation, the lowest lying structures of the brain, the tonsils of the cerebellum, descend into and become entrapped by the foramen
magnum, the circular bony opening at the base of the skull where the spinal cord exits. While most of these individuals are asymptomatic,
many suffer from more severe forms of the syndrome (e.g., type II or Arnold-Chiari syndrome), in which brain stem compression results
in severe neurological symptoms. The Chiari syndrome is also called Cerebellar Tonsillar Ectopia (CTE) because of the displacement (ectopia)
of the cerebellar tonsils. Classic symptoms of Chiari syndrome include the &#8220;drop attack,&#8221; in which the afflicted individual
unexpectedly experiences an explosive rush at the base of the brain that runs down the body to the extremities, causing the patient to
collapse in a temporary neuromuscular paralysis. These symptoms subside when the patient is lying down. Conventional lie-down MRI scanners
cannot make an adequate evaluation of the pathology since this pathology is most visible and the symptoms are most acute when the patient
is scanned in the upright, weight-bearing position (Brain Injury 2010, 24 (7-8) 988-994).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In the body, the Upright&#174; MRI is being utilized
in a variety of ways, for example to image pelvic organ prolapse in the standing posture, inguinal hernias, defecation in the sitting
posture (utilizing cine MRI), and the prostate in the sitting posture (utilizing a flat, multi-channel receiver coil on top of which the
patient simply sits).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline">PRODUCT MARKETING</span></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR&#8217;s principal marketing efforts in the medical
equipment segment have been focused on the Upright&#174; MRI, which we believe is a unique product. We expect to focus on the Upright&#174;
MRI going forward.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The principal markets for the Company&#8217;s scanners
are private diagnostic imaging centers and hospital outpatient imaging facilities.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We use internal personnel and independent manufacturer&#8217;s
representatives for domestic and foreign sales.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR&#8217;s marketing strategy has been designed
to reach key purchasing decision makers with information concerning the Upright&#174; MRI. This has led to many inquiries and some sales
of the Upright&#174; MRI scanner and is intended to increase FONAR&#8217;s presence in the medical equipment market. FONAR focuses primarily
on four target audiences: neurosurgeons, orthopedic surgeons, radiologists, and general physicians.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our advertising for FONAR and HMCA reinforces the
unique value provided by the FONAR Upright&#174; MRI scanner. We have increased internet awareness of our product by driving patient traffic
to the HMCA scanning centers we manage via the FONAR website as well as through websites for each HMCA location. These websites give prospective
customers of Upright&#174; MRI scanners a view of operating Upright&#174; MRI centers and highlight the benefits of using the Upright&#174;
MRI scanner. A complete list of the sites managed by HMCA can be found at HMCA&#8217;s website, www.hmca.com.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline">SERVICE AND UPGRADES FOR MRI SCANNERS</span></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Income is generated from the installed base in two
principal areas, namely, service and upgrades. Service and maintenance revenues from our external installed base were approximately $7.6
million in fiscal 2024 and $7.5 million in fiscal 2023.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We expect to maintain service revenues at present
levels or better, based on the demonstrated longevity of the Upright&#174; MRI scanner and continued customer satisfaction with the product.
Critical to this longevity and customer satisfaction is the stream of software improvements and hardware upgrades that FONAR has delivered
over the years to keep the scanners competitive with the latest technology in the marketplace. We also anticipate that our installed base
of scanners will generate income from upgrades in future fiscal years.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have engaged with a third-party software vendor,
AIRS Medical USA, Inc., to distribute their SwiftMR<sup>TM</sup> to our installed base of customers. We believe that the SwiftMR<sup>TM
</sup>product significantly improves the image quality and efficiency of both the Upright&#174; MRI and the outside manufacturer equipment
that is operated by our installed base. Revenues from the sale of SwiftMR<sup>TM </sup>are included in the service and maintenance revenues
described above.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have also formed a new subsidiary, Opus Diagnostic
Management, LLC, which is focused on providing service for MRI scanners sold by other manufacturers. We hope to control the cost of maintaining
and repairing the outside manufacturer equipment operated by HMCA, and eventually expand into providing maintenance and repair services
to third party operators of outside manufacturer equipment. Revenues from Opus are included in the service and maintenance revenues described
above.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline">RESEARCH AND DEVELOPMENT</span></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the fiscal year ended June 30, 2024, we incurred
expenditures of $1,735,949, none of which were capitalized, on research and development, as compared to $1,567,749, none of which were
capitalized, during the fiscal year ended June 30, 2023.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development activities have focused principally
on software improvements to the user interface of the MRI scanner. The Windows-based Sympulse&#8482; platform controls all of the functions
of the Upright&#174; scanner except those of the versatile, multi-position patient table. Separate, dedicated, motion-control software
is used to maneuver the Upright&#174; bed, and development of this software is ongoing as well.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">While software improvements to the user interface
are important in their own right, significant value is added to the MRI scanner by the modification of existing protocols for examining
various parts of the body, and the development of new protocols that utilize new underlying capabilities of the pulse sequence software.
Over time, FONAR users have become accustomed to the steady improvement in the recommended clinical protocols that accompany new software
releases. More significantly, in recent years we have seen increasing adoption of FONAR-recommended clinical protocols over those developed
on site. This is a testament to the superior image quality they produce in attractively short scan times.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The development of clinically practical scan protocols
and software depends on close contact between research and development scientists and engineers, and end users. That close contact is
facilitated in part by the relationship with HMCA and the scanning centers. In addition to that collaboration, R&amp;D staff have pursued
a variety of novel and Upright&#174; MRI-specific research projects. It is anticipated that these will ultimately lead to new applications
that are made available to existing customers as upgrade add-ons to their machines. For example, phase-contrast imaging techniques originally
developed for angiography have recently been applied to cerebro-spinal fluid (CSF) flow. Analysis of CSF flow in upright and recumbent
postures may prove to be of significant value in the evaluation of a variety of disorders and lead to a better understanding of human
physiology.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline">PATENTS AND LICENSES</span></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: red"><b><i>&#160;</i></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We currently have numerous patents in effect which
relate to the technology and components of our MRI scanners. We believe that these patents, and the know-how we have developed, are material
to our business.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our seminal patent, issued in the name of Dr. Damadian
and licensed to FONAR, was United States patent No. 3,789,832, Apparatus and Method for Detecting Cancer in Tissue, also referred to in
this report as the &#8220;1974 Patent&#8221;. The 1974 Patent was the first MRI patent issued by the United States Patent Office. The
development of our MRI scanners has been based upon the 1974 Patent, and we believe that the 1974 Patent was the first of its kind to
utilize MR to scan the human body and to detect cancer. The 1974 Patent was extended beyond its original 17-year term and expired in February,
1992. A number of FONAR&#8217;s existing patents specifically relate to protecting FONAR&#8217;s position in the Upright MRI market. The
patents further enhance Dr. Damadian&#8217;s pioneer patent that initiated the MRI industry and provided the original invention of MRI
scanning.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We maintain a robust patent portfolio that provides
us, under the aegis of United States patent law, &#8220;the exclusive right to make, use and sell&#8221; many of the scanner features
which FONAR pioneered and which are now incorporated in most MRI scanners sold by the industry. As of June 30, 2024, a total of 241 patents
have been issued to FONAR. In fiscal year 2024, we obtained two new patents. One such patent deals with a method of detecting coronary
and/or pulmonary deficiencies using Upright&#174; MRI technology. Another describes a method for quantification of Cerebro-Spinal Fluid
flor anywhere in the cerebro-spinal anatomy. Perhaps most significantly, shortly after the close of fiscal 2024 we obtained approval for
a patent related to the development of our next generation patient positioning system. We have several other matters pending before the
patent office as of this filing.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline">PRODUCT COMPETITION</span></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>MRI SCANNERS</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR faces competition for MRI product sales from
companies such as Siemens, General Electric, Hitachi, Philips, Canon, and United Imaging. Each of these is primarily focused on the high-field
(1.0 T and above) marketplace, though some have produced open MRI scanners for imaging in the recumbent posture. None of these firms has
so far introduced an open, upright MRI.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In recent years, other companies have introduced MRI
scanners aimed at the upright, weight-bearing MRI market. Their success in the US has so far been limited. We believe that the higher
field strength and larger dimensions of the FONAR Upright&#174; MRI magnet, together with the greater variety of patient positioning possibilities
afforded by the FONAR Upright&#174; MRI bed, give us a competitive advantage over the products introduced by these companies.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Most of our competitors have marketing and financial
resources more substantial than those available to us. They have in the past, and may in the future, heavily discount the sales price
of their scanners.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>OTHER IMAGING MODALITIES</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR&#8217;s MRI scanners also compete with other
diagnostic imaging systems, all of which are based upon the ability of some form of energetic wave to penetrate human tissue and be detected
by either photographic film or electronic devices for presentation on a display monitor. Three different kinds of energy waves &#8211;
x-ray, gamma, and sound &#8211; are used in medical imaging techniques that compete with MRI, the first two of which involve exposing
the patient to potentially harmful radiation. These other imaging modalities compete with MRI products on the basis of cost, space requirements,
and specific clinical applications.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">X-rays are the most common energy source used in imaging
the body and are employed in three imaging modalities: conventional x-ray systems, computerized tomography (CT), and digital radiography.
None of these enjoy the exquisite soft-tissue contrast of MRI, but they do offer high resolution imaging in certain applications and high
speed of image acquisition.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Nuclear medicine systems, which are based upon the
detection of photons (gamma radiation) generated by radioactive pharmaceuticals introduced into the body, are used to provide information
concerning soft tissue and internal body organs and particularly to examine organ function over time.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ultrasound systems emit, detect, and process high
frequency sound waves reflected from organ boundaries and tissue interfaces to generate images of soft tissue and internal body organs.
Although the images are substantially less detailed than those obtainable with x-rays or MRI, ultrasound is generally considered harmless
and therefore has found applications in imaging the pregnant uterus and the breast, to name two.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">X-ray (including CT), nuclear medicine, and ultrasound
compete with the MRI scanners by offering significantly lower price and space requirements. However, history has shown that the superior
tissue contrast characteristics of MRI have secured its place as the diagnostic imaging modality of choice for a wide variety of pathologies.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline">GOVERNMENT REGULATION</span></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>FDA Regulation</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Food and Drug Administration in accordance with
Title 21 of the Code of Federal Regulations regulates the manufacturing and marketing of FONAR&#8217;s MRI scanners. The regulations can
be classified as either pre-market or post-market. The pre-market requirements include obtaining marketing clearance, proper device labeling,
establishment registration and device listing. Once the products are on the market, FONAR must comply with post-market surveillance controls.
These requirements include the Quality Systems Regulation, or &#8220;QSR&#8221;, also known as Current Good Manufacturing Practices or
CGMPs, and Medical Device Reporting, also referred to as MDR regulations. The QSR is a quality assurance requirement that covers the design,
packaging, labeling and manufacturing of a medical device. The MDR regulation is an adverse event-reporting program.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Classes of Products</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the Medical Device Amendments of 1976 to the
Federal Food, Drug and Cosmetic Act, all medical devices are classified by the FDA into one of three classes. A Class I device is subject
only to general controls, such as labeling requirements and manufacturing practices; a Class II device must comply with certain performance
standards established by the FDA; and a Class III device must obtain pre-market approval from the FDA prior to commercial marketing. FONAR&#8217;s
products are Class II devices. Class II devices are subject to &#8220;General Controls&#8221;; General Controls include:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 18pt">1.</td><td style="text-align: justify">Establishment registration of companies which are required to register under 21 CFR Part 807.20, such
as manufacturers, distributors, re-packagers and re-labelers.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify; text-indent: -18pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 18pt">2.</td><td style="text-align: justify">Medical device listing with FDA of devices to be marketed.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify; text-indent: -18pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 18pt">3.</td><td style="text-align: justify">Manufacturing devices in accordance with the Current Good Manufacturing Practices Quality System Regulation
in 21 CFR Part 820.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify; text-indent: -18pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 18pt">4.</td><td style="text-align: justify">Labeling devices in accordance with labeling regulations in 21 CFR Part 801 or 809.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify; text-indent: -18pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 18pt">5.</td><td style="text-align: justify">Submission of a Premarket Notification, pursuant to 510(k), before marketing a device.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify; text-indent: -18pt">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition to complying with general controls, Class
II devices are also subject to special controls. Special controls may include special labeling requirements, guidance documents, mandatory
performance standards and post-market surveillance.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 3, 2000 FONAR received FDA clearance for
the Upright&#174; MRI under the name &#8220;Indomitable&#8221;.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Premarketing Submission</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i></i></p>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Each person who wants to market Class I, II and some
III devices intended for human use in the U.S. must submit a 510(k) to FDA at least 90 days before marketing unless the device is exempt
from 510(k) requirements. A 510(k) is a pre-marketing submission made to FDA to demonstrate that the device to be marketed is as safe
and effective, that is, substantially equivalent, SE, to a legally marketed device that is not subject to pre-market approval, PMA. Applicants
must compare their 510(k) device to one or more similar devices currently on the U.S. market and make and support their substantial equivalency
claims.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The FDA is committed to a 90-day clearance after submission
of a 510(k), provided the 510(k) is complete and there is no need to submit additional information or data.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The 510(k) is essentially a brief statement and description
of the product. As FONAR&#8217;s scanner products are Class II products, there are no pre-market data requirements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">An investigational device exemption, also referred
to as IDE, allows the investigational device to be used in a clinical study pending FDA clearance in order to collect safety and effectiveness
data required to support the Premarket Approval, also referred to as PMA, application or a Premarket Notification pursuant to 510(k),
submission to the FDA. Clinical studies are most often conducted to support a PMA.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the most part, however, we have not found it necessary
to utilize IDE&#8217;s. The standard 90 day clearance for our new MRI scanner products classified as Class II products makes the IDE unnecessary,
particularly in view of the time and effort involved in compiling the information necessary to support an IDE.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Quality System Regulation</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Quality Management System is applicable to the
design, manufacture, administration of installation and servicing of magnetic resonance imaging scanner systems. The FDA has authority
to conduct detailed inspections of manufacturing plants, to establish Good Manufacturing Practices which must be followed in the manufacture
of medical devices, to require periodic reporting of product defects and to prohibit the exportation of medical devices that do not comply
with the law.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Medical Device Reporting Regulation</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Manufacturers must report all MDR reportable events
to the FDA. Each manufacturer must review and evaluate all complaints to determine whether the complaint represents an event which is
required to be reported to FDA. Section 820.3(b) of the Quality Systems regulation defines a complaint as, &#8220;any written, electronic
or oral communication that alleges deficiencies related to the identity, quality, durability, reliability, safety, effectiveness, or performance
of a device after it is released for distribution.&#8221;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A report is required when a manufacturer becomes aware
of information that reasonably suggests that one of their marketed devices has or may have caused or contributed to a death, serious injury,
or has malfunctioned and that the device or a similar device marketed by the manufacturer would be likely to cause or contribute to a
death or serious injury if the malfunction were to recur.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Malfunctions are not reportable if they are not likely
to result in a death, serious injury or other significant adverse event experience.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A malfunction which is or can be corrected during
routine service or device maintenance still must be reported if the recurrence of the malfunction is likely to cause or contribute to
a death or serious injury if it were to recur.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have established and maintained written procedures
for implementation of the MDR regulation. These procedures include internal systems that:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">provide for timely and effective identification,
communication and evaluation of adverse events;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">provide a standardized review process and procedures
for determining whether or not an event is reportable; and</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">provide procedures to insure the timely transmission
of complete reports.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These procedures also include documentation and record
keeping requirements for information that was evaluated to determine if an event was reportable;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">all medical device reports and information submitted
to the FDA;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">any information that was evaluated during preparation
of annual certification reports; and</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">systems that ensure access to information that facilitates
timely follow up and inspection by the FDA.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>FDA Enforcement</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FDA may take the following actions to enforce the
MDR regulation:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FDA-Initiated or Voluntary Recalls</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Recalls are regulatory actions that remove a hazardous,
potentially hazardous, or a misbranded product from the marketplace. Recalls are also used to convey additional information to the user
concerning the safe use of the product. Either FDA or the manufacturer can initiate recalls.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There are three classifications, i.e., I, II, or III,
assigned by the Food and Drug Administration to a particular product recall to indicate the relative degree of health hazard presented
by the product being recalled.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Class I</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Is a situation in which there is a reasonable probability
that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Class II</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Is a situation in which use of, or exposure to, a
violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse
health consequences is remote.&#8195;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Class III</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Is a situation in which use of, or exposure to, a
violative product is not likely to cause adverse health consequences.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR has initiated six voluntary recalls which occurred
between 1987 and 2016. Five of the recalls were Class II and one was Class III. The recalls involved making minor corrections to the product
in the field. Frequently, corrections which are made at the site of the device are called field corrections as opposed to recalls.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Civil Money Penalties</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The FDA, after an appropriate hearing, may impose
civil money penalties for violations of the FD&amp;C Act that relate to medical devices. In determining the amount of a civil penalty,
FDA will take into account the nature, circumstances, extent, and gravity of the violations, the violator&#8217;s ability to pay, the
effect on the violator&#8217;s ability to continue to do business, and any history of prior violations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Warning Letters</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FDA issues written communications to a firm, indicating
that the firm may incur more severe sanctions if the violations described in the letter are not corrected. Warning letters are issued
to cause prompt correction of violations that pose a hazard to health or that involve economic deception. The FDA generally issues the
letters before pursuing more severe sanctions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Seizure</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A seizure is a civil court action against a specific
quantity of goods which enables the FDA to remove these goods from commercial channels. After seizure, no one may tamper with the goods
except by permission of the court. The court usually gives the owner or claimant of the seized merchandise approximately 30 days to decide
a course of action. If they take no action, the court will recommend disposal of the goods. If the owner decides to contest the government&#8217;s
charges, the court will schedule the case for trial. A third option allows the owner of the goods to request permission of the court to
bring the goods into compliance with the law. The owner of the goods is required to provide a bond or, security deposit, to assure that
they will perform the orders of the court, and the owner must pay for FDA supervision of any activities by the company to bring the goods
into compliance.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Citation</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A citation is a formal warning to a firm of intent
to prosecute the firm if violations of the FD&amp;C Act are not corrected. It provides the firm an opportunity to convince FDA not to
prosecute.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">Injunction</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">An injunction is a civil action filed by FDA against
an individual or company. Usually, FDA files an injunction to stop a company from continuing to manufacture, package or distribute products
that are in violation of the law.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prosecution</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prosecution is a criminal action filed by FDA against
a company or individual charging violation of the law for past practices.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Foreign and Export Regulation</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We obtain approvals as necessary in connection with
the sales of our products in foreign countries. In some cases, FDA approval has been sufficient for foreign sales as well. Our standard
practice has been to require either the distributor or the customer to obtain any such foreign approvals or licenses which may be required.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Legally marketed devices that comply with the requirements
of the Food Drug &amp; Cosmetic Act require a Certificate to Foreign Government issued by the FDA for export. Other devices that do not
meet the requirements of the FD&amp;C Act but comply with the laws of a foreign government require a Certificate of Exportability issued
by the FDA. All products which we sell have FDA clearance and would fall into the first category.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Foreign governments have differing requirements concerning
the import of medical devices into their respective jurisdictions. The European Union&#8217;s new medical device regulation, EU 2017/745
went into effect on May 25, 2021, and contains significant changes from the prior European regulatory scheme. We have applied to the Notified
Body, TUV-SUD, to perform a Conformity Assessment of our technical documentation and our Quality Management System.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Other countries require that their own testing laboratories
perform an evaluation of our devices. This requires that we must bring the foreign agency&#8217;s personnel to the USA to perform the
evaluation at our expense before exporting.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Some countries, including many in Latin America and
Africa, have very few regulatory requirements, beyond FDA clearance.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">To date, FONAR has been able to comply with all foreign
regulatory requirements applicable to its export sales.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline">PHYSICIAN AND DIAGNOSTIC SERVICES MANAGEMENT
BUSINESS</span></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Health Diagnostics Management, LLC (HDM) is owned
by Health Management Corporation of America (70.8%) and investors (29.2%). Health Management Corporation of America is owned 100% by FONAR
Corporation.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HDM operates under the assumed name &#8220;Health
Management Company of America&#8221; (&#8220;HMCA&#8221;).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The combined business (HDM and Health Management Corporation
of America) will be referred to as &#8220;HMCA&#8221; for all periods before and after July 1, 2015, unless otherwise indicated.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HMCA provides comprehensive non-medical management
services to diagnostic imaging facilities. These services include administrative services, billing and collection services, credentialing
services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and
management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance
with legal and regulatory matters, and the development and implementation of practice growth and marketing strategies.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2024, HMCA managed a total of 42 MRI
scanners of which twenty-five (25) scanners are located in New York and seventeen (17) scanners are located in Florida. For the 2024 fiscal
year, the revenues HMCA recognized from the MRI facilities has increased to $94.6 million from $90.4 million in fiscal 2023. Six of the
facilities in Florida are owned by HMCA subsidiaries, where the corporate practice of medicine is permitted.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We believe the utilization of FONAR Upright&#174; MRI
scanning systems, which are produced under the protection of our patents, accounts for the historically robust patient volume at the scanning
facilities. During fiscal 2024, a new stand-alone facility was opened in the Bronx, New York. During fiscal 2023, two scanners were installed
in Casselberry, Florida. During fiscal year 2025, we intend to install two additional high field magnets in Naples, Florida and Lynbrook,
New York, to supplement the existing FONAR Upright&#174; MRI scanning systems at those facilities.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>HMCA GROWTH STRATEGY</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HMCA&#8217;s growth strategy focuses on upgrading
and expanding the existing facilities it manages and expanding the number of facilities it either owns or manages for its clients, including
new sites. In connection with improving the performance of the facilities, we have added high field MRI scanners, extremity scanners and
x-ray machines to the Upright&#174; MRI scanners at certain of the sites where such additional diagnostic imaging modalities are expected
to produce the greatest return.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>PHYSICIAN AND DIAGNOSTIC MANAGEMENT SERVICES</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HMCA&#8217;s services to the facilities it manages
encompass substantially all of their business operations. Each facility is controlled, however, not by HMCA, but by the physician owner,
or in the case of the six Florida sites owned by HMCA subsidiaries, by the medical director. All medical services are performed by physicians
and other medical personnel under the physician-owner&#8217;s supervision. HMCA is the management company and performs services of a non-medical
nature. These services include:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">1. Offices and Equipment. HMCA identifies, negotiates
leases for and/or provides office space and equipment to its clients. This includes technologically sophisticated medical equipment. HMCA
also provides improvements to leaseholds, assistance in site selection and advice on improving, updating, expanding and adapting to new
technology.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">2. Personnel. HMCA staffs all the non-medical positions
of its clients with its own employees, eliminating the client&#8217;s need to interview, train and manage non-medical employees. HMCA
processes the necessary tax, insurance and other documentation relating to employees.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">3. Administrative. HMCA assists in the scheduling
of patient appointments, purchasing of office and medical supplies and equipment and handling of reporting, accounting, processing and
filing systems. It prepares and files the physician portions of complex applications to enable its clients to participate in managed care
programs and to qualify for insurance reimbursement. HMCA assists the clients to implement programs and procedures to ensure full and
timely regulatory compliance and appropriate cost reimbursement under no-fault insurance and Workers&#8217; Compensation guidelines, as
well as compliance with other applicable governmental requirements and regulations, including HIPAA and other privacy requirements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;4. Billing and Collections. HMCA is responsible
for the billing and collection of revenues from third-party payors including those governed by No-Fault and Workers&#8217; Compensation
statutes.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">5. Cost Saving Programs. Based on available volume
discounts, HMCA seeks to assist in obtaining favorable pricing for office and medical supplies, equipment, contrast agents, and other
inventory for its clients.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">6. Diagnostic Imaging and Ancillary Services. HMCA
can offer access to diagnostic imaging equipment through diagnostic imaging facilities it manages. The Company is expanding the ancillary
services offered in its network to include x-rays, and other MRI equipment such as high-field (1.5 or 3.0 Tesla magnet strength) MRI scanners
and extremity MRI scanners.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">7. Marketing Strategies. HMCA is responsible for developing
and proposing marketing plans for its clients.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">8. Expansion Plans. HMCA assists the clients in developing
expansion plans including the opening of new or replacement facilities where appropriate.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HMCA&#8217;s objective is to free physicians from
as many non-medical duties as is practicable, allowing physicians to spend less time on business and administrative matters and more time
practicing medicine.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The exceptions to this general model of operation
are six of the facilities located in Florida. These Florida facilities are owned by limited liability companies which, as our subsidiaries,
conduct their operations directly and bill and collect their fees from the patients and third-party payors.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The facilities enter into contracts with third-party
payors, including managed care companies. None of HMCA&#8217;s clients, however, participate in any capitated plans or other risk sharing
arrangements. Capitated plans are those HMO programs where the provider is paid a flat monthly fee per patient.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The management fees payable by the facilities to
HMCA are flat monthly fees. In fiscal 2024, the aggregate amount of active management fees was $4,960,733 per month. In fiscal 2023,
the aggregate amount of active management fees was $4,860,732 per month.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fees under the management agreements are subject to
adjustment by mutual agreement on an annual basis.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Timothy Damadian currently owns three HMCA-managed
MRI facilities in Florida. The facilities were owned by Dr. Damadian until his passing in August of 2022. The fees for these three sites
are flat monthly fees which are subject to adjustment by mutual agreement on an annual basis. In fiscal 2024 and fiscal 2023, the aggregate
monthly amount of management fees payable to HMCA by these sites was $995,825.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The six Florida facilities owned by HMCA
subsidiaries directly bill their patients or the patients&#8217; insurance carriers. Patient fees net of contractual allowances and
discounts were $33,815,796 in fiscal 2024 as compared to $29,793,993 in fiscal 2023.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>HMCA MARKETING</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HMCA&#8217;s marketing strategy is to expand the business
and improve the facilities which it manages. HMCA is seeking to increase the number of locations of those facilities where market conditions
are promising and to promote growth of our clients&#8217; and Florida subsidiaries&#8217; patient volume and revenue.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>DIAGNOSTIC IMAGING FACILITIES</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Diagnostic imaging facilities managed by HMCA provide
diagnostic imaging services to patients referred by physicians. The facilities are operated in a manner which eliminates the admission
and other administrative inconveniences of in-hospital diagnostic imaging services. Imaging services are performed in an outpatient setting
by trained medical technologists under the direction of physicians. Following diagnostic procedures, the images are reviewed by the interpreting
physicians who prepare reports of these tests and their findings. The vast majority of reports for the New York facilities are transcribed
by HMCA personnel and the remainder are outsourced to professional transcription services. Reports for the Florida facilities are outsourced
to professional transcription services.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HMCA develops marketing programs and educational programs
in an effort to establish and maintain referring physician relationships for our clients and Florida subsidiaries.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Managed care providers are an important factor in
the diagnostic imaging industry. To further its position, HMCA is seeking to expand the imaging modalities offered at its managed and
owned diagnostic imaging facilities. Four facilities in New York and eight facilities in Florida have two or more MRI scanners. One facility
in New York and two in Florida also perform X-rays.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>REIMBURSEMENT</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HMCA&#8217;s clients receive reimbursements for their
services through Medicare, Medicaid, managed care, private commercial insurance, third-party administrators, Workers&#8217; Compensation,
No-Fault and other insurance.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">Medicare</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Medicare program provides reimbursement for hospitalization,
physician, diagnostic and certain other services to eligible persons 65 years of age and over and certain other individuals. Providers
are paid by the federal government in accordance with regulations promulgated by the Department of Health and Human Services, HSS, and
generally accept the payment with nominal deductible and co-insurance amounts required to be paid by the service recipient, as payment
in full. Hospital inpatient services are reimbursed under a prospective payment system. Hospitals receive a specific prospective payment
for inpatient treatment services based upon the diagnosis of the patient.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under Medicare&#8217;s prospective payment system
for hospital outpatient services, or OPPS, a hospital is paid for outpatient services on a rate per service basis that varies according
to the ambulatory payment classification group, or APC, to which the service is assigned rather than on a hospital&#8217;s costs. Each
year the Centers for Medicare and Medicaid Services, or CMS, publishes new APC rates that are determined in accordance with the promulgated
methodology.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Services provided in non-hospital based freestanding
facilities are paid under the Medicare Physician Fee Schedule, or MPFS. All of HMCA&#8217;s clients are presently in this category. The
MPFS is updated on an annual basis and sometimes modified more frequently.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have experienced reimbursement reductions for radiology
services provided to Medicare beneficiaries. In calendar year 2024, changes to the MPFS included a reduction in the conversion factor.
For our fiscal year ended June 30, 2024, Medicare revenues represented approximately 2.7% of the revenues for HMCA&#8217;s clients and
subsidiaries as compared to 2.9% for the fiscal year ended June 30, 2023.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Medicaid</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Medicaid program is a jointly-funded federal and
state program providing coverage for low-income persons. In addition to federally-mandated basic services, the services offered and reimbursement
methods vary from state to state. In many states, Medicaid reimbursement is patterned after the Medicare program; however, an increasing
number of states have established or are establishing payment methodologies intended to provide healthcare services to Medicaid patients
through managed care arrangements. In fiscal 2024, approximately 0.06% of the revenues of HMCA&#8217;s clients were attributable to Medicaid,
as compared to 0.05% in fiscal 2023.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Managed Care and Private Insurance</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Health Maintenance Organizations, or HMO&#8217;s,
Preferred Provider Organizations, or PPOs, and other managed care organizations attempt to control the cost of healthcare services by
a variety of measures, including imposing lower payment rates, preauthorization requirements, limiting services and mandating less costly
treatment alternatives. Managed care contracting is competitive and reimbursement schedules in many cases can be at or below Medicare
reimbursement levels. Some managed care organizations have reduced or otherwise limited, and other managed care organizations may reduce
or otherwise limit, reimbursement in response to reductions in government reimbursement. These reductions could have an adverse impact
on our financial condition and results of operations. These reductions have been, and any future reductions may be, similar to the reimbursement
reductions previously proposed.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i></i></p>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><i><span style="text-decoration: underline">HMCA COMPETITION</span></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The physician and diagnostic management services field
is highly competitive. A number of large hospitals have acquired medical practices and this trend may continue. HMCA expects that more
competition will develop. Many competitors have greater financial and other resources than HMCA.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">With respect to the diagnostic imaging facilities
managed by HMCA, the outpatient diagnostic imaging industry is highly competitive. Competition focuses primarily on attracting physician
referrals at the local market level and increasing referrals through relationships with managed care organizations, as well as emphasizing
to potential referral sources the advantages of Upright&#174; MRI scanning. HMCA believes that principal competitors for the diagnostic
imaging centers are hospitals and independent or management company-owned imaging centers. Competitive factors include quality and timeliness
of test results, ability to develop and maintain relationships with managed care organizations and referring physicians, type and quality
of equipment, facility location, convenience of scheduling and availability of patient appointment times. HMCA believes that it will be
able to effectively meet the competition in the outpatient diagnostic imaging industry with the FONAR Upright&#174; MRI scanners and strategically
placed high field MRI scanners at its facilities.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline">GOVERNMENT REGULATION APPLICABLE TO HMCA</span></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>FEDERAL REGULATION</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The healthcare industry is highly regulated and changes
in laws and regulations can be significant. Changes in the law or new interpretation of existing laws can have a material effect on our
permissible activities, the relative costs associated with doing business and the amount of reimbursement by government and other third-party
payors.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Federal False Claims Act</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The federal False Claims Act and, in particular, the
False Claims Act&#8217;s &#8220;qui tam&#8221; or &#8220;whistleblower&#8221; provisions allow a private individual to bring actions in
the name of the government alleging that a defendant has made false claims for payment from federal funds. After the individual has initiated
the lawsuit the government must decide whether to intervene in the lawsuit and to become the primary prosecutor. If the government declines
to join the lawsuit, the individual may choose to pursue the case alone, although the government must be kept apprised of the progress
of the lawsuit, and may intervene later. Whether or not the federal government intervenes in the case, it will receive the majority of
any recovery.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">When an entity is determined to have violated the
federal False Claims Act, it must pay three times the actual damages sustained by the government, plus mandatory civil penalties for each
separate false claim and the government&#8217;s attorneys&#8217; fees. Liability arises when an entity knowingly submits, or causes someone
else to submit, a false claim for reimbursement to the federal government. The False Claims Act defines the term &#8220;knowingly&#8221;
broadly, though simple negligence will not give rise to liability under the False Claims Act. Examples of the other actions which may
lead to liability under the False Claims Act are set forth below:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify">Failure to comply with the many technical
billing requirements applicable to our Medicare and Medicaid business;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify">Failure to comply with the prohibition against
billing for services ordered or supervised by a physician who is excluded from any federal healthcare program, or the prohibition against
employing or contracting with any person or entity excluded from any federal healthcare program;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify">Failure to comply with the Medicare physician
supervision requirements for the services we provide, or the Medicare documentation requirements concerning physician supervision.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Fraud Enforcement and Recovery Act of 2009 expanded
the scope of the False Claims Act by, among other things, broadening protections for whistleblowers and creating liability for knowingly
retaining a government overpayment, acting in deliberate ignorance of a government overpayment or acting in reckless disregard of a government
overpayment. The healthcare reform bills in the form of the Patient Protection and Affordable Care Act, as amended by the Health Care
and Education Reconciliation Act of 2010 (collectively, &#8220;PPACA&#8221;) expanded on changes made by the 2009 Fraud Enforcement and
Recovery Act with regard to such &#8220;reverse false claims.&#8221; Under PPACA, the knowing failure to report and return an overpayment
within 60 days of identifying the overpayment or by the date a corresponding cost report is due, whichever is later, constitutes a violation
of the False Claims Act. HMCA and its clients have never been sued under the False Claims Act and believe they are in compliance with
the law.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stark Law</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the federal Self-Referral Law, also referred
to as the &#8220;Stark Law&#8221;, which is applicable to Medicare and Medicaid patients, and the self-referral laws of various States,
certain health practitioners, including physicians, chiropractors and podiatrists, are prohibited from referring their patients for the
provision of designated health services, including diagnostic imaging and physical therapy services, to any entity with which they or
their immediate family members have a financial relationship, unless the referral fits within one of the specific exceptions in the statutes
or regulations. The federal government has taken the position that a violation of the federal Stark Law is also a violation of the Federal
False Claims Act. Statutory exceptions under the Stark Law include, among others, direct physician services, in-office ancillary services
rendered within a group practice, space and equipment rental and services rendered to enrollees of certain prepaid health plans. Some
of these exceptions are also available under the State self-referral laws. HMCA believes that it and its clients are in compliance with
these laws.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Anti-kickback Regulation</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are subject to federal and state laws which govern
financial and other arrangements between healthcare providers. These include the federal anti-kickback statute which, among other things,
prohibits the knowing and willful solicitation, offer, payment or receipt of any remuneration, direct or indirect, in cash or in kind,
in return for or to induce the referral of patients for items or services covered by Medicare, Medicaid and certain other governmental
health programs. Under PPACA, knowledge of the anti-kickback statute or the specific intent to violate the law is not required. Violation
of the anti-kickback statute may result in civil or criminal penalties and exclusion from the Medicare, Medicaid and other federal healthcare
programs, and according to PPACA, now provides a basis for liability under the False Claims Act. In addition, it is possible that private
parties may file &#8220;qui tam&#8221; actions based on claims resulting from relationships that violate the anti-kickback statute, seeking
significant financial rewards. Many states have enacted similar statutes, which are not limited to items and services paid for under Medicare
or a federally funded healthcare program. Neither HMCA nor its clients engage in this practice.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In fiscal 2024, approximately 2.7% of the revenues
of HMCA&#8217;s clients were attributable to Medicare and 0.06% were attributable to Medicaid. In fiscal 2023, approximately 2.9% of the
revenues of HMCA&#8217;s clients were attributable to Medicare and 0.05% were attributable to Medicaid.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Health Insurance Portability and Accountability Act</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Congress enacted the Health Insurance Portability
and Accountability Act of 1996, or HIPAA, in part, to combat healthcare fraud and to protect the privacy and security of patients&#8217;
individually identifiable healthcare information. HIPAA, among other things, amends existing crimes and criminal penalties for Medicare
fraud and enacts new federal healthcare fraud crimes, including actions affecting non-governmental healthcare benefit programs by means
of false or fraudulent representations in connection with the delivery of healthcare services is subject to a fine or imprisonment, or
potentially both. In addition, HIPAA authorizes the imposition of civil money penalties against entities that employ or enter into contracts
with excluded Medicare or Medicaid program participants if such entities provide services to federal health program beneficiaries. A finding
of liability under HIPAA could have a material adverse effect on our business, financial condition and results of operations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Further, HIPAA requires healthcare providers and their
business associates to maintain the privacy and security of individually identifiable protected health information (&#8220;PHI&#8221;).
HIPAA imposes federal standards for electronic transactions, for the security of electronic health information and for protecting the
privacy of PHI. The Health Information Technology for Economic and Clinical Health Act of 2009 (&#8220;HITECH&#8221;), signed into law
on February 17, 2009, dramatically expanded, among other things, (1) the scope of HIPAA to now apply directly to &#8220;business associates,&#8221;
or independent contractors who receive or obtain PHI in connection with providing a service to a covered entity, (2) substantive security
and privacy obligations, including new federal security breach notification requirements to affected individuals, DHHS and prominent media
outlets, of certain breaches of unsecured PHI, (3) restrictions on marketing communications and a prohibition on covered entities or business
associates from receiving remuneration in exchange for PHI, and (4) the civil and criminal penalties that may be imposed for HIPAA violations,
increasing the annual cap in penalties from $25,000 to $1.5 million per occurrence. In 2013 additional legal requirements were adopted
to provide further protection for PHI.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, many states have enacted comparable privacy
and security statues or regulations that, in some cases, are most stringent than HIPAA requirements. In those cases it may be necessary
to modify our operations and procedures to comply with the more stringent state laws, which may entail significant and costly changes
for us. We believe that we are in compliance with such state laws and regulations. However, if we fail to comply with applicable state
laws and regulations, we could be subject to sanctions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We believe that we are in compliance with the current
HIPAA requirements, as amended by HITECH, together with other legislation and regulations, and comparable state laws, but we anticipate
that we may encounter certain costs associated with future compliance. Moreover, we cannot guarantee that enforcement agencies or courts
will not make interpretations of the HIPAA standards that are inconsistent with ours, or the interpretations of our contracted radiology
practices or their affiliated physicians. A finding of liability under the HIPAA standards may result in significant criminal and civil
penalties. Noncompliance also may result in exclusion from participation in government programs, including Medicare and Medicaid. These
actions could have a material adverse effect on our business, financial condition, and results of operations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Civil Money Penalty Law and Other Federal Statutes</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Civil Money Penalty, or CMP, law covers a variety
of practices. It provides a means of administrative enforcement of the anti-kickback statute, and prohibits false claims, claims for medically
unnecessary services, violations of Medicare participating provider or assignment agreements and other practices. The statute gives the
Office of Inspector General of the HHS the power to seek substantial civil fines, exclusion and other sanctions against providers or others
who violate the CMP prohibitions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, in 1996, Congress created a new federal
crime: healthcare fraud and false statements relating to healthcare matters. The healthcare fraud statute prohibits knowingly and willfully
executing a scheme to defraud any healthcare benefit program, including private payors. A violation of this statute is a felony and may
result in fines, imprisonment or exclusion from government sponsored programs such as the Medicare and Medicaid programs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certificates of Need</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Some states require hospitals and certain other healthcare
facilities and providers to obtain a certificate of need, or CON, or similar regulatory approval prior to establishing certain healthcare
operations or services, incurring certain capital projects and/or the acquisition of major medical equipment including MRI and PET/CT
systems. We are not operating in any such states.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">State Regulation</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition to the federal self-referral law and federal
Anti-kickback statute, many States, including those in which HMCA and its clients operate, have their own versions of self-referral and
anti-kickback laws. These laws are not limited in their applicability, as are the federal laws, to specific programs. HMCA believes that
it and its clients are in compliance with these laws.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Various States prohibit business corporations from
practicing medicine. Various States, including New York, also prohibit the sharing of professional fees or fee splitting. Consequently,
in New York HMCA leases space and equipment to clients and provides clients with a range of non-medical administrative and managerial
services for agreed upon fees. Under Florida law a business entity can bill patients and third-party payors directly if that entity is
properly licensed through AHCA. All of the nine facilities in Florida are licensed healthcare clinics through AHCA.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HMCA&#8217;s clients and subsidiaries generate revenue
from patients covered by no-fault insurance and workers&#8217; compensation programs. For the fiscal year ended June 30, 2024 approximately
58.0% of our clients&#8217; receipts were from patients covered by no-fault insurance and approximately 8.8% of our client&#8217;s receipts
were from patients covered by workers&#8217; compensation programs. For the fiscal year ended June 30, 2023, approximately 58.4% of HMCA&#8217;s
clients&#8217; receipts were from patients covered by no-fault insurance and approximately 8.6% of HMCA&#8217;s clients&#8217; receipts
were from patients covered by workers&#8217; compensation programs. The foregoing numbers do not include payments from third-party administrators.
In the event that changes in these laws alter the fee structures or methods of providing service, or impose additional or different requirements,
HMCA could be required to modify its business practices and services in ways that could be more costly to HMCA or in ways that decrease
the revenues which HMCA receives from its clients.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">Compliance Program</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We maintain a program to monitor compliance with federal
and state laws and regulations applicable to the healthcare entities. The compliance program includes the adoption of (i) Standards of
Conduct for our employees and affiliates and (ii) a process that specifies how employees, affiliates and others may report regulatory
or ethical concerns. We believe that our compliance program meets the relevant standards provided by the Office of Inspector General of
the Department of Health and Human Services.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">An important part of our compliance program consists
of conducting periodic audits of various aspects of our operations and that of the contracted radiology practices. We also assist our
clients with educational programs designed to familiarize them with the regulatory requirements and specific elements of our compliance
program.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HMCA believes that it and its clients are in compliance
with applicable Federal, State and local laws. HMCA does not believe that such laws will have any adverse material effect on its business.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline">EMPLOYEES</span></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR and HMCA had approximately 520 employees as
of September 12, 2024. This total number included employees engaged in production, customer support, research and development, information
technology, employees engaged in marketing and sales, billing and collection, legal and compliance matters, as well as transcriptionists,
Florida technologists, field service technicians and individuals in various administrative positions. A significant number of employees
were employed at the MRI facilities managed or owned by HMCA, primarily in administrative positions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_002"></span>ITEM 1A. RISK FACTORS</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">An investment in our securities is subject to various
risks, the most significant of which are summarized below.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 36pt">1.</td><td style="text-align: justify">Reduced Reimbursement Rates. Most of our revenues are derived from our scanning center business conducted
by HMCA. Our scanning center clients and the Florida facilities owned by HMCA are experiencing lower reimbursement rates from Medicare,
other government programs and private insurance companies. To the extent possible, we counter these reductions by increasing scanning
volume and controlling operating expenses. Inflation in the cost of both materials and labor have limited our ability to control our costs,
negatively impacting our ability to maintain profitability in this business segment.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 36pt">2.</td><td style="text-align: justify">Inflation and Increasing Interest Rates. Inflation has drastically increased our costs for both materials
and labor. The Federal Reserve has increased interest rates substantially in an attempt to control inflation, which in turn has increased
the cost of capital. Diagnostic imaging facilities require significant amounts of capital to operate, particularly in the context of opening
new diagnostic imaging centers. These increased costs make it more difficult to achieve organic growth and extend the time that a new
center takes to achieve profitability. Continued costs increases, coupled with reduced reimbursement rates, may threaten the profitability
of our current operations and cause the cost of expansion to become prohibitively high.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt"></p>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 36pt">3.</td><td style="text-align: justify">Cybersecurity threats. The healthcare industry has increasingly become a target for threat actors. Our
organization relies on information technology systems and computer networks to operate. Our partners, vendors and business associates
are equally reliant on their own computer systems to provide the services that we depend on to perform core functions such as scheduling
and billing. Data incidents in the form of breaches, ransomware attacks, denial-of-service attacks, and a variety of other hazards could
materially disrupt our operations, or the operations of our partners. In addition, the costs to respond to such incidents related to rebuilding
internal systems, restoring data, responding to regulatory investigations and/or litigation could be significant. Our cybersecurity liability
insurance may be inadequate to cover these losses. The cost of maintaining and improving our security technologies to protect ourselves
from these threats is increasing. Risk outside of our control, such as cybersecurity attacks to our partners, vendors and business associates
could threaten our ability to operate in the short term and reduce operating margins.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 36pt">4.</td><td style="text-align: justify">Dependence on Referrals. HMCA derives substantially all of its revenue, directly or indirectly, from fees
charged for the diagnostic imaging services performed at the facilities. We depend on referrals of patients from unaffiliated physicians
and other third parties to the facilities we manage or own for the services we perform. If these physicians and other third parties were
to reduce the number of patients they refer or discontinue referring patients, scan volumes could decrease, which would reduce our net
revenue and operating margins.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 36pt">5.</td><td style="text-align: justify">Pressure to Control Healthcare Costs. One of the principal objectives of health maintenance organizations
and preferred provider organizations is to control the cost of healthcare services. Healthcare providers participating in managed care
plans may be required to refer diagnostic imaging tests to certain providers depending on the plan in which a covered patient is enrolled.
In addition, managed care contracting has become very competitive. The expansion of health maintenance organizations, preferred provider
organizations and other managed care organizations in New York or Florida could have a negative impact on the utilization and pricing
of services performed at the facilities HMCA manages or owns to the extent these organizations exert control over patients&#8217; access
to diagnostic imaging services, selections of the provider of such services and reimbursement rates for those services.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 36pt">6.</td><td style="text-align: justify">Scanning Facility Competition. The market for diagnostic imaging services is highly competitive. The facilities
we manage or own compete for patients on the basis of reputation, location and the quality of diagnostic imaging services. Groups of radiologists,
established hospitals, clinics and other independent organizations that own and operate imaging equipment are the principal competitors.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt"></p>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 36pt">7.</td><td style="text-align: justify">Eligibility Changes to Insurance Programs. Due to potential decreased availability of healthcare through
private employers, the number of patients who are uninsured or participate in governmental programs may increase. Healthcare reform legislation
will increase the participation of individuals in the Medicaid program in states that elect to participate in the expanded Medicaid coverage.
A shift in payor mix from managed care and other private payors to government payors or an increase in the number of uninsured patients
may result in a reduction in the rates of reimbursement or an increase in uncollectible receivables or uncompensated care, with a corresponding
decrease in net revenue. Policies now being offered under various insurance plans are expected to reduce demand for MRI scans as they
become less affordable. Changes in the eligibility requirements for governmental programs such as the Medicaid program and state decisions
on whether to participate in the expansion of such programs also could increase the number of patients who participate in such programs
and the number of uninsured patients. Even for those patients who remain in private insurance plans, changes to those plans could increase
patient financial responsibility, resulting in a greater risk of uncollectible receivables. These factors and events could have a material
adverse effect on our business, financial condition, and results of operations.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 36pt">8.</td><td style="text-align: justify">Federal and state privacy and information security laws. We must comply with numerous federal and state
laws and regulations governing the collection, dissemination, access, use, security and privacy of PHI, including HIPAA and its implementing
privacy and security regulations, as amended by the federal HITECH Act. If we fail to comply with applicable privacy and security laws,
regulations and standards, properly maintain the integrity of our data, protect our proprietary rights to our systems, or defend against
cybersecurity attacks, our business, reputation, results of operations, financial position and cash flows could be materially and adversely
affected.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 36pt">9.</td><td style="text-align: justify">Current and future changes in Florida Insurance Law. On March 24, 2023, Florida Governor Ron DeSantis
signed into law House Bill 837. Dubbed the Tort Reform Act. The bill makes sweeping changes to Florida&#8217;s negligence laws. These
changes will negatively impact our Florida diagnostic imaging facilities (both those we own and those we manage) with more unpaid bills,
and lower reimbursement rates. The full extent of those reductions are unclear at this time. Florida legislators continue to propose significant
changes to the current structure of Florida&#8217;s auto insurance industry, which may impact our future operations in Florida.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 36pt">10.</td><td style="text-align: justify">Demand for MRI Scanners. The reduced margins have a negative effect on our sales of MRI scanners. With
lower revenue projections, prospective customers demand lower prices for scanners. Although the reduced reimbursements may not affect
foreign demand, a lower number of sales in the aggregate could reduce economies of scale and consequently, profit margins.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 36pt">11.</td><td style="text-align: justify">Manufacturing Competition. Many if not most of our competing scanner manufacturers have significantly
greater financial resources, production capacity, and other resources than we do. Such competitors would include General Electric, Siemens,
Hitachi and Phillips. Although FONAR is the only company which can manufacture and sell the unique Stand-Up&#174; (Upright&#174;) MRI scanner,
potential customers must be convinced that the purchase of a FONAR scanner is their best choice. We believe that with time, that objective
will be reached, particularly with customers scanning patients having neck, back, knee and various orthopedic issues who would benefit
from being scanned in weight-bearing positions.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt"></p>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 36pt">12.</td><td style="text-align: justify">Other changes in Domestic and Worldwide Economic Conditions. We are subject to risk arising from adverse
changes in general domestic and global economic conditions, including recession or economic slowdown and disruption of credit markets.
Turbulence and uncertainty in the United States and international markets and economies may adversely affect our liquidity, financial
condition, revenues, profitability and business operations generally.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_003"></span>ITEM 1B. UNRESOLVED STAFF COMMENTS</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">None.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_004"></span>ITEM 1C. CYBERSECURITY </b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Risk Management and Strategy</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our Cybersecurity Risk Management Strategy includes
a myriad of tools and resources that are designed to ensure the integrity of our information systems. We place a particular emphasis on
protecting the privacy of our patient data pursuant to the HIPAA Security Rule. Our cybersecurity risk management process is integrated
with our larger risk management system and is considered a core function of our overall risk management strategy.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our strategy is based around the identification, mitigation,
avoidance and response to material cybersecurity risks. We employ physical and electronic safeguards to control access to our systems.
We employ additional electronic safeguards to control/limit access to the data contained in those systems. We review and re-assess these
processes on a rolling basis with the assistance of both internal staff and outside vendors, including assessors, consultants, auditors,
and other third parties. Some steps we take include the use of standard security protocols such as password maintenance, multi-factor
identification, and penetration testing. We take other steps as may be situationally appropriate for the specific risk presented.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We require all of our employees to receive cybersecurity
training as part of their initial onboarding process, and employees are required to complete additional training throughout the year.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We evaluate all of our vendors and third-party partners
for material cybersecurity risks and take steps to mitigate risk through insurance and contractual risk transfer provisions when appropriate.
Our Information Technology department works collaboratively with our third party vendors to coordinate a mutually beneficial approach
to cybersecurity in the specific context in which risk is presented. These collaborations sometimes take place on a rolling basis, and
sometimes take place on a semi-annual or annual basis.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">At the present time, risks from cybersecurity threats have not materially
affected the Company. However, cybersecurity threats have the potential to significantly impair our operations and the operations of the
various third parties upon whom we rely.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt"></p>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Governance</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The audit committee of our Board of Directors provides
oversight of cybersecurity risks. It receives regular reports from management, including our General Counsel, on various cybersecurity
matters during each board meeting. Such reports include information on current cybersecurity risks facing the organization, cybersecurity
incidents involving our partners and/or other participants in our industry, and routine updates on the status of our internal cybersecurity
risk management plan.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our General Counsel oversees and manages our cybersecurity
program. Our General Counsel acts as the coordinator of our cybersecurity team, which includes representatives from our Information Technology
department and Compliance department. In addition, he regularly interacts with various department heads from both our New York and Florida
regions regarding the prevention, detection, mitigation and remediation of cybersecurity risks. Our General Counsel has an educational
background in computer science and has relevant work experience in cybersecurity insurance and risk management, in addition to his relevant
legal experience.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_005"></span>ITEM 2. PROPERTIES</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR and HMCA currently lease approximately 78,000
square feet of office and plant space at its principal offices in Melville, New York. The term of the lease runs through November, 2033.
Management believes that the premises will be adequate for its current needs. HMCA also maintains office space for the Facilities owned
by its subsidiaries in Florida and for its clients at the clients&#8217; sites in New York and Florida under leases having various terms.
HMCA owns the building for the client&#8217;s premises in Tallahassee, Florida. The Company received approval from the Suffolk County
Industrial Development Agency on February 29, 2016 of a 50% property tax abatement, valued at $440,000, over a 10 year period commencing
January, 2017.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_006"></span>ITEM 3. LEGAL PROCEEDINGS.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">There are no material legal proceedings threatened or pending against the
Company.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_007"></span>ITEM 4. MINE SAFETY DISCLOSURES.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b><br/>
Not Applicable</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>PART II</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_008"></span>ITEM 5. MARKET FOR REGISTRANT&#8217;S COMMON EQUITY AND RELATED STOCKHOLDER
MATTERS</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our Common Stock is traded on NASDAQ Capital Markets
under the symbol FONR.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 12, 2024, we had approximately 978 stockholders
of record of our Common Stock, 12 stockholders of record of our Class B Common Stock, 3 stockholders of record of our Class C Common Stock
and 1,008 stockholders of record of our Class A Non-voting Preferred Stock<span style="color: red">.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: red"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: red"></p>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: red">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At the present time, the only class of our securities
for which there is a market is the Common Stock.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We currently have a policy of retaining earnings to
finance the development and expansion of our business. We expect to continue this policy for the foreseeable future.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Performance Graph</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The following graph compares
the Company&#8217;s cumulative total stockholder return on its Common Stock against industry and broad-market indexes which have been
compiled by the Nasdaq Global Index Group. The periods commence on June 28, 2020 for five years and end on June 30, 2024.. The graph assumes
$100 is invested in FONAR Common Stock (NASDAQ: FONR), the Nasdaq Composite Total Return (Nasdaq Composite), Nasdaq Health Care Management
Services (Nasdaq Health), and Nasdaq Medical Equipment (Nasdaq Equipment). The comparisons in the graph below are based on historical
data and are not intended to forecast the possible future performance of the common stock.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">Date</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2020</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2021</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 35%; text-align: left; text-indent: -11pt">FONR Common Stock</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">100</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">83</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">71</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">80</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">75</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Nasdaq Composite</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">100</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">145</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">111</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">140</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">182</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Health Care Management Services</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">100</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">139</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">169</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">162</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">177</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Medical Equipment</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">100</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">145</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">121</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">137</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">143</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;<img src="fonar-performance_graph.jpg" alt="" style="height: 289px; width: 670px"/></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Share Repurchase Program</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">In
September 2022, our Board of Directors authorized a program to repurchase up to $9 million of our common stock. Under this program, we
may purchase stock in the open market or through privately negotiated transactions in accordance with applicable securities laws, including
pursuant to pre-arranged stock trading plans. The timing and actual amount of the stock repurchases will depend on several factors including
price, capital availability, regulatory requirements, and other market conditions. We are not obligated to repurchase a specific number
of shares under this program and it may be modified, suspended or discontinued at any time. </span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The following table summarizes
the number of shares repurchased during the three months ended June 30, 2024:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="3" style="text-align: center">Fiscal Month</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">Total Number of Shares Purchased</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">Average Price Paid per Share</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">Total Number of Shares Purchased as Part of Publicly Announced Programs</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">Maximum Dollar Value that May Still Be Purchased Under the Program (In Thousands)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; width: 30%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">April 1, 2024 &#8211; April 30, 2024</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">5,355</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">May 1, 2024 &#8211; May 31, 2024</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,851</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">15.02</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,851</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,087</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">June 1, 2024 &#8211; June 30, 2024</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,847</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">15.45</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,847</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,734</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><b>Total</b></span></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,698</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">15.26</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,698</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_009"></span>ITEM 6. [Reserved]</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Not applicable.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_010"></span>ITEM 7. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATION.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>INTRODUCTION.</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR was formed in 1978 to engage in the business
of designing, manufacturing and selling MRI scanners. HMCA, a subsidiary of FONAR, provides management services to diagnostic imaging
facilities.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR&#8217;s principal MRI product is its Upright&#174;
MRI (also called Stand-Up&#174; MRI) scanner. The Upright&#174; MRI allows patients to be scanned for the first time under weight-bearing
conditions. The Stand-Up&#174; MRI is the only MRI capable of producing images in the weight-bearing state.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At 0.6 Tesla field strength, the Upright&#174; MRI
is among the highest field open MRI scanners in the industry, offering non-claustrophobic MRI together with high-field image quality.
FONAR&#8217;s open MRI scanners were the first high field strength open MRI scanners in the industry.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HMCA generates revenues from providing comprehensive
management services, including development, administration, accounting, billing and collection services, together with office space, medical
equipment, supplies and non-medical personnel to its clients. Revenues are in the form of fees which are earned under contracts with HMCA&#8217;s
clients except for its six Florida subsidiaries which engage in the practice of medicine, and bill and collect fees from patients, insurers
and other third-party payors directly.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>CRITICAL ACCOUNTING ESTIMATES </i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our discussion and analysis of financial condition
and results of operations are based on our consolidated financial statements that were prepared in accordance with U.S. generally accepted
accounting principles, or GAAP. Management makes estimates and assumptions when preparing financial statements. These estimates and assumptions
affect various matters, including:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our reported amounts of assets and liabilities in
our consolidated balance sheets at the dates of the financial statements;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our disclosure of contingent assets and liabilities
at the dates of the financial statements; and</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our reported amounts of net revenue and expenses in
our consolidated statements of operations during the reporting periods</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These estimates involve judgments with respect to
numerous factors that are difficult to predict and are beyond management&#8217;s control. As a result, actual amounts could differ materially
from these estimates.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We believe our critical accounting estimates in the
following areas affect our more significant judgments and estimates used in the preparation of our consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">Revenue Recognition and Receivable
Allowances</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s receivables from the related and
non-related professional corporations, as well as those receivables due under fee-for-service contracts at the Florida subsidiaries, are
largely dependent on collection of fees from various third-party payers. As described in greater detail in Note 2, we recognize revenue
in accordance with ASC 606, as the services are provided.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Medical
receivables are due under fee-for-service contracts with third-party payors, such as hospitals, government sponsored healthcare programs,
patients legal counsel and directly from patients. The carrying amount of the medical receivable is reduced by contractual allowances
and discounts based on the historical experience with each payor class on a per location basis.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Management
fee receivable is related to the management fees outstanding from the related and no-related professional corporations (&#8220;PCs&#8221;)
under management agreements. The Company establishes a current expected credit loss (&#8220;CECL&#8221;) to address the risk that a portion
of the contractually obligated management fees receivable from the PCs may not be paid. The PCs may be limited in their ability to pay
the full management fees receivable if they do not collect sufficient expected fees from third-party payers and patients. The Company&#8217;s
management fees are collateralized, individually and collectively, by the assets of the PCs. The CECL is determined based upon the difference
between the management fee receivable and the current amount of outstanding fees estimated to be collected by the PCs. The Company&#8217;s
considerations into the estimate of the PCs fee collection included historical loss rates to pools of receivables with similar risks
and characteristics, current and forward looking economic conditions, and the financial condition of each PC.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">We
recognize revenue and related costs of revenue from sales contracts for our MRI scanners and major upgrades, under the percentage-of-completion
method. Under this method, we recognize revenue and related costs of revenue, as each sub-assembly is completed. Amounts received in
advance of our commencement of production are recorded as customer advances.</span></p>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Income
Taxes and Related Tax Asset Valuation Allowances</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">We
qualitatively and quantitatively evaluate the realizability (including both positive and negative evidence) of the net deferred tax assets
and assess the valuation allowance periodically. Our evaluation considers the financial condition of the Company and both the business
conditions and regulatory environment of the industry. If future taxable income or other factors are not consistent with our expectations,
an adjustment to our allowance for net deferred tax assets may be required. For net deferred tax assets we consider estimates of future
taxable income, including tax planning strategies, in determining whether our net deferred tax assets are more likely than not to be
realized. Our ability to project future taxable income may be significantly affected by our ability to determine the impact of regulatory
changes which could adversely affect our future profits. As a result, the benefits of our net operating loss carry forwards could expire
before they are utilized.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">At
June 30, 2023, the net deferred tax asset was valued at $10,041,960<span style="color: red">. </span>At June 30, 2024, the net deferred
tax asset was valued at $7,223,255.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: red"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">Long-Lived and Intangible Assets</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We depreciate our long-lived assets over their estimated
economic useful lives, with the exception of leasehold improvements. With respect to leasehold improvements, we use the shorter of the
assets useful lives or the lease term of the facility for which these assets are associated.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We amortize our intangible assets, including patents,
and capitalized software development costs, over the shorter of the contractual/legal life or the estimated economic life. Our amortization
life for patents and capitalized software development costs is 15 to 17 years and 5 years, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Goodwill is recorded as a result of business combinations.
Management evaluates goodwill, at a minimum, on an annual basis and whenever events and changes in circumstances suggest that the carrying
amount may not be recoverable. Impairment of goodwill is tested by comparing the reporting unit&#8217;s carrying amount, including goodwill,
to the fair value of the reporting unit. The fair value of a reporting unit is estimated using a combination of the income or discounted
cash flows approach and the market approach, which uses comparable market data. If the carrying amount of the reporting unit exceeds its
fair value, goodwill is considered impaired and a second step is performed to measure the amount of impairment loss, if any. Based on
our test for goodwill impairment, we noted no impairment related to goodwill. However, if estimates or the related assumptions change
in the future, we may be required to record impairment charges to reduce the carrying amount of goodwill.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We periodically assess the recoverability of long-lived
assets, including property and equipment, intangibles and management agreements, when there are indications of potential impairment, based
on estimates of undiscounted future cash flows. The amount of impairment is calculated by comparing anticipated discounted future cash
flows with the carrying value of the related asset. In performing this analysis, management considers such factors as current results,
trends, and future prospects, in addition to other economic factors.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i></i></p>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><i>RESULTS OF OPERATIONS. FISCAL 2024 COMPARED TO
FISCAL 2023</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In fiscal 2024, we recognized net income of $14.1
million on revenues of $102.9 million, as compared to net income of $12.1 million on revenues of $98.6 million for fiscal 2023. This represents
an increase in revenues of 4.3%. Total costs and expenses increased by 3.0%. Our consolidated operating results increased by 11.8% to
an operating income of $16.5 million for fiscal 2024 as compared to operating income of $14.8 million for fiscal 2023.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Discussion of Operating Results of Medical Equipment
Segment</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fiscal 2024 Compared to Fiscal 2023</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: red">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenues attributable to our medical equipment segment
remained constant at $8.3 million in fiscal 2024 and in fiscal 2023, with product sales revenues increasing by 0.8% from $732,000 in fiscal
2023 to $738,000 in fiscal 2024. Service revenue increased by 0.8% from $7.5 million in fiscal 2023 to $7.6 million in fiscal 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Lower reimbursement rates have reduced the demand
for our MRI products, resulting in lower sales volumes. As a result of fewer sales, service revenues have decreased since as older scanners
are taken out of service, there are fewer new scanners available to sign service contracts.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The operating loss for the medical equipment segment
increased from an operating loss of $5.9 million in fiscal 2023 to an operating loss of $7.0 million in fiscal 2024. The losses are attributable
most significantly to the fact that costs increased by a greater amount than revenues.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The increase in costs was the result of several factors.
We made a significant investment into developing the capacity to service MRI equipment manufactured by third manufacturers through our
Opus Diagnostic Services, LLC subsidiary. We made additional investments into sales and marketing of image enhancement software SwiftMR<sup>TM</sup>
pursuant to our distribution agreement with AIRS Medical USA, Inc. We hope these ventures will develop into a viable source of new revenue
in the future. We also discontinued the prosecution of two patents that ultimately did not issue, after substantial investment into their
pursuit.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development expenses increased to $1.7
million in fiscal 2024 from $1.6 million in fiscal 2023. Our expenses for fiscal 2024 represented continued research and development of
various upgrades for the Upright&#174; MRI scanner.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>Discussion of Operating Results of Physician and Diagnostic Services
Management Segment</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Fiscal 2024 Compared to Fiscal 2023</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenues attributable to the Company&#8217;s
physician and diagnostic services management segment, HMCA, increased to $94.6 million in fiscal 2024 as compared to $90.4 million
in fiscal 2023. The increase in revenues was due to an increase of $4.0 million of patient fees (net of contractual allowances and
discounts) from patient and third-party payers recognized by six of the facilities in Florida. Management
and other fees increased by $0.1 million.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cost of revenues as a percentage of the related revenues
for our physician and diagnostic services management segment increased from $49.0 million or 54.1% of related revenues for the year ended
June 30, 2023 to $53.0 million, or 56.0% of related revenues for the year ended June 30, 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Operating results of this segment increased from operating
income of $20.7 million in fiscal 2023 to operating income of $23.5 million in fiscal 2024. The increase is due mainly to increased patient
fee revenue due to higher scan volumes. We believe that our efforts to expand and improve the operation of our physician and diagnostic
services management segment are directly responsible for the profitability of this segment and our company as a whole.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the fiscal year ended June 30, 2024, 11.6% of
total revenues were derived from contracts with facilities that are currently owned by Timothy Damadian, the Chief Executive Officer of
FONAR, and were previously owned and operated by Dr. Raymond V. Damadian until his passing. 12.1% of total revenues were derived from
these contracts for the 2023 fiscal year. The agreements with these MRI facilities are for one-year terms which renew automatically on
an annual basis, unless terminated. The fees for these sites, which are located in Florida, are flat monthly fees.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Discussion of Certain Consolidated Results of Operations</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fiscal 2024 Compared to Fiscal 2023</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Interest and investment income increased in 2024 compared
to 2023. We recognized interest income of $2.1 million in 2024 as compared to $1.2 million in fiscal 2023, representing an increase of
74.0%. This is due to the increase in the prime interest rate and the Company placing cash in interest bearing accounts and purchasing
short term treasury bills.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Interest expense of $76,997 was recognized in fiscal
2024, as compared to interest expense of $50,131 in fiscal 2023.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The 29.2% non-controlling interest allocations of
$3,530,000 and $2,751,000 for fiscal 2024 and fiscal 2023, respectively, have been calculated by Income from operations, and adding depreciation
and amortization net of miscellaneous losses and other income from the Physician and Diagnostic Service Management segment (See Note 16).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">While revenue increased by 4.3% selling, general and
administrative expenses decreased by 8.6% to $26.9 million in fiscal 2024 from $29.4 million in fiscal 2023. This difference in selling,
general and administrative expenses was due to less reserves on management fees and other receivables due to increased scan volume as
compared to fiscal 2023.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue from service and repair fees increased from
$7.5 million in fiscal 2023 to $7.6 million in fiscal 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Continuing our tradition as the originator of MRI,
we remain committed to maintaining our position as the leading innovator of the industry through investing in research and development.
In fiscal 2024 we continued our investment in the development of various upgrades for the UPRIGHT&#174; MRI, with an investment of $1,735,949
in research and development, none of which was capitalized, as compared to $1,567,749, none of which was capitalized, in fiscal 2023.
The research and development expenditures were approximately 20.8% of revenues attributable to our medical equipment segment and 1.7%
of total revenues in 2024, and 18.9% of medical equipment segment revenues and 1.5% of total revenues in fiscal 2023. This represented
a 10.7% increase in research and development expenditures in fiscal 2024 as compared to fiscal 2023.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the physician and diagnostic services management
segment, HMCA, revenues increased to $94.6 million in fiscal 2024 as compared to $90.4 million in fiscal 2023. This is primarily attributable
to an increase in patient scans resulting from our marketing efforts.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the fiscal year 2024 the Company recorded an
income tax expense of $5.2 million compared with an income tax expense of $3.6 million for 2023. The income tax benefits are
attributable to the expected tax benefits associated with the projected realization and utilization of our net state operating
losses in future periods. The Company has recorded a deferred tax asset of $7.2 million as of June 30, 2024, primarily relating to
the tax benefits from the net state operating loss carry forwards, allowance for credit losses and tax credits available
to offset future taxable income. The utilization of these tax benefits is dependent on the Company generating future taxable income
and other factors. A partial valuation allowance will be maintained until evidence exists to support that it is no longer needed,
(principally related to research and development credits and unrealizable state operating losses). Although the Company is expecting
to generate taxable income in future periods, we cannot accurately measure the full impact of the adoption of healthcare
regulations, including the impact of continuing changes in MRI scanning reimbursement rates, which could materially impact
operations. A partial valuation allowance will be maintained until evidence exists to support that it is no longer needed. As of
June 30, 2024, the valuation allowance was $193,000.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have been taking steps to improve HMCA revenues
by our marketing efforts, which focus on the unique capability of our Upright&#174; MRI scanners to scan patients in different positions.
We have also been increasing the number of health insurance plans in which our clients participate. Operationally, we have invested in
technology that we believe will reduce scan times and improve operational efficiency in the centers that we manage.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our management fees are dependent on collection by
our clients of fees from reimbursements from Medicare, Medicaid, private insurance, no fault and workers&#8217; compensation carriers,
self&#8211;pay and other third-party payers. The health care industry is experiencing the effects of the federal and state governments&#8217;
trend toward cost containment, as governments and other third-party payers seek to impose lower reimbursement and utilization rates and
negotiate reduced payment schedules with providers. The cost-containment measures, consolidated with the increasing influence of managed-care
payers and competition for patients, have resulted in reduced rates of reimbursement for services provided by our clients from time to
time. Our future revenues and results of operations may be adversely impacted by future reductions in reimbursement rates.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain third-party payers have proposed and implemented
changes in the methods and rates of reimbursement that have had the effect of substantially decreasing reimbursement for diagnostic imaging
services that HMCA&#8217;s clients provide. To the extent reimbursement from third-party payers is reduced, it will likely have an adverse
impact on the rates they pay us, as they would need to reduce the management fees they pay HMCA to offset such decreased reimbursement
rates. Furthermore, many commercial health care insurance arrangements are changing, so that individuals bear greater financial responsibility
through high deductible plans, co-insurance and higher co-payments, which may result in patients delaying or foregoing medical procedures.
More frequently, however, patients are scanned and we experience difficulty in collecting deductibles and co-payments. We expect recent
changes to the Florida insurance laws to result in less patients being reimbursed through no-fault auto insurance, resulting in both lower
reimbursement rates and a higher rate of uncollectible billings. Further, we believe that the passage of New York Public Health Law Article
49A will have a significant negative impact on our collection rates. We expect that any further changes to the rates or methods of reimbursement
for services, which reduce the reimbursement per scan of our clients may partially offset the increases in scan volume we are working
to achieve for our clients, and indirectly will result in a decline in our revenues.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, the use of radiology benefit managers,
or RBM&#8217;s has increased in recent years. It is common practice for health insurance carriers to contract with RBMs to manage utilization
of diagnostic imaging procedures for their insureds. In many cases, this leads to lower utilization of imaging procedures based on a determination
of medical necessity. The efficacy of RBMs is still a highly controversial topic. We cannot predict whether the use of RBMs will negatively
impact our business, but it is possible that our financial position and results of operations could be negatively affected.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>LIQUIDITY AND CAPITAL RESOURCES</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash, and cash equivalents increased by 9.9% from
$51.3 million at June 30, 2023 to $56.3 million at June 30, 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash provided by operating activities for fiscal
2024 approximated $14.1 million. Cash provided by operating activities was attributable to the net income of $14.1 million,
depreciation and amortization of $4.6 million, provision for credit losses of $1.9 million, deferred income tax expense benefit of
$2.8 million which was offset by the increase in accounts, and medical and management fee receivables of $11.7 million.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash used in investing activities for fiscal 2024
approximated $851,000. The cash used in investing activities was attributable to purchases of property and equipment of $790,000, purchase
of short term investments of $103,000, costs of patents of $33,000, offset by proceeds from sale of equipment of $75,000.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash used in financing activities for fiscal 2024
approximated $8.2 million. The principal uses of cash used in financing activities included the repayment of borrowings and capital lease
obligations of $45,000, purchase of treasury stock of $2.5 million and distributions to non-controlling interests of $5.6 million.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Total liabilities increased by 15.5% during fiscal
2024, from approximately $49.8 million at June 30, 2023 to approximately $57.5 million at June 30, 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At June 30, 2024, we had working capital of approximately
$122.5 million as compared to working capital of $110.00 million at June 30, 2023, and stockholders&#8217; equity of $156.8 million at
June 30, 2024 as compared to stockholders&#8217; equity of $150.8 million at June 30, 2023. For the year ended June 30, 2024, we realized
a net income of $14.1 million.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our principal sources of liquidity are derived from
revenues.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our business plan includes a program for manufacturing
and selling our Upright&#174; MRI scanners. In addition, we are enhancing our revenue by participating in the physician and diagnostic
services management business through our subsidiary, HMCA. As of June 30, 2024, HMCA manages a total of 42 MRI scanners of which 25 MRI
scanners are located in New York and 17 are located in Florida. We have also intensified our marketing activities through the hiring of
additional marketers for HMCA&#8217;s clients.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our business plan also calls for a continuing emphasis
on providing our customers with enhanced equipment service and maintenance capabilities and delivering state-of-the-art, innovative and
high quality equipment upgrades at competitive prices. Fees for on-going service and maintenance from our installed base of scanners were
$7.5 million for the year ended June 30, 2023 and $7.6 million for the year ended June 30, 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In order to promote profitability and to reduce demands
on our cash and other liquid reserves, we maintain an aggressive program of cost containment. Previously, these measures included consolidating
HMCA&#8217;s office space with FONAR&#8217;s office space and reducing the size of our workforce, compensation and benefits. We continue
to attempt to contain expenses across the board, despite significant increases in the cost of labor and materials as the result of inflation.
The cost control efforts are intended to enable us to withstand periods of low volumes of MRI scanner sales, by keeping expenditures at
levels which can be supported by service revenues and HMCA revenues. To this end, we have formed a subsidiary, Opus Diagnostic Management,
LLC, to provide in-house repair and maintenance of third party manufactured MRI equipment that we operate. We hope this entity will contain
and eventually reduce the maintenance and repair costs of our equipment fleet, and eventually expand into providing service to outside
entities.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Current economic credit conditions have contributed
to a slower than optimal business environment. As a result our business may suffer, should the credit markets not improve in the near
future. The direct impact of these conditions is not fully known.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenues from HMCA have been the principal reason
for our profitability, and we have so far been able to maintain and increase such revenues by increasing the number of scans being performed
by the sites we manage and those we own, notwithstanding reductions in reimbursement rates from third-party payers. The likelihood and
effect of any subsequent reimbursement reductions is not fully known.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Capital expenditures for fiscal 2024 approximated $926,000. Capitalized
patent costs were approximately $33,000. Purchases of property and equipment were approximately $790,000. Purchase of short term
investments was $103,000.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR has committed to making any material capital
expenditures in the 2025 fiscal year by installing an additional scanner in two of its current locations. One is being installed in Florida
and is expected to be completed by October 2024 and the other is being installed in New York and is expected to be completed in the third
quarter of fiscal 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company believes that its business plan has been
responsible for the past five consecutive fiscal years of profitability (fiscal 2024, fiscal 2023, fiscal 2022, fiscal 2021 and fiscal
2020) and that its capital resources will be adequate to support operations at current levels through September 30, 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 13, 2022, the Company adopted a stock
repurchase plan. On September 26, 2022, the Board of Directors has approved up to $9 million to be repurchased under the plan which will
be purchased on the open market at prevailing prices. During fiscal 2024, we repurchased 156,206 shares for $2.5 million.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During January 2024 the Company renewed their revolving
credit agreement. The terms include borrowing limits of up to $10,000,000 and the agreement was extended to November 14, 2024. The interest
rate on unpaid principal remains at 4% along with certain financial covenants still applicable.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_011"></span>ITEM 7A. QUALITATIVE AND QUANTITATIVE DISCLOSURES
ABOUT MARKET RISK</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company does not have any investments in marketable
securities, foreign currencies, mutual funds, certificates of deposit or other fixed rate instruments. All of our funds are in cash accounts
or money market accounts which are liquid.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All of our revenue, expense and capital purchasing
activities are transacted in United States dollars.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">See Note 10 to the consolidated Financial Statements for information on
long-term debt.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_012"></span>ITEM 8. &#8211; FINANCIAL STATEMENTS AND FOOTNOTES</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">PAGE.</span></td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: bottom; width: 90%; text-indent: 0pt"><a href="#b_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">REPORT
    OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (PCAOB ID 688)</span></a></td>
    <td style="padding: 0pt; width: 10%; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">39</span></td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="#b_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">CONSOLIDATED BALANCE SHEETS</span></a></td>
    <td style="padding: 0pt; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">42</span></td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">As of June 30, 2024
    and 2023</span></td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="#b_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">CONSOLIDATED STATEMENTS OF INCOME</span></a></td>
    <td style="padding: 0pt; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">45</span></td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">For the Years Ended
    June 30, 2024 and 2023</span></td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="#b_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></a></td>
    <td style="padding: 0pt; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">47</span></td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">For the Years Ended
    June 30, 2024 and 2023</span></td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="#b_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></a></td>
    <td style="padding: 0pt; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">49</span></td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">For the Years Ended
    June 30, 2024 and 2023</span></td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="#b_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></a></td>
    <td style="padding: 0pt; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">51</span></td></tr>
  </table>



<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><b><span id="b_001"></span>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">To the Shareholders and Board of Directors of</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR Corporation and Subsidiaries</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Opinion on the Financial Statements</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have audited the accompanying consolidated balance
sheets of FONAR Corporation and Subsidiaries (the &#8220;Company&#8221;) as of June 30, 2024 and 2023, the related consolidated statements
of income, stockholders&#8217; equity and cash flows for each of the two years in the period ended June 30, 2024, and the related notes
(collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all
material respects, the financial position of the Company as of June 30, 2024 and 2023, and the results of its operations and its cash
flows for each of the two years in the period ended June 30, 2024, in conformity with accounting principles generally accepted in the
United States of America.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Basis for Opinion</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These financial statements are the responsibility
of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We
are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are
required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We conducted our audits in accordance with the standards
of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements
are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform,
an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal
control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control
over financial reporting. Accordingly, we express no such opinion.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our audits included performing procedures to assess
the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating
the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Critical Audit Matters</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The critical audit matters communicated below are
matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the
audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially
challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the
financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions
on the critical audit matters or on the accounts or disclosures to which they relate.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><b>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (Continued)</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-bottom: 0"><b>Medical Receivable&#8211; Refer to Note 2 to the financial statements&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline">Critical Audit Matter Description </span></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; color: #1F497D"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Medical receivables are due under fee-for-service
contracts from third-party payors, such as hospitals, government sponsored healthcare programs, patients legal counsel, and directly from
patients. Medical receivables are recorded at net realizable value based on the estimated amounts the Company expects to receive from
patients and third-party payers. The medical receivable is reduced by estimated contractual adjustments based on historical experience
with each payor class at each location. &#160;The principal consideration for our determination that performing procedures of the medical
receivable is a critical audit matter is due to the nature and extent of audit effort required to perform procedures over management&#8217;s
estimates of the contractual allowances.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline">How the Critical Audit Matter Was Addressed
in the Audit</span></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our audit procedures related to the net realizable
value of medical receivables included the following:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We obtained an understanding, evaluated the design
and implementation, of certain controls that address the risks of material misstatement relating to the measurement of patient fee revenue
and medical receivables. </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We tested information technology general controls
around the Company&#8217;s billing system and associated database. </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We evaluated and tested management&#8217;s methodology
and related assumptions in the determination of amounts estimated to be collected from patients and third-party payors.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We tested the underlying data related to the
recognition of patient level charges and the subsequent activities, including cash collections and non-cash adjustments. </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We tested the estimated contractual adjustments
set forth by the third-party payers. </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We tested the mathematical accuracy of the estimates
applied to the medical receivables. </span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span style="text-decoration: underline">Management Fees Receivable &#160;&#8211;
Refer to Note 2 to the financial statements. </span></i></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management fees receivable is related to management
fees outstanding from the related and non-related professional corporations (&#8220;PCs&#8221;) under management agreements. The Company
has established a current expected credit loss (&#8220;CECL&#8221;) to address the risk that a portion of the contractually obligated
management fees receivable from the PCs may not be paid. The PCs may be limited in their ability to pay the full management fee receivable
if they do not collect sufficient expected fees from third-party payers and patients. The Company&#8217;s management fees are collateralized,
individually and collectively, by the assets of the PCs. &#160;The CECL is determined based on the difference between the management fee
receivable and the current amount of outstanding fees estimated to be collected by the PCs. The Company&#8217;s considerations into the
estimate of the PCs&#8217; fee collection include historical loss rates to pools of receivables with similar risks characteristics, current
and forward-looking economic conditions, and the financial condition of each PC. The principal consideration for our determination that
the management fees receivable is a critical audit matter is due to the nature and extent of audit effort required to perform procedures
over the Company&#8217;s CECL estimate.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -18pt"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -18pt"></p>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -18pt">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><b>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (Continued)</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline">How the Critical Audit Matter Was Addressed in the Audit</span></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our audit procedures related to the CECL estimate
of management fees receivable included the following:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">-</span></td><td style="text-align: justify"><span style="font-size: 11pt">We obtained an understanding, and evaluated the design and implementation
of, certain controls that address the risk of material misstatement related to the measurement of the CECL estimate.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">-</span></td><td style="text-align: justify"><span style="font-size: 11pt">We verified that all management fees for the year agreed with the executed
management fee contracts with each PC.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">-</span></td><td style="text-align: justify"><span style="font-size: 11pt">We tested information technology general controls surrounding the billing
system utilized by the PCs.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We evaluated and tested management&#8217;s methodology
and related assumptions in the determination of the PC&#8217;s amounts estimated to be collected from patients and third-party payors.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">-</span></td><td style="text-align: justify"><span style="font-size: 11pt">We obtained and verified the terms of the cross-collateralization agreements.
</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 11pt">-</span></td><td style="text-align: justify"><span style="font-size: 11pt">We tested the mathematical accuracy of the calculations used to determine
the CECL estimate.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">/s/ Marcum <span style="font-variant: small-caps">llp</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-variant: small-caps">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_902_edei--AuditorName_c20230701__20240630_zPl250BV9ea9"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000061" name="dei:AuditorName">Marcum</ix:nonNumeric> <span style="font-variant: small-caps"> llp</span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_901_edei--AuditorFirmId_c20230701__20240630_zF2Zc3aF4hB8" style="display: none"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000062" name="dei:AuditorFirmId">688</ix:nonNumeric></span><span style="font-variant: small-caps">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have served as the Company&#8217;s auditor since 1990, such date takes
into account the merger of Tabb, Conigliaro, McGann, P.C. (&#8220;Tabb&#8221;) into another firm in approximately 2001 and the former
partners of Tabb joining Marcum LLP in 2002.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_90B_edei--AuditorLocation_c20230701__20240630_zcecHqz1ouJ7"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000063" name="dei:AuditorLocation">New York, NY</ix:nonNumeric></span><br/>
September 27, 2024</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="b_002"></span>CONSOLIDATED BALANCE SHEETS</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">ASSETS</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_302_111_zMtw9E1hDgk6" summary="xdx: Statement - CONSOLIDATED BALANCE SHEETS" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20240630" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_491_20230630" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_403_eus-gaap--AssetsCurrentAbstract_iB_zYvgKCPTalUe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Current Assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i01I_maACzhK1_zJATz5kvdDU3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; width: 56%; text-align: left; text-indent: -11pt">Cash and cash equivalents</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2024-06-30" id="Fact000068" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,341,193</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-06-30" id="Fact000069" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,279,707</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ShortTermInvestments_i01I_maACzhK1_zly6SFKXLbPl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Short-term investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2024-06-30" id="Fact000071" format="ixt:numdotdecimal" decimals="0" unitRef="USD">136,102</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2023-06-30" id="Fact000072" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,799</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AccountsReceivableNetCurrent_i01I_maACzhK1_zA6Ud90FARS4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Accounts receivable &#8211; net of allowances for credit losses of $<span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20240630_zHethzL0Ib9d" title="Accounts receivable - net of allowances for credit losses"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" contextRef="AsOf2024-06-30" id="Fact000077" format="ixt:numdotdecimal" decimals="0" unitRef="USD">166,049</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20230630_zBI95zh2vce2" title="Accounts receivable - net of allowances for credit losses"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" contextRef="AsOf2023-06-30" id="Fact000079" format="ixt:numdotdecimal" decimals="0" unitRef="USD">198,593</ix:nonFraction></span> at June 30, 2024 and 2023, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2024-06-30" id="Fact000074" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,035,336</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2023-06-30" id="Fact000075" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,861,512</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--MedicalReceivable_i01I_maACzhK1_zyvrDlNlInQa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Medical receivables &#8211; net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2024-06-30" id="Fact000081" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,991,533</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2023-06-30" id="Fact000082" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,259,262</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AccruedFeesAndOtherRevenueReceivable_i01I_maACzhK1_zFjWjJX49Gm" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Management and other fees receivable &#8211; net of allowances for credit losses of $<span id="xdx_90B_ecustom--ManagementAndOtherReceivableAllowancesForDoubtfulAccounts_iI_c20240630_zj7mHpetRfpk" title="Management and other fees receivable - net of allowances for credit losses"><ix:nonFraction name="FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" contextRef="AsOf2024-06-30" id="Fact000087" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,369,921</ix:nonFraction></span> and $<span id="xdx_909_ecustom--ManagementAndOtherReceivableAllowancesForDoubtfulAccounts_iI_c20230630_zqftfsx3CJ0i" title="Management and other fees receivable - net of allowances for credit losses"><ix:nonFraction name="FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" contextRef="AsOf2023-06-30" id="Fact000089" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,608,567</ix:nonFraction></span> as of June 30, 2024 and 2023, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedFeesAndOtherRevenueReceivable" contextRef="AsOf2024-06-30" id="Fact000084" format="ixt:numdotdecimal" decimals="0" unitRef="USD">41,953,657</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedFeesAndOtherRevenueReceivable" contextRef="AsOf2023-06-30" id="Fact000085" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,888,253</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_i01I_maACzhK1_zfszUS5joy81" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Management and other fees receivable &#8211; related party medical practices &#8211; net of allowances for credit losses of $<span id="xdx_90B_ecustom--RelatedPartyReceivableAllowancesForDoubtfulAccounts_iI_c20240630_zeDAAQ7LEdXe" title="Management and other fees receivable - related party medical practices - net of allowances for credit losses"><ix:nonFraction name="FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts" contextRef="AsOf2024-06-30" id="Fact000094" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,110,399</ix:nonFraction></span> and $<span id="xdx_90B_ecustom--RelatedPartyReceivableAllowancesForDoubtfulAccounts_iI_c20230630_zDDVM8tZNRQ5" title="Management and other fees receivable - related party medical practices - net of allowances for credit losses"><ix:nonFraction name="FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts" contextRef="AsOf2023-06-30" id="Fact000096" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,989,692</ix:nonFraction></span> as of June 30, 2024 and 2023, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2024-06-30" id="Fact000091" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,865,061</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2023-06-30" id="Fact000092" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,161,870</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--InventoryNet_i01I_maACzhK1_z6myx07doYbf" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-indent: -11pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2024-06-30" id="Fact000098" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,715,441</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2023-06-30" id="Fact000099" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,569,666</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i01I_maACzhK1_zlNcSpOCg7bk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Prepaid expenses and other current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2024-06-30" id="Fact000101" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,285,962</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-06-30" id="Fact000102" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,607,768</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AssetsCurrent_i01TI_mtACzhK1_maAzsfb_ze8HYxf0X4o2" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -11pt">Total Current Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-06-30" id="Fact000104" format="ixt:numdotdecimal" decimals="0" unitRef="USD">140,324,285</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-06-30" id="Fact000105" format="ixt:numdotdecimal" decimals="0" unitRef="USD">125,660,837</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--AccountsReceivableNetLongTerm_i01I_maAzsfb_ziW6VoL1dttc" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Accounts receivable &#8211; long term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2024-06-30" id="Fact000107" format="ixt:numdotdecimal" decimals="0" unitRef="USD">829,473</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2023-06-30" id="Fact000108" format="ixt:numdotdecimal" decimals="0" unitRef="USD">710,085</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--NoteReceivableRelatedParty_i01I_d0_maAzsfb_zgMD5gxVHvte" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Note receivable &#8211; related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:NoteReceivableRelatedParty" contextRef="AsOf2024-06-30" id="Fact000110" format="ixt:numdotdecimal" decimals="0" unitRef="USD">581,183</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:NoteReceivableRelatedParty" contextRef="AsOf2023-06-30" id="Fact000111" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetsDeferredIncome_i01I_maAzsfb_zxrDIF6Qpd2b" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Deferred income tax asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2024-06-30" id="Fact000113" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,223,255</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2023-06-30" id="Fact000114" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,041,960</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maAzsfb_zxF9pbG2hred" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Property and equipment &#8211; net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-06-30" id="Fact000116" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,708,920</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-06-30" id="Fact000117" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,146,373</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_maAzsfb_zUurxq2oh2ig" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Right-of-use-assets &#8211; operating leases</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2024-06-30" id="Fact000119" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,427,757</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2023-06-30" id="Fact000120" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,068,755</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--FinanceLeaseRightOfUseAsset_i01I_maAzsfb_zr8ZW6YYMJIj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Right-of-use-asset &#8211; financing lease</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2024-06-30" id="Fact000122" format="ixt:numdotdecimal" decimals="0" unitRef="USD">530,348</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2023-06-30" id="Fact000123" format="ixt:numdotdecimal" decimals="0" unitRef="USD">729,229</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--Goodwill_i01I_maAzsfb_zO9j3QtlfWu3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-indent: -11pt">Goodwill</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2024-06-30" id="Fact000125" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,269,277</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-06-30" id="Fact000126" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,269,277</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i01I_maAzsfb_zcuwZ5843jPc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Other intangible assets &#8211; net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2024-06-30" id="Fact000128" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,870,324</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-06-30" id="Fact000129" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,431,865</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OtherAssets_i01I_maAzsfb_zoWnV1TMkVk9" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Other assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2024-06-30" id="Fact000131" format="ixt:numdotdecimal" decimals="0" unitRef="USD">481,147</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2023-06-30" id="Fact000132" format="ixt:numdotdecimal" decimals="0" unitRef="USD">523,506</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--Assets_i01TI_mtAzsfb_zSffdohoxJKj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total Assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-06-30" id="Fact000134" format="ixt:numdotdecimal" decimals="0" unitRef="USD">214,245,969</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-06-30" id="Fact000135" format="ixt:numdotdecimal" decimals="0" unitRef="USD">200,581,887</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">CONSOLIDATED BALANCE SHEETS</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">LIABILITIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesCurrentAbstract_iB_zjxZKSC9WZxd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Current Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LongTermDebtCurrent_i01I_maLCzeS8_zMZ3l8T0E5J4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; width: 56%; text-align: left; text-indent: -11pt">Current portion of long-term debt</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2024-06-30" id="Fact000140" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,002</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2023-06-30" id="Fact000141" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,767</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccountsPayableCurrent_i01I_maLCzeS8_zsYfXjpF8Wyl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2024-06-30" id="Fact000143" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,855,879</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-06-30" id="Fact000144" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,579,240</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OtherLiabilitiesCurrent_i01I_maLCzeS8_z0997Jy9ACKd" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Other current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact000146" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,941,039</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-06-30" id="Fact000147" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,443,724</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_maLCzeS8_zxYy4xATbfRb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Operating lease liabilities &#8211; current portion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2024-06-30" id="Fact000149" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,473,674</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-06-30" id="Fact000150" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,905,484</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--FinanceLeaseLiabilityCurrent_i01I_maLCzeS8_zrYIZkPCKyc" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Financing lease liability &#8211; current portion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="AsOf2024-06-30" id="Fact000152" format="ixt:numdotdecimal" decimals="0" unitRef="USD">225,786</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="AsOf2023-06-30" id="Fact000153" format="ixt:numdotdecimal" decimals="0" unitRef="USD">217,597</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--DeferredRevenueCurrent_i01I_maLCzeS8_zoKsm7jXhFQ4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Unearned revenue on service contracts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2024-06-30" id="Fact000155" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,870,229</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2023-06-30" id="Fact000156" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,832,184</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--CustomerDeposits_i01I_maLCzeS8_zcqQ5HQkd75e" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Customer deposits</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:CustomerDeposits" contextRef="AsOf2024-06-30" id="Fact000158" format="ixt:numdotdecimal" decimals="0" unitRef="USD">443,471</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:CustomerDeposits" contextRef="AsOf2023-06-30" id="Fact000159" format="ixt:numdotdecimal" decimals="0" unitRef="USD">602,377</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LiabilitiesCurrent_i01TI_mtLCzeS8_maLzwsF_zo7Tvkw4Sp8l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -11pt">Total Current Liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact000161" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,857,080</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-06-30" id="Fact000162" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,624,373</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesNoncurrentAbstract_iB_zVutGuXueX23" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Long-Term Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DeferredRevenueNoncurrent_i01I_maLNz0h3_zHDhGtk2ruab" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Unearned revenue on service contracts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueNoncurrent" contextRef="AsOf2024-06-30" id="Fact000167" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,174,844</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueNoncurrent" contextRef="AsOf2023-06-30" id="Fact000168" format="ixt:numdotdecimal" decimals="0" unitRef="USD">760,242</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_i01I_maLNz0h3_zao6xGfBEfxk" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Deferred income tax liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" contextRef="AsOf2024-06-30" id="Fact000170" format="ixt:numdotdecimal" decimals="0" unitRef="USD">371,560</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" contextRef="AsOf2023-06-30" id="Fact000171" format="ixt:numdotdecimal" decimals="0" unitRef="USD">394,758</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--AccountsPayableRelatedPartyNoncurrent_i01I_maLNz0h3_zHsQVHsYRcol" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Due to related party medical practices</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:AccountsPayableRelatedPartyNoncurrent" contextRef="AsOf2024-06-30" id="Fact000173" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92,663</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:AccountsPayableRelatedPartyNoncurrent" contextRef="AsOf2023-06-30" id="Fact000174" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92,663</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_maLNz0h3_z3lJ9eM6gWnh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Operating lease liabilities &#8211; net of current portion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2024-06-30" id="Fact000176" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,467,746</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-06-30" id="Fact000177" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,105,405</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--FinanceLeaseLiabilityNoncurrent_i01I_maLNz0h3_zTHs2gZ1sBt1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Financing lease liability &#8211; net of current portion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="AsOf2024-06-30" id="Fact000179" format="ixt:numdotdecimal" decimals="0" unitRef="USD">394,723</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="AsOf2023-06-30" id="Fact000180" format="ixt:numdotdecimal" decimals="0" unitRef="USD">620,481</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LongTermDebtNoncurrent_i01I_maLNz0h3_z3TthCLXs5w5" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Long-term debt and capital leases, less current portion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2024-06-30" id="Fact000182" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,938</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2023-06-30" id="Fact000183" format="ixt:numdotdecimal" decimals="0" unitRef="USD">115,075</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OtherLiabilities_i01I_maLNz0h3_z6QtCHmvGoa1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Other liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2024-06-30" id="Fact000185" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,026</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2023-06-30" id="Fact000186" format="ixt:numdotdecimal" decimals="0" unitRef="USD">41,750</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesNoncurrent_i01TI_mtLNz0h3_maLzwsF_zm7ReiYPeRp2" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -11pt">Total Long-Term Liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2024-06-30" id="Fact000188" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,600,500</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2023-06-30" id="Fact000189" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,130,374</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--Liabilities_i01TI_mtLzwsF_maLASEzyw7_zlWETFw6UpPk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total Liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2024-06-30" id="Fact000191" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,457,580</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-06-30" id="Fact000192" format="ixt:numdotdecimal" decimals="0" unitRef="USD">49,754,747</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CommitmentsAndContingencies_i01I_zxpAEHLLDVKa" style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 11pt; text-align: left; text-indent: -11pt">Commitments and Contingencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><b></b></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><b style="display: none"><span style="-sec-ix-hidden: xdx2ixbrl0195">&#8212;</span></b></td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 43; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">CONSOLIDATED BALANCE SHEETS</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">STOCKHOLDERS&#8217; EQUITY</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_40C_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Stockholders&#8217; Equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; width: 56%; text-align: left; text-indent: -11pt">Class A non-voting preferred stock $<span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_c20240630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_pdd" title="Preferred stock, par value"><span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_c20230630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_pdd" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember" id="Fact000200" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember" id="Fact000202" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_c20240630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zsWXbaF3LMsf" title="Preferred stock, shares authorized"><span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_c20230630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_z7rJuCfsErsb" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember" id="Fact000204" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember" id="Fact000206" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">453,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized at June 30, 2024 and 2023, <span id="xdx_90C_eus-gaap--PreferredStockSharesIssued_c20240630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zcdKJ7Bm2Xi6" title="Preferred stock, shares issued"><span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_c20240630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zGIfu4CzDb57" title="Preferred stock, shares outstanding"><span id="xdx_908_eus-gaap--PreferredStockSharesIssued_c20230630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zTTJZMOqGWYj" title="Preferred stock, shares issued"><span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_c20230630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zwi7AGjJDhO8" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember" id="Fact000208" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember" id="Fact000210" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember" id="Fact000212" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember" id="Fact000214" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">313,438</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued and outstanding at June 30, 2024 and 2023</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--PreferredStockValue_i01I_maSEzM9Y_c20240630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zz9ZaPLYpwok" title="Preferred stock value" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember" id="Fact000216" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--PreferredStockValue_i01I_maSEzM9Y_c20230630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zicuib9n9uU4" title="Preferred stock value" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember" id="Fact000218" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">&#160;Preferred stock $<span id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zjKHMd6E5byj" title="Preferred stock, par value"><span id="xdx_909_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_za905KuRUAA2" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember" id="Fact000220" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember" id="Fact000222" decimals="INF" unitRef="USDPShares">.001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zd6bdFa2JOM4" title="Preferred stock, shares authorized"><span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zpos21NPj25a" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember" id="Fact000224" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember" id="Fact000226" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">567,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized at June 30, 2024 and 2023, issued and outstanding &#8211; <span id="xdx_902_eus-gaap--PreferredStockSharesIssued_dn_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zyymfcFwph85" title="Preferred stock, shares issued"><span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_dn_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zjv9bs2OGzB4" title="Preferred stock, shares outstanding"><span id="xdx_908_eus-gaap--PreferredStockSharesIssued_dn_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zyndlRv1Gn6k" title="Preferred stock, shares issued"><span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_dn_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zUvA3nzKwna8" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember" id="Fact000228" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember" id="Fact000230" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember" id="Fact000232" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember" id="Fact000234" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PreferredStockValue_i01I_d0_maSEzM9Y_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_ztsXbhgxK2N1" title="Preferred stock value" style="text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember" id="Fact000236" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PreferredStockValue_i01I_d0_maSEzM9Y_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zdhvjKGDIKg6" title="Preferred stock value" style="text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember" id="Fact000238" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Common stock $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zdeiRkgZGiV4" title="Common stock, par value"><span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000240" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000242" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z9Tjcgt51Sgh" title="Common stock, shares authorized"><span id="xdx_901_eus-gaap--CommonStockSharesAuthorized_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zTdNIPyKL7u3" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000244" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000246" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,500,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized at June 30, 2024 and 2023, <span id="xdx_90E_eus-gaap--CommonStockSharesIssued_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zMUYH7VUDde4" title="Common stock, shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000248" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,373,375</ix:nonFraction></span> and <span id="xdx_906_eus-gaap--CommonStockSharesIssued_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zdaMiefw9aa7" title="Common stock, shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000250" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,462,345</ix:nonFraction></span> issued at June 30, 2024 and 2023, respectively <span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zEl29TPpni42" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000252" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,328,294</ix:nonFraction></span> and <span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zK9b7YrdPeRb" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000254" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,450,882</ix:nonFraction></span> outstanding at June 30, 2024 and 2023, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--CommonStockValue_i01I_maSEzM9Y_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zfWDqdbFHBPl" title="Common stock value" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000256" format="ixt:numdotdecimal" decimals="0" unitRef="USD">635</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--CommonStockValue_i01I_maSEzM9Y_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zcHcvJazw7Oc" title="Common stock value" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000258" format="ixt:numdotdecimal" decimals="0" unitRef="USD">647</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Class B convertible common stock (10 votes per share) $<span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zI450pdoWIh8" title="Common stock, par value"><span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z72c4ATcuLl1" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember" id="Fact000260" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember" id="Fact000262" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_ziaQSpw4vZB2" title="Common stock, shares authorized"><span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zwcyE5iwNCo6" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember" id="Fact000264" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember" id="Fact000266" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">227,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized at June 30, 2024 and 2023, <span id="xdx_907_eus-gaap--CommonStockSharesIssued_iI_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zLxThgQkWoQ6" title="Common stock, shares issued"><span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_ztemypKc5QRk" title="Common stock, shares outstanding"><span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zOgjWV58Riv2" title="Common stock, shares issued"><span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_iI_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zlL3dTWp8s27" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember" id="Fact000268" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember" id="Fact000270" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember" id="Fact000272" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember" id="Fact000274" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">146</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued and outstanding at June 30, 2024 and 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--CommonStockValue_i01I_d0_maSEzM9Y_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zt72ML5e4cfb" title="Common stock value" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember" id="Fact000276" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--CommonStockValue_i01I_d0_maSEzM9Y_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zU9owViG6fMj" title="Common stock value" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember" id="Fact000278" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Class C common stock (25 votes per share) $<span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zanpeBdL3608" title="Common stock, par value"><span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember" id="Fact000280" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-06-30_us-gaap_CommonClassCMember" id="Fact000282" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zmrMOabUu223" title="Common stock, shares authorized"><span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zkOz6GNFrMj3" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember" id="Fact000284" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-06-30_us-gaap_CommonClassCMember" id="Fact000286" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">567,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized at June 30, 2024 and 2023, <span id="xdx_90D_eus-gaap--CommonStockSharesIssued_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zaC8wJX1XyZ9" title="Common stock, shares issued"><span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zriacRlv27l2" title="Common stock, shares outstanding"><span id="xdx_906_eus-gaap--CommonStockSharesIssued_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNdzW47waHaa" title="Common stock, shares issued"><span id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zd2fpCKhB3Vk" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember" id="Fact000288" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember" id="Fact000290" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-06-30_us-gaap_CommonClassCMember" id="Fact000292" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonClassCMember" id="Fact000294" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued and outstanding at June 30, 2024 and 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--CommonStockValue_i01I_maSEzM9Y_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zmDMCDf5Lu02" title="Common stock value" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember" id="Fact000296" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--CommonStockValue_i01I_maSEzM9Y_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zOugDIMcchKj" title="Common stock value" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-06-30_us-gaap_CommonClassCMember" id="Fact000298" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AdditionalPaidInCapital_i01I_maSEzM9Y_z0LqWWZHBUV6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-indent: -11pt">Paid-in capital in excess of par value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2024-06-30" id="Fact000300" format="ixt:numdotdecimal" decimals="0" unitRef="USD">180,607,510</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-06-30" id="Fact000301" format="ixt:numdotdecimal" decimals="0" unitRef="USD">182,612,518</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RetainedEarningsAccumulatedDeficit_i01I_maSEzM9Y_zOxZGh8N1lE1" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Accumulated deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-06-30" id="Fact000303" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">13,623,585</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-06-30" id="Fact000304" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">24,190,981</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--TreasuryStockValue_i01NI_di_msSEzM9Y_z2ycKSslQERd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Treasury stock, at cost &#8211; <span id="xdx_90A_eus-gaap--TreasuryStockCommonShares_c20240630_ztZDP56NRbda" title="Treasury stock, shares"><ix:nonFraction name="us-gaap:TreasuryStockCommonShares" contextRef="AsOf2024-06-30" id="Fact000309" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">45,081</ix:nonFraction></span> and <span id="xdx_90E_eus-gaap--TreasuryStockCommonShares_c20230630_z7GndePHLH3b" title="Treasury stock, shares"><ix:nonFraction name="us-gaap:TreasuryStockCommonShares" contextRef="AsOf2023-06-30" id="Fact000311" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,463</ix:nonFraction></span> shares of common stock at June 30, 2024 and 2023, respectively</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2024-06-30" id="Fact000306" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,016,632</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2023-06-30" id="Fact000307" format="ixt:numdotdecimal" decimals="0" unitRef="USD">515,820</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--StockholdersEquity_i01TI_mtSEzM9Y_maSEIPAzuBL_zBTvY89tysib" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total Fonar Corporation&#8217;s Stockholders&#8217; Equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30" id="Fact000313" format="ixt:numdotdecimal" decimals="0" unitRef="USD">165,967,997</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30" id="Fact000314" format="ixt:numdotdecimal" decimals="0" unitRef="USD">157,906,433</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--MinorityInterest_i01I_maSEIPAzuBL_z8lIE5Yept73" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Noncontrolling interests</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2024-06-30" id="Fact000316" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,179,608</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2023-06-30" id="Fact000317" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,079,293</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_i01TI_mtSEIPAzuBL_maLASEzyw7_zGVd0ujQlo39" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total Stockholders&#8217; Equity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30" id="Fact000319" format="ixt:numdotdecimal" decimals="0" unitRef="USD">156,788,389</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30" id="Fact000320" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,827,140</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEzyw7_zHD0OiD5rSzd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total Liabilities and Stockholders&#8217; Equity</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-06-30" id="Fact000322" format="ixt:numdotdecimal" decimals="0" unitRef="USD">214,245,969</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-06-30" id="Fact000323" format="ixt:numdotdecimal" decimals="0" unitRef="USD">200,581,887</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 44; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="b_003"></span>CONSOLIDATED STATEMENTS OF INCOME</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_306_113_zIqH4Dovh8Uj" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF INCOME" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49D_20230701_20240630" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20220701_20230630" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_407_eus-gaap--RevenuesAbstract_iB_zm4q4T999Ei1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_i01_maRz6Rf_zZdahYoZvMJi" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; width: 56%; text-align: left; text-indent: -11pt">Patient fee revenue, net of contractual allowances and discounts</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" contextRef="From2023-07-01to2024-06-30" id="Fact000328" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,815,796</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" contextRef="From2022-07-012023-06-30" id="Fact000329" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,793,993</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--ProductSalesNet_i01_maRz6Rf_zoh3kNKSXfec" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Product sales</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:ProductSalesNet" contextRef="From2023-07-01to2024-06-30" id="Fact000331" format="ixt:numdotdecimal" decimals="0" unitRef="USD">737,727</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:ProductSalesNet" contextRef="From2022-07-012023-06-30" id="Fact000332" format="ixt:numdotdecimal" decimals="0" unitRef="USD">731,607</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--ServiceAndRepairFeesNet_i01_maRz6Rf_z43b0H44efsj" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Service and repair fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:ServiceAndRepairFeesNet" contextRef="From2023-07-01to2024-06-30" id="Fact000334" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,452,212</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:ServiceAndRepairFeesNet" contextRef="From2022-07-012023-06-30" id="Fact000335" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,419,104</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--ServiceAndRepairFeesRelatedPartiesNet_i01_maRz6Rf_zwKEUZVhElt6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Service and repair fees &#8211; related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:ServiceAndRepairFeesRelatedPartiesNet" contextRef="From2023-07-01to2024-06-30" id="Fact000337" format="ixt:numdotdecimal" decimals="0" unitRef="USD">139,167</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:ServiceAndRepairFeesRelatedPartiesNet" contextRef="From2022-07-012023-06-30" id="Fact000338" format="ixt:numdotdecimal" decimals="0" unitRef="USD">110,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--ManagementAndOtherFeesNet_i01_maRz6Rf_zTplTVbEcFka" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Management and other fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:ManagementAndOtherFeesNet" contextRef="From2023-07-01to2024-06-30" id="Fact000340" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,789,287</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:ManagementAndOtherFeesNet" contextRef="From2022-07-012023-06-30" id="Fact000341" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,640,497</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--ManagementAndOtherFeesRelatedMedicalPracticesNet_i01_maRz6Rf_zyLD5bhQ8Kj7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Management and other fees &#8211; related party medical practices</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet" contextRef="From2023-07-01to2024-06-30" id="Fact000343" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,949,900</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet" contextRef="From2022-07-012023-06-30" id="Fact000344" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,949,900</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--Revenues_iT_mtRz6Rf_maILFCOzRn5_zPXaFJ92yeFl" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -11pt">Total Revenues &#8211; Net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-01to2024-06-30" id="Fact000346" format="ixt:numdotdecimal" decimals="0" unitRef="USD">102,884,089</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-07-012023-06-30" id="Fact000347" format="ixt:numdotdecimal" decimals="0" unitRef="USD">98,645,101</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CostsAndExpensesAbstract_iB_z591qp0KceV5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Costs and Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--CostsRelatedToProductSales_i01_maCAEzSDb_z81tuHuxaDu6" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Costs related to product sales</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:CostsRelatedToProductSales" contextRef="From2023-07-01to2024-06-30" id="Fact000352" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,052,159</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:CostsRelatedToProductSales" contextRef="From2022-07-012023-06-30" id="Fact000353" format="ixt:numdotdecimal" decimals="0" unitRef="USD">852,025</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--CostsRelatedToServiceAndRepairFees_i01_maCAEzSDb_zfQM0moqfgj4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Costs related to service and repair fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFees" contextRef="From2023-07-01to2024-06-30" id="Fact000355" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,577,570</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFees" contextRef="From2022-07-012023-06-30" id="Fact000356" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,033,967</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--CostsRelatedToServiceAndRepairFeesRelatedParties_i01_maCAEzSDb_zi6ZiNhGP2Id" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Costs related to service and repair fees &#8211; related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFeesRelatedParties" contextRef="From2023-07-01to2024-06-30" id="Fact000358" format="ixt:numdotdecimal" decimals="0" unitRef="USD">144,413</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFeesRelatedParties" contextRef="From2022-07-012023-06-30" id="Fact000359" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,983</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--OtherCostOfOperatingRevenue_i01_maCAEzSDb_zPXdcquWkpe1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Costs related to patient fee revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherCostOfOperatingRevenue" contextRef="From2023-07-01to2024-06-30" id="Fact000361" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,199,579</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherCostOfOperatingRevenue" contextRef="From2022-07-012023-06-30" id="Fact000362" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,183,166</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--CostsRelatedToManagementAndOtherFees_i01_maCAEzSDb_z0cfSfOvGeKa" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Costs related to management and other fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFees" contextRef="From2023-07-01to2024-06-30" id="Fact000364" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,626,595</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFees" contextRef="From2022-07-012023-06-30" id="Fact000365" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,975,563</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_i01_maCAEzSDb_zf1b50Digq1f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Costs related to management and other fees &#8211; related party medical practices</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" contextRef="From2023-07-01to2024-06-30" id="Fact000367" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,143,728</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" contextRef="From2022-07-012023-06-30" id="Fact000368" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,807,454</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ResearchAndDevelopmentExpense_i01_maCAEzSDb_zi4YWXrscATi" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Research and development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-07-01to2024-06-30" id="Fact000370" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,735,949</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-07-012023-06-30" id="Fact000371" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,567,749</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_maCAEzSDb_zNQ8Isdfmnd8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2023-07-01to2024-06-30" id="Fact000373" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,868,732</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2022-07-012023-06-30" id="Fact000374" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,390,932</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--CostsAndExpenses_i01T_mtCAEzSDb_msILFCOzRn5_zdX4hbm2ZH88" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -11pt">Total Costs and Expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2023-07-01to2024-06-30" id="Fact000376" format="ixt:numdotdecimal" decimals="0" unitRef="USD">86,348,725</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2022-07-012023-06-30" id="Fact000377" format="ixt:numdotdecimal" decimals="0" unitRef="USD">83,855,839</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_iT_mtILFCOzRn5_maONIEzqND_zbAFifK3MWig" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Income from Operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" contextRef="From2023-07-01to2024-06-30" id="Fact000379" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,535,364</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" contextRef="From2022-07-012023-06-30" id="Fact000380" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,789,262</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OtherNonoperatingIncomeExpenseAbstract_iB_zIeQKzR1KwD" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Other Income and (Expenses):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--InterestExpenseNonoperating_iN_di_msONIEzqND_zyY1T1JUtBei" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2023-07-01to2024-06-30" id="Fact000385" format="ixt:numdotdecimal" decimals="0" unitRef="USD">76,997</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2022-07-012023-06-30" id="Fact000386" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,131</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_ecustom--InvestmentIncomeRelatedParty_d0_maONIEzqND_zljLchqWObw2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Investment income &#8211; related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:InvestmentIncomeRelatedParty" contextRef="From2023-07-01to2024-06-30" id="Fact000388" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,959</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:InvestmentIncomeRelatedParty" contextRef="From2022-07-012023-06-30" id="Fact000389" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--InvestmentIncomeNet_maONIEzqND_zQUiQwantlCd" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Investment income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2023-07-01to2024-06-30" id="Fact000391" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,126,439</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2022-07-012023-06-30" id="Fact000392" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,222,176</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--OtherIncomeRelatedParty_d0_maONIEzqND_zQso0T2aKJu3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Other income &#8211; related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:OtherIncomeRelatedParty" contextRef="From2023-07-01to2024-06-30" id="Fact000394" format="ixt:numdotdecimal" decimals="0" unitRef="USD">576,857</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:OtherIncomeRelatedParty" contextRef="From2022-07-012023-06-30" id="Fact000395" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OtherNonoperatingIncomeExpense_maONIEzqND_zUVfx8mMm6b2" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Other income (expense)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2023-07-01to2024-06-30" id="Fact000397" format="ixt:numdotdecimal" decimals="0" unitRef="USD">78,763</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2022-07-012023-06-30" id="Fact000398" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">202,720</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtONIEzqND_maPLzOwn_z9bWK9KqBglg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Income before provision for income taxes and noncontrolling interests</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-07-01to2024-06-30" id="Fact000400" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,266,385</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-07-012023-06-30" id="Fact000401" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,758,587</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncomeTaxExpenseBenefit_iN_di_msPLzOwn_zPGRSYVHJWPl" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Provision for Income Taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-07-01to2024-06-30" id="Fact000403" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,168,968</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-07-012023-06-30" id="Fact000404" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,632,071</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--ProfitLoss_iT_mtPLzOwn_maNILzt1K_zdP8CoNARKVd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Net Income</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-01to2024-06-30" id="Fact000406" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,097,417</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30" id="Fact000407" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,126,516</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_di_msNILzt1K_z0AZzF3dHVid" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Net Income &#8211; Noncontrolling Interests</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-01to2024-06-30" id="Fact000409" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,530,021</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-012023-06-30" id="Fact000410" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,750,740</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_iT_mtNILzt1K_zIwITZS0AQA4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Net Income &#8211; Attributable to FONAR</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-01to2024-06-30" id="Fact000412" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,567,396</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-06-30" id="Fact000413" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,375,776</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;See accompanying notes to consolidated financial statements.&#160;<br/></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 45; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">CONSOLIDATED STATEMENTS OF INCOME (Continued)</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Net Income Available to Common&#160;Stockholders</td><td style="width: 8%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zeuGxgGl3yP3" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgSU5DT01FAA__" title="Net Income Available to Common Stockholders" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-07-012024-06-30_custom_CommonStockholdersMember" id="Fact000415" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,908,920</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 8%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zSvZeEX6jHzd" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgSU5DT01FAA__" title="Net Income Available to Common Stockholders" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2022-07-012023-06-30_custom_CommonStockholdersMember" id="Fact000417" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,801,974</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Net Income Available to Class A Non-Voting Preferred Stockholders</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockholdersMember_z9Wk578xfH4d" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgSU5DT01FAA__" title="Net Income Available to Common Stockholders" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-07-012024-06-30_custom_ClassANonVotingPreferredStockholdersMember" id="Fact000419" format="ixt:numdotdecimal" decimals="0" unitRef="USD">490,776</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockholdersMember_z6U3oVPmTuV2" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgSU5DT01FAA__" title="Net Income Available to Common Stockholders" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2022-07-012023-06-30_custom_ClassANonVotingPreferredStockholdersMember" id="Fact000421" format="ixt:numdotdecimal" decimals="0" unitRef="USD">427,666</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Net Income Available to Class C Common&#160;Stockholders</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNSgyHXdR3B1" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgSU5DT01FAA__" title="Net Income Available to Common Stockholders" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember" id="Fact000423" format="ixt:numdotdecimal" decimals="0" unitRef="USD">167,700</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCsjMONm0AYi" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgSU5DT01FAA__" title="Net Income Available to Common Stockholders" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember" id="Fact000425" format="ixt:numdotdecimal" decimals="0" unitRef="USD">146,136</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Basic Net Income Per Common Share Available to Common Stockholders</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--EarningsPerShareBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_z6xWP734iu7l" title="Basic Net Income Per Common Share Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgSU5DT01FAA__"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-07-012024-06-30_custom_CommonStockholdersMember" id="Fact000427" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.56</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--EarningsPerShareBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zStrXpQFmQdc" title="Basic Net Income Per Common Share Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgSU5DT01FAA__" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-07-012023-06-30_custom_CommonStockholdersMember" id="Fact000429" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.35</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Diluted Net Income Per Common Share Available to Common Stockholders</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zkwIQeDPnyJg" title="Diluted Net Income Per Common Share Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgSU5DT01FAA__" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012024-06-30_custom_CommonStockholdersMember" id="Fact000431" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.53</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_ziiuSV1EVVbh" title="Diluted Net Income Per Common Share Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgSU5DT01FAA__" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-07-012023-06-30_custom_CommonStockholdersMember" id="Fact000433" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.32</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Basic and Diluted Income Per Share &#8211;&#160;Class C Common</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--EarningsPerShareBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zOcFCAKDPAg4" title="Basic Net Income Per Common Share Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgSU5DT01FAA__"><span id="xdx_90E_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zmsOWkp97Wd9" title="Diluted Net Income Per Common Share Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgSU5DT01FAA__"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember" id="Fact000435" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember" id="Fact000437" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.44</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--EarningsPerShareBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zTIRiBrvuDDe" title="Basic Net Income Per Common Share Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgSU5DT01FAA__"><span id="xdx_900_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zIryZyq226Af" title="Diluted Net Income Per Common Share Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgSU5DT01FAA__"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember" id="Fact000439" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember" id="Fact000441" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.38</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Weighted Average Basic Shares Outstanding &#8211; Common Stockholders</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zH8EpRkyApdg" title="Weighted Average Basic Shares Outstanding - Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgSU5DT01FAA__" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-012024-06-30_custom_CommonStockholdersMember" id="Fact000443" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,350,862</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zu0AgFCJWfS4" title="Weighted Average Number of Shares Outstanding, Basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgSU5DT01FAA__" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-012023-06-30_custom_CommonStockholdersMember" id="Fact000445" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,539,376</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Weighted Average Diluted Shares Outstanding &#8211; Common Stockholders</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zIU5ziiOYFd7" title="Weighted Average Diluted Shares Outstanding - Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgSU5DT01FAA__" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-07-012024-06-30_custom_CommonStockholdersMember" id="Fact000447" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,478,366</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220701__20230630__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_z0v9fDpx2Dy4" title="Weighted Average Diluted Shares Outstanding - Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgSU5DT01FAA__" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-07-012023-06-30_custom_CommonStockholdersMember" id="Fact000449" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,666,880</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Weighted Average Basic and Diluted Shares Outstanding &#8211; Class C Common</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zDmFZeo76fdj" title="Weighted Average Basic Shares Outstanding - Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgSU5DT01FAA__"><span id="xdx_904_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zJF9dRQb1uSb" title="Weighted Average Diluted Shares Outstanding - Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgSU5DT01FAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember" id="Fact000451" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember" id="Fact000453" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zwVjLH4qfGs6" title="Weighted Average Basic Shares Outstanding - Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgSU5DT01FAA__"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z3lS5LyntYD9" title="Weighted Average Diluted Shares Outstanding - Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgSU5DT01FAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember" id="Fact000455" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember" id="Fact000457" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 46; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="b_004"></span>CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FOR THE YEARS ENDED JUNE 30, 2024 AND 2023</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_303_114_zJH3RRrwVBD8" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_custom--ClassANonVotingPreferredMember_zaJCA4Dz6Ft7" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BA_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zBIHp43yt7K4" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_custom--ClassCCommonStockMember_zXgzx4trX60a" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class A Non-Voting Preferred</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Common Shares</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Stock Amount</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class C Common Stock</td></tr>
  <tr id="xdx_431_c20220701__20230630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_z4Pq4ud7fDG7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 40%; text-indent: -11pt">Balance, July 1, 2022</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredMember" id="Fact000459" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharesOutstanding_iS_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zL7ExZIVxZo3" title="Beginning balance, shares" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" id="Fact000463" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,554,210</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" id="Fact000460" format="ixt:numdotdecimal" decimals="0" unitRef="USD">657</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_custom_ClassCCommonStockMember" id="Fact000461" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--ProfitLoss_zAWLEA2ZEIQ8" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0465">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0466">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0467">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--StockRepurchasedDuringPeriodValue_iN_di_zgVa0U6tzhe1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Purchase of treasury shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0469">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0470">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0471">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationForfeited_zt85qCQGfzNa" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Cancellation of shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0473">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zf4s10hzP4Fl" title="Cancellation of shares, shares" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="Fact000477" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">103,328</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="Fact000474" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0475">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_zmwGDDpFNOta" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Distributions to noncontrolling interests</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0479">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0480">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0481">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20230701__20240630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zOhiSVRYOvJ5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Balance, June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredMember" id="Fact000483" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZyp6sg40Gi1" title="Beginning balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember958664140" id="Fact000487" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,450,882</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember958664140" id="Fact000484" format="ixt:numdotdecimal" decimals="0" unitRef="USD">647</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_custom_ClassCCommonStockMember" id="Fact000485" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ProfitLoss_zfY59wfz2jdc" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0489">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0490">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0491">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--StockRepurchasedDuringPeriodValue_iN_di_zJkMP6NrZ2dg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Purchase of treasury shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0493">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0494">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0495">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationForfeited_zTJTxqSy0ak9" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Cancellation of shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0497">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zeGWtBvqFvN7" title="Cancellation of shares, shares" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000501" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">122,588</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000498" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">12</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0499">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_zb9WQChuoJT8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Distributions to noncontrolling interests</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0503">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0504">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0505">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_436_c20230701__20240630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zHOupUN1bP4e" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Balance, June 30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredMember" id="Fact000507" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iE_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zuDBjV6rcki8" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember958664218" id="Fact000511" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,328,294</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember958664218" id="Fact000508" format="ixt:numdotdecimal" decimals="0" unitRef="USD">635</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_custom_ClassCCommonStockMember" id="Fact000509" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zo1gZ6gGlvc1" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BA_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zumBduDnMief" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Paid-in Capital in Excess of Par Value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Accumulated Deficit</td></tr>
  <tr id="xdx_434_c20220701__20230630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zj4EG4Q5fvT9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-indent: -11pt">Balance, July 1, 2022</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000513" format="ixt:numdotdecimal" decimals="0" unitRef="USD">184,531,535</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember" id="Fact000514" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">33,566,757</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--ProfitLoss_zRdfjBtINmb7" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0516">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="Fact000517" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,375,776</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--StockRepurchasedDuringPeriodValue_iN_di_zUd25tNWLH4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Purchase of treasury shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0519">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0520">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationForfeited_zUaOtB9OQkKg" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Cancellation of shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000522" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,919,017</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0523">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_zpdTuMSsIp58" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Distributions to noncontrolling interests</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0525">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0526">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43C_c20230701__20240630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_z0qz0r9VWrN3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Balance, June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000528" format="ixt:numdotdecimal" decimals="0" unitRef="USD">182,612,518</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember" id="Fact000529" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">24,190,981</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--ProfitLoss_zMnAx6rgsSK2" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0531">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="Fact000532" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,567,396</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--StockRepurchasedDuringPeriodValue_iN_di_zp1xPyaWxr32" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Purchase of treasury shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0534">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0535">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationForfeited_zyJmSMRMxazd" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Cancellation of shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000537" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,005,008</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0538">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_zFZZxDTQ45xb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Distributions to noncontrolling interests</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0540">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0541">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_436_c20230701__20240630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zQV32Yhn6iDj" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Balance, June 30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000543" format="ixt:numdotdecimal" decimals="0" unitRef="USD">180,607,510</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember" id="Fact000544" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">13,623,585</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">See accompanying notes to consolidated financial statements.<br/></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 47; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FOR THE YEARS ENDED JUNE 30, 2024 AND 2023</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B9_us-gaap--StatementEquityComponentsAxis_us-gaap--TreasuryStockCommonMember_zyZY5Hxc2zp" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B0_us-gaap--StatementEquityComponentsAxis_us-gaap--NoncontrollingInterestMember_znC4J0Uod00f" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B6_zCNJbRBIBHWb" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Treasury Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Noncontrolling Interests</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td></tr>
  <tr id="xdx_431_c20220701__20230630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_z1NCIlsnjPG3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 46%; text-indent: -11pt">Balance, July 1, 2022</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000546" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">675,390</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember" id="Fact000547" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,053,833</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30" id="Fact000548" format="ixt:numdotdecimal" decimals="0" unitRef="USD">146,236,281</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ProfitLoss_zcaPbTVQ4Zwk" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0550">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30_us-gaap_NoncontrollingInterestMember" id="Fact000551" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,750,740</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30" id="Fact000552" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,126,516</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--StockRepurchasedDuringPeriodValue_iN_di_zJ53LCVgHV54" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Purchase of treasury shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012023-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000554" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,759,457</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0555">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012023-06-30" id="Fact000556" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,759,457</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationForfeited_zVxB2hyuodV6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Cancellation of shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2022-07-012023-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000558" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,919,027</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0559">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0560">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_zGzyxt5zqaK9" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Distributions to noncontrolling interests</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0562">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012023-06-30_us-gaap_NoncontrollingInterestMember" id="Fact000563" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,776,200</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012023-06-30" id="Fact000564" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,776,200</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_436_c20230701__20240630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zqgLVe2BshQd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Balance, June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000566" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">515,820</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_NoncontrollingInterestMember" id="Fact000567" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,079,293</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30" id="Fact000568" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,827,140</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ProfitLoss_zKZPeav882d9" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0570">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012024-06-30_us-gaap_NoncontrollingInterestMember" id="Fact000571" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,530,021</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-01to2024-06-30" id="Fact000572" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,097,417</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--StockRepurchasedDuringPeriodValue_iN_di_z8INMDu8gVli" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Purchase of treasury shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000574" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,505,832</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0575">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-01to2024-06-30" id="Fact000576" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,505,832</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationForfeited_zLN6tCIipfH7" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Cancellation of shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000578" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,005,020</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0579">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0580">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_zzZiRmxogyHg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Distributions to noncontrolling interests</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0582">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012024-06-30_us-gaap_NoncontrollingInterestMember" id="Fact000583" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,630,336</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-01to2024-06-30" id="Fact000584" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,630,336</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43B_c20230701__20240630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zXNNw2tPp03k" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Balance, June 30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000586" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,016,632</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_NoncontrollingInterestMember" id="Fact000587" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,179,608</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30" id="Fact000588" format="ixt:numdotdecimal" decimals="0" unitRef="USD">156,788,389</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 48; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="b_005"></span>CONSOLIDATED STATEMENTS OF CASH FLOWS</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_301_112_z95nOt1KFaJ3" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20230701__20240630_znVyjqFh8S0f" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20220701__20230630_zMp1HGT5U7Qk" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30,</td></tr>
  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zZgV6Q8hvnBh" style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">CASH FLOWS FROM OPERATING ACTIVITIES</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_40D_eus-gaap--ProfitLoss_maNCPBUzS6D_zapCuUY1WmRe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Net Income</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-01to2024-06-30" id="Fact000593" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,097,417</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30" id="Fact000594" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,126,516</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_iB_zeCTzZMIbmw" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Adjustments to reconcile net income to net cash provided by operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DepreciationAndAmortization_i01_maNCPBUzS6D_z58G0VbmsNX7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2023-07-01to2024-06-30" id="Fact000599" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,596,421</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2022-07-012023-06-30" id="Fact000600" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,540,135</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--ProvisionForBadDebts_i01_maNCPBUzS6D_zi27g5U9rYeb" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Provision for credit losses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:ProvisionForBadDebts" contextRef="From2023-07-01to2024-06-30" id="Fact000602" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,882,061</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:ProvisionForBadDebts" contextRef="From2022-07-012023-06-30" id="Fact000603" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,513,476</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredIncomeTaxExpenseBenefit_i01_maNCPBUzS6D_zZllOykZfCk7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Deferred income tax - net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2023-07-01to2024-06-30" id="Fact000605" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,795,507</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2022-07-012023-06-30" id="Fact000606" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,979,550</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_i01_maNCPBUzS6D_zpU2hbLYxxe9" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Amortization on right-of-use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2023-07-01to2024-06-30" id="Fact000608" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,311,762</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2022-07-012023-06-30" id="Fact000609" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,264,818</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--GainOnSaleOfEquipmentRelatedParty_i01N_di_msNCPBUzS6D_zdf5c6qOpB77" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Gain on sale of equipment &#8211; related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="FONR:GainOnSaleOfEquipmentRelatedParty" contextRef="From2023-07-01to2024-06-30" id="Fact000611" format="ixt:numdotdecimal" decimals="0" unitRef="USD">581,183</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0612">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--GainlossOnDispositionOfFixedAssets_iN_di_msNCPBUzS6D_zrvQBrgnPbgd" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">(Gain)Loss on disposition of fixed assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="FONR:GainlossOnDispositionOfFixedAssets" contextRef="From2023-07-01to2024-06-30" id="Fact000614" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75,411</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:GainlossOnDispositionOfFixedAssets" contextRef="From2022-07-012023-06-30" id="Fact000615" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">213,244</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--AbandonedPatents_d0_maNCPBUzS6D_z9v9wX3ZyRO8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Abandoned patents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:AbandonedPatents" contextRef="From2023-07-01to2024-06-30" id="Fact000617" format="ixt:numdotdecimal" decimals="0" unitRef="USD">225,419</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:AbandonedPatents" contextRef="From2022-07-012023-06-30" id="Fact000618" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInOperatingAssetsAbstract_iB_zxxEhew2P4O1" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Changes in assets and liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInAccountsReceivable_i01N_di_msNCPBUzS6D_zpOZUY0K75G8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Accounts, medical and management fee receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2023-07-01to2024-06-30" id="Fact000623" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,676,139</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2022-07-012023-06-30" id="Fact000624" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,055,843</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_ecustom--IncreaseDecreaseInNotesReceivable_i01_maNCPBUzS6D_z8LZWfc6QNij" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Notes receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:IncreaseDecreaseInNotesReceivable" contextRef="From2023-07-01to2024-06-30" id="Fact000626" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,200</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="FONR:IncreaseDecreaseInNotesReceivable" contextRef="From2022-07-012023-06-30" id="Fact000627" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">64,532</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInInventories_i01N_di_msNCPBUzS6D_z9hxUEZJQImi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2023-07-01to2024-06-30" id="Fact000629" format="ixt:numdotdecimal" decimals="0" unitRef="USD">145,775</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2022-07-012023-06-30" id="Fact000630" format="ixt:numdotdecimal" decimals="0" unitRef="USD">209,845</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i01N_di_msNCPBUzS6D_zY8F5W1Kbw08" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2023-07-01to2024-06-30" id="Fact000632" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">266,606</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2022-07-012023-06-30" id="Fact000633" format="ixt:numdotdecimal" decimals="0" unitRef="USD">438,911</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInOtherNoncurrentAssets_i01N_di_msNCPBUzS6D_z6cIvcVkRf5i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Other assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2023-07-01to2024-06-30" id="Fact000635" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">42,359</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2022-07-012023-06-30" id="Fact000636" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,763</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInAccountsPayable_i01_maNCPBUzS6D_zntuCpt7X3u8" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2023-07-01to2024-06-30" id="Fact000638" format="ixt:numdotdecimal" decimals="0" unitRef="USD">276,639</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2022-07-012023-06-30" id="Fact000639" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,685</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--IncreaseDecreaseInOtherCurrentLiabilities_i01_maNCPBUzS6D_zDcbLMmmDVGg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Other current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2023-07-01to2024-06-30" id="Fact000641" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,949,962</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2022-07-012023-06-30" id="Fact000642" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,527,100</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_ecustom--IncreaseDecreaseInCustomerAdvance_i01_maNCPBUzS6D_zmA0YnkOibF9" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Customer advances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="FONR:IncreaseDecreaseInCustomerAdvance" contextRef="From2023-07-01to2024-06-30" id="Fact000644" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">158,906</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:IncreaseDecreaseInCustomerAdvance" contextRef="From2022-07-012023-06-30" id="Fact000645" format="ixt:numdotdecimal" decimals="0" unitRef="USD">241,132</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_i01_maNCPBUzS6D_zLhNtoTplWf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2023-07-01to2024-06-30" id="Fact000647" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,541,352</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2022-07-012023-06-30" id="Fact000648" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,862,814</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInTradingLiabilities_i01_maNCPBUzS6D_ztO4AvK11q81" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Financing lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInTradingLiabilities" contextRef="From2023-07-01to2024-06-30" id="Fact000650" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">217,569</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInTradingLiabilities" contextRef="From2022-07-012023-06-30" id="Fact000651" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">210,353</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--IncreaseDecreaseInOtherAccruedLiabilities_i01_maNCPBUzS6D_ze5TzX11mWQ3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Other liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" contextRef="From2023-07-01to2024-06-30" id="Fact000653" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,724</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" contextRef="From2022-07-012023-06-30" id="Fact000654" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">64,791</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtNCPBUzS6D_maCCERCzgW3_zNlHcnwfiETk" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">NET CASH PROVIDED BY OPERATING ACTIVITIES</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-07-01to2024-06-30" id="Fact000656" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,093,294</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-07-012023-06-30" id="Fact000657" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,467,130</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 49; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zRtw9EgpWjp8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">CASH FLOWS FROM INVESTING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUzoxO_z2SaSRmWPZb6" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Purchases of property and equipment</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2023-07-01to2024-06-30" id="Fact000662" format="ixt:numdotdecimal" decimals="0" unitRef="USD">789,961</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2022-07-012023-06-30" id="Fact000663" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,218,084</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--PaymentsForProceedsFromShortTermInvestments_i01N_di_msNCPBUzoxO_z3hXaH7Tve45" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Purchase of Short-term investment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsForProceedsFromShortTermInvestments" contextRef="From2023-07-01to2024-06-30" id="Fact000665" format="ixt:numdotdecimal" decimals="0" unitRef="USD">103,303</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsForProceedsFromShortTermInvestments" contextRef="From2022-07-012023-06-30" id="Fact000666" format="ixt:numdotdecimal" decimals="0" unitRef="USD">473</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--ProceedsFromSaleOfPropertyPlantAndEquipment_i01_d0_maNCPBUzoxO_zmBIedQ9EoIi" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Proceeds from sale of equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" contextRef="From2023-07-01to2024-06-30" id="Fact000668" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75,411</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" contextRef="From2022-07-012023-06-30" id="Fact000669" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--PaymentsToAcquireIntangibleAssets_iN_di_msNCPBUzoxO_zn6yz49rvte" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Cost of patents</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2023-07-01to2024-06-30" id="Fact000671" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,885</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2022-07-012023-06-30" id="Fact000672" format="ixt:numdotdecimal" decimals="0" unitRef="USD">119,571</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInInvestingActivities_iT_mtNCPBUzoxO_maCCERCzgW3_zGwjWrRja28c" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">NET CASH USED IN INVESTING ACTIVITIES</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-07-01to2024-06-30" id="Fact000674" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">850,738</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-07-012023-06-30" id="Fact000675" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,338,128</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zD9FUcPbhCV7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">CASH FLOWS FROM FINANCING ACTIVITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--RepaymentsOfNotesPayable_i01N_di_msNCPBUzOn6_zsmCovjssBZ1" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Repayment of borrowings and capital lease obligations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2023-07-01to2024-06-30" id="Fact000680" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,902</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2022-07-012023-06-30" id="Fact000681" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,615</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--PaymentsForRepurchaseOfEquity_i01N_di_msNCPBUzOn6_zG80azg53dl7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Purchase of treasury stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfEquity" contextRef="From2023-07-01to2024-06-30" id="Fact000683" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,505,832</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfEquity" contextRef="From2022-07-012023-06-30" id="Fact000684" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,759,457</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--PaymentsOfDividendsMinorityInterest_i01N_di_msNCPBUzOn6_zy7qnGhXmLx5" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Distributions to noncontrolling interests</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2023-07-01to2024-06-30" id="Fact000686" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,630,336</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2022-07-012023-06-30" id="Fact000687" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,776,200</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzOn6_maCCERCzgW3_zL5BSApjwn2j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">NET CASH USED IN FINANCING ACTIVITIES</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-07-01to2024-06-30" id="Fact000689" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,181,070</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-07-012023-06-30" id="Fact000690" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,572,272</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_i01T_mtCCERCzgW3_zaTyu0wVoIuj" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">NET INCREASE IN CASH AND CASH EQUIVALENTS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2023-07-01to2024-06-30" id="Fact000692" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,061,486</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2022-07-012023-06-30" id="Fact000693" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,556,730</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01S_zXSm9je29PGi" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-06-30" id="Fact000695" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,279,707</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-06-30" id="Fact000696" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,722,977</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01E_zll3DTK7POhc" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">CASH AND CASH EQUIVALENTS - END OF YEAR</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2024-06-30" id="Fact000698" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,341,193</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-06-30" id="Fact000699" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,279,707</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 50; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="b_006"></span>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000701" name="us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock"><p id="xdx_808_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_z6rKFXjrXCi9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 1 - <span id="xdx_822_z4fTfDmZVo21">DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Description of Business</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR Corporation (the &#8220;Company&#8221; or &#8220;FONAR&#8221;)
is a Delaware corporation, which was incorporated on July 17, 1978. FONAR is engaged in the research, development, production and marketing
of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (&#8220;MRI&#8221;) for the detection and diagnosis
of human diseases. In addition to deriving revenues from the direct sale of MRI equipment, revenue is also generated from our installed-base
of customers through our service and upgrade programs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR, through its wholly-owned subsidiary Health
Management Corporation of America (&#8220;HMCA&#8221;) provides comprehensive management services to diagnostic imaging facilities. The
services provided by the Company include development, administration, leasing of office space, facilities and medical equipment, provision
of supplies, staffing and supervision of non-medical personnel, legal services, accounting, billing and collection and the development
and implementation of practice growth and marketing strategies.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 1, 2015, the Company restructured the corporate
organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely
integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized
in the business of Health Management Corporation of America) to HDM and received a <span id="xdx_907_eus-gaap--InvestmentOwnedPercentOfNetAssets_iI_dp_c20150701__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_z9afFNvkf4n3" title="Interest received percentage"><ix:nonFraction name="us-gaap:InvestmentOwnedPercentOfNetAssets" contextRef="AsOf2015-07-01_us-gaap_OtherInvesteesMember" id="Fact000703" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24.2</ix:nonFraction></span>% interest in HDM. Health Management Corporation
of America retained a direct ownership interest of <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20150701__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zb83N4OFrGSk" title="Ownership interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2015-07-01_us-gaap_OtherInvesteesMember" id="Fact000705" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">45.8</ix:nonFraction></span>% in HDM, and the original investors in HDM retained a <span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20150701__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zABV9QRzTqZj" title="Ownership interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember" id="Fact000707" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">30.0</ix:nonFraction></span>% ownership interest
in the newly expanded HDM. During the year ended June 30, 2022, the Company purchased noncontrolling interests for $<span id="xdx_904_eus-gaap--ProceedsFromPaymentsToMinorityShareholders_c20210701__20220630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zed18GeiCmL7" title="Non-controlling interests from the minority shareholders"><ix:nonFraction name="us-gaap:ProceedsFromPaymentsToMinorityShareholders" contextRef="From2021-07-012022-06-30_us-gaap_OtherInvesteesMember" id="Fact000709" format="ixt:numdotdecimal" decimals="0" unitRef="USD">546,000</ix:nonFraction></span> giving the
Company a direct ownership interest of <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20220630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zycUAw1DDfJc" title="Ownership interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2022-06-30_us-gaap_OtherInvesteesMember" id="Fact000711" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">70.8</ix:nonFraction></span>% and the investors&#8217; a <span id="xdx_901_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zeEsYG8cPVpe" title="Ownership interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember" id="Fact000713" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">29.2</ix:nonFraction></span>% ownership interest. The entire management of diagnostic
imaging centers business segment is now being conducted by HDM.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000715" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_80A_eus-gaap--SignificantAccountingPoliciesTextBlock_zHYHmiqo2pn8" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 2 - <span id="xdx_82D_z5LNp253d4Kb">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000717" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zwyUDgDQDNFi" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_869_z2pxossBaQ4j">Principles of Consolidation</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements include the
accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships. The operating activities of subsidiaries are
included in the accompanying consolidated statements from the date of acquisition. All significant intercompany accounts and transactions
have been eliminated in consolidation.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><p id="xdx_236_z9Wu3jPnshXe" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 51; Value: 2 -->
    <div id="xdx_237_zjCsxUOG09a3" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23F_zvo7bQBLdtM9" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_z0NJBn3gTJn" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_235_zjOa03ba3i58" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zKeBrgB1OBFf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_239_zE4hk8gX00Ih" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_237_zlomoRZCs9N5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zKSsxVffn6a" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zXtLEXVYs0mf" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000727" name="us-gaap:UseOfEstimates"><p id="xdx_84E_eus-gaap--UseOfEstimates_zqEKKHEfG9S9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_865_zDrffM0Rk6Ua">Use of Estimates</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the consolidated financial statements
in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities in the consolidated financial
statements and accompanying notes. The most significant estimates relate to receivable allowances, income taxes and related tax asset
valuation allowances, contingencies, and revenue recognition. In addition, healthcare industry reforms and reimbursement practices will
continue to impact the Company&#8217;s operations and the determination of contractual and other allowance estimates. Actual results could
differ from those estimates.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000729" name="us-gaap:InventoryWorkInProcessPolicy"><p id="xdx_84E_eus-gaap--InventoryWorkInProcessPolicy_zJRpuO4jgf7e" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_860_zYX965COlutb">Inventories</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventories consist of purchased parts, components
and supplies, as well as work-in-process, and are stated at the lower of cost or net realizable value.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000731" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zDew3dopOlpd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_865_z84usRR4a1s">Property and Equipment</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment procured in the normal course
of business is stated at cost less accumulated depreciation. Property and equipment purchased in connection with an acquisition is stated
at its estimated fair value, generally based on an appraisal. Property and equipment is being depreciated for financial accounting purposes
using the straight-line method over their estimated useful lives. Leasehold improvements are being amortized over the shorter of the useful
life or the remaining lease term. Upon retirement or other disposition of these assets, the cost and related accumulated depreciation
of these assets are removed from the accounts and the resulting gains or losses are reflected in the results of operations. Expenses for
maintenance and repairs are charged to operations. Renewals and betterments are capitalized. Maintenance and repair expenses totaled approximately
$<span id="xdx_90A_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20230701__20240630_zvKqLaoduv4e" title="Maintenance and repair expenses"><ix:nonFraction name="us-gaap:CostOfPropertyRepairsAndMaintenance" contextRef="From2023-07-01to2024-06-30" id="Fact000733" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,948,000</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20220701__20230630_zULLmiJZg0Ba" title="Maintenance and repair expenses"><ix:nonFraction name="us-gaap:CostOfPropertyRepairsAndMaintenance" contextRef="From2022-07-012023-06-30" id="Fact000735" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,801,000</ix:nonFraction></span> for the years ended June 30, 2024 and 2023 respectively. The estimated useful lives in years are generally as
follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000737" name="FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock"><table cellspacing="0" cellpadding="0" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)" id="xdx_88E_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_z1vIwy6ZISK9" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td colspan="3" style="border-bottom: Black 1pt solid; padding: 0pt; text-align: left; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_8BF_zs2gNJdAoczg" style="display: none">Schedule
of estimated useful life in years for property and equipment</span></span></td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: bottom; width: 87%; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Diagnostic equipment</span></td>
<td style="padding: 0pt; vertical-align: bottom; width: 12%; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zLKj6odAoCG5"><ix:nonNumeric contextRef="AsOf2024-06-30_srt_MinimumMember_custom_DiagnosticEquipmentMember" format="ixt-sec:duryear" id="Fact000738" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span>&#8211;<span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_z15gqxQVKlt" title="Estimated useful lives"><ix:nonNumeric contextRef="AsOf2024-06-30_srt_MaximumMember_custom_DiagnosticEquipmentMember" format="ixt-sec:duryear" id="Fact000740" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">13</ix:nonNumeric></span></span></td>
<td style="padding: 0pt; width: 1%; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Research, development and demonstration equipment</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zD1kMI5H9Pfk"><ix:nonNumeric contextRef="AsOf2024-06-30_srt_MinimumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember" format="ixt-sec:duryear" id="Fact000741" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span>-<span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_z6eK5e3xFzCa"><ix:nonNumeric contextRef="AsOf2024-06-30_srt_MaximumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember" format="ixt-sec:duryear" id="Fact000742" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">7</ix:nonNumeric></span></span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Machinery and equipment</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_za6eX1JyjcW7"><ix:nonNumeric contextRef="AsOf2024-06-30_srt_MinimumMember_us-gaap_MachineryAndEquipmentMember" format="ixt-sec:duryear" id="Fact000743" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">2</ix:nonNumeric></span>-<span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zHXeZQTExWYd"><ix:nonNumeric contextRef="AsOf2024-06-30_srt_MaximumMember_us-gaap_MachineryAndEquipmentMember" format="ixt-sec:duryear" id="Fact000744" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">7</ix:nonNumeric></span></span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Furniture and fixtures</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zPVJ7nKtC0lg"><ix:nonNumeric contextRef="AsOf2024-06-30_srt_MinimumMember_us-gaap_FurnitureAndFixturesMember" format="ixt-sec:duryear" id="Fact000745" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span>-<span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z2TR8Wlv23Fc"><ix:nonNumeric contextRef="AsOf2024-06-30_srt_MaximumMember_us-gaap_FurnitureAndFixturesMember" format="ixt-sec:duryear" id="Fact000746" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">9</ix:nonNumeric></span></span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Leasehold improvements</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zy1haNsqvvPb"><ix:nonNumeric contextRef="AsOf2024-06-30_srt_MinimumMember_us-gaap_LeaseholdImprovementsMember" format="ixt-sec:duryear" id="Fact000747" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span>&#8211;<span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z3GQyurSiPwa"><ix:nonNumeric contextRef="AsOf2024-06-30_srt_MaximumMember_us-gaap_LeaseholdImprovementsMember" format="ixt-sec:duryear" id="Fact000748" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">10</ix:nonNumeric></span></span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Building</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--WeightedAverageMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zP9U3mTibM8l" title="Estimated useful lives"><ix:nonNumeric contextRef="AsOf2024-06-30_srt_WeightedAverageMember_us-gaap_BuildingMember" format="ixt-sec:duryear" id="Fact000750" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">28</ix:nonNumeric></span></span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><p id="xdx_234_zIfwbfIG5Om4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 52; Value: 2 -->
    <div id="xdx_23B_zXBc6acnmkTj" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_230_zP52jN2C8Jhb" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zylJg2P58onf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zzoQWkOlpa7e" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_233_zef3LxWyEsM1" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zpBymEFG6jik" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zYLcENu50eJd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zw4gYin4pEac" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zIpEBipk1yUg" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000760" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"><p id="xdx_842_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zhUDRnXmYAj4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_862_zAIQkiz1EDza">Long-Lived Assets</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company periodically assesses the recoverability
of long-lived assets, including property and equipment and intangibles, other than goodwill, when events or changes in circumstances indicate
that the carrying value of long-lived assets may not be recoverable. If indicators are present, the Company performs a recoverability
test by comparing the sum of the estimated undiscounted future cash flows attributable to the asset group in question to its carrying
amount. An impairment loss is recognized if it is determined that the long-lived asset group is not recoverable and is calculated by comparing
the discounted future cash flows with the carrying value of the related asset group. In performing this analysis, management considers
such factors as current results, trends, and future prospects, in addition to other economic factors.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000762" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock"><p id="xdx_84C_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zpdPcnvzbad3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_860_zfvdavdczYO5">Other Intangible Assets</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">1) Patents and Copyrights</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Patent and copyrights are professional costs incurred
to acquire certain patent and copyrights. Amortization is calculated on the straight-line basis over <span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zAvQaEtly327" title="Finite-lived intangible asset, useful life"><ix:nonNumeric contextRef="AsOf2024-06-30_us-gaap_IntellectualPropertyMember" format="ixt-sec:duryear" id="Fact000764" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">15</ix:nonNumeric></span> years.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">2) Non-Competition Agreements</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The non-competition agreements are agreements entered
into with past principal owners of entities that the Company had acquired. The non-competition agreements are being amortized on the straight-line
basis over the length of the agreement (<span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_z0tdVFCqcb8j" title="Finite-lived intangible asset, useful life"><ix:nonNumeric contextRef="AsOf2024-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt-sec:duryear" id="Fact000766" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">7</ix:nonNumeric></span> years).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">3) Customer Relationships</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Customer relationships represents customer lists acquired
in acquisition of prior entities. Amortization is calculated on the straight-line basis over <span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zhmAQeXD3XE8" title="Finite-lived intangible asset, useful life"><ix:nonNumeric contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear" id="Fact000768" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">20</ix:nonNumeric></span> years.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000770" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy"><p id="xdx_847_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_ztol9VfCLX07" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_866_ze2XHKlM2Ggl">Goodwill</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Goodwill represents the cost of a business acquisition
in excess of the fair value of the net assets acquired. Goodwill is not amortized and is reviewed for impairment annually, or more frequently
if facts and circumstances indicate that it is more likely than not that the fair value of the reporting unit is less than its carrying
amount including goodwill. If it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the
Company performs a quantitative test to identify and measure the amount of goodwill impairment loss. The Company compares the fair value
of the reporting unit with its carrying amount. If the carrying amount exceeds fair value, goodwill of the reporting unit is considered
impaired, and that excess is recognized as a goodwill impairment loss.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><p id="xdx_23C_zXsCgUw5AGi5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 53; Value: 2 -->
    <div id="xdx_233_z4hVTIx51IT6" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23B_zR0PTyWMxkJi" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zKkWKrpP4292" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zQkcMORsfVa4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_znmzhQSSk5C2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_235_z1HCVWBjVbm" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_232_zALQAxGGPjU6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zxY6Rf76lbud" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zKRf57Cz8jO4" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000780" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zjVfGdP4cLJl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_867_zdNR78TDJ4c4">Revenue Recognition</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue on sales contracts for scanners, included
in &#8220;product sales&#8221; in the accompanying consolidated statements of operations, is recognized under the percentage-of-completion
method in accordance with FASB ASC 606, &#8220;Revenue Recognition &#8211; Construction-Type and Production-Type Contracts&#8221;. The
Company manufactures its scanners under specific contracts that provide for progress payments. Production and installation take approximately
three to six months.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue on scanner service contracts is recognized
on the straight-line method over the related contract period, usually one year. As of June 30, 2023, the Company had unearned revenue
on service contracts of $3,832,184 of which all was recognized as revenue in the fiscal year ending June 30, 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue from product sales (upgrades and supplies)
is recognized upon shipment.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue under management contracts is recognized
based upon contractual agreements for management services rendered by the Company primarily under various long-term agreements with
various medical providers (the &#8220;PCs&#8221;). As of June 30, 2024, the Company has <span id="xdx_90E_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20240630_zXpwoYmmoGR3" title="Management agreements with company total medical practices"><ix:nonFraction name="FONR:ManagementAgreementsWithCompanyTotalMedicalPractices" contextRef="AsOf2024-06-30" id="Fact000782" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">22</ix:nonFraction></span>
management agreements of which <span id="xdx_90F_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20240630_zNWAb72g9LO9" title="Scanners with management agreements with company owned by related party"><ix:nonFraction name="FONR:ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" contextRef="AsOf2024-06-30" id="Fact000784" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">3</ix:nonFraction></span>
were with PC&#8217;s owned by Timothy Damadian, Chairman of the Board, President, Chief Executive Officer and Treasurer (formerly
owned by Raymond V. Damadian, M.D., Chairman of the Board of FONAR until his unexpected death in August 2022)(&#8220;the Related
medical practices&#8221;) and <span id="xdx_901_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20240630_zaNpGoUYnkHe" title="Scanners with management with company located in new york state"><ix:nonFraction name="FONR:ScannersWithManagementWithCompanyLocatedInNewYorkState" contextRef="AsOf2024-06-30" id="Fact000786" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">19</ix:nonFraction></span>
are with PC&#8217;s, which are all located in the state of New York (&#8220;the New York PC&#8217;s&#8221;), owned by two unrelated
radiologists. The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility
ranging from approximately $<span id="xdx_90E_ecustom--ContractualFeesForServicesRenderedMinimum_iI_pdp0_c20240630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zjiq4LJFqZza" title="Contractual fees for services rendered minimum"><ix:nonFraction name="FONR:ContractualFeesForServicesRenderedMinimum" contextRef="AsOf2024-06-30_custom_DiagnosticImagingFacilityMember" id="Fact000788" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">84,000</ix:nonFraction></span>
to $<span id="xdx_905_ecustom--ContractualFeesForServicesRenderedMaximum_iI_c20240630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zHPpdazHDQgg" title="Contractual fees for services rendered maximum"><ix:nonFraction name="FONR:ContractualFeesForServicesRenderedMaximum" contextRef="AsOf2024-06-30_custom_DiagnosticImagingFacilityMember" id="Fact000790" format="ixt:numdotdecimal" decimals="0" unitRef="USD">447,000</ix:nonFraction></span>.
All fees are re-negotiable at the anniversary of the agreements and each year thereafter. The Company records a credit loss expense for
estimated uncollectible fees, which is reflected in other operating expenses on the Consolidated Statement of Operations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company currently recognizes revenue in accordance
with the recognition accounting standard issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;) and codified in the ASC
as topic 606 (&#8220;ASC 606&#8221;). The revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing
revenue as performance obligations, defined in a contract with a customer as goods or services transferred to the customer in exchange
for consideration, are satisfied. The standard also requires expanded disclosures regarding the Company&#8217;s revenue recognition policies
and significant judgments employed in the determination of revenue.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><p id="xdx_235_zNwO2PNxHjSa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 54; Value: 2 -->
    <div id="xdx_235_zzaRdQ1QvMjd" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_230_zIpxAfEkHsTj" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zF8ms59Krbxh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zLJkFZXPXES4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_z0BKEusDc6t9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_237_zSMhdsW7Wuc9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_238_zPphvjzK5AX2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zDRTCkBe7Eo9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_236_zrVswvcpPmM7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_232_zRgugWMklDia" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue Recognition (Continued)</p></ix:exclude>

<ix:exclude><p id="xdx_238_zsR6dMdmEnnk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s revenues generally relate to net
patient fees&#160;received from various payers and patients themselves under contracts in which our performance obligations are to provide
diagnostic services to the patients. Revenues are recorded during the period our obligations to provide diagnostic services are satisfied.
Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships
with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health plans and commercial insurance
companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent
upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the
third-party payers. The payment arrangements with third-party payers for the services we provide to the related patients typically specify
payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services
or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates
to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s patient fee revenues, net of contractual
allowances and discounts for the years ended June 30, 2024 and 2023 are summarized in the following table.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000802" name="us-gaap:DisaggregationOfRevenueTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--DisaggregationOfRevenueTableTextBlock_zKieyjyUMs7l" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8B2_zibRPTtp76H6" style="display: none">Schedule of patient fee
    revenue - net</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Commercial Insurance/ Managed Care</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zQP7AjRvBfCb" title="Net Patient Fee Revenue" style="width: 12%; text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2023-07-012024-06-30_custom_CommercialInsuranceManagedCareMember" id="Fact000804" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,952,712</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zSWvqUvUpEb1" title="Net Patient Fee Revenue" style="width: 12%; text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2022-07-012023-06-30_custom_CommercialInsuranceManagedCareMember" id="Fact000806" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,124,646</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Medicare/Medicaid</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zgZLnk8r0RPj" title="Net Patient Fee Revenue" style="text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2023-07-012024-06-30_custom_MedicareMedicaidMember" id="Fact000808" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,138,176</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zUubfFwT39r" title="Net Patient Fee Revenue" style="text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2022-07-012023-06-30_custom_MedicareMedicaidMember" id="Fact000810" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,063,846</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Workers&#8217; Compensation/Personal Injury</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zPcuEffR23yd" title="Net Patient Fee Revenue" style="text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2023-07-012024-06-30_custom_WorkersCompensationPersonalInjuryMember" id="Fact000812" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,673,483</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zNq4J8jwHUGl" title="Net Patient Fee Revenue" style="text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2022-07-012023-06-30_custom_WorkersCompensationPersonalInjuryMember" id="Fact000814" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,670,019</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zVCGIZyggKpg" title="Net Patient Fee Revenue" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2023-07-012024-06-30_custom_OtherRevenueSourceMember" id="Fact000816" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,051,425</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zdne1tGYBBZ2" title="Net Patient Fee Revenue" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2022-07-012023-06-30_custom_OtherRevenueSourceMember" id="Fact000818" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,935,482</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Net Patient Fee Revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630_zpm5teBsyZ91" title="Net Patient Fee Revenue" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2023-07-01to2024-06-30" id="Fact000820" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,815,796</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630_zT2g27BSSgz8" title="Net Patient Fee Revenue" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2022-07-012023-06-30" id="Fact000822" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,793,993</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000824" name="FONR:MedicalReceivableAndManagementAndOtherFeesReceivablePolicyTextBlock"><p id="xdx_847_ecustom--MedicalReceivableAndManagementAndOtherFeesReceivablePolicyTextBlock_zQcxncB6FOvk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86A_z16itZ81ONV4">Medical Receivable and Management and Other Fees Receivable</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span>Medical Receivable</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management fees receivable is related to management fees outstanding
from the related and non related PCs under management agreements. The Company has established a current expected credit loss (&#8220;CECL&#8221;)
to address the risk that a portion of the contractually obligated management fees receivable from the PCs may not be paid. The PC&#8217;s
may be limited in their ability to pay the full management fee receivable if they do not collect sufficient expected fees from third-party
payers and patients. The Company&#8217;s management fees are collateralized, individually and collectively, by the assets of the PCs.
The CECL is determined based on the difference between the management fee receivable and the current amount of outstanding fees estimated
to be collected by the PCs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><p id="xdx_234_zeHRLuNeelk8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 55; Value: 2 -->
    <div id="xdx_230_zEZ20paBDrEj" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23F_zStZ5NB8r9X" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23B_zPVLTHh3wz63" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zbNfev46464f" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zAGtrxv9git6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_232_ziqyG54g4Vye" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zbDl1LeAr4Al" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zj9eJBkFBTx8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zoANRvvGui95" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span>Management and Other Fees Receivable</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management fees receivable is related to management
fees outstanding from the related and non related PCs under management agreements. The Company has established a current expected credit
loss (&#8220;CECL&#8221;) to address the risk that a portion of the contractually obligated management fees receivable from the PCs may
not be paid. The PC&#8217;s may be limited in their ability to pay the full management fee receivable if they do not collect sufficient
expected fees from third-party payers and patients. The Company&#8217;s management fees are collateralized, individually and collectively,
by the assets of the PCs. The CECL is determined based on the difference between the management fee receivable and the current amount
of outstanding fees estimated to be collected by the PCs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s considerations into the estimate
of the PC&#8217;s fee collection is based on a combination of factors. As each management agreement specifies the Company&#8217;s ultimate
collateral for unpaid management fees are the patient fee receivables owned by each PC, the Company considers the historical loss rates
to pools of receivables with similar risks characteristics, aging of the patient fee receivables, and the financial condition of each
PC. In addition, the Company subjectively adjusts its estimated expected credit losses for current and forward-looking economic conditions
which would include trends seen within the industry and newly enacted regulation. The Company also incorporates qualitative factors, such
as changes in the nature and volume of receivables, regulatory changes, and other relevant factors. Specifically, insurance carriers covering
automobile no-fault and workers compensation claims incur longer payment cycles and rigorous informational requirements and certain other
disallowed claims. Approximately 67% of the PCs&#8217; 2024 and 2023 net revenues were derived from no-fault and personal injury protection
claims.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; background-color: white">The Company combines
an objective and subjective loss-rate methodology to estimate expected credit losses based on the collateral owned by each PC. This involves
objectively using historical loss rates to pools of receivables with similar risk characteristics (i.e., various insurance payors) and
then subjectively adjusting for current and forward-looking economic conditions which would include trends seen within the industry and
newly enacted regulation. The Company also incorporates qualitative factors, such as changes in the nature and volume of the receivables,
regulatory changes, and other relevant factors.</p>

<p style="font: 11pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify">The provision for credit losses for the year
ended June 30, 2024 was $<span id="xdx_902_ecustom--ProvisionForBadDebts_c20230701__20240630_zyJjWYtgVg0e"><ix:nonFraction name="FONR:ProvisionForBadDebts" contextRef="From2023-07-01to2024-06-30" id="Fact000833" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,882,061</ix:nonFraction></span>. This can be attributable to an increase in scan volume at all the PC&#8217;s and due to the nature
of the payor classes, where there is a longer expected payment term. Additionally, newly proposed legislation around credit reporting
on individual medical debts increasing the likelihood of non-payment of individual patient accounts. The management fee receivable for
unrelated and related parties as of July 1, 2022 was $<span id="xdx_906_ecustom--ManagementFeeReceivableForUnrelatedParties_iI_c20220702_zkNt4LsmZD46"><ix:nonFraction name="FONR:ManagementFeeReceivableForUnrelatedParties" contextRef="AsOf2022-07-02" id="Fact000834" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,419,219</ix:nonFraction>
</span>and $<span id="xdx_908_ecustom--ManagementFeeReceivableForRelatedParties_iI_c20220702_zPKWt8qGodgf"><ix:nonFraction name="FONR:ManagementFeeReceivableForRelatedParties" contextRef="AsOf2022-07-02" id="Fact000835" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,602,561</ix:nonFraction></span>,
respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>




<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000837" name="us-gaap:ReceivablesPolicyTextBlock"><p id="xdx_84F_eus-gaap--ReceivablesPolicyTextBlock_zM7aYnXv6Xpd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86C_zkRXn4BeEfgg">Accounts Receivable</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Credit risk with respect to the Company&#8217;s
accounts receivable related to product sales and service and repair fees is limited due to the customer advances received prior to the
commencement of work performed and the billing of amounts to customers as sub-assemblies are completed. Service and repair fees are billed
on a monthly or quarterly basis and the Company does not continue providing these services if accounts receivable become past due. The
Company controls credit risk with respect to accounts receivable from service and repair fees through its credit evaluation process,
credit limits, monitoring procedures and reasonably short collection terms. The Company performs ongoing credit authorizations before
a product sales contract is entered into or service and repair fees are provided.&#160;The account receivable balance for scanner service
contracts as of July 1, 2022 was $<span id="xdx_905_ecustom--AccountsReceivableServiceContractsNet_iI_c20220702_zniw8wLrrNx4"><ix:nonFraction name="FONR:AccountsReceivableServiceContractsNet" contextRef="AsOf2022-07-02" id="Fact000838" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,335,956</ix:nonFraction></span>.</p>

<ix:exclude><!-- Field: Page; Sequence: 56; Value: 2 -->
    <div id="xdx_234_zvUsUodgkPse" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23D_z1qz9Q2cEJC4" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zorsxUVES3T2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_zl6Cwmq4HYDc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_231_zveQ5JXQGYyf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_235_zo3rdZyTcLDc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_235_zBirvJPPNsr8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zAcMNOehO0Pa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(CONTINUED)</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000846" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><p id="xdx_840_eus-gaap--ResearchAndDevelopmentExpensePolicy_zQV6jIMjdrmd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_860_z7fpB9w5Lmb2">Research and Development Costs</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development costs are charged to expense
as incurred. The costs of equipment that are acquired or constructed for research and development activities, and have alternative future
uses (either in research and development, marketing or production), are classified as property and equipment and depreciated over their
estimated useful lives.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000848" name="us-gaap:AdvertisingCostsPolicyTextBlock"><p id="xdx_84F_eus-gaap--AdvertisingCostsPolicyTextBlock_zQcdQH8wfeA5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_861_zAXOhmeiQA89">Advertising Costs</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Advertising costs are expensed as incurred. Advertising
expense approximated $<span id="xdx_90E_eus-gaap--AdvertisingExpense_c20230701__20240630_zxCMQfhbqrrj"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2023-07-01to2024-06-30" id="Fact000849" format="ixt:numdotdecimal" decimals="0" unitRef="USD">731,000</ix:nonFraction></span> and $<span id="xdx_905_eus-gaap--AdvertisingExpense_c20220701__20230630_z5aKmIyxUmni"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2022-07-012023-06-30" id="Fact000850" format="ixt:numdotdecimal" decimals="0" unitRef="USD">570,000</ix:nonFraction>
</span>and for the years ended June 30, 2024 and 2023, respectively.<b>&#160;</b></p>

<ix:exclude><p id="xdx_231_zFPusrFjMu98" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000853" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_zGk2PMILa6eh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_868_zqA8dJzcQkL8">Income Taxes</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Deferred tax assets and liabilities are determined
based on the difference between the financial statement carrying amounts and tax basis of assets and liabilities using enacted tax rates
in effect in the years in which the differences are expected to reverse.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The ultimate realization of deferred tax assets is
dependent on the generation of future taxable income during the periods in which temporary differences become deductible or when such
net operating losses can be utilized. The Company considers projected future taxable income, the regulatory environment of the industry,
and tax planning strategies in making this assessment. At present, the Company believes that it is more likely than not that the benefits
from certain deferred tax asset carryforwards, will not all be fully realized. In recognition of this inherent risk, a valuation allowance
was established for the partial value of the deferred tax asset, which principally related to certain state net operating losses. A valuation
allowance will be maintained until sufficient positive evidence exists to support the reversal of the remainder of the valuation.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with ASC 740, &#8220;Accounting for
Income Taxes&#8221;, prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement
of tax positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be
taken in a tax return and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits.
A liability is recognized (or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax
benefit because it represents an enterprise&#8217;s potential future obligation to the taxing authority for a tax position that was not
recognized as a result of applying the provisions of ASC 740. The Company believes there are no uncertain tax positions in prior year&#8217;s
tax filings and therefore it has not recorded a liability for unrecognized tax benefits.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with ASC 740, interest costs related
to unrecognized tax benefits are required to be calculated (if applicable) and would be classified as &#8220;Interest expense, net. Penalties
if incurred would be recognized as a component of &#8220;Selling, general and administrative&#8221; expenses. Penalties for the years
ended June 30, 2024 and June 30, 2023 were $<span id="xdx_905_eus-gaap--IncomeTaxExaminationPenaltiesExpense_c20230701__20240630_z9Q0Hn5aAaTh" title="Penalties"><ix:nonFraction name="us-gaap:IncomeTaxExaminationPenaltiesExpense" contextRef="From2023-07-01to2024-06-30" id="Fact000855" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,444</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--IncomeTaxExaminationPenaltiesExpense_c20220701__20230630_z8bTkU63dY9" title="Penalties"><ix:nonFraction name="us-gaap:IncomeTaxExaminationPenaltiesExpense" contextRef="From2022-07-012023-06-30" id="Fact000857" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31,122</ix:nonFraction></span>, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><p id="xdx_23A_zeKfucB3NCs7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 57; Value: 2 -->
    <div id="xdx_23E_zd6xfenypCU4" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_231_zK7X4zstofLa" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zxJImbtBkkgh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zUYDIF5oSXC5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zVE5qUCWFtcl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zXPHeSnrWGgc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zT12uUDiofhd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zsL3BUevL1Dc" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_23A_z80H92bxbLvk" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000867" name="FONR:CustomerAdvancesPolicyTextBlock"><p id="xdx_849_ecustom--CustomerAdvancesPolicyTextBlock_zifYBNqOen18" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86A_zROga0l6TK7j">Customer Advances</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash advances and progress payments received on sales
orders are reflected as customer advances until such time as revenue recognition occurs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000869" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_zUPGfY2S3991" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_869_zkNcgjyuBKRe">Earnings Per Share</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic earnings per share (&#8220;EPS&#8221;) is computed
by dividing net income available to common stockholders by the weighted average number of shares of common stock outstanding during the
period. In accordance with ASC topic 260-10, &#8220;Participating Securities and the Two-Class Method&#8221;, the Company used the Two-Class
method for calculating basic earnings per share and applied the if converted method in calculating diluted earnings per share for the
years ended June 30, 2024 and 2023.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Diluted EPS reflects the potential dilution from the
exercise or conversion of all dilutive securities into common stock based on the average market price of common shares outstanding during
the period. For the years ended June 30, 2024 and 2023, diluted EPS for common shareholders includes <span id="xdx_900_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20230701__20240630_zXgmLFs4rzuc" title="Conversion of Class C Common Stock"><span id="xdx_904_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20220701__20230630_zMkTYZPbhp7k" title="Conversion of Class C Common Stock"><ix:nonFraction name="FONR:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" contextRef="From2023-07-01to2024-06-30" id="Fact000871" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="FONR:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" contextRef="From2022-07-012023-06-30" id="Fact000873" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">127,504</ix:nonFraction></ix:nonFraction></span></span> shares upon conversion of
Class C Common.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000875" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zQOGX5QvAza3" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BF_zywvfBLj6VWf" style="display: none">Schedule of earnings per share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Basic</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class C Common Stock</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Numerator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 46%; text-align: left; text-indent: -11pt">Net income available to common stockholders</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630_z5Rcu2Wqc693" title="Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2023-07-01to2024-06-30" id="Fact000877" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,567,396</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z7tmlgA6yw86" title="Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember958666312" id="Fact000879" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,908,920</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zS3OC7vju5ra" title="Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember" id="Fact000881" format="ixt:numdotdecimal" decimals="0" unitRef="USD">167,700</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Weighted average shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630_zODObpn37tXd" title="Weighted average shares outstanding basic" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2023-07-01to2024-06-30" id="Fact000883" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,350,862</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_983_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z1NzWS5YYt6j" title="Weighted average shares outstanding basic" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember958666312" id="Fact000885" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,350,862</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zsv8MvcuX5Jg" title="Weighted average shares outstanding basic" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember" id="Fact000887" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Basic income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630_za6Cya3uMO29" title="Basic income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2023-07-01to2024-06-30" id="Fact000889" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.66</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zbT5oyjhJ3Ha" title="Basic income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember958666312" id="Fact000891" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.56</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zo2AdSpO5Nch" title="Basic income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember" id="Fact000893" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.44</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Weighted average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z6Dsgme3pJZ9" title="Weighted average shares outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember958666312" id="Fact000895" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,350,862</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zJaoalYiGapd" title="Weighted average shares outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember" id="Fact000897" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Class C Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zTUCK9K36mxc" title="Class C Common Stock" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:IncrementalCommonSharesAttributableToConversionOfCommonStock" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember958666312" id="Fact000899" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">127,504</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zKDHmj3FQQP" title="Class C Common Stock" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember" id="Fact000901" format="ixt:zerodash" decimals="INF" unitRef="Shares">&#8212;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zo0pacwcLj68" title="Total Denominator for diluted earnings per share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember958666312" id="Fact000903" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,478,366</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_ztshFF2cGGVa" title="Total Denominator for diluted earnings per share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember" id="Fact000905" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zvB8OZFZJUHb" title="Diluted income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember958666312" id="Fact000907" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.53</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zS00GW4GVGzg" title="Diluted income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember" id="Fact000909" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.44</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<ix:exclude><p id="xdx_236_zmTtiILi6xF3" style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 58; Value: 2 -->
    <div id="xdx_23B_zrL4xcvPbVi6" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_235_z7KrLMZJBpy1" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zF5jOtxB6jek" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zRiEQQ40AKIa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_235_zAaNHb3VYTHf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zlcbg9JbvQye" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_23C_ztGgrdZoUip4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_238_ziAGRJOhbF" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_231_zLxRWRwKZ528" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_233_z9PblN15wq25" style="font: 11pt Times New Roman, Times, Serif; margin: 0">Earnings Per Share (Continued)</p></ix:exclude>

<ix:exclude><p id="xdx_236_zLwsOFp8Xxzl" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2023</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Basic</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class C Common Stock</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Numerator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 46%; text-align: left; text-indent: -11pt">Net income available to common stockholders</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20220701__20230630_zxtZWKIKsiff" title="Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2022-07-012023-06-30" id="Fact000921" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,375,776</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zwJEvY67Iumb" title="Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember958666343" id="Fact000923" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,801,974</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z3Qi4OsGnkJ3" title="Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember" id="Fact000925" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">146,136</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Weighted average shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630_zB7YdIopqgb6" title="Weighted average shares outstanding basic" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2022-07-012023-06-30" id="Fact000927" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,539,376</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zbeFLt3EWpwj" title="Weighted average shares outstanding basic" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember958666343" id="Fact000929" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,539,376</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z69RHhQSz9a5" title="Weighted average shares outstanding basic" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember" id="Fact000931" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Basic income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630_zytNpUPMRTf3" title="Basic income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2022-07-012023-06-30" id="Fact000933" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.43</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zEsXKtKOJyIe" title="Basic income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember958666343" id="Fact000935" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.35</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zEWBFp7LRyXf" title="Basic income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember" id="Fact000937" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.38</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Weighted average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zaiGOcIWQt49" title="Weighted average shares outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember958666343" id="Fact000939" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,539,376</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z14HKTw8KMnj" title="Weighted average shares outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember" id="Fact000941" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Class C Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zaUCBatpgKp5" title="Class C Common Stock" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:IncrementalCommonSharesAttributableToConversionOfCommonStock" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember958666343" id="Fact000943" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">127,504</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zZLCrPweHY4b" title="Class C Common Stock" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember" id="Fact000945" format="ixt:zerodash" decimals="INF" unitRef="Shares">&#8212;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zh3uUtS9SNpk" title="Total Denominator for diluted earnings per share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember958666343" id="Fact000947" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,666,880</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zcsRabBp4lNh" title="Total Denominator for diluted earnings per share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember" id="Fact000949" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zvhfQ9yDrIPb" title="Diluted income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember958666343" id="Fact000951" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.32</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zuZoteG2VhO1" title="Diluted income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember" id="Fact000953" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.38</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A1_zOL0s9iyGBTk" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000955" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z33M7wt7oICl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_869_zhbMc3xQZmNe">Cash and Cash Equivalents</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash and cash equivalents includes cash on hand, cash
in banks, investments in certificates of deposit with original maturities of 90 days or less, and money market funds.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000957" name="us-gaap:InvestmentPolicyTextBlock"><p id="xdx_848_eus-gaap--InvestmentPolicyTextBlock_zNVmvzpue4E7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_860_zKPyc0dKGqci">Short-Term Investments</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Short-term investments include certificates of deposit
with original maturities of greater than 90 days. Interest is recorded as earned.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000959" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zjfBs4dogapf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_866_zTIqGj8fSFsd">Concentration of Credit Risk</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash: The Company maintains its cash and cash equivalents
with various financial institutions, which exceed federally insured limits throughout the year. At June 30, 2024, the Company had cash
on deposit of approximately $<span id="xdx_907_eus-gaap--Cash_iI_pp0p0_c20240630_zls9uqywcjkh" title="Cash deposit"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2024-06-30" id="Fact000961" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">53,883,000</ix:nonFraction></span> in excess of federally insured limits of $<span id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20240630_zBSk8mx3ekc3" title="Federally insured limits"><ix:nonFraction name="us-gaap:CashFDICInsuredAmount" contextRef="AsOf2024-06-30" id="Fact000963" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">250,000</ix:nonFraction></span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Related Parties: Net revenues from related parties
accounted for approximately <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zcUvQhEqKW3f" title="Concentration risk, percentage"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zSnnpyzSZ80h" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-07-012024-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMember" id="Fact000965" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-07-012023-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMember" id="Fact000967" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></ix:nonFraction></span></span>% of the consolidated net revenues for the years ended June 30, 2024 and 2023. Net management fee receivables
from the related party medical practices accounted for approximately <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMedicalPracticesMember_z9UgZHdapRv" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-07-012024-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMedicalPracticesMember" id="Fact000969" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMedicalPracticesMember_zrb3soJNEv93" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-07-012023-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMedicalPracticesMember" id="Fact000971" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13</ix:nonFraction></span>% of the consolidated accounts receivable as of June 30,
2024 and 2023, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">See Note 3 regarding the Company&#8217;s concentrations
in the healthcare industry.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><p id="xdx_232_z7vevhhIgrB8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 59; Value: 2 -->
    <div id="xdx_231_zBpUpJghxxtg" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_232_zpFRCh4cV6Sc" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_zSbMkc0N6dFc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zHPnd4R3K0Nc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zzPf21iwyAm6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_237_zEfEXwcISVw9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zshYDeoTQ202" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zgs0zQ2MYIUi" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 2 &#8211; SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zSr28v3gj9Oi" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000981" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_843_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zioSBMNADrJ2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_867_zrF5xqH8vBS8">Fair Value of Financial Instruments</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company measures fair value in accordance with
ASC 820-10, &#8220;Fair Value Measurements and Disclosures&#8221;. ASC 820-10 clarifies that fair value is an exit price, representing
the amount that would be received by selling an asset or paid to transfer a liability in an orderly transaction between market participants.
As such, fair value is a market-based measurement that should be determined based on assumptions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The standard establishes a three-tier fair value hierarchy,
which prioritizes the inputs used in measuring and revaluing fair value. These tiers include, Level 1, defined as observable inputs such
as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or
indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity
to develop its own assumptions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following methods and assumptions were used to
estimate the fair value of each class of financial instruments for which it is practicable to estimate that value:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash and cash equivalents: The carrying amount approximates
fair value because of the short-term maturity of those instruments.</p>

<ix:exclude><p id="xdx_23F_zSR0CTUIlWWc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zzebV60p1PDh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fair Value of Financial Instruments (Continued)</p></ix:exclude>

<ix:exclude><p id="xdx_231_zx9n6eSI6Qf7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Short-term investments: The carrying amount approximates
fair value because of the short-term maturity of those instruments. Such amounts include Certificates of Deposits with original maturities
greater than 90 days. These securities are classified as Level 1.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Receivable and accounts payable: The carrying amounts
approximate fair value because of the short maturity of those instruments.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Notes receivable: The carrying amount approximates
fair value because the discounted present value of the cash flow generated by the parties approximates the carrying value of the amounts
due to the Company.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long-term debt and notes payable: The carrying amounts
of debt and notes payable approximate fair value due to the length of the maturities, the interest rates being tied to market indices
and/or due to the interest rates not being significantly different from the current market rates available to the Company.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All of the Company&#8217;s financial instruments are
held for purposes other than trading.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000986" name="FONR:RecentAccountingStandardsPolicyTextBlock"><p id="xdx_84B_ecustom--RecentAccountingStandardsPolicyTextBlock_zgf8tw78paHl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_863_zlONLM6d1tvh">Recent Accounting Standards</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><p id="xdx_239_zV9bHlpNjoc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 60; Value: 2 -->
    <div id="xdx_23D_znZZy5rKWX9j" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23E_zgWWrINsvipc" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zdtYZCWzVvCi" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zORYJSTxJdGe" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_238_zy7q619v75A3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_232_z75EdUfA3nK1" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_230_zPoZzxNFtG29" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zb6PAxrgXfr7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_234_z9Na3VjGRo4f" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2023, The Financial Accounting Standards
Board (&#8220;FASB&#8221;) issued ASU 2023-09, &#8220;Income Taxes (740) &#8220;Improvements to Income Tax Disclosures&#8221;, which requires
the annual financial statements to include consistent categories and great disaggregation of information in the rate reconciliation and
income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for the Company&#8217;s annual reporting beginning after December
15, 2024, with early adoption permitted, and should be applied on a prospective basis, with a retrospective option. The Company is currently
evaluating the effect that the adoption of ASU 2023-09 will have on our disclosures.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2023, FASB issued ASU 2023-07, &#8220;Segment
Reporting (Topic 280)&#8221;, which is intended to improve reportable segment disclosure requirements through enhanced disclosures about
significant segment expenses. The amendments require disclosure of significant segment expenses regularly provided to the chief operating
decision maker (CODM) as well as other segment items, extended certain annual disclosures to interim periods, clarify the applicability
to single reportable segment entities, permit more than one measure of profit or loss to be reported under certain conditions, and require
disclosure of the title and position of the CODM. The effective date for public entities is for fiscal years beginning after December
15, 2023 and interim periods with fiscal years beginning after December 15, 2024. The Company is expected to adopt the new disclosures
as required and are currently evaluating the impact on the related disclosures.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000996" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zyzmnEIgfeC5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_866_zGeyNISx7NB9">Recently Adopted Accounting Standards</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company adopted ASU 2016-13, &#8220;Financial
Instruments &#8211; Credit Losses&#8221; (Topic 326) &#8220;Measurement of Credit Losses on Financial Instruments&#8221;, on July 1, 2023,
as amended which replaces the incurred loss methodology with an expected loss methodology that is referred to as the current expected
credit loss (CECL) methodology, The measurement of expected credit losses under the CECL methodology is applicable to financial assets
measured at amortized cost, including loan receivables and held-to-maturity debt securities. It also applies to off-balance sheet credit
exposures not accounted for as insurance (loan commitments, standby letters of credit, financial guarantees, and other similar instruments)
and net investments in leases recognized by a lessor in accordance with Topic 842 on leases. The Company used a modified retrospective
approach, which required a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting in which the standard
was effective. The adoption did not have a material effect on the Company&#8217;s consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FASB, the Emerging Issues Task Force and the SEC have
issued certain other accounting standards, updates, and regulations as of June 30, 2024 that will become effective in subsequent periods;
however, management does not believe that any of those updates would have significantly affected the Company&#8217;s financial accounting
measures or disclosures had they been in effect during 2024 or 2023, and it does not believe that any of those standards will have a significant
impact on the Company&#8217;s consolidated financial statements at the time they become effective.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><p id="xdx_233_zMe0JVsmmld2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 61; Value: 2 -->
    <div id="xdx_239_zbSeEXxLLSMg" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_236_zEbrcL5dcR45" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zyuVVc0yCTq5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zKq1vV3AMCIc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_238_zrxbqQFZmNEj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_230_zlX65wFy3jkg" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zkZCisXwjkT5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001004" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"><p id="xdx_80B_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zJuoXdjIIoJ" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;NOTE 3 &#8211; <span id="xdx_82D_zXjOevyDt1Gc">ACCOUNTS RECEIVABLE, MEDICAL
RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long Term Accounts Receivable</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long term accounts receivable balances at June 30,
2024 and June 30, 2023 amounted to $<span id="xdx_907_ecustom--AccountsReceivableNetLongTerm_iI_c20240630_zk5RlgsJy513" title="Long term accounts receivable balances"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2024-06-30" id="Fact001006" format="ixt:numdotdecimal" decimals="0" unitRef="USD">829,473</ix:nonFraction></span> and $<span id="xdx_90C_ecustom--AccountsReceivableNetLongTerm_iI_c20230630_zAPvrQOBno15" title="Long term accounts receivable balances"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2023-06-30" id="Fact001008" format="ixt:numdotdecimal" decimals="0" unitRef="USD">710,085</ix:nonFraction></span>, respectively. The Company will generate revenue from long-term, non-cancellable
contracts to provide service and repair services. Future revenue to be recognized over the following four years at June 30, 2024 is as
follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001010" name="us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zLQiGYyfu0bi" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="5" style="border-bottom: Black 1pt solid; text-align: left"><span id="xdx_8B3_zxULpWrUqVfg" style="display: none">Schedule of receivables -
    non current - net</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 76%; text-align: left; text-indent: -11pt">2026</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pp0p0_c20240630_z65xpqNEy7Og" title="2026" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ContractReceivableDueTwoToThreeYears" contextRef="AsOf2024-06-30" id="Fact001012" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">631,415</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pp0p0_c20240630_zkbrS17Eqe14" title="2027" style="text-align: right"><ix:nonFraction name="us-gaap:ContractReceivableDueThreeToFourYears" contextRef="AsOf2024-06-30" id="Fact001014" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">369,429</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">2028</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pp0p0_c20240630_z8vnE3Dkn9V4" title="2028" style="text-align: right"><ix:nonFraction name="us-gaap:ContractReceivableDueFourToFiveYears" contextRef="AsOf2024-06-30" id="Fact001016" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">87,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">2029</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ContractReceivableDueFiveYearsOrMore_iI_pp0p0_c20240630_zy0Txw28f7U8" title="2029" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ContractReceivableDueFiveYearsOrMore" contextRef="AsOf2024-06-30" id="Fact001018" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">87,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Total</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_pp0p0_c20240630_ztUVSFFardm4" title="Total" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms" contextRef="AsOf2024-06-30" id="Fact001020" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,174,844</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;The following represents a summary of allowance
for credit losses for the years ended June 30, 2024 and 2023, respectively:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001022" name="us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zFFO6u20j805" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="17" style="text-align: left"><span id="xdx_8B0_zD3XG0pfFJHc" style="display: none">Summary of allowance for credit losses</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Description</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Balance<br/> June 30, 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Additions(Recovery) (1)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Deductions</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Balance <br/> June 30, 2024</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 40%; text-align: left; text-indent: -11pt">Accounts receivable</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zBF6ClyECdHd" title="Beginning Balance" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2023-06-30_us-gaap_AccountsReceivableMember" id="Fact001024" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">198,593</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zUMoQ2PipMO9" title="Additions (Included in provision for bad debts)" style="width: 10%; text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2023-07-012024-06-30_us-gaap_AccountsReceivableMember" id="Fact001026" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_znx3PMN111dh" title="Deductions" style="width: 10%; text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2023-07-012024-06-30_us-gaap_AccountsReceivableMember" id="Fact001028" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">32,544</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zIWDN5ZXQ1C7" title="Ending Balance" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2024-06-30_us-gaap_AccountsReceivableMember" id="Fact001030" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">166,049</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Management and other fees receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zA1qbdfRARjj" style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableMember" id="Fact001031" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,608,567</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zZnbvQ3gXM91" style="text-align: right">(<ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2023-07-012024-06-30_custom_ManagementAndOtherFeesReceivableMember" id="Fact001032" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">238,646</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zRQV4n4uybB1" style="text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2023-07-012024-06-30_custom_ManagementAndOtherFeesReceivableMember" id="Fact001033" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zDMXfB5alEwb" style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2024-06-30_custom_ManagementAndOtherFeesReceivableMember" id="Fact001034" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,369,921</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Management and other fees receivable - related medical practices</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zrNOpFQWEGs1" style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="Fact001035" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,989,692</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zfG1pNXhkK4b" style="text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2023-07-012024-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="Fact001036" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,120,707</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_ztnXmPeg2XR4" style="text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2023-07-012024-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="Fact001037" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zVHM9lvFsM9d" style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2024-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="Fact001038" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,110,399</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Notes receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zxHpUcPE0KIf" style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2023-06-30_us-gaap_NotesReceivableMember" id="Fact001039" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">777,354</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zVw03YpOdjX" style="text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2023-07-012024-06-30_us-gaap_NotesReceivableMember" id="Fact001040" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zjb73ljDLr72" style="text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2023-07-012024-06-30_us-gaap_NotesReceivableMember" id="Fact001041" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zObfmcnQMtFh" style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2024-06-30_us-gaap_NotesReceivableMember" id="Fact001042" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">777,354</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Balance</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Balance</td></tr>
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Description</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2022</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Additions</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Deductions</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2023</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 11pt; width: 40%; text-align: left; text-indent: -11pt">Accounts receivable</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_986_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zkjZ0KCipFG6" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2022-06-30_us-gaap_AccountsReceivableMember" id="Fact001043" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">204,597</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zfiFNBpauq5" style="width: 10%; text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2022-07-012023-06-30_us-gaap_AccountsReceivableMember" id="Fact001044" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,000</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zmou41KxiL8j" style="width: 10%; text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2022-07-012023-06-30_us-gaap_AccountsReceivableMember" id="Fact001045" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">61,004</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_znJjja0WDUR4" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2023-06-30_us-gaap_AccountsReceivableMember" id="Fact001046" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">198,593</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Management and other fees receivable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zBpI8XxzF22a" style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableMember" id="Fact001047" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,627,917</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_ztRazgyEAwhk" style="text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2022-07-012023-06-30_custom_ManagementAndOtherFeesReceivableMember" id="Fact001048" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,007,382</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zGnS8dg6pbul" style="text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2022-07-012023-06-30_custom_ManagementAndOtherFeesReceivableMember" id="Fact001049" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,026,732</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_982_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zTVo2UAOtnW7" style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableMember" id="Fact001050" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,608,567</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Management and other fees receivable - related medical practices</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zuOWkhbmYtb8" style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="Fact001051" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,686,893</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zkQHOCML4XN6" style="text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2022-07-012023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="Fact001052" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,451,094</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zxDJ4eMv3sw3" style="text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2022-07-012023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="Fact001053" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,148,295</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zuCIkEopmD" style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="Fact001054" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,989,692</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Notes receivable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zhnpJ6qYQTca" style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2022-06-30_us-gaap_NotesReceivableMember" id="Fact001055" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">777,354</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zyxGjMNrEsrj" style="text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2022-07-012023-06-30_us-gaap_NotesReceivableMember" id="Fact001056" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zT3J173ma649" style="text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2022-07-012023-06-30_us-gaap_NotesReceivableMember" id="Fact001057" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zEkAq0VH0ngb" style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2023-06-30_us-gaap_NotesReceivableMember" id="Fact001058" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">777,354</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4px; padding-left: 11pt; text-align: justify"><span id="xdx_F0C_zrCZXU1ui0Y7" style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(1)</span></td>
    <td style="padding-left: 11pt; text-align: justify"><span id="xdx_F1A_zsRxEBUXR3me" style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><ix:footnote id="Footnote001059" xml:lang="en-US">Included in provision for credit losses.</ix:footnote></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A8_ztKyRO3m0ZRd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_233_zMzNgG9BWfTh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 62; Value: 2 -->
    <div id="xdx_23C_zVhq2q64AgVb" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_237_z93Bp0rY62o9" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zJKcuDvvhQV" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zWdmXVOq9E3b" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_230_zj5iapFcOPz9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_238_znjOJ70karkj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_232_zQcgOyAb5QVe" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zB1qJYpHMMCj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE
AND MANAGEMENT AND OTHER FEES RECEIVABLE (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zMn4jTNGZMVj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Net revenues from management and other fees charged
to the related party medical practices accounted for approximately <span id="xdx_904_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20230701__20240630_zJwmpjKgEhIh" title="Percentage of consolidated net revenue from management fees"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2023-07-01to2024-06-30" id="Fact001069" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>% and <span id="xdx_90E_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20220701__20230630_zrywzfceAFc3" title="Percentage of consolidated net revenue from management fees"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2022-07-012023-06-30" id="Fact001071" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>%, of the consolidated net revenues for the years ended June
30, 2024 and 2023, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Tallahassee Magnetic Resonance Imaging, PA, Stand
Up MRI of Boca Raton, PA and Stand Up MRI &amp; Diagnostic Center, PA (all related party medical practices) entered into a guaranty agreement,
pursuant to which they cross guaranteed all management fees which are payable to the Company, which have arisen under each individual
management agreement.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth the number of our facilities
for the years ended June 30, 2024 and 2023.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">Total Facilities</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001073" name="FONR:TotalFacilitiesOwnedOrManagedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zfYGN6cu7R9l" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BA_zJnWAxBnUaec" style="display: none">Schedule of facilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20230701__20240630_zcfnQrId55si" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20220701__20230630_zoCB6mcCEOF8" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Year Ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_40C_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_zEHDaxHV6qma" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Total Facilities Owned or Managed (at Beginning of Year)</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear" contextRef="From2023-07-01to2024-06-30" id="Fact001075" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">27</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear" contextRef="From2022-07-012023-06-30" id="Fact001076" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">27</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Facilities Added by:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--ManagedFacilitiesAddedByInternalDevelopment_z0bbJ3tHn9Oj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Internal development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:ManagedFacilitiesAddedByInternalDevelopment" contextRef="From2023-07-01to2024-06-30" id="Fact001078" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:ManagedFacilitiesAddedByInternalDevelopment" contextRef="From2022-07-012023-06-30" id="Fact001079" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">1</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--ManagedFacilitiesClosedDuringYear_d0_zJpUq4cJUVHc" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Managed Facilities Closed</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:ManagedFacilitiesClosedDuringYear" contextRef="From2023-07-01to2024-06-30" id="Fact001081" format="ixt:zerodash" decimals="INF" unitRef="Integer">&#8212;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="FONR:ManagedFacilitiesClosedDuringYear" contextRef="From2022-07-012023-06-30" id="Fact001082" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Integer">1</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_z2BaW7Ft6d7a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total Facilities Owned or Managed (at End of Year)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear" contextRef="From2023-07-01to2024-06-30" id="Fact001084" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">28</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear" contextRef="From2022-07-012023-06-30" id="Fact001085" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">27</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001087" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_80E_eus-gaap--InventoryDisclosureTextBlock_zTrA76cWlrtj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 4 &#8211; <span id="xdx_82E_zu6ohMdAktFb">INVENTORIES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventories included in the accompanying consolidated
balance sheets consist of:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001089" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zwnAgOCuvp7d" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BF_zqv8kemkf119" style="display: none">Schedule of inventories</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20240630_z08defaRLD9e" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20230630_z4g7daxKJPD4" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">As of June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_40E_eus-gaap--OtherInventorySupplies_iI_maIFGAWzdt0_zBMZYvgXWDf8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Purchased parts and components</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OtherInventorySupplies" contextRef="AsOf2024-06-30" id="Fact001091" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,524,201</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OtherInventorySupplies" contextRef="AsOf2023-06-30" id="Fact001092" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,346,300</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_maIFGAWzdt0_zuttCjsifXc1" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Work-in-process</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2024-06-30" id="Fact001094" format="ixt:numdotdecimal" decimals="0" unitRef="USD">191,240</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2023-06-30" id="Fact001095" format="ixt:numdotdecimal" decimals="0" unitRef="USD">223,366</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--InventoryNet_iTI_mtIFGAWzdt0_zdvRqeSPTQ6b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Inventories</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2024-06-30" id="Fact001097" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,715,441</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2023-06-30" id="Fact001098" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,569,666</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<ix:exclude><p id="xdx_230_zC45yIqcUG2i" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 63; Value: 2 -->
    <div id="xdx_236_zhXCku9NWPM4" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23A_zLtxnngNeMqf" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23B_zjpWBzElPkYc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zpVApRFIZZW8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_23E_z4KQT3FmBM9a" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zlVJaQPoLCKe" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zDRrFm42tuOa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001106" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_801_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zOzVAobHVl3k" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 5 - <span id="xdx_823_zo7KbIYIqZr7">PROPERTY AND EQUIPMENT</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment, at cost, less accumulated
depreciation and amortization, at June 30, 2024 and 2023, is comprised of:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001108" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--PropertyPlantAndEquipmentTextBlock_zeZShXzkNEya" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT - Property and equipment (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8B1_z0kZGrhTUiIk" style="display: none">Schedule of property and equipment, at cost, less accumulated
depreciation and amortization</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">As of June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Diagnostic equipment</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zbs7snyeOlNl" title="Property plant and equipment, gross" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-06-30_custom_DiagnosticEquipmentMember" id="Fact001110" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,243,694</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zKk3jW2LEiCc" title="Property plant and equipment, gross" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-06-30_custom_DiagnosticEquipmentMember" id="Fact001112" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,144,266</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Research, development and demonstration equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDevelopmentAndDemonstrationEquipmentMember_zxFK8qFrWdzc" title="Property plant and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-06-30_custom_ResearchDevelopmentAndDemonstrationEquipmentMember" id="Fact001114" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,199,941</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDevelopmentAndDemonstrationEquipmentMember_zuyNjcZHQj0d" title="Property plant and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-06-30_custom_ResearchDevelopmentAndDemonstrationEquipmentMember" id="Fact001116" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,199,941</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Machinery and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zIN3xebDOpg" title="Property plant and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-06-30_us-gaap_MachineryAndEquipmentMember" id="Fact001118" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,069,055</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zoAqAHSXPpJc" title="Property plant and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-06-30_us-gaap_MachineryAndEquipmentMember" id="Fact001120" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,069,055</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Furniture and fixtures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zHfP635UCEC1" title="Property plant and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-06-30_us-gaap_FurnitureAndFixturesMember" id="Fact001122" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,742,169</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zv8nRRhPnyT5" title="Property plant and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-06-30_us-gaap_FurnitureAndFixturesMember" id="Fact001124" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,714,499</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zocD8M52HM84" title="Property plant and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-06-30_us-gaap_LeaseholdImprovementsMember" id="Fact001126" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,312,904</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zQKg145Wc3z2" title="Property plant and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-06-30_us-gaap_LeaseholdImprovementsMember" id="Fact001128" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,650,041</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Building</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zAca8yQwTd9e" title="Property plant and equipment, gross" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-06-30_us-gaap_BuildingMember" id="Fact001130" format="ixt:numdotdecimal" decimals="0" unitRef="USD">939,614</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zxHktrqlZYw9" title="Property plant and equipment, gross" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-06-30_us-gaap_BuildingMember" id="Fact001132" format="ixt:numdotdecimal" decimals="0" unitRef="USD">939,614</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630_zv2RGMKNlZbi" title="Property plant and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-06-30" id="Fact001134" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">62,507,377</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630_zBPrJZmZavl6" title="Property plant and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-06-30" id="Fact001136" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">61,717,416</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Less: Accumulated depreciation and amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20240630_zYTlQhk0vYi8" title="Less: Accumulated depreciation and amortization" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2024-06-30" id="Fact001138" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,798,457</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20230630_zsRQ2IVkT9w9" title="Less: Accumulated depreciation and amortization" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2023-06-30" id="Fact001140" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">39,571,043</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20240630_zdZ6fHZ8gPT" title="Property plant and equipment, net" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-06-30" id="Fact001142" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,708,920</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20230630_zvEiv82swc5f" title="Property plant and equipment, net" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-06-30" id="Fact001144" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,146,373</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Depreciation and amortization of property and equipment
for the years ended June 30, 2024 and 2023 was $<span id="xdx_90C_eus-gaap--OtherDepreciationAndAmortization_pp0p0_c20230701__20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_ztWb38BZePDf" title="Depreciation and amortization of property and equipment"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2023-07-012024-06-30_us-gaap_PropertyPlantAndEquipmentMember" id="Fact001146" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,227,414</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--OtherDepreciationAndAmortization_pp0p0_c20220701__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_zo0jkFNmHUOb" title="Depreciation and amortization of property and equipment"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2022-07-012023-06-30_us-gaap_PropertyPlantAndEquipmentMember" id="Fact001148" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,148,544</ix:nonFraction></span>, respectively.</p>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001150" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_80B_eus-gaap--LesseeOperatingLeasesTextBlock_ztqvZWXCtYpl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 6 &#8211; <span id="xdx_825_zYCZnDcxHQJl">OPERATING &amp; FINANCING LEASES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for its various operating leases
in accordance with Accounting Standards Codification (&#8216;ASC&#8217;) 842 &#8211; Lease, as updated by ASU 2016-02. At the inception
of a lease, the Company recognizes right-of-use lease assets and related lease liabilities measured at present value of future lease payments
on its balance sheet. Lease expense is recognized on a straight-line basis over the term of the lease. Our most common initial term varies
in length from 2 to 19 years. Including renewal options negotiated with the landlord, we have a total span of 2 to 16 years at the facilities
we lease. The Company reviewed its contracts with vendors and customers, determining that its right-to-use lease assets consisted of only
office space operating leases. In determining the right-to-use lease assets and liabilities, the Company did recognize lease extension
options which the Company feels would be reasonably exercised. Our incremental borrowing rate (&#8220;IBR&#8221;) used to discount the
stream of operating lease payments is closely related to the interest rates available to the Company. A reconciliation of operating and
financing lease payments undiscounted cash flows to lease liabilities recognized as of June 30, 2024 is as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><p id="xdx_232_zH5Ee6GIy8Za" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 64; Value: 2 -->
    <div id="xdx_237_zDNpSf39phQc" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23F_za5fM47omU9i" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zRTOodMRCgTi" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zjOamh1tpqj3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zrsOeioveW0j" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_238_z8fdQeIL1oO5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zEoPe153j7ul" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_235_zLH0wteXuUPb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 6 &#8211; OPERATING &amp; FINANCING LEASES
(CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_237_zEZ9RsUX25u8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001160" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zxWPFt2jtes7" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Lease payments (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td colspan="3" style="text-align: center"><span id="xdx_8B6_zuSTGREMEtnb" style="display: none">Schedule of reconciliation of operating and financing
lease payments</span></td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Year Ending June 30,</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Operating Lease Payments</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Financing Lease Payments</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 1%; text-align: left">&#160;</td>
<td style="padding: 0pt 0pt 0pt 11pt; width: 26%; text-align: center">2025</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zqSak3qkBvEl" title="2025" style="width: 26%; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2024-06-30_custom_OperatingLeasePaymentsMember" id="Fact001162" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,895,014</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_981_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zaetlJMqecnb" title="2025" style="width: 26%; text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2024-06-30_custom_FinancingLeasePaymentsMember" id="Fact001164" format="ixt:numdotdecimal" decimals="0" unitRef="USD">244,343</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">&#160;</td>
<td style="padding: 0pt 0pt 0pt 11pt; text-align: center">2026</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zVAslA7beGhj" title="2026" style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2024-06-30_custom_OperatingLeasePaymentsMember" id="Fact001166" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,561,968</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zGD3L8Yr9Fmf" title="2026" style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2024-06-30_custom_FinancingLeasePaymentsMember" id="Fact001168" format="ixt:numdotdecimal" decimals="0" unitRef="USD">244,343</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">&#160;</td>
<td style="padding: 0pt 0pt 0pt 11pt; text-align: center">2027</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_znXbPoZA6cjj" title="2027" style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2024-06-30_custom_OperatingLeasePaymentsMember" id="Fact001170" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,226,352</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_ziANxjpZgdki" title="2027" style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2024-06-30_custom_FinancingLeasePaymentsMember" id="Fact001172" format="ixt:numdotdecimal" decimals="0" unitRef="USD">162,897</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">&#160;</td>
<td style="padding: 0pt 0pt 0pt 11pt; text-align: center">2028</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zixNMdUG7s6k" title="2028" style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2024-06-30_custom_OperatingLeasePaymentsMember" id="Fact001174" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,194,655</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_d0_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_ztABDuAvvCRe" title="2028" style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2024-06-30_custom_FinancingLeasePaymentsMember" id="Fact001176" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">&#160;</td>
<td style="padding: 0pt 0pt 0pt 11pt; text-align: center">2029</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zZhQOIZmIFUj" title="2029" style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2024-06-30_custom_OperatingLeasePaymentsMember" id="Fact001178" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,865,285</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_d0_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zftT6Aci8Xsc" title="2029" style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2024-06-30_custom_FinancingLeasePaymentsMember" id="Fact001180" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">&#160;</td>
<td style="padding: 0pt 0pt 0pt 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Thereafter</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zKAMGbtPidmj" title="Thereafter" style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2024-06-30_custom_OperatingLeasePaymentsMember" id="Fact001182" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,295,110</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_d0_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z1vKArLZveq3" title="Thereafter" style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2024-06-30_custom_FinancingLeasePaymentsMember" id="Fact001184" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">&#160;</td>
<td style="padding: 0pt 0pt 0pt 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Present value discount</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_988_ecustom--PresentValueDiscount_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zI3jKE4AE5ag" title="Present value discount" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="FONR:PresentValueDiscount" contextRef="AsOf2024-06-30_custom_OperatingLeasePaymentsMember" id="Fact001186" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">15,096,964</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_982_ecustom--PresentValueDiscountFinancingLease_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zpoBhrJkD4Si" title="Present value discount" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="FONR:PresentValueDiscountFinancingLease" contextRef="AsOf2024-06-30_custom_FinancingLeasePaymentsMember" id="Fact001188" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">31,074</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">&#160;</td>
<td style="padding: 0pt 0pt 0pt 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Total lease liability</span></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98B_eus-gaap--OperatingLeaseLiability_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zxwBPf5hn9j5" title="Total lease liability" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2024-06-30_custom_OperatingLeasePaymentsMember" id="Fact001190" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,941,420</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_989_eus-gaap--FinanceLeaseLiability_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_ztaaIsy0HIh5" title="Total lease liability" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiability" contextRef="AsOf2024-06-30_custom_FinancingLeasePaymentsMember" id="Fact001192" format="ixt:numdotdecimal" decimals="0" unitRef="USD">620,509</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A5_z63dNoSslRJ8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Weighted Average Remaining Lease Term</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001194" name="FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_zygwCTE1sr35" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Weighted average remaining lease term (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8B4_zWFj85KW5wka" style="display: none">Schedule
    of weighted average remaining lease term</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 70%; text-align: left; text-indent: -11pt">Operating leases - years</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right"><span id="xdx_909_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240630_z4cUpqCdVwT1" title="Operating leases - years"><ix:nonNumeric contextRef="AsOf2024-06-30" format="ixt-sec:duryear" id="Fact001196" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">11.0</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Finance lease - years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240630_zokYbdtNjWGi" title="Finance lease - years"><ix:nonNumeric contextRef="AsOf2024-06-30" format="ixt-sec:duryear" id="Fact001198" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1">2.6</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Weighted Average Discount Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Operating leases</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20240630_zGPIFz2bvSkj" title="Weighted average discount rate, operating leases"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2024-06-30" id="Fact001200" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.4</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Finance lease</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20240630_zk49Yn4GCN54" title="Weighted average discount rate, finance leases"><ix:nonFraction name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2024-06-30" id="Fact001202" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.6</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8AA_z6bQkgs6xFBb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">The components of lease expense were as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001204" name="us-gaap:LeaseCostTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--LeaseCostTableTextBlock_zChHtcRNhfh8" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Components of lease expense (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BC_z3vKzFFltW5e" style="display: none">Schedule of components
    of lease expense</span></td><td>&#160;</td>
    <td colspan="3" id="xdx_495_20230701__20240630_zRYYaviEFZCl" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_499_20220701__20230630_zyTFfjRrVyhh" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For Year Ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Operating lease cost</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2023-07-01to2024-06-30" id="Fact001206" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,685,008</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2022-07-012023-06-30" id="Fact001207" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,887,390</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--FinanceLeaseCostsAbstract_iB_zeM01tV7OYff" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Finance lease cost:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0_zXU0EuIp7Ta7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Depreciation of leased equipment</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="FONR:DepreciationOfLeasedEquipment" contextRef="From2023-07-01to2024-06-30" id="Fact001212" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">198,881</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="FONR:DepreciationOfLeasedEquipment" contextRef="From2022-07-012023-06-30" id="Fact001213" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">198,881</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Interest on lease liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseInterestExpense" contextRef="From2023-07-01to2024-06-30" id="Fact001215" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">26,534</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseInterestExpense" contextRef="From2022-07-012023-06-30" id="Fact001216" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">35,833</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--FinanceLeaseCost_i01_pp0p0_z7ekTXZ28Dqg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total finance lease cost</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="FONR:FinanceLeaseCost" contextRef="From2023-07-01to2024-06-30" id="Fact001218" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">225,415</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="FONR:FinanceLeaseCost" contextRef="From2022-07-012023-06-30" id="Fact001219" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">234,714</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A6_zHeHskNhqtq6" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<ix:exclude><p id="xdx_232_zme4NpEKACNf" style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 65; Value: 2 -->
    <div id="xdx_235_zko3Ovjif6vd" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23C_zWB2Q7kvAMQb" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zRAhFfsR4aAa" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_ztM4ZbBlTVCh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_23F_ztP5niBiWhda" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_235_zulG6gacCHnf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_237_zrhuQbmpgZwh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zaAtuFIEm9z" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 6 &#8211; OPERATING &amp; FINANCING LEASES
(CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zqBHwjFgWbnb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Supplemental cash flow information related to leases
was as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001229" name="FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_zdQTVXAaEMC2" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BE_zKRrkpPwBYH5" style="display: none">Schedule
    of supplemental cash flow information related to leases</span></td><td>&#160;</td>
    <td colspan="3" id="xdx_492_20230701__20240630_z1ipsSFewXC1" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_497_20220701__20230630_ztGFuONv9TVf" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For Year Ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Cash paid for amounts included in the measurement of lease liabilities:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_40A_ecustom--OperatingCashFlowsFromOperatingLeases_zHCoVLOQMixl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Operating cash flows from operating leases</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="FONR:OperatingCashFlowsFromOperatingLeases" contextRef="From2023-07-01to2024-06-30" id="Fact001231" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,363,561</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="FONR:OperatingCashFlowsFromOperatingLeases" contextRef="From2022-07-012023-06-30" id="Fact001232" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,577,578</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--FinancingCashFlowsFromFinancingLeases_zAKnEkj1TkP3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Financing cash flows from financing leases</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="FONR:FinancingCashFlowsFromFinancingLeases" contextRef="From2023-07-01to2024-06-30" id="Fact001234" format="ixt:numdotdecimal" decimals="0" unitRef="USD">244,344</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="FONR:FinancingCashFlowsFromFinancingLeases" contextRef="From2022-07-012023-06-30" id="Fact001235" format="ixt:numdotdecimal" decimals="0" unitRef="USD">244,344</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB_zYcS5XR52d8l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Right-of-use and equipment assets obtained in exchange for lease obligations:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_z6SkehgmknMh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Operating leases</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" contextRef="From2023-07-01to2024-06-30" id="Fact001240" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,715,138</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" contextRef="From2022-07-012023-06-30" id="Fact001241" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,902,584</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8AA_zALHWBB9Y7mh" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001243" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_809_eus-gaap--IntangibleAssetsDisclosureTextBlock_z3Qx9sBrFId" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 7 - <span id="xdx_828_zgI2U6s9Rgfc">OTHER INTANGIBLE ASSETS</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Other intangible assets, net of accumulated amortization,
at June 30, 2024 and 2023, are comprised of:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001245" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zTZeAiPTZlPj" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BD_zRldzUPfbKR5" style="display: none">Schedule of other intangible assets, net of accumulated amortization</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">As of June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Capitalized software development costs</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zHo6lKBP5wYk" title="Gross other intangible assets" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" id="Fact001247" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,004,847</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_z450GDfCMzka" title="Gross other intangible assets" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" id="Fact001249" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,004,847</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Patents and copyrights</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zVQZvLqOXcMl" title="Gross other intangible assets" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-06-30_custom_PatentsAndCopyrightsMember" id="Fact001251" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,259,811</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zpu9ss2TXRt4" title="Gross other intangible assets" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-06-30_custom_PatentsAndCopyrightsMember" id="Fact001253" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,452,345</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Non-competition agreements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zWLQ1yIC7Ur" title="Gross other intangible assets" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-06-30_us-gaap_NoncompeteAgreementsMember" id="Fact001255" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,150,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zcSFlPvCTD52" title="Gross other intangible assets" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-06-30_us-gaap_NoncompeteAgreementsMember" id="Fact001257" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,150,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Customer relationships</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zGsg1YJ41Z6a" title="Gross other intangible assets" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001259" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,900,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zUO0SAKgJ1j4" title="Gross other intangible assets" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001261" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,900,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630_zkC0ARlF12Dk" title="Gross other intangible assets" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-06-30" id="Fact001263" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,314,658</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630_z6SexuNOt9df" title="Gross other intangible assets" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-06-30" id="Fact001265" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,507,192</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Less: Accumulated amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630_zmnZWQ2tYfRh" title="Less: Accumulated amortization" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2024-06-30" id="Fact001267" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,444,334</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20230630_zd9g3M1lpcD6" title="Less: Accumulated amortization" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-06-30" id="Fact001269" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,075,327</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630_zkfwcF55JAW2" title="Other intangible assets-net" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-06-30" id="Fact001271" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,870,324</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230630_zL2qSjTom81a" title="Other intangible assets-net" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-06-30" id="Fact001273" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,431,865</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A6_zOQE8wglUrRd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The estimated amortization of other intangible assets
for the five years ending June 30, 2029 and thereafter is as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001275" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zALUw94kCrH" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span id="xdx_8B0_zS5rMT1DnUo3">Schedule of other intangible assets</span> For the Years Ending June 30,</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Patents and Copyrights</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Customer Relationships</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; width: 20%; text-align: center">2025</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20240630_z2zhaLeG9YAh" title="2025" style="width: 19%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2024-06-30" id="Fact001277" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">351,882</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zucE2paX80F8" title="2025" style="width: 19%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2024-06-30_us-gaap_PatentsMember" id="Fact001279" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">151,882</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zoyvb9MaEDCc" title="2025" style="width: 19%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001281" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; text-align: center">2026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20240630_zvj8mnVqegOk" title="2026" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2024-06-30" id="Fact001283" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">339,179</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zVU2rNpDwL1b" title="2026" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2024-06-30_us-gaap_PatentsMember" id="Fact001285" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">139,179</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zrJYijuNDFu2" title="2026" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001287" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; text-align: center">2027</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20240630_zAHlj2WdIAe5" title="2027" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2024-06-30" id="Fact001289" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">326,502</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zZniJvrzVxo" title="2027" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2024-06-30_us-gaap_PatentsMember" id="Fact001291" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">126,502</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zqeH9Pk1dTml" title="2027" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001293" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; text-align: center">2028</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20240630_zXrZZsgNe8Yk" title="2028" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2024-06-30" id="Fact001295" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">320,232</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zjtKAMTleb85" title="2028" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2024-06-30_us-gaap_PatentsMember" id="Fact001297" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">120,232</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyJWgNWYLOri" title="2028" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001299" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; text-align: center">2029</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20240630_zcvLXcvugUPh" title="2029" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2024-06-30" id="Fact001301" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">313,052</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zGLJ10r989x9" title="2029" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2024-06-30_us-gaap_PatentsMember" id="Fact001303" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">113,052</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zUbrEh1xJHrg" title="2029" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001305" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Thereafter</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20240630_zbUh6zNdAbIg" title="Thereafter" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2024-06-30" id="Fact001307" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,219,477</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zu3VCQTvoTQc" title="Thereafter" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2024-06-30_us-gaap_PatentsMember" id="Fact001309" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">505,310</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zeVa6aaccMXb" title="Thereafter" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001311" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">714,167</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Other intangible assets - net</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20240630_z3zOxK7AmWli" title="Other intangible assets - net" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2024-06-30" id="Fact001313" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,870,324</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zGttMuYsbUQ4" title="Other intangible assets - net" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2024-06-30_us-gaap_PatentsMember" id="Fact001315" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,156,157</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zvLJHoyziiAb" title="Other intangible assets - net" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001317" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,714,167</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A5_z1hZhXrbu854" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<ix:exclude><p id="xdx_23D_zX5z6xCtfT0c" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 66; Value: 2 -->
    <div id="xdx_238_zbcE9yIAn0Zb" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_233_z4NuMuxJcXAk" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zQdwBGjhgPIg" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zcCNBmIGNW31" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_zy5keu6rbJte" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_237_zQ9A9rrOnTv3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_230_zftYVfHJwNYb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zaQGi4GsCwHa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 7 - OTHER INTANGIBLE ASSETS (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zuJSQo67alX7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The weighted average amortization period for other
intangible assets is <span id="xdx_90A_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630_zIANwAAmTnoa" title="Weighted average amortization period for other intangible assets"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt-sec:duryear" id="Fact001327" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">9.9</ix:nonNumeric></span> years and they have no expected residual value.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Information related to the above intangible assets
for the years ended June 30, 2024 and 2023 is as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001329" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zFFQU4AQoQhe" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Intangle assets - (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8B0_z3TpVubR3Ppe" style="display: none">Schedule of other
    intangible assets</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Year-ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Balance &#8211; Beginning of Year</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20230701__20240630_zuRowUPpOm92" title="Balance - Beginning of Year" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2023-06-30" id="Fact001331" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,431,865</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20220701__20230630_zqsUC5ramWs5" title="Balance - Beginning of Year" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2022-06-30" id="Fact001333" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,703,885</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Amounts capitalized</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--AmountsCapitalized_pp0p0_c20230701__20240630_zh8mT33OD2Mk" title="Amounts capitalized" style="text-align: right"><ix:nonFraction name="FONR:AmountsCapitalized" contextRef="From2023-07-01to2024-06-30" id="Fact001335" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">32,885</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--AmountsCapitalized_pp0p0_c20220701__20230630_zaeCIwycCfm5" title="Amounts capitalized" style="text-align: right"><ix:nonFraction name="FONR:AmountsCapitalized" contextRef="From2022-07-012023-06-30" id="Fact001337" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">119,571</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Patents written off</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_c20230701__20240630_zynJp5KK9b49" title="Patents written off" style="text-align: right">(<ix:nonFraction name="FONR:SoftwareOrPatentsWrittenOff" contextRef="From2023-07-01to2024-06-30" id="Fact001339" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">225,419</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_d0_c20220701__20230630_zCs18PKjwHuk" title="Patents written off" style="text-align: right"><ix:nonFraction name="FONR:SoftwareOrPatentsWrittenOff" contextRef="From2022-07-012023-06-30" id="Fact001341" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AdjustmentForAmortization_pp0p0_c20230701__20240630_zzPIoTiTtdK1" title="Amortization" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentForAmortization" contextRef="From2023-07-01to2024-06-30" id="Fact001343" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">369,007</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AdjustmentForAmortization_pp0p0_c20220701__20230630_zOPGATxicSzf" title="Amortization" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentForAmortization" contextRef="From2022-07-012023-06-30" id="Fact001345" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">391,591</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Balance &#8211; End of Year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20230701__20240630_zpfOyF6P9aPh" title="Balance - End of Year" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2024-06-30" id="Fact001347" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,870,324</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20220701__20230630_zaSgAbRZInOf" title="Balance - End of Year" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2023-06-30" id="Fact001349" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,431,865</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8AA_z5RPc7GCOIZa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Amortization of patents and copyrights for the years
ended June 30, 2024 and 2023 amounted to $<span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zPlXpGxsdT0h" title="Amortization"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-07-012024-06-30_us-gaap_PatentsMember" id="Fact001351" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">169,007</ix:nonFraction></span> and $<span id="xdx_902_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220701__20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_z7UJXbSpDTXc" title="Amortization of patents and copyrights"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-07-012023-06-30_us-gaap_PatentsMember" id="Fact001353" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">191,591</ix:nonFraction></span>, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Amortization of customer relationships for the years
ended June 30, 2024 and 2023 amounted to $<span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zqboraOBnNTh" title="Amortization"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-07-012024-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001355" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220701__20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zLpN060Jthb2" title="Amortization of customer relationships"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-07-012023-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001357" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></span>, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001359" name="FONR:CapitalStockDisclosureTextblock"><p id="xdx_80C_ecustom--CapitalStockDisclosureTextblock_zD1szU3WK4H2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 8 - <span id="xdx_828_zJhikIMjg9na">CAPITAL STOCK</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Common Stock</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_903_eus-gaap--DividendsPayableNature_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zLrVfGdLc9W4" title="Dividends payable, nature"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember958666312" id="Fact001361" name="us-gaap:DividendsPayableNature">Cash dividends payable on the common stock shall,
in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend payable on shares of Class B common stock
and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common stock.</ix:nonNumeric></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Class B Common Stock</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_903_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zHXG2OEjuIi9" title="Conversuion of shares into one-for-one basis"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_CommonClassBMember" id="Fact001363" name="us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare">Class B common stock is convertible into shares of
common stock on a one-for-one basis.</ix:nonNumeric></span> <span id="xdx_908_eus-gaap--CommonStockVotingRights_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_ztQ5eGUQqoi6" title="Common stock, voting rights"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_CommonClassBMember" id="Fact001365" name="us-gaap:CommonStockVotingRights">Class B common stock has 10 votes per share.</ix:nonNumeric></span> There were <span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zSjtFcfBpUNl" title="Common stock, shares outstanding"><span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z2t3VxrjBu" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember" id="Fact001367" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember" id="Fact001369" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">146</ix:nonFraction></ix:nonFraction></span></span> of such shares outstanding at June 30,
2024 and 2023.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><p id="xdx_232_zSaupNHHu6y7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 67; Value: 2 -->
    <div id="xdx_238_ziXWn3jbVzd2" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_235_zk5tqlzVlyCa" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zQw8ZFo6rgyj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_236_zot3RtA1cxmb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_238_zHeocOLAwoI4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zHpewNQ1fss9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23D_z3xNkh0fWH0j" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_23F_z4vq6o5yOic2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zlL7VanRGBLh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 8 - CAPITAL STOCK (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_233_zDYzXhFPVei7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Class C Common Stock</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_90A_eus-gaap--CommonStockVotingRights_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdw8lY2faNv8" title="Common stock, voting rights"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember" id="Fact001380" name="us-gaap:CommonStockVotingRights">The Class C common stock has 25 votes per share</ix:nonNumeric></span>, as
compared to 10 votes per share for the Class B common stock and <span id="xdx_90C_eus-gaap--CommonStockVotingRights_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zfDoUeFYeS9" title="Common stock, voting rights"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember958666312" id="Fact001382" name="us-gaap:CommonStockVotingRights">one vote per share for the common stock.</ix:nonNumeric></span> <span id="xdx_902_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zL9aBo6vSOX8"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember" id="Fact001383" name="us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare">The Class C common stock was
offered on a three-for-one basis to the holders of the Class B common stock.</ix:nonNumeric></span> Although having greater voting power, each share of Class
C common stock has only one-third of the rights of a share of Class B common stock to dividends and distributions. <span id="xdx_90C_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zAL9kWUwKp4i"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember958666312" id="Fact001384" name="us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare">Class C common stock
is convertible into shares of common stock on a three-for-one basis.</ix:nonNumeric></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Class A Non-Voting Preferred Stock</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 3, 1995, the stockholders ratified a proposal
consisting of the creation of a new class of Class A non-voting preferred stock with special dividend rights and the declaration of a
stock dividend on the Company&#8217;s common stock consisting of <span id="xdx_907_eus-gaap--CommonStockVotingRights_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zbCGzX4Iq4Sk"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_PreferredClassAMember" id="Fact001385" name="us-gaap:CommonStockVotingRights">one share of Class A non-voting preferred stock for every five shares
of common stock.</ix:nonNumeric></span> <span id="xdx_904_eus-gaap--DividendsPayableNature_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zo09MgJXnlRe"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_PreferredClassAMember" id="Fact001386" name="us-gaap:DividendsPayableNature">The stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued
pursuant to such stock dividend approximates 313,000 shares.</ix:nonNumeric></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Class A non-voting preferred stock is entitled
to a special dividend equal to 3-1/4% of the first $10 million, 4-1/2% of the next $20 million and 5-1/2% on amounts in excess of $30
million of the amount of any cash awards or settlements received by the Company in connection with the enforcement of five of the Company&#8217;s
patents in its patent lawsuits, less the revised special dividend payable on the common stock with respect to one of the Company&#8217;s
patents.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Class A non-voting preferred stock participates
on an equal per share basis with the common stock in any dividends declared and ranks equally with the common stock on distribution rights,
liquidation rights and other rights and preferences (other than the voting rights).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock Bonus Plans</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 23, 2010, the Board approved the 2010 Stock
Bonus Plan. The plan entitles the Company to reserve <span id="xdx_903_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20100423__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zxlYUqSSnPd1" title="Common stock, capital shares reserved for future issuance"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2010-04-23_custom_N2010StockBonusPlanMember" id="Fact001388" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></span> shares of common stock. On August 10, 2010, the Company filed Form S-8
to register the <span id="xdx_90A_ecustom--SharesRegistered_iI_c20100810__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zs0dmncvVWbe" title="Shares registered"><ix:nonFraction name="FONR:SharesRegistered" contextRef="AsOf2010-08-10_custom_N2010StockBonusPlanMember" id="Fact001390" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></span> shares. As of June 30, 2024, <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20240630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zewLkGWB5kL7" title="Number of shares available for future grant"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2024-06-30_custom_N2010StockBonusPlanMember" id="Fact001392" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">450,177</ix:nonFraction></span> shares of common stock of FONAR were available for future grant under this
plan. For the years ended June 30, 2024 and 2023, <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20230701__20240630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zUicNQ8RZAx5" title="Number of shares were issued"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20220701__20230630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zTieJANGutxj" title="Number of shares were issued"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" contextRef="From2023-07-012024-06-30_custom_N2010StockBonusPlanMember" id="Fact001394" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" contextRef="From2022-07-012023-06-30_custom_N2010StockBonusPlanMember" id="Fact001396" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></ix:nonFraction></span></span> shares were issued.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><p id="xdx_231_zuW1ZbqE4lli" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 68; Value: 2 -->
    <div id="xdx_238_zkOs8n9JyVw1" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_239_zerpMJ5z4sV3" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zauSWweqgv21" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_235_zMxTdC8NnJ4a" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zf6a3TZqG7eh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_231_zUmcuvWbp3xj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_234_zFByvJXbH2ff" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zwpNcM4zw3Pi" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 8 - CAPITAL STOCK (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_235_z44HgIktXO7a" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Treasury Stock</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 13, 2022, the Company adopted a stock
repurchase plan. The plan has no expiration date and cannot determine the number of shares which will be repurchased. On September 26,
2022, the Board of Directors has approved up to $<span id="xdx_901_eus-gaap--PaymentsForRepurchaseOfEquity_pdn6_c20220925__20220926__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zd63ALfSTw93" title="Payments for repurchase of equity"><ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfEquity" contextRef="From2022-09-252022-09-26_srt_BoardOfDirectorsChairmanMember" id="Fact001406" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">9</ix:nonFraction></span> million to be repurchased under the plan which will be purchased on the publicly traded
open market at prevailing prices.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company utilizes the cost method of accounting
to value the treasury stock when repurchasing stock. Under this method, the shares are valued at the price paid and recorded to treasury
stock. When the treasury stock is cancelled, the par value of the stock is reduced and the additional paid in capital is reduced for the
remaining value based upon the original stock sale. For the year ended June 30, 2024, the Company purchased <span id="xdx_901_eus-gaap--StockRepurchasedDuringPeriodShares_c20230701__20240630_zL2RInDExWQ9" title="Purchase of treasury shares"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2023-07-01to2024-06-30" id="Fact001408" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">156,206</ix:nonFraction></span> shares at a cost of
$<span id="xdx_90D_eus-gaap--StockRepurchasedDuringPeriodValue_pp0p0_c20230701__20240630_zh5RR7drRSFd" title="Purchase of treasury stock"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-01to2024-06-30" id="Fact001410" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,505,832</ix:nonFraction></span> and cancelled <span id="xdx_90F_ecustom--CancellationOfTreasuryShares_c20230701__20240630_z8qjbsWJnIjl" title="Cancellation of treasury shares"><ix:nonFraction name="FONR:CancellationOfTreasuryShares" contextRef="From2023-07-01to2024-06-30" id="Fact001412" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">122,588</ix:nonFraction></span> shares valued at $<span id="xdx_902_ecustom--CancellationOfTreasuryStock_c20230701__20240630_zxkEZOBtjq96" title="Cancellation of treasury stock"><ix:nonFraction name="FONR:CancellationOfTreasuryStock" contextRef="From2023-07-01to2024-06-30" id="Fact001414" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,005,020</ix:nonFraction></span>. For the year ended June 30, 2023, the Company purchased <span id="xdx_90A_eus-gaap--StockRepurchasedDuringPeriodShares_c20220701__20230630_zyt0He4RBsn9" title="Purchase of treasury shares"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2022-07-012023-06-30" id="Fact001416" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">103,148</ix:nonFraction></span> shares at
a cost of $<span id="xdx_907_eus-gaap--StockRepurchasedDuringPeriodValue_pp0p0_c20220701__20230630_ztYQ1MHrW7xl" title="Purchase of treasury stock"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012023-06-30" id="Fact001418" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,759,457</ix:nonFraction></span> and cancelled <span id="xdx_900_ecustom--CancellationOfTreasuryShares_c20220701__20230630_zX8YjFScYHB9" title="Cancellation of treasury shares"><ix:nonFraction name="FONR:CancellationOfTreasuryShares" contextRef="From2022-07-012023-06-30" id="Fact001420" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">103,328</ix:nonFraction></span> shares valued at $<span id="xdx_903_ecustom--CancellationOfTreasuryStock_c20220701__20230630_z5yFAJ01Ftr9" title="Cancellation of treasury stock"><ix:nonFraction name="FONR:CancellationOfTreasuryStock" contextRef="From2022-07-012023-06-30" id="Fact001422" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,919,027</ix:nonFraction></span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><p id="xdx_23F_zPiWzM7eF8w1" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 69; Value: 2 -->
    <div id="xdx_234_zmw5uUPC5lVk" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_230_zJP87S2cjvrd" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_zHSHFqke2yU6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_zjR2brDbP1cj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zxyIfd5vfjJ" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_237_zaKb2ZOVRtW3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_230_zoOCipsbbfD7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001430" name="us-gaap:MinorityInterestDisclosureTextBlock"><p id="xdx_801_eus-gaap--MinorityInterestDisclosureTextBlock_zs3umEEjdeL7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;<b>NOTE 9 &#8211; <span id="xdx_82A_zn0ptgZX6le3">CONTROLLING AND NONCONTROLLING
INTERESTS</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 13, 2013, the Company entered into an
agreement with outside investors to acquire a 50.5% controlling interest in a newly formed limited liability company, Health Diagnostics
Management LLC (HDM). According to the February 13, 2013, LLC operating agreement of HDM there are two classes of members; Class A members
and one Class B member. The Class A members have an ownership interest of <span id="xdx_904_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_zmnAJQhrNIJ8" title="Ownership interest"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" contextRef="AsOf2013-02-13_custom_HDMMember_custom_ClassAControllingInterestsMember" id="Fact001432" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">49.5</ix:nonFraction></span>% of HDM. The Class B member (HMCA) has an ownership of
<span id="xdx_90C_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember_zDQrufwjbrB1" title="Ownership percenatge"><ix:nonFraction name="FONR:EquityMethodInvestmentOwnershipPercentages" contextRef="AsOf2013-02-13_custom_HDMMember_custom_ClassBControllingInterestsMember" id="Fact001434" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50.5</ix:nonFraction></span>% of HDM. On all matters on which members may vote every member is entitled to cast the percentage of votes equal to their percentage
of ownership interest. Profits and losses on all items of income, gain or loss, deductions or other allocations of the Company will be
allocated among the members in the same proportions as their membership interests in the Company bear to all the Class A and Class B membership
interests of the Company in the aggregate outstanding. All of the depreciation and amortization of the assets of the Company will be allocated
solely to the Class A members, unless and until their interests have been redeemed by the Company in full pursuant to the provisions of
the operating agreement. The Company contributed $<span id="xdx_902_ecustom--ProceedsFromContributionsFromCompany_pp0p0_c20130212__20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember_zYW9Dqv6WFul" title="Company contribution"><ix:nonFraction name="FONR:ProceedsFromContributionsFromCompany" contextRef="From2013-02-122013-02-13_custom_HDMMember_custom_ClassBControllingInterestsMember" id="Fact001436" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,200,000</ix:nonFraction></span> to HDM and the group of outside investors contributed $<span id="xdx_900_eus-gaap--ProceedsFromContributionsFromAffiliates_pp0p0_c20130212__20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_zb14mRksmjc5" title="Investors contribution"><ix:nonFraction name="us-gaap:ProceedsFromContributionsFromAffiliates" contextRef="From2013-02-122013-02-13_custom_HDMMember_custom_ClassAControllingInterestsMember" id="Fact001438" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,800,000</ix:nonFraction></span> for its
non-controlling membership interest.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 5, 2013, HDM purchased from Health Diagnostics,
LLC (&#8220;HD&#8221;) and certain of its subsidiaries, a business managing twelve (<span id="xdx_909_ecustom--PurchaseOfStandupMriCenters_iI_uInteger_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zkIdegjdxrU9" title="Purchase of stand up MRI centers"><ix:nonFraction name="FONR:PurchaseOfStandupMriCenters" contextRef="AsOf2013-03-05_custom_HDMMember" id="Fact001440" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">12</ix:nonFraction></span>) Stand-Up MRI Centers and two (<span id="xdx_90E_ecustom--PurchaseOfOtherMriCenters_iI_uInteger_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zP7e7nvsGKig" title="Purchase of other MRI centers"><ix:nonFraction name="FONR:PurchaseOfOtherMriCenters" contextRef="AsOf2013-03-05_custom_HDMMember" id="Fact001442" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">2</ix:nonFraction></span>) other scanning
centers located in the States of New York and Florida for a total purchase price (including consideration of $<span id="xdx_903_ecustom--ConsiderationToOutsideInvestors_iI_pn5n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zUur4HS6hQ5k" title="HDM purchase price includes consideration to outside investors"><ix:nonFraction name="FONR:ConsiderationToOutsideInvestors" contextRef="AsOf2013-03-05_custom_HDMMember" id="Fact001444" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.5</ix:nonFraction></span> million to outside investors)
aggregating $<span id="xdx_907_ecustom--TotalPurchasePrice_iI_pn5n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zfoEHPjghhfg" title="HDM purchase from Health Diagnostics (HD) ($)"><ix:nonFraction name="FONR:TotalPurchasePrice" contextRef="AsOf2013-03-05_custom_HDMMember" id="Fact001446" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">35.9</ix:nonFraction></span> million. Concurrently with the acquisition, HDM entered into several consulting and non-competition agreements for a
consideration of $<span id="xdx_900_ecustom--ConsiderationForNoncompetitionAndConsultingAgreements_iI_pn5n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zcwLY6zvZ4A7" title="HDM entered agreement for consulting and non-competition agreement ($)"><ix:nonFraction name="FONR:ConsiderationForNoncompetitionAndConsultingAgreements" contextRef="AsOf2013-03-05_custom_HDMMember" id="Fact001448" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">4.1</ix:nonFraction></span> million. The acquisition was accounted for using the purchase method in accordance with ASC 805, &#8220;Business
Combinations&#8221;. The Company recognized and measured goodwill as of the acquisition date, as the excess of the fair value of the consideration
paid over the fair value of the identified net assets acquired.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 8, 2015, the Company purchased <span id="xdx_907_ecustom--EquityMethodInvestmentsOwnershipPercentage_iI_dp_c20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zQyErlqKzwF" title="Purchase of interests from Class A,  percentage"><ix:nonFraction name="FONR:EquityMethodInvestmentsOwnershipPercentage" contextRef="AsOf2015-01-08_custom_ClassAControllingInterestsMember_custom_HDMMember" id="Fact001450" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction></span>%
of the Class A members ownership interest at a cost of $<span id="xdx_90C_ecustom--DirectPurchaseOfNoncontrollingInterests_c20150107__20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zlUWeSmllwA3" title="Purchase of interests from Class A"><ix:nonFraction name="FONR:DirectPurchaseOfNoncontrollingInterests" contextRef="From2015-01-072015-01-08_custom_ClassAControllingInterestsMember_custom_HDMMember" id="Fact001452" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,971,094</ix:nonFraction></span>. The Company has a <span id="xdx_909_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zI5klHa894oj" title="Ownership interest in HDM"><ix:nonFraction name="FONR:EquityMethodInvestmentOwnershipPercentages" contextRef="AsOf2015-01-08_custom_ClassAControllingInterestsMember_custom_HDMMember" id="Fact001454" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60.4</ix:nonFraction></span>% ownership interest in HDM after this transaction.
During the year ended June 30, 2022, the Company purchased noncontrolling interests for $<span id="xdx_90A_ecustom--DirectPurchaseOfNoncontrollingInterests_c20220701__20230630__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_z4gbFFBihfKg" title="Purchase of interests from Class A"><ix:nonFraction name="FONR:DirectPurchaseOfNoncontrollingInterests" contextRef="From2022-07-012023-06-30_custom_ClassAControllingInterestsMember_custom_HDMMember" id="Fact001456" format="ixt:numdotdecimal" decimals="0" unitRef="USD">546,000</ix:nonFraction></span> giving the Company a direct ownership
interest of <span id="xdx_908_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20230630__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_z2mseZiMkMp6" title="Ownership interest of company"><ix:nonFraction name="FONR:EquityMethodInvestmentOwnershipPercentages" contextRef="AsOf2023-06-30_custom_ClassAControllingInterestsMember_custom_HDMMember" id="Fact001458" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">70.8</ix:nonFraction></span>% and the investors&#8217; a <span id="xdx_901_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20230630__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_zrOgXXUzdfLl" title="Ownership interest of investors"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" contextRef="AsOf2023-06-30_custom_HDMMember_custom_ClassAControllingInterestsMember" id="Fact001460" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">29.2</ix:nonFraction></span>% ownership interest.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The amount of each class of HDM members&#8217; equity
as of June 30, 2024 and 2023 is as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001462" name="us-gaap:RedeemableNoncontrollingInterestTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zKcjhoIk1oE5" summary="xdx: Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"><span id="xdx_8B6_zPPYXjlVbfU6" style="display: none">Schedule of HDM members equity</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2023</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class A Members</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class B Member</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class A Members</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class B Member</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 40%; text-align: left; text-indent: -11pt">Opening Members&#8217; Equity</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">($</td><td id="xdx_98B_ecustom--OpeningMembersEquity_iI_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zBrXOeaQEJwc" title="Opening Members Equity" style="width: 10%; text-align: right"><ix:nonFraction name="FONR:OpeningMembersEquity" contextRef="AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" id="Fact001464" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,079,293</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--OpeningMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_z4Zn1ILvbg73" title="Opening Members Equity" style="width: 10%; text-align: right"><ix:nonFraction name="FONR:OpeningMembersEquity" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" id="Fact001466" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">54,781,813</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">($</td><td id="xdx_98F_ecustom--OpeningMembersEquity_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zGlkxvIQK5Kg" title="Opening Members Equity" style="width: 10%; text-align: right"><ix:nonFraction name="FONR:OpeningMembersEquity" contextRef="AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" id="Fact001468" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,053,833</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--OpeningMembersEquity_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zyBUIwmC4wYk" title="Opening Members Equity" style="width: 10%; text-align: right"><ix:nonFraction name="FONR:OpeningMembersEquity" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" id="Fact001470" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,292,073</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Share of Net Income</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_ecustom--ShareOfNetIncome_iI_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zYqKH0W5ebKf" title="Share of Net Income" style="text-align: right"><ix:nonFraction name="FONR:ShareOfNetIncome" contextRef="AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" id="Fact001472" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,530,021</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_ecustom--ShareOfNetIncome_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zdz67QBQ0yl9" title="Share of Net Income" style="text-align: right"><ix:nonFraction name="FONR:ShareOfNetIncome" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" id="Fact001474" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,705,681</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_ecustom--ShareOfNetIncome_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zSlaohGV2h4c" title="Share of Net Income" style="text-align: right"><ix:nonFraction name="FONR:ShareOfNetIncome" contextRef="AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" id="Fact001476" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,750,740</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_ecustom--ShareOfNetIncome_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zlT3nROLK6m8" title="Share of Net Income" style="text-align: right"><ix:nonFraction name="FONR:ShareOfNetIncome" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" id="Fact001478" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,513,540</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Buyout of noncontrolling interests</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zwpPHKapcr12" title="Buyout of noncontrolling interests" style="text-align: right"><ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterestsValue" contextRef="AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" id="Fact001480" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zX1yBm6E3Y2k" title="Buyout of noncontrolling interests" style="text-align: right"><ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterestsValue" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" id="Fact001482" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z98PGEPUkOv5" title="Buyout of noncontrolling interests" style="text-align: right"><ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterestsValue" contextRef="AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" id="Fact001484" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zlk1aGDOh0Oj" title="Buyout of noncontrolling interests" style="text-align: right"><ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterestsValue" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" id="Fact001486" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Distributions</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">($</td><td id="xdx_984_ecustom--Distributions_iI_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z5zqKPDZWYsf" title="Distributions" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:Distributions" contextRef="AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" id="Fact001488" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,630,336</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_985_ecustom--Distributions_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_z7b6UFqLQgo" title="Distributions" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="FONR:Distributions" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" id="Fact001490" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">13,669,664</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">($</td><td id="xdx_985_ecustom--Distributions_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zPHCdZMK2cBg" title="Distributions" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:Distributions" contextRef="AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" id="Fact001492" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,776,200</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98F_ecustom--Distributions_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zdchjKdL0Ezl" title="Distributions" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="FONR:Distributions" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" id="Fact001494" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">14,023,800</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Ending Members&#8217; Equity</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">($</td><td id="xdx_98D_ecustom--EndingMembersEquity_iI_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zKBuYx21MFQ7" title="Ending Members Equity" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:EndingMembersEquity" contextRef="AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" id="Fact001496" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,179,608</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_ecustom--EndingMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zbZexYRUnqP2" title="Ending Members Equity" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:EndingMembersEquity" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" id="Fact001498" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">61,817,830</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">($</td><td id="xdx_984_ecustom--EndingMembersEquity_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zItXO6WH3voi" title="Ending Members Equity" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:EndingMembersEquity" contextRef="AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" id="Fact001500" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,079,293</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--EndingMembersEquity_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zf5BC2bLsAnl" title="Ending Members Equity" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:EndingMembersEquity" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" id="Fact001502" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">54,781,813</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<ix:exclude><p id="xdx_236_zQYiMk5Pm7Z1" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 70; Value: 2 -->
    <div id="xdx_232_zSwfsmghP611" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_236_zwLHNs3oI4s4" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zcIHG6UJyK21" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_238_zV6yHxZBRl4k" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_234_ziH9tPHVuy36" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zCqiAinEqw7g" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zIisX3xOnBRa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001510" name="FONR:LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock"><p id="xdx_80A_ecustom--LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock_zQ0vH4QulR5j" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 10 - <span id="xdx_82F_zHnhBzj6k18h">LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL
LEASES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long-term debt, notes payable and capital leases consist
of the following:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001512" name="us-gaap:ScheduleOfDebtTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfDebtTableTextBlock_zQd3FnJ62l5h" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 11pt; text-align: center; text-indent: -11pt"><span id="xdx_8B8_zTOADzhp4Yxf" style="display: none">Schedule of long-term debt, notes payable and capital leases</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Note payable requiring monthly payments of interest at a rate of <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zCoNuW4lw4Rh" title="Interest rate" class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2023-07-012024-06-30_custom_NotePayable1Member" id="Fact001514" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7</ix:nonFraction></span>% until May 2009 followed by <span id="xdx_907_ecustom--MonthlyPaymentPeriod_dtM_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zEfEk1ny04yb" title="Monthly payment period" class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_NotePayable1Member" format="ixt-sec:durmonth" id="Fact001516" name="FONR:MonthlyPaymentPeriod">240</ix:nonNumeric></span> monthly payments of $<span id="xdx_90A_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zzqajwERB2m8" title="Debt instrument, periodic payment" class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2023-07-012024-06-30_custom_NotePayable1Member" id="Fact001518" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,472</ix:nonFraction></span> through <span id="xdx_904_ecustom--MaturityDate_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zvmge24Fcs0b" title="Maturity date" class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_NotePayable1Member" id="Fact001520" name="FONR:MaturityDate">October 2026</ix:nonNumeric></span>. The loan is collateralized by a building with a net book value of $<span id="xdx_907_ecustom--BookValueOfBuilding_iI_pp0p0_c20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zzp5O41HW52k" title="Book value of building" class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><ix:nonFraction name="FONR:BookValueOfBuilding" contextRef="AsOf2024-06-30_custom_NotePayable1Member" id="Fact001522" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">310,827</ix:nonFraction></span> as of June 30, 2024.</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--LongTermDebt_iI_pp0p0_c20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zbUgTaZIhN53" title="Long term debt current" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2024-06-30_custom_NotePayable1Member" id="Fact001524" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">113,940</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--LongTermDebt_iI_pp0p0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zDuORGkrKj52" title="Long term debt current" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2023-06-30_custom_NotePayable1Member" id="Fact001526" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">158,842</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">The revolving credit note was extended to November 14, 2024. The Company can borrow up to $<span id="xdx_908_eus-gaap--ProceedsFromLinesOfCredit_pp0p0_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zdj4WL0iZapd" title="Proceeds from lines of credit" class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><ix:nonFraction name="us-gaap:ProceedsFromLinesOfCredit" contextRef="From2023-07-012024-06-30_custom_NotePayable2Member" id="Fact001528" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,000,000</ix:nonFraction></span> and prepay the loan in whole or part in multiples of $100,000 at any time without penalty. The note bears interest at a rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_z7tulAvfFHJh" title="Interest rate" class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2023-07-012024-06-30_custom_NotePayable2Member" id="Fact001530" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.5</ix:nonFraction></span>% per annum and is payable monthly. The loan is collateralized by substantially all of the Company&#8217;s assets. The loan also contains certain financial covenants that must be met on a periodic basis. The Company still has the ability to draw down on the line.</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LongTermDebt_iI_pp0p0_d0_c20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zpXEHFFS9VQ2" title="Long term debt current" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2024-06-30_custom_NotePayable2Member" id="Fact001532" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--LongTermDebt_iI_pp0p0_d0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zAKwtNt9oiD5" title="Long term debt current" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2023-06-30_custom_NotePayable2Member" id="Fact001534" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--LongTermDebt_iI_pp0p0_c20240630_zcvkeYpicsM" title="Long term debt, notes payable and capital leases" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2024-06-30" id="Fact001536" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">113,940</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--LongTermDebt_iI_pp0p0_c20230630_zuxIcoMpqRM3" title="Long term debt, notes payable and capital leases" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2023-06-30" id="Fact001538" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">158,842</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Less: Current portion</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_iI_pp0p0_c20240630_znlIwV9UoGta" title="Current portion of long term debt, notes payable and capital leases" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="AsOf2024-06-30" id="Fact001540" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">47,002</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_iI_pp0p0_c20230630_zEnznTi3X4zd" title="Current portion of long term debt, notes payable and capital leases" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="AsOf2023-06-30" id="Fact001542" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,767</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--LongTermDebtAndCapitalLeaseObligations_iI_pp0p0_c20240630_ziLKPxsGuGtl" title="Long term debt, notes payable and capital leases less current portion" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="AsOf2024-06-30" id="Fact001544" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">66,938</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--LongTermDebtAndCapitalLeaseObligations_iI_pp0p0_c20230630_zdnuz2CUgs9l" title="Long term debt, notes payable and capital leases less current portion" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="AsOf2023-06-30" id="Fact001546" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">115,075</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A4_zakCJzmO0Ri" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The maturities of debt over the next three years are
as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>



<p style="margin-top: 0pt; margin-bottom: 0pt"></p><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001548" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zpq2vdDgH7uh" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities of long term debt over 5 years - (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom">

    <td style="text-align: left"><span id="xdx_8B7_zTuYv98oVxkd" style="display: none">Schedule of maturities of long-term debt</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left">Years Ending June 30,</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 76%; text-align: left; text-indent: -11pt">2025</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_pp0p0_c20240630_zvpfG79G2mDa" title="2024" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" contextRef="AsOf2024-06-30" id="Fact001550" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">47,002</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_pp0p0_c20240630_z24gB1xe98dd" title="2025" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" contextRef="AsOf2024-06-30" id="Fact001552" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,448</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">2027</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_pp0p0_c20240630_zUrn8wDlhbU9" title="2026" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" contextRef="AsOf2024-06-30" id="Fact001554" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,490</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; color: white; text-align: left; text-indent: -11pt"><span style="font: normal 11pt Times New Roman, Times, Serif; text-decoration: none; color: Black; vertical-align: baseline">Long-Term
    Debt Over Five Years and Thereafter</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--LongTermDebt_iI_c20240630_zGxdSee5wQ13" title="Total long term debt" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2024-06-30" id="Fact001556" format="ixt:numdotdecimal" decimals="0" unitRef="USD">113,940</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A2_zVNQBoyGmDPf" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<ix:exclude><p id="xdx_23E_zlc2GAcr7CYi" style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 71; Value: 2 -->
    <div id="xdx_239_zffs4KZ1V3Z7" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_239_zk1k2CxN2srd" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zHG03g5tSaB2" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zwtF3fqX5Ub8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zdpqnig3Bqfe" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zDXv4HhThUr5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_238_zpZMr83ALKAd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001564" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_80A_eus-gaap--IncomeTaxDisclosureTextBlock_zGLmlguh1OA8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 11 - <span id="xdx_825_z8VWpc9FtsZk">INCOME TAXES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;The Company has recorded a deferred tax
asset of $<span id="xdx_906_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_c20240630_zbP3UzWjg9v5" title="Deferred tax asset"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2024-06-30" id="Fact001566" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,223,255</ix:nonFraction></span>
and a deferred tax liability of $<span id="xdx_909_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_iI_pp0p0_c20240630_zj2S1M07nD99" title="Deferred tax liability"><ix:nonFraction name="us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" contextRef="AsOf2024-06-30" id="Fact001568" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">371,560</ix:nonFraction></span>
as of June 30, 2024, primarily relating to its allowance for credit losses of $3,970,000 and tax credits of approximately $<span id="xdx_907_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20240630_zjNfDjOdaXIc" title="Allowance for doubtful accounts and tax credits"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2024-06-30" id="Fact001570" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,323,000</ix:nonFraction></span>
available to offset future taxable income through 2043. During fiscal 2024, the Company utilized all Federal loss carryforwards. In
addition the Company has state operating loss carryforwards of approximately $<span id="xdx_90F_eus-gaap--OperatingIncomeLoss_pp0p0_c20230701__20240630_zPecr9kFqVu" title="State operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-07-01to2024-06-30" id="Fact001572" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,516,000</ix:nonFraction></span>
and city operating loss carryforwards of approximately $<span id="xdx_906_eus-gaap--OtherOperatingIncome_pp0p0_c20230701__20240630_z3KFShJTBQRe" title="City operating loss carryforwards"><ix:nonFraction name="us-gaap:OtherOperatingIncome" contextRef="From2023-07-01to2024-06-30" id="Fact001574" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">618,000</ix:nonFraction></span>.
The net operating losses begin to expire in 2026 for state income tax purposes. The Company has also recorded a valuation allowance
against $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwardsValuationAllowance_iI_pp0p0_c20240630_zRE0FmCB4E8c" title="Valuation allowance of state operating losses"><ix:nonFraction name="us-gaap:OperatingLossCarryforwardsValuationAllowance" contextRef="AsOf2024-06-30" id="Fact001576" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,746,000</ix:nonFraction></span>
of the state operating losses since the Company doesn&#8217;t anticipate being able to utilize them.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company files corporate income tax returns in
the United States (federal) and in various state and local jurisdictions. In most instances, the Company is no longer subject to federal,
state and local income tax examinations by tax authorities for years prior to 2020.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Future ownership changes as determined under Section
382 of the Internal Revenue code could further limit the utilization of net operating loss carryforwards. As of June 30, 2024, no such
changes in ownership have occurred.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Inflation Reduction Act (&#8220;IRA&#8221;) was
enacted on August 16, 2022. The IRA includes provisions imposing a <span id="xdx_907_ecustom--PercentageOfExciseTax_dp_c20230701__20240630_zxikkdOY9Wj2" title="Percentage of excise tax"><ix:nonFraction name="FONR:PercentageOfExciseTax" contextRef="From2023-07-01to2024-06-30" id="Fact001578" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1</ix:nonFraction></span>% excise tax on share repurchases that occur after December 31, 2022
and introduces a <span id="xdx_905_ecustom--CorporateAlternativeMinimumTaxPercentage_dp_c20230701__20240630_zL6GqyTjidY4" title="Corporate alternative minimum tax percentage"><ix:nonFraction name="FONR:CorporateAlternativeMinimumTaxPercentage" contextRef="From2023-07-01to2024-06-30" id="Fact001580" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction></span>%&#160;corporate alternative minimum tax (&#8220;CAMT&#8221;) on adjusted financial statement income. The CAMT will
be effective for tax years beginning after December 31, 2022. Currently, the IRA did not have a material impact to the Company&#8217;s
financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The valuation allowance for deferred tax assets decreased
during the year ended June 30, 2024, by approximately $<span id="xdx_908_eus-gaap--DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_iI_pp0p0_c20240630_zIHvpFYikvCl" title="Valuation allowance for deferred tax assets"><ix:nonFraction name="us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" contextRef="AsOf2024-06-30" id="Fact001582" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">171,000</ix:nonFraction></span>. The valuation allowance decreased by approximately $<span id="xdx_90D_eus-gaap--DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_iI_pp0p0_c20230630_zNi7bIeV7nYa" title="Valuation allowance for deferred tax assets"><ix:nonFraction name="us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" contextRef="AsOf2023-06-30" id="Fact001584" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">78,000</ix:nonFraction></span> during the
year ended June 30, 2023.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><p id="xdx_232_zc5nKEBfFLUg" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 72; Value: 2 -->
    <div id="xdx_23D_zc2KxDwXXM1k" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23B_z5juvYAuE4Vh" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zSmknI9goxM" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zlIMX67FKqik" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zKh5y43xXSyb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_233_z8xcl68lMmA7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_232_zHo4BuGNMNzl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zTRPWCnFHOs6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 11 - INCOME TAXES (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_236_zYgqNZakIEn" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Components of the provision for income taxes are as
follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001594" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z9sWZUCGaNVi" summary="xdx: Disclosure - INCOME TAXES - Components of provision for income taxes (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BE_z1SNdi7WdLbh" style="display: none">Schedule of components
    of the provision for income taxes</span></td><td>&#160;</td>
    <td colspan="3" id="xdx_49B_20230701__20240630_zpKh9SmNlITi" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_492_20220701__20230630_zLdD00Lt5SIk" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">Years Ended June 30,</td></tr>
  <tr id="xdx_404_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_zsZixD2IhqMh" style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Current:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_401_eus-gaap--CurrentFederalTaxExpenseBenefit_d0_maCITEBzHyE_zBjL8rWRkwP2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; width: 56%; text-align: left; text-indent: -11pt">Federal</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2023-07-01to2024-06-30" id="Fact001599" format="ixt:numdotdecimal" decimals="0" unitRef="USD">429,873</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2022-07-012023-06-30" id="Fact001600" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCITEBzHyE_zW3qlNcMdLHg" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">State</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2023-07-01to2024-06-30" id="Fact001602" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,943,588</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2022-07-012023-06-30" id="Fact001603" format="ixt:numdotdecimal" decimals="0" unitRef="USD">652,521</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_maITEBzXA8_mtCITEBzHyE_znFk5QhjYvZi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="From2023-07-01to2024-06-30" id="Fact001605" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,373,461</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="From2022-07-012023-06-30" id="Fact001606" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">652,521</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_pp0p0_z6x46xBkG5Sd" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Deferred:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzROz_zpQoQ3jM4Tq2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Federal deferred taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2023-07-01to2024-06-30" id="Fact001611" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,585,515</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2022-07-012023-06-30" id="Fact001612" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,770,980</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzROz_zv38VAZL6vDj" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">State deferred taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2023-07-01to2024-06-30" id="Fact001614" format="ixt:numdotdecimal" decimals="0" unitRef="USD">209,992</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2022-07-012023-06-30" id="Fact001615" format="ixt:numdotdecimal" decimals="0" unitRef="USD">208,570</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DeferredIncomeTaxExpensesBenefit_iT_pp0p0_mtDITEBzROz_maITEBzXA8_zsNcthnIZjMd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:DeferredIncomeTaxExpensesBenefit" contextRef="From2023-07-01to2024-06-30" id="Fact001617" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,795,507</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:DeferredIncomeTaxExpensesBenefit" contextRef="From2022-07-012023-06-30" id="Fact001618" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,979,550</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzXA8_zMR6xz0x1AC" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Provision (Benefit) for Income Taxes - Net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-07-01to2024-06-30" id="Fact001620" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,168,968</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-07-012023-06-30" id="Fact001621" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,632,071</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8AD_zYtgKg9sCJFf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A reconciliation of the federal statutory income tax
rate to the Company&#8217;s effective tax rate as reported is as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001623" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zoscTUSQtz28" summary="xdx: Disclosure - INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8B8_ze4WkrOfrg1h" style="display: none">Schedule of
    reconciliation of federal statutory income tax rate to company&#8217;s effective tax rate</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">Years Ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Taxes at federal statutory rate</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_906_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_dp_c20230701__20240630_zCe5Cd2yv06f" title="Taxes at federal statutory rate"><ix:nonFraction name="FONR:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates" contextRef="From2023-07-01to2024-06-30" id="Fact001625" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_903_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_dp_c20220701__20230630_zneX5UxD0w05" title="Taxes at federal statutory rate"><ix:nonFraction name="FONR:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates" contextRef="From2022-07-012023-06-30" id="Fact001627" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">State and local income taxes (benefit), net of federal benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20230701__20240630_zUmPEuw7Kqsd" title="State and local income taxes (benefit), net of federal benefit"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2023-07-01to2024-06-30" id="Fact001629" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.1</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20220701__20230630_zgoczKdnDywd" title="State and local income taxes (benefit), net of federal benefit"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2022-07-012023-06-30" id="Fact001631" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.1</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Non-controlling interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20230701__20240630_zK78v0AH8uT3" title="Noncontrolling interest">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" contextRef="From2023-07-01to2024-06-30" id="Fact001633" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">5.3</ix:nonFraction></span></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20220701__20230630_zcxnrAndN7Eg" title="Noncontrolling interest">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" contextRef="From2022-07-012023-06-30" id="Fact001635" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">4.6</ix:nonFraction></span></td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Expiration of tax credits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_c20230701__20240630_zgbX50BtWvQa" title="Expiration of tax credits"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" contextRef="From2023-07-01to2024-06-30" id="Fact001637" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.2</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_c20220701__20230630_zGIokfHUIDUj" title="Expiration of tax credits"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" contextRef="From2022-07-012023-06-30" id="Fact001639" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.8</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Return to provision adjustments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp0_c20230701__20240630_zaG6vhJN5Pac" title="Return to provision adjustments"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2023-07-01to2024-06-30" id="Fact001641" format="ixt:zerodash" decimals="INF" scale="-2" unitRef="Pure">&#8212;</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_c20220701__20230630_zEkgoYvjVo0k" title="Return to provision adjustments">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2022-07-012023-06-30" id="Fact001643" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">2.3</ix:nonFraction></span></td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Change in the valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20230701__20240630_z7RL2utqT1Wa" title="Change in the valuation allowance">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2023-07-01to2024-06-30" id="Fact001645" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.2</ix:nonFraction></span></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20220701__20230630_z1H0ZT04BBbb" title="Change in the valuation allowance">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2022-07-012023-06-30" id="Fact001647" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.5</ix:nonFraction></span></td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20230701__20240630_zap2RVYajSSa" title="Other"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" contextRef="From2023-07-01to2024-06-30" id="Fact001649" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.0</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20220701__20230630_zsd62kktcE1d" title="Other"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" contextRef="From2022-07-012023-06-30" id="Fact001651" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.5</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Effective income tax rate</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20230701__20240630_z5nDSWn7b8x1" title="Effective income tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2023-07-01to2024-06-30" id="Fact001653" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">26.8</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20220701__20230630_zcCDzM2z68u8" title="Effective income tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2022-07-012023-06-30" id="Fact001655" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">23.0</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8AB_zh4LD6ASuwFa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_234_zGIbL3dDdQxl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 73; Value: 2 -->
    <div id="xdx_23A_zUM9InkcSnyb" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_232_zkCSaYIWog1e" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_z9VhQKA1gU16" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_z30z1pgqNXW2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_23E_ztjUYGOseqFa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_234_zMhL3XNYkb88" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zEmXDMBg8GKe" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_235_zkyRwqT9hUJ6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 11 - INCOME TAXES (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zUOVLvU4ynfj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2024, the Company utilized all Federal
net operating loss (&#8220;NOL&#8221;) carryforwards as compared to NOL&#8217;s of approximately $9,110,000 as of June 30, 2023. The utilization
of certain of the NOLs is limited by separate return limitation year rules pursuant to Section 1502 of the Internal Revenue Code.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has, for federal income tax purposes,
research and development tax credits and investments tax credits carryforwards aggregating $<span id="xdx_90F_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_iI_pp0p0_c20240630_zvulAavt8qd4" title="Tax credits carryforwards"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" contextRef="AsOf2024-06-30" id="Fact001665" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,323,000</ix:nonFraction></span>. However, the realization of these
credits may be limited as a result of expiring prior to their utilization. These credits can only be applied after all net operating losses
have been used.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;Significant components of the Company&#8217;s
deferred tax assets and liabilities at June 30, 2024 and 2023 are as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001667" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zMqcrx20DgGf" summary="xdx: Disclosure - INCOME TAXES - Deferred tax assets and liabilities - (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BC_zMULfEhGAqE2" style="display: none">Schedule of company&#8217;s
deferred tax assets and liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20240630_zmuKQ9m5zlZd" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20230630_zdjeToFeSOIh" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzM4n_zibiFm5K9Qah" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Allowance for credit losses</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" contextRef="AsOf2024-06-30" id="Fact001672" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,969,819</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" contextRef="AsOf2023-06-30" id="Fact001673" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,360,809</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzM4n_zszFOdQf73S" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Non-deductible accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2024-06-30" id="Fact001675" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">758,700</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2023-06-30" id="Fact001676" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">707,400</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzM4n_ztlOIfuAk64e" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Net operating carryforwards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2024-06-30" id="Fact001678" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">396,092</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2023-06-30" id="Fact001679" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,768,844</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzM4n_zLQMYZfL8LK3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Tax credits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" contextRef="AsOf2024-06-30" id="Fact001681" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,323,018</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" contextRef="AsOf2023-06-30" id="Fact001682" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,981,214</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_i01I_pp0p0_maDTAGzM4n_z9dgsUKM8Mp" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Capitalized research and development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" contextRef="AsOf2024-06-30" id="Fact001684" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">747,407</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" contextRef="AsOf2023-06-30" id="Fact001685" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">369,675</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--DeferredTaxAssetsInRightUseAssetsAndLiabilities_i01I_pp0p0_maDTAGzM4n_zwpnzLQy2uyg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Right of use assets and lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:DeferredTaxAssetsInRightUseAssetsAndLiabilities" contextRef="AsOf2024-06-30" id="Fact001687" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">114,116</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FONR:DeferredTaxAssetsInRightUseAssetsAndLiabilities" contextRef="AsOf2023-06-30" id="Fact001688" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">112,938</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzM4n_zuyGoIorZQdd" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Inventories</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInventory" contextRef="AsOf2024-06-30" id="Fact001690" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">106,879</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInventory" contextRef="AsOf2023-06-30" id="Fact001691" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">105,310</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzM4n_maDTANzJzu_z9l7g2nMCjca" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Deferred Tax Assets - gross</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2024-06-30" id="Fact001693" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,416,031</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2023-06-30" id="Fact001694" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,406,190</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzJzu_zdkzvBgmTDcl" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2024-06-30" id="Fact001696" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">192,776</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2023-06-30" id="Fact001697" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">364,230</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzJzu_maDTALNzFAZ_z8c8sM4QmDc4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2024-06-30" id="Fact001699" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,223,255</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2023-06-30" id="Fact001700" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,041,960</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_pp0p0_di_maDTLzImD_z0HSCRTtRFx3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Property and equipment and depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" contextRef="AsOf2024-06-30" id="Fact001702" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">267,124</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" contextRef="AsOf2023-06-30" id="Fact001703" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">151,007</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzImD_zAENllX4Dqi2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Intangibles</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" contextRef="AsOf2024-06-30" id="Fact001705" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">104,436</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" contextRef="AsOf2023-06-30" id="Fact001706" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">243,751</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_msDTALNzFAZ_mtDTLzImD_zNqihF02Jv1b" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total deferred tax liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" contextRef="AsOf2024-06-30" id="Fact001708" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">371,560</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" contextRef="AsOf2023-06-30" id="Fact001709" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">394,758</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzFAZ_zy4p6iK9IJuj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Net deferred tax asset</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2024-06-30" id="Fact001711" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,851,695</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2023-06-30" id="Fact001712" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,647,202</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A9_zyTQ0sZfOKpk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_232_zDpUhvXsdLj7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 74; Value: 2 -->
    <div id="xdx_238_zut78dh5izx7" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_231_zarw0fTOzSc1" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_z0eDxW71T4N5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zdnvFAYED5S4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zTTJnvvrntBd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zJjPA6vfhuaj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zMp16HHmsMB" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001720" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"><p id="xdx_80C_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_ztqTOz9sie16" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 12 - <span id="xdx_825_zEInyM7QGgQc">OTHER CURRENT LIABILITIES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Included in other current liabilities are the following:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001722" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zLPhW9v4htne" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8B7_zJqBC5NLE9O8" style="display: none">Schedule of other current liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20240630_zITTz9uZyXrl" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20230630_zVHCeNkN7jb9" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_40D_eus-gaap--AccruedSalariesCurrent_iI_maOLCzbf4_zNVOmqy10yI9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Accrued salaries, commissions and payroll taxes</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2024-06-30" id="Fact001724" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,677,690</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2023-06-30" id="Fact001725" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,413,044</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_maOLCzbf4_zQ7LK7x0eAb2" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Sales tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="AsOf2024-06-30" id="Fact001727" format="ixt:numdotdecimal" decimals="0" unitRef="USD">197,317</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="AsOf2023-06-30" id="Fact001728" format="ixt:numdotdecimal" decimals="0" unitRef="USD">193,041</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_maOLCzbf4_zEvlcDCGHTx" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">State income taxes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:TaxesPayableCurrentAndNoncurrent" contextRef="AsOf2024-06-30" id="Fact001730" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,461,336</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:TaxesPayableCurrentAndNoncurrent" contextRef="AsOf2023-06-30" id="Fact001731" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,353</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AccruedProfessionalFeesCurrent_iI_maOLCzbf4_zUdGxQjdaOdc" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Legal and other professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2024-06-30" id="Fact001733" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,207</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2023-06-30" id="Fact001734" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,207</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_maOLCzbf4_zESr0jVwOI9f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Accounting fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" contextRef="AsOf2024-06-30" id="Fact001736" format="ixt:numdotdecimal" decimals="0" unitRef="USD">119,800</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" contextRef="AsOf2023-06-30" id="Fact001737" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--SelfInsuranceReserve_iI_maOLCzbf4_zJPW3PvDhDM5" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Self-funded health insurance reserve</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2024-06-30" id="Fact001739" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121,445</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2023-06-30" id="Fact001740" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,971</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_maOLCzbf4_zkT55C58U2e3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Accrued interest and penalty</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesNoncurrent" contextRef="AsOf2024-06-30" id="Fact001742" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,534</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesNoncurrent" contextRef="AsOf2023-06-30" id="Fact001743" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,534</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OtherSundryLiabilitiesCurrent_iI_maOLCzbf4_zxPXP6ULGWHh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherSundryLiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact001745" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,348,710</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherSundryLiabilitiesCurrent" contextRef="AsOf2023-06-30" id="Fact001746" format="ixt:numdotdecimal" decimals="0" unitRef="USD">573,574</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--OtherLiabilitiesCurrent_iTI_mtOLCzbf4_zMLrUOLXO7Ye" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Other current liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact001748" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,941,039</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-06-30" id="Fact001749" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,443,724</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001751" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zZKbgkWCscSh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 13 - <span id="xdx_828_zQtsp1iuWmoe">COMMITMENTS AND CONTINGENCIES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Leases</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company rents its operating facilities and certain
equipment, pursuant to operating lease agreements expiring at various dates through November 2033. The leases for certain facilities contain
escalation clauses relating to increases in real property taxes as well as certain maintenance costs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Rent expense for operating leases approximated $<span id="xdx_903_ecustom--LeaseAndRentalExpenses_pp0p0_c20230701__20240630_zRAAc6o6VfKf" title="Rent expense for operating leases"><ix:nonFraction name="FONR:LeaseAndRentalExpenses" contextRef="From2023-07-01to2024-06-30" id="Fact001753" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,685,000</ix:nonFraction></span>
and $<span id="xdx_90C_ecustom--LeaseAndRentalExpenses_pp0p0_c20220701__20230630_zzakPXfsHYk5" title="Rent expense for operating leases"><ix:nonFraction name="FONR:LeaseAndRentalExpenses" contextRef="From2022-07-012023-06-30" id="Fact001755" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,887,000</ix:nonFraction></span>, for the years ended June 30, 2024 and 2023, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company received approval from the Suffolk County
Industrial Development Agency on February 29, 2016 of a <span id="xdx_90B_ecustom--PropertyTaxAbatementFromSuffolkCountyIda_dp_c20160228__20160229_ztie8PuWue76" title="Property tax abatement from suffolk county IDA"><ix:nonFraction name="FONR:PropertyTaxAbatementFromSuffolkCountyIda" contextRef="From2016-02-282016-02-29" id="Fact001757" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span>% property tax abatement, valued at $<span id="xdx_90E_ecustom--PropertyTaxAbatement_pp0p0_c20160228__20160229_zDQJRCzzWWTh" title="Property tax abatement"><ix:nonFraction name="FONR:PropertyTaxAbatement" contextRef="From2016-02-282016-02-29" id="Fact001759" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">440,000</ix:nonFraction></span>, over a 10 year period commencing
January 2017.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Employee Benefit Plans</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has a non-contributory 401(k) Plan (the
&#8220;401(k) Plan&#8221;). The 401(k) Plan covers all non-union employees who are at least 21 years of age with no minimum service requirements.
There were $<span id="xdx_90A_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_pp0p0_c20230701__20240630_zsDqLxzdTUNb" title="Employer contributions"><ix:nonFraction name="us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP" contextRef="From2023-07-01to2024-06-30" id="Fact001761" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_pp0p0_c20220701__20230630_zbGhCYkXGVO4" title="Employer contributions"><ix:nonFraction name="us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP" contextRef="From2022-07-012023-06-30" id="Fact001763" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">36,523</ix:nonFraction></span> employer contributions to the Plan for the years ended June 30, 2024 and 2023, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The stockholders of the Company approved the 2000
Employee Stock Purchase Plan (&#8220;ESPP&#8221;) at the Company&#8217;s annual stockholders&#8217; meeting in April 2000. The ESPP provides
for eligible employees to acquire common stock of the Company at a discount, not to exceed 15%. This plan has not been put into effect
as of June 30, 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><p id="xdx_230_zRqa8ysDlm69" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 75; Value: 2 -->
    <div id="xdx_238_zso5sNKq4Opd" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_239_z4sXBF4dNxll" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zB36qDlBwj56" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_238_zKHyrdCgst5a" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zS3cAW3RC3xf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23E_za4tzXljbpX4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zpXmvX5Jeeh9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zNuQ1hUz5INf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 13 - COMMITMENTS AND CONTINGENCIES (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_230_zeuTUFBUfPXf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Other Matters</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is subject to other legal proceedings
and claims arising from the ordinary course of its business, including personal injury, customer contract and employment claims besides
the claim above. In the opinion of management, and with consultation with legal counsel, the aggregate liability, if any, with respect
to such actions, will not have a material adverse effect on the consolidated financial position or results of operations of the Company.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company maintains a self-funded health insurance
program with a stop-loss umbrella policy with a third-party insurer to limit the maximum potential liability for individual claims to
$<span id="xdx_905_eus-gaap--ReinsurancePayable_iI_c20240630_zYqMrA883wj9" title="Liability for individual claims"><ix:nonFraction name="us-gaap:ReinsurancePayable" contextRef="AsOf2024-06-30" id="Fact001773" format="ixt:numdotdecimal" decimals="0" unitRef="USD">110,000</ix:nonFraction></span> per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company
considers historical and projected medical utilization data when estimating its health insurance program liability and related expense.
As of June 30, 2024 and 2023, the Company had approximately $<span id="xdx_906_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpense_iI_c20240630_zZv1oBgSkdPa" title="Reserve for self-funded"><ix:nonFraction name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" contextRef="AsOf2024-06-30" id="Fact001775" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121,000</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpense_iI_c20230630_zxuJypjvlCT2" title="Reserve for self-funded"><ix:nonFraction name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" contextRef="AsOf2023-06-30" id="Fact001777" format="ixt:numdotdecimal" decimals="0" unitRef="USD">101,000</ix:nonFraction></span>, respectively, in reserve for its self-funded health
insurance programs. The reserves are included in &#8220;Other current liabilities&#8221; in the consolidated balance sheets.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company regularly analyzes its reserves for incurred
but not reported claims, and for reported but not paid claims related to its reinsurance and self-funded insurance programs. The Company
believes its reserves are adequate. However, significant judgment is involved in assessing these reserves such as assessing historical
paid claims, average lags between the claims&#8217; incurred date, reported dates and paid dates, and the frequency and severity of claims.
There may be differences between actual settlement amounts and recorded reserves and any resulting adjustments are included in expense
once a probable amount is known. There were no significant adjustments recorded in the years covered by this report.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001779" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock"><p id="xdx_805_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_zWJG6q65f5th" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 14 - <span id="xdx_82A_zkvg7ceUmV65">SUPPLEMENTAL CASH FLOW INFORMATION</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the years ended June 30, 2024 and 2023 the
Company paid $<span id="xdx_900_eus-gaap--InterestPaidNet_c20230701__20240630_zcyOH2kUY779" title="Interest paid"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2023-07-01to2024-06-30" id="Fact001781" format="ixt:numdotdecimal" decimals="0" unitRef="USD">76,997</ix:nonFraction></span> and $<span id="xdx_90E_eus-gaap--InterestPaidNet_c20220701__20230630_ztn0BYRDTbva" title="Interest paid"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2022-07-012023-06-30" id="Fact001783" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,132</ix:nonFraction></span> for interest, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the years ended June 30, 2024 and 2023 the
Company paid $<span id="xdx_902_eus-gaap--IncomeTaxesPaid_c20230701__20240630_zjTqW99SYPS1" title="Income taxes paid"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2023-07-01to2024-06-30" id="Fact001785" format="ixt:numdotdecimal" decimals="0" unitRef="USD">507,139</ix:nonFraction></span> and $<span id="xdx_907_eus-gaap--IncomeTaxesPaid_c20220701__20230630_zadEMEw0Uj22" title="Income taxes paid"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2022-07-012023-06-30" id="Fact001787" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,439,507</ix:nonFraction></span> for income taxes, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><p id="xdx_237_zXQB4ot3EdW8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 76; Value: 2 -->
    <div id="xdx_233_zjQkuyIFgCek" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_230_zkO9GH03bBqa" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zXlwi8I32syl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zn2NG9lS0312" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zCyfbkL212r2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23B_znM41QUjay2a" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_237_zb0NCFH8M5Ye" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001795" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_801_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zZC3AuLwFS1f" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 15 &#8211; <span id="xdx_82C_zM1GSWVc1qq5">RELATED PARTY TRANSACTIONS</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 31, 2023, the Company entered into an
agreement with Magnetic Resonance Management, LLC (&#8220;MRM&#8221;) for the sale of a MRI scanner. MRM is owned by the CEO and President
of the Company. The sales price of the equipment was $<span id="xdx_90D_eus-gaap--ConvertibleNotesPayable_iI_c20231231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zapqcbK7XOg1" title="Sale of price of the equipment"><ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2023-12-31_custom_MagneticResonanceManagementMember" id="Fact001797" format="ixt:numdotdecimal" decimals="0" unitRef="USD">576,857</ix:nonFraction></span> which is payable based upon a promissory note dated December 1, 2023. The
note bears interest at a rate of <span id="xdx_908_eus-gaap--DerivativeFixedInterestRate_iI_dp_c20231231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zgit3f9dZIO8" title="Bears interest rate"><ix:nonFraction name="us-gaap:DerivativeFixedInterestRate" contextRef="AsOf2023-12-31_custom_MagneticResonanceManagementMember" id="Fact001799" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9</ix:nonFraction></span>% and is payable in full at the maturity of the note in December 2028. The MRI scanner had zero basis,
which resulted in a gain of $<span id="xdx_901_eus-gaap--DeferredGainOnSaleOfProperty_iI_c20231231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zxBPl1xA3u9f" title="Gain on sale of equipments"><ix:nonFraction name="us-gaap:DeferredGainOnSaleOfProperty" contextRef="AsOf2023-12-31_custom_MagneticResonanceManagementMember" id="Fact001801" format="ixt:numdotdecimal" decimals="0" unitRef="USD">576,857</ix:nonFraction></span>. The Company has the option but not the obligation to re-take possession of the scanner in lieu of
payment upon maturity of the note.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_907_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20230701__20240630__dei--LegalEntityAxis__custom--BensonhurstMRILimitedPartnershipMember_zbgnOk3x02t7" title="Related party transaction, description"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_BensonhurstMRILimitedPartnershipMember" id="Fact001803" name="us-gaap:RelatedPartyTransactionDescriptionOfTransaction">Bensonhurst
MRI Limited Partnership (&#8220;Bensonhurst&#8221;), in which the CEO and President of the Company holds an interest, is party to an
agreement with the Company for the service and maintenance of its Upright MRI Scanner for a price of $110,000 per annum. On February
1, 2024, Bensonhurst entered into a second contract with the Company for the service and maintenance of a High-Field MRI Scanner for
a price of $70,000 per annum. Also, during fiscal year ended June 30, 2024, the Company charged Bensonhurst MRI Limited Partnership
$190,362 for reimbursable salaries and marketing expenses.</ix:nonNumeric></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The CEO and President of the Company was a minority
owner of a billing company, which performs billing and collection services with respect to No-Fault and Workers&#8217; Compensation claims
of the Company&#8217;s clients. The Company terminated this agreement on January 1, 2021. On June 1, 2017, the Company had also entered
into a one year renewable agreement to provide IT services to the billing company for a monthly fee of $<span id="xdx_903_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20170530__20170601_zjp8pwJkyf5k" title="Monthly fee"><ix:nonFraction name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="From2017-05-302017-06-01" id="Fact001805" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,884</ix:nonFraction></span>. The agreement was terminated
on May 31, 2023.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_90A_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20230701__20240630__dei--LegalEntityAxis__custom--RadianHealthcareManagementLLCMember_zC5YBQQHVWth" title="Related party transaction, description"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_RadianHealthcareManagementLLCMember" id="Fact001807" name="us-gaap:RelatedPartyTransactionDescriptionOfTransaction">Radian Healthcare Management, LLC (&#8220;Radian&#8221;),
which is owned by the son-in-law of the CEO and President of the Company provided the Company with personnel recruitment of 32 new employees
at a fee of approximately $200,000 during the fiscal year ended June 30, 2024.</ix:nonNumeric></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001809" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_803_eus-gaap--SegmentReportingDisclosureTextBlock_zcg6tWgYUPX8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 16 - <span id="xdx_820_zrgqTbZFfdA3">SEGMENT AND RELATED INFORMATION</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company provides segment data in accordance with
the provisions of ASC 280, &#8220;Disclosures about Segments of an Enterprise and Related Information&#8221;.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company operates in two industry segments - manufacturing
and the servicing of medical equipment and management of diagnostic imaging centers.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accounting policies of the segments are the same
as those described in the summary of significant accounting policies. All intersegment sales are market-based. The Company evaluates performance
based on income or loss from operations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Summarized financial information concerning the Company&#8217;s
reportable segments is shown in the following table:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><p id="xdx_23C_zU6GPkzrYa3c" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 77; Value: 2 -->
    <div id="xdx_232_zB3IRePfzVo" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_230_z87CA8p9KcZa" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zrbgsjelLdw3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_z4NMKzlhTN6b" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zNIbrovxceB1" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_236_zGTiysvhMkAb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_235_zl6e3VxdkSG3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zLdz9d83ZYZ9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;<b>NOTE 16 - SEGMENT AND RELATED INFORMATION
(CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_238_zCZnYG3O3LK1" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_91F_eus-gaap--HealthCareMember_zrbbrh8Nq8gi"><b style="display: none">Manufacturing
and Servicing of Medical Equipment [Member] </b></span><b><span id="xdx_91A_eus-gaap--HealthCareOtherMember_zwfA1uFTuOY3" style="display: none">Management
of Diagnostic Imaging Center [Member]</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001821" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zA71g3xO3oA4" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"><span id="xdx_8BE_zwqIFlHSQafg" style="display: none">Schedule of summarized segment financial information</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">Manufacturing and Servicing of Medical</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">Management of Diagnostic Imaging</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Fiscal 2024:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Center</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Totals</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; width: 46%; text-align: left; text-indent: -11pt">Net revenues from external customers</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--Revenues_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zTMiA4oQGU86" title="Net revenues from external customers" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012024-06-30_us-gaap_HealthCareMember" id="Fact001823" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,329,106</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zP5FyMWHPOql" title="Net revenues from external customers" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012024-06-30_us-gaap_HealthCareOtherMember" id="Fact001825" format="ixt:numdotdecimal" decimals="0" unitRef="USD">94,554,983</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_c20230701__20240630_zVnyRssIqxyj" title="Net revenues from external customers" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-01to2024-06-30" id="Fact001827" format="ixt:numdotdecimal" decimals="0" unitRef="USD">102,884,089</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Intersegment net revenues *</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_ecustom--IntersegmentNetRevenues_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_fKg_____zsmgMH9E59ib" title="Inter-segment net revenues" style="text-align: right"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2023-07-012024-06-30_us-gaap_HealthCareMember" id="Fact001829" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,073,333</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_ecustom--IntersegmentNetRevenues_d0_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_fKg_____zrUKfCDHutK8" title="Inter-segment net revenues" style="text-align: right"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2023-07-012024-06-30_us-gaap_HealthCareOtherMember" id="Fact001831" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_ecustom--IntersegmentNetRevenues_c20230701__20240630_fKg_____zUkVPQEM3tbd" title="Inter-segment net revenues" style="text-align: right"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2023-07-01to2024-06-30" id="Fact001833" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,073,333</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">(Loss) Income from operations</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperations_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zmyXcXzbgiqd" title="(Loss) Income from operations" style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-07-012024-06-30_us-gaap_HealthCareMember" id="Fact001835" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,958,012</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperations_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zzGA0IqxmlIe" title="(Loss) Income from operations" style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-07-012024-06-30_us-gaap_HealthCareOtherMember" id="Fact001837" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,493,376</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20230701__20240630_zhW7fHRstad1" title="(Loss) Income from operations" style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-07-01to2024-06-30" id="Fact001839" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,535,364</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zKoTIcpgsPMg" title="Depreciation and amortization" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-07-012024-06-30_us-gaap_HealthCareMember" id="Fact001841" format="ixt:numdotdecimal" decimals="0" unitRef="USD">238,802</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zwEQkny54BJa" title="Depreciation and amortization" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-07-012024-06-30_us-gaap_HealthCareOtherMember" id="Fact001843" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,357,619</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20230701__20240630_zz4PjQT86Uca" title="Depreciation and amortization" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-07-01to2024-06-30" id="Fact001845" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,596,421</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Total identifiable assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsNet_iI_c20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_znTU5qLeEuEk" title="Total identifiable assets" style="text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2024-06-30_us-gaap_HealthCareMember" id="Fact001847" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,360,188</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsNet_iI_c20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zfygfHXMgf2l" title="Total identifiable assets" style="text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2024-06-30_us-gaap_HealthCareOtherMember" id="Fact001849" format="ixt:numdotdecimal" decimals="0" unitRef="USD">183,885,781</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--AssetsNet_iI_c20240630_zULDki0ufAV8" title="Total identifiable assets" style="text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2024-06-30" id="Fact001851" format="ixt:numdotdecimal" decimals="0" unitRef="USD">214,245,969</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Capital expenditures</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--PaymentsToAcquireProductiveAssets_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zSXFWTmaLcMa" title="Capital expenditures" style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2023-07-012024-06-30_us-gaap_HealthCareMember" id="Fact001853" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,885</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zEiSLrMAOXn6" title="Capital expenditures" style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2023-07-012024-06-30_us-gaap_HealthCareOtherMember" id="Fact001855" format="ixt:numdotdecimal" decimals="0" unitRef="USD">789,961</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_c20230701__20240630_z36IwKzGEBJh" title="Capital expenditures" style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2023-07-01to2024-06-30" id="Fact001857" format="ixt:numdotdecimal" decimals="0" unitRef="USD">822,846</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Fiscal 2023:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Net revenues from external customers</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zaN9AzScedn8" title="Net revenues from external customers" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-07-012023-06-30_us-gaap_HealthCareMember" id="Fact001859" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,260,711</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--Revenues_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zWF3Zns9v0Md" title="Net revenues from external customers" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-07-012023-06-30_us-gaap_HealthCareOtherMember" id="Fact001861" format="ixt:numdotdecimal" decimals="0" unitRef="USD">90,384,390</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20220701__20230630_zUOVGy35HEFd" title="Net revenues from external customers" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-07-012023-06-30" id="Fact001863" format="ixt:numdotdecimal" decimals="0" unitRef="USD">98,645,101</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Intersegment net revenues *</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_ecustom--IntersegmentNetRevenues_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_fKg_____z6eheYM24d34" title="Inter-segment net revenues" style="text-align: right"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2022-07-012023-06-30_us-gaap_HealthCareMember" id="Fact001865" format="ixt:numdotdecimal" decimals="0" unitRef="USD">985,833</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_ecustom--IntersegmentNetRevenues_d0_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_fKg_____z572vB3OXIGk" title="Inter-segment net revenues" style="text-align: right"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2022-07-012023-06-30_us-gaap_HealthCareOtherMember" id="Fact001867" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_ecustom--IntersegmentNetRevenues_c20220701__20230630_fKg_____zFchbOhMwL31" title="Inter-segment net revenues" style="text-align: right"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2022-07-012023-06-30" id="Fact001869" format="ixt:numdotdecimal" decimals="0" unitRef="USD">985,833</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">(Loss) Income from operations</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zf4rqOpSeg4l" title="(Loss) Income from operations" style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-07-012023-06-30_us-gaap_HealthCareMember" id="Fact001871" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,875,126</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zYgu0HNxD36c" title="(Loss) Income from operations" style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-07-012023-06-30_us-gaap_HealthCareOtherMember" id="Fact001873" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,664,388</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230630_zQQ6ZmcIK5Ej" title="(Loss) Income from operations" style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-07-012023-06-30" id="Fact001875" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,789,262</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zCrhWL1BCx18" title="Depreciation and amortization" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-07-012023-06-30_us-gaap_HealthCareMember" id="Fact001877" format="ixt:numdotdecimal" decimals="0" unitRef="USD">263,720</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_ztWMPkpsRrtb" title="Depreciation and amortization" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-07-012023-06-30_us-gaap_HealthCareOtherMember" id="Fact001879" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,276,415</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230630_zxZkR34GdXec" title="Depreciation and amortization" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-07-012023-06-30" id="Fact001881" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,540,135</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Total identifiable assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsNet_iI_c20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zi9yx79H9G3a" title="Total identifiable assets" style="text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2023-06-30_us-gaap_HealthCareMember" id="Fact001883" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,892,807</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsNet_iI_c20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zVczUvnXtAab" title="Total identifiable assets" style="text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2023-06-30_us-gaap_HealthCareOtherMember" id="Fact001885" format="ixt:numdotdecimal" decimals="0" unitRef="USD">170,153,612</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsNet_iI_c20230630_zYv2i4PPTnn7" title="Total identifiable assets" style="text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2023-06-30" id="Fact001887" format="ixt:numdotdecimal" decimals="0" unitRef="USD">201,046,419</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Capital expenditures</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zqUwEC7PUS0f" title="Capital expenditures" style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2022-07-012023-06-30_us-gaap_HealthCareMember" id="Fact001889" format="ixt:numdotdecimal" decimals="0" unitRef="USD">119,571</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--PaymentsToAcquireProductiveAssets_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zRKM4MQOQHok" title="Capital expenditures" style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2022-07-012023-06-30_us-gaap_HealthCareOtherMember" id="Fact001891" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,218,084</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--PaymentsToAcquireProductiveAssets_c20220701__20230630_z9foLkt23973" title="Capital expenditures" style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2022-07-012023-06-30" id="Fact001893" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,337,655</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4px; padding-left: 11pt; text-align: justify"><span id="xdx_F03_z2AsoMtRz1Kb" style="font-family: Times New Roman, Times, Serif; font-size: 11pt">*</span></td>
    <td style="padding-left: 11pt; text-align: justify"><span id="xdx_F13_zGOAjo82oomk" style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><ix:footnote id="Footnote001894" xml:lang="en-US">Amounts eliminated in consolidation</ix:footnote></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AB_zL5RHqsaxZ2a" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Export Product Sales</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s areas of operations are principally
in the United States. The Company had export sales of medical equipment amounting to <span id="xdx_906_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20230701__20240630_zzydAcmfkBY6" title="Export sales of medical equipment percentage"><ix:nonFraction name="FONR:ExportSalesOfMedicalEquipmentPercentage" contextRef="From2023-07-01to2024-06-30" id="Fact001896" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.2</ix:nonFraction></span>% and <span id="xdx_90A_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20220701__20230630_ztlb31XNbj8k" title="Export sales of medical equipment percentage"><ix:nonFraction name="FONR:ExportSalesOfMedicalEquipmentPercentage" contextRef="From2022-07-012023-06-30" id="Fact001898" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">14.1</ix:nonFraction></span>% of product sales revenues to third
parties for the years ended June 30, 2024 and 2023, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The foreign product sales, as a percentage of product
sales to unrelated parties, were made to customers in the following countries:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001900" name="FONR:ScheduleOfExportProductSalesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfExportProductSalesTableTextBlock_zPxvt0Md6uRd" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"><span id="xdx_8BA_zV8IvqceoLdk" style="display: none">Schedule of export product sales</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-indent: -11pt">Canada</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_909_ecustom--ForeignProductSales_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zY8o9O0ihNw6" title="Foreign product sales"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2023-07-012024-06-30_country_CA" id="Fact001902" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.2</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90B_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CA_z6VZMCBFzPJa" title="Foreign product sales"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2022-07-012023-06-30_country_CA" id="Fact001904" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.5</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Germany</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_ecustom--ForeignProductSales_dp0_c20230701__20240630__srt--StatementGeographicalAxis__country--DE_zmBAUyyf01rj" title="Foreign product sales"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2023-07-012024-06-30_country_DE" id="Fact001906" format="ixt:zerodash" decimals="INF" scale="-2" unitRef="Pure">&#8212;</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DE_ziwtdxJ09DCg" title="Foreign product sales"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2022-07-012023-06-30_country_DE" id="Fact001908" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.9</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">United Arab Emirates</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecustom--ForeignProductSales_dp0_c20230701__20240630__srt--StatementGeographicalAxis__country--AE_zwJcDCMPuaIj" title="Foreign product sales"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2023-07-012024-06-30_country_AE" id="Fact001910" format="ixt:zerodash" decimals="INF" scale="-2" unitRef="Pure">&#8212;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AE_zCSOYTp2ycS7" title="Foreign product sales"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2022-07-012023-06-30_country_AE" id="Fact001912" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.7</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_ecustom--ForeignProductSales_dp_c20230701__20240630_zTYH7ZgvBT45" title="Foreign product sales"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2023-07-01to2024-06-30" id="Fact001914" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.2</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_ecustom--ForeignProductSales_dp_c20220701__20230630_zgnSQ5SgksR5" title="Foreign product sales"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2022-07-012023-06-30" id="Fact001916" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">14.1</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zqabiH0gy4Ni" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<ix:exclude><p id="xdx_232_z5HYuR0nJyNl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 78; Value: 2 -->
    <div id="xdx_237_zHOk0ccp23Qb" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_236_zbHcCB3y2Ay3" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zkNT0djdo0Ch" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zacYA8NWw2el" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_zCW7SKsNjYqa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_236_zswPn7QBabN1" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2024 and 2023</p></ix:exclude>

<ix:exclude><p id="xdx_23A_z1yj4iWel5ff" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_zOaG7LXClNr8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;<b>NOTE 16 - SEGMENT AND RELATED INFORMATION
(CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_231_zVw4PKpXMCHl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Foreign Service and Repair Fees</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s areas of service and repair are
principally in the United States. The Company had foreign revenues of service and repair of medical equipment amounting to <span id="xdx_902_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20230701__20240630_zD7klvy2hoIl" title="Percentage of service and repair of medical equipment"><ix:nonFraction name="FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" contextRef="From2023-07-01to2024-06-30" id="Fact001926" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.4</ix:nonFraction></span>% and <span id="xdx_90F_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20220701__20230630_zsReGTMvXxUi" title="Percentage of service and repair of medical equipment"><ix:nonFraction name="FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" contextRef="From2022-07-012023-06-30" id="Fact001928" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.4</ix:nonFraction></span>%
of consolidated net service and repair fees for the years ended June 30, 2024 and 2023, respectively. Foreign service and repair fees,
as a percentage of total service and repair fees, were provided principally to the following countries:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;Foreign Service and Repair Fees</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001930" name="FONR:ScheduleOfExportServiceRevenuesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfExportServiceRevenuesTableTextBlock_z7jiVO9m4v1j" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"><span id="xdx_8BA_z5mx20i5YrCa" style="display: none">Schedule of export service revenues</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Puerto Rico</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90E_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--PR_z4TR3fJLSEf9" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2023-07-012024-06-30_country_PR" id="Fact001932" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.9</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_905_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--PR_z4pkxQDKv8vk" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2022-07-012023-06-30_country_PR" id="Fact001934" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.5</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Switzerland</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CH_z5ThHoeCyosa" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2023-07-012024-06-30_country_CH" id="Fact001936" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CH_z7Bm71O8iZY6" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2022-07-012023-06-30_country_CH" id="Fact001938" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Germany</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--DE_zRYwYFliwQ83" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2023-07-012024-06-30_country_DE" id="Fact001940" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.0</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DE_zsz2GlSfRBfh" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2022-07-012023-06-30_country_DE" id="Fact001942" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.6</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">England</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--GB_z3K53JttbUh4" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2023-07-012024-06-30_country_GB" id="Fact001944" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.7</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--GB_zV3kqEMVFlPj" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2022-07-012023-06-30_country_GB" id="Fact001946" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.6</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">United Arab Emirates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--AE_zMbLBBGpuaFa" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2023-07-012024-06-30_country_AE" id="Fact001948" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AE_zn3tqTDy40he" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2022-07-012023-06-30_country_AE" id="Fact001950" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.1</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Dominican Republic</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--DO_zMCibsAKuY33" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2023-07-012024-06-30_country_DO" id="Fact001952" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.2</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DO_zlhfPHoNaW0b" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2022-07-012023-06-30_country_DO" id="Fact001954" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.5</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Canada</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_ecustom--ForeignServiceAndRepairFees_dp0_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zn8wMDBi7iYi" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2023-07-012024-06-30_country_CA" id="Fact001956" format="ixt:zerodash" decimals="INF" scale="-2" unitRef="Pure">&#8212;</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CA_zoyPr5HlQdOc" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2022-07-012023-06-30_country_CA" id="Fact001958" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.6</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Greece</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--GR_z8xAcCJrq6Od" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2023-07-012024-06-30_country_GR" id="Fact001960" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--GR_zE1T9oHhrLL2" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2022-07-012023-06-30_country_GR" id="Fact001962" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 1pt 11pt; text-indent: -11pt">Australia</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--AU_zFcb35Wfn3Di" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2023-07-012024-06-30_country_AU" id="Fact001964" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.7</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AU_zrFkQP17t7mb" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2022-07-012023-06-30_country_AU" id="Fact001966" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.9</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 2.5pt 11pt; text-indent: -11pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630_zPsaKxpaO687" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2023-07-01to2024-06-30" id="Fact001968" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.4</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630_zok0Okk7tur9" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2022-07-012023-06-30" id="Fact001970" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.4</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8AB_zy8qXKfYo7ma" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;The Company does not have any material assets
outside of the United States.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact001972" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_80A_eus-gaap--SubsequentEventsTextBlock_zv0m0gtYAXd9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 17 &#8211; <span id="xdx_826_zDRw4DBAztga">SUBSEQUENT EVENTS</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates events that have occurred after
the balance sheet date, but before the consolidated financial statements are issued.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 18, 2024, the Company repurchased
<span id="xdx_90F_esrt--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_iI_c20240918__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSFLRoUFIB04" title="Number of shares repurchased, shares"><ix:nonFraction name="srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" contextRef="AsOf2024-09-18_us-gaap_SubsequentEventMember" id="Fact001974" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">19,914</ix:nonFraction></span> shares at a cost of $<span id="xdx_908_eus-gaap--StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_iI_c20240918__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTfz2Td2y8e9" title="Number of shares repurchased, value"><ix:nonFraction name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" contextRef="AsOf2024-09-18_us-gaap_SubsequentEventMember" id="Fact001976" format="ixt:numdotdecimal" decimals="0" unitRef="USD">340,933</ix:nonFraction></span> which was authorized under the stock repurchase plan adopted in September 2022.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><p id="xdx_819_z11m6h0o85d7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 79; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_013"></span>ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS
ON ACCOUNTING AND FINANCIAL DISCLOSURE.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There have been no disagreements with our independent
registered public accounting firm or other matters requiring disclosure under Regulation S-K, Item 304(b).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_014"></span>ITEM 9A. CONTROLS AND PROCEDURES</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Evaluation of Disclosure Controls and Procedures</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of the end of the period covered by this Annual
Report on Form 10-K, we performed an evaluation under the supervision of and with the participation of management, including our Principal
Executive Officer and our Acting Principal Financial Officer, of the design and effectiveness of our disclosure controls and procedures
(as defined in Rules 13a-15(e) or 15d-15(e) under the Securities Exchange Act of 1934 as amended (the &#8220;Exchange Act&#8221;). Based
upon that evaluation, our Principal Executive Officer and Acting Principal Financial Officer concluded, as of the end of the period covered
by this Annual Report that our disclosure controls and procedures were effective.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management&#8217;s Report on Internal Control Over
Financial Reporting</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our management is responsible for establishing and
maintaining adequate internal control over financial reporting, as is defined in the Exchange Act. Internal control over financial reporting
is a process designed to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial
statements for external reporting purposes in accordance with GAAP.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Because of its inherent limitations, internal control
over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods
are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the
policies or procedures may deteriorate.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our management conducted an evaluation of the effectiveness
of our internal control over financial reporting based on the framework in Internal Control-Integrated Framework issued by the Committee
of Sponsoring Organizations of the Treadway Commission (COSO-2013). Based on this evaluation, our management concluded that our internal
control over financial reporting was effective at June 30, 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Based on the COSO criteria, management concluded that
our internal controls were effective to prevent material misstatements of the Company&#8217;s annual or interim financial statements for
the fiscal year ending June 30, 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Changes in Internal Controls over Financial Reporting</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There have been no changes in our internal control
over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during the most recent fiscal quarter and year ended June
30, 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 80; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span id="a_015" style="font: normal 11pt Times New Roman, Times, Serif"><b>Item 9B. OTHER INFORMATION</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Rule
10b5-1 Trading Plan</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">During
the fiscal quarter ended June 30, 2024, none of our directors or executive officers adopted or terminated any contract, instruction or
written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)
or any "non-Rule 10b5-1 trading arrangement".</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span id="a_016" style="font: normal 11pt Times New Roman, Times, Serif">Item
9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS </span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">None.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>PART III</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_017"></span>ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Directors serve from the date of their election until
the next annual meeting of stockholders and until their successors are elected and qualify. During fiscal 2024, each director received
a base fee of $20,000 per annum for his or her service as a director, with greater amounts for additional services on the Board of Directors.
Officers serve at the discretion of the Board of Directors.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A majority of our board of directors is composed of
independent directors: consisting of, Ronald G. Lehman, Richard E. Turk and Jessica Maher. The outside directors also serve as the members
of the audit committee, which is a standing committee of the board of directors having a charter describing its responsibilities.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have adopted a code of ethics applicable to, among
other personnel, our principal executive officer, principal financial officer, controllers and persons performing similar functions. The
code is designed to deter wrongdoing and to promote: 1. honest and ethical conduct, including the ethical handling of actual or apparent
conflicts of interest between personal and professional relationships; 2. full, fair, accurate, timely and understandable disclosure in
reports and documents that we file or submit to the Securities and Exchange Commission and in other public communications we make; 3.
compliance with applicable governmental laws, rules and regulations; 4. the prompt internal reporting of violations of the code to an
appropriate person or persons identified in the code and 5. accountability for adherence to the code. We will provide a copy of the code
to any person who requests a copy. A person may request a copy by writing to FONAR Corporation, 110 Marcus Drive, Melville, New York 11747,
to the attention of the Legal Department or Investor Relations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The officers and directors of the Company are set
forth below:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 22%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Timothy R. Damadian</span></td>
    <td style="width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">60</span></td>
    <td style="width: 70%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Chairman of the Board, President, Chief Executive Officer and Treasurer</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Luciano B. Bonanni</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">69</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Executive Vice President, Chief Operating Officer and acting Principal Financial Officer</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Claudette J.V. Chan</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">86</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Director</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Ronald J. Lehman</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">48</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Director</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Richard E. Turk</span></td>
    <td style="text-align: center">40</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Director</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Jessica Maher</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">27</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Director</span></td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 81; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Timothy Damadian has been the Chairman of the Board
and Treasurer of FONAR since September 7, 2022 and the President and Chief Executive Officer of FONAR since February 11, 2016. From 2010
to 2016 he served as an independent consultant, with a focus on the Company&#8217;s MRI facility management business. Timothy Damadian
began his career at FONAR in 1985, installing MRI scanners and components for FONAR customers. Over the course of the following 16 years,
he held positions of increasing authority, eventually becoming Vice President of Operations. In 1997, Timothy Damadian was appointed President
of the newly formed Health Management Corporation of America (HMCA), a wholly-owned subsidiary of FONAR that was formed to manage medical
and diagnostic imaging offices. In 2001, Timothy Damadian left FONAR to form Integrity Healthcare Management, Inc., a diagnostic imaging
management company that would eventually manage MRI scanning centers in New York and Florida. The company was a success and was sold to
Health Diagnostics, LLC in 2007. Mr. Damadian returned to FONAR as a consultant in 2010. He also serves as a Manager of Health Diagnostics
Management, LLC, which are subsidiaries of HMCA.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Luciano B. Bonanni has served as Chief Operating Officer
(COO) and Executive Vice President (EVP) for FONAR Corporation since June 27, 2016. In September 2022, he was appointed to fill the position
of acting Principal Financial Officer. Prior to his appointment as COO, Mr. Bonanni had served the Company as Vice President since 1989,
during which time he oversaw general operations, research and development, manufacturing, service, sales, finance, accounting and regulatory
compliance. Prior to 1989, Mr. Bonanni held the title of Vice President of Production and Engineering from the time of FONAR&#8217;s initial
public offering in 1981. Mr. Bonanni joined the Company as an electrical engineer in 1978. He holds a Bachelor of Electrical Engineering
degree from Manhattan College.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Claudette J.V. Chan has been a Director of FONAR since
October 1987 and Secretary of FONAR since January 2008. Mrs. Chan was employed from 1992 through 1997 by Raymond V. Damadian, M.D. MR
Scanning Centers Management Company and since 1997 by HMCA, as &#8220;site inspector,&#8221; in which capacity she is responsible for
supervising and implementing standard procedures and policies for MRI scanning centers. From 1989 to 1994 Mrs. Chan was employed by St.
Matthew&#8217;s and St. Timothy&#8217;s Neighborhood Center, Inc., as the director of volunteers in the &#8220;Meals on Wheels&#8221;
program, a program which cares for the elderly. From approximately 1983 to 1989, Mrs. Chan was President of the Claudette Penot Collection,
a retail mail-order business specializing in women&#8217;s apparel and gifts. Mrs. Chan practiced and taught in the field of nursing until
1973, when her son was born. She received a Bachelor of Science degree in nursing from Cornell University in 1960.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ronald G. Lehman has been a Director of FONAR since
April, 2012, and chair of the audit committee since 2021. .Mr. Lehman is Managing Director and Head of Investment Banking at Bruderman
Advisory Group, LLC where he is responsible for the firm&#8217;s sell-side advisory and capital raising processes. Mr. Lehman is also
a Partner at Sandy Hill Investors, LLC, participating in and overseeing many of the firm&#8217;s investments. He is Chairman of portfolio
company Persante Acquisition Corp., and was a board member at Seviroli Foods, LLC during the firm&#8217;s investment period. From 2000-2008,
Mr. Lehman worked for various Bruderman entities as a buy and sell-side advisor, and as a principal in several private equity transactions.
In 2008, Mr. Lehman joined Health Diagnostics, LLC, one of the country&#8217;s fastest growing diagnostic imaging providers, as Senior
Vice President of Acquisitions, where he managed the company&#8217;s acquisition and corporate finance activities. Mr. Lehman returned
to Bruderman in 2010 to lead the firm&#8217;s investment banking efforts. Lehman is a graduate of Columbia University and worked at Deutsche
Bank from 1998-2000.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 82; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Richard E. Turk has been a Director of FONAR since
June, 2020. Mr. Turk is the Chief Financial Officer of PRISM Vision Group, a private equity-backed, multi-location, outpatient comprehensive
eye care practice headquartered in New Providence, New Jersey. Mr. Turk joined PRISM in November, 2018 as the Chief Development Officer
and became CFO in March 2021. Mr. Turk has helped PRISM expand from a single-specialty (retina) provider with 17 locations and 21 physicians
to a comprehensive, vertically-integrated, multi-specialty, eye care organization with approximately 190 physicians and more than 90 locations
across New Jersey, Pennsylvania, Delaware, Virginia, Washington, DC, and Maryland. Prior to his tenure at PRISM, Mr. Turk was employed
by Professional Physical Therapy, a private equity-backed outpatient physical and occupational therapy company headquartered in Uniondale,
New York with more than 180 locations across New York, New Jersey, Connecticut, Massachusetts and New Hampshire. During his four years
at Professional Physical Therapy, Mr. Turk sourced, analyzed, and completed 32 acquisitions comprised of 116 clinics, expanding the company&#8217;s
services and adding three states to its geographic footprint. From 2007 to 2014, Mr. Turk was employed by Bruderman Brothers, a broker
dealer involved in investment banking, merchant banking, investment advisory, and consulting for lower middle market companies ($10M-$250M
of enterprise value) in a variety of industries, including healthcare. Mr. Turk was Vice President of Bruderman Brothers from 2011 to
2014. Mr. Turk graduated from Columbia University in 2007.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Jessica Maher has been a Director of FONAR since March
2023. Mrs. Maher is a staff accountant at Ives &amp; Sultan, LLP in Woodbury, New York, where she is responsible for preparing audited
financial statements for various clients, overseeing audit testing areas, audits of 401(k) plans, and personal and company tax returns.
Mrs. Maher holds a Bachelor of Science in Accounting with a minor in Accounting Information Systems, and a Master of Science in Accounting
from Fairfield University in Fairfield, Connecticut. During her early undergraduate years, Mrs. Maher worked for Tritech Healthcare Management
in Melville, New York, where she reviewed patient files, insurance, charts and documents to ensure that the services provided by clients
were being properly billed. In her senior year, Mrs. Maher interned at Northwell Health in Westbury, New York, where she supported the
financial reporting team for two hospitals, reported into accounts receivable software, and analyzed patient billing records to identify
overpayments. Mrs. Maher&#8217;s first position out of college was with PriceWaterhouseCoopers in Melville, New York, where she was assigned
to two private equity clients, was responsible for a variety of the audit areas, and assisted managers in reviewing financial statements,
footnote disclosures, and audit opinions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 83; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td colspan="3" style="border: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Board Diversity Matrix as of September 12, 2024</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; width: 73%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Total Number of Directors</span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">5</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Part I: Gender Identity</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Female</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Male</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Directors</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">3</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Part II: Demographic Background</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">White</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">3</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td colspan="3" style="border: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Board Diversity Matrix as of September 12, 2023</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; width: 73%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Total Number of Directors</span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">5</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Part I: Gender Identity</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Female</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Male</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Directors</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">3</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Part II: Demographic Background</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">White</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">3</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_018"></span>ITEM 11. EXECUTIVE COMPENSATION.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">With the exception of the Chief Executive Officer
and the Chairman of the Board of Directors, the compensation of the Company&#8217;s executive officers is based on a combination of salary
and bonuses based on performance. The Chief Executive Officer and the Chairman of the Board have no understandings with the Company with
respect to bonuses, options or other incentives; they are not subject to our general policy later discussed.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;The Board of Directors does not have a compensation
Committee. The Chief Executive Officer and the Chief Operating Officer participate in the determination of compensation for the Company&#8217;s
management and other employees.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Board of Directors has established an audit committee.
The members of the committee are Ronald G. Lehman, Richard E. Turk and Jessica Maher.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our compensation policy includes a combination of
salary, commissions, bonuses, stock bonuses and stock options, designed to incentivize our employees. There is no universal plan applicable
to all of our employees. The fixed and variable components of our employees&#8217; compensation tend to be individualized, based on a
combination of the employees&#8217; performance, responsibilities and position, our assessment of how best to motivate a person in such
a position and the needs and preferences of the particular employees, as negotiated between employees and their supervisors or management.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;There is set forth in the following Summary
Compensation Table the compensation provided by us during fiscal 2024, 2023 and 2022 to our Principal Executive Officer, and our acting
Principal Financial Officer. There is set forth in the following Outstanding Equity Awards Table and Director Compensation Table the required
information.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 84; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 36pt">I.</td><td>SUMMARY COMPENSATION TABLE</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: -36pt">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">(Reflects information up to end of Fiscal 2024)</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Name and All Other Principal Position</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Salary<br/> ($)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Cash Bonuses<br/> ($)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Stock Awards<br/> ($)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total Compensation ($)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">(a)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(b)</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(c)</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(d)</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(e)</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(f)</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 35%; text-align: left; text-indent: -11pt">Timothy R. Damadian</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2024</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">372,885</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">372,885</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">President, Principal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">152,900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">152,900</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Executive Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">305,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">305,800</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Luciano Bonanni</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">148,241</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">350,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">498,241</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Chief Operating Officer,</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">143,416</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">305,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">449,216</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Executive Vice President and</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">148,572</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">305,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">458,895</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">acting Principal Financial Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Raymond V. Damadian</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Chairman of the Board,</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">23,553</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">305,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">329,353</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Treasurer and</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">153,095</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">305,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">458,895</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Principal Financial Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 18pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 7.2pt"/><td style="width: 36pt">II.</td><td>OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END</td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Name</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">Number Of Securities Underlying Unexercised Options (#) Exercisable</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">Option Exercise Price ($)</td><td>&#160;</td>
    <td style="text-align: center">Option Exercise Expiration Date</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(a)</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(b)</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">(c)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 36%; text-align: left; text-indent: -11pt">Timothy R. Damadian, President and Principal Executive Officer</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 15%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 15%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 15%; text-align: right; padding-left: 5.4pt">N/A</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Luciano Bonanni, Chief Operating Officer, Executive Vice President and acting Principal Financial Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right; padding-left: 5.4pt">N/A</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Raymond V. Damadian Chairman of the Board, Treasurer and
    Principal Financial Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right; padding-left: 5.4pt">N/A</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-indent: -18pt"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 85; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 18pt">III</td><td>DIRECTOR COMPENSATION</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-indent: -18pt">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">The following table shows the compensation paid to the Directors for fiscal
2024:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Name</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">Fees earned in pad &#160; in cash ($)</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">Stock awards ($)</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">Option awards ($)</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">Non-equity incentive plan compen- &#160; sation</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">Nonqualified deferred compen- &#160; sation earnings &#160; ($)</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">All other compen- &#160; sation ($)</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">Total ($)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">(a)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">(b)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">(c)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">(d)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">(e)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">(f)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">(g)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">(h)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 37%; text-align: left; text-indent: -11pt">A. Claudette J.V. Chan</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">20,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">38,880</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">58,880</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">B. Ronald G. Lehman</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">65,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">85,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">C. Richard E. Turk</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">15,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">35,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">D. Jessica Maher</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">15,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">35,000</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>EMPLOYEE COMPENSATION PLANS</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR adopted its 2010 Stock Bonus Plan, on June 28,
2010. This Plan permits FONAR to issue an aggregate of 2,000,000 shares of common stock of FONAR as bonus or compensation. As of June
30, 2024, 450,177 shares were available for issuance.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 86; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_019"></span>ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">The following table sets forth the number and percentage of shares of FONAR&#8217;s
securities held by each director, by each person known by us to own in excess of five percent of FONAR&#8217;s voting securities and by
all officers and directors as a group as of September 20, 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 11pt; text-align: left; text-indent: -11pt">Name and Address of Beneficial Owner (1)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Shares Beneficially Owned</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Percent of Class</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Timothy R. Damadian, as Trustee of the FONAR Class C Trust</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">c/o FONAR Corporation, Melville, New York</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Class C Stock</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">382,447</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">99.98</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Kayne Anderson Rudnick</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Investment Management LLC</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">1800 Avenue of the Stars, 2nd Floor</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Los Angeles, CA 90067</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Common Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">609,789</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9.64</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">The Vanguard Group, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">100 Vanguard Boulevard</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Malvern, PA 19355-2331</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Common Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">390,345</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.80</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Dimensional Fund Advisors LP</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Building One</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">6300 Bee Cave Road</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Austin, Texas 78746</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Common Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">380,808</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.01</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Money Concepts Capital Corp..</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">11440 North Jog Road</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Palm Beach Gardens, FL 33418-3764</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Common Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">362,447</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.72</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Timothy R. Damadian,</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Chairman of the Board, President,</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Chief Executive Officer and Treasurer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Common Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">79,059</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">*</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Class A Preferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">*</td></tr>
  </table>




<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 87; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Continued:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Name and Address of Beneficial Owner (1)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Shares Beneficially Owned</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Percent of Class</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Luciano B. Bonanni,</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Executive Vice President,</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Chief Operating Officer and acting &#160; Principal Financial Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Common Stock</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">54,253</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"/><td style="width: 1%; text-align: left">*</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Class A Preferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,285</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">*</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Claudette Chan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Director and Secretary</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Common Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">106</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">*</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Class A Preferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">*</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Ronald G. Lehman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Director</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Common Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,330</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">*</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Richard E. Turk</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Director</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Common Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">*</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Jessica Maher &#160; Director &#160; Common Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">*</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">All Officers and Directors &#160; as a Group (6 persons)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Common Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">137,721</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.18</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Class C Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">382,447</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">99.98</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Class A Preferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,117</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"></span></td><td style="text-align: left">*</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">* Less than one percent</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

























































<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 25%"/>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt">1. Address provided for each beneficial
owner owning more than five percent of the voting securities of FONAR.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 88; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_020"></span>ITEM 13.&#160;CERTAIN RELATIONSHIPS AND RELATED
TRANSACTIONS AND DIRECTOR INDEPENDENCE.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to HMCA&#8217;s management agreements with
its clients, HMCA provides comprehensive non-medical management and administrative services, including billing and collection of accounts,
payroll and accounts payable processing, office facilities, supplies and utilities. Under the management agreements, HMCA also provides
service for the Fonar Upright&#174; MRI scanners through Fonar. In total, as of September 5, 2024, 22 of our clients had management agreements
with HMCA. Six sites in Florida are owned and operated directly by HMCA subsidiaries.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fees charged under the management agreements are
flat fees charged on a monthly basis. These fees ranged from $84,152 to $446,639 per month in fiscal 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Timothy Damadian, Chairman of the Board, President,
Chief Executive Officer and Treasurer(formerly owned by Dr. Raymond Damadian, the Chairman of the Board and principal stockholder of the
Company until his death in August 2022), owned three of the imaging facilities in Florida managed by HMCA. (See note below) The facilities
owned by Timothy Damadian in Florida pay HMCA flat rate monthly fees ranging from $245,535 to $411,589 per month. These fees are renegotiable
on an annual basis.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the fiscal years ended June 30, 2024, June
30, 2023 and June 30, 2022, the net revenues received by HMCA from the imaging facilities owned by Timothy Damadian and formerly Dr. Damadian
were approximately $11.9 million, $11.9 million and $11.6 million respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Timothy Damadian, the President and Chief Executive
Officer of Fonar, is one of the former owners of a billing company, which performed billing and collection services for HMCA with respect
to No-Fault and Workers&#8217; Compensation claims of HMCA&#8217;s clients. On June 1, 2017, the Company also entered into a one year
renewable agreement to provide IT services to the billing company for a monthly fee of $23,884. On May 31, 2023, this agreement was terminated.
Timothy Damadian is also a Manager of Health Management Company of America.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Magnetic Resonance Management, LLC, in which Timothy
Damadian, the CEO and President of the Company owns, entered in to an agreement to purchase equipment from the Company. The selling price
of such equipment was $567,857 which is payable based upon a promissory note dated December 1, 2023. The note bears interest at a rate
of 9% and is payable in full at the maturity of the note in December 2028. The equipment had a zero basis which resulted in a gain of
$576,857. The Company has the option but not the obligation to re-take possession in lieu of payment upon maturity of the note.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Bensonhurst MRI Limited Partnership, in which Timothy
Damadian, the CEO and President of the Company holds an interest, is party to two agreements with the Company for the service and maintenance
of its Upright MRI and High-Field Scanners for a price of $110,000 per annum and $70,000 per annum, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Radian Healthcare Management, LLC which Matt Pluta,
the son-in-law of Timothy Damadian, the CEO and President of the Company owns, provided the Company with personnel recruitment of 32 new
employees at a fee $200,347 during the fiscal year ended June 30, 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ronald Lehman, a Director of Fonar, holds a .0378%
interest in Health Management Company of America&#8217;s Class A membership interests.<br/></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 89; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Jessica Maher, a Director of Fonar, holds a .015%
interest in Health Management Company of America&#8217;s Class A membership interests.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Claudette J.V. Chan, a Director and the Secretary
of Fonar, owns a .0378% interest in Health Management Company of America&#8217;s Class A Membership interests.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_021"></span>ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Audit Fees</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The aggregate fees billed by Marcum LLP for the audit
of our annual consolidated financial statements for the fiscal year ended June 30, 2024 and the reviews of the financial statements included
in our Forms 10-Q for the fiscal year ended June 30, 2024 were $442,000.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The aggregate fees billed by Marcum LLP for the audit
of our annual financial statements for the fiscal year ended June 30, 2023 and the reviews of the financial statements included in our
Forms 10-Q for the fiscal year ended June 30, 2023 were $379,000.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Audit Related Fees</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">No fees were billed by Marcum LLP for the fiscal years
ended June 30, 2024 or June 30, 2023 for services related to the Audit or review of our financial statements that are not included under
the caption &#8220;Audit Fees&#8221;.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">No fees were billed by Marcum LLP for the fiscal years
ended June 30, 2024 or June 30, 2023 for designing, operating, supervising or implementing any of our financial information systems or
any hardware or software systems for our financial information.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Tax Fees</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">No fees were billed by Marcum LLP for tax compliance,
tax advice and tax planning in the fiscal year ended June 30, 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">No fees billed by Marcum LLP for tax compliance, tax
advice and tax planning in the fiscal year ended June 30, 2023.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All Other Fees</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">No fees were billed by Marcum LLP for any other services
during the fiscal years ended June 30, 2024 and June 30, 2023.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 90; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Since January 1, 2003, the audit committee has adopted
policies and procedures for pre-approving all non-audit work performed by the auditors. Specifically, the committee must pre-approve the
use of the auditors for all such services. The audit committee has pre-approved all non-audit work since that time and in making its determination
has considered whether the provision of such services was compatible with the independence of the auditors.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our audit committee believes that the provision by
Marcum LLP of services in addition to audit services in previous years were compatible with maintaining their independence.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>PART IV</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_022"></span>ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES,
AND REPORTS ON FORM 8-K.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 18pt">a)</td><td style="text-align: justify">FINANCIAL STATEMENTS AND SCHEDULES</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify; text-indent: -18pt">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following consolidated financial statements are
included in Part II, Item 8.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Report of Independent Registered Public Accounting
Firm</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Consolidated Balance Sheets as at June 30, 2024 and
2023.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: red">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Consolidated Statements of Income for the Years Ended
June 30, 2024 and 2023<span style="color: red">.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Consolidated Statements of Stockholders&#8217; Equity
for the Years Ended June 30, 2024 and 2023.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Consolidated Statements of Cash Flows for the Years
Ended June 30, 2024 and 2023 .</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Notes to Consolidated Financial Statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Information required by schedules called for under
Regulation S-X is either not applicable or is included in the consolidated financial statements or notes to the consolidated financial
statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 18pt">b)</td><td style="text-align: justify">REPORTS
ON FORM 8-K</td></tr></table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">1. </span></td>
<td style="text-align: justify; width: 95%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/355019/000035501923000048/fonar_8-k.htm" style="-sec-extract: exhibit">Registrant's Report on Form 8-K: Item 2.02, Results of Operations and Financial Condition for the Fiscal Year ended June 30, 2023, reported September 28, 2023. Commission File No. 0-10248.</a></span></td></tr>
<tr style="vertical-align: top">
<td colspan="2" style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">2. </span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/355019/000035501924000030/fonar_8-k.htm" style="-sec-extract: exhibit">Registrant&#8217;s Report on Form 8-K: Item 5.07, Submission of Matters to a Vote of Security Holders, at the annual meeting of stockholders, reported on May 20, 2024. Commission File No. 0-10248.</a></span></td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 91; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 18pt">c)</td><td style="text-align: justify">EXHIBITS</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 14.4pt; text-align: justify; text-indent: -14.4pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">3.1 </span></td>
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Certificate of Incorporation, as amended, of the Registrant incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s registration statement on Form S-1,Commission File No. 33-13365.</span></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding: 0pt; text-align: justify; text-indent: 0pt">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">3.2 </span></td>
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-95-000015.txt">Article Fourth of the Certificate of Incorporation, as amended, of the Registrant incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s registration statement on Form S-8, Commission File No. 33- 62099.</a></span></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding: 0pt; text-align: justify; text-indent: 0pt">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">3.3</span></td>
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501901500018/ex0403.txt">Section A of Article Fourth of the Certificate of Incorporation, as amended, of the Registrant incorporated by reference to Exhibit 4.3 to the Registrant&#8217;s registration statement on Form S-3, Commission File No. 333-63782.</a></span></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding: 0pt; text-align: justify; text-indent: 0pt">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">3.4 </span></td>
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501903000019/x033.txt">Section A of Article Fourth of the Certificate of Incorporation, as amended, of the Registrant incorporated by reference to Exhibit 3.3 of the Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2003, Commission File No. 0-10248.</a></span></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding: 0pt; text-align: justify; text-indent: 0pt">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">3.5 </span></td>
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">By-Laws, as amended, of the Registrant incorporated by reference to Exhibit 3.2 to the Registrant&#8217;s registration statement on Form S-1, Commission File No. 33-13365.</span></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding: 0pt; text-align: justify; text-indent: 0pt">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">4.1 </span></td>
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Specimen Common Stock Certificate incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s registration statement on Form S-1, Commission File No. 33-13365.</span></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding: 0pt; text-align: justify; text-indent: 0pt">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">4.2 </span></td>
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Specimen Class B Common Stock Certificate incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s registration statement on Form S-1, Commission File No. 33-13365.</span></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding: 0pt; text-align: justify; text-indent: 0pt">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">10.1 </span></td>
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">License Agreement between the Registrant and Raymond V. Damadian incorporated by reference to Exhibit 10 (e) to Form 10-K for the fiscal year ended June 30, 1983, Commission File No. 0-10248.</span></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding: 0pt; text-align: justify; text-indent: 0pt">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">10.2</span></td>
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-97-000036.txt">Stock Purchase Agreement, dated July 31, 1997, by and between U.S. Health Management Corporation, Raymond V. Damadian, M.D. MR Scanning Centers Management Company and Raymond V. Damadian, incorporated by reference to Exhibit 2.1 to the Registrant&#8217;s Form 8-K, July 31, 1997, commission File No: 0-10248.</a></span></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding: 0pt; text-align: justify; text-indent: 0pt">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">10.3 </span></td>
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-97-000029.txt">Merger Agreement and Supplemental Agreement dated June 17, 1997 and Letter of Amendment dated June 27, 1997 by and among U.S. Health Management Corporation and Affordable Diagnostics Inc. et al., incorporated by reference to Exhibit 2.1 to the Registrant&#8217;s 8-K, June 30, 1997, Commission File No: 0-10248.</a></span></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding: 0pt; text-align: justify; text-indent: 0pt">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">10.4</span></td>
<td style="padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-98-000004.txt">Stock Purchase Agreement dated March 20, 1998 by and among Health Management Corporation of America, FONAR Corporation, Giovanni Marciano, Glenn Muraca et al., incorporated by reference to Exhibit 2.1 to the Registrant&#8217;s 8-K, March 20, 1998, Commission File No: 0-10248.</a></span></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding: 0pt; text-align: justify; text-indent: 0pt">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="padding: 0pt; text-align: justify; text-indent: 0pt; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">10.5</span></td>
<td style="padding: 0pt; text-align: justify; text-indent: 0pt; width: 92%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-98-000013.txt">Stock Purchase Agreement dated August 20, 1998 by and among Health Management Corporation of America, FONAR Corporation, Stuart Blumberg and Steven Jonas, incorporated by reference to Exhibit 2 to the Registrant&#8217;s 8-K, September 3, 1998, Commission File No. 0-10248.</a></span></td></tr>
</table>




<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 14.4pt; text-align: justify; text-indent: -14.4pt"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: blue"></p>

<!-- Field: Page; Sequence: 92; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: blue">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">10.6</span></td>
<td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501902000016/x99.txt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">2002 Incentive Stock Option Plan incorporated by reference to Exhibit 99.1 to the Registrant</span><span style="font-size: 11pt">&#8217;<span style="font-family: Times New Roman, Times, Serif">s</span></span> <span style="font-size: 11pt">registration statement on Form S-8, Commission File No.: 333-96557.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-size: 11pt">10.7</span></td>
<td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501905000018/x2-50801.txt"><span style="font-size: 11pt">Asset Purchase Agreement dated July 28, 2005 among Health Plus Management Services, L.L.C.,</span> <span style="font-size: 11pt">Health Management Corporation of America, Dynamic Healthcare Management, Inc. and FONAR</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Corporation, incorporated by reference to Exhibit 2 to the Registrant</span><span style="font-size: 11pt">&#8217;<span style="font-family: Times New Roman, Times, Serif">s Form 8-K, August 2, 2005,</span></span> <span style="font-size: 11pt">Commission File No. 0-10248.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-size: 11pt">10.8</span></td>
<td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501908000021/x10.txt"><span style="font-size: 11pt">Partnership Interest Purchase Agreement dated September 29, 2008 by and between Diagnostic</span> <span style="font-size: 11pt">Management, LLC and Raymond V. Damadian, M.D. MR Scanning Centers Management Company,</span> <span style="font-size: 11pt">incorporated by reference to Exhibit 10.35 to Form 10-K for the fiscal year ended June 30, 2008.</span> <span style="font-size: 11pt">Commission File No. 0-10248.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">10.9</span></td>
<td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501910000014/x99.txt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">2010 Stock Bonus Plan, incorporated by reference to Exhibit 99.1 to the Registrant</span><span style="font-size: 11pt">&#8217;<span style="font-family: Times New Roman, Times, Serif">s registration</span></span> <span style="font-size: 11pt">statement on Form S-8, Commission File No. 333-168771.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-size: 11pt">10.10</span></td>
<td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501911000020/fonar10x.txt"><span style="font-size: 11pt">Operating Agreement for Imperial Management Services, LLC, incorporated by reference to</span> <span style="font-size: 11pt">Exhibit 10.37 to Form 10-K for the fiscal year ended June 30, 2011. Commission File No. 0-10248.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-size: 11pt">10.11</span></td>
<td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501913000029/fonar_exhibit10-38.htm"><span style="font-size: 11pt">Operating Agreement for Health Diagnostics Management, LLC, incorporated by reference to</span> <span style="font-size: 11pt">Exhibit 10.38 to Form 10-K for the fiscal year ended June 30, 2013. Commission File No. 0-10248.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-size: 11pt">10.12</span></td>
<td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501913000029/fonar_exhibit10-38.htm"><span style="font-size: 11pt">Modification to Operating Agreement for Health Diagnostics Management, LLC., See Exhibits.</span> <span style="font-size: 11pt">incorporated by reference to Exhibit 10.38 to Form 10-K for the fiscal year ended June 30, 2013.</span> <span style="font-size: 11pt">Commission File No. 0-10248.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-size: 11pt">10.13</span></td>
<td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501913000007/fonar_exhibit-10.htm"><span style="font-size: 11pt">Purchase Agreement dated March 5, 2013 among Health Diagnostics Management, LLC, Health</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Diagnostics, LLC and others. Incorporated by reference to Exhibit 10.1 to the Registrant</span><span style="font-size: 11pt">&#8217;<span style="font-family: Times New Roman, Times, Serif">s Form 8-K filed</span></span> <span style="font-size: 11pt">March 11, 2013. Commission File No. 0-10248.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">14.1</span></td>
<td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501904000028/x141.txt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Code of Ethics, incorporated by reference to Exhibit 14.1 of Registrant</span><span style="font-size: 11pt">&#8217;<span style="font-family: Times New Roman, Times, Serif">s Form 10-K for the fiscal</span></span> <span style="font-size: 11pt">year ended June 30, 2004, Commission File No.: 0-10248.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">21.1 </span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><a href="fonar_exhibit-21.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Subsidiaries of the Registrant. See Exhibits.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">23.1 </span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><a href="fonar_exhibit-23.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Consent of Marcum LLP Independent Registered Public Accounting Firm. See Exhibits.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">31.1</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><a href="fonar_exhibit-31.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Section 302 Certification. See Exhibits.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">32.1</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><a href="fonar_exhibit-32.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Section 906 Certification. See Exhibits.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-size: 11pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">97.1 </span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; width: 92%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><a href="fonar_exhibit-97.htm">Policy for the Recovery of Erroneously Awarded Compensation Pursuant to SEC Exchange Act Rule 10D-1</a></span></td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 93; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">SIGNATURES.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of Section 13 or 15 (d)
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td colspan="3" style="padding: 0pt; white-space: nowrap; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">FONAR CORPORATION</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"></span></td></tr>
<tr style="vertical-align: bottom">
<td colspan="3" style="padding: 0pt; white-space: nowrap; text-indent: 0pt">&#160;</td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; width: 50%; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Dated: September 28, 2024</span></td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; width: 5%; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">By:</span></td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; width: 45%; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">/s/Timothy Damadian</span></td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Timothy Damadian, </span></td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Chairman of the Board of Directors </span></td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Chief Executive Officer</span></td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">President and Treasurer </span></td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">By</span></td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">/s/Luciano B. Bonanni</span></td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Luciano B. Bonanni</span></td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;Executive Vice President, </span></td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Chief Operating Officer and </span></td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Acting Principal Financial Officer </span></td></tr>
</table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Signature</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Title</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Date</span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">/s/
    Timothy R. Damadian </span></td>
    <td style="vertical-align: top; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: top; width: 43%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Chairman
    of the Board of Directors </span></td>
    <td style="vertical-align: top; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">September
    27, 2024</span></td>
    <td style="line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Timothy
    R. Damadian</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Chief
    Executive Officer</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">President
    and Treasurer </span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">/s/Claudette
    J.V. Chan</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Director</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">September
    27, 2024</span></td>
    <td style="line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Claudette
    J.V. Chan</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">/s/Ronald
    G. Lehman</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Director</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">September
    27, 2024</span></td>
    <td style="line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Ronald
    G. Lehman</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">/s/Richard
    E. Turk</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Director</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">September
    27, 2024 </span></td>
    <td style="line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Richard
    E. Turk</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">/s/Jessica
    Maher</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Director</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">September
    27, 2024 </span></td>
    <td style="line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Jessica
    Maher</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0; margin-bottom: 0">Page 94</p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!--   -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>2
<FILENAME>fonar_exhibit-21.htm
<DESCRIPTION>SUBSIDIARIES OF THE REGISTRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Exhibit 21.1 Subsidiaries of the Registrant</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">Imperial Management
Services, LLC (New York)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">Health Diagnostic
Management, LLC d/b/a Health Management Company of America (New York)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">Health Management
Corporation of America (Delaware)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">Fair Haven Services,
Inc. (New York)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">HMCM, Inc. (New York)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">Raymond V. Damadian,
M.D. MR Scanning Center Management Company (Delaware)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">Dynamic Services,
Inc. (New York)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">Central Health Care
Management Company, Inc. (Delaware)</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>fonar_exhibit-23.htm
<DESCRIPTION>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMS REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">Exhibit
23.1&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">Independent
Registered Public Accounting Firm&rsquo;s Consent</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; text-transform: uppercase"><U>Independent
Registered Public Accounting Firm&rsquo;s Consent</U></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">We
consent to the incorporation by reference in the Registration Statement of FONAR Corporation and Subsidiaries on Form S-8 File No. 333-168771
of our report dated September 27, 2024, with respect to our audits of the consolidated financial statements of FONAR Corporation and
Subsidiaries as of June 30, 2024 and 2023 and for the two years ended June 30, 2024, which report is included in this Annual Report on
Form 10-K of FONAR Corporation and Subsidiaries for the year ended June 30, 2024.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">/s/
Marcum <FONT STYLE="font-variant: small-caps">llp</FONT></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">Marcum
<FONT STYLE="font-variant: small-caps">llp</FONT></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; color: #202124"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; background-color: white">New
York, NY</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; color: #202124"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; background-color: white">September
27, 2024</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>4
<FILENAME>fonar_exhibit-31.htm
<DESCRIPTION>SECTION 302 CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Exhibit 31.1</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">CERTIFICATION</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">I, Timothy R. Damadian certify that:</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">and</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">I, Luciano Bonanni, certify that:</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">1.I have reviewed this annual report on Form 10-K of
Fonar Corporation;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">2.Based on my knowledge, this annual report does not
contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements made, not misleading with respect to the period covered by this annual report; and</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">3.Based on my knowledge, the financial statements,
and other financial information, included in this annual report, fairly present in all material respects the financial condition, results
of operations and cash flows of the registrant as of, and for, the periods presented in this annual report.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">4.I am responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financialreporting
(as defined in Exchange Act Rules 13a-15(f) and 15(f)for the registrant and I have:</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify">a) Designed such disclosure controls and procedures,
or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to
the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the
period in which this report is being prepared;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify">b) Designed such internal control over financial
reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance
regarding the reliability of financial statements for external purposes in accordance with generally accepted accounting principles;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify">c) Evaluated the effectiveness of the registrant&rsquo;s
disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and
procedures as of the end of the period covered by this report based on such evaluation; and</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify">d) Disclosed in this report any change in the
registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the
registrant&rsquo;s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially
affect, the registrant&rsquo;s internal control over financial reporting; and</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">5.I have disclosed, based on my most recent evaluation
of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of registrant&rsquo;s board of
directors (or persons performing the equivalent functions):</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify">a) all significant deficiencies and material
weakness in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s
ability to record, process, summarize and report financial data; and</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify">b) any fraud, whether or not material, that
involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Date: September 27, 2024</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">/s/ Timothy R. Damadian</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">Timothy R. Damadian,</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">President and Principal Executive
Officer</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">/s/ Luciano Bonanni</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">Luciano Bonanni,</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">Executive Vice President, COO and</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">Acting Principal Financial Officer</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>fonar_exhibit-32.htm
<DESCRIPTION>SECTION 906 CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">Exhibit
32.1</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">In
connection with the Annual Report of Fonar Corporation and Subsidiaries (the &ldquo;Company&rdquo;) on Form 10K for the fiscal year ended
June 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), I, Timothy Damadian,
President and Chief Executive Officer of the Company, and I, Luciano Bonanni, Executive Vice President, certify, pursuant to 18 U.S.C.
ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">The
Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">The
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Company.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">/s/
Timothy R. Damadian</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">Timothy
R. Damadian,</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">President
and Principal Executive Officer</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">/s/
Luciano Bonanni</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">Luciano
Bonanni,</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">Executive
Vice President, COO and</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">Acting
Principal Financial Officer</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">Date:September
27, 2024</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">A
signed original of this written statement required by Section 906 has been provided to Fonar Corporation and will be retained by Fonar
Corporation and furnished to the Securities and Exchange Commission or its staff upon request.</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97
<SEQUENCE>6
<FILENAME>fonar_exhibit-97.htm
<DESCRIPTION>POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION PURSUANT TO SEC EXCHANGE ACT RULE 10D-1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">Exhibit
97</FONT></P>

<P STYLE="font: 7.5pt Arial, Helvetica, Sans-Serif; margin: 0.1pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: bold 14pt Times New Roman, Times, Serif; margin: 4.7pt 83.35pt 0 83.2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">FONAR
Corporation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.55pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 83.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B>POLICY
FOR <FONT STYLE="letter-spacing: -0.25pt">THE</FONT></B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 83.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B>RECOVERY
OF ERRONEOUSLY AWARDED <FONT STYLE="letter-spacing: -0.1pt">COMPENSATION PURSUANT TO SEC EXCHANGE ACT RULE 10D-1</FONT></B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 48pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.65pt">A.</FONT></TD><TD STYLE="text-align: left; padding-right: 83.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.1pt">OVERVIEW</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 23.75pt 0 24pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">In
accordance with the applicable rules of The Nasdaq Stock Market (the <B><I>&ldquo;Nasdaq Rules&rdquo;</I></B>), Section 10D and Rule
10D-1 of the Securities Exchange Act of 1934, as amended (the &ldquo;<B><I>Exchange Act</I></B>&rdquo;) (&ldquo;<B><I>Rule 10D-1</I></B>&rdquo;),
the Board of Directors (the &ldquo;<B><I>Board</I></B>&rdquo;) of FONAR Corporation (the &ldquo;<B><I>Company</I></B>&rdquo;) has adopted
this Policy (the &ldquo;<B><I>Policy</I></B>&rdquo;) to provide for the recovery of erroneously awarded Incentive-based Compensation
from Executive Officers. All capitalized terms used and not otherwise defined herein shall have the meanings set forth in Section H,
<FONT STYLE="letter-spacing: -0.1pt">below.</FONT></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 23.75pt 0 24pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 23.75pt 0 24pt; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 48pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.65pt">B..</FONT></TD><TD STYLE="text-align: left; padding-right: 21pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">RECOVERY
                                            OF ERRONEOUSLY AWARDED <FONT STYLE="letter-spacing: -0.4pt">C</FONT><FONT STYLE="letter-spacing: -0.1pt">OMPENSATION</FONT></FONT></TD></TR></TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 23.75pt 0 24pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 24pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.05pt">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">In the event of an Accounting Restatement, the Company
will reasonably promptly recover the Erroneously Awarded Compensation Received in accordance with Nasdaq Rules and Rule 10D-1 as follows:</FONT></P>

<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 60pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.05pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">After
                                            an Accounting Restatement, a majority of independent directors serving on the Board (the
                                            &ldquo;<B><I>Committee</I></B>&rdquo;) shall determine the amount of any Erroneously Awarded
                                            Compensation Received by each Executive Officer and shall promptly notify each Executive
                                            Officer with a written notice containing the amount of any Erroneously Awarded Compensation
                                            and a demand for repayment or return of such compensation, as applicable.</FONT></TD></TR></TABLE>

<P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 3.95pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 96pt"></TD><TD STYLE="width: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.05pt">(a)</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">For
                                            Incentive-based Compensation based on (or derived from) the Company&rsquo;s stock price or
                                            total shareholder return, where the amount of Erroneously Awarded Compensation is not subject
                                            to mathematical recalculation directly from the information in the applicable Accounting
                                            Restatement:</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3.95pt 23.9pt 0 123pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 126.95pt"></TD><TD STYLE="width: 23.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.1pt">i.</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">The
                                            amount to be repaid or returned shall be determined by the Committee based on a reasonable
                                            estimate of the effect of the Accounting Restatement on the Company&rsquo;s stock price or
                                            total shareholder return upon which the Incentive-based Compensation was Received; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 124.8pt"></TD><TD STYLE="width: 25.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.1pt">ii.</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">The
                                            Company shall maintain documentation of the determination of such reasonable estimate and
                                            provide the relevant documentation as required to Nasdaq.</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 23.9pt 0 150pt; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 60pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.05pt">(ii)</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">The
                                            Committee shall have discretion to determine the appropriate means of recovering Erroneously
                                            Awarded Compensation based on the particular facts and circumstances. Notwithstanding the
                                            foregoing, except as set forth in Section B(2) below, in no event may the Company accept
                                            an amount that is less than the amount of Erroneously Awarded Compensation in satisfaction
                                            of an Executive Officer&rsquo;s obligations hereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 60pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.05pt">(iii)</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">To
                                            the extent that the Executive Officer has already reimbursed the Company for any Erroneously
                                            Awarded Compensation Received under any duplicative recovery obligations established by the
                                            Company or applicable law, it shall be appropriate for any such reimbursed amount to be credited
                                            to the amount of Erroneously Awarded Compensation that is subject to recovery under this
                                            Policy. </FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 60pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.05pt">(iv)</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">To
                                            the extent that an Executive Officer fails to repay all Erroneously Awarded Compensation
                                            to the Company when due, the Company shall take all actions reasonable and appropriate to
                                            recover such Erroneously Awarded Compensation from the applicable Executive Officer. The
                                            applicable Executive Officer shall be required to reimburse the Company for any and all expenses
                                            reasonably incurred (including legal fees) by the Company in recovering such Erroneously
                                            Awarded Compensation in accordance with the immediately preceding sentence.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 23.9pt 0 24pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.05pt">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">Notwithstanding anything herein to the contrary, the
Company shall not be required to take the actions contemplated by Section B(1) above if the Committee determines that recovery would
be impracticable <I>and </I>either of the following conditions are met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.55pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/98% Times New Roman, Times, Serif; margin-top: 3.95pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 60pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.05pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding-right: 25.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">The
                                            Committee has determined that the direct expenses paid to a third party to assist in enforcing
                                            the Policy would exceed the amount to be recovered. Before making this determination, the
                                            Company must make a reasonable attempt to recover the Erroneously Awarded Compensation, documented
                                            such attempt(s) and provided such documentation to <FONT STYLE="letter-spacing: -0.1pt">Nasdaq;</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0.15pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/98% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 60pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.05pt">(ii)</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">Recovery
                                            would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly
                                            available to employees of the Company, to fail to meet the requirements of Section 401(a)(13)
                                            or Section 411(a) of the Internal Revenue Code of 1986, as amended, and regulations thereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 48pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.65pt">C.</FONT></TD><TD STYLE="text-align: left; padding-right: 83.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.1pt">DISCLOSURE
                                            REQUIREMENTS</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 23.9pt 0 27.55pt; text-align: justify; text-indent: 28.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">The
Company shall file all disclosures with respect to this Policy required by applicable U.S. Securities and Exchange Commission (&ldquo;<B><I>SEC</I></B>&rdquo;)
filings and rules.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 23.9pt 0 27.55pt; text-align: justify; text-indent: 28.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 23.9pt 0 27.55pt; text-align: justify; text-indent: 28.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 23.9pt 0 27.55pt; text-align: justify; text-indent: 28.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 48pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.65pt">D.</FONT></TD><TD STYLE="text-align: left; padding-right: 83.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.2pt">PROHIBITION
                                            OF INDEMNIFICATION</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 23.65pt 0 27.55pt; text-align: justify; text-indent: 28.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.1pt">The
Company shall not be permitted to insure or indemnify any Executive Officer against (i) the loss of </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">any
Erroneously Awarded Compensation that is repaid, returned or recovered pursuant to the terms of this Policy, or (ii) any claims relating
to the Company&rsquo;s enforcement of its rights under this Policy. Further, the <FONT STYLE="letter-spacing: -0.2pt">Company shall not
enter into any agreement that exempts any Incentive-based Compensation that is granted, </FONT><FONT STYLE="letter-spacing: -0.1pt">paid
or awarded to an Executive Officer from the application of this Policy or that waives the Company&rsquo;s right to recovery of any Erroneously
Awarded Compensation, and this Policy shall supersede any such agreement </FONT>(whether entered into before, on or after the Effective
Date of this Policy).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 48pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.65pt">E.</FONT></TD><TD STYLE="text-align: left; padding-right: 83.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">ADMINISTRATION
                                            AND <FONT STYLE="letter-spacing: -0.1pt">INTERPRETATION</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.55pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 24.15pt 0 24pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">This
Policy shall be administered by the Committee, and any determinations made by the Committee shall be final and binding on all affected
individuals.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.55pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 23.75pt 0 27.55pt; text-align: justify; text-indent: 28.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">The
Committee is authorized to interpret and construe this Policy and to make all determinations necessary, appropriate, or advisable for
the administration of this Policy and for the Company&rsquo;s compliance with Nasdaq Rules, Section 10D, Rule 10D-1 and any other applicable
law, regulation, rule or interpretation of the SEC or Nasdaq promulgated or issued in connection therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.45pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 48pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.65pt">F.</FONT></TD><TD STYLE="text-align: left; padding-right: 83.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">AMENDMENT;
                                            <FONT STYLE="letter-spacing: -0.1pt">TERMINATION</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 23.75pt 0 27.55pt; text-align: justify; text-indent: 28.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">The
Committee may amend this Policy from time to time in its discretion and shall amend this Policy as it deems necessary. Notwithstanding
anything in this Section F to the contrary, no amendment or termination of this Policy shall be effective if such amendment or termination
would (after taking <FONT STYLE="letter-spacing: -0.2pt">into </FONT>account any actions taken by the Company contemporaneously with
such amendment or termination) cause the Company to violate any federal securities laws, SEC rule or Nasdaq rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.55pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 48pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.65pt">G.</FONT></TD><TD STYLE="text-align: left; padding-right: 83.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.1pt">OTHER
                                            RECOVERY RIGHTS</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 23.9pt 0 27.55pt; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">This
Policy shall be binding and enforceable against all Executive Officers and, to the extent required by applicable law or guidance from
the SEC or Nasdaq, their beneficiaries, heirs, executors, administrators or other legal representatives. The Committee intends that this
Policy will be applied to the fullest extent required by applicable law. Any employment agreement, equity award agreement, compensatory
plan or any other agreement or arrangement with an Executive Officer shall be deemed to include, as a condition to the grant of any benefit
thereunder, an agreement by the Executive Officer to abide by the terms of this Policy. Any right of recovery under this Policy is in
addition to, and not in lieu of, any other remedies or rights of recovery that may be available to the Company under applicable law,
regulation or rule or pursuant to the terms of any policy of the Company or any provision in any employment agreement, equity award agreement,
compensatory plan, agreement or other <FONT STYLE="letter-spacing: -0.1pt">arrangement.</FONT></FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0.05pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 48pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.65pt">H.</FONT></TD><TD STYLE="text-align: left; padding-right: 83.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.1pt">DEFINITIONS</FONT></TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 60pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">For
purposes of this Policy, the following capitalized terms shall have the meanings set forth <FONT STYLE="letter-spacing: -0.1pt">below.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 60pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">1.</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&ldquo;<B><I>Accounting
                                            Restatement</I></B>&rdquo; means an accounting restatement due to the material noncompliance
                                            of the Company with any financial reporting requirement under the securities laws, including
                                            any required accounting restatement to correct an error in previously issued financial statements
                                            that is material to the previously issued financial statements (a &ldquo;Big R&rdquo; restatement),
                                            or that would result in a material misstatement if the error were corrected in the current
                                            period or left uncorrected in the current period (a &ldquo;little r&rdquo; restatement).</FONT></TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 23.75pt 0 60pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 60pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">2.</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B><I>&ldquo;Clawback
                                            Eligible Incentive Compensation&rdquo;</I></B> means all Incentive-based Compensation Received
                                            by an Executive Officer (i) on or after the effective date of the applicable Nasdaq rules,(ii)
                                            after beginning service as an Executive Officer, (iii) who served as an Executive Officer
                                            at any time during the applicable performance period relating to any Incentive-based Compensation
                                            (whether or not such Executive Officer is serving at the time the Erroneously Awarded Compensation
                                            is required to be repaid to the Company), (iv) while the Company has a class of securities
                                            listed on a national securities exchange or a national securities association, and (v) during
                                            the applicable Clawback Period (as defined below).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 60pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">3.</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B><I>&ldquo;Clawback
                                            Period&rdquo; </I></B>means, with respect to any Accounting Restatement, the three completed
                                            fiscal years of the Company immediately preceding the Restatement Date (as defined below),and
                                            if the Company changes its fiscal year, any transition period of less than nine months within
                                            or immediately following those three completed fiscal years.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.45pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 60pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">4.</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B><I>&ldquo;Erroneously
                                            Awarded Compensation&rdquo;</I></B> means, with respect to each Executive Officer in connection
                                            with an Accounting Restatement, the amount of Clawback Eligible Incentive Compensation that
                                            exceeds the amount of Incentive-based Compensation that otherwise would have been Received
                                            had it been determined based on the restated amounts, computed without regard to any taxes
                                            paid. </FONT></TD></TR></TABLE>

<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 60pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">5.</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B><I>&ldquo;Executive
                                            Officer&rdquo;</I></B> means each individual who is currently or was previously designated
                                            as an &ldquo;officer&rdquo; of the Company as defined in Rule 16a-1(f) under the Exchange
                                            Act. For the avoidance of doubt, the identification of an executive officer for purposes
                                            of this Policy shall include each executive officer who meets the definition of executive
                                            officer set forth in Rule 10D-1 and the Listing Standards. </FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 24pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.05pt 23.75pt 0 96pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 60pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">6.</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B><I>&ldquo;Financial
                                            Reporting Measures&rdquo; </I></B>means measures that are determined and presented in accordance
                                            with the accounting principles used in preparing the Company&rsquo;s financial statements,
                                            and all other measures that are derived wholly or in part from such measures. Stock price
                                            and total shareholder return (and any measures that are derived wholly or in part from stock
                                            price or total shareholder return) shall, for purposes of this Policy, be considered Financial
                                            Reporting Measures. For the avoidance of doubt, a Financial Reporting Measure need not be
                                            presented in the Company&rsquo;s financial statements or included in a filing with the SEC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 60pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">7.</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B><I>&ldquo;Incentive-based
                                            Compensation&rdquo; </I></B>means any compensation that is granted, earned or vested based
                                            wholly or in part upon the attainment of a Financial Reporting Measure.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 60pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">8.</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B><I>&ldquo;Nasdaq&rdquo;
                                            </I></B>means The Nasdaq Stock Market.</FONT></TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 23.75pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 60pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">9.</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B><I>&ldquo;Received&rdquo;
                                            </I></B>means, with respect to any Incentive-based Compensation, actual or deemed receipt,
                                            and Incentive-based Compensation shall be deemed received in the Company&rsquo;s fiscal period
                                            during which the Financial Reporting Measure specified in the Incentive-based Compensation
                                            award is attained, even if the payment or grant of the Incentive-based Compensation to the
                                            Executive Officer occurs after the end of that period.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 60pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">10.</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B><I>&ldquo;Restatement
                                            Date&rdquo;</I></B> means the earlier to occur of (i) the date the Board, a committee of
                                            the Board or the officers of the Company authorized to take such action if Board action is
                                            not required, concludes, or reasonably should have concluded, that the Company is required
                                            to prepare an Accounting Restatement, or (ii) the date a court, regulator or other legally
                                            authorized body directs the Company to prepare an Accounting Restatement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.45pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.45pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.45pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.05pt 0 0 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">Effective
as of <FONT STYLE="letter-spacing: -0.2pt">December 1, 2023. </FONT></FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.2pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.05pt 0 0 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3.8pt 83.05pt 0 83.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B>Exhibit
<FONT STYLE="letter-spacing: -0.5pt">A</FONT></B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.05pt 25.45pt 0 25.65pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B>ATTESTATION
AND ACKNOWLEDGEMENT OF POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.45pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.05pt 0 0 5.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">By
my signature below, I acknowledge and agree <FONT STYLE="letter-spacing: -0.2pt">that:</FONT></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 26.6pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#183;</FONT></TD><TD STYLE="text-align: justify; padding-right: 5.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">I
                                            have received and read the attached Policy for the Recovery of Erroneously Awarded Compensation
                                            (this <FONT STYLE="letter-spacing: -0.1pt">&ldquo;<B><I>Policy</I></B>&rdquo;).</FONT></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 26.6pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#183;</FONT></TD><TD STYLE="text-align: justify; padding-right: 5.65pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">I
                                            hereby agree to abide by all of the terms of this Policy both during and after my employment
                                            with the Company, including, without limitation, by promptly repaying or returning any Erroneously
                                            Awarded Compensation to the Company as determined in accordance with this Policy.</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 221.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.1pt">Signature:</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><U>&#9;</U></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.35pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 4.65pt 0 0 221.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">Printed
<FONT STYLE="letter-spacing: -0.1pt">Name:</FONT><U>&#9;</U></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 4.65pt 0 0 221.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.1pt">Date:</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><U>&#9;</U></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>fonar_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fonar_logo.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" !# ;H# 2(  A$! Q$!_\0
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M1?R76I:O?2WE]<2MEI)9'+LQ/N2:SJ_%L=Q%FF)Q<ZL*LHQ;T2>RZ?\ !/\
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MA^$LYI9EEM)0PN(TY8JRA4BE=);)27O+S4NQW5% (/0T5]B?@!Q/[0GBW5_
M7P/\9>.?#LJ)J.C^&;Z]L7DCW*LL4#NA([C('%?C"O\ P7#_ ."@( SXXT(\
M?] !/\:_8K]KC_DV+XC?]B5JF/\ P$DK^;A<XY'TK\^XUQ^-P5>C&A4<4TV[
M.W4_JKZ.?"O#?$.6YA/,\)3KN$Z:BYQ4K)J3:5^Y]>M_P7$_X* GIXYT,?\
M< 3_ !I#_P %PO\ @H&>GCO1!_W (_\ &OD2C-?$?VYG'_01+[S^DO\ B&?A
M]_T*J'_@M'UW_P /P_\ @H(1@^/-$_\ !!'_ (T?\/PO^"@?_0^:)_X((_\
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M#_HH6N_^$O=?_$U];]=X<_GI?^2GX5_JQXO_ /0+C?\ P&L>N_\ #OS]C/\
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M]#%?DT/B1_==?^#+T?Y'],OP_P#E\)Z0H_Z!<'_HM:W:PO !SX5TG_L%P?\
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MOV.[_P#8C_:,O?A&=4>_TNYLH]2T"]D #RVDC.H#X_B5XW4_[H/>O#:^O/\
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M,D[;K]6>!Q+XB<'<'XR&%S?%>RG./,ERS=U=J]XQ:W3/S8HK]*/^(<#XE_\
M1U&A?^$Q-_\ 'Z/^(<#XE_\ 1U&A?^$Q-_\ 'Z[?]5,]?_+G\8_YGSO_ !'+
MPN_Z&*_\ J__ "!^:]%?I1_Q#@?$O_HZC0O_  F)O_C]'_$.!\2_^CJ-"_\
M"8F_^/T?ZJY[_P ^?QC_ )A_Q''PN_Z&*_\  *O_ ,@:'_!%+XCI\'_V*OCA
M\49?#\>JKH-S]M;397VI<>7:;MC'!P#TZ&L@?\%]O"X_YL@\.'T_XF*?_(]?
M4_[&'_!,&_\ V7/V<OB/\"?'?Q4M-<MO'2.)+ZPTUK?[+&;?RCE7=MQ_BZCI
M7S __!#W]EZ-VB?]O^P5E.&#6MH"#Z?Z^OJJF&XCP>78:EA[1:B^9-QWOYOL
M^A^&83.O!_/N+<XQN<\]55*D'2E!5]8<B3TII6U7VDF5_P#A_OX8/3]B#PY^
M.HI_\CUZ-^R)_P %D?#_ .T'^T=X4^#L7[)VA:"^NZB+=-6MKQ7DMR5)W*!"
MOIZBN!'_  1 _9=_Z2 :?^-M9_\ Q^NX_9K_ ."4O[.O[/GQZ\+?&+P[^W'I
MFJ7FA:HES#I\D5JHN".-F5G)!.<=*C"_ZV?6(>U<7&ZO\&U]>IU9Y_Q 2>2X
MF.!I557=.?)=8JW/ROEO=-6O:]].Y^ED)RGXT^H[5U>,E&R,\'\ :DK]%/Y*
M6P4444#&RG$9/M7P%_P4)_X*KZ+^R-^T5-\([[]FG1O%4D>CVUW_ &K>WBH^
M)-_R8,3<#;Z]Z^_+@D0L1Z5^??[=/_!-_P" G[6W[1.H_%CQA^V+IOAJ]^QP
M6$FC;+9VM_)4C#%IE.XDDX(&.E>+GW]H?4E]2:Y[K>VW7?0_1/#%<)?ZRM\1
MQE+#*G+X54;YKKE_A>\NN^AXL?\ @OOX;[_L0>&Q]-13_P",4A_X+Z^&SU_8
MD\. >VH)_P#&*M#_ ((?_LN9_P"4@6G?C;V?_P D4A_X(A_LM\X_;_L!@<'[
M-9X_]**^-_XS-?:C]]/^OQ/Z$YOH[2T5*K]V+/T-_8V^-L'[1O[,?ASXS6WA
M"#08];M)9$TFU?=';A99$P#M7/W,]!UK^=_QY_R/&L_]A:X_]&M7]%_[+'P7
MT+]GC]G'PS\&O#/B4ZQ8:'I9BMM5,:K]J5V:3S,*2 #O/0FOYT/'G_(\:S_V
M%KC_ -&M5<:*JL%A?:.\K._K:-S+Z.<L!/B7/98%6H<T.1.]^3GJ\OQ:[6WU
M[F57U?\ \$3+I;;_ (**^#HGDVBXL-3BSZYLI3C_ ,=KY0KZ9_X(\7#6_P#P
M49^'!5R-]W>H>>N;&XKX_)I..;X=K^='] >(=-5> LTB_P#H'J_A!G[D?&SX
M,^!OCK\+M9^%/Q%TQ;W2-:LV@NHG ^7/W74]F5@&![$"OY]OVS?V3O'/['/Q
MOU+X3^+XGEMD<S:)J>WY+ZT8_)(#ZXX8=B#7]&[HKKM8<&OFW_@IA^PGX<_;
M3^ UQHVG00VWB_15:Z\+ZDX_Y:@9:W<_\\Y -I]#@]N?U/BC)%FV$YZ:_>PV
M\UU7^7F?Q'X,>)4^!,\^KXN7^QUVE/\ N2Z5$O+:7>.NZ1^ 5.BFEMY5N()&
M1XV#(Z'!4@Y!&*N^*O"_B#P3XDOO"'BK2IK'4M-NGM[VTG3:\4BG#*1]15"O
MQMIIV:LS_0J,Z=>FI0:<6ODS]K?^".'_  4.3]ICX7?\*3^)&J@^-_"EHH5Y
MG&[5+(?*LR^KIPKCW4]Z^,O^"_6DBQ_;>M=3"$?VAX.LI6)'=7EC_DHKY)^"
M7QC\<? #XI:/\7/AUJK6>JZ/=+-"ZGB1?XHV'=6&01Z&O<_^"G_[8WPY_;8^
M(/@_XH>!K&]M+NT\)1V6O6=W;[!#="5W(1LG>OSG!]J^NQ&=PS'AIX:M+]["
M4;?WE?3YK9GX#E7AI7X0\8(9MEM-_4\13J<R2TI3:3Y?*,FKQ[.ZZ(^8JN^%
MR3XCT\D?\OT7_H8JE5[PP"?$NG ?\_T7_H8KY*'QH_?:_P#!EZ,_IF^'R[O!
MVD2D\G2X./\ MFM:U[+'!"9Y9%14RS.QP% '))[5D> &V^"-'/\ U#8/_18K
MY7_X+(?MG)^S+^S;-X*\,:F$\5>-%DL=-6-OG@M\8FG]L [1[M7[]B\92P&#
MGB*FT5?_ "1_E9D>18WB?B&EE>$5ZE6?*O+763\DM7Z'YM?\%;?VPW_:M_:?
MO;/PUJ32>%/"+/IF@JK?),ZG$UQ_P-Q@?[*KZFOED#%*S,[%W8EB<DGJ325^
M$XW%U<?BIUZN\G?_ "7R1_I[PYD6!X8R/#Y7@U:G2BHKS[R?G)ZOS9I^#/"&
MO^/_ !;IO@CPM8FYU+5KV.ULH%_CD=@JCV&3UK^B3]D3X"^$_P!EK]GCPQ\%
M?#]S%G2M.3^T;E, W5V_S32G_><MCT&!VK^<_3-4U+1;^+5-(OYK6YA;=#<6
M\I1T/J&'(-='_P +T^-?_17?$W_@]N/_ (NO9X>SK#Y+.=2=)SE+1.]K+[NI
M^=>*WAOFWB/1P^&I8R-"C3;DXN#DY2>B>DEI%7LN[9_2X=5LBI7[2G3KO%>;
M?M6? ;P7^U'\"/$7P9\374*+JUBZV=TV#]FN1\T4H_W7 SZC([U_/9_PO3XU
M_P#17?$W_@]N/_BZ/^%Y_&KO\7/$Q^NN7'_Q=?25>.L+6IN$\.VFK/WEL_D?
MC^#^C+G& Q=/$X?-8QJ0:E%JF]&G=/XS,\>^!O$GPR\;:K\//&%@;75-%OY;
M.^@)^[)&Q4X/<<9![@@UD58U35M5UW4)=5UK4KB\NICF:YNIFDDD.,99F))/
MUJO7YU+EYGR[=+G]=457]A%5VG.RYFE9-VU:71-WT/N3_@A]^V2OP/\ C[_P
MH;QGJK1^'O'4RPV3228CMM2'^K/)X$GW/]XK7[4P?ZOK^-?R[Z?J%WI.HV^J
M:?<O#<VLZ36\T;8:-U(*L#V((!_"OZ!/^":G[7]E^U_^S)I'C"]O4/B'2XUL
M/$D'&X7**!YF/1QAOJ37Z5P1FWM*3P%1ZQUCZ=5\C^-_I(\"_4\PI\2X6/NU
M;0JVZ32]V?\ V\M'YKS.]_:WY_9B^(X_ZDG5/_222OYN1P,5_2+^UF=W[,OQ
M&)_Z$G5/_262OYNNIXZ8KCX^_P!YH?X7^:/HOHM?\BK,_P#'3_\ 29"*21R*
MU_!OCSQM\.]7.O\ @'Q9J&C7S0M$UWIEV\$AC)!*[D(."0./85D@@]*LZ5HV
MKZ[=&QT32KF\F"%S#:P-(VT=\*"<<BO@8.<9IQ>O2Q_4N(AAZE"4:Z3@]U*U
MFO.^G7J=O_PU=^TUV^/WC#_PH;C_ .+I?^&K_P!IDCGX^^,/_"AN/_BZY=OA
MW\05^]X$UD?72Y?_ (FF_P#" >//^A(U@?73)?\ XFNKV^/_ )I_?(\599PK
MTHT/_ :?^1U/_#5W[3/;X^^+_P#PH;C_ .+JIK7[27[0GB/3Y-(U[XW>*KNU
MF4K+;SZ[.R.#U!!?FL ^ _'(&3X,U;_P72__ !-07GA3Q3IUNUWJ'AK4((E^
M]+-92(J_4D8%3*MC6O>E*WJRZ>5\-1FI0H4KK9J,/\B@QW<G/N<U;T70=<\2
M7\>E^'='NKZYE8+';VD#2.Q] %!-5/:M3PAXU\7^ -:B\1>"?$M[I5_ VZ&[
ML+AHW0^Q4US0Y.97V\O^#H>QB'B?8R]A9SMIS72OTO9-V^1^G/\ P2"_X)2>
M.?!7C&R_:B_:4\/?V7/9Y?PMX:NA^_1R.+J9?X, _(A^;N0. ?T_%OM 42-@
M"ORO_P""6/\ P6$\>Z]\0]+_ &=OVHM:&IQ:O*+?0O%$H FBG/W(9SP'5CP&
MZ@D Y'3]3Q/D9W#\Q7[3PM/+7E:6!V6][<U_,_SH\9H<9QXSG/B3EYVE[/DO
M[/V?10OJDNJ?O7OS'\WO[9?R_M<_$X#_ **#K'_I=+7FO5,?2O1_VQR1^US\
M3QC./B#J_/\ V^RUYS_!^(K\<QEOKE3_ !2_]*9_H)P]KD&$?_3JG_Z1$]X_
MX)C'/[?WPL_[&F+_ - >OZ$H(T)8%1VK^>[_ ()@\_M_?"PD=/$Z?^BI*_H2
MMNA'L*_3. W_ ,)M3_&_RB?QM])U?\9EA/\ KPO_ $Y,?Y47]P?E1Y47]P?E
M3J*^Y/YKLAOE1?W!^5'DQ?W!^5.HH'9$%];P364L,T09'C*LI'!!&#7X(?MZ
M_L&?&KX)?M/>)?#WA/X<:UJNA7]\^H:)?Z;I\DT;V\K%@I* @,I)4CV]Z_?8
M@'@BN8^+ND_$?5/ 6HP?"/Q#IVF>(O)SIESJU@;BV\P=%D165MIZ9!!'7GI7
MB9YDU'.,,H2;3CJFDK^FO<_2/#/Q#S+P]S>I7P\(SA52C*,VXQT=U*Z3:Y=>
MCT;/YS/^&<?VA/\ HBWBK_P23_\ Q-/@_9X_:+M+B.ZM?@YXLCEC<-'(FBS@
MJP.00=O!S7W7^T-_P50_X*J_LK>+)/"'QE^$_A/3&1RMM?'P_.]K=+GAHY1/
MM8'ZY]J\[/\ P7^_;A/31O W_@BE_P#C]?F-7 Y%0FX3K5(M='"S7XH_L[!<
M3>)^:82.(PN782I3FKJ2Q+E%I_\ <-IG=? '_@JW_P %)_A'X3M?!OCO]F>\
M\9V]E"(H+Z^T:[MKPJHP \B*5?CN4R>YKT;_ (?8?MC#C_AWK?GZW-Y_\CU\
M_G_@O]^V^!SHG@8_]P.;_P"/T'_@O[^W"RX&B>!A_P!P*;_X_7M4L[HT8**Q
MU2R[TX_F]3\\Q?AEF&.Q$J]7AK!\TG=\N*K17_@,4DODDCZ!_P"'V/[8_P#T
MCSU#_P ";S_Y'H_X?8_MC'@?\$];_P#\";S_ .1Z^?3_ ,%_/VX,8&C>!0>_
M_$BE_P#C]*/^"_O[</?1? W_ ((IO_C]7_;]+_H.G_X+B<W_ !"?%_\ 1-87
M_P *\1_D>I?%7_@K_P#\%&O&6@SZ'\//V2+CPM+<1%#J(TJ\O)XLCJFY%13[
ME6KX.\0_!#]I[Q5KUYXF\1_"KQA>ZAJ%T]S>W=QHUPSS2NQ9G8E>222:^H#_
M ,%__P!M_I_8O@;_ ,$<W_Q^@?\ !?[]N G_ ) O@8_]P.7_ ./UYV-Q>6Y@
MT\1C*DK;>XDON32^]'U_#>1<9\(PE'*,APE+GM=K$3<G;9.4J;=M=DT?*G_#
M./[0A_YHMXJ_\$<__P 370?"G]C#]H_XK_$?1OAU8?"G7[.35]0CMVO+W2Y8
MXK=&/S2NS* %5<D_2OJ'P3_P6^_X**?$WQ';^$/ /P[\*ZQJ=TX2WLM.\-3R
MR.2<=!/T]SQ7ZA?LC#]J+4/A;!K_ .UJ^@P^);YA*-)T&R,<>GQ$<1NQ=]\G
MK@@#ISUK?*L@RK-*W[FK4:6K?*DO2YY?'7BOQQP5@;9A@\-"I.ZC&->4YWM\
M7)R+2+U;;2V2=V=SX-\+Z9X(\%:=X,T5-MGI.FQ6=L/^F<481?T45_-%X\_Y
M'C6?^PM<?^C6K^G.\"K$YP  A_D:_F-\=@GQQK) _P"8K<?^C6KTN/4HTL.E
M_>_0^+^BW*<\PS6<G=M4F_6]0R:^B?\ @DW<-:_\%#OAA(O\6MR(3_O6TP_K
M7SL>.O%?0/\ P2M./^"A/PKQ_P!#'_[0EKX7*I6S.C_BC^9_37'$5+@S,K_]
M ];_ -(9_0?3+A0R8]^*?00#U%?OQ_EH?F5_P6^_X)WGQ+HLW[87P?TC=J5@
M@'C'3+:+FXMQP+M0.K)P'ZY4Y_A.?RDK^H/7-.LM5L)=,U&R2XMKB)HIX9$!
M5U88((/8C-?AG_P5E_X)_P![^QY\7CXS\%Z=(? OBFY>72I%4E;&X.6>U8]N
MY7U7Z&OS3C'(?9S^OT%H_B2_,_L;Z/?B;];HQX7S.?OP7[B3>\5_R[N^L=X=
MU=;I'R111@^E&#Z&OSVZ/ZNT85?\*D#Q/IQ/_/\ 0_\ H8JA@^AJ_P"&$)\2
MZ<,?\OT/_H8JX-<Z,JW\&7HS^EKP]K6E^'/A=9>(-;O$M[.RT6*>ZGE;"QQK
M$"S$^@ K\"?^"B7[6&I_M@?M/:W\1UN'&B6;G3_#5J6.(K.-B V/[SG+D^K8
M["OT(_X+-?MD'X._LT:!^SEX-U,)X@\::- VI/$_S6VFJ@#'CH9&&T>P;TK\
MA*^[XTS;VDXX&F]%K+UZ+Y'\O?1SX%^J8>MQ-BH>_4;A2OTA=\\E_BDE%/LI
M=PJ[X<\.:]XOUZT\,>%](N+_ %&_G6&SL[6,O)-(QP%4#J:I$C'TK]&_^""G
M[&Q\9^,[S]K;QKI1;3=#D:R\,"6/Y9KLC$LPSU"*=H/]YCZ&ODLJR^KFN.AA
MX==WV75G[QQSQ9@^"N&:^;5]>16C'^:;TC'[VK]E<^34_P""='[<<BAU_9A\
M78/_ %"VI?\ AW-^W)_T;!XN_P#!6U?T1P@>4./S%/P/05^@K@/ ?\_9?A_D
M?RC_ ,3/\6?] 5'_ ,G_ /DC^=G_ (=R_MR_]&P>+O\ P5M1_P .YOVY,X_X
M9@\7?^"MJ_HFP/048'H*?^H> _Y^R_#_ "#_ (F?XL_Z Z/_ )/_ /)'\Z\O
M_!.C]N1%W']F'Q=_X*VKQ_5](U3P]J]UH&N6$MK>V-P\%W;3H5>*5&*LC \@
M@@@BOZA+A<QX &<\<5^*?_!<S]E<?!G]I:/XR^'=-,6B^.T,\Q1,)%?I@2CZ
ML-K?4FO$S_A2GE6!^L49N5GK>VB?4_2O"SQSQG&W$CRG-*-.DYQ;IN'-K*.K
MB[MK6-VO1GP_@'J*^L/^"0?[8S?LM?M.V>@>*-1\KPIXSD33=8:1\+;3,<07
M/T5SM;_9<GM7R?0'>-A)&Q5E(*L.H/K7R6!QE3 8N&(IO6+_ .'/W?B3(<#Q
M/D>(RO&+]W5BXONGTDO.+M)>A_2/^U;M;]ECXAR @Y\$:I\P[_Z+)7\VZ]!]
M*_93]C7]L<?M3?\ !,KQQH/B34!)XI\'^!M0T[6-[9>:(6<GDS>I+*,$^JFO
MQL ( ^E?6<98NCC5A:]-^[*+?XK3Y'X1]'K(\=PU5SK*\9&U2E5A%^=HRLUY
M-6:\FAHY.5X%?<7_  ;_ %I;7G[=%_'>6Z2I_P *_P!0PLB @'[19\\_C7P\
M"<9Q7W)_P;Z'/[==^>/^2>ZA_P"E-G7@\.V>>4%_>1^H>+#:\-\S?_3J7Z'[
M1?V#H??1K7\;=?\ "D/A[0#UT.S_ / 9/\*N45^Y\L>Q_FC[6JOM/[RD?#?A
MT]=!LO\ P%3_  K*\4?#7P%XLTJYT#Q'X-TN\LKN,QW%M<6,;*ZD<@@BNBI"
M%/4"DX0:LT.->O&2E&337FS^>3_@I%^SEI'[+7[8'BKX5^&8&CT<2QW^CQL<
M[+:X02*GT4ED_P" UX77VG_P7L8']OJY (X\(Z:/_1M?%E?@^<TJ>'S6O3AH
ME)V/]/O#S,,5FO V78K$RYJDZ,')]6^5*[_K<M:'KM]X8UNS\2Z7(4N=.NX[
MFV<'&V2-@RG\P*_ID\(ZFNI>%-+U&>,E[C3H)')/4M&I/\Z_F.F9?);G^$U_
M31\/44^ =#)8?\@>V_\ 12U]GP#+6NG_ '?U/YW^E/"E%95.4;O]\O\ TW_7
MS/F+QY_P3*_8=\<>.M7\8^*?@5#=:EJ^JW%YJ-R=>U!/.FDD9W?:MP%7+,3@
M  9X%9R_\$G?^"?9.#^SU!_X46I__)-%%>[7P6#=9OV<=WT7=^1^!X?C#BZG
MAX1AF%=))))5:EDET7O;'2_!W_@G#^Q;\)?BKH?Q%^'OP3BT[6=)OO/T^]77
M+^0PR!&PVV2=E;KT((KZNMB223117L972I4:$E3BEKT5CYO/LTS/-<5"KC:\
MZLDK)SE*32N]+R;=O(FHHHKTCQ HHHH *1_NFBB@:W.?\=^!?!?Q!TAO#GCK
MPII^KV$^5EM-1M$F1@1Z,#7YS?\ !1C]@+]D'X<Z0_BGP'\%;/2+R5F+G3]0
MNHHNO:)9?+7\%%%%>!Q)0H3RZ4I13?=I7W/TCPLS?-L#Q+0I8;$3A&3=U&<H
MIZ/=)I/YGY@:SI&G6>IW%M;V^U$E8*N\G S[FJOV&UV9\K]3117XH]C_ $>P
MTYRH1<G=V0HL;7 _=_\ CQI$L;4YS'GZL:**DTC)]QT%A:,X!B[_ -XU]O?\
M$^/V./V;_C1JUNGQ,^&ZZHIA#E6U6[B!.?2.5?RZ445[.04Z=7,$II->>O4_
M+/%?,<PP'#52>&K2INSUC)Q?7JFC]7O@O^SA\!_@5H\=E\(/A-H?A]-F&?3K
M!5D;KRSG+,?<DUZ#;CY,T45^W4X0I0C&"25NFA_G=B,3B<97G5KS<Y-ZN3;;
M^;U$N(TE/E2+E67!%?&=_P#\$LOV"-3O[C4;[]GRU>:>X>25_P"W-0&YBQ).
M!<8'-%%>?F="C6Y?:13WW2?8]C),XS;*'.6 Q$Z+E:[A.4+VO:_*U?YD0_X)
M2_\ !/\ '3]G>U_\'NH__)%=5\$_^"=G[&?PD^*VB_$7X>?!*VT[6=)O!-I]
M\NKWLAA<J5W;9)F4\,1R#UHHKSZ."P<:L6J<;W71?Y'K8GC#BVOA)TZF85Y1
MDFFG5J---.Z:<M4^Q]64445]*?%!7"?M%?!GX8?'GX97WP]^+G@^VUO1[@QR
M26=RSK\ZME65D965@>ZD&BBL<3&,\/-25U8Z<'6K8;%TZM*3C*+333::?=-:
MIGS*_P#P2C_X)_*<#]G>UZ?]!W4?_DBD_P"'4G_!/[_HW>T_\'NH_P#R1117
MS?U'!?\ /J/_ ("O\C[5\:<8\_\ R,L1_P"#JG_R0?\ #J3_ ()_?]&[VG_@
M]U'_ .2*EL?^"5?[ EK?0W,'[/5JKQRJR,-=U#@@@@_\?%%%'U'!?\^H_P#@
M*_R)_P!=.,7&SS*O_P"#JG_R1Z#\8OV"OV1_C/XXE\9?%#X,6>LZG]EAMA=W
M5_=96*- J( LH  '8#U]37(S_P#!+3]@,#C]F[2NO_00O/\ X]11777P>#G4
ME*5.+;;Z+N<N!XKXIPN A2HX^M&,59)59I)=DE*R(W_X):?L"-'N/[.&EY![
M:C>?_'J^EO@A\+_ 'P;^&6E_#OX8^&+?1]%TZ$K9V%MN*Q[CN8Y8DDDDDDDD
MDT45T9?AL/1K-TX).W1)=3SLWX@S[-L-&ECL75JQ3NE.I.:3MNE)M7.LHHHK
MUSYX**** "O,?VH_V?O@Y^T3X)MO"/QH\"VVO:?;7@N;>"XED0QR@$;E:-E8
M<'UP:**PQ4(5,/*,E=6ZG7@<5B<%C:=?#S<)QDFI1;33ONFK-?(\)'_!*G_@
MG\.G[.&G_P#@VOO_ (_2C_@E1_P3^VEO^&<-/S_V%K[_ ./T45\XL#@K+]U'
M_P !7^1]Q_KEQ?;_ )&-?_P=4_\ DCL/@_\ L+?LI?!U]>A^&OPC@TJ/7]$E
MT[6(X=3NW6ZMG&&C8/*1ZX(P1DX(S7"M_P $J_V 5 "_LZ6/_@XO_P#X_117
M35P>$=&"=.-E?HO(\J'%G%-'&UJL,?64I<O,U5FF[*RN^:[LM%?8;_PZM_8#
M_P"C=+#_ ,&]_P#_ !^O2/V7_P!B#]EC]GCXFR^/?@U\([70]7?39;1KV'4+
MJ4F%V1F3$LK+@E%/3/%%%3A<)A*>(A*-.*=^B1>+XKXHQN J4<1CJTX25G&5
M6;35UHTY-->I]#T445]&?'!0>GXT44 ?-G[2W["G[*/[0'Q/E^(?Q?\ A#;Z
MSK+V,=NU[)J=W$3&F[:NV*55XR>V>:\_'_!*O]@(\?\ #/%G_P"#O4/_ )(H
MHKYK$83"U,1.4J<6[O=(^SP7%G%.#R^E1P^/K0A%62C5FDEV24K)#+S_ ()4
M?L K;.R_L[V><?\ 0;U#_P"2*^Q-*TRPTW3+;3K*W$<-O D<* D[550 .?84
H45WY3AZ%+FY();;)(\GB+.LXS>E2>/Q-2MRMVYYRG:]KVYF[7\C_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>fonar-performance_graph.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fonar-performance_graph.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0$N17AI9@  24DJ  @    " !(! P !
M     0   !SJ!P   0  )@         <Z@    $
M
M
M
M
M
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MY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(H EHK.\2>*=+\(V]O-JNHV.F17EU#8P/=7"0K-<3.(XH5+$!I'=E54&2S$
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M5%8W<5_:1SP21S03J)(Y(V#)(I&0P(X((YR*EH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS^T'9>%/V>_#?P<^W^(+&\^/VKKX:U6XT+2+O5]2TWPVFV36KN*UM(III/\
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M?O+V]U>[2%G2*WN(KV&*(NHV 2Q2 L1\RC)  O\ P6H^'&F_\$<_^"T/[/\
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M>X$#L\0D2-5;8S*I*Y!P2H)&,@=*V*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2T'J* /&/V-->N]=3XJ"[F>
M;[%\1-7M8=QSY<:^454>PR:]GKPW]A_I\7O^REZS_P"T*]RH **** "BBB@
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M)/A'_A*/&?QX\7^(?#^C76HQVNH:W87EP+BWGMH9"'G5HE9CY88J$;<!BOU
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MAS3;&:[U6\U2:.&RM;1(V>:2=Y"$2)8PQ=G(4*"2<"OYUO\ @A!_P5#^$?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]&HH \Y_X96\(_W_ !?_ .%AJ_\ \DT?\,K>$?[_ (O_ /"PU?\ ^2:]&HH
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M_P#X6&K_ /R31_PRMX1_O^+_ /PL-7_^2:]&HH \Y_X96\(_W_%__A8:O_\
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M]&HH \Y_X96\(_W_ !?_ .%AJ_\ \DT?\,K>$?[_ (O_ /"PU?\ ^2:]&HH
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M_P#X6&K_ /R31_PRMX1_O^+_ /PL-7_^2:]&HH \Y_X96\(_W_%__A8:O_\
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M444 %!ZBB@]10!X;^P_T^+W_ &4O6?\ VA7N5>&_L/\ 3XO?]E+UG_VA7N5
M'E_[1/\ R.?PI_['!/\ T@O:]0KR_P#:)_Y'/X4_]C@G_I!>UZA0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%&:* "BBC- !1110 4444 %%%% !1110 45Q_
MQ^^.OA7]F/X,^)/B!XWU:#0_"?A*QDU'4[V4%A%$@Z!0"6=B0JHH+,S*H!)
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M6?AMHWB/4%M[_P 3^(-0U*VT[1+<*SRW$C2Z/&A941MB%T\QRB;E+ U^G"\
M4 >'?L/]/B]_V4O6?_:%>Y5X;^P_T^+W_92]9_\ :%>Y4 >7_M$_\CG\*?\
ML<$_](+VO4*\O_:)_P"1S^%/_8X)_P"D%[7J% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD_\ #1OP]_Z'OP?_ .#FW_\ BZ/^&C?A[_T/?@__ ,'-O_\ %UK?\*M\,_\
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M:#_X 1?_ !-'_"K?#/\ T+F@_P#@!%_\30!D_P##1OP]_P"A[\'_ /@YM_\
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MX/\ _!S;_P#Q=:W_  JWPS_T+F@_^ $7_P 31_PJWPS_ -"YH/\ X 1?_$T
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M>_!__@YM_P#XNC_AHWX>_P#0]^#_ /P<V_\ \76M_P *M\,_]"YH/_@!%_\
M$T?\*M\,_P#0N:#_ . $7_Q- &3_ ,-&_#W_ *'OP?\ ^#FW_P#BZ/\ AHWX
M>_\ 0]^#_P#P<V__ ,76M_PJWPS_ -"YH/\ X 1?_$T?\*M\,_\ 0N:#_P"
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M&C?A[_T/?@__ ,'-O_\ %UK?\*M\,_\ 0N:#_P" $7_Q-'_"K?#/_0N:#_X
M1?\ Q- &3_PT;\/?^A[\'_\ @YM__BZ/^&C?A[_T/?@__P '-O\ _%UK?\*M
M\,_]"YH/_@!%_P#$T?\ "K?#/_0N:#_X 1?_ !- &3_PT;\/?^A[\'_^#FW_
M /BZ/^&C?A[_ -#WX/\ _!S;_P#Q=:W_  JWPS_T+F@_^ $7_P 31_PJWPS_
M -"YH/\ X 1?_$T 9/\ PT;\/?\ H>_!_P#X.;?_ .+H_P"&C?A[_P!#WX/_
M /!S;_\ Q=:W_"K?#/\ T+F@_P#@!%_\31_PJWPS_P!"YH/_ ( 1?_$T 9/_
M  T;\/?^A[\'_P#@YM__ (NC_AHWX>_]#WX/_P#!S;__ !=:W_"K?#/_ $+F
M@_\ @!%_\31_PJWPS_T+F@_^ $7_ ,30!D_\-&_#W_H>_!__ (.;?_XNC_AH
MWX>_]#WX/_\ !S;_ /Q=:W_"KO#/_0N:#_X 1?\ Q-'_  JWPS_T+F@_^ $7
M_P 30!D_\-&_#W_H>_!__@YM_P#XNC_AHWX>_P#0]^#_ /P<V_\ \76M_P *
MM\,_]"YH/_@!%_\ $T?\*M\,_P#0N:#_ . $7_Q- &3_ ,-&_#W_ *'OP?\
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M=:W_  JWPS_T+F@_^ $7_P 31_PJWPS_ -"YH/\ X 1?_$T 9/\ PT;\/?\
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ML'_QVB4)1^(&K&8/VC/AZ!_R/?@\_P#<9M__ (NC_AHWX>Y_Y'KP?_X.;?\
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M<QS?*,1G>(QE.C3I:<LI+GDTKVBGW]3]8/CO_P %?O@/\"6:*Z\9VFN7B_\
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MH \O_:)_Y'/X4_\ 8X)_Z07M>H5Y?^T3_P CG\*?^QP3_P!(+VO4* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ H-%'?VH ;@GJ,T,">W2N-^,7[0G@GX Z7'>^
M,_%&C>'+:;/E&^N4C:?'4(I^9S[*":^4_BW_ ,%\/@9\//-BT:?7_&-T@( T
M^Q:* _\  YBAQ_NJU;TL)5J_!%LN-.3V1]O[MJT(<BORITK_ (.*-=\8_%K1
M=,TCX86HT:_O8[:2-[^2;4)%=@N4"J$##.<8;/M7ZI6<_P!HMD?:REAG##!'
MU]Z,1A*E!KVJL$Z;CN+,X7<2< #DD\"O%?C#_P %$_@K\"99X?$?Q#\.6][
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M]#!HO_@;'_C1_P +4\-?]#!HO_@;'_C0!OT5@?\ "U/#7_0P:+_X&Q_XT?\
M"U/#7_0P:+_X&Q_XT ;]%8'_  M3PU_T,&B_^!L?^-'_  M3PU_T,&B_^!L?
M^- &_16!_P +4\-?]#!HO_@;'_C1_P +4\-?]#!HO_@;'_C0!OT5@?\ "U/#
M7_0P:+_X&Q_XT?\ "U/#7_0P:+_X&Q_XT ;]%8'_  M3PU_T,&B_^!L?^-'_
M  M3PU_T,&B_^!L?^- &_16!_P +4\-?]#!HO_@;'_C1_P +4\-?]#!HO_@;
M'_C0!OT5@?\ "U/#7_0P:+_X&Q_XT?\ "U/#7_0P:+_X&Q_XT ;]%8'_  M3
MPU_T,&B_^!L?^-'_  M3PU_T,&B_^!L?^- &_16!_P +4\-?]#!HO_@;'_C1
M_P +4\-?]#!HO_@;'_C0!OT5@?\ "U/#7_0P:+_X&Q_XT?\ "U/#7_0P:+_X
M&Q_XT ;]%8'_  M3PU_T,&B_^!L?^-'_  M3PU_T,&B_^!L?^- &_16!_P +
M4\-?]#!HO_@;'_C1_P +4\-?]#!HO_@;'_C0!O9^;\*4G%8'_"U/#7_0P:+_
M .!L?^-8/C']I_X;^ #'_;OC_P %Z()03&;_ %NVMO,'?&]QFFHMZ)#2;V.[
M));BE7)'-?/OQ#_X*A_ +X;6;3WOQ3\)7P5<B/2;U=3=OH+??S7D/@K_ (+P
M?!_XA?&?1/">FV'BTP:U=I91ZI/:)%"DCMM0E-^_9DC+$ CKBME@Z[7-RNQ2
MIRM=GW#BF2/L))X ]ZP8OBGX:"X/B#1>O_/['_C7+?''5-&^*GPB\3>&]/\
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M\,@?\C!HO_@;'_C6\,?7A'V<).Q:JR2LF<;\(?V,OA7\!6BD\)> _#.BW$.
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M&C_S,&B_^!L?^- &_15'1]?LO$-NT]A=VU["K;#)!(LBYP#C(XS@C\ZNKTH
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M&O;U.1^.* /#_P!A_I\7O^REZS_[0KW*O#?V'^GQ>_[*7K/_ +0KW*@#R_\
M:)_Y'/X4_P#8X)_Z07M>H5Y?^T3_ ,CG\*?^QP3_ -(+VO4* "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HQ137ZB@!N<-2LV>O KSC]I7]J?P-^REX/37/'&N0Z-9W
M#F*V4HTDMU(!G9&B@ECQZ8&>2*_/S]H3_@XH@B6>R^&7@Z28C*IJ6N2;$/;*
MP(<G\7'N!7NY5PSF.9>]A:;<>^R^]GSF<<59;ECY<34][^5:O[C]1)[R.V#/
M)(L:H,DL0 !ZFN7\*_'7P;XX\37>C:+XJ\/ZKJMAS<VEI?Q330_[RJQ(K\+=
M>_: _:6_X*+^('TRVO?%OB2WG<*UCH\#6VG0Y('[P1XCVC_IHQ]<GJ?HSX=?
M\&\GCT>&4U+4?B-IGAWQ$RAX[:SM9;A8B>=K3AT((/=5//K7TM;@[+L)3Y<Q
MQL8S[13E9^>WZ'S7^N&;8B2E@<!)T^\GRMKR/UP292<;ASZ'-.+X'3\:_*:7
M]AW]MG]G.!YO"/Q+D\26=JID6'^VGE+!><".Z0K@@8P#_.O-_@G_ ,%N/VBI
MM9O-);0=+\>76D!GO84TB5;J%4;:S/Y!  !P#\O?K7FRX2C4M]4Q5.=]ES6?
MW/\ S/6H<3XETY5,1@JL8QW:CS17JT?M#U'UIRG>/2OS.\!_\'$>G6FHQV?C
MKX9:WHDRLJRR65R)2A/4F*58V  YX)..@)K['\=_\%"?@S\,- MK[7_B'X:L
M/M,"3I;?:1/=%64-S#'ND!P>F,CN*\?,^'<?@9*.(IVYMK:W^X]G)\^P>:)O
M!RYK;Z-?F>UYVCM2!OFR:^3OA%_P66^"?QK^-FG>!]%U+6?MNKR&"SO+FQ:&
MTGDQE4W,=P+= 64<X'>OJV*Z25 5=6'J#7EUL-5I?Q(M'KRDHOED]1\KXY[?
MSKSOXJ?M8_#3X)6\C^+?'/AG0C&#F*YU&,3''I&#O)^@-1?M>?"OQ#\;OV<O
M%WA;PKKA\/:]K5@UO:7XD:,1-D$J67YE# %2P&0&)%?F%\-_^#=?XC^*;_SO
M&?C?P_H<6_YOLJ2ZA.X!QWV+T]ZZL)AZ$XN5:?+Y=3:$(/63/J7XN_\ !?;X
M'^ #+%H1\1>,ITR%^PV9@A8_[\VTX]PIKW[]B#]LS0OVX_@O_P )AH5AJ.EQ
MPWLFGW-I>!3)#,@5B R\,"KH<CU]J^=/A)_P;[_!CP,J2>([OQ)XQN5^\MQ=
M"TMV/J$A ?\ -S7V/\(?@WX7^ O@>V\-^#]%LM!T2S+-':VRX4,QRSDY)+$]
M23DU6+^IJ/+A[W\QU/9V]TZ@YVG./2O@W_@I'_P2!UW]N+]H"P\8:9XYM-%M
M%T^.QN+2]MWG^S["QWPA3C!!Y4E?FR<G.!]Z(1MXY_K1U%<E#$2I2YX:,B,G
M%W1^>GPB_P"#=WX7^%/+E\6^(_$WBJ=>&BB,=A;OCU5 SX^C U]4?!#]@KX0
M_LZWL%WX1\!Z%INHVW^KOI(?M%VAP!D2R%G!('8BO8P<]NE!Z=:TJXZO4TG)
M_H.523W8D7W3]:=2+TZYI:YB HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:WWQ3
MLTS=\V: %8@-[TG4&JVJZI!I5I+<W,R000KN=W.%4#WKY4_:#_X+-? KX"Q7
M,#^+8?$.K6Q938Z.GVIRP_A+KB-3]6%<F*QE##QYJ\E%>;L>WD?#6:9S6]AE
M>'G6E_=BY6];;?,^LU.3VI?O$]Z_&KX]?\'(/C#Q/*UK\./!UGH2$X2ZU-S=
M3L,?\\D(4'_@3?2OT)_X)A_'WQ_^TE^RKI?B7XC:,-(UZXN)44B!K<74*MA)
M1&Q)7</?G&>AQ7G8#/\ !XRLZ.&;E;K;0^SXL\(N(>&\LAF><PC3C.7*H\Z<
M]KZQ3>GS/HF0[3Z$5\4?%'_@L'I_PX_X* Z=\$7\&ZC=1W5W;:=+JBS8*33A
M2A6+;\T8++N;=Z\';S]KX SZ'UKD=5^!7@[5?B5;^+[KP[I$_B>TC,4.IO9H
M;J)?02$9'4]^YKT<92KS@E0DD[K6U].I\AP[C,KP\ZLLUP[JJ4&HI2:M-[2T
MWMV.MBE#HI&>1WZFN6^-'P=T'X^?#?5_"?B>Q74M"UF PW5NS%=PR#P5P5((
M!!!SD#&,5U<0SCIQQQ0QP:Z)0C*/+)77WGBT*]2C5C6HMJ2=TUNFMG\CYB^
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MT3_R.?PI_P"QP3_T@O:]0H **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHS0 4444 '6F-BG]:BF=8P23@8]2*5F]$)M+
M5CL8(I3R,UX]\?/VZOA3^S3;ROXN\::/I]W&,_88I1<7;>PA3+_I^-?#/[0_
M_!Q1;0^=9_#+P;+<,"534]=<QQX_O+!&VXCZN,<9%?0Y7PKFF/\ ]VI/E[O1
M?>SYK->+LKP":K5%S=EJ_N1^H-W<1VX+.Z*JCDL> *^?OVA/^"HOP6_9P2>+
M6/&-EJ&IPY']G:2?MMR6_NG9E4/^^RU^6+>)_P!K;_@I=>;;4^*]0T&]8C;
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MIU%2KPG3D]+2BU^5S]#TYYI3U'%1Q-A,^H[5B>(/B3H'A75K:PU/6])TZ_O
M6MK>ZO(XI9P.I5&8%L>PKY2-.4O=BKGU\ZL(*\G9&\3M-.!R*K66HP7<0>*:
M*1&Y#*P(/TJP"".#FJY6MT.%2,E>+N+10#FBD6%%%% !11FB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "B@G%-256SAE/TH 5A@Y]>*9
MR"<BDDN$C;EER?4UXQ^W%^V?H7[$OP-O?&FJ6\VK&&>.UM[&V91+<3.> ">
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MB9I:#OY.E.?YN*_0:60\-\J=7'?=%_\ !/S>IQ%Q.YN-+ Z><D?=NI_\%/\
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MP>00?I2KR:_/#6OV._VU?A/:/%X.^/%CXEMH_P#5C4[>,W# =!F>*4<^[&N
MU3X]?\% ?@'=F77/#$7C*TC.28M)M;M' ZD?8BCK]2HKUJ/"JQ"OA\52D^SD
MXO\ %'C5N+Y8=VQ6$JQ\U&Z_!GZG?P4F?EX.#7Q7_P $\_\ @H]\1OVH?BQ>
M^$/''PMO_#$UG9/=OJ*0SQ0(RLH\MTD7*EMW&&/3I7VD6V@YS7@YCEM; UG0
MKVNNS3_%'T>69E1Q]!8BA>S[JUOD2;LBCH/05Y_J'[4GPXTGQS<^&KOQQX5M
MM?LF"SZ?+J<*7$)(& 48@@X(_.NVTS5[74K5);:Y@N(I!E'C<,K#V.37-/#U
M8)2G%I/NC>GC*$Y.,)IM>:+2=*=34(/<'Z4ZLSI3N%%%% PHHS10 4444 %%
M%&<T %%%% !1110 4444 %%%% !1110 4G\?X4N<TC>HQF@!I;YJ,\<FJ^I:
MA!IEI)<7,L<-O"I>221@JHH&223P .N:\<\6_P#!13X(>! PU+XG>#XY$X,<
M6H1SR9_W8RQ_2MZ&"Q&(=J,'+T3?Y(X\5C\-A]<144?5V_-GM8//;\J",#_Z
MU?(GB_\ X+@?L]>%U;[/XJU#6'!QBQTJ=L_BZJ/UKRSQ?_P<5?#+2FD&C^$?
M&.JOSM,J06R-^)D8@?A^%>YA^$,YK/W,/+YJWYV/!Q'&>2T5>>(C\G?\C]#0
M<\9%'7\*_*+Q?_P<B:G<*ZZ%\,;.W/\ "][J[29]\)$O\ZX:R_X+Z_''Q?XN
ML;?1_"GA:<33JOV"WL;F:>Y!./+5O,XSG (!P?:O37AWG*INI4@HV762_0\G
M_B)&3.:ITG*=^T6?LL%R>_-*>36=X5U"XUCP[87=W:O9W-S;QRRP,<M"[*"R
M''<$D?A3?%_B>T\&>&M0U:_F^S6&FV\EQ/*1D1HH+$_@ :^(FN1VET/OZ*=;
MEY$VY6LOR+\DX3G<H_$5EZUX\T7PW"TNHZMIEC&G5I[I(U'U+$5^+?PML?C%
M_P %4/CEX]C\&?&/4#I>DWAGBAU2^N=/7[+)(_DE+>%2BC"X*CH>U>OZ+_P;
MM^*O$\J3^*_BS;R2_P 0AL);ML=_WDDB\^^VOKL#DN35:,:]7'QU6RBV?+Y]
MB^),LQL\#5RV49Q_G:CH]G;S/O[Q;^WU\&/ XD&I?$WP9"T?WECU2&9A]51B
M?TKRSQA_P6M_9X\(A@OC.;5)!T6QTNYE#?0[ /UKX_\ VD?^#>37?#/@VQE^
M&/BD>(M:\XK?0:NJVD7ED#:T;1@X((.0V<AJR_A%_P &Z'CO7]DWC/Q]I.AQ
MD@M;Z;9/=2>XWN553_P%J)_ZL4)\DI5:OG%)+\3T,!D_$N.PGUN=?#8=:^[-
MRE+[HI_?8^@/%W_!Q!\*=+$@TCPUXRU:4="\$-LCGM@F0G_QVOJ[]C;]K30_
MVT/@I:>-=!M+VPMIII+::VNU EMY8SAE)'!Z@Y''-?-OPJ_X("_!/P;#GQ'_
M ,)'XQFQAA<Z@]I&>.H%OL8?]]&OL+X1_!WPU\"_ MIX:\):1::'HE@"(;2W
M&$4DY9B222Q/)))))YK'-\1D<\/&.74IQJ7U<GT^3.#+,#GE'%R_M"O"I#^X
MFE^*3.@N?,,<@4$$J0ISR.*_'#]H;_AMWX)_M!>+KBPN_B'>6'B#4)A8OI%O
M_:%@;8/F(1H%=8"%(YVJ?7-?LL5 7'I370$],\5XN58RGA,7'$SIJIRW]U[:
M]6CZ/'^UKY=7RZE+D55*\E\2L[Z/I?K8_$&+X!_MO_&PDW;?%!HIOX;[6391
M_P#?+2*%'X#CM5[3/^"&_P"T9\1I!)X@N]"M"3DG4]:>Y<'_ +9J^3[YK]L5
MC"C@#\JD&",5]K+Q(QL%RX:C3@O*/_!_0_.:?AGA>;GQ&(JS?^(_(WP?_P &
MX?BN\*G7/B-HMDN/F6ST^2X(_%V3->I>#_\ @W&\"66UM=\?>*=1(ZBS@@M%
M/_?0D/\ *OT>9<4,,#ITKS:W'N=S5HUK+R27Z'K4N <F6M2FYO\ O2;_ %/G
M_P#8^_X)P?#C]B35=1U'PA:7\NK:I MK/?7]T9YFC#!M@X"@%@I.!R5'I7O\
M:_)UX-+GY:.AYKY7%XNMBZKK5Y<TGNV?48+ X?!TE1P\>6*Z(26!)U*NH8$=
M".*1+2-5 5$ 'M4F_P!:-XK)29TNG%N[0T0(H^ZOY4HC7LH_*EP&HV"B[*4(
MKH&T>@I<8H Q12'9!1110,**** "BBB@ Q1C-%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 8S1110 4444 %%%% !1110 444
M4 %%%% !1110!Q'[2OP.TO\ :;_9Z\<_#C6I9[?2?'OA^^\/7DT(!E@BNK=X
M&D3=D;U#[E)'# 5^!WP8_:I^+_\ P0?^.7P(^!'[4_A^[F^"WPL\>W_B+PI\
M0=+MI;J&>SN-$UK3O(CXQ+&LVJK.T9(G@1779(K1 ?OE^T;\==$_9B^!GBSX
MB>)5O&\/^"]+FU?4?LJ*\WD0J7<HK,JDA03@D=.M>!?\%*O@UX*_:K\1_LR^
M#O&>BZ1XS\#^+?B3>1WEC= 36M["?!/BB2-P5YR&5)$D5@RLJ,I# $ 'NOP:
MN_ /Q4W?%;P-?Z3KT'C[2[*+^WM-O#<6VJ6ELUPUOMPQCRC7-P"0 V6VMG8
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MH_X;*\ _\_\ K7_A/:C_ /&*]2HH \M_X;*\ _\ /_K7_A/:C_\ &*/^&RO
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M_P#">U'_ .,5ZB!@4M9W;U9#9Y;_ ,-E> ?^?_6O_">U'_XQ1_PV5X!_Y_\
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MI/%>#WW_  3V\0_!^Z:Y^&/QYUV J2RPOHFMZ8_^Z3%&P8\=PH]J_2CX*_\
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MQ_P54^%/[*_C*_\ #NO76L7NM::JM<V^GV1E$!90P5G)5<D$' /&:^=O%_\
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MNI//X8:*.U7RV:-T,4(;=O [$$$^E?HDO[8G@%5Q]OUH?3P]J/\ \8IG@?\
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M[4?_ (Q1_P -E> ?^?\ UK_PGM1_^,5ZE10!Y;_PV5X!_P"?_6O_  GM1_\
MC%'_  V5X!_Y_P#6O_">U'_XQ7J5% 'EO_#97@'_ )_]:_\ ">U'_P",4?\
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M_6O_  GM1_\ C%'_  V5X!_Y_P#6O_">U'_XQ7J5% 'EO_#97@'_ )_]:_\
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MK:O?7=W+?ZGKE]+S)=W=U,S2SS.<DLS'K@8 Q7E__!23_@E3H?\ P5!\(_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=2E_ADTON3LSYB_X)Y_\$QO#/_!/:/Q#)HNM:KKM[XA:/SI[W8OEI'NV(JJ
M/XFR<=37TY"<*#W'% 3+9[T]0 3QBM,-A:="DJ-%<L5T/.SO/,=G&,GF&8U'
M4JSWD]WTZ'R/_P %.OVH?C9^SO-X1'PD\ /XOBU6Y9=1N! ]QY&"NV+8C!EW
M@M^\/RKM]Z^F_ASK>I>(O >D7VKZ<=)U6\M(I[NR,JR?99&0%X]R\-M)(R.N
M*VI(TD'S ''(R,XI!Q@=?0XI4Z,HU95')M.UEI96_P S3%YG0K8&C@X4(PG3
MO>:OS3OWN[:>1'=0B9'1@2KKM/?K[5\!ZY_P;T?"?Q7\7M7\27^L>*)++5KR
M2];2X[A(X8F=BS*&";]N2<?,.,#)K] 2F0.N:%^[^E9XO+\/BDHXB*E;74ZN
M'>+\YR&4YY/B)495%:3B[-KU/G+X4?\ !)_X"?!T0OIGP\T:>ZA(*W%^K7DH
M([@REB/PQ7OWAWPOIWA6Q2VTVRM+*",85((@B@?0 5H8)%*IP.:UH82C15J,
M$O16./-.(<SS.?/F&(G5;_FDY?FQR=*6D!R*6NE'DH,4444 &,4444 %%%%
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M:7?6-C>0V>B;]8N(;F98':.^>4K"1)(A'EP!P%;$@)X^E_\ @FU_P4U^%_\
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M'^GQ>_[*7K/_ +0KW*O#?V'^GQ>_[*7K/_M"O:[V=K>*1UC>4HI8(@RSD#.
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M^00VF]2"#Y,8&1GL[,.!7V_;0K#"JJ-J@8 QC KR]/VD]1[?"_XDM[BTM/\
MY(IP_:1U$?\ -+OB7_X!VG_R17RU?$5:LKU97/K95'/5L]2HKR[_ (:1U+_H
MEOQ+_P# .T_^2*/^&D=2_P"B6_$O_P  [3_Y(K(D]1HKR[_AI'4O^B6_$O\
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MI'4O^B6_$O\ \ [3_P"2* /4:*\N_P"&D=2_Z);\2_\ P#M/_DBC_AI'4O\
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MI'4O^B6_$O\ \ [3_P"2* /4:*\N_P"&D=2_Z);\2_\ P#M/_DBC_AI'4O\
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MC17EW_#2.I?]$M^)?_@':?\ R11_PTCJ7_1+?B7_ . =I_\ )% 'J-%>7?\
M#2.I?]$M^)?_ (!VG_R11_PTCJ7_ $2WXE_^ =I_\D4 >HT5Y=_PTCJ7_1+?
MB7_X!VG_ ,D4?\-(ZE_T2WXE_P#@':?_ "10!ZC17EW_  TCJ7_1+?B7_P"
M=I_\D4?\-(ZE_P!$M^)?_@':?_)% 'J-%>7?\-(ZE_T2WXE_^ =I_P#)%'_#
M2.I?]$M^)?\ X!VG_P D4 >HT5Y=_P -(ZE_T2WXE_\ @':?_)%'_#2.I?\
M1+?B7_X!VG_R10!ZC17EW_#2.I?]$M^)?_@':?\ R11_PTCJ7_1+?B7_ . =
MI_\ )% 'J-%>7?\ #2.I?]$M^)?_ (!VG_R11_PTCJ7_ $2WXE_^ =I_\D4
M>HT5Y=_PTCJ7_1+?B7_X!VG_ ,D4?\-(ZE_T2WXE_P#@':?_ "10!ZC17EW_
M  TCJ7_1+?B7_P" =I_\D4?\-(ZE_P!$M^)?_@':?_)% 'J-%>7?\-(ZE_T2
MWXE_^ =I_P#)%'_#2.I?]$M^)?\ X!VG_P D4 >HT5Y=_P -(ZE_T2WXE_\
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M_P!$M^)?_@':?_)% 'J-%>7?\-(ZE_T2WXE_^ =I_P#)%'_#2.I?]$M^)?\
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ME:5:Z)IMO9V5M!9V=H@BA@@B$<<" 8"JHP  . !TKS7XQ?L,?!/]HSQ8FO\
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M+9ZUW*'('&.: /#_ -A_I\7O^REZS_[0KW*O#?V'^GQ>_P"REZS_ .T*]RH
M\O\ VB?^1S^%/_8X)_Z07M>F2C=D8SQT/0UYG^T3_P CG\*?^QP3_P!(+VO3
MS_/BDV^@-=SS[Q3^RW\.?&<\TFJ>!O"=[).2TDDNE0-(Y/4EMF<^]>:>*/\
M@E=\$/%(D)\%VUC*Y^_:7$L)'T"M@?E7T7MXQ[T@4XJ:J572IKZGC8SA[+<7
M_O5"$_5)L^*/%/\ P0X^%^KLS:?JGBC23U7R[M)%'U#QDD?C7FGBW_@@>ZQN
MVB?$'<V<JEWIHP!_O*_]*_2'[IQ@4JGGT%<DLNP\MX_<SY;%^%W#5>[EADF_
MY6U^3/R5UW_@BG\7O"LQN-%U?P]J#)]TQ74MO,?Q*X'YUC/^RG^UC\(4_P!
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF:*7?2O$'AO4 I^4%YK=V^OR$?K0L3C8_%3^Y_\ #@N*^-L+_O>6J:7\LO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K-\4^*]+\&:='>:QJ=AI
M-I-=6]A'->7"01R7%S/';V\(9R 9)9Y8HD4<N\B* 68"KMW.+:%I&#E8U+$(
MI=L#T49)/H "37XI_"#XR:W_ ,%F_P!C+5/COXQ^)?CS2]/F^.GA#POH7@3P
MMXAFT33O"U@WBO0H4:X-L4FN-0:*Z,ZSR2$12&%X5B>-2 #]L%'7ZTM?&G[+
M'@;XN_LN_P#!0O6/AGKWQ1\3?$WX->(_!$WB;PJ?%*Q76M:+?6]];6]U:O>J
MBRW$02ZB=6E)8!PO5"S^)_M ?\$L?VDO^"@7[27C7XD/^U=\7_V>O!ES?-I?
MA7P9X7NKZW,=C:GR!?7"QW<*+)=.DDX787$<L0=@P,: 'Z;T5^)MA_P3]^-O
M[+O_  5R_9J^&3?MF_M&_%2R\22W_C'Q3IVI>)M0M[6STC3-CHDR"]D\V.ZN
M"+<@@+@L#G.!^@7_  5Z_:W_ .&;_P!G'3?#&C>,]%\!^//C/K$/@GPWKVIW
MT=I!X?:YS]JU5G=T %I;"65?F&Z;R(P=TBB@#ZPH/45^3?P*_P""!/Q^TGXA
M^$_$^K_\%'_COXZ\(V6HVNHWNEVUYJUO%KMHDJO);BY769 BRH"F]5; 8D U
M^L2=!]: /#_V'^GQ>_[*7K/_ +0KW*O#?V'^GQ>_[*7K/_M"O<J /+_VB?\
MD<_A3_V."?\ I!>UZA7E_P"T3_R.?PI_['!/_2"]KU"@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &
ML!G[H/X5&]K%)UC3\5%2E@*"<CK01**>Z,77_ >C>)[8PZAI=A>PGJD\*2*?
MP((KSOQ3^PG\)/&B,+_P!X88MU,=C'"W_?2 &O7"N1G.<4J'G\*B=.$OB29Y
M^(R? 5U:O1C+U2?Z'ROXO_X(\?!/Q.C?9]"O]&D;^*SU&8'\G9E_2O,O%O\
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M0"#T.:*#0**** "BBB@ HHHH **** "BBB@ HHS10 4444 %%%!.* "BBC-
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MW'BWPY$YZJD$L@!_$#^5+ZYB7_RZ_$/]>>*JNM'*FEYRM^A^DUA\=?!^H_\
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M?^"N?P _9R_:[M/@AX_\?67@KQO?:;%JEL^M0R6>ER1REQ&GVUP(%=MC8#,
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M9_X"6?\ \DUZE10!Y;_PTCJG_1*_B9_X"6?_ ,DT?\-(ZI_T2OXF?^ EG_\
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MVVUKXEST_>I:0@?C)< 5VF@?\%$?"WBG;_9F@^(+\MT$%UI;D_E>&OF/7?\
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M^(8]?(\/VK8_.]%=-H__  2ATF!1_:&D?&BY'?R-)TZ(G\[EZ_4]FP:0<_\
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M->IT4!8\L_X:/U,_\TJ^)?\ X!V?_P DTA_:-U,_\TJ^)7_@'9__ "37JE%
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MOP;>$_\  15:Y\*:;>9\ZQM),C'S1*?Z53P-?I5?]?,7_$.^((_P\WJ?-/\
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M_2"]KU"O+_VB?^1S^%/_ &."?^D%[7J% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 (5!["D>!'ZJI^HIU%!+B
MGHR"2RA<X:*,_5:H:IX0TO6(&BNK"UN(FZH\093^!K48#/-!&.E)I/<QEAJ,
M])P3]4CA;C]F[P#/=>?)X,\,/+G.]M,@+?GMK=TCX;Z#H 'V'2-.M.P\BV1.
M/P%;OS4$G&#1RHPCEF%B[QI1^Y%6+2K:,<01#Z(*F6UA0<1I_P!\BI$^E.)Q
M3.F-"FMHH8D2 <(H_"G;0.PI0<T4&J26P8'H****!V#&**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** #&:
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ QFC%%% !1110 4444
M%%%% !1110 4444 %%%<[\6OBCH7P.^%WB7QKXIOO[+\,^#])NM;U>\\F2?[
M'9VT+S3R^7&K2/MC1CM168XP 3@4 =%12)TI: "BBB@ H/444'J* /#?V'^G
MQ>_[*7K/_M"O<J\-_8?Z?%[_ +*7K/\ [0KW*@#R_P#:)_Y'/X4_]C@G_I!>
MUZA7E_[1/_(Y_"G_ +'!/_2"]KU"@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR!6V"12&0!AU!]3_ ."]'[<?B_X9:Q\$OV</A;X@N_"GQ$_:5\3P:!+XALV
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M_P#[FH_X6#\6/^B;^'?_  J__N:@#U&BO+O^%@_%C_HF_AW_ ,*O_P"YJ/\
MA8/Q8_Z)OX=_\*O_ .YJ /4:*\N_X6#\6/\ HF_AW_PJ_P#[FH_X6#\6/^B;
M^'?_  J__N:@#U&BO+O^%@_%C_HF_AW_ ,*O_P"YJ/\ A8/Q8_Z)OX=_\*O_
M .YJ /4:*\N_X6#\6/\ HF_AW_PJ_P#[FH_X6#\6/^B;^'?_  J__N:@#U&B
MO+O^%@_%C_HF_AW_ ,*O_P"YJ/\ A8/Q8_Z)OX=_\*O_ .YJ /4:*\N_X6#\
M6/\ HF_AW_PJ_P#[FH_X6#\6/^B;^'?_  J__N:@#U&BO+O^%@_%C_HF_AW_
M ,*O_P"YJ/\ A8/Q8_Z)OX=_\*O_ .YJ /4:*\N_X6#\6/\ HF_AW_PJ_P#[
MFK#^(OQ]^)'PR\(W>N:I\-]$^PV.SS?)\4[G^=U08'V;GEA^&: /;:*\M7X@
M_%C'_)-_#O\ X5?_ -S4O_"P?BQ_T3?P[_X5?_W-0!ZC17EW_"P?BQ_T3?P[
M_P"%7_\ <U'_  L'XL?]$W\._P#A5_\ W-0!ZC17EW_"P?BQ_P!$W\._^%7_
M /<U'_"P?BQ_T3?P[_X5?_W-0!ZC17EW_"P?BQ_T3?P[_P"%7_\ <U'_  L'
MXL?]$W\._P#A5_\ W-0!ZC17EW_"P?BQ_P!$W\._^%7_ /<U'_"P?BQ_T3?P
M[_X5?_W-0!ZC17EW_"P?BQ_T3?P[_P"%7_\ <U'_  L'XL?]$W\._P#A5_\
MW-0!ZC17EW_"P?BQ_P!$W\._^%7_ /<U'_"P?BQ_T3?P[_X5?_W-0!ZC17EW
M_"P?BQ_T3?P[_P"%7_\ <U'_  L'XL?]$W\._P#A5_\ W-0!ZC17EW_"P?BQ
M_P!$W\._^%7_ /<U'_"P?BQ_T3?P[_X5?_W-0!ZC17EW_"P?BQ_T3?P[_P"%
M7_\ <U'_  L'XL?]$W\._P#A5_\ W-0!ZC17EW_"P?BQ_P!$W\._^%7_ /<U
M'_"P?BQ_T3?P[_X5?_W-0!ZC17EW_"P?BQ_T3?P[_P"%7_\ <U'_  L'XL?]
M$W\._P#A5_\ W-0!ZC17EW_"P?BQ_P!$W\._^%7_ /<U'_"P?BQ_T3?P[_X5
M?_W-0!ZC17EW_"P?BQ_T3?P[_P"%7_\ <U'_  L'XL?]$W\._P#A5_\ W-0!
MZC17EW_"P?BQ_P!$W\._^%7_ /<U'_"P?BQ_T3?P[_X5?_W-0!ZC17EW_"P?
MBQ_T3?P[_P"%7_\ <U'_  L'XL?]$W\._P#A5_\ W-0!ZC17EW_"P?BQ_P!$
MW\._^%7_ /<U'_"P?BQ_T3?P[_X5?_W-0!ZC17EW_"P?BQ_T3?P[_P"%7_\
M<U'_  L'XL?]$W\._P#A5_\ W-0!ZC17DNJ?$_XIZ78W%U-\-_#_ )5M$TC8
M\5Y.!R?^7;T'3OQ5+P-\;_B9X_\ !>DZ[I_PWT+[#K%I%>V_F>*MK^7(@=<C
M[-P<$4 >ST5Y=_PL'XL?]$W\._\ A5__ '-1_P +!^+'_1-_#O\ X5?_ -S4
M >HT5Y=_PL'XL?\ 1-_#O_A5_P#W-1_PL'XL?]$W\._^%7_]S4 >HT5Y=_PL
M'XL?]$W\._\ A5__ '-1_P +!^+'_1-_#O\ X5?_ -S4 >HT5Y=_PL'XL?\
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M?]$W\._^%7_]S4 >HT5Y=_PL'XL?]$W\._\ A5__ '-1_P +!^+'_1-_#O\
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M_P#[FH_X6#\6/^B;^'?_  J__N:@#U&BO+O^%@_%C_HF_AW_ ,*O_P"YJ/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR'_@50_M8W<UE_P>,_LQ)9NR)>?":]COA&/]8GD^)V ?_@21'G^ZM 'Z\(,
M_6D?]*<.E% 'P+\:M/\ VS_VW/$?B'5O@?\ %+P-^S]\-]&OKC3?#EQ?^&X]
M?UGQ>]O*\,MY/]HC>&UM))4;R-B/(\:B0_+(HK+_ ."*7_!2OXN?M)?%3XP_
M /\ :'T+2M.^-'P-N88[[4M(C\JRURUE+!)M@^56.$<,H57CFC(1"&!^]/B'
MX_T7X5>"-7\2^(]4L]$\/Z!9RZAJ-_=2"."S@C0L\CL>BJH)KXW_ ."4'[-N
MKZO\:_C?^U5XRT:^\/\ B?\ :,U2UDT31[Z,Q7>C^&K&!;?3O/CX,=S/$B32
M1MR@$:G#!Q0!!9?ME^./V]?^"C'Q,^"'PF\82_#WP!\!K2U3QMXOTNPL[_6=
M1UFZ,GEZ;9"]AGM(8HA%-YTDD,CF2)D55'SUL_L<?MV>*=-_;[^)'[*GQ:U"
MUUOQKX1TR#Q3X1\4Q6B63>+]#F"!C<01XBCN[>1Q&YB5(Y0K.L<80[OEO_@U
MB1]1\6_MFZO>AY-8U'XN70O9Y.'E97N'Y'3(>60_5JB_:QNYK+_@\9_9B2S=
MD2\^$U['?",?ZQ/)\3L _P#P)(CS_=6@#Z ^-EC^VA^V]XE\0ZM\$/BCX%_9
M]^'&C7UQIGAV>_\ #<6OZSXO>VD>&:\G^T1O#:VCRHP@\M&D>-1(?E=165_P
M13_X*5_%S]I'XK?%_P" G[0^A:3IOQH^!MU#'?:EI$?E66N6LI8)/L!VJQPC
MAE"JZ31D(I#"OO3XA>/]%^%7@C5_$WB/5+31/#^@V<NH:C?W<@C@LX(T+O([
M'HJJ":^-_P#@E!^S;K&K_&OXX?M5>,M&OO#WB?\ :,U.UET32+Y#%=Z/X;L8
M%M]-%Q'C,=S<1(DLD9Y0"-3A@XH L?\ !=[]L3XT?L&_L#^,?BE\*8_ ENGA
M9+%;R\UL3W=XGVJ^BLQ]GME58MR-/$VZ5V4@N/+^4;_I3]CWQWJOQ2_9*^%_
MB?7KO[?KGB/PEI6IZC<^6D7VBYFLXI)7V(%5=SLQPH &> !Q7R+_ ,'1?_*"
M?XY]\_V!S_W,&F5]2?L ?\F'?!/_ +$+0O\ TW04 >N4444 %%%% !1110 4
M444 %%%% !37X.:=10!^5W_!TSH_B'X&_L*7GQF^'_Q-^,7P]\;Z9K>FZ<Q\
M-^/M7T[3KJWE9XV1[**X%LK<AO,CC5R5&YF'%?;W_!/GX)6_P8_9;\(,/$WQ
M!\7:GX@T2PU'4]3\7>+=1\075U</;(SR*;N:18%)))C@"1]]N>:^./\ @[K_
M .4-/B'_ +&?1_\ T>:H_P#!<_\ 9^\#_$S_ (-]K_Q9X@\)^']6\4^"O ^B
M3Z!K5S91OJ&C,\U@L@MYR/,C5Q@.JL%<8# B@#]1U&,^YS2U^:_[>GP)\&_&
M;_@VW2^\5^&-%U^^\'_!6TUK0KJ]M5EN-'O(M'B9+B"0C=&X( )4@L 0<@D5
MXU^U!X9-S_P:.>"_$5KK'BK1=8\+?"[0;BPET?Q!>Z8CF22RC=9XH)DCN49"
MPV3K(J[B5 /- '[&T5^*'QX_X)@>!?BA_P &]'A#XT>*];\=:[\3? ?P0T;Q
M'X2U4^(;JUMO"QMM(MIH;>TLH9%ME7:BJTC1M,YRY<-C'I/Q?_X*2?$;P5_P
M0'_9C\3V>H^(+CXB_'*^\,_#^?6M.F@&KJ]TLHN;J"2X9(5NY(;24))(ZHLL
MZN6 &X 'ZS45^/?_  4._85\;?$+X0Z/K/[,/[)'Q:^#_P"T%X1U*TO-&\;M
MXD\)6-U?1HX%Q'J5W%KLT]\'CR?](64LR@,=K.#^K'P%UCQ5XA^!W@V_\=:3
M%H/C:^T.RN/$.F131SIIVHM;HUS LD;,CB.8NH9&*G;D$C!H X3]KKX0?$7X
M_P!MI'A+PAX]U/X6>'+P33>(O$NAK"^OLB[5BLK$S(\=N9"SN]R59D$(1$)E
M,D?Y_P#PJT#XX_\ !+[_ (+5_"'X-6WQM^)_QY^#OQST;5+RXL_'NI-K.L^&
MI+*!W,_VH@%4WB$!@$1Q+(A0NJ/7ZH>/;'7-3\':G;>&M2TW1M?GMI$T^_U"
MP?4+6SG*G9));I+"TJJ>2@EC+8QN'6OQP\8?$']J'_@DM_P5S\"^._CGK'@S
MXW^ _P!H?5K'X=0^*-.T4:=?>%T>=C!9V\1)-K&)93,T0DF6=8G8MYB@@ ^P
MO^"PW[>7BOX%>)_@K\#/A;J<6B_%?]HKQ/'H-GK36ZW+>%M+22,7VHK$P9'E
M19 (U<;3B1N?+Q7G_P#P4D\<^(O^"*'@WX?_ !N\)^,/B7XR\ V_B6UT#XEZ
M%XL\4WWB(:AI]V'7^T[8W;R&TNH957$=KY,#^;M,> ,>6_\ !3.TE@_X.?OV
M(+F^!729=!U"*W>8_N3<A=0)5<\;\O!TYY3VKU/_ (.OKR&U_P""*'Q#CDD"
M/<ZOHL<08\NPU*!B!GK\JL>.P]* /T9T35[;7](M;ZRGCNK.]B2>":,[DEC=
M0RLI[@@@@^]6J\L_8:T^\TG]BGX/VFHQS0ZA:^"=%AN8YO\ 6)*MA"'#=\A@
M<UZG0!\W_MO_  _^,'[1OBC1?AM\-O&VI_"/PW-9OJGBSQK8:>MQJ8C+^7;Z
M;IS2#RTFE*S/+-\S0)%%A<SJ:_/+XOP?M%_\$)?VZ/@3*?CO\1/V@/@/\;/%
M-MX-U73O'VHMJ.IZ->3R)&CQW$A)!"NTJ&/8K>3(KKRKG]FW&X]Q_6OAGQ]\
M+X_^"H'_  4.\#:V8!<_!#]E_5I]3@OB T'C#QBI\I8X,\/;Z9L;?*I -TQB
M&[RI-H!+_P %A_V\/%?P(\3_  5^!GPLU*+1?BO^T5XGCT&RUEH%N6\+:6DD
M8O=16)P4>5$D41JXVG]XW/ED5Y]_P4D\<^(O^"*'@WX?_&[PGXP^)?C+P#;^
M);70/B7H7BSQ3?>(AJ&GW8=?[3MC=O(;2ZAE5<1VODP/YNTQX QY=_P4TM98
M?^#G_P#8AN;T%=)FT+4(K=YC^X-R%U D+GC?EX.G/*>U>I?\'7UY#:_\$4/B
M'')($>YU?18X@QY=AJ4#$#/7Y58\=AZ4 ?1/[8GA7XK_ +5FH^'/ OPI\>W_
M ,+/!^IZ<=;\2^.],L5N=0EMW(6UL-,>0>4LLV)I))QN:%(XL+F937Y^?%^#
M]HO_ ((2_MT? F4_'?XB?M ? ?XV>*;;P;JNG>/M1;4=3T:\GD2-'CN)"2"%
M=I4,>Q6\F177E7/ZD?L.Z=>:5^Q5\'[34(YX=0M?!&BPW23#]XDJV$(=6SSD
M-G/>OFSQ]\+X_P#@J!_P4.\#:V8!<_!#]E_5I]3@OB T'C#QBI\I8X,\/;Z9
ML;?*I -TQB&[RI-H!ZO^VY\/_C!^T9XGT7X;?#;QMJ?PB\-S6;ZIXL\:V%@+
MC4Q$7\NWTW3FD'EI-*5F>6;YF@6*+"YG4U^>?Q?@_:+_ ."$O[='P)E/QW^(
MG[0'P'^-GBFV\&ZKIWC[46U'4]&O)Y$C1X[B0D@A7:5#'L5O)D5UY5S^S(!;
MN>?Q%?#?C[X7Q_\ !4#_ (*'>!M;, N?@A^R_JT^IP7Q :#QAXQ4^4L<&>'M
M],V-OE4@&Z8Q#=Y4FT ^YTZ4M-C^[]??-.H **** "BBB@ HHHH **** &N.
M>#SZ5^27_!=C]H;]I3]B7]IKX"6'PL_:+\2Z-H/QY\8OX=N-,U'PGX>OXO#V
M^XM$1K61K 2O&JW+?+,\C_(,R'FOUOK\A_\ @YX _P"&H_V!\]/^%L1Y^GVO
M2Z /U1^#_@;5OASX"M-)USQGXB\?ZG;EVEUO6[>PM[RYW,6 9+&WM[<!0=HV
MQ X W%FRQZ>OR]_X..9O$7P"T?X#_$KP+\0_BKX-\0^(/B[H/A+5;71O&^J6
M>D:CI\T5W*\<E@DXM0Q:V0%UC5F#.'+\87_@ZBN/$GP9_P""?C?%CP'\1/BI
M\/?&?A[6=/TN*7POXTU/2+2ZMIY7#I-;03+ [9;<)"@D^4#?M&V@#]0:*_+?
M_@Z*^,_Q7_9B_9K^&GB_X9?%;QKX-EU_X@Z;X5O='TN>WL[2\BFM[VY,AN8X
M/ML;[K9$(2?RRC-F,G!K@?\ @N=X4^/'_!/#X(:=^U)HG[3?Q2U/QIH7BBP@
MU'PB)HK/P-<6DS,#;0Z9&O"J0J[[B6:1EW$MO(:@#]AJ*^%/^"G/_!0^[^$O
MQ5_9V^%&A7_BWPW+\>+N^OM6UGPYX<NM?UO2M&L+(74T5G:6D%Q*US<,Z1"5
M(9/)02R$ *''S/\ M/\ Q]^)7[+_ .U7\(?&O[,-I^V-\1?"VJZS_9OQ(\%>
M,/!?C?4]-;3W:/\ TRVEUJUW6LR@RG$$H4,L?R+&'5P#]@7."*^<_P!KKPS^
MT/\ &[Q2?"7P;\;>'O@MHMC;+-J/CC4_#:>(K^YN'R4MK"RDD2#8B@&6:<GF
M1%125<K]&1C ^IS7%?M#:G\1-(^%M_/\+-%\(:]XS4 65IXFU:XTS3C_ 'F>
M6"WGD)'&$"J&/5TZT ?"_P#P2V_;4_:%TC_@HI\5?V3?VC-4T#Q]XB\%>'8_
M&&A>-])TV/35U6P>>WBVSP1!8U<FY3 55*F&8$R#:]>G_MM?MV^*C^W3\,/V
M5_A#J&FZ3\0?'=A/XD\3>);JT6^7P=H, ?\ >Q0,=DEY.\;1Q"0,B$JSHRL,
M?)__  2:_;#^(GP?_P""N'Q%^#O[4OPOTWPS^T!\;8F\0:7XOTNX:>SUO3[*
MWD\C3X%W.L=K%!;W+1LC EXY1*#*=U2_LK//KG_!XW^TO]O,LR:-\)[,:;OR
M! A@\-DA?;=--^+M0!])>(?VQ_&G_!/S_@H1\*O@U\4_&.H?$CX??'R&XL_"
M/B[5["QLM8TC7+=EW:?=BQ@M[6:"<30+"Z01NLC[6WCYU^Z$^[7Y'_\ !U#<
M3:?KO['%U9EDU&W^+]H]J\?,JONA(V_\""_B!7ZX+TH 1_ID?3K7R'^UYXA_
M:5_:+^,.J_#K]GKQ1X0^$VB^$((1XF\?:WI(UJ\.HSQ+/'IUA9/^Z)CMWAFE
MEFR,74*H"5>OKZFOWZ]* /RU_8;_ ."@G[3'[-__  53L?V1?VJ+SP]X_O/'
M.CW.M>!_'FBZ9'I_]II!#-.Z30Q(D0'EVMP" BO')&!^\21''O?[;/[=OBH_
MMT_##]E?X0ZAIND_$#QW8W'B3Q-XENK1;Y?!V@PB3][% QV27D[QM'&) R(=
MK.C*PQR_P4^%:?M\?\%<I_VDQ&6^&?P+T.Z\"^ ;S&%\1ZQ*TJ:KJ<)_BM8D
ME>S5L%9'$K*<)EOGW]E1[C7/^#QK]I87YEF31?A-9C3=X($"F#PV2%_V=TTW
MXL: /I+Q#^V1XU_X)]_\%!OA5\&?BGXPU#XD?#[X^0W-IX2\7:O86-CK&D:Y
M;LF[3[O[#!;VLT,XF@$+I!&ZR/M;>N77JOVO/$/[2O[1GQAU3X=?L\^*/"/P
MGT3PA!"/$OC_ %O2!K-X=1GB6>/3K"R?]T3';O#+-+-D?Z5$J#*O7R;_ ,'4
M-Q-I^N_L<75F634;?XOVCVKQ\RJ^Z$C;_P ""_B!7ZW'H>I_2@#\M_V&O^"@
MO[3/[-__  51L/V1?VI[SP]X_O/'6D7.M^!_'FBZ9'I_]II!#-.Z311)'$H\
MNUN01L5XY(U&9$D1Q]>_M=>&?VB/C=XG_P"$2^#?C7P]\%=%LK59]1\<:IX<
M3Q%J%S</DI;6%E)*D&Q% ,LTY/,B*BL5<CQ3X*?"M/V^?^"N4W[28C+?#/X%
M:)=>!? -YC"^(]8F:5-5U.%OXK6))'LT;E9'65E.%^;[ _:"U3XB:3\*[^X^
M%FB^$=>\9J +*T\3:M<:7IQ'=GEAMYY"1QA JACU=.M 'PS_ ,$M?VU?VA=&
M_P""BOQ6_9._:-U30/'WB+P3X=C\8:%XWTG38]-&JZ>\\$6V:"(+&KDW28"H
MNUH9@3(-KU^CR'*YK\@/^"37[8GQ$^#W_!7#XB_![]J3X7Z9X9_:"^-L3:_I
M7B[2[@SV>N:?96\GD:? NYUCM(H+>X:,HP)>*02@RG<?U_7IS0 M%%% !111
M0 4444 %%%% !1110 QS\V/:OQ[_ &@_C9^U%\+?^"]_P?\ V6-*_:G\;R^
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M5+/1/#^@6<NH:C?W4@C@LX(T+/(['HJJ": /@O\ X(I?\%+/BY^TE\5?C#\
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M@\/?M8?;HYOBU!XEP=5OIH#Y$;P81%CL83^Z2V1$\@G#!BXFE_3)!A: $?\
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M_#C1KZXTSP[/?^&XM?UGQ>]M(\,UY/\ :(WAM;1Y480>6C2/&HD/RNHKY_\
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M\"?#%K\'_$-CXSG&J^,M5N)-0U&-8'DM%\O2 %MTE21%E)WRKL<QPG,=;_\
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M36?BOKNC1>&-$TS13+)H_@G1T8N;6VFF1);F:61G>2X>.,_.RI'&I8'ZPHH
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M$VDO;Z+Q;+]GUSQ;>M%)#'9K:;$>*SB,GGO+)M,CQ0*H*^81]FDX/Z^E/HH
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M/'_AO4_!NF'P]!X*^&_A_5D$6K+8*-UQJ-W""3;/*_F".)R)%29]ZJ0N?O\
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M_86\"?#73;2V@T?2]0G^)NDZAI_AN ;8EF:TBF22:.%/F\M&!;;QGH?TZHH
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MOA9X;N/&7BCX4_$+2?'O]A6J[[G58+2&[B>*%0<N^;E6VKEBJ,%#,0#\[_\
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M_"'>*]%N=!U#5[*XAB@O;=[:\6&3>HA=-HVB6*>4QNQ$6[N_V=?^"B7[2?\
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MA_5D$6K+8*-UQJ-W""3;/*_F".)R)%29]ZJ0N?#OVC_^"JGC/XM_M6-;:_\
ML@_MA>*/@MX%NXKK1-,TWX87BQ>,-2B?<FH7ZW"HPM[=U22VMMO,@2>7#I'&
MGZX44 ?%O['?_!2CQ_\ MV_'5?";?LR?&3X0^";+2KB^U_6_B7X>FTE;W($,
M-C91\+)([R>8[LY"QP.NPF173LQ_P1:_9*8<_LY?![TS_P (Q:\_^.5]/T4
M?E#_ ,&_G_!,[P[\'OB+\?/%OC+X'0>%/%'A_P",&M?\('JFL^&&L;JUT9D5
M(6T^21%/V4HSJK1'80S =37ZNITI:* "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH ***3'S9H 6BBB@ HHSFB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA]\2!X-UWXQ?"S1/%Y<1#0[_ ,66%MJ1<D@+]G>429)!XV\X- 'J]%1QR"1
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M=\>?%/PQ\++6RF\3^(]"\.0ZG=QZ?9R:G?Q6:W5Q*P2.&,R,-\CNRJJ+EF+
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M.H:[K5]J$EM\9-9-SJ6K7KSSR+'IFE R332$EB%4;F8]N:^P?^"?'[?.@_\
M!37PO\9M5\,3PS>"/"/CN\\$:)JFGSR0RZI;0Z;822W8E5L@M<7-QY<D>W]V
M(2,-DD ^G**_)G_@@#97&@?\%4O^"A^C2ZQXBUNVT'Q7HNG64^N:M<ZK>1V\
M=QK8CB:XN'>5PH. 68G'4DY-?K-0 44U@"V.^*_-N;]N[XA?\%0O^"CWCGX
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M5A7QMN:$8P5DDK1VT74P?B>,?#+Q+_V"[G_T4]?GM\'/^";?@C_@J1_P;U?
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MB^2P6>UMI5!VR6_VF(RM V5;SH0PRHK[*_:H_9"^.O\ P48^%R?"?XKM\,/
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M  C@:6X9CYCOYVZ4NX:1@[$^"_\ !:WX9?$/X*?\&OOA[P;\5O%7A[QMX_\
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M;2^!/B5X97PS;Z=8^,/"K:O8I%'I:13/&^J+$Q8:;AE$PQYV0QVX(!Z7XO\
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M\/?C#\&=?\&'Q7XTO_&MCK:>(=$U+3PD]O9P?9'6VO7N%FS;LP81&,@G+(0
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MVL7U_K%KXGU"6ST[5;&6V$+V;-%'))OD+;D(3:C1!B1@*P!^;/B;X6_MT?\
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MVD '[;T5%90-;6D<;RR3NBA6ED"AY"!C<=H R>O  ] *EH **:YY'6ORZ_9
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MH ]AHI$&%I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ^(MS)J-EXBM((DBCLKVUU"YM98 BDA?+:$IC+'Y>23DU] 4 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP[I?@ZPM+Z&]EFWWL4(O9R]LD<<5H95;>29$4!B >9_\%BOVK/B3)X,_8O\
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ME)_P3Z^!TK@R?"3X<R%.1O\ #MHV/_'*(_\ @GY\$(HU5/A/\/451@*N@6H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% ",N32D9HHH 0+BEHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*JZMJMMHT"S7=S!:PM)'"KS2!%:21UCC3)XW,[*H'4E@!SQ5JB@!$X'3%+11
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 5G^(]-NM5LHXK34;C2Y5N()FF@CC=W
MCCF1Y(2)%9=LJ*T3$#<%D)4JP5AH44 -CSCFG444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
0% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>fonr-20240630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9a45o7xRiXhun8uGbHdcOamGOaP9wZ932ekhsGR7benK7yooRj8JaCcGgSymQZkK -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:FONR="http://fonar.com/20240630" elementFormDefault="qualified" targetNamespace="http://fonar.com/20240630">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://fonar.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
          <link:definition>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ConsolidatedStatementsOfIncome" id="ConsolidatedStatementsOfIncome">
          <link:definition>00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" id="ConsolidatedStatementsOfStockholdersEquity">
          <link:definition>00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
          <link:definition>00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" id="DescriptionOfBusinessAndLiquidityAndCapitalResources">
          <link:definition>995612 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
          <link:definition>995613 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable">
          <link:definition>995614 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/Inventories" id="Inventories">
          <link:definition>995615 - Disclosure - INVENTORIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/PropertyAndEquipment" id="PropertyAndEquipment">
          <link:definition>995616 - Disclosure - PROPERTY AND EQUIPMENT</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases" id="OperatingFinancingLeases">
          <link:definition>995617 - Disclosure - OPERATING &amp; FINANCING LEASES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssets" id="OtherIntangibleAssets">
          <link:definition>995618 - Disclosure - OTHER INTANGIBLE ASSETS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CapitalStock" id="CapitalStock">
          <link:definition>995619 - Disclosure - CAPITAL STOCK</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests" id="ControllingAndNoncontrollingInterests">
          <link:definition>995620 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases" id="Long-termDebtNotesPayableAndCapitalLeases">
          <link:definition>995621 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/IncomeTaxes" id="IncomeTaxes">
          <link:definition>995622 - Disclosure - INCOME TAXES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherCurrentLiabilities" id="OtherCurrentLiabilities">
          <link:definition>995623 - Disclosure - OTHER CURRENT LIABILITIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
          <link:definition>995624 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SupplementalCashFlowInformation" id="SupplementalCashFlowInformation">
          <link:definition>995625 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
          <link:definition>995626 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformation" id="SegmentAndRelatedInformation">
          <link:definition>995627 - Disclosure - SEGMENT AND RELATED INFORMATION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SubsequentEvents" id="SubsequentEvents">
          <link:definition>995628 - Disclosure - SUBSEQUENT EVENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
          <link:definition>995629 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
          <link:definition>995630 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables">
          <link:definition>995631 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/InventoriesTables" id="InventoriesTables">
          <link:definition>995632 - Disclosure - INVENTORIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
          <link:definition>995633 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeasesTables" id="OperatingFinancingLeasesTables">
          <link:definition>995634 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" id="OtherIntangibleAssetsTables">
          <link:definition>995635 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" id="ControllingAndNoncontrollingInterestsTables">
          <link:definition>995636 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables" id="Long-termDebtNotesPayableAndCapitalLeasesTables">
          <link:definition>995637 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
          <link:definition>995638 - Disclosure - INCOME TAXES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" id="OtherCurrentLiabilitiesTables">
          <link:definition>995639 - Disclosure - OTHER CURRENT LIABILITIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" id="SegmentAndRelatedInformationTables">
          <link:definition>995640 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" id="DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative">
          <link:definition>995641 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" id="SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details">
          <link:definition>995642 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" id="SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1">
          <link:definition>995643 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" id="SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details">
          <link:definition>995644 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
          <link:definition>995645 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails">
          <link:definition>995646 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails">
          <link:definition>995647 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails">
          <link:definition>995648 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative">
          <link:definition>995649 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/Inventories-InventoriesDetails" id="Inventories-InventoriesDetails">
          <link:definition>995650 - Disclosure - INVENTORIES - Inventories (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" id="PropertyAndEquipment-PropertyAndEquipmentDetails">
          <link:definition>995651 - Disclosure - PROPERTY AND EQUIPMENT - Property and equipment (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" id="PropertyAndEquipmentDetailsNarrative">
          <link:definition>995652 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" id="OperatingFinancingLeases-LeasePaymentsDetails">
          <link:definition>995653 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease payments (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" id="OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails">
          <link:definition>995654 - Disclosure - OPERATING &amp; FINANCING LEASES - Weighted average remaining lease term (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails" id="OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails">
          <link:definition>995655 - Disclosure - OPERATING &amp; FINANCING LEASES - Components of lease expense (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails" id="OperatingFinancingLeases-RelatedToLeasesDetails">
          <link:definition>995656 - Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails" id="OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails">
          <link:definition>995657 - Disclosure - OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details" id="OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details">
          <link:definition>995658 - Disclosure - OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details" id="OtherIntangibleAssets-IntangleAssets-Details">
          <link:definition>995659 - Disclosure - OTHER INTANGIBLE ASSETS - Intangle assets - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" id="OtherIntangibleAssetsDetailsNarrative">
          <link:definition>995660 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CapitalStockDetailsNarrative" id="CapitalStockDetailsNarrative">
          <link:definition>995661 - Disclosure - CAPITAL STOCK (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" id="ControllingAndNoncontrollingInterests-HdmMembersEquityDetails">
          <link:definition>995662 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" id="ControllingAndNoncontrollingInterestsDetailsNarrative">
          <link:definition>995663 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Details" id="Long-termDebtNotesPayableAndCapitalLeases-Details">
          <link:definition>995664 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLongTermDebtOver5Years-Details" id="Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLongTermDebtOver5Years-Details">
          <link:definition>995665 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities of long term debt over 5 years - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative" id="Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative">
          <link:definition>995666 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" id="IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails">
          <link:definition>995667 - Disclosure - INCOME TAXES - Components of provision for income taxes (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" id="IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails">
          <link:definition>995668 - Disclosure - INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details" id="IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details">
          <link:definition>995669 - Disclosure - INCOME TAXES - Deferred tax assets and liabilities - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
          <link:definition>995670 - Disclosure - INCOME TAXES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" id="OtherCurrentLiabilities-OtherCurrentLiabilities-Details">
          <link:definition>995671 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
          <link:definition>995672 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" id="SupplementalCashFlowInformationDetailsNarrative">
          <link:definition>995673 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
          <link:definition>995674 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details" id="SegmentAndRelatedInformation-SummarizedSegments-Details">
          <link:definition>995675 - Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" id="SegmentAndRelatedInformation-ForeignProductSales-Details">
          <link:definition>995676 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" id="SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details">
          <link:definition>995677 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" id="SegmentAndRelatedInformationDetailsNarrative">
          <link:definition>995678 - Disclosure - SEGMENT AND RELATED INFORMATION (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
          <link:definition>995679 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="fonr-20240630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="fonr-20240630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="fonr-20240630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="fonr-20240630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="FONR_ClassANonVotingPreferredStockMember" name="ClassANonVotingPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CommonStockholdersMember" name="CommonStockholdersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassANonVotingPreferredStockholdersMember" name="ClassANonVotingPreferredStockholdersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassANonVotingPreferredMember" name="ClassANonVotingPreferredMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassCCommonStockMember" name="ClassCCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DiagnosticImagingFacilityMember" name="DiagnosticImagingFacilityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RelatedPartiesMember" name="RelatedPartiesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RelatedPartiesMedicalPracticesMember" name="RelatedPartiesMedicalPracticesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DiagnosticEquipmentMember" name="DiagnosticEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" name="ResearchDeveopmentAndDemonstrationEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CommercialInsuranceManagedCareMember" name="CommercialInsuranceManagedCareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicareMedicaidMember" name="MedicareMedicaidMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WorkersCompensationPersonalInjuryMember" name="WorkersCompensationPersonalInjuryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OtherRevenueSourceMember" name="OtherRevenueSourceMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesReceivableMember" name="ManagementAndOtherFeesReceivableMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" name="ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ResearchDevelopmentAndDemonstrationEquipmentMember" name="ResearchDevelopmentAndDemonstrationEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OperatingLeasePaymentsMember" name="OperatingLeasePaymentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinancingLeasePaymentsMember" name="FinancingLeasePaymentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PatentsAndCopyrightsMember" name="PatentsAndCopyrightsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_N2010StockBonusPlanMember" name="N2010StockBonusPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_HDMMember" name="HDMMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassAControllingInterestsMember" name="ClassAControllingInterestsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassBControllingInterestsMember" name="ClassBControllingInterestsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_HDMEquityMember" name="HDMEquityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NotePayable1Member" name="NotePayable1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NotePayable2Member" name="NotePayable2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MagneticResonanceManagementMember" name="MagneticResonanceManagementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BensonhurstMRILimitedPartnershipMember" name="BensonhurstMRILimitedPartnershipMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RadianHealthcareManagementLLCMember" name="RadianHealthcareManagementLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicalReceivable" name="MedicalReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" name="ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableNetLongTerm" name="AccountsReceivableNetLongTerm" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NoteReceivableRelatedParty" name="NoteReceivableRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CustomerDeposits" name="CustomerDeposits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsPayableRelatedPartyNoncurrent" name="AccountsPayableRelatedPartyNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" name="ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" name="RelatedPartyReceivableAllowancesForDoubtfulAccounts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" name="PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProductSalesNet" name="ProductSalesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ServiceAndRepairFeesNet" name="ServiceAndRepairFeesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ServiceAndRepairFeesRelatedPartiesNet" name="ServiceAndRepairFeesRelatedPartiesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesNet" name="ManagementAndOtherFeesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" name="ManagementAndOtherFeesRelatedMedicalPracticesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToProductSales" name="CostsRelatedToProductSales" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToServiceAndRepairFees" name="CostsRelatedToServiceAndRepairFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" name="CostsRelatedToServiceAndRepairFeesRelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToManagementAndOtherFees" name="CostsRelatedToManagementAndOtherFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" name="CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_InvestmentIncomeRelatedParty" name="InvestmentIncomeRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OtherIncomeRelatedParty" name="OtherIncomeRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProvisionForBadDebts" name="ProvisionForBadDebts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_GainOnSaleOfEquipmentRelatedParty" name="GainOnSaleOfEquipmentRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_GainlossOnDispositionOfFixedAssets" name="GainlossOnDispositionOfFixedAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AbandonedPatents" name="AbandonedPatents" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInNotesReceivable" name="IncreaseDecreaseInNotesReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInCustomerAdvance" name="IncreaseDecreaseInCustomerAdvance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DisclosureOperatingFinancingLeasesAbstract" name="DisclosureOperatingFinancingLeasesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DisclosureCapitalStockAbstract" name="DisclosureCapitalStockAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CapitalStockDisclosureTextblock" name="CapitalStockDisclosureTextblock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" name="DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock" name="LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicalReceivableAndManagementAndOtherFeesReceivablePolicyTextBlock" name="MedicalReceivableAndManagementAndOtherFeesReceivablePolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CustomerAdvancesPolicyTextBlock" name="CustomerAdvancesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RecentAccountingStandardsPolicyTextBlock" name="RecentAccountingStandardsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" name="EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" name="TotalFacilitiesOwnedOrManagedTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" name="ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" name="SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ScheduleOfExportProductSalesTableTextBlock" name="ScheduleOfExportProductSalesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ScheduleOfExportServiceRevenuesTableTextBlock" name="ScheduleOfExportServiceRevenuesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetPatientFeeRevenue" name="NetPatientFeeRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetIncomeLossAvailableToCommonStockholderBasic" name="NetIncomeLossAvailableToCommonStockholderBasic" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WeightedAverageSharesOutstandingBasic" name="WeightedAverageSharesOutstandingBasic" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" name="IncrementalCommonSharesAttributableToConversionOfCommonStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WeightedAverageNumberOfDilutedEarningsPerShare" name="WeightedAverageNumberOfDilutedEarningsPerShare" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" name="ManagementAgreementsWithCompanyTotalMedicalPractices" nillable="true" xbrli:periodType="instant" type="xbrli:pureItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" name="ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" nillable="true" xbrli:periodType="instant" type="xbrli:pureItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" name="ScannersWithManagementWithCompanyLocatedInNewYorkState" nillable="true" xbrli:periodType="instant" type="xbrli:pureItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ContractualFeesForServicesRenderedMinimum" name="ContractualFeesForServicesRenderedMinimum" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ContractualFeesForServicesRenderedMaximum" name="ContractualFeesForServicesRenderedMaximum" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementFeeReceivableForUnrelatedParties" name="ManagementFeeReceivableForUnrelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementFeeReceivableForRelatedParties" name="ManagementFeeReceivableForRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableServiceContractsNet" name="AccountsReceivableServiceContractsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" name="NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AllowanceForDoubtfulAccountsAdditions" name="AllowanceForDoubtfulAccountsAdditions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AllowanceForDoubtfulAccountsDeductions" name="AllowanceForDoubtfulAccountsDeductions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" name="TotalFacilitiesOwnedOrManagedAtBeginningOfYear" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagedFacilitiesAddedByInternalDevelopment" name="ManagedFacilitiesAddedByInternalDevelopment" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagedFacilitiesClosedDuringYear" name="ManagedFacilitiesClosedDuringYear" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" name="TotalFacilitiesOwnedOrManagedAtEndOfYear" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" name="PercentageOfConsolidatedNetRevenueFromManagementFees" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PresentValueDiscount" name="PresentValueDiscount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PresentValueDiscountFinancingLease" name="PresentValueDiscountFinancingLease" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinanceLeaseCostsAbstract" name="FinanceLeaseCostsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DepreciationOfLeasedEquipment" name="DepreciationOfLeasedEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinanceLeaseCost" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OperatingCashFlowsFromOperatingLeases" name="OperatingCashFlowsFromOperatingLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinancingCashFlowsFromFinancingLeases" name="FinancingCashFlowsFromFinancingLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" name="RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" name="RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AmountsCapitalized" name="AmountsCapitalized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SoftwareOrPatentsWrittenOff" name="SoftwareOrPatentsWrittenOff" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SharesRegistered" name="SharesRegistered" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CancellationOfTreasuryShares" name="CancellationOfTreasuryShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CancellationOfTreasuryStock" name="CancellationOfTreasuryStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OpeningMembersEquity" name="OpeningMembersEquity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ShareOfNetIncome" name="ShareOfNetIncome" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BuyoutOfNoncontrollingInterestsValue" name="BuyoutOfNoncontrollingInterestsValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_Distributions" name="Distributions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EndingMembersEquity" name="EndingMembersEquity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EquityMethodInvestmentOwnershipPercentages" name="EquityMethodInvestmentOwnershipPercentages" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProceedsFromContributionsFromCompany" name="ProceedsFromContributionsFromCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PurchaseOfStandupMriCenters" name="PurchaseOfStandupMriCenters" nillable="true" xbrli:periodType="instant" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PurchaseOfOtherMriCenters" name="PurchaseOfOtherMriCenters" nillable="true" xbrli:periodType="instant" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ConsiderationToOutsideInvestors" name="ConsiderationToOutsideInvestors" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalPurchasePrice" name="TotalPurchasePrice" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ConsiderationForNoncompetitionAndConsultingAgreements" name="ConsiderationForNoncompetitionAndConsultingAgreements" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EquityMethodInvestmentsOwnershipPercentage" name="EquityMethodInvestmentsOwnershipPercentage" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DirectPurchaseOfNoncontrollingInterests" name="DirectPurchaseOfNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MonthlyPaymentPeriod" name="MonthlyPaymentPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MaturityDate" name="MaturityDate" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BookValueOfBuilding" name="BookValueOfBuilding" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DeferredIncomeTaxExpensesBenefit" name="DeferredIncomeTaxExpensesBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates" name="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities" name="DeferredTaxAssetsInRightUseAssetsAndLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PercentageOfExciseTax" name="PercentageOfExciseTax" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CorporateAlternativeMinimumTaxPercentage" name="CorporateAlternativeMinimumTaxPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_LeaseAndRentalExpenses" name="LeaseAndRentalExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PropertyTaxAbatementFromSuffolkCountyIda" name="PropertyTaxAbatementFromSuffolkCountyIda" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PropertyTaxAbatement" name="PropertyTaxAbatement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IntersegmentNetRevenues" name="IntersegmentNetRevenues" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ForeignProductSales" name="ForeignProductSales" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ForeignServiceAndRepairFees" name="ForeignServiceAndRepairFees" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ExportSalesOfMedicalEquipmentPercentage" name="ExportSalesOfMedicalEquipmentPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" name="ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>fonr-20240630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20240630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:href="fonr-20240630.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20240630.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfIncome" xlink:href="fonr-20240630.xsd#ConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="fonr-20240630.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="fonr-20240630.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:href="fonr-20240630.xsd#DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20240630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20240630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories" xlink:href="fonr-20240630.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipment" xlink:href="fonr-20240630.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases" xlink:href="fonr-20240630.xsd#OperatingFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets" xlink:href="fonr-20240630.xsd#OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CapitalStock" xlink:href="fonr-20240630.xsd#CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests" xlink:href="fonr-20240630.xsd#ControllingAndNoncontrollingInterests" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases" xlink:href="fonr-20240630.xsd#Long-termDebtNotesPayableAndCapitalLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes" xlink:href="fonr-20240630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities" xlink:href="fonr-20240630.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingencies" xlink:href="fonr-20240630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformation" xlink:href="fonr-20240630.xsd#SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/RelatedPartyTransactions" xlink:href="fonr-20240630.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation" xlink:href="fonr-20240630.xsd#SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEvents" xlink:href="fonr-20240630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20240630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20240630.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20240630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/InventoriesTables" xlink:href="fonr-20240630.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipmentTables" xlink:href="fonr-20240630.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:href="fonr-20240630.xsd#OperatingFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:href="fonr-20240630.xsd#OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" xlink:href="fonr-20240630.xsd#ControllingAndNoncontrollingInterestsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:href="fonr-20240630.xsd#Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesTables" xlink:href="fonr-20240630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:href="fonr-20240630.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:href="fonr-20240630.xsd#SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:href="fonr-20240630.xsd#DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:href="fonr-20240630.xsd#SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:href="fonr-20240630.xsd#SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:href="fonr-20240630.xsd#SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20240630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:href="fonr-20240630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails" xlink:href="fonr-20240630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:href="fonr-20240630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20240630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories-InventoriesDetails" xlink:href="fonr-20240630.xsd#Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:href="fonr-20240630.xsd#PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="fonr-20240630.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20240630.xsd#OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:href="fonr-20240630.xsd#OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails" xlink:href="fonr-20240630.xsd#OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails" xlink:href="fonr-20240630.xsd#OperatingFinancingLeases-RelatedToLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails" xlink:href="fonr-20240630.xsd#OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details" xlink:href="fonr-20240630.xsd#OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details" xlink:href="fonr-20240630.xsd#OtherIntangibleAssets-IntangleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20240630.xsd#OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CapitalStockDetailsNarrative" xlink:href="fonr-20240630.xsd#CapitalStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:href="fonr-20240630.xsd#ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:href="fonr-20240630.xsd#ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Details" xlink:href="fonr-20240630.xsd#Long-termDebtNotesPayableAndCapitalLeases-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLongTermDebtOver5Years-Details" xlink:href="fonr-20240630.xsd#Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLongTermDebtOver5Years-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative" xlink:href="fonr-20240630.xsd#Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:href="fonr-20240630.xsd#IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:href="fonr-20240630.xsd#IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details" xlink:href="fonr-20240630.xsd#IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:href="fonr-20240630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20240630.xsd#OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20240630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20240630.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="fonr-20240630.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details" xlink:href="fonr-20240630.xsd#SegmentAndRelatedInformation-SummarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:href="fonr-20240630.xsd#SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:href="fonr-20240630.xsd#SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" xlink:href="fonr-20240630.xsd#SegmentAndRelatedInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:href="fonr-20240630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedFeesAndOtherRevenueReceivable" xlink:label="loc_us-gaapAccruedFeesAndOtherRevenueReceivable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccruedFeesAndOtherRevenueReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_FONRAccountsReceivableNetLongTerm" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_NoteReceivableRelatedParty" xlink:label="loc_FONRNoteReceivableRelatedParty" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_FONRNoteReceivableRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_FONRCustomerDeposits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_AccountsPayableRelatedPartyNoncurrent" xlink:label="loc_FONRAccountsPayableRelatedPartyNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_FONRAccountsPayableRelatedPartyNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRProductSalesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRServiceAndRepairFeesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRManagementAndOtherFeesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToProductSales" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_InvestmentIncomeRelatedParty" xlink:label="loc_FONRInvestmentIncomeRelatedParty" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_FONRInvestmentIncomeRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_OtherIncomeRelatedParty" xlink:label="loc_FONROtherIncomeRelatedParty" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_FONROtherIncomeRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ProvisionForBadDebts" xlink:label="loc_FONRProvisionForBadDebts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRProvisionForBadDebts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_GainOnSaleOfEquipmentRelatedParty" xlink:label="loc_FONRGainOnSaleOfEquipmentRelatedParty" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRGainOnSaleOfEquipmentRelatedParty" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_GainlossOnDispositionOfFixedAssets" xlink:label="loc_FONRGainlossOnDispositionOfFixedAssets" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRGainlossOnDispositionOfFixedAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_AbandonedPatents" xlink:label="loc_FONRAbandonedPatents" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRAbandonedPatents" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_IncreaseDecreaseInNotesReceivable" xlink:label="loc_FONRIncreaseDecreaseInNotesReceivable" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInNotesReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="loc_FONRIncreaseDecreaseInCustomerAdvance" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInCustomerAdvance" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInTradingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInTradingLiabilities" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInTradingLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" />
      <link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:label="loc_us-gaapPaymentsForProceedsFromShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsForProceedsFromShortTermInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfEquity" xlink:label="loc_us-gaapPaymentsForRepurchaseOfEquity" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsForRepurchaseOfEquity" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:title="995612 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="995613 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="995614 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories" xlink:title="995615 - Disclosure - INVENTORIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipment" xlink:title="995616 - Disclosure - PROPERTY AND EQUIPMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases" xlink:title="995617 - Disclosure - OPERATING &amp; FINANCING LEASES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets" xlink:title="995618 - Disclosure - OTHER INTANGIBLE ASSETS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CapitalStock" xlink:title="995619 - Disclosure - CAPITAL STOCK" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterests" xlink:title="995620 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases" xlink:title="995621 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes" xlink:title="995622 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities" xlink:title="995623 - Disclosure - OTHER CURRENT LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingencies" xlink:title="995624 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformation" xlink:title="995625 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactions" xlink:title="995626 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation" xlink:title="995627 - Disclosure - SEGMENT AND RELATED INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEvents" xlink:title="995628 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="995629 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="995630 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="995631 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/InventoriesTables" xlink:title="995632 - Disclosure - INVENTORIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipmentTables" xlink:title="995633 - Disclosure - PROPERTY AND EQUIPMENT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:title="995634 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:title="995635 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" xlink:title="995636 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:title="995637 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesTables" xlink:title="995638 - Disclosure - INCOME TAXES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:title="995639 - Disclosure - OTHER CURRENT LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:title="995640 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:title="995641 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:title="995642 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:title="995643 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:title="995644 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="995645 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:title="995646 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails" xlink:title="995647 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:title="995648 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="995649 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories-InventoriesDetails" xlink:title="995650 - Disclosure - INVENTORIES - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherInventorySupplies" xlink:label="loc_us-gaapOtherInventorySupplies" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapOtherInventorySupplies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:title="995651 - Disclosure - PROPERTY AND EQUIPMENT - Property and equipment (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="995652 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="995653 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease payments (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:title="995654 - Disclosure - OPERATING &amp; FINANCING LEASES - Weighted average remaining lease term (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails" xlink:title="995655 - Disclosure - OPERATING &amp; FINANCING LEASES - Components of lease expense (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails" xlink:title="995656 - Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails" xlink:title="995657 - Disclosure - OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details" xlink:title="995658 - Disclosure - OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details" xlink:title="995659 - Disclosure - OTHER INTANGIBLE ASSETS - Intangle assets - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:title="995660 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CapitalStockDetailsNarrative" xlink:title="995661 - Disclosure - CAPITAL STOCK (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:title="995662 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:title="995663 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Details" xlink:title="995664 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLongTermDebtOver5Years-Details" xlink:title="995665 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities of long term debt over 5 years - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative" xlink:title="995666 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:title="995667 - Disclosure - INCOME TAXES - Components of provision for income taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DeferredIncomeTaxExpensesBenefit" xlink:label="loc_FONRDeferredIncomeTaxExpensesBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRDeferredIncomeTaxExpensesBenefit" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRDeferredIncomeTaxExpensesBenefit" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_FONRDeferredIncomeTaxExpensesBenefit" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:title="995668 - Disclosure - INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details" xlink:title="995669 - Disclosure - INCOME TAXES - Deferred tax assets and liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="loc_us-gaapDeferredTaxAssetsInProcessResearchAndDevelopment" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities" xlink:label="loc_FONRDeferredTaxAssetsInRightUseAssetsAndLiabilities" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_FONRDeferredTaxAssetsInRightUseAssetsAndLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaapDeferredTaxAssetsInventory" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsInventory" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxLiabilities" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:title="995670 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="995671 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapTaxesPayableCurrentAndNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapTaxesPayableCurrentAndNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="loc_us-gaapOtherSundryLiabilitiesCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapOtherSundryLiabilitiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="995672 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="995673 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="995674 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details" xlink:title="995675 - Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:title="995676 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:title="995677 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" xlink:title="995678 - Disclosure - SEGMENT AND RELATED INFORMATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:title="995679 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>fonr-20240630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20240630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:href="fonr-20240630.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20240630.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfIncome" xlink:href="fonr-20240630.xsd#ConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="fonr-20240630.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="fonr-20240630.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:href="fonr-20240630.xsd#DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20240630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20240630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories" xlink:href="fonr-20240630.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipment" xlink:href="fonr-20240630.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases" xlink:href="fonr-20240630.xsd#OperatingFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets" xlink:href="fonr-20240630.xsd#OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CapitalStock" xlink:href="fonr-20240630.xsd#CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests" xlink:href="fonr-20240630.xsd#ControllingAndNoncontrollingInterests" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases" xlink:href="fonr-20240630.xsd#Long-termDebtNotesPayableAndCapitalLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes" xlink:href="fonr-20240630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities" xlink:href="fonr-20240630.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingencies" xlink:href="fonr-20240630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformation" xlink:href="fonr-20240630.xsd#SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/RelatedPartyTransactions" xlink:href="fonr-20240630.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation" xlink:href="fonr-20240630.xsd#SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEvents" xlink:href="fonr-20240630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20240630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20240630.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20240630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/InventoriesTables" xlink:href="fonr-20240630.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipmentTables" xlink:href="fonr-20240630.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:href="fonr-20240630.xsd#OperatingFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:href="fonr-20240630.xsd#OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" xlink:href="fonr-20240630.xsd#ControllingAndNoncontrollingInterestsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:href="fonr-20240630.xsd#Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesTables" xlink:href="fonr-20240630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:href="fonr-20240630.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:href="fonr-20240630.xsd#SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:href="fonr-20240630.xsd#DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:href="fonr-20240630.xsd#SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:href="fonr-20240630.xsd#SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:href="fonr-20240630.xsd#SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20240630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:href="fonr-20240630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails" xlink:href="fonr-20240630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:href="fonr-20240630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20240630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories-InventoriesDetails" xlink:href="fonr-20240630.xsd#Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:href="fonr-20240630.xsd#PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="fonr-20240630.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20240630.xsd#OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:href="fonr-20240630.xsd#OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails" xlink:href="fonr-20240630.xsd#OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails" xlink:href="fonr-20240630.xsd#OperatingFinancingLeases-RelatedToLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails" xlink:href="fonr-20240630.xsd#OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details" xlink:href="fonr-20240630.xsd#OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details" xlink:href="fonr-20240630.xsd#OtherIntangibleAssets-IntangleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20240630.xsd#OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CapitalStockDetailsNarrative" xlink:href="fonr-20240630.xsd#CapitalStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:href="fonr-20240630.xsd#ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:href="fonr-20240630.xsd#ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Details" xlink:href="fonr-20240630.xsd#Long-termDebtNotesPayableAndCapitalLeases-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLongTermDebtOver5Years-Details" xlink:href="fonr-20240630.xsd#Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLongTermDebtOver5Years-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative" xlink:href="fonr-20240630.xsd#Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:href="fonr-20240630.xsd#IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:href="fonr-20240630.xsd#IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details" xlink:href="fonr-20240630.xsd#IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:href="fonr-20240630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20240630.xsd#OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20240630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20240630.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="fonr-20240630.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details" xlink:href="fonr-20240630.xsd#SegmentAndRelatedInformation-SummarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:href="fonr-20240630.xsd#SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:href="fonr-20240630.xsd#SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" xlink:href="fonr-20240630.xsd#SegmentAndRelatedInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:href="fonr-20240630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosureWithAdditionalMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpTable" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsToCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListsByExecutiveCategory" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpExecutiveCategoriesOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTypeOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TradingArrangmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ForgoneRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#OutstandingRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardsCloseToMnpiDisc" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangemenstByInd" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/Defaults" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#Defaults" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_70" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_70" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_70" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_70" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_70" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_70" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_70" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_70" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_70" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_70" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_70" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_70" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_70" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_70" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_70" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_70" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_70" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_70" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_70" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_70" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_70" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_70" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_70" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_70" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_70" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_70" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_70" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_70" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_70" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_70" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_70" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_70" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_70" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_70" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_70" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_70" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_70" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_70" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_70" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_70" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_70" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_70" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_70" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_70" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_70" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_deiDocumentFinStmtErrorCorrectionFlag_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFinStmtErrorCorrectionFlag_70" xlink:type="arc" order="58" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorName_70" xlink:type="arc" order="59" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorFirmId_70" xlink:type="arc" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorLocation_70" xlink:type="arc" order="61" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsCurrentAbstract_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapShortTermInvestments_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAccountsReceivableNetCurrent_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRMedicalReceivable_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedFeesAndOtherRevenueReceivable" xlink:label="loc_us-gaapAccruedFeesAndOtherRevenueReceivable_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAccruedFeesAndOtherRevenueReceivable_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapInventoryNet_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAssetsCurrent_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRAccountsReceivableNetLongTerm_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_NoteReceivableRelatedParty" xlink:label="loc_FONRNoteReceivableRelatedParty_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRNoteReceivableRelatedParty_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome_130" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_130" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_130" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset_130" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapGoodwill_130" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_130" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapOtherAssets_130" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAssets_130" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapLongTermDebtCurrent_130" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapAccountsPayableCurrent_130" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_130" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent_130" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent_130" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapDeferredRevenueCurrent_130" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_FONRCustomerDeposits_130" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapLiabilitiesCurrent_130" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapDeferredRevenueNoncurrent_130" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_130" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_AccountsPayableRelatedPartyNoncurrent" xlink:label="loc_FONRAccountsPayableRelatedPartyNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_FONRAccountsPayableRelatedPartyNoncurrent_130" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent_130" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent_130" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLongTermDebtNoncurrent_130" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapOtherLiabilities_130" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLiabilitiesNoncurrent_130" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLiabilities_130" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapCommitmentsAndContingencies_130" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapPreferredStockValue_130" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapCommonStockValue_130" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapAdditionalPaidInCapital_130" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_130" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapTreasuryStockValue_130" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapStockholdersEquity_130" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapMinorityInterest_130" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_130" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_130" xlink:type="arc" order="49" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:label="loc_FONRManagementAndOtherReceivableAllowancesForDoubtfulAccounts_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRManagementAndOtherReceivableAllowancesForDoubtfulAccounts_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:label="loc_FONRRelatedPartyReceivableAllowancesForDoubtfulAccounts_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRRelatedPartyReceivableAllowancesForDoubtfulAccounts_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaapTreasuryStockCommonShares_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockCommonShares_130" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CommonStockholdersMember" xlink:label="loc_FONRCommonStockholdersMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRCommonStockholdersMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ClassANonVotingPreferredStockholdersMember" xlink:label="loc_FONRClassANonVotingPreferredStockholdersMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockholdersMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRProductSalesNet_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRServiceAndRepairFeesNet_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRManagementAndOtherFeesNet_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaapCostsAndExpensesAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesAbstract_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToProductSales_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees_90" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_90" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_90" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense_90" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_us-gaapCostsAndExpenses_90" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_90" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract_90" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpenseNonoperating_90" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_InvestmentIncomeRelatedParty" xlink:label="loc_FONRInvestmentIncomeRelatedParty_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRInvestmentIncomeRelatedParty_90" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentIncomeNet_90" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_OtherIncomeRelatedParty" xlink:label="loc_FONROtherIncomeRelatedParty_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROtherIncomeRelatedParty_90" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense_90" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_90" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_90" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_90" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_90" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_90" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_90" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_90" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_90" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_90" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_90" xlink:type="arc" order="34" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ClassANonVotingPreferredMember" xlink:label="loc_FONRClassANonVotingPreferredMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FONRClassANonVotingPreferredMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ClassCCommonStockMember" xlink:label="loc_FONRClassCCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FONRClassCCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaapTreasuryStockCommonMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapTreasuryStockCommonMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationForfeited_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationForfeited_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_90" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:title="995612 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="995613 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="995614 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories" xlink:title="995615 - Disclosure - INVENTORIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipment" xlink:title="995616 - Disclosure - PROPERTY AND EQUIPMENT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases" xlink:title="995617 - Disclosure - OPERATING &amp; FINANCING LEASES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets" xlink:title="995618 - Disclosure - OTHER INTANGIBLE ASSETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CapitalStock" xlink:title="995619 - Disclosure - CAPITAL STOCK" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterests" xlink:title="995620 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases" xlink:title="995621 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes" xlink:title="995622 - Disclosure - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities" xlink:title="995623 - Disclosure - OTHER CURRENT LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingencies" xlink:title="995624 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformation" xlink:title="995625 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactions" xlink:title="995626 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation" xlink:title="995627 - Disclosure - SEGMENT AND RELATED INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEvents" xlink:title="995628 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="995629 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="995630 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="995631 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/InventoriesTables" xlink:title="995632 - Disclosure - INVENTORIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipmentTables" xlink:title="995633 - Disclosure - PROPERTY AND EQUIPMENT (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:title="995634 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:title="995635 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" xlink:title="995636 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:title="995637 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesTables" xlink:title="995638 - Disclosure - INCOME TAXES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:title="995639 - Disclosure - OTHER CURRENT LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:title="995640 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:title="995641 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherInvesteesMember" xlink:label="loc_us-gaapOtherInvesteesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_us-gaapOtherInvesteesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentOwnedPercentOfNetAssets" xlink:label="loc_us-gaapInvestmentOwnedPercentOfNetAssets_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedPercentOfNetAssets_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:label="loc_us-gaapProceedsFromPaymentsToMinorityShareholders_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromPaymentsToMinorityShareholders_60" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:title="995642 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_WeightedAverageMember" xlink:label="loc_srtWeightedAverageMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtWeightedAverageMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="loc_FONRDiagnosticEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRDiagnosticEquipmentMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" xlink:label="loc_FONRResearchDeveopmentAndDemonstrationEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRResearchDeveopmentAndDemonstrationEquipmentMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_120" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:title="995643 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="loc_FONRCommercialInsuranceManagedCareMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRCommercialInsuranceManagedCareMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_MedicareMedicaidMember" xlink:label="loc_FONRMedicareMedicaidMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRMedicareMedicaidMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="loc_FONRWorkersCompensationPersonalInjuryMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRWorkersCompensationPersonalInjuryMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_OtherRevenueSourceMember" xlink:label="loc_FONROtherRevenueSourceMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONROtherRevenueSourceMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_NetPatientFeeRevenue" xlink:label="loc_FONRNetPatientFeeRevenue_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_FONRNetPatientFeeRevenue_110" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:title="995644 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_NetIncomeLossAvailableToCommonStockholderBasic" xlink:label="loc_FONRNetIncomeLossAvailableToCommonStockholderBasic_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetIncomeLossAvailableToCommonStockholderBasic_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_WeightedAverageSharesOutstandingBasic" xlink:label="loc_FONRWeightedAverageSharesOutstandingBasic_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageSharesOutstandingBasic_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:label="loc_us-gaapWeightedAverageBasicSharesOutstandingProForma_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageBasicSharesOutstandingProForma_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" xlink:label="loc_FONRIncrementalCommonSharesAttributableToConversionOfCommonStock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRIncrementalCommonSharesAttributableToConversionOfCommonStock_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:label="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_70" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="995645 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntellectualPropertyMember" xlink:label="loc_us-gaapIntellectualPropertyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapIntellectualPropertyMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapTransactionTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DiagnosticImagingFacilityMember" xlink:label="loc_FONRDiagnosticImagingFacilityMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_FONRDiagnosticImagingFacilityMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_RelatedPartiesMember" xlink:label="loc_FONRRelatedPartiesMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_FONRRelatedPartiesMember_80" xlink:type="arc" order="83" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_RelatedPartiesMedicalPracticesMember" xlink:label="loc_FONRRelatedPartiesMedicalPracticesMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_FONRRelatedPartiesMedicalPracticesMember_100" xlink:type="arc" order="103" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfPropertyRepairsAndMaintenance" xlink:label="loc_us-gaapCostOfPropertyRepairsAndMaintenance_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCostOfPropertyRepairsAndMaintenance_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" xlink:label="loc_FONRManagementAgreementsWithCompanyTotalMedicalPractices_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRManagementAgreementsWithCompanyTotalMedicalPractices_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:label="loc_FONRScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:label="loc_FONRScannersWithManagementWithCompanyLocatedInNewYorkState_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRScannersWithManagementWithCompanyLocatedInNewYorkState_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ContractualFeesForServicesRenderedMinimum" xlink:label="loc_FONRContractualFeesForServicesRenderedMinimum_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRContractualFeesForServicesRenderedMinimum_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ContractualFeesForServicesRenderedMaximum" xlink:label="loc_FONRContractualFeesForServicesRenderedMaximum_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRContractualFeesForServicesRenderedMaximum_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ProvisionForBadDebts" xlink:label="loc_FONRProvisionForBadDebts_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRProvisionForBadDebts_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementFeeReceivableForUnrelatedParties" xlink:label="loc_FONRManagementFeeReceivableForUnrelatedParties_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRManagementFeeReceivableForUnrelatedParties_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementFeeReceivableForRelatedParties" xlink:label="loc_FONRManagementFeeReceivableForRelatedParties_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRManagementFeeReceivableForRelatedParties_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_AccountsReceivableServiceContractsNet" xlink:label="loc_FONRAccountsReceivableServiceContractsNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRAccountsReceivableServiceContractsNet_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAdvertisingExpense_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationPenaltiesExpense" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesExpense_130" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:label="loc_FONRNumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRNumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_130" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCash_130" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCashFDICInsuredAmount_130" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_130" xlink:type="arc" order="16" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:title="995646 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails" xlink:title="995647 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAccountsReceivableMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementAndOtherFeesReceivableMember" xlink:label="loc_FONRManagementAndOtherFeesReceivableMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_FONRManagementAndOtherFeesReceivableMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:label="loc_FONRManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_FONRManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesReceivableMember" xlink:label="loc_us-gaapNotesReceivableMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapNotesReceivableMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_210" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_AllowanceForDoubtfulAccountsAdditions" xlink:label="loc_FONRAllowanceForDoubtfulAccountsAdditions_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAllowanceForDoubtfulAccountsAdditions_210" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_AllowanceForDoubtfulAccountsDeductions" xlink:label="loc_FONRAllowanceForDoubtfulAccountsDeductions_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAllowanceForDoubtfulAccountsDeductions_210" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:title="995648 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="995649 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories-InventoriesDetails" xlink:title="995650 - Disclosure - INVENTORIES - Inventories (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:title="995651 - Disclosure - PROPERTY AND EQUIPMENT - Property and equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="loc_FONRDiagnosticEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRDiagnosticEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ResearchDevelopmentAndDemonstrationEquipmentMember" xlink:label="loc_FONRResearchDevelopmentAndDemonstrationEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRResearchDevelopmentAndDemonstrationEquipmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_150" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="995652 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapPropertyPlantAndEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapPropertyPlantAndEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapOtherDepreciationAndAmortization_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="995653 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease payments (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_OperatingLeasePaymentsMember" xlink:label="loc_FONROperatingLeasePaymentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONROperatingLeasePaymentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_FinancingLeasePaymentsMember" xlink:label="loc_FONRFinancingLeasePaymentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONRFinancingLeasePaymentsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PresentValueDiscount" xlink:label="loc_FONRPresentValueDiscount_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscount_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="loc_FONRPresentValueDiscountFinancingLease_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscountFinancingLease_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaapFinanceLeaseLiability_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiability_30" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:title="995654 - Disclosure - OPERATING &amp; FINANCING LEASES - Weighted average remaining lease term (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails" xlink:title="995655 - Disclosure - OPERATING &amp; FINANCING LEASES - Components of lease expense (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails" xlink:title="995656 - Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails" xlink:title="995657 - Disclosure - OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_110" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details" xlink:title="995658 - Disclosure - OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_40" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details" xlink:title="995659 - Disclosure - OTHER INTANGIBLE ASSETS - Intangle assets - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:title="995660 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_60" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CapitalStockDetailsNarrative" xlink:title="995661 - Disclosure - CAPITAL STOCK (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredClassAMember" xlink:label="loc_us-gaapPreferredClassAMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredClassAMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_N2010StockBonusPlanMember" xlink:label="loc_FONRN2010StockBonusPlanMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_FONRN2010StockBonusPlanMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtBoardOfDirectorsChairmanMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableNature" xlink:label="loc_us-gaapDividendsPayableNature_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPayableNature_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:label="loc_us-gaapStockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaapCommonStockVotingRights_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockVotingRights_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_SharesRegistered" xlink:label="loc_FONRSharesRegistered_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRSharesRegistered_150" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_150" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_150" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfEquity" xlink:label="loc_us-gaapPaymentsForRepurchaseOfEquity_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForRepurchaseOfEquity_150" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_150" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue_150" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CancellationOfTreasuryShares" xlink:label="loc_FONRCancellationOfTreasuryShares_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCancellationOfTreasuryShares_150" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CancellationOfTreasuryStock" xlink:label="loc_FONRCancellationOfTreasuryStock_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCancellationOfTreasuryStock_150" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:title="995662 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestLineItems" xlink:label="loc_us-gaapMinorityInterestLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestTable" xlink:label="loc_us-gaapMinorityInterestTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_us-gaapMinorityInterestTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_HDMEquityMember" xlink:label="loc_FONRHDMEquityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRHDMEquityMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_OpeningMembersEquity" xlink:label="loc_FONROpeningMembersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONROpeningMembersEquity_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ShareOfNetIncome" xlink:label="loc_FONRShareOfNetIncome_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRShareOfNetIncome_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_BuyoutOfNoncontrollingInterestsValue" xlink:label="loc_FONRBuyoutOfNoncontrollingInterestsValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRBuyoutOfNoncontrollingInterestsValue_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_Distributions" xlink:label="loc_FONRDistributions_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRDistributions_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_EndingMembersEquity" xlink:label="loc_FONREndingMembersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONREndingMembersEquity_50" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:title="995663 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_HDMMember" xlink:label="loc_FONRHDMMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_FONRHDMMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_srtOwnershipAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ClassAControllingInterestsMember" xlink:label="loc_FONRClassAControllingInterestsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_FONRClassAControllingInterestsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherOwnershipInterestsByNameAxis" xlink:label="loc_us-gaapOtherOwnershipInterestsByNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapOtherOwnershipInterestsByNameAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherOwnershipInterestsNameDomain" xlink:label="loc_us-gaapOtherOwnershipInterestsNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapOtherOwnershipInterestsByNameAxis" xlink:to="loc_us-gaapOtherOwnershipInterestsNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherOwnershipInterestsNameDomain" xlink:label="loc_us-gaapOtherOwnershipInterestsNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOtherOwnershipInterestsByNameAxis" xlink:to="loc_us-gaapOtherOwnershipInterestsNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ClassBControllingInterestsMember" xlink:label="loc_FONRClassBControllingInterestsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherOwnershipInterestsNameDomain" xlink:to="loc_FONRClassBControllingInterestsMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ClassAControllingInterestsMember" xlink:label="loc_FONRClassAControllingInterestsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherOwnershipInterestsNameDomain" xlink:to="loc_FONRClassAControllingInterestsMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_EquityMethodInvestmentOwnershipPercentages" xlink:label="loc_FONREquityMethodInvestmentOwnershipPercentages_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONREquityMethodInvestmentOwnershipPercentages_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ProceedsFromContributionsFromCompany" xlink:label="loc_FONRProceedsFromContributionsFromCompany_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRProceedsFromContributionsFromCompany_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="loc_us-gaapProceedsFromContributionsFromAffiliates_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapProceedsFromContributionsFromAffiliates_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PurchaseOfStandupMriCenters" xlink:label="loc_FONRPurchaseOfStandupMriCenters_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRPurchaseOfStandupMriCenters_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PurchaseOfOtherMriCenters" xlink:label="loc_FONRPurchaseOfOtherMriCenters_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRPurchaseOfOtherMriCenters_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ConsiderationToOutsideInvestors" xlink:label="loc_FONRConsiderationToOutsideInvestors_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRConsiderationToOutsideInvestors_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_TotalPurchasePrice" xlink:label="loc_FONRTotalPurchasePrice_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRTotalPurchasePrice_110" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ConsiderationForNoncompetitionAndConsultingAgreements" xlink:label="loc_FONRConsiderationForNoncompetitionAndConsultingAgreements_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRConsiderationForNoncompetitionAndConsultingAgreements_110" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_EquityMethodInvestmentsOwnershipPercentage" xlink:label="loc_FONREquityMethodInvestmentsOwnershipPercentage_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONREquityMethodInvestmentsOwnershipPercentage_110" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="loc_FONRDirectPurchaseOfNoncontrollingInterests_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRDirectPurchaseOfNoncontrollingInterests_110" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Details" xlink:title="995664 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_NotePayable1Member" xlink:label="loc_FONRNotePayable1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_FONRNotePayable1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_NotePayable2Member" xlink:label="loc_FONRNotePayable2Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_FONRNotePayable2Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebt_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligations_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligations_70" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLongTermDebtOver5Years-Details" xlink:title="995665 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities of long term debt over 5 years - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative" xlink:title="995666 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_NotePayable1Member" xlink:label="loc_FONRNotePayable1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_FONRNotePayable1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_NotePayable2Member" xlink:label="loc_FONRNotePayable2Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_FONRNotePayable2Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_MonthlyPaymentPeriod" xlink:label="loc_FONRMonthlyPaymentPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_FONRMonthlyPaymentPeriod_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_MaturityDate" xlink:label="loc_FONRMaturityDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_FONRMaturityDate_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_BookValueOfBuilding" xlink:label="loc_FONRBookValueOfBuilding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_FONRBookValueOfBuilding_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromLinesOfCredit_40" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:title="995667 - Disclosure - INCOME TAXES - Components of provision for income taxes (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:title="995668 - Disclosure - INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details" xlink:title="995669 - Disclosure - INCOME TAXES - Deferred tax assets and liabilities - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:title="995670 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="995671 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="995672 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="995673 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="995674 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_MagneticResonanceManagementMember" xlink:label="loc_FONRMagneticResonanceManagementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_FONRMagneticResonanceManagementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_BensonhurstMRILimitedPartnershipMember" xlink:label="loc_FONRBensonhurstMRILimitedPartnershipMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRBensonhurstMRILimitedPartnershipMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_RadianHealthcareManagementLLCMember" xlink:label="loc_FONRRadianHealthcareManagementLLCMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRRadianHealthcareManagementLLCMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFixedInterestRate" xlink:label="loc_us-gaapDerivativeFixedInterestRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDerivativeFixedInterestRate_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredGainOnSaleOfProperty" xlink:label="loc_us-gaapDeferredGainOnSaleOfProperty_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDeferredGainOnSaleOfProperty_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:label="loc_us-gaapRelatedPartyTransactionDescriptionOfTransaction_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionDescriptionOfTransaction_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="loc_us-gaapRelatedPartyTransactionAmountsOfTransaction_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionAmountsOfTransaction_50" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details" xlink:title="995675 - Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:label="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:label="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareMember" xlink:label="loc_us-gaapHealthCareMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapHealthCareMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareOtherMember" xlink:label="loc_us-gaapHealthCareOtherMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapHealthCareOtherMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapRevenues_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_IntersegmentNetRevenues" xlink:label="loc_FONRIntersegmentNetRevenues_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_FONRIntersegmentNetRevenues_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNet" xlink:label="loc_us-gaapAssetsNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapAssetsNet_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets_130" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:title="995676 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CA" xlink:label="loc_countryCA_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_DE" xlink:label="loc_countryDE_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDE_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_AE" xlink:label="loc_countryAE_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAE_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ForeignProductSales" xlink:label="loc_FONRForeignProductSales_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_FONRForeignProductSales_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:title="995677 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_PR" xlink:label="loc_countryPR_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryPR_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CH" xlink:label="loc_countryCH_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCH_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_DE" xlink:label="loc_countryDE_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDE_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GB" xlink:label="loc_countryGB_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryGB_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_AE" xlink:label="loc_countryAE_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAE_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_DO" xlink:label="loc_countryDO_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDO_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CA" xlink:label="loc_countryCA_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GR" xlink:label="loc_countryGR_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryGR_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_AU" xlink:label="loc_countryAU_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAU_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ForeignServiceAndRepairFees" xlink:label="loc_FONRForeignServiceAndRepairFees_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_FONRForeignServiceAndRepairFees_210" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" xlink:title="995678 - Disclosure - SEGMENT AND RELATED INFORMATION (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:title="995679 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="loc_srtStockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_srtStockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_20" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>fonr-20240630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US">Common Class B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassCMember" xlink:label="us-gaap_CommonClassCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassCMember" xlink:to="us-gaap_CommonClassCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassCMember_lbl" xml:lang="en-US">Common Class C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="FONR_ClassANonVotingPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredStockMember" xlink:to="FONR_ClassANonVotingPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassANonVotingPreferredStockMember_lbl" xml:lang="en-US">Class A Non Voting Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CommonStockholdersMember" xlink:label="FONR_CommonStockholdersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommonStockholdersMember" xlink:to="FONR_CommonStockholdersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CommonStockholdersMember_lbl" xml:lang="en-US">Common Stockholders [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ClassANonVotingPreferredStockholdersMember" xlink:label="FONR_ClassANonVotingPreferredStockholdersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredStockholdersMember" xlink:to="FONR_ClassANonVotingPreferredStockholdersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassANonVotingPreferredStockholdersMember_lbl" xml:lang="en-US">Class A Non Voting Preferred Stockholders [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ClassANonVotingPreferredMember" xlink:label="FONR_ClassANonVotingPreferredMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredMember" xlink:to="FONR_ClassANonVotingPreferredMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassANonVotingPreferredMember_lbl" xml:lang="en-US">Class A Non Voting Preferred [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ClassCCommonStockMember" xlink:label="FONR_ClassCCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassCCommonStockMember" xlink:to="FONR_ClassCCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassCCommonStockMember_lbl" xml:lang="en-US">Class C Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="us-gaap_TreasuryStockCommonMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonMember" xlink:to="us-gaap_TreasuryStockCommonMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockCommonMember_lbl" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US">Investment, Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherInvesteesMember" xlink:label="us-gaap_OtherInvesteesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInvesteesMember" xlink:to="us-gaap_OtherInvesteesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInvesteesMember_lbl" xml:lang="en-US">Nonconsolidated Investees, Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntellectualPropertyMember" xlink:label="us-gaap_IntellectualPropertyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntellectualPropertyMember" xlink:to="us-gaap_IntellectualPropertyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntellectualPropertyMember_lbl" xml:lang="en-US">Intellectual Property [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="us-gaap_NoncompeteAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncompeteAgreementsMember" xlink:to="us-gaap_NoncompeteAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncompeteAgreementsMember_lbl" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US">Customer Relationships [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransactionTypeAxis" xlink:label="us-gaap_TransactionTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransactionTypeAxis" xlink:to="us-gaap_TransactionTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransactionTypeAxis_lbl" xml:lang="en-US">Transaction Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DiagnosticImagingFacilityMember" xlink:label="FONR_DiagnosticImagingFacilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DiagnosticImagingFacilityMember" xlink:to="FONR_DiagnosticImagingFacilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DiagnosticImagingFacilityMember_lbl" xml:lang="en-US">Diagnostic Imaging Facility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_RelatedPartiesMember" xlink:label="FONR_RelatedPartiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RelatedPartiesMember" xlink:to="FONR_RelatedPartiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RelatedPartiesMember_lbl" xml:lang="en-US">Related Parties [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_RelatedPartiesMedicalPracticesMember" xlink:label="FONR_RelatedPartiesMedicalPracticesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RelatedPartiesMedicalPracticesMember" xlink:to="FONR_RelatedPartiesMedicalPracticesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RelatedPartiesMedicalPracticesMember_lbl" xml:lang="en-US">Related Parties Medical Practices [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="FONR_DiagnosticEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DiagnosticEquipmentMember" xlink:to="FONR_DiagnosticEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DiagnosticEquipmentMember_lbl" xml:lang="en-US">Diagnostic Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" xlink:label="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" xlink:to="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember_lbl" xml:lang="en-US">Research Deveopment And Demonstration Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_WeightedAverageMember" xlink:label="srt_WeightedAverageMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_WeightedAverageMember" xlink:to="srt_WeightedAverageMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_WeightedAverageMember_lbl" xml:lang="en-US">Weighted Average [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingMember" xlink:to="us-gaap_BuildingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingMember_lbl" xml:lang="en-US">Building [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xml:lang="en-US">Health Care Organization, Revenue Sources [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="FONR_CommercialInsuranceManagedCareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommercialInsuranceManagedCareMember" xlink:to="FONR_CommercialInsuranceManagedCareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CommercialInsuranceManagedCareMember_lbl" xml:lang="en-US">Commercial Insurance/ Managed Care [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_MedicareMedicaidMember" xlink:label="FONR_MedicareMedicaidMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicareMedicaidMember" xlink:to="FONR_MedicareMedicaidMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicareMedicaidMember_lbl" xml:lang="en-US">Medicare/Medicaid [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="FONR_WorkersCompensationPersonalInjuryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WorkersCompensationPersonalInjuryMember" xlink:to="FONR_WorkersCompensationPersonalInjuryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WorkersCompensationPersonalInjuryMember_lbl" xml:lang="en-US">Workers? Compensation/Personal Injury [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_OtherRevenueSourceMember" xlink:label="FONR_OtherRevenueSourceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherRevenueSourceMember" xlink:to="FONR_OtherRevenueSourceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OtherRevenueSourceMember_lbl" xml:lang="en-US">Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xml:lang="en-US">Receivable Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementAndOtherFeesReceivableMember" xlink:label="FONR_ManagementAndOtherFeesReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesReceivableMember" xlink:to="FONR_ManagementAndOtherFeesReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesReceivableMember_lbl" xml:lang="en-US">Management And Other Fees Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:label="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:to="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_lbl" xml:lang="en-US">Management And Other Fees Receivable Related Medical Practices [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesReceivableMember" xlink:label="us-gaap_NotesReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesReceivableMember" xlink:to="us-gaap_NotesReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesReceivableMember_lbl" xml:lang="en-US">Notes Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ResearchDevelopmentAndDemonstrationEquipmentMember" xlink:label="FONR_ResearchDevelopmentAndDemonstrationEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ResearchDevelopmentAndDemonstrationEquipmentMember" xlink:to="FONR_ResearchDevelopmentAndDemonstrationEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ResearchDevelopmentAndDemonstrationEquipmentMember_lbl" xml:lang="en-US">Research, development and demonstration equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="us-gaap_PropertyPlantAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentMember" xlink:to="us-gaap_PropertyPlantAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentMember_lbl" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_OperatingLeasePaymentsMember" xlink:label="FONR_OperatingLeasePaymentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OperatingLeasePaymentsMember" xlink:to="FONR_OperatingLeasePaymentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OperatingLeasePaymentsMember_lbl" xml:lang="en-US">Operating Lease Payments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_FinancingLeasePaymentsMember" xlink:label="FONR_FinancingLeasePaymentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinancingLeasePaymentsMember" xlink:to="FONR_FinancingLeasePaymentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinancingLeasePaymentsMember_lbl" xml:lang="en-US">Financing Lease Payments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="FONR_PatentsAndCopyrightsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatentsAndCopyrightsMember" xlink:to="FONR_PatentsAndCopyrightsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PatentsAndCopyrightsMember_lbl" xml:lang="en-US">Patents and copyrights [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PatentsMember" xlink:label="us-gaap_PatentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PatentsMember_lbl" xml:lang="en-US">Patents [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredClassAMember" xlink:label="us-gaap_PreferredClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredClassAMember" xlink:to="us-gaap_PreferredClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredClassAMember_lbl" xml:lang="en-US">Preferred Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_N2010StockBonusPlanMember" xlink:label="FONR_N2010StockBonusPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_N2010StockBonusPlanMember" xlink:to="FONR_N2010StockBonusPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_N2010StockBonusPlanMember_lbl" xml:lang="en-US">N 2010 Stock Bonus Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title and Position [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="srt_BoardOfDirectorsChairmanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl" xml:lang="en-US">Board of Directors Chairman [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_HDMMember" xlink:label="FONR_HDMMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HDMMember" xlink:to="FONR_HDMMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_HDMMember_lbl" xml:lang="en-US">HDM [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_OwnershipAxis_lbl" xml:lang="en-US">Ownership [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ClassAControllingInterestsMember" xlink:label="FONR_ClassAControllingInterestsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassAControllingInterestsMember" xlink:to="FONR_ClassAControllingInterestsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassAControllingInterestsMember_lbl" xml:lang="en-US">Class A Controlling Interests [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherOwnershipInterestsByNameAxis" xlink:label="us-gaap_OtherOwnershipInterestsByNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOwnershipInterestsByNameAxis" xlink:to="us-gaap_OtherOwnershipInterestsByNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherOwnershipInterestsByNameAxis_lbl" xml:lang="en-US">Other Ownership Interests Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ClassBControllingInterestsMember" xlink:label="FONR_ClassBControllingInterestsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassBControllingInterestsMember" xlink:to="FONR_ClassBControllingInterestsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassBControllingInterestsMember_lbl" xml:lang="en-US">Class B Controlling Interests [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassAMember_lbl" xml:lang="en-US">Common Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_HDMEquityMember" xlink:label="FONR_HDMEquityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HDMEquityMember" xlink:to="FONR_HDMEquityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_HDMEquityMember_lbl" xml:lang="en-US">HDM Equity [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_NotePayable1Member" xlink:label="FONR_NotePayable1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NotePayable1Member" xlink:to="FONR_NotePayable1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NotePayable1Member_lbl" xml:lang="en-US">Note Payable 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_NotePayable2Member" xlink:label="FONR_NotePayable2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NotePayable2Member" xlink:to="FONR_NotePayable2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NotePayable2Member_lbl" xml:lang="en-US">Note Payable 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_MagneticResonanceManagementMember" xlink:label="FONR_MagneticResonanceManagementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MagneticResonanceManagementMember" xlink:to="FONR_MagneticResonanceManagementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MagneticResonanceManagementMember_lbl" xml:lang="en-US">Magnetic Resonance Management [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_BensonhurstMRILimitedPartnershipMember" xlink:label="FONR_BensonhurstMRILimitedPartnershipMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BensonhurstMRILimitedPartnershipMember" xlink:to="FONR_BensonhurstMRILimitedPartnershipMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BensonhurstMRILimitedPartnershipMember_lbl" xml:lang="en-US">Bensonhurst MRI Limited Partnership [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_RadianHealthcareManagementLLCMember" xlink:label="FONR_RadianHealthcareManagementLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RadianHealthcareManagementLLCMember" xlink:to="FONR_RadianHealthcareManagementLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RadianHealthcareManagementLLCMember_lbl" xml:lang="en-US">Radian Healthcare Management LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareMember" xlink:label="us-gaap_HealthCareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareMember" xlink:to="us-gaap_HealthCareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HealthCareMember_lbl" xml:lang="en-US">Manufacturing and Servicing of Medical Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareOtherMember" xlink:label="us-gaap_HealthCareOtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOtherMember" xlink:to="us-gaap_HealthCareOtherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HealthCareOtherMember_lbl" xml:lang="en-US">Management of Diagnostic Imaging Center [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CA" xlink:label="country_CA" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CA" xlink:to="country_CA_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CA_lbl" xml:lang="en-US">CANADA</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_DE" xlink:label="country_DE" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_DE" xlink:to="country_DE_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_DE_lbl" xml:lang="en-US">GERMANY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_AE" xlink:label="country_AE" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_AE" xlink:to="country_AE_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_AE_lbl" xml:lang="en-US">UNITED ARAB EMIRATES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_PR" xlink:label="country_PR" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_PR" xlink:to="country_PR_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_PR_lbl" xml:lang="en-US">PUERTO RICO</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CH" xlink:label="country_CH" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CH" xlink:to="country_CH_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CH_lbl" xml:lang="en-US">SWITZERLAND</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GB" xlink:label="country_GB" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_GB" xlink:to="country_GB_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_GB_lbl" xml:lang="en-US">UNITED KINGDOM</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_DO" xlink:label="country_DO" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_DO" xlink:to="country_DO_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_DO_lbl" xml:lang="en-US">DOMINICAN REPUBLIC</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GR" xlink:label="country_GR" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_GR" xlink:to="country_GR_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_GR_lbl" xml:lang="en-US">GREECE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_AU" xlink:label="country_AU" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_AU" xlink:to="country_AU_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_AU_lbl" xml:lang="en-US">AUSTRALIA</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">Short-term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable &#8211; net of allowances for credit losses of $166,049 and $198,593 at June 30, 2024 and 2023, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_MedicalReceivable" xlink:label="FONR_MedicalReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivable" xlink:to="FONR_MedicalReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicalReceivable_lbl" xml:lang="en-US">Medical receivables &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedFeesAndOtherRevenueReceivable" xlink:label="us-gaap_AccruedFeesAndOtherRevenueReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedFeesAndOtherRevenueReceivable" xlink:to="us-gaap_AccruedFeesAndOtherRevenueReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedFeesAndOtherRevenueReceivable_lbl" xml:lang="en-US">Management and other fees receivable &#8211; net of allowances for credit losses of $12,369,921 and $12,608,567 as of June 30, 2024 and 2023, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_lbl" xml:lang="en-US">Management and other fees receivable &#8211; related party medical practices &#8211; net of allowances for credit losses of $6,110,399 and $3,989,692 as of June 30, 2024 and 2023, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="FONR_AccountsReceivableNetLongTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetLongTerm" xlink:to="FONR_AccountsReceivableNetLongTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableNetLongTerm_lbl" xml:lang="en-US">Accounts receivable &#8211; long term</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_NoteReceivableRelatedParty" xlink:label="FONR_NoteReceivableRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NoteReceivableRelatedParty" xlink:to="FONR_NoteReceivableRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NoteReceivableRelatedParty_lbl" xml:lang="en-US">Note receivable &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xml:lang="en-US">Deferred income tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right-of-use-assets &#8211; operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right-of-use-asset &#8211; financing lease</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Other intangible assets &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US">Current portion of long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liabilities &#8211; current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xml:lang="en-US">Financing lease liability &#8211; current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Unearned revenue on service contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CustomerDeposits" xlink:label="FONR_CustomerDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CustomerDeposits" xlink:to="FONR_CustomerDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CustomerDeposits_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Long-Term Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xml:lang="en-US">Unearned revenue on service contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:to="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Deferred income tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_AccountsPayableRelatedPartyNoncurrent" xlink:label="FONR_AccountsPayableRelatedPartyNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsPayableRelatedPartyNoncurrent" xlink:to="FONR_AccountsPayableRelatedPartyNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsPayableRelatedPartyNoncurrent_lbl" xml:lang="en-US">Due to related party medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liabilities &#8211; net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Financing lease liability &#8211; net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US">Long-term debt and capital leases, less current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total Long-Term Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; Equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Paid-in capital in excess of par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US">Treasury stock, at cost &#8211; 45,081 and 11,463 shares of common stock at June 30, 2024 and 2023, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Fonar Corporation&#8217;s Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">Noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Total Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:label="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:to="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_lbl" xml:lang="en-US">Accounts receivable - net of allowances for credit losses</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:label="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:to="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts_lbl" xml:lang="en-US">Management and other fees receivable - net of allowances for credit losses</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:label="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:to="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts_lbl" xml:lang="en-US">Management and other fees receivable - related party medical practices - net of allowances for credit losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="us-gaap_TreasuryStockCommonShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonShares" xlink:to="us-gaap_TreasuryStockCommonShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockCommonShares_lbl" xml:lang="en-US">Treasury stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:to="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_lbl" xml:lang="en-US">Patient fee revenue, net of contractual allowances and discounts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ProductSalesNet" xlink:label="FONR_ProductSalesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProductSalesNet" xlink:to="FONR_ProductSalesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProductSalesNet_lbl" xml:lang="en-US">Product sales</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="FONR_ServiceAndRepairFeesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesNet" xlink:to="FONR_ServiceAndRepairFeesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ServiceAndRepairFeesNet_lbl" xml:lang="en-US">Service and repair fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:to="FONR_ServiceAndRepairFeesRelatedPartiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet_lbl" xml:lang="en-US">Service and repair fees &#8211; related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="FONR_ManagementAndOtherFeesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesNet" xlink:to="FONR_ManagementAndOtherFeesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesNet_lbl" xml:lang="en-US">Management and other fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:to="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_lbl" xml:lang="en-US">Management and other fees &#8211; related party medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Total Revenues &#8211; Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="us-gaap_CostsAndExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xml:lang="en-US">Costs and Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CostsRelatedToProductSales" xlink:label="FONR_CostsRelatedToProductSales" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToProductSales" xlink:to="FONR_CostsRelatedToProductSales_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToProductSales_lbl" xml:lang="en-US">Costs related to product sales</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="FONR_CostsRelatedToServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFees" xlink:to="FONR_CostsRelatedToServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToServiceAndRepairFees_lbl" xml:lang="en-US">Costs related to service and repair fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:to="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_lbl" xml:lang="en-US">Costs related to service and repair fees &#8211; related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="us-gaap_OtherCostOfOperatingRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCostOfOperatingRevenue" xlink:to="us-gaap_OtherCostOfOperatingRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCostOfOperatingRevenue_lbl" xml:lang="en-US">Costs related to patient fee revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="FONR_CostsRelatedToManagementAndOtherFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFees" xlink:to="FONR_CostsRelatedToManagementAndOtherFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToManagementAndOtherFees_lbl" xml:lang="en-US">Costs related to management and other fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:to="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_lbl" xml:lang="en-US">Costs related to management and other fees &#8211; related party medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Total Costs and Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_lbl" xml:lang="en-US">Income from Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other Income and (Expenses):</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="us-gaap_InterestExpenseNonoperating" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseNonoperating" xlink:to="us-gaap_InterestExpenseNonoperating_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpenseNonoperating_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_InvestmentIncomeRelatedParty" xlink:label="FONR_InvestmentIncomeRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_InvestmentIncomeRelatedParty" xlink:to="FONR_InvestmentIncomeRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_InvestmentIncomeRelatedParty_lbl" xml:lang="en-US">Investment income &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet" xlink:label="us-gaap_InvestmentIncomeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeNet_lbl" xml:lang="en-US">Investment income</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_OtherIncomeRelatedParty" xlink:label="FONR_OtherIncomeRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherIncomeRelatedParty" xlink:to="FONR_OtherIncomeRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OtherIncomeRelatedParty_lbl" xml:lang="en-US">Other income &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Income before provision for income taxes and noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net Income &#8211; Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income &#8211; Attributable to FONAR</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net Income Available to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic Net Income Per Common Share Available to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted Net Income Per Common Share Available to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted Average Basic Shares Outstanding - Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted Average Diluted Shares Outstanding - Common Stockholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xml:lang="en-US">Purchase of treasury shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_lbl" xml:lang="en-US">Cancellation of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl" xml:lang="en-US">Cancellation of shares, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xml:lang="en-US">Distributions to noncontrolling interests</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Ending balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProfitLoss_3_lbl" xml:lang="en-US">Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ProvisionForBadDebts" xlink:label="FONR_ProvisionForBadDebts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProvisionForBadDebts" xlink:to="FONR_ProvisionForBadDebts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProvisionForBadDebts_lbl" xml:lang="en-US">Provision for credit losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred income tax - net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US">Amortization on right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_GainOnSaleOfEquipmentRelatedParty" xlink:label="FONR_GainOnSaleOfEquipmentRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_GainOnSaleOfEquipmentRelatedParty" xlink:to="FONR_GainOnSaleOfEquipmentRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_GainOnSaleOfEquipmentRelatedParty_lbl" xml:lang="en-US">Gain on sale of equipment &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_GainlossOnDispositionOfFixedAssets" xlink:label="FONR_GainlossOnDispositionOfFixedAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_GainlossOnDispositionOfFixedAssets" xlink:to="FONR_GainlossOnDispositionOfFixedAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_GainlossOnDispositionOfFixedAssets_lbl" xml:lang="en-US">(Gain)Loss on disposition of fixed assets</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_AbandonedPatents" xlink:label="FONR_AbandonedPatents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AbandonedPatents" xlink:to="FONR_AbandonedPatents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AbandonedPatents_lbl" xml:lang="en-US">Abandoned patents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xml:lang="en-US">Changes in assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts, medical and management fee receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_IncreaseDecreaseInNotesReceivable" xlink:label="FONR_IncreaseDecreaseInNotesReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInNotesReceivable" xlink:to="FONR_IncreaseDecreaseInNotesReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInNotesReceivable_lbl" xml:lang="en-US">Notes receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="FONR_IncreaseDecreaseInCustomerAdvance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInCustomerAdvance" xlink:to="FONR_IncreaseDecreaseInCustomerAdvance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInCustomerAdvance_lbl" xml:lang="en-US">Customer advances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInTradingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInTradingLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInTradingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInTradingLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInTradingLiabilities_lbl" xml:lang="en-US">Financing lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">NET CASH PROVIDED BY OPERATING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:label="us-gaap_PaymentsForProceedsFromShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:to="us-gaap_PaymentsForProceedsFromShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForProceedsFromShortTermInvestments_lbl" xml:lang="en-US">Purchase of Short-term investment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US">Proceeds from sale of equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Cost of patents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">NET CASH USED IN INVESTING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Repayment of borrowings and capital lease obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfEquity" xlink:label="us-gaap_PaymentsForRepurchaseOfEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfEquity" xlink:to="us-gaap_PaymentsForRepurchaseOfEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForRepurchaseOfEquity_lbl" xml:lang="en-US">Purchase of treasury stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xml:lang="en-US">Distributions to noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">NET CASH USED IN FINANCING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">NET INCREASE IN CASH AND CASH EQUIVALENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS - END OF YEAR</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="ecd_PvpTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTable" xlink:to="ecd_PvpTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTable_lbl" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis" xlink:label="ecd_ExecutiveCategoryAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ExecutiveCategoryAxis" xlink:to="ecd_ExecutiveCategoryAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ExecutiveCategoryAxis_lbl" xml:lang="en-US">Executive Category [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="ecd_IndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_IndividualAxis" xlink:to="ecd_IndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_IndividualAxis_lbl" xml:lang="en-US">Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="ecd_AdjToCompAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAxis" xlink:to="ecd_AdjToCompAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAxis_lbl" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis" xlink:label="ecd_MeasureAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureAxis" xlink:to="ecd_MeasureAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureAxis_lbl" xml:lang="en-US">Measure [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="ecd_PvpTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTableTextBlock" xlink:to="ecd_PvpTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTableTextBlock_lbl" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="ecd_CoSelectedMeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureName" xlink:to="ecd_CoSelectedMeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureName_lbl" xml:lang="en-US">Company Selected Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="ecd_PeerGroupIssuersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupIssuersFnTextBlock" xlink:to="ecd_PeerGroupIssuersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupIssuersFnTextBlock_lbl" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="ecd_ChangedPeerGroupFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChangedPeerGroupFnTextBlock" xlink:to="ecd_ChangedPeerGroupFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChangedPeerGroupFnTextBlock_lbl" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="ecd_PeoTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoTotalCompAmt" xlink:to="ecd_PeoTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoTotalCompAmt_lbl" xml:lang="en-US">PEO Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="ecd_PeoActuallyPaidCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoActuallyPaidCompAmt" xlink:to="ecd_PeoActuallyPaidCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoActuallyPaidCompAmt_lbl" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="ecd_AdjToPeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToPeoCompFnTextBlock" xlink:to="ecd_AdjToPeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToPeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="ecd_TabularListTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TabularListTableTextBlock" xlink:to="ecd_TabularListTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TabularListTableTextBlock_lbl" xml:lang="en-US">Tabular List, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="ecd_TotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnAmt" xlink:to="ecd_TotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnAmt_lbl" xml:lang="en-US">Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net Income (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="ecd_CoSelectedMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureAmt" xlink:to="ecd_CoSelectedMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureAmt_lbl" xml:lang="en-US">Company Selected Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="ecd_OtherPerfMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OtherPerfMeasureAmt" xlink:to="ecd_OtherPerfMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OtherPerfMeasureAmt_lbl" xml:lang="en-US">Other Performance Measure, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="ecd_AdjToCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAmt" xlink:to="ecd_AdjToCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAmt_lbl" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="ecd_PeoName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoName" xlink:to="ecd_PeoName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoName_lbl" xml:lang="en-US">PEO Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="ecd_MeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureName" xlink:to="ecd_MeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xml:lang="en-US">Non-GAAP Measure Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="ecd_Additional402vDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Additional402vDisclosureTextBlock" xlink:to="ecd_Additional402vDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Additional402vDisclosureTextBlock_lbl" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="ecd_PnsnBnftsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PnsnBnftsAdjFnTextBlock" xlink:to="ecd_PnsnBnftsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PnsnBnftsAdjFnTextBlock_lbl" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="ecd_ErrCompRecoveryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompRecoveryTable" xlink:to="ecd_ErrCompRecoveryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompRecoveryTable_lbl" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="ecd_RestatementDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDateAxis" xlink:to="ecd_RestatementDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDateAxis_lbl" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="ecd_RestatementDeterminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDeterminationDate" xlink:to="ecd_RestatementDeterminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDeterminationDate_lbl" xml:lang="en-US">Restatement Determination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="ecd_AggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompAmt" xlink:to="ecd_AggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompAmt_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="ecd_ErrCompAnalysisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompAnalysisTextBlock" xlink:to="ecd_ErrCompAnalysisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompAnalysisTextBlock_lbl" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="ecd_OutstandingAggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingAggtErrCompAmt" xlink:to="ecd_OutstandingAggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingAggtErrCompAmt_lbl" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="ecd_ForgoneRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_ForgoneRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="ecd_OutstandingRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_OutstandingRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="ecd_OutstandingRecoveryCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryCompAmt" xlink:to="ecd_OutstandingRecoveryCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryCompAmt_lbl" xml:lang="en-US">Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xml:lang="en-US">Restatement does not require Recovery</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="ecd_AwardsCloseToMnpiDiscTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTable" xlink:to="ecd_AwardsCloseToMnpiDiscTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTable_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="ecd_AwardTmgMnpiDiscTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiDiscTextBlock" xlink:to="ecd_AwardTmgMnpiDiscTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiDiscTextBlock_lbl" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="ecd_AwardTmgMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMethodTextBlock" xlink:to="ecd_AwardTmgMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMethodTextBlock_lbl" xml:lang="en-US">Award Timing Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="ecd_AwardTmgPredtrmndFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgPredtrmndFlag" xlink:to="ecd_AwardTmgPredtrmndFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgPredtrmndFlag_lbl" xml:lang="en-US">Award Timing Predetermined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xml:lang="en-US">Award Timing MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="ecd_MnpiDiscTimedForCompValFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MnpiDiscTimedForCompValFlag" xlink:to="ecd_MnpiDiscTimedForCompValFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MnpiDiscTimedForCompValFlag_lbl" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="ecd_AwardsCloseToMnpiDiscIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="ecd_AwardUndrlygSecuritiesAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardUndrlygSecuritiesAmt" xlink:to="ecd_AwardUndrlygSecuritiesAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardUndrlygSecuritiesAmt_lbl" xml:lang="en-US">Underlying Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="ecd_AwardExrcPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardExrcPrice" xlink:to="ecd_AwardExrcPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardExrcPrice_lbl" xml:lang="en-US">Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="ecd_AwardGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardGrantDateFairValue" xlink:to="ecd_AwardGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardGrantDateFairValue_lbl" xml:lang="en-US">Fair Value as of Grant Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="ecd_UndrlygSecurityMktPriceChngPct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_UndrlygSecurityMktPriceChngPct" xlink:to="ecd_UndrlygSecurityMktPriceChngPct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_UndrlygSecurityMktPriceChngPct_lbl" xml:lang="en-US">Underlying Security Market Price Change</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable" xlink:label="ecd_TradingArrByIndTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrByIndTable" xlink:to="ecd_TradingArrByIndTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrByIndTable_lbl" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis" xlink:label="ecd_TradingArrAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrAxis" xlink:to="ecd_TradingArrAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrAxis_lbl" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="ecd_TrdArrIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_TrdArrIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="ecd_TrdArrIndTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndTitle" xlink:to="ecd_TrdArrIndTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndTitle_lbl" xml:lang="en-US">Title</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="ecd_TrdArrAdoptionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrAdoptionDate_lbl" xml:lang="en-US">Adoption Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="ecd_TrdArrTerminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrTerminationDate" xlink:to="ecd_TrdArrTerminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrTerminationDate_lbl" xml:lang="en-US">Termination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="ecd_TrdArrExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrExpirationDate" xlink:to="ecd_TrdArrExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrExpirationDate_lbl" xml:lang="en-US">Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="ecd_TrdArrDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrDuration" xlink:to="ecd_TrdArrDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrDuration_lbl" xml:lang="en-US">Arrangement Duration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="ecd_InsiderTradingPoliciesProcLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingPoliciesProcLineItems" xlink:to="ecd_InsiderTradingPoliciesProcLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingPoliciesProcLineItems_lbl" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US">DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ReceivablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesAbstract_lbl" xml:lang="en-US">Receivables [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xml:lang="en-US">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">PROPERTY AND EQUIPMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="FONR_DisclosureOperatingFinancingLeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:to="FONR_DisclosureOperatingFinancingLeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DisclosureOperatingFinancingLeasesAbstract_lbl" xml:lang="en-US">Operating Financing Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">OPERATING &amp; FINANCING LEASES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">OTHER INTANGIBLE ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DisclosureCapitalStockAbstract" xlink:label="FONR_DisclosureCapitalStockAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureCapitalStockAbstract" xlink:to="FONR_DisclosureCapitalStockAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DisclosureCapitalStockAbstract_lbl" xml:lang="en-US">Capital Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CapitalStockDisclosureTextblock" xlink:label="FONR_CapitalStockDisclosureTextblock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CapitalStockDisclosureTextblock" xlink:to="FONR_CapitalStockDisclosureTextblock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CapitalStockDisclosureTextblock_lbl" xml:lang="en-US">CAPITAL STOCK</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="us-gaap_NoncontrollingInterestAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestAbstract" xlink:to="us-gaap_NoncontrollingInterestAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestAbstract_lbl" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xml:lang="en-US">CONTROLLING AND NONCONTROLLING INTERESTS</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:label="FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:to="FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract_lbl" xml:lang="en-US">Long-term Debt Notes Payable And Capital Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock" xlink:label="FONR_LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock" xlink:to="FONR_LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock_lbl" xml:lang="en-US">LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xml:lang="en-US">OTHER CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xml:lang="en-US">SUPPLEMENTAL CASH FLOW INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY TRANSACTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">SEGMENT AND RELATED INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessPolicy" xlink:label="us-gaap_InventoryWorkInProcessPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcessPolicy" xlink:to="us-gaap_InventoryWorkInProcessPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryWorkInProcessPolicy_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Long-Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US">Other Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_MedicalReceivableAndManagementAndOtherFeesReceivablePolicyTextBlock" xlink:label="FONR_MedicalReceivableAndManagementAndOtherFeesReceivablePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivableAndManagementAndOtherFeesReceivablePolicyTextBlock" xlink:to="FONR_MedicalReceivableAndManagementAndOtherFeesReceivablePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicalReceivableAndManagementAndOtherFeesReceivablePolicyTextBlock_lbl" xml:lang="en-US">Medical Receivable and Management and Other Fees Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="us-gaap_ReceivablesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesPolicyTextBlock" xlink:to="us-gaap_ReceivablesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl" xml:lang="en-US">Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xml:lang="en-US">Advertising Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CustomerAdvancesPolicyTextBlock" xlink:label="FONR_CustomerAdvancesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CustomerAdvancesPolicyTextBlock" xlink:to="FONR_CustomerAdvancesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CustomerAdvancesPolicyTextBlock_lbl" xml:lang="en-US">Customer Advances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="us-gaap_InvestmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Short-Term Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_RecentAccountingStandardsPolicyTextBlock" xlink:label="FONR_RecentAccountingStandardsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RecentAccountingStandardsPolicyTextBlock" xlink:to="FONR_RecentAccountingStandardsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RecentAccountingStandardsPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Standards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently Adopted Accounting Standards</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" xlink:label="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" xlink:to="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_lbl" xml:lang="en-US">Schedule of estimated useful life in years for property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">Schedule of patient fee revenue - net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of earnings per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of receivables - non current - net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:label="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:to="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_lbl" xml:lang="en-US">Summary of allowance for credit losses</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:label="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:to="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock_lbl" xml:lang="en-US">Schedule of facilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of property and equipment, at cost, less accumulated depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Schedule of reconciliation of operating and financing lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" xlink:label="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" xlink:to="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_lbl" xml:lang="en-US">Schedule of weighted average remaining lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">Schedule of components of lease expense</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:label="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:to="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_lbl" xml:lang="en-US">Schedule of supplemental cash flow information related to leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xml:lang="en-US">Schedule of other intangible assets, net of accumulated amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule of other intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of other intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:label="us-gaap_RedeemableNoncontrollingInterestTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:to="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" xml:lang="en-US">Schedule of HDM members equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xml:lang="en-US">Schedule of long-term debt, notes payable and capital leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xml:lang="en-US">Schedule of maturities of long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Schedule of components of the provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of reconciliation of federal statutory income tax rate to company&#8217;s effective tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of company&#8217;s deferred tax assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Schedule of summarized segment financial information</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ScheduleOfExportProductSalesTableTextBlock" xlink:label="FONR_ScheduleOfExportProductSalesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScheduleOfExportProductSalesTableTextBlock" xlink:to="FONR_ScheduleOfExportProductSalesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ScheduleOfExportProductSalesTableTextBlock_lbl" xml:lang="en-US">Schedule of export product sales</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ScheduleOfExportServiceRevenuesTableTextBlock" xlink:label="FONR_ScheduleOfExportServiceRevenuesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScheduleOfExportServiceRevenuesTableTextBlock" xlink:to="FONR_ScheduleOfExportServiceRevenuesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ScheduleOfExportServiceRevenuesTableTextBlock_lbl" xml:lang="en-US">Schedule of export service revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentOwnedPercentOfNetAssets" xlink:label="us-gaap_InvestmentOwnedPercentOfNetAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedPercentOfNetAssets" xlink:to="us-gaap_InvestmentOwnedPercentOfNetAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedPercentOfNetAssets_lbl" xml:lang="en-US">Interest received percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Ownership interest percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:label="us-gaap_ProceedsFromPaymentsToMinorityShareholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:to="us-gaap_ProceedsFromPaymentsToMinorityShareholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromPaymentsToMinorityShareholders_lbl" xml:lang="en-US">Non-controlling interests from the minority shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Estimated useful lives</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_NetPatientFeeRevenue" xlink:label="FONR_NetPatientFeeRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetPatientFeeRevenue" xlink:to="FONR_NetPatientFeeRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetPatientFeeRevenue_lbl" xml:lang="en-US">Net Patient Fee Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_NetIncomeLossAvailableToCommonStockholderBasic" xlink:label="FONR_NetIncomeLossAvailableToCommonStockholderBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetIncomeLossAvailableToCommonStockholderBasic" xlink:to="FONR_NetIncomeLossAvailableToCommonStockholderBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetIncomeLossAvailableToCommonStockholderBasic_lbl" xml:lang="en-US">Net income available to common stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_WeightedAverageSharesOutstandingBasic" xlink:label="FONR_WeightedAverageSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WeightedAverageSharesOutstandingBasic" xlink:to="FONR_WeightedAverageSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WeightedAverageSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average shares outstanding basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xml:lang="en-US">Basic income per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:label="us-gaap_WeightedAverageBasicSharesOutstandingProForma" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:to="us-gaap_WeightedAverageBasicSharesOutstandingProForma_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageBasicSharesOutstandingProForma_lbl" xml:lang="en-US">Weighted average shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" xlink:label="FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" xlink:to="FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock_lbl" xml:lang="en-US">Class C Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xml:lang="en-US">Class C Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:label="FONR_WeightedAverageNumberOfDilutedEarningsPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:to="FONR_WeightedAverageNumberOfDilutedEarningsPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WeightedAverageNumberOfDilutedEarningsPerShare_lbl" xml:lang="en-US">Total Denominator for diluted earnings per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_2_lbl" xml:lang="en-US">Diluted income per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ScheduleOfProductInformationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfProductInformationTable_lbl" xml:lang="en-US">Nature of Operation, Product Information, Concentration of Risk [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductInformationLineItems" xlink:label="us-gaap_ProductInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ProductInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductInformationLineItems_lbl" xml:lang="en-US">Product Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfPropertyRepairsAndMaintenance" xlink:label="us-gaap_CostOfPropertyRepairsAndMaintenance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfPropertyRepairsAndMaintenance" xlink:to="us-gaap_CostOfPropertyRepairsAndMaintenance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfPropertyRepairsAndMaintenance_lbl" xml:lang="en-US">Maintenance and repair expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Finite-lived intangible asset, useful life</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" xlink:label="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" xlink:to="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices_lbl" xml:lang="en-US">Management agreements with company total medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:label="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:to="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_lbl" xml:lang="en-US">Scanners with management agreements with company owned by related party</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:label="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:to="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState_lbl" xml:lang="en-US">Scanners with management with company located in new york state</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ContractualFeesForServicesRenderedMinimum" xlink:label="FONR_ContractualFeesForServicesRenderedMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ContractualFeesForServicesRenderedMinimum" xlink:to="FONR_ContractualFeesForServicesRenderedMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ContractualFeesForServicesRenderedMinimum_lbl" xml:lang="en-US">Contractual fees for services rendered minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ContractualFeesForServicesRenderedMaximum" xlink:label="FONR_ContractualFeesForServicesRenderedMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ContractualFeesForServicesRenderedMaximum" xlink:to="FONR_ContractualFeesForServicesRenderedMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ContractualFeesForServicesRenderedMaximum_lbl" xml:lang="en-US">Contractual fees for services rendered maximum</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProvisionForBadDebts" xlink:to="FONR_ProvisionForBadDebts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_ProvisionForBadDebts_2_lbl" xml:lang="en-US">[custom:ProvisionForBadDebts]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementFeeReceivableForUnrelatedParties" xlink:label="FONR_ManagementFeeReceivableForUnrelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementFeeReceivableForUnrelatedParties" xlink:to="FONR_ManagementFeeReceivableForUnrelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementFeeReceivableForUnrelatedParties_lbl" xml:lang="en-US">[custom:ManagementFeeReceivableForUnrelatedParties-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementFeeReceivableForRelatedParties" xlink:label="FONR_ManagementFeeReceivableForRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementFeeReceivableForRelatedParties" xlink:to="FONR_ManagementFeeReceivableForRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementFeeReceivableForRelatedParties_lbl" xml:lang="en-US">[custom:ManagementFeeReceivableForRelatedParties-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_AccountsReceivableServiceContractsNet" xlink:label="FONR_AccountsReceivableServiceContractsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableServiceContractsNet" xlink:to="FONR_AccountsReceivableServiceContractsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableServiceContractsNet_lbl" xml:lang="en-US">[custom:AccountsReceivableServiceContractsNet-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingExpense_lbl" xml:lang="en-US">Advertising Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationPenaltiesExpense" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesExpense" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesExpense_lbl" xml:lang="en-US">Penalties</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:label="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:to="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_lbl" xml:lang="en-US">Conversion of Class C Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="us-gaap_CashFDICInsuredAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFDICInsuredAmount" xlink:to="us-gaap_CashFDICInsuredAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFDICInsuredAmount_lbl" xml:lang="en-US">Federally insured limits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration risk, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractReceivableDueTwoToThreeYears" xlink:label="us-gaap_ContractReceivableDueTwoToThreeYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueTwoToThreeYears" xlink:to="us-gaap_ContractReceivableDueTwoToThreeYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueTwoToThreeYears_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractReceivableDueThreeToFourYears" xlink:label="us-gaap_ContractReceivableDueThreeToFourYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueThreeToFourYears" xlink:to="us-gaap_ContractReceivableDueThreeToFourYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueThreeToFourYears_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractReceivableDueFourToFiveYears" xlink:label="us-gaap_ContractReceivableDueFourToFiveYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueFourToFiveYears" xlink:to="us-gaap_ContractReceivableDueFourToFiveYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueFourToFiveYears_lbl" xml:lang="en-US">2028</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractReceivableDueFiveYearsOrMore" xlink:label="us-gaap_ContractReceivableDueFiveYearsOrMore" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueFiveYearsOrMore" xlink:to="us-gaap_ContractReceivableDueFiveYearsOrMore_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueFiveYearsOrMore_lbl" xml:lang="en-US">2029</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:to="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xml:lang="en-US">Accounts and Financing Receivables [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xml:lang="en-US">Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_AllowanceForDoubtfulAccountsAdditions" xlink:label="FONR_AllowanceForDoubtfulAccountsAdditions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AllowanceForDoubtfulAccountsAdditions" xlink:to="FONR_AllowanceForDoubtfulAccountsAdditions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AllowanceForDoubtfulAccountsAdditions_lbl" xml:lang="en-US">Additions (Included in provision for bad debts)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_AllowanceForDoubtfulAccountsDeductions" xlink:label="FONR_AllowanceForDoubtfulAccountsDeductions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AllowanceForDoubtfulAccountsDeductions" xlink:to="FONR_AllowanceForDoubtfulAccountsDeductions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AllowanceForDoubtfulAccountsDeductions_lbl" xml:lang="en-US">Deductions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_2_lbl" xml:lang="en-US">Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" xlink:to="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear_lbl" xml:lang="en-US">Total Facilities Owned or Managed (at Beginning of Year)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagedFacilitiesAddedByInternalDevelopment" xlink:label="FONR_ManagedFacilitiesAddedByInternalDevelopment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagedFacilitiesAddedByInternalDevelopment" xlink:to="FONR_ManagedFacilitiesAddedByInternalDevelopment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagedFacilitiesAddedByInternalDevelopment_lbl" xml:lang="en-US">Internal development</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagedFacilitiesClosedDuringYear" xlink:label="FONR_ManagedFacilitiesClosedDuringYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagedFacilitiesClosedDuringYear" xlink:to="FONR_ManagedFacilitiesClosedDuringYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagedFacilitiesClosedDuringYear_lbl" xml:lang="en-US">Managed Facilities Closed</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" xlink:to="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear_lbl" xml:lang="en-US">Total Facilities Owned or Managed (at End of Year)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetLongTerm" xlink:to="FONR_AccountsReceivableNetLongTerm_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_AccountsReceivableNetLongTerm_2_lbl" xml:lang="en-US">Long term accounts receivable balances</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:to="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_lbl" xml:lang="en-US">Percentage of consolidated net revenue from management fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherInventorySupplies" xlink:label="us-gaap_OtherInventorySupplies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInventorySupplies" xlink:to="us-gaap_OtherInventorySupplies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInventorySupplies_lbl" xml:lang="en-US">Purchased parts and components</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work-in-process</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_2_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property plant and equipment, gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less: Accumulated depreciation and amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Property plant and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="us-gaap_OtherDepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherDepreciationAndAmortization" xlink:to="us-gaap_OtherDepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherDepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2028</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2028</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">2029</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">2029</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PresentValueDiscount" xlink:label="FONR_PresentValueDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscount" xlink:to="FONR_PresentValueDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PresentValueDiscount_lbl" xml:lang="en-US">Present value discount</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="FONR_PresentValueDiscountFinancingLease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscountFinancingLease" xlink:to="FONR_PresentValueDiscountFinancingLease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_PresentValueDiscountFinancingLease_lbl" xml:lang="en-US">Present value discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Total lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability" xlink:label="us-gaap_FinanceLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiability" xlink:to="us-gaap_FinanceLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiability_lbl" xml:lang="en-US">Total lease liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:to="FONR_DisclosureOperatingFinancingLeasesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_DisclosureOperatingFinancingLeasesAbstract_2_lbl" xml:lang="en-US">Operating Financing Leases - Weighted Average Remaining Lease Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Operating leases - years</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Finance lease - years</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Weighted average discount rate, operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Weighted average discount rate, finance leases</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:to="FONR_DisclosureOperatingFinancingLeasesAbstract_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="FONR_DisclosureOperatingFinancingLeasesAbstract_3_lbl" xml:lang="en-US">Operating Financing Leases - Components Of Lease Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Operating lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_FinanceLeaseCostsAbstract" xlink:label="FONR_FinanceLeaseCostsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinanceLeaseCostsAbstract" xlink:to="FONR_FinanceLeaseCostsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinanceLeaseCostsAbstract_lbl" xml:lang="en-US">Finance lease cost:</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DepreciationOfLeasedEquipment" xlink:label="FONR_DepreciationOfLeasedEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DepreciationOfLeasedEquipment" xlink:to="FONR_DepreciationOfLeasedEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DepreciationOfLeasedEquipment_lbl" xml:lang="en-US">Depreciation of leased equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="us-gaap_FinanceLeaseInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseInterestExpense" xlink:to="us-gaap_FinanceLeaseInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseInterestExpense_lbl" xml:lang="en-US">Interest on lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_FinanceLeaseCost" xlink:label="FONR_FinanceLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinanceLeaseCost" xlink:to="FONR_FinanceLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinanceLeaseCost_lbl" xml:lang="en-US">Total finance lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_OperatingCashFlowsFromOperatingLeases" xlink:label="FONR_OperatingCashFlowsFromOperatingLeases" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OperatingCashFlowsFromOperatingLeases" xlink:to="FONR_OperatingCashFlowsFromOperatingLeases_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OperatingCashFlowsFromOperatingLeases_lbl" xml:lang="en-US">Operating cash flows from operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_FinancingCashFlowsFromFinancingLeases" xlink:label="FONR_FinancingCashFlowsFromFinancingLeases" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinancingCashFlowsFromFinancingLeases" xlink:to="FONR_FinancingCashFlowsFromFinancingLeases_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinancingCashFlowsFromFinancingLeases_lbl" xml:lang="en-US">Financing cash flows from financing leases</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:to="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_lbl" xml:lang="en-US">Right-of-use and equipment assets obtained in exchange for lease obligations:</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:to="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_lbl" xml:lang="en-US">Operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Intangible Asset, Finite-Lived [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Gross other intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Less: Accumulated amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Other intangible assets-net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">2028</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US">2029</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xml:lang="en-US">Other intangible assets - net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="us-gaap_OtherIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsNet" xlink:to="us-gaap_OtherIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_OtherIntangibleAssetsNet_lbl" xml:lang="en-US">Balance - Beginning of Year</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_AmountsCapitalized" xlink:label="FONR_AmountsCapitalized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AmountsCapitalized" xlink:to="FONR_AmountsCapitalized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AmountsCapitalized_lbl" xml:lang="en-US">Amounts capitalized</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_SoftwareOrPatentsWrittenOff" xlink:label="FONR_SoftwareOrPatentsWrittenOff" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SoftwareOrPatentsWrittenOff" xlink:to="FONR_SoftwareOrPatentsWrittenOff_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SoftwareOrPatentsWrittenOff_lbl" xml:lang="en-US">Patents written off</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentForAmortization" xlink:label="us-gaap_AdjustmentForAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentForAmortization" xlink:to="us-gaap_AdjustmentForAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentForAmortization_lbl" xml:lang="en-US">Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsNet" xlink:to="us-gaap_OtherIntangibleAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_OtherIntangibleAssetsNet_2_lbl" xml:lang="en-US">Balance - End of Year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xml:lang="en-US">Weighted average amortization period for other intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of customer relationships</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableNature" xlink:label="us-gaap_DividendsPayableNature" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableNature" xlink:to="us-gaap_DividendsPayableNature_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPayableNature_lbl" xml:lang="en-US">Dividends payable, nature</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:label="us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:to="us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_lbl" xml:lang="en-US">Conversuion of shares into one-for-one basis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockVotingRights" xlink:label="us-gaap_CommonStockVotingRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockVotingRights" xlink:to="us-gaap_CommonStockVotingRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockVotingRights_lbl" xml:lang="en-US">Common stock, voting rights</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Common stock, capital shares reserved for future issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_SharesRegistered" xlink:label="FONR_SharesRegistered" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SharesRegistered" xlink:to="FONR_SharesRegistered_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SharesRegistered_lbl" xml:lang="en-US">Shares registered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Number of shares available for future grant</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xml:lang="en-US">Number of shares were issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfEquity" xlink:to="us-gaap_PaymentsForRepurchaseOfEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfEquity_2_lbl" xml:lang="en-US">Payments for repurchase of equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Purchase of treasury shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xml:lang="en-US">Purchase of treasury stock</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CancellationOfTreasuryShares" xlink:label="FONR_CancellationOfTreasuryShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CancellationOfTreasuryShares" xlink:to="FONR_CancellationOfTreasuryShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CancellationOfTreasuryShares_lbl" xml:lang="en-US">Cancellation of treasury shares</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CancellationOfTreasuryStock" xlink:label="FONR_CancellationOfTreasuryStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CancellationOfTreasuryStock" xlink:to="FONR_CancellationOfTreasuryStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CancellationOfTreasuryStock_lbl" xml:lang="en-US">Cancellation of treasury stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestTable" xlink:label="us-gaap_MinorityInterestTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestTable" xlink:to="us-gaap_MinorityInterestTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestTable_lbl" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestLineItems" xlink:label="us-gaap_MinorityInterestLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestLineItems" xlink:to="us-gaap_MinorityInterestLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestLineItems_lbl" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_OpeningMembersEquity" xlink:label="FONR_OpeningMembersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OpeningMembersEquity" xlink:to="FONR_OpeningMembersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OpeningMembersEquity_lbl" xml:lang="en-US">Opening Members Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ShareOfNetIncome" xlink:label="FONR_ShareOfNetIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ShareOfNetIncome" xlink:to="FONR_ShareOfNetIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ShareOfNetIncome_lbl" xml:lang="en-US">Share of Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_BuyoutOfNoncontrollingInterestsValue" xlink:label="FONR_BuyoutOfNoncontrollingInterestsValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BuyoutOfNoncontrollingInterestsValue" xlink:to="FONR_BuyoutOfNoncontrollingInterestsValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BuyoutOfNoncontrollingInterestsValue_lbl" xml:lang="en-US">Buyout of noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_Distributions" xlink:label="FONR_Distributions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_Distributions" xlink:to="FONR_Distributions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_Distributions_lbl" xml:lang="en-US">Distributions</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_EndingMembersEquity" xlink:label="FONR_EndingMembersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EndingMembersEquity" xlink:to="FONR_EndingMembersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EndingMembersEquity_lbl" xml:lang="en-US">Ending Members Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xml:lang="en-US">Consolidation, Less-than-Wholly-Owned Subsidiary, Parent Ownership Interest, Effect of Change [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" xml:lang="en-US">Ownership interest of investors</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_EquityMethodInvestmentOwnershipPercentages" xlink:label="FONR_EquityMethodInvestmentOwnershipPercentages" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EquityMethodInvestmentOwnershipPercentages" xlink:to="FONR_EquityMethodInvestmentOwnershipPercentages_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EquityMethodInvestmentOwnershipPercentages_lbl" xml:lang="en-US">Ownership interest of company</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ProceedsFromContributionsFromCompany" xlink:label="FONR_ProceedsFromContributionsFromCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProceedsFromContributionsFromCompany" xlink:to="FONR_ProceedsFromContributionsFromCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProceedsFromContributionsFromCompany_lbl" xml:lang="en-US">Company contribution</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="us-gaap_ProceedsFromContributionsFromAffiliates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromContributionsFromAffiliates" xlink:to="us-gaap_ProceedsFromContributionsFromAffiliates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromContributionsFromAffiliates_lbl" xml:lang="en-US">Investors contribution</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PurchaseOfStandupMriCenters" xlink:label="FONR_PurchaseOfStandupMriCenters" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfStandupMriCenters" xlink:to="FONR_PurchaseOfStandupMriCenters_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PurchaseOfStandupMriCenters_lbl" xml:lang="en-US">Purchase of stand up MRI centers</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PurchaseOfOtherMriCenters" xlink:label="FONR_PurchaseOfOtherMriCenters" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfOtherMriCenters" xlink:to="FONR_PurchaseOfOtherMriCenters_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PurchaseOfOtherMriCenters_lbl" xml:lang="en-US">Purchase of other MRI centers</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ConsiderationToOutsideInvestors" xlink:label="FONR_ConsiderationToOutsideInvestors" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConsiderationToOutsideInvestors" xlink:to="FONR_ConsiderationToOutsideInvestors_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ConsiderationToOutsideInvestors_lbl" xml:lang="en-US">HDM purchase price includes consideration to outside investors</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_TotalPurchasePrice" xlink:label="FONR_TotalPurchasePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalPurchasePrice" xlink:to="FONR_TotalPurchasePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalPurchasePrice_lbl" xml:lang="en-US">HDM purchase from Health Diagnostics (HD) ($)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ConsiderationForNoncompetitionAndConsultingAgreements" xlink:label="FONR_ConsiderationForNoncompetitionAndConsultingAgreements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConsiderationForNoncompetitionAndConsultingAgreements" xlink:to="FONR_ConsiderationForNoncompetitionAndConsultingAgreements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ConsiderationForNoncompetitionAndConsultingAgreements_lbl" xml:lang="en-US">HDM entered agreement for consulting and non-competition agreement ($)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_EquityMethodInvestmentsOwnershipPercentage" xlink:label="FONR_EquityMethodInvestmentsOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EquityMethodInvestmentsOwnershipPercentage" xlink:to="FONR_EquityMethodInvestmentsOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EquityMethodInvestmentsOwnershipPercentage_lbl" xml:lang="en-US">Purchase of interests from Class A, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="FONR_DirectPurchaseOfNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DirectPurchaseOfNoncontrollingInterests" xlink:to="FONR_DirectPurchaseOfNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DirectPurchaseOfNoncontrollingInterests_lbl" xml:lang="en-US">Purchase of interests from Class A</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US">Long term debt, notes payable and capital leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_lbl" xml:lang="en-US">Current portion of long term debt, notes payable and capital leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations_lbl" xml:lang="en-US">Long term debt, notes payable and capital leases less current portion</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:to="FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract_2_lbl" xml:lang="en-US">Long-term Debt Notes Payable And Capital Leases - Maturities Of Long Term Debt Over 5 Years -</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xml:lang="en-US">2026</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebt_2_lbl" xml:lang="en-US">Total long term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_MonthlyPaymentPeriod" xlink:label="FONR_MonthlyPaymentPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MonthlyPaymentPeriod" xlink:to="FONR_MonthlyPaymentPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MonthlyPaymentPeriod_lbl" xml:lang="en-US">Monthly payment period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xml:lang="en-US">Debt instrument, periodic payment</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_MaturityDate" xlink:label="FONR_MaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MaturityDate" xlink:to="FONR_MaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MaturityDate_lbl" xml:lang="en-US">Maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_BookValueOfBuilding" xlink:label="FONR_BookValueOfBuilding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BookValueOfBuilding" xlink:to="FONR_BookValueOfBuilding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BookValueOfBuilding_lbl" xml:lang="en-US">Book value of building</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xml:lang="en-US">Proceeds from lines of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xml:lang="en-US">Current:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">State</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Subtotal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xml:lang="en-US">Deferred:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Federal deferred taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">State deferred taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DeferredIncomeTaxExpensesBenefit" xlink:label="FONR_DeferredIncomeTaxExpensesBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DeferredIncomeTaxExpensesBenefit" xlink:to="FONR_DeferredIncomeTaxExpensesBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="FONR_DeferredIncomeTaxExpensesBenefit_lbl" xml:lang="en-US">Subtotal</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Provision (Benefit) for Income Taxes - Net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates" xlink:label="FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates" xlink:to="FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_lbl" xml:lang="en-US">Taxes at federal statutory rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State and local income taxes (benefit), net of federal benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_lbl" xml:lang="en-US">Noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_lbl" xml:lang="en-US">Expiration of tax credits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xml:lang="en-US">Return to provision adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in the valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective income tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xml:lang="en-US">Deferred tax assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl" xml:lang="en-US">Allowance for credit losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Non-deductible accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xml:lang="en-US">Tax credits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xml:lang="en-US">Capitalized research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities" xlink:label="FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities" xlink:to="FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities_lbl" xml:lang="en-US">Right of use assets and lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="us-gaap_DeferredTaxAssetsInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInventory" xlink:to="us-gaap_DeferredTaxAssetsInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsInventory_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Deferred Tax Assets - gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Total deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment and depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_lbl" xml:lang="en-US">Intangibles</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xml:lang="en-US">Total deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred tax asset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:label="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:to="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_lbl" xml:lang="en-US">Deferred tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Allowance for doubtful accounts and tax credits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">State operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherOperatingIncome" xlink:label="us-gaap_OtherOperatingIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingIncome" xlink:to="us-gaap_OtherOperatingIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherOperatingIncome_lbl" xml:lang="en-US">City operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:label="us-gaap_OperatingLossCarryforwardsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:to="us-gaap_OperatingLossCarryforwardsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance of state operating losses</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PercentageOfExciseTax" xlink:label="FONR_PercentageOfExciseTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfExciseTax" xlink:to="FONR_PercentageOfExciseTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PercentageOfExciseTax_lbl" xml:lang="en-US">Percentage of excise tax</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CorporateAlternativeMinimumTaxPercentage" xlink:label="FONR_CorporateAlternativeMinimumTaxPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CorporateAlternativeMinimumTaxPercentage" xlink:to="FONR_CorporateAlternativeMinimumTaxPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CorporateAlternativeMinimumTaxPercentage_lbl" xml:lang="en-US">Corporate alternative minimum tax percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" xlink:label="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" xlink:to="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_lbl" xml:lang="en-US">Valuation allowance for deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xml:lang="en-US">Tax credits carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalariesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xml:lang="en-US">Accrued salaries, commissions and payroll taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xml:lang="en-US">Sales tax payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="us-gaap_TaxesPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:to="us-gaap_TaxesPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxesPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">State income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xml:lang="en-US">Legal and other professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounting fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserve" xlink:label="us-gaap_SelfInsuranceReserve" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SelfInsuranceReserve" xlink:to="us-gaap_SelfInsuranceReserve_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SelfInsuranceReserve_lbl" xml:lang="en-US">Self-funded health insurance reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl" xml:lang="en-US">Accrued interest and penalty</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_2_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_LeaseAndRentalExpenses" xlink:label="FONR_LeaseAndRentalExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_LeaseAndRentalExpenses" xlink:to="FONR_LeaseAndRentalExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_LeaseAndRentalExpenses_lbl" xml:lang="en-US">Rent expense for operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PropertyTaxAbatementFromSuffolkCountyIda" xlink:label="FONR_PropertyTaxAbatementFromSuffolkCountyIda" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PropertyTaxAbatementFromSuffolkCountyIda" xlink:to="FONR_PropertyTaxAbatementFromSuffolkCountyIda_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PropertyTaxAbatementFromSuffolkCountyIda_lbl" xml:lang="en-US">Property tax abatement from suffolk county IDA</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PropertyTaxAbatement" xlink:label="FONR_PropertyTaxAbatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PropertyTaxAbatement" xlink:to="FONR_PropertyTaxAbatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PropertyTaxAbatement_lbl" xml:lang="en-US">Property tax abatement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP_lbl" xml:lang="en-US">Employer contributions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReinsurancePayable" xlink:label="us-gaap_ReinsurancePayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReinsurancePayable" xlink:to="us-gaap_ReinsurancePayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReinsurancePayable_lbl" xml:lang="en-US">Liability for individual claims</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_lbl" xml:lang="en-US">Reserve for self-funded</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Income taxes paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="us-gaap_ConvertibleNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayable_lbl" xml:lang="en-US">Sale of price of the equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFixedInterestRate" xlink:label="us-gaap_DerivativeFixedInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFixedInterestRate" xlink:to="us-gaap_DerivativeFixedInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeFixedInterestRate_lbl" xml:lang="en-US">Bears interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredGainOnSaleOfProperty" xlink:label="us-gaap_DeferredGainOnSaleOfProperty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredGainOnSaleOfProperty" xlink:to="us-gaap_DeferredGainOnSaleOfProperty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredGainOnSaleOfProperty_lbl" xml:lang="en-US">Gain on sale of equipments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionDescriptionOfTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:to="us-gaap_RelatedPartyTransactionDescriptionOfTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDescriptionOfTransaction_lbl" xml:lang="en-US">Related party transaction, description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xml:lang="en-US">Monthly fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_lbl" xml:lang="en-US">Segment Reporting, Revenue from External Customer, Product and Service [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:label="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_lbl" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Net revenues from external customers</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_IntersegmentNetRevenues" xlink:label="FONR_IntersegmentNetRevenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IntersegmentNetRevenues" xlink:to="FONR_IntersegmentNetRevenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IntersegmentNetRevenues_lbl" xml:lang="en-US">Inter-segment net revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="us-gaap_IncomeLossFromContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperations_lbl" xml:lang="en-US">(Loss) Income from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNet" xlink:label="us-gaap_AssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNet_lbl" xml:lang="en-US">Total identifiable assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US">Capital expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ForeignProductSales" xlink:label="FONR_ForeignProductSales" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ForeignProductSales" xlink:to="FONR_ForeignProductSales_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ForeignProductSales_lbl" xml:lang="en-US">Foreign product sales</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ForeignServiceAndRepairFees" xlink:label="FONR_ForeignServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ForeignServiceAndRepairFees" xlink:to="FONR_ForeignServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ForeignServiceAndRepairFees_lbl" xml:lang="en-US">Foreign service and repair fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ExportSalesOfMedicalEquipmentPercentage" xlink:label="FONR_ExportSalesOfMedicalEquipmentPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ExportSalesOfMedicalEquipmentPercentage" xlink:to="FONR_ExportSalesOfMedicalEquipmentPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ExportSalesOfMedicalEquipmentPercentage_lbl" xml:lang="en-US">Export sales of medical equipment percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" xlink:label="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" xlink:to="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_lbl" xml:lang="en-US">Percentage of service and repair of medical equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xml:lang="en-US">Number of shares repurchased, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xml:lang="en-US">Number of shares repurchased, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IntersegmentNetRevenues" xlink:to="FONR_IntersegmentNetRevenues_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_IntersegmentNetRevenues_doc" xml:lang="en-US">This represents the amount of intersegment net revenues during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatentsAndCopyrightsMember" xlink:to="FONR_PatentsAndCopyrightsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PatentsAndCopyrightsMember_doc" xml:lang="en-US">Patents and copyrights - Member - Custom elements</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueNoncurrent_2_lbl" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockValue_2_lbl" xml:lang="en-US">Treasury Stock, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Equity, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_2_lbl" xml:lang="en-US">Costs and Expenses [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseNonoperating" xlink:to="us-gaap_InterestExpenseNonoperating_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseNonoperating_2_lbl" xml:lang="en-US">Interest Expense, Nonoperating</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_lbl" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_GainOnSaleOfEquipmentRelatedParty" xlink:to="FONR_GainOnSaleOfEquipmentRelatedParty_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_GainOnSaleOfEquipmentRelatedParty_2_lbl" xml:lang="en-US">GainOnSaleOfEquipmentRelatedParty</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_GainlossOnDispositionOfFixedAssets" xlink:to="FONR_GainlossOnDispositionOfFixedAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_GainlossOnDispositionOfFixedAssets_2_lbl" xml:lang="en-US">GainlossOnDispositionOfFixedAssets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expenses, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:to="us-gaap_PaymentsForProceedsFromShortTermInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForProceedsFromShortTermInvestments_2_lbl" xml:lang="en-US">Payments for (Proceeds from) Short-Term Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_2_lbl" xml:lang="en-US">Repayments of Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_2_lbl" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryIndName_2_lbl" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryIndName_2_lbl" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndName_2_lbl" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcessPolicy" xlink:to="us-gaap_InventoryWorkInProcessPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcessPolicy_2_lbl" xml:lang="en-US">Inventory Work in Process, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_2_lbl" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_2_lbl" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_3_lbl" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscountFinancingLease" xlink:to="FONR_PresentValueDiscountFinancingLease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PresentValueDiscountFinancingLease_2_lbl" xml:lang="en-US">PresentValueDiscountFinancingLease</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiability" xlink:to="us-gaap_FinanceLeaseLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiability_2_lbl" xml:lang="en-US">Finance Lease, Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsNet" xlink:to="us-gaap_OtherIntangibleAssetsNet_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIntangibleAssetsNet_3_lbl" xml:lang="en-US">Other Intangible Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_2_lbl" xml:lang="en-US">Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_2_lbl" xml:lang="en-US">Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DeferredIncomeTaxExpensesBenefit" xlink:to="FONR_DeferredIncomeTaxExpensesBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DeferredIncomeTaxExpensesBenefit_2_lbl" xml:lang="en-US">DeferredIncomeTaxExpensesBenefit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInventory" xlink:to="us-gaap_DeferredTaxAssetsInventory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInventory_2_lbl" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_2_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Goodwill and Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilities_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="us-gaap_OtherSundryLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent_2_lbl" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>fonr-20240630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20240630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:href="fonr-20240630.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20240630.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfIncome" xlink:href="fonr-20240630.xsd#ConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="fonr-20240630.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="fonr-20240630.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:href="fonr-20240630.xsd#DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20240630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20240630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories" xlink:href="fonr-20240630.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipment" xlink:href="fonr-20240630.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases" xlink:href="fonr-20240630.xsd#OperatingFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets" xlink:href="fonr-20240630.xsd#OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CapitalStock" xlink:href="fonr-20240630.xsd#CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests" xlink:href="fonr-20240630.xsd#ControllingAndNoncontrollingInterests" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases" xlink:href="fonr-20240630.xsd#Long-termDebtNotesPayableAndCapitalLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes" xlink:href="fonr-20240630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities" xlink:href="fonr-20240630.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingencies" xlink:href="fonr-20240630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformation" xlink:href="fonr-20240630.xsd#SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/RelatedPartyTransactions" xlink:href="fonr-20240630.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation" xlink:href="fonr-20240630.xsd#SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEvents" xlink:href="fonr-20240630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20240630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20240630.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20240630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/InventoriesTables" xlink:href="fonr-20240630.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipmentTables" xlink:href="fonr-20240630.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:href="fonr-20240630.xsd#OperatingFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:href="fonr-20240630.xsd#OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" xlink:href="fonr-20240630.xsd#ControllingAndNoncontrollingInterestsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:href="fonr-20240630.xsd#Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesTables" xlink:href="fonr-20240630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:href="fonr-20240630.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:href="fonr-20240630.xsd#SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:href="fonr-20240630.xsd#DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:href="fonr-20240630.xsd#SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:href="fonr-20240630.xsd#SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:href="fonr-20240630.xsd#SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20240630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:href="fonr-20240630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails" xlink:href="fonr-20240630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:href="fonr-20240630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20240630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories-InventoriesDetails" xlink:href="fonr-20240630.xsd#Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:href="fonr-20240630.xsd#PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="fonr-20240630.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20240630.xsd#OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:href="fonr-20240630.xsd#OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails" xlink:href="fonr-20240630.xsd#OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails" xlink:href="fonr-20240630.xsd#OperatingFinancingLeases-RelatedToLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails" xlink:href="fonr-20240630.xsd#OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details" xlink:href="fonr-20240630.xsd#OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details" xlink:href="fonr-20240630.xsd#OtherIntangibleAssets-IntangleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20240630.xsd#OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CapitalStockDetailsNarrative" xlink:href="fonr-20240630.xsd#CapitalStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:href="fonr-20240630.xsd#ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:href="fonr-20240630.xsd#ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Details" xlink:href="fonr-20240630.xsd#Long-termDebtNotesPayableAndCapitalLeases-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLongTermDebtOver5Years-Details" xlink:href="fonr-20240630.xsd#Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLongTermDebtOver5Years-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative" xlink:href="fonr-20240630.xsd#Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:href="fonr-20240630.xsd#IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:href="fonr-20240630.xsd#IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details" xlink:href="fonr-20240630.xsd#IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:href="fonr-20240630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20240630.xsd#OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20240630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20240630.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="fonr-20240630.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details" xlink:href="fonr-20240630.xsd#SegmentAndRelatedInformation-SummarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:href="fonr-20240630.xsd#SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:href="fonr-20240630.xsd#SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" xlink:href="fonr-20240630.xsd#SegmentAndRelatedInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:href="fonr-20240630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_deiDocumentFinStmtErrorCorrectionFlag" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFinStmtErrorCorrectionFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedFeesAndOtherRevenueReceivable" xlink:label="loc_us-gaapAccruedFeesAndOtherRevenueReceivable" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccruedFeesAndOtherRevenueReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountsReceivableNetLongTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_NoteReceivableRelatedParty" xlink:label="loc_FONRNoteReceivableRelatedParty" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRNoteReceivableRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_FONRCustomerDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_AccountsPayableRelatedPartyNoncurrent" xlink:label="loc_FONRAccountsPayableRelatedPartyNoncurrent" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_FONRAccountsPayableRelatedPartyNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:label="loc_FONRManagementAndOtherReceivableAllowancesForDoubtfulAccounts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:label="loc_FONRRelatedPartyReceivableAllowancesForDoubtfulAccounts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRRelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaapTreasuryStockCommonShares" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockCommonShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CommonStockholdersMember" xlink:label="loc_FONRCommonStockholdersMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRCommonStockholdersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ClassANonVotingPreferredStockholdersMember" xlink:label="loc_FONRClassANonVotingPreferredStockholdersMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockholdersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRProductSalesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRServiceAndRepairFeesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRManagementAndOtherFeesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaapCostsAndExpensesAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToProductSales" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_InvestmentIncomeRelatedParty" xlink:label="loc_FONRInvestmentIncomeRelatedParty" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRInvestmentIncomeRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_OtherIncomeRelatedParty" xlink:label="loc_FONROtherIncomeRelatedParty" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROtherIncomeRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="80" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ClassANonVotingPreferredMember" xlink:label="loc_FONRClassANonVotingPreferredMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_FONRClassANonVotingPreferredMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ClassCCommonStockMember" xlink:label="loc_FONRClassCCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_FONRClassCCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaapTreasuryStockCommonMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapTreasuryStockCommonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationForfeited" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ProvisionForBadDebts" xlink:label="loc_FONRProvisionForBadDebts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRProvisionForBadDebts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_GainOnSaleOfEquipmentRelatedParty" xlink:label="loc_FONRGainOnSaleOfEquipmentRelatedParty" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRGainOnSaleOfEquipmentRelatedParty" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_GainlossOnDispositionOfFixedAssets" xlink:label="loc_FONRGainlossOnDispositionOfFixedAssets" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_FONRGainlossOnDispositionOfFixedAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_AbandonedPatents" xlink:label="loc_FONRAbandonedPatents" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_FONRAbandonedPatents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_IncreaseDecreaseInNotesReceivable" xlink:label="loc_FONRIncreaseDecreaseInNotesReceivable" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_FONRIncreaseDecreaseInNotesReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="loc_FONRIncreaseDecreaseInCustomerAdvance" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_FONRIncreaseDecreaseInCustomerAdvance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInTradingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInTradingLiabilities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInTradingLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:label="loc_us-gaapPaymentsForProceedsFromShortTermInvestments" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForProceedsFromShortTermInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfEquity" xlink:label="loc_us-gaapPaymentsForRepurchaseOfEquity" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForRepurchaseOfEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:title="995410 - Disclosure - Pay vs Performance Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="loc_ecdPayVsPerformanceDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="loc_ecdPvpTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis" xlink:label="loc_ecdExecutiveCategoryAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdExecutiveCategoryAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember" xlink:label="loc_ecdAllExecutiveCategoriesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdExecutiveCategoryAxis" xlink:to="loc_ecdAllExecutiveCategoriesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="loc_ecdAdjToCompAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdAdjToCompAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAdjToCompAxis" xlink:to="loc_ecdAllAdjToCompMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis" xlink:label="loc_ecdMeasureAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdMeasureAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="loc_ecdPvpTableTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="loc_ecdCoSelectedMeasureName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdCoSelectedMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="loc_ecdNamedExecutiveOfficersFnTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNamedExecutiveOfficersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="loc_ecdPeerGroupIssuersFnTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupIssuersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="loc_ecdChangedPeerGroupFnTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdChangedPeerGroupFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="loc_ecdPeoTotalCompAmt" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="loc_ecdPeoActuallyPaidCompAmt" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoActuallyPaidCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="loc_ecdAdjToPeoCompFnTextBlock" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToPeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="loc_ecdNonPeoNeoAvgTotalCompAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="loc_ecdAdjToNonPeoNeoCompFnTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdAdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:presentationArc order="2140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" />
      <link:presentationArc order="2150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" />
      <link:presentationArc order="2160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="loc_ecdTabularListTableTextBlock" />
      <link:presentationArc order="2170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTabularListTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="loc_ecdTotalShareholderRtnAmt" />
      <link:presentationArc order="2180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="loc_ecdPeerGroupTotalShareholderRtnAmt" />
      <link:presentationArc order="2190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdPeerGroupTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="2200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="loc_ecdCoSelectedMeasureAmt" />
      <link:presentationArc order="2210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdCoSelectedMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="loc_ecdOtherPerfMeasureAmt" />
      <link:presentationArc order="2220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdOtherPerfMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="loc_ecdAdjToCompAmt" />
      <link:presentationArc order="2230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdAdjToCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="loc_ecdPeoName" />
      <link:presentationArc order="2240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdPeoName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="loc_ecdMeasureName" />
      <link:presentationArc order="2250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="loc_ecdNonGaapMeasureDescriptionTextBlock" />
      <link:presentationArc order="2260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdMeasureName" xlink:to="loc_ecdNonGaapMeasureDescriptionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="loc_ecdAdditional402vDisclosureTextBlock" />
      <link:presentationArc order="2270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdditional402vDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="loc_ecdPnsnBnftsAdjFnTextBlock" />
      <link:presentationArc order="2280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPnsnBnftsAdjFnTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:title="995440 - Disclosure - Recovery of Erroneously Awarded Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems" xlink:label="loc_ecdRecoveryOfErrCompDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="loc_ecdErrCompRecoveryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdErrCompRecoveryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="loc_ecdRestatementDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdRestatementDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="loc_ecdRestatementDeterminationDate" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdRestatementDeterminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="loc_ecdAggtErrCompAmt" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="loc_ecdErrCompAnalysisTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdErrCompAnalysisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="loc_ecdOutstandingAggtErrCompAmt" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdOutstandingAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="loc_ecdAggtErrCompNotYetDeterminedTextBlock" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdAggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="loc_ecdForgoneRecoveryIndName" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="loc_ecdOutstandingRecoveryIndName" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="loc_ecdOutstandingRecoveryCompAmt" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:title="995443 - Disclosure - Award Timing Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems" xlink:label="loc_ecdAwardTmgDiscLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="loc_ecdAwardsCloseToMnpiDiscTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_ecdIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="loc_ecdAwardTmgMnpiDiscTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiDiscTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="loc_ecdAwardTmgMethodTextBlock" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="loc_ecdAwardTmgPredtrmndFlag" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgPredtrmndFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="loc_ecdAwardTmgMnpiCnsdrdFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiCnsdrdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="loc_ecdMnpiDiscTimedForCompValFlag" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdMnpiDiscTimedForCompValFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="loc_ecdAwardsCloseToMnpiDiscIndName" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="loc_ecdAwardUndrlygSecuritiesAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardUndrlygSecuritiesAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="loc_ecdAwardExrcPrice" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardExrcPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="loc_ecdAwardGrantDateFairValue" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="loc_ecdUndrlygSecurityMktPriceChngPct" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdUndrlygSecurityMktPriceChngPct" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable" xlink:label="loc_ecdTradingArrByIndTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTradingArrByIndTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis" xlink:label="loc_ecdTradingArrAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdTradingArrAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember" xlink:label="loc_ecdAllTradingArrangementsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrAxis" xlink:to="loc_ecdAllTradingArrangementsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="loc_ecdMtrlTermsOfTrdArrTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdMtrlTermsOfTrdArrTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="loc_ecdTrdArrIndName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="loc_ecdTrdArrIndTitle" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="loc_ecdTrdArrAdoptionDate" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrAdoptionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="loc_ecdTrdArrTerminationDate" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrTerminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="loc_ecdTrdArrExpirationDate" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="loc_ecdTrdArrDuration" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrDuration" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="loc_ecdInsiderTradingPoliciesProcLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:title="995612 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="995613 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="995614 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories" xlink:title="995615 - Disclosure - INVENTORIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipment" xlink:title="995616 - Disclosure - PROPERTY AND EQUIPMENT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases" xlink:title="995617 - Disclosure - OPERATING &amp; FINANCING LEASES">
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets" xlink:title="995618 - Disclosure - OTHER INTANGIBLE ASSETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CapitalStock" xlink:title="995619 - Disclosure - CAPITAL STOCK">
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DisclosureCapitalStockAbstract" xlink:label="loc_FONRDisclosureCapitalStockAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CapitalStockDisclosureTextblock" xlink:label="loc_FONRCapitalStockDisclosureTextblock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureCapitalStockAbstract" xlink:to="loc_FONRCapitalStockDisclosureTextblock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterests" xlink:title="995620 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="loc_us-gaapMinorityInterestDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapMinorityInterestDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases" xlink:title="995621 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES">
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:label="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock" xlink:label="loc_FONRLongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:to="loc_FONRLongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes" xlink:title="995622 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities" xlink:title="995623 - Disclosure - OTHER CURRENT LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingencies" xlink:title="995624 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformation" xlink:title="995625 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactions" xlink:title="995626 - Disclosure - RELATED PARTY TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation" xlink:title="995627 - Disclosure - SEGMENT AND RELATED INFORMATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEvents" xlink:title="995628 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="995629 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessPolicy" xlink:label="loc_us-gaapInventoryWorkInProcessPolicy" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryWorkInProcessPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsGoodwillPolicy" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_MedicalReceivableAndManagementAndOtherFeesReceivablePolicyTextBlock" xlink:label="loc_FONRMedicalReceivableAndManagementAndOtherFeesReceivablePolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_FONRMedicalReceivableAndManagementAndOtherFeesReceivablePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="loc_us-gaapReceivablesPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapReceivablesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaapAdvertisingCostsPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAdvertisingCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CustomerAdvancesPolicyTextBlock" xlink:label="loc_FONRCustomerAdvancesPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_FONRCustomerAdvancesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="loc_us-gaapInvestmentPolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInvestmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_RecentAccountingStandardsPolicyTextBlock" xlink:label="loc_FONRRecentAccountingStandardsPolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_FONRRecentAccountingStandardsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="995630 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" xlink:label="loc_FONREstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_FONREstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaapDisaggregationOfRevenueTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="995631 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:label="loc_us-gaapAllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapAllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:label="loc_FONRTotalFacilitiesOwnedOrManagedTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRTotalFacilitiesOwnedOrManagedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/InventoriesTables" xlink:title="995632 - Disclosure - INVENTORIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipmentTables" xlink:title="995633 - Disclosure - PROPERTY AND EQUIPMENT (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:title="995634 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)">
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" xlink:label="loc_FONRScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_FONRScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaapLeaseCostTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLeaseCostTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:label="loc_FONRSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_FONRSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:title="995635 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" xlink:title="995636 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:title="995637 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)">
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:label="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfDebtTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:to="loc_us-gaapScheduleOfDebtTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:to="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesTables" xlink:title="995638 - Disclosure - INCOME TAXES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:title="995639 - Disclosure - OTHER CURRENT LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:title="995640 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ScheduleOfExportProductSalesTableTextBlock" xlink:label="loc_FONRScheduleOfExportProductSalesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_FONRScheduleOfExportProductSalesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ScheduleOfExportServiceRevenuesTableTextBlock" xlink:label="loc_FONRScheduleOfExportServiceRevenuesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_FONRScheduleOfExportServiceRevenuesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:title="995641 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherInvesteesMember" xlink:label="loc_us-gaapOtherInvesteesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_us-gaapOtherInvesteesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentOwnedPercentOfNetAssets" xlink:label="loc_us-gaapInvestmentOwnedPercentOfNetAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedPercentOfNetAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:label="loc_us-gaapProceedsFromPaymentsToMinorityShareholders" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromPaymentsToMinorityShareholders" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:title="995642 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_WeightedAverageMember" xlink:label="loc_srtWeightedAverageMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtWeightedAverageMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="loc_FONRDiagnosticEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRDiagnosticEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" xlink:label="loc_FONRResearchDeveopmentAndDemonstrationEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRResearchDeveopmentAndDemonstrationEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:title="995643 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapDisaggregationOfRevenueLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="loc_FONRCommercialInsuranceManagedCareMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRCommercialInsuranceManagedCareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_MedicareMedicaidMember" xlink:label="loc_FONRMedicareMedicaidMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRMedicareMedicaidMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="loc_FONRWorkersCompensationPersonalInjuryMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRWorkersCompensationPersonalInjuryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_OtherRevenueSourceMember" xlink:label="loc_FONROtherRevenueSourceMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONROtherRevenueSourceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_NetPatientFeeRevenue" xlink:label="loc_FONRNetPatientFeeRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_FONRNetPatientFeeRevenue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:title="995644 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_NetIncomeLossAvailableToCommonStockholderBasic" xlink:label="loc_FONRNetIncomeLossAvailableToCommonStockholderBasic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetIncomeLossAvailableToCommonStockholderBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_WeightedAverageSharesOutstandingBasic" xlink:label="loc_FONRWeightedAverageSharesOutstandingBasic" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:label="loc_us-gaapWeightedAverageBasicSharesOutstandingProForma" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageBasicSharesOutstandingProForma" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" xlink:label="loc_FONRIncrementalCommonSharesAttributableToConversionOfCommonStock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRIncrementalCommonSharesAttributableToConversionOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:label="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="995645 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntellectualPropertyMember" xlink:label="loc_us-gaapIntellectualPropertyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapIntellectualPropertyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapTransactionTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DiagnosticImagingFacilityMember" xlink:label="loc_FONRDiagnosticImagingFacilityMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_FONRDiagnosticImagingFacilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_RelatedPartiesMember" xlink:label="loc_FONRRelatedPartiesMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_FONRRelatedPartiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_RelatedPartiesMedicalPracticesMember" xlink:label="loc_FONRRelatedPartiesMedicalPracticesMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_FONRRelatedPartiesMedicalPracticesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfPropertyRepairsAndMaintenance" xlink:label="loc_us-gaapCostOfPropertyRepairsAndMaintenance" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCostOfPropertyRepairsAndMaintenance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" xlink:label="loc_FONRManagementAgreementsWithCompanyTotalMedicalPractices" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRManagementAgreementsWithCompanyTotalMedicalPractices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:label="loc_FONRScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:label="loc_FONRScannersWithManagementWithCompanyLocatedInNewYorkState" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ContractualFeesForServicesRenderedMinimum" xlink:label="loc_FONRContractualFeesForServicesRenderedMinimum" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRContractualFeesForServicesRenderedMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ContractualFeesForServicesRenderedMaximum" xlink:label="loc_FONRContractualFeesForServicesRenderedMaximum" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRContractualFeesForServicesRenderedMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ProvisionForBadDebts" xlink:label="loc_FONRProvisionForBadDebts" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRProvisionForBadDebts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementFeeReceivableForUnrelatedParties" xlink:label="loc_FONRManagementFeeReceivableForUnrelatedParties" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRManagementFeeReceivableForUnrelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementFeeReceivableForRelatedParties" xlink:label="loc_FONRManagementFeeReceivableForRelatedParties" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRManagementFeeReceivableForRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_AccountsReceivableServiceContractsNet" xlink:label="loc_FONRAccountsReceivableServiceContractsNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRAccountsReceivableServiceContractsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationPenaltiesExpense" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:label="loc_FONRNumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRNumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCashFDICInsuredAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:title="995646 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractReceivableDueTwoToThreeYears" xlink:label="loc_us-gaapContractReceivableDueTwoToThreeYears" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueTwoToThreeYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractReceivableDueThreeToFourYears" xlink:label="loc_us-gaapContractReceivableDueThreeToFourYears" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueThreeToFourYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractReceivableDueFourToFiveYears" xlink:label="loc_us-gaapContractReceivableDueFourToFiveYears" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueFourToFiveYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractReceivableDueFiveYearsOrMore" xlink:label="loc_us-gaapContractReceivableDueFiveYearsOrMore" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueFiveYearsOrMore" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails" xlink:title="995647 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementAndOtherFeesReceivableMember" xlink:label="loc_FONRManagementAndOtherFeesReceivableMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_FONRManagementAndOtherFeesReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:label="loc_FONRManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_FONRManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesReceivableMember" xlink:label="loc_us-gaapNotesReceivableMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapNotesReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_AllowanceForDoubtfulAccountsAdditions" xlink:label="loc_FONRAllowanceForDoubtfulAccountsAdditions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAllowanceForDoubtfulAccountsAdditions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_AllowanceForDoubtfulAccountsDeductions" xlink:label="loc_FONRAllowanceForDoubtfulAccountsDeductions" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAllowanceForDoubtfulAccountsDeductions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:title="995648 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" xlink:label="loc_FONRTotalFacilitiesOwnedOrManagedAtBeginningOfYear" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRTotalFacilitiesOwnedOrManagedAtBeginningOfYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagedFacilitiesAddedByInternalDevelopment" xlink:label="loc_FONRManagedFacilitiesAddedByInternalDevelopment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRManagedFacilitiesAddedByInternalDevelopment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ManagedFacilitiesClosedDuringYear" xlink:label="loc_FONRManagedFacilitiesClosedDuringYear" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRManagedFacilitiesClosedDuringYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" xlink:label="loc_FONRTotalFacilitiesOwnedOrManagedAtEndOfYear" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRTotalFacilitiesOwnedOrManagedAtEndOfYear" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="995649 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRAccountsReceivableNetLongTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:label="loc_FONRPercentageOfConsolidatedNetRevenueFromManagementFees" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRPercentageOfConsolidatedNetRevenueFromManagementFees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories-InventoriesDetails" xlink:title="995650 - Disclosure - INVENTORIES - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherInventorySupplies" xlink:label="loc_us-gaapOtherInventorySupplies" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapOtherInventorySupplies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:title="995651 - Disclosure - PROPERTY AND EQUIPMENT - Property and equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="loc_FONRDiagnosticEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRDiagnosticEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ResearchDevelopmentAndDemonstrationEquipmentMember" xlink:label="loc_FONRResearchDevelopmentAndDemonstrationEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRResearchDevelopmentAndDemonstrationEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="995652 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapPropertyPlantAndEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapPropertyPlantAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="995653 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease payments (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_OperatingLeasePaymentsMember" xlink:label="loc_FONROperatingLeasePaymentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONROperatingLeasePaymentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_FinancingLeasePaymentsMember" xlink:label="loc_FONRFinancingLeasePaymentsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONRFinancingLeasePaymentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PresentValueDiscount" xlink:label="loc_FONRPresentValueDiscount" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="loc_FONRPresentValueDiscountFinancingLease" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscountFinancingLease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaapFinanceLeaseLiability" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:title="995654 - Disclosure - OPERATING &amp; FINANCING LEASES - Weighted average remaining lease term (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapFinanceLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapFinanceLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails" xlink:title="995655 - Disclosure - OPERATING &amp; FINANCING LEASES - Components of lease expense (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_FinanceLeaseCostsAbstract" xlink:label="loc_FONRFinanceLeaseCostsAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_FONRFinanceLeaseCostsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DepreciationOfLeasedEquipment" xlink:label="loc_FONRDepreciationOfLeasedEquipment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRFinanceLeaseCostsAbstract" xlink:to="loc_FONRDepreciationOfLeasedEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="loc_us-gaapFinanceLeaseInterestExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRFinanceLeaseCostsAbstract" xlink:to="loc_us-gaapFinanceLeaseInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_FinanceLeaseCost" xlink:label="loc_FONRFinanceLeaseCost" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRFinanceLeaseCostsAbstract" xlink:to="loc_FONRFinanceLeaseCost" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails" xlink:title="995656 - Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_OperatingCashFlowsFromOperatingLeases" xlink:label="loc_FONROperatingCashFlowsFromOperatingLeases" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_FONROperatingCashFlowsFromOperatingLeases" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_FinancingCashFlowsFromFinancingLeases" xlink:label="loc_FONRFinancingCashFlowsFromFinancingLeases" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_FONRFinancingCashFlowsFromFinancingLeases" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:label="loc_FONRRightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_FONRRightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:label="loc_FONRRightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_FONRRightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails" xlink:title="995657 - Disclosure - OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details" xlink:title="995658 - Disclosure - OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details" xlink:title="995659 - Disclosure - OTHER INTANGIBLE ASSETS - Intangle assets - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_AmountsCapitalized" xlink:label="loc_FONRAmountsCapitalized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_FONRAmountsCapitalized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_SoftwareOrPatentsWrittenOff" xlink:label="loc_FONRSoftwareOrPatentsWrittenOff" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_FONRSoftwareOrPatentsWrittenOff" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaapAdjustmentForAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapAdjustmentForAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherIntangibleAssetsNet_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:title="995660 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CapitalStockDetailsNarrative" xlink:title="995661 - Disclosure - CAPITAL STOCK (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DisclosureCapitalStockAbstract" xlink:label="loc_FONRDisclosureCapitalStockAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureCapitalStockAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredClassAMember" xlink:label="loc_us-gaapPreferredClassAMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_N2010StockBonusPlanMember" xlink:label="loc_FONRN2010StockBonusPlanMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_FONRN2010StockBonusPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtBoardOfDirectorsChairmanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableNature" xlink:label="loc_us-gaapDividendsPayableNature" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPayableNature" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:label="loc_us-gaapStockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaapCommonStockVotingRights" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockVotingRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_SharesRegistered" xlink:label="loc_FONRSharesRegistered" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRSharesRegistered" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfEquity" xlink:label="loc_us-gaapPaymentsForRepurchaseOfEquity" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForRepurchaseOfEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CancellationOfTreasuryShares" xlink:label="loc_FONRCancellationOfTreasuryShares" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCancellationOfTreasuryShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CancellationOfTreasuryStock" xlink:label="loc_FONRCancellationOfTreasuryStock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCancellationOfTreasuryStock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:title="995662 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestTable" xlink:label="loc_us-gaapMinorityInterestTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapMinorityInterestTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestLineItems" xlink:label="loc_us-gaapMinorityInterestLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_us-gaapMinorityInterestLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_HDMEquityMember" xlink:label="loc_FONRHDMEquityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRHDMEquityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_OpeningMembersEquity" xlink:label="loc_FONROpeningMembersEquity" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONROpeningMembersEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ShareOfNetIncome" xlink:label="loc_FONRShareOfNetIncome" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRShareOfNetIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_BuyoutOfNoncontrollingInterestsValue" xlink:label="loc_FONRBuyoutOfNoncontrollingInterestsValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRBuyoutOfNoncontrollingInterestsValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_Distributions" xlink:label="loc_FONRDistributions" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRDistributions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_EndingMembersEquity" xlink:label="loc_FONREndingMembersEquity" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONREndingMembersEquity" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:title="995663 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_HDMMember" xlink:label="loc_FONRHDMMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_FONRHDMMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_srtOwnershipAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ClassAControllingInterestsMember" xlink:label="loc_FONRClassAControllingInterestsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_FONRClassAControllingInterestsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherOwnershipInterestsByNameAxis" xlink:label="loc_us-gaapOtherOwnershipInterestsByNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapOtherOwnershipInterestsByNameAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherOwnershipInterestsNameDomain" xlink:label="loc_us-gaapOtherOwnershipInterestsNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherOwnershipInterestsByNameAxis" xlink:to="loc_us-gaapOtherOwnershipInterestsNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ClassBControllingInterestsMember" xlink:label="loc_FONRClassBControllingInterestsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherOwnershipInterestsNameDomain" xlink:to="loc_FONRClassBControllingInterestsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ClassAControllingInterestsMember" xlink:label="loc_FONRClassAControllingInterestsMember_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherOwnershipInterestsNameDomain" xlink:to="loc_FONRClassAControllingInterestsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_EquityMethodInvestmentOwnershipPercentages" xlink:label="loc_FONREquityMethodInvestmentOwnershipPercentages" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONREquityMethodInvestmentOwnershipPercentages" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ProceedsFromContributionsFromCompany" xlink:label="loc_FONRProceedsFromContributionsFromCompany" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRProceedsFromContributionsFromCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="loc_us-gaapProceedsFromContributionsFromAffiliates" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapProceedsFromContributionsFromAffiliates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PurchaseOfStandupMriCenters" xlink:label="loc_FONRPurchaseOfStandupMriCenters" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRPurchaseOfStandupMriCenters" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PurchaseOfOtherMriCenters" xlink:label="loc_FONRPurchaseOfOtherMriCenters" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRPurchaseOfOtherMriCenters" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ConsiderationToOutsideInvestors" xlink:label="loc_FONRConsiderationToOutsideInvestors" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRConsiderationToOutsideInvestors" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_TotalPurchasePrice" xlink:label="loc_FONRTotalPurchasePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRTotalPurchasePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ConsiderationForNoncompetitionAndConsultingAgreements" xlink:label="loc_FONRConsiderationForNoncompetitionAndConsultingAgreements" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRConsiderationForNoncompetitionAndConsultingAgreements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_EquityMethodInvestmentsOwnershipPercentage" xlink:label="loc_FONREquityMethodInvestmentsOwnershipPercentage" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONREquityMethodInvestmentsOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="loc_FONRDirectPurchaseOfNoncontrollingInterests" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRDirectPurchaseOfNoncontrollingInterests" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Details" xlink:title="995664 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:label="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_NotePayable1Member" xlink:label="loc_FONRNotePayable1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_FONRNotePayable1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_NotePayable2Member" xlink:label="loc_FONRNotePayable2Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_FONRNotePayable2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLongTermDebtOver5Years-Details" xlink:title="995665 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities of long term debt over 5 years - (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:label="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative" xlink:title="995666 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:label="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_NotePayable1Member" xlink:label="loc_FONRNotePayable1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_FONRNotePayable1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_NotePayable2Member" xlink:label="loc_FONRNotePayable2Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_FONRNotePayable2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_MonthlyPaymentPeriod" xlink:label="loc_FONRMonthlyPaymentPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_FONRMonthlyPaymentPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_MaturityDate" xlink:label="loc_FONRMaturityDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_FONRMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_BookValueOfBuilding" xlink:label="loc_FONRBookValueOfBuilding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_FONRBookValueOfBuilding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromLinesOfCredit" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:title="995667 - Disclosure - INCOME TAXES - Components of provision for income taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefitAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefitAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DeferredIncomeTaxExpensesBenefit" xlink:label="loc_FONRDeferredIncomeTaxExpensesBenefit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONRDeferredIncomeTaxExpensesBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:title="995668 - Disclosure - INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates" xlink:label="loc_FONREffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONREffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details" xlink:title="995669 - Disclosure - INCOME TAXES - Deferred tax assets and liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="loc_us-gaapDeferredTaxAssetsNetAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="loc_us-gaapDeferredTaxAssetsInProcessResearchAndDevelopment" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities" xlink:label="loc_FONRDeferredTaxAssetsInRightUseAssetsAndLiabilities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_FONRDeferredTaxAssetsInRightUseAssetsAndLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaapDeferredTaxAssetsInventory" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsInventory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssets" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:title="995670 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:label="loc_us-gaapDeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherOperatingIncome" xlink:label="loc_us-gaapOtherOperatingIncome" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOtherOperatingIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:label="loc_us-gaapOperatingLossCarryforwardsValuationAllowance" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwardsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PercentageOfExciseTax" xlink:label="loc_FONRPercentageOfExciseTax" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONRPercentageOfExciseTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_CorporateAlternativeMinimumTaxPercentage" xlink:label="loc_FONRCorporateAlternativeMinimumTaxPercentage" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONRCorporateAlternativeMinimumTaxPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" xlink:label="loc_us-gaapDeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="995671 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapTaxesPayableCurrentAndNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapTaxesPayableCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="loc_us-gaapOtherSundryLiabilitiesCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherSundryLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="995672 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_LeaseAndRentalExpenses" xlink:label="loc_FONRLeaseAndRentalExpenses" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_FONRLeaseAndRentalExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PropertyTaxAbatementFromSuffolkCountyIda" xlink:label="loc_FONRPropertyTaxAbatementFromSuffolkCountyIda" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_FONRPropertyTaxAbatementFromSuffolkCountyIda" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_PropertyTaxAbatement" xlink:label="loc_FONRPropertyTaxAbatement" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_FONRPropertyTaxAbatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:label="loc_us-gaapEmployeeStockOwnershipPlanESOPCashContributionsToESOP" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapEmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReinsurancePayable" xlink:label="loc_us-gaapReinsurancePayable" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapReinsurancePayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="loc_us-gaapLiabilityForClaimsAndClaimsAdjustmentExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="995673 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapIncomeTaxesPaid" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="995674 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_MagneticResonanceManagementMember" xlink:label="loc_FONRMagneticResonanceManagementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_FONRMagneticResonanceManagementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_BensonhurstMRILimitedPartnershipMember" xlink:label="loc_FONRBensonhurstMRILimitedPartnershipMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRBensonhurstMRILimitedPartnershipMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_RadianHealthcareManagementLLCMember" xlink:label="loc_FONRRadianHealthcareManagementLLCMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRRadianHealthcareManagementLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFixedInterestRate" xlink:label="loc_us-gaapDerivativeFixedInterestRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDerivativeFixedInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredGainOnSaleOfProperty" xlink:label="loc_us-gaapDeferredGainOnSaleOfProperty" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDeferredGainOnSaleOfProperty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:label="loc_us-gaapRelatedPartyTransactionDescriptionOfTransaction" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionDescriptionOfTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="loc_us-gaapRelatedPartyTransactionAmountsOfTransaction" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionAmountsOfTransaction" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details" xlink:title="995675 - Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:label="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:label="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareMember" xlink:label="loc_us-gaapHealthCareMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapHealthCareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareOtherMember" xlink:label="loc_us-gaapHealthCareOtherMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapHealthCareOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_IntersegmentNetRevenues" xlink:label="loc_FONRIntersegmentNetRevenues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_FONRIntersegmentNetRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNet" xlink:label="loc_us-gaapAssetsNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:title="995676 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CA" xlink:label="loc_countryCA" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_DE" xlink:label="loc_countryDE" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDE" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_AE" xlink:label="loc_countryAE" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAE" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ForeignProductSales" xlink:label="loc_FONRForeignProductSales" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_FONRForeignProductSales" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:title="995677 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_PR" xlink:label="loc_countryPR" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryPR" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CH" xlink:label="loc_countryCH" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCH" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_DE" xlink:label="loc_countryDE" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDE" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GB" xlink:label="loc_countryGB" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryGB" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_AE" xlink:label="loc_countryAE" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAE" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_DO" xlink:label="loc_countryDO" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDO" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CA" xlink:label="loc_countryCA" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GR" xlink:label="loc_countryGR" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryGR" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_AU" xlink:label="loc_countryAU" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAU" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ForeignServiceAndRepairFees" xlink:label="loc_FONRForeignServiceAndRepairFees" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_FONRForeignServiceAndRepairFees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" xlink:title="995678 - Disclosure - SEGMENT AND RELATED INFORMATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ExportSalesOfMedicalEquipmentPercentage" xlink:label="loc_FONRExportSalesOfMedicalEquipmentPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_FONRExportSalesOfMedicalEquipmentPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20240630.xsd#FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" xlink:label="loc_FONRForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_FONRForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:title="995679 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="loc_srtStockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_srtStockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845744941216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Sep. 18, 2024</div></th>
<th class="th"><div>Dec. 29, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-10248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FONAR CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000355019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">11-2464137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">110 Marcus Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Melville<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">11747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">694-2929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.0001 par
    value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FONR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 121.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Marcum<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">New York, NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,328,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845744437520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 56,341,193<span></span>
</td>
<td class="nump">$ 51,279,707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">136,102<span></span>
</td>
<td class="nump">32,799<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable &#8211; net of allowances for credit losses of $166,049 and $198,593 at June 30, 2024 and 2023, respectively</a></td>
<td class="nump">4,035,336<span></span>
</td>
<td class="nump">3,861,512<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical receivables &#8211; net</a></td>
<td class="nump">23,991,533<span></span>
</td>
<td class="nump">21,259,262<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedFeesAndOtherRevenueReceivable', window );">Management and other fees receivable &#8211; net of allowances for credit losses of $12,369,921 and $12,608,567 as of June 30, 2024 and 2023, respectively</a></td>
<td class="nump">41,953,657<span></span>
</td>
<td class="nump">35,888,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable &#8211; related party medical practices &#8211; net of allowances for credit losses of $6,110,399 and $3,989,692 as of June 30, 2024 and 2023, respectively</a></td>
<td class="nump">9,865,061<span></span>
</td>
<td class="nump">9,161,870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">2,715,441<span></span>
</td>
<td class="nump">2,569,666<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,285,962<span></span>
</td>
<td class="nump">1,607,768<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">140,324,285<span></span>
</td>
<td class="nump">125,660,837<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableNetLongTerm', window );">Accounts receivable &#8211; long term</a></td>
<td class="nump">829,473<span></span>
</td>
<td class="nump">710,085<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NoteReceivableRelatedParty', window );">Note receivable &#8211; related party</a></td>
<td class="nump">581,183<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred income tax asset</a></td>
<td class="nump">7,223,255<span></span>
</td>
<td class="nump">10,041,960<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment &#8211; net</a></td>
<td class="nump">18,708,920<span></span>
</td>
<td class="nump">22,146,373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use-assets &#8211; operating leases</a></td>
<td class="nump">38,427,757<span></span>
</td>
<td class="nump">33,068,755<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Right-of-use-asset &#8211; financing lease</a></td>
<td class="nump">530,348<span></span>
</td>
<td class="nump">729,229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">4,269,277<span></span>
</td>
<td class="nump">4,269,277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets &#8211; net</a></td>
<td class="nump">2,870,324<span></span>
</td>
<td class="nump">3,431,865<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets</a></td>
<td class="nump">481,147<span></span>
</td>
<td class="nump">523,506<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">214,245,969<span></span>
</td>
<td class="nump">200,581,887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">47,002<span></span>
</td>
<td class="nump">43,767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,855,879<span></span>
</td>
<td class="nump">1,579,240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">7,941,039<span></span>
</td>
<td class="nump">5,443,724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities &#8211; current portion</a></td>
<td class="nump">3,473,674<span></span>
</td>
<td class="nump">3,905,484<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Financing lease liability &#8211; current portion</a></td>
<td class="nump">225,786<span></span>
</td>
<td class="nump">217,597<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Unearned revenue on service contracts</a></td>
<td class="nump">3,870,229<span></span>
</td>
<td class="nump">3,832,184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CustomerDeposits', window );">Customer deposits</a></td>
<td class="nump">443,471<span></span>
</td>
<td class="nump">602,377<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">17,857,080<span></span>
</td>
<td class="nump">15,624,373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Unearned revenue on service contracts</a></td>
<td class="nump">1,174,844<span></span>
</td>
<td class="nump">760,242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent', window );">Deferred income tax liability</a></td>
<td class="nump">371,560<span></span>
</td>
<td class="nump">394,758<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsPayableRelatedPartyNoncurrent', window );">Due to related party medical practices</a></td>
<td class="nump">92,663<span></span>
</td>
<td class="nump">92,663<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities &#8211; net of current portion</a></td>
<td class="nump">37,467,746<span></span>
</td>
<td class="nump">32,105,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Financing lease liability &#8211; net of current portion</a></td>
<td class="nump">394,723<span></span>
</td>
<td class="nump">620,481<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt and capital leases, less current portion</a></td>
<td class="nump">66,938<span></span>
</td>
<td class="nump">115,075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">32,026<span></span>
</td>
<td class="nump">41,750<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Long-Term Liabilities</a></td>
<td class="nump">39,600,500<span></span>
</td>
<td class="nump">34,130,374<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">57,457,580<span></span>
</td>
<td class="nump">49,754,747<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Paid-in capital in excess of par value</a></td>
<td class="nump">180,607,510<span></span>
</td>
<td class="nump">182,612,518<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(13,623,585)<span></span>
</td>
<td class="num">(24,190,981)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost &#8211; 45,081 and 11,463 shares of common stock at June 30, 2024 and 2023, respectively</a></td>
<td class="num">(1,016,632)<span></span>
</td>
<td class="num">(515,820)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Fonar Corporation&#8217;s Stockholders&#8217; Equity</a></td>
<td class="nump">165,967,997<span></span>
</td>
<td class="nump">157,906,433<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="num">(9,179,608)<span></span>
</td>
<td class="num">(7,079,293)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total Stockholders&#8217; Equity</a></td>
<td class="nump">156,788,389<span></span>
</td>
<td class="nump">150,827,140<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders&#8217; Equity</a></td>
<td class="nump">214,245,969<span></span>
</td>
<td class="nump">200,581,887<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock value</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
<td class="nump">635<span></span>
</td>
<td class="nump">647<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsPayableRelatedPartyNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsPayableRelatedPartyNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableNetLongTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableNetLongTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CustomerDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CustomerDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MedicalReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MedicalReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NoteReceivableRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NoteReceivableRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedFeesAndOtherRevenueReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, the amount of fees and other revenue, excluding investment income receivable, earned but not yet received, which were recognized in conformity with revenue recognition criteria based on estimates or specific contractual terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedFeesAndOtherRevenueReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other liabilities expected to be paid after one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845745892336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables', window );">Accounts receivable - net of allowances for credit losses</a></td>
<td class="nump">$ 166,049<span></span>
</td>
<td class="nump">$ 198,593<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts', window );">Management and other fees receivable - net of allowances for credit losses</a></td>
<td class="nump">12,369,921<span></span>
</td>
<td class="nump">12,608,567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts', window );">Management and other fees receivable - related party medical practices - net of allowances for credit losses</a></td>
<td class="nump">$ 6,110,399<span></span>
</td>
<td class="nump">$ 3,989,692<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares</a></td>
<td class="nump">45,081<span></span>
</td>
<td class="nump">11,463<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">453,000<span></span>
</td>
<td class="nump">453,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">313,438<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">313,438<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">567,000<span></span>
</td>
<td class="nump">567,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">8,500,000<span></span>
</td>
<td class="nump">8,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">6,373,375<span></span>
</td>
<td class="nump">6,462,345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">6,328,294<span></span>
</td>
<td class="nump">6,450,882<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">227,000<span></span>
</td>
<td class="nump">227,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">567,000<span></span>
</td>
<td class="nump">567,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845743211136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">$ 33,815,796<span></span>
</td>
<td class="nump">$ 29,793,993<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ProductSalesNet', window );">Product sales</a></td>
<td class="nump">737,727<span></span>
</td>
<td class="nump">731,607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ServiceAndRepairFeesNet', window );">Service and repair fees</a></td>
<td class="nump">7,452,212<span></span>
</td>
<td class="nump">7,419,104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ServiceAndRepairFeesRelatedPartiesNet', window );">Service and repair fees &#8211; related parties</a></td>
<td class="nump">139,167<span></span>
</td>
<td class="nump">110,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesNet', window );">Management and other fees</a></td>
<td class="nump">48,789,287<span></span>
</td>
<td class="nump">48,640,497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet', window );">Management and other fees &#8211; related party medical practices</a></td>
<td class="nump">11,949,900<span></span>
</td>
<td class="nump">11,949,900<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues &#8211; Net</a></td>
<td class="nump">102,884,089<span></span>
</td>
<td class="nump">98,645,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToProductSales', window );">Costs related to product sales</a></td>
<td class="nump">1,052,159<span></span>
</td>
<td class="nump">852,025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToServiceAndRepairFees', window );">Costs related to service and repair fees</a></td>
<td class="nump">3,577,570<span></span>
</td>
<td class="nump">3,033,967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToServiceAndRepairFeesRelatedParties', window );">Costs related to service and repair fees &#8211; related parties</a></td>
<td class="nump">144,413<span></span>
</td>
<td class="nump">44,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCostOfOperatingRevenue', window );">Costs related to patient fee revenue</a></td>
<td class="nump">18,199,579<span></span>
</td>
<td class="nump">16,183,166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToManagementAndOtherFees', window );">Costs related to management and other fees</a></td>
<td class="nump">28,626,595<span></span>
</td>
<td class="nump">26,975,563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices', window );">Costs related to management and other fees &#8211; related party medical practices</a></td>
<td class="nump">6,143,728<span></span>
</td>
<td class="nump">5,807,454<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">1,735,949<span></span>
</td>
<td class="nump">1,567,749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">26,868,732<span></span>
</td>
<td class="nump">29,390,932<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Costs and Expenses</a></td>
<td class="nump">86,348,725<span></span>
</td>
<td class="nump">83,855,839<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet', window );">Income from Operations</a></td>
<td class="nump">16,535,364<span></span>
</td>
<td class="nump">14,789,262<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Income and (Expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="num">(76,997)<span></span>
</td>
<td class="num">(50,131)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_InvestmentIncomeRelatedParty', window );">Investment income &#8211; related party</a></td>
<td class="nump">25,959<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment income</a></td>
<td class="nump">2,126,439<span></span>
</td>
<td class="nump">1,222,176<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OtherIncomeRelatedParty', window );">Other income &#8211; related party</a></td>
<td class="nump">576,857<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense)</a></td>
<td class="nump">78,763<span></span>
</td>
<td class="num">(202,720)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes and noncontrolling interests</a></td>
<td class="nump">19,266,385<span></span>
</td>
<td class="nump">15,758,587<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for Income Taxes</a></td>
<td class="num">(5,168,968)<span></span>
</td>
<td class="num">(3,632,071)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">14,097,417<span></span>
</td>
<td class="nump">12,126,516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income &#8211; Noncontrolling Interests</a></td>
<td class="num">(3,530,021)<span></span>
</td>
<td class="num">(2,750,740)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income &#8211; Attributable to FONAR</a></td>
<td class="nump">10,567,396<span></span>
</td>
<td class="nump">9,375,776<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_CommonStockholdersMember', window );">Common Stockholders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Income and (Expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Income Available to Common Stockholders</a></td>
<td class="nump">$ 9,908,920<span></span>
</td>
<td class="nump">$ 8,801,974<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 1.56<span></span>
</td>
<td class="nump">$ 1.35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 1.53<span></span>
</td>
<td class="nump">$ 1.32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Basic Shares Outstanding - Common Stockholders</a></td>
<td class="nump">6,350,862<span></span>
</td>
<td class="nump">6,539,376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Diluted Shares Outstanding - Common Stockholders</a></td>
<td class="nump">6,478,366<span></span>
</td>
<td class="nump">6,666,880<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockholdersMember', window );">Class A Non Voting Preferred Stockholders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Income and (Expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Income Available to Common Stockholders</a></td>
<td class="nump">$ 490,776<span></span>
</td>
<td class="nump">$ 427,666<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Income and (Expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Income Available to Common Stockholders</a></td>
<td class="nump">$ 167,700<span></span>
</td>
<td class="nump">$ 146,136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Basic Shares Outstanding - Common Stockholders</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Diluted Shares Outstanding - Common Stockholders</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToManagementAndOtherFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToManagementAndOtherFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToProductSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToProductSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToServiceAndRepairFeesRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToServiceAndRepairFeesRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_InvestmentIncomeRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_InvestmentIncomeRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OtherIncomeRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OtherIncomeRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProductSalesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProductSalesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ServiceAndRepairFeesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ServiceAndRepairFeesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ServiceAndRepairFeesRelatedPartiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ServiceAndRepairFeesRelatedPartiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostOfOperatingRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other costs incurred during the reporting period related to other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostOfOperatingRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_CommonStockholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_CommonStockholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845743642432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br></strong></div></th>
<th class="th"><div>Class A Non Voting Preferred [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Class C Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Treasury Stock, Common [Member]</div></th>
<th class="th"><div>Noncontrolling Interest [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Jun. 30, 2022</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 657<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 184,531,535<span></span>
</td>
<td class="num">$ (33,566,757)<span></span>
</td>
<td class="num">$ (675,390)<span></span>
</td>
<td class="num">$ (4,053,833)<span></span>
</td>
<td class="nump">$ 146,236,281<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,554,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,375,776<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,750,740<span></span>
</td>
<td class="nump">12,126,516<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of treasury shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,759,457)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,759,457)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Cancellation of shares</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (10)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,919,017)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,919,027<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Cancellation of shares, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(103,328)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(5,776,200)<span></span>
</td>
<td class="num">(5,776,200)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Jun. 30, 2023</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">$ 647<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">182,612,518<span></span>
</td>
<td class="num">(24,190,981)<span></span>
</td>
<td class="num">(515,820)<span></span>
</td>
<td class="num">(7,079,293)<span></span>
</td>
<td class="nump">150,827,140<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,450,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">10,567,396<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,530,021<span></span>
</td>
<td class="nump">14,097,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of treasury shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,505,832)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,505,832)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Cancellation of shares</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (12)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,005,008)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,005,020<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Cancellation of shares, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(122,588)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(5,630,336)<span></span>
</td>
<td class="num">(5,630,336)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Jun. 30, 2024</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 635<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 180,607,510<span></span>
</td>
<td class="num">$ (13,623,585)<span></span>
</td>
<td class="num">$ (1,016,632)<span></span>
</td>
<td class="num">$ (9,179,608)<span></span>
</td>
<td class="nump">$ 156,788,389<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,328,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845748297440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">$ 14,097,417<span></span>
</td>
<td class="nump">$ 12,126,516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,596,421<span></span>
</td>
<td class="nump">4,540,135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ProvisionForBadDebts', window );">Provision for credit losses</a></td>
<td class="nump">1,882,061<span></span>
</td>
<td class="nump">5,513,476<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax - net</a></td>
<td class="nump">2,795,507<span></span>
</td>
<td class="nump">2,979,550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization on right-of-use assets</a></td>
<td class="nump">4,311,762<span></span>
</td>
<td class="nump">4,264,818<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_GainOnSaleOfEquipmentRelatedParty', window );">Gain on sale of equipment &#8211; related party</a></td>
<td class="num">(581,183)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_GainlossOnDispositionOfFixedAssets', window );">(Gain)Loss on disposition of fixed assets</a></td>
<td class="num">(75,411)<span></span>
</td>
<td class="nump">213,244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AbandonedPatents', window );">Abandoned patents</a></td>
<td class="nump">225,419<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>Changes in assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts, medical and management fee receivables</a></td>
<td class="num">(11,676,139)<span></span>
</td>
<td class="num">(8,055,843)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInNotesReceivable', window );">Notes receivable</a></td>
<td class="nump">55,200<span></span>
</td>
<td class="num">(64,532)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(145,775)<span></span>
</td>
<td class="num">(209,845)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">266,606<span></span>
</td>
<td class="num">(438,911)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">42,359<span></span>
</td>
<td class="nump">2,763<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">276,639<span></span>
</td>
<td class="nump">19,685<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="nump">2,949,962<span></span>
</td>
<td class="num">(2,527,100)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInCustomerAdvance', window );">Customer advances</a></td>
<td class="num">(158,906)<span></span>
</td>
<td class="nump">241,132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(4,541,352)<span></span>
</td>
<td class="num">(3,862,814)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTradingLiabilities', window );">Financing lease liabilities</a></td>
<td class="num">(217,569)<span></span>
</td>
<td class="num">(210,353)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities', window );">Other liabilities</a></td>
<td class="num">(9,724)<span></span>
</td>
<td class="num">(64,791)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">NET CASH PROVIDED BY OPERATING ACTIVITIES</a></td>
<td class="nump">14,093,294<span></span>
</td>
<td class="nump">14,467,130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(789,961)<span></span>
</td>
<td class="num">(4,218,084)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromShortTermInvestments', window );">Purchase of Short-term investment</a></td>
<td class="num">(103,303)<span></span>
</td>
<td class="num">(473)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of equipment</a></td>
<td class="nump">75,411<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Cost of patents</a></td>
<td class="num">(32,885)<span></span>
</td>
<td class="num">(119,571)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">NET CASH USED IN INVESTING ACTIVITIES</a></td>
<td class="num">(850,738)<span></span>
</td>
<td class="num">(4,338,128)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of borrowings and capital lease obligations</a></td>
<td class="num">(44,902)<span></span>
</td>
<td class="num">(36,615)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfEquity', window );">Purchase of treasury stock</a></td>
<td class="num">(2,505,832)<span></span>
</td>
<td class="num">(1,759,457)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Distributions to noncontrolling interests</a></td>
<td class="num">(5,630,336)<span></span>
</td>
<td class="num">(5,776,200)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">NET CASH USED IN FINANCING ACTIVITIES</a></td>
<td class="num">(8,181,070)<span></span>
</td>
<td class="num">(7,572,272)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">NET INCREASE IN CASH AND CASH EQUIVALENTS</a></td>
<td class="nump">5,061,486<span></span>
</td>
<td class="nump">2,556,730<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR</a></td>
<td class="nump">51,279,707<span></span>
</td>
<td class="nump">48,722,977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS - END OF YEAR</a></td>
<td class="nump">$ 56,341,193<span></span>
</td>
<td class="nump">$ 51,279,707<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AbandonedPatents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AbandonedPatents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_GainOnSaleOfEquipmentRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_GainOnSaleOfEquipmentRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_GainlossOnDispositionOfFixedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_GainlossOnDispositionOfFixedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInCustomerAdvance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInCustomerAdvance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProvisionForBadDebts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProvisionForBadDebts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpensesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTradingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of trading liabilities from the reporting entity's trading activities. This include liabilities resulting from sales of assets that the reporting entity does not own and revaluation losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTradingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount paid (received) by the reporting entity through acquisition or sale and maturities of short-term investments with an original maturity that is three months or less which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845743115440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 10,567,396<span></span>
</td>
<td class="nump">$ 9,375,776<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845838138336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock', window );">DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</a></td>
<td class="text"><p id="xdx_808_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_z6rKFXjrXCi9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 1 - <span id="xdx_822_z4fTfDmZVo21">DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Description of Business</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR Corporation (the &#8220;Company&#8221; or &#8220;FONAR&#8221;)
is a Delaware corporation, which was incorporated on July 17, 1978. FONAR is engaged in the research, development, production and marketing
of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (&#8220;MRI&#8221;) for the detection and diagnosis
of human diseases. In addition to deriving revenues from the direct sale of MRI equipment, revenue is also generated from our installed-base
of customers through our service and upgrade programs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR, through its wholly-owned subsidiary Health
Management Corporation of America (&#8220;HMCA&#8221;) provides comprehensive management services to diagnostic imaging facilities. The
services provided by the Company include development, administration, leasing of office space, facilities and medical equipment, provision
of supplies, staffing and supervision of non-medical personnel, legal services, accounting, billing and collection and the development
and implementation of practice growth and marketing strategies.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 1, 2015, the Company restructured the corporate
organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely
integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized
in the business of Health Management Corporation of America) to HDM and received a <span id="xdx_907_eus-gaap--InvestmentOwnedPercentOfNetAssets_iI_dp_c20150701__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_z9afFNvkf4n3" title="Interest received percentage">24.2</span>% interest in HDM. Health Management Corporation
of America retained a direct ownership interest of <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20150701__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zb83N4OFrGSk" title="Ownership interest percentage">45.8</span>% in HDM, and the original investors in HDM retained a <span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20150701__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zABV9QRzTqZj" title="Ownership interest percentage">30.0</span>% ownership interest
in the newly expanded HDM. During the year ended June 30, 2022, the Company purchased noncontrolling interests for $<span id="xdx_904_eus-gaap--ProceedsFromPaymentsToMinorityShareholders_c20210701__20220630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zed18GeiCmL7" title="Non-controlling interests from the minority shareholders">546,000</span> giving the
Company a direct ownership interest of <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20220630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zycUAw1DDfJc" title="Ownership interest percentage">70.8</span>% and the investors&#8217; a <span id="xdx_901_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zeEsYG8cPVpe" title="Ownership interest percentage">29.2</span>% ownership interest. The entire management of diagnostic
imaging centers business segment is now being conducted by HDM.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845740424912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--SignificantAccountingPoliciesTextBlock_zHYHmiqo2pn8" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 2 - <span id="xdx_82D_z5LNp253d4Kb">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zwyUDgDQDNFi" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_869_z2pxossBaQ4j">Principles of Consolidation</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements include the
accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships. The operating activities of subsidiaries are
included in the accompanying consolidated statements from the date of acquisition. All significant intercompany accounts and transactions
have been eliminated in consolidation.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



















<p id="xdx_84E_eus-gaap--UseOfEstimates_zqEKKHEfG9S9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_865_zDrffM0Rk6Ua">Use of Estimates</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the consolidated financial statements
in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities in the consolidated financial
statements and accompanying notes. The most significant estimates relate to receivable allowances, income taxes and related tax asset
valuation allowances, contingencies, and revenue recognition. In addition, healthcare industry reforms and reimbursement practices will
continue to impact the Company&#8217;s operations and the determination of contractual and other allowance estimates. Actual results could
differ from those estimates.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84E_eus-gaap--InventoryWorkInProcessPolicy_zJRpuO4jgf7e" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_860_zYX965COlutb">Inventories</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventories consist of purchased parts, components
and supplies, as well as work-in-process, and are stated at the lower of cost or net realizable value.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zDew3dopOlpd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_865_z84usRR4a1s">Property and Equipment</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment procured in the normal course
of business is stated at cost less accumulated depreciation. Property and equipment purchased in connection with an acquisition is stated
at its estimated fair value, generally based on an appraisal. Property and equipment is being depreciated for financial accounting purposes
using the straight-line method over their estimated useful lives. Leasehold improvements are being amortized over the shorter of the useful
life or the remaining lease term. Upon retirement or other disposition of these assets, the cost and related accumulated depreciation
of these assets are removed from the accounts and the resulting gains or losses are reflected in the results of operations. Expenses for
maintenance and repairs are charged to operations. Renewals and betterments are capitalized. Maintenance and repair expenses totaled approximately
$<span id="xdx_90A_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20230701__20240630_zvKqLaoduv4e" title="Maintenance and repair expenses">2,948,000</span> and $<span id="xdx_906_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20220701__20230630_zULLmiJZg0Ba" title="Maintenance and repair expenses">2,801,000</span> for the years ended June 30, 2024 and 2023 respectively. The estimated useful lives in years are generally as
follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88E_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_z1vIwy6ZISK9" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)">
<tr style="vertical-align: bottom">
<td colspan="3" style="border-bottom: Black 1pt solid; padding: 0pt; text-align: left; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_8BF_zs2gNJdAoczg" style="display: none">Schedule
of estimated useful life in years for property and equipment</span></span></td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: bottom; width: 87%; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Diagnostic equipment</span></td>
<td style="padding: 0pt; vertical-align: bottom; width: 12%; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zLKj6odAoCG5">5</span>&#8211;<span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_z15gqxQVKlt" title="Estimated useful lives">13</span></span></td>
<td style="padding: 0pt; width: 1%; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Research, development and demonstration equipment</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zD1kMI5H9Pfk">3</span>-<span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_z6eK5e3xFzCa">7</span></span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Machinery and equipment</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_za6eX1JyjcW7">2</span>-<span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zHXeZQTExWYd">7</span></span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Furniture and fixtures</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zPVJ7nKtC0lg">3</span>-<span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z2TR8Wlv23Fc">9</span></span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Leasehold improvements</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zy1haNsqvvPb">5</span>&#8211;<span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z3GQyurSiPwa">10</span></span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Building</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--WeightedAverageMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zP9U3mTibM8l" title="Estimated useful lives">28</span></span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



















<p id="xdx_842_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zhUDRnXmYAj4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_862_zAIQkiz1EDza">Long-Lived Assets</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company periodically assesses the recoverability
of long-lived assets, including property and equipment and intangibles, other than goodwill, when events or changes in circumstances indicate
that the carrying value of long-lived assets may not be recoverable. If indicators are present, the Company performs a recoverability
test by comparing the sum of the estimated undiscounted future cash flows attributable to the asset group in question to its carrying
amount. An impairment loss is recognized if it is determined that the long-lived asset group is not recoverable and is calculated by comparing
the discounted future cash flows with the carrying value of the related asset group. In performing this analysis, management considers
such factors as current results, trends, and future prospects, in addition to other economic factors.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84C_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zpdPcnvzbad3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_860_zfvdavdczYO5">Other Intangible Assets</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">1) Patents and Copyrights</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Patent and copyrights are professional costs incurred
to acquire certain patent and copyrights. Amortization is calculated on the straight-line basis over <span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zAvQaEtly327" title="Finite-lived intangible asset, useful life">15</span> years.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">2) Non-Competition Agreements</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The non-competition agreements are agreements entered
into with past principal owners of entities that the Company had acquired. The non-competition agreements are being amortized on the straight-line
basis over the length of the agreement (<span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_z0tdVFCqcb8j" title="Finite-lived intangible asset, useful life">7</span> years).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">3) Customer Relationships</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Customer relationships represents customer lists acquired
in acquisition of prior entities. Amortization is calculated on the straight-line basis over <span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zhmAQeXD3XE8" title="Finite-lived intangible asset, useful life">20</span> years.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_847_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_ztol9VfCLX07" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_866_ze2XHKlM2Ggl">Goodwill</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Goodwill represents the cost of a business acquisition
in excess of the fair value of the net assets acquired. Goodwill is not amortized and is reviewed for impairment annually, or more frequently
if facts and circumstances indicate that it is more likely than not that the fair value of the reporting unit is less than its carrying
amount including goodwill. If it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the
Company performs a quantitative test to identify and measure the amount of goodwill impairment loss. The Company compares the fair value
of the reporting unit with its carrying amount. If the carrying amount exceeds fair value, goodwill of the reporting unit is considered
impaired, and that excess is recognized as a goodwill impairment loss.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



















<p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zjVfGdP4cLJl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_867_zdNR78TDJ4c4">Revenue Recognition</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue on sales contracts for scanners, included
in &#8220;product sales&#8221; in the accompanying consolidated statements of operations, is recognized under the percentage-of-completion
method in accordance with FASB ASC 606, &#8220;Revenue Recognition &#8211; Construction-Type and Production-Type Contracts&#8221;. The
Company manufactures its scanners under specific contracts that provide for progress payments. Production and installation take approximately
three to six months.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue on scanner service contracts is recognized
on the straight-line method over the related contract period, usually one year. As of June 30, 2023, the Company had unearned revenue
on service contracts of $3,832,184 of which all was recognized as revenue in the fiscal year ending June 30, 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue from product sales (upgrades and supplies)
is recognized upon shipment.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue under management contracts is recognized
based upon contractual agreements for management services rendered by the Company primarily under various long-term agreements with
various medical providers (the &#8220;PCs&#8221;). As of June 30, 2024, the Company has <span id="xdx_90E_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20240630_zXpwoYmmoGR3" title="Management agreements with company total medical practices">22</span>
management agreements of which <span id="xdx_90F_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20240630_zNWAb72g9LO9" title="Scanners with management agreements with company owned by related party">3</span>
were with PC&#8217;s owned by Timothy Damadian, Chairman of the Board, President, Chief Executive Officer and Treasurer (formerly
owned by Raymond V. Damadian, M.D., Chairman of the Board of FONAR until his unexpected death in August 2022)(&#8220;the Related
medical practices&#8221;) and <span id="xdx_901_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20240630_zaNpGoUYnkHe" title="Scanners with management with company located in new york state">19</span>
are with PC&#8217;s, which are all located in the state of New York (&#8220;the New York PC&#8217;s&#8221;), owned by two unrelated
radiologists. The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility
ranging from approximately $<span id="xdx_90E_ecustom--ContractualFeesForServicesRenderedMinimum_iI_pdp0_c20240630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zjiq4LJFqZza" title="Contractual fees for services rendered minimum">84,000</span>
to $<span id="xdx_905_ecustom--ContractualFeesForServicesRenderedMaximum_iI_c20240630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zHPpdazHDQgg" title="Contractual fees for services rendered maximum">447,000</span>.
All fees are re-negotiable at the anniversary of the agreements and each year thereafter. The Company records a credit loss expense for
estimated uncollectible fees, which is reflected in other operating expenses on the Consolidated Statement of Operations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company currently recognizes revenue in accordance
with the recognition accounting standard issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;) and codified in the ASC
as topic 606 (&#8220;ASC 606&#8221;). The revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing
revenue as performance obligations, defined in a contract with a customer as goods or services transferred to the customer in exchange
for consideration, are satisfied. The standard also requires expanded disclosures regarding the Company&#8217;s revenue recognition policies
and significant judgments employed in the determination of revenue.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s revenues generally relate to net
patient fees&#160;received from various payers and patients themselves under contracts in which our performance obligations are to provide
diagnostic services to the patients. Revenues are recorded during the period our obligations to provide diagnostic services are satisfied.
Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships
with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health plans and commercial insurance
companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent
upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the
third-party payers. The payment arrangements with third-party payers for the services we provide to the related patients typically specify
payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services
or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates
to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s patient fee revenues, net of contractual
allowances and discounts for the years ended June 30, 2024 and 2023 are summarized in the following table.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--DisaggregationOfRevenueTableTextBlock_zKieyjyUMs7l" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8B2_zibRPTtp76H6" style="display: none">Schedule of patient fee
    revenue - net</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Commercial Insurance/ Managed Care</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zQP7AjRvBfCb" style="width: 12%; text-align: right" title="Net Patient Fee Revenue">4,952,712</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zSWvqUvUpEb1" style="width: 12%; text-align: right" title="Net Patient Fee Revenue">4,124,646</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Medicare/Medicaid</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zgZLnk8r0RPj" style="text-align: right" title="Net Patient Fee Revenue">1,138,176</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zUubfFwT39r" style="text-align: right" title="Net Patient Fee Revenue">1,063,846</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Workers&#8217; Compensation/Personal Injury</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zPcuEffR23yd" style="text-align: right" title="Net Patient Fee Revenue">20,673,483</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zNq4J8jwHUGl" style="text-align: right" title="Net Patient Fee Revenue">18,670,019</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zVCGIZyggKpg" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue">7,051,425</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zdne1tGYBBZ2" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue">5,935,482</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Net Patient Fee Revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630_zpm5teBsyZ91" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue">33,815,796</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630_zT2g27BSSgz8" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue">29,793,993</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_847_ecustom--MedicalReceivableAndManagementAndOtherFeesReceivablePolicyTextBlock_zQcxncB6FOvk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86A_z16itZ81ONV4">Medical Receivable and Management and Other Fees Receivable</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span>Medical Receivable</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management fees receivable is related to management fees outstanding
from the related and non related PCs under management agreements. The Company has established a current expected credit loss (&#8220;CECL&#8221;)
to address the risk that a portion of the contractually obligated management fees receivable from the PCs may not be paid. The PC&#8217;s
may be limited in their ability to pay the full management fee receivable if they do not collect sufficient expected fees from third-party
payers and patients. The Company&#8217;s management fees are collateralized, individually and collectively, by the assets of the PCs.
The CECL is determined based on the difference between the management fee receivable and the current amount of outstanding fees estimated
to be collected by the PCs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span>Management and Other Fees Receivable</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management fees receivable is related to management
fees outstanding from the related and non related PCs under management agreements. The Company has established a current expected credit
loss (&#8220;CECL&#8221;) to address the risk that a portion of the contractually obligated management fees receivable from the PCs may
not be paid. The PC&#8217;s may be limited in their ability to pay the full management fee receivable if they do not collect sufficient
expected fees from third-party payers and patients. The Company&#8217;s management fees are collateralized, individually and collectively,
by the assets of the PCs. The CECL is determined based on the difference between the management fee receivable and the current amount
of outstanding fees estimated to be collected by the PCs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s considerations into the estimate
of the PC&#8217;s fee collection is based on a combination of factors. As each management agreement specifies the Company&#8217;s ultimate
collateral for unpaid management fees are the patient fee receivables owned by each PC, the Company considers the historical loss rates
to pools of receivables with similar risks characteristics, aging of the patient fee receivables, and the financial condition of each
PC. In addition, the Company subjectively adjusts its estimated expected credit losses for current and forward-looking economic conditions
which would include trends seen within the industry and newly enacted regulation. The Company also incorporates qualitative factors, such
as changes in the nature and volume of receivables, regulatory changes, and other relevant factors. Specifically, insurance carriers covering
automobile no-fault and workers compensation claims incur longer payment cycles and rigorous informational requirements and certain other
disallowed claims. Approximately 67% of the PCs&#8217; 2024 and 2023 net revenues were derived from no-fault and personal injury protection
claims.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; background-color: white">The Company combines
an objective and subjective loss-rate methodology to estimate expected credit losses based on the collateral owned by each PC. This involves
objectively using historical loss rates to pools of receivables with similar risk characteristics (i.e., various insurance payors) and
then subjectively adjusting for current and forward-looking economic conditions which would include trends seen within the industry and
newly enacted regulation. The Company also incorporates qualitative factors, such as changes in the nature and volume of the receivables,
regulatory changes, and other relevant factors.</p>

<p style="font: 11pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify">The provision for credit losses for the year
ended June 30, 2024 was $<span id="xdx_902_ecustom--ProvisionForBadDebts_c20230701__20240630_zyJjWYtgVg0e">1,882,061</span>. This can be attributable to an increase in scan volume at all the PC&#8217;s and due to the nature
of the payor classes, where there is a longer expected payment term. Additionally, newly proposed legislation around credit reporting
on individual medical debts increasing the likelihood of non-payment of individual patient accounts. The management fee receivable for
unrelated and related parties as of July 1, 2022 was $<span id="xdx_906_ecustom--ManagementFeeReceivableForUnrelatedParties_iI_c20220702_zkNt4LsmZD46">33,419,219
</span>and $<span id="xdx_908_ecustom--ManagementFeeReceivableForRelatedParties_iI_c20220702_zPKWt8qGodgf">8,602,561</span>,
respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>




<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84F_eus-gaap--ReceivablesPolicyTextBlock_zM7aYnXv6Xpd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86C_zkRXn4BeEfgg">Accounts Receivable</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Credit risk with respect to the Company&#8217;s
accounts receivable related to product sales and service and repair fees is limited due to the customer advances received prior to the
commencement of work performed and the billing of amounts to customers as sub-assemblies are completed. Service and repair fees are billed
on a monthly or quarterly basis and the Company does not continue providing these services if accounts receivable become past due. The
Company controls credit risk with respect to accounts receivable from service and repair fees through its credit evaluation process,
credit limits, monitoring procedures and reasonably short collection terms. The Company performs ongoing credit authorizations before
a product sales contract is entered into or service and repair fees are provided.&#160;The account receivable balance for scanner service
contracts as of July 1, 2022 was $<span id="xdx_905_ecustom--AccountsReceivableServiceContractsNet_iI_c20220702_zniw8wLrrNx4">4,335,956</span>.</p>















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_840_eus-gaap--ResearchAndDevelopmentExpensePolicy_zQV6jIMjdrmd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_860_z7fpB9w5Lmb2">Research and Development Costs</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development costs are charged to expense
as incurred. The costs of equipment that are acquired or constructed for research and development activities, and have alternative future
uses (either in research and development, marketing or production), are classified as property and equipment and depreciated over their
estimated useful lives.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84F_eus-gaap--AdvertisingCostsPolicyTextBlock_zQcdQH8wfeA5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_861_zAXOhmeiQA89">Advertising Costs</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Advertising costs are expensed as incurred. Advertising
expense approximated $<span id="xdx_90E_eus-gaap--AdvertisingExpense_c20230701__20240630_zxCMQfhbqrrj">731,000</span> and $<span id="xdx_905_eus-gaap--AdvertisingExpense_c20220701__20230630_z5aKmIyxUmni">570,000
</span>and for the years ended June 30, 2024 and 2023, respectively.<b>&#160;</b></p>



<p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_zGk2PMILa6eh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_868_zqA8dJzcQkL8">Income Taxes</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Deferred tax assets and liabilities are determined
based on the difference between the financial statement carrying amounts and tax basis of assets and liabilities using enacted tax rates
in effect in the years in which the differences are expected to reverse.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The ultimate realization of deferred tax assets is
dependent on the generation of future taxable income during the periods in which temporary differences become deductible or when such
net operating losses can be utilized. The Company considers projected future taxable income, the regulatory environment of the industry,
and tax planning strategies in making this assessment. At present, the Company believes that it is more likely than not that the benefits
from certain deferred tax asset carryforwards, will not all be fully realized. In recognition of this inherent risk, a valuation allowance
was established for the partial value of the deferred tax asset, which principally related to certain state net operating losses. A valuation
allowance will be maintained until sufficient positive evidence exists to support the reversal of the remainder of the valuation.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with ASC 740, &#8220;Accounting for
Income Taxes&#8221;, prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement
of tax positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be
taken in a tax return and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits.
A liability is recognized (or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax
benefit because it represents an enterprise&#8217;s potential future obligation to the taxing authority for a tax position that was not
recognized as a result of applying the provisions of ASC 740. The Company believes there are no uncertain tax positions in prior year&#8217;s
tax filings and therefore it has not recorded a liability for unrecognized tax benefits.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with ASC 740, interest costs related
to unrecognized tax benefits are required to be calculated (if applicable) and would be classified as &#8220;Interest expense, net. Penalties
if incurred would be recognized as a component of &#8220;Selling, general and administrative&#8221; expenses. Penalties for the years
ended June 30, 2024 and June 30, 2023 were $<span id="xdx_905_eus-gaap--IncomeTaxExaminationPenaltiesExpense_c20230701__20240630_z9Q0Hn5aAaTh" title="Penalties">20,444</span> and $<span id="xdx_906_eus-gaap--IncomeTaxExaminationPenaltiesExpense_c20220701__20230630_z8bTkU63dY9" title="Penalties">31,122</span>, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



















<p id="xdx_849_ecustom--CustomerAdvancesPolicyTextBlock_zifYBNqOen18" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86A_zROga0l6TK7j">Customer Advances</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash advances and progress payments received on sales
orders are reflected as customer advances until such time as revenue recognition occurs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_zUPGfY2S3991" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_869_zkNcgjyuBKRe">Earnings Per Share</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic earnings per share (&#8220;EPS&#8221;) is computed
by dividing net income available to common stockholders by the weighted average number of shares of common stock outstanding during the
period. In accordance with ASC topic 260-10, &#8220;Participating Securities and the Two-Class Method&#8221;, the Company used the Two-Class
method for calculating basic earnings per share and applied the if converted method in calculating diluted earnings per share for the
years ended June 30, 2024 and 2023.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Diluted EPS reflects the potential dilution from the
exercise or conversion of all dilutive securities into common stock based on the average market price of common shares outstanding during
the period. For the years ended June 30, 2024 and 2023, diluted EPS for common shareholders includes <span id="xdx_900_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20230701__20240630_zXgmLFs4rzuc" title="Conversion of Class C Common Stock"><span id="xdx_904_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20220701__20230630_zMkTYZPbhp7k" title="Conversion of Class C Common Stock">127,504</span></span> shares upon conversion of
Class C Common.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zQOGX5QvAza3" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BF_zywvfBLj6VWf" style="display: none">Schedule of earnings per share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Basic</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class C Common Stock</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Numerator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 46%; text-align: left; text-indent: -11pt">Net income available to common stockholders</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630_z5Rcu2Wqc693" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders">10,567,396</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z7tmlgA6yw86" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders">9,908,920</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zS3OC7vju5ra" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders">167,700</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Weighted average shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630_zODObpn37tXd" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">6,350,862</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_983_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z1NzWS5YYt6j" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">6,350,862</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zsv8MvcuX5Jg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">382,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Basic income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630_za6Cya3uMO29" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.66</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zbT5oyjhJ3Ha" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.56</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zo2AdSpO5Nch" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">0.44</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Weighted average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z6Dsgme3pJZ9" style="text-align: right" title="Weighted average shares outstanding">6,350,862</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zJaoalYiGapd" style="text-align: right" title="Weighted average shares outstanding">382,513</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Class C Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zTUCK9K36mxc" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock">127,504</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zKDHmj3FQQP" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zo0pacwcLj68" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share">6,478,366</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_ztshFF2cGGVa" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share">382,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zvB8OZFZJUHb" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share">1.53</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zS00GW4GVGzg" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share">0.44</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>























<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2023</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Basic</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class C Common Stock</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Numerator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 46%; text-align: left; text-indent: -11pt">Net income available to common stockholders</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20220701__20230630_zxtZWKIKsiff" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders">9,375,776</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zwJEvY67Iumb" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders">8,801,974</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z3Qi4OsGnkJ3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders">146,136</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Weighted average shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630_zB7YdIopqgb6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">6,539,376</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zbeFLt3EWpwj" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">6,539,376</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z69RHhQSz9a5" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">382,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Basic income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630_zytNpUPMRTf3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.43</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zEsXKtKOJyIe" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.35</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zEWBFp7LRyXf" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">0.38</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Weighted average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zaiGOcIWQt49" style="text-align: right" title="Weighted average shares outstanding">6,539,376</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z14HKTw8KMnj" style="text-align: right" title="Weighted average shares outstanding">382,513</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Class C Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zaUCBatpgKp5" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock">127,504</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zZLCrPweHY4b" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zh3uUtS9SNpk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share">6,666,880</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zcsRabBp4lNh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share">382,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zvhfQ9yDrIPb" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share">1.32</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zuZoteG2VhO1" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share">0.38</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8A1_zOL0s9iyGBTk" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z33M7wt7oICl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_869_zhbMc3xQZmNe">Cash and Cash Equivalents</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash and cash equivalents includes cash on hand, cash
in banks, investments in certificates of deposit with original maturities of 90 days or less, and money market funds.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_848_eus-gaap--InvestmentPolicyTextBlock_zNVmvzpue4E7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_860_zKPyc0dKGqci">Short-Term Investments</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Short-term investments include certificates of deposit
with original maturities of greater than 90 days. Interest is recorded as earned.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zjfBs4dogapf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_866_zTIqGj8fSFsd">Concentration of Credit Risk</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash: The Company maintains its cash and cash equivalents
with various financial institutions, which exceed federally insured limits throughout the year. At June 30, 2024, the Company had cash
on deposit of approximately $<span id="xdx_907_eus-gaap--Cash_iI_pp0p0_c20240630_zls9uqywcjkh" title="Cash deposit">53,883,000</span> in excess of federally insured limits of $<span id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20240630_zBSk8mx3ekc3" title="Federally insured limits">250,000</span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Related Parties: Net revenues from related parties
accounted for approximately <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zcUvQhEqKW3f" title="Concentration risk, percentage"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zSnnpyzSZ80h" title="Concentration risk, percentage">12</span></span>% of the consolidated net revenues for the years ended June 30, 2024 and 2023. Net management fee receivables
from the related party medical practices accounted for approximately <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMedicalPracticesMember_z9UgZHdapRv" title="Concentration risk, percentage">12</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMedicalPracticesMember_zrb3soJNEv93" title="Concentration risk, percentage">13</span>% of the consolidated accounts receivable as of June 30,
2024 and 2023, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">See Note 3 regarding the Company&#8217;s concentrations
in the healthcare industry.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



















<p id="xdx_843_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zioSBMNADrJ2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_867_zrF5xqH8vBS8">Fair Value of Financial Instruments</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company measures fair value in accordance with
ASC 820-10, &#8220;Fair Value Measurements and Disclosures&#8221;. ASC 820-10 clarifies that fair value is an exit price, representing
the amount that would be received by selling an asset or paid to transfer a liability in an orderly transaction between market participants.
As such, fair value is a market-based measurement that should be determined based on assumptions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The standard establishes a three-tier fair value hierarchy,
which prioritizes the inputs used in measuring and revaluing fair value. These tiers include, Level 1, defined as observable inputs such
as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or
indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity
to develop its own assumptions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following methods and assumptions were used to
estimate the fair value of each class of financial instruments for which it is practicable to estimate that value:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash and cash equivalents: The carrying amount approximates
fair value because of the short-term maturity of those instruments.</p>







<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Short-term investments: The carrying amount approximates
fair value because of the short-term maturity of those instruments. Such amounts include Certificates of Deposits with original maturities
greater than 90 days. These securities are classified as Level 1.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Receivable and accounts payable: The carrying amounts
approximate fair value because of the short maturity of those instruments.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Notes receivable: The carrying amount approximates
fair value because the discounted present value of the cash flow generated by the parties approximates the carrying value of the amounts
due to the Company.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long-term debt and notes payable: The carrying amounts
of debt and notes payable approximate fair value due to the length of the maturities, the interest rates being tied to market indices
and/or due to the interest rates not being significantly different from the current market rates available to the Company.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All of the Company&#8217;s financial instruments are
held for purposes other than trading.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84B_ecustom--RecentAccountingStandardsPolicyTextBlock_zgf8tw78paHl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_863_zlONLM6d1tvh">Recent Accounting Standards</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2023, The Financial Accounting Standards
Board (&#8220;FASB&#8221;) issued ASU 2023-09, &#8220;Income Taxes (740) &#8220;Improvements to Income Tax Disclosures&#8221;, which requires
the annual financial statements to include consistent categories and great disaggregation of information in the rate reconciliation and
income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for the Company&#8217;s annual reporting beginning after December
15, 2024, with early adoption permitted, and should be applied on a prospective basis, with a retrospective option. The Company is currently
evaluating the effect that the adoption of ASU 2023-09 will have on our disclosures.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2023, FASB issued ASU 2023-07, &#8220;Segment
Reporting (Topic 280)&#8221;, which is intended to improve reportable segment disclosure requirements through enhanced disclosures about
significant segment expenses. The amendments require disclosure of significant segment expenses regularly provided to the chief operating
decision maker (CODM) as well as other segment items, extended certain annual disclosures to interim periods, clarify the applicability
to single reportable segment entities, permit more than one measure of profit or loss to be reported under certain conditions, and require
disclosure of the title and position of the CODM. The effective date for public entities is for fiscal years beginning after December
15, 2023 and interim periods with fiscal years beginning after December 15, 2024. The Company is expected to adopt the new disclosures
as required and are currently evaluating the impact on the related disclosures.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zyzmnEIgfeC5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_866_zGeyNISx7NB9">Recently Adopted Accounting Standards</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company adopted ASU 2016-13, &#8220;Financial
Instruments &#8211; Credit Losses&#8221; (Topic 326) &#8220;Measurement of Credit Losses on Financial Instruments&#8221;, on July 1, 2023,
as amended which replaces the incurred loss methodology with an expected loss methodology that is referred to as the current expected
credit loss (CECL) methodology, The measurement of expected credit losses under the CECL methodology is applicable to financial assets
measured at amortized cost, including loan receivables and held-to-maturity debt securities. It also applies to off-balance sheet credit
exposures not accounted for as insurance (loan commitments, standby letters of credit, financial guarantees, and other similar instruments)
and net investments in leases recognized by a lessor in accordance with Topic 842 on leases. The Company used a modified retrospective
approach, which required a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting in which the standard
was effective. The adoption did not have a material effect on the Company&#8217;s consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FASB, the Emerging Issues Task Force and the SEC have
issued certain other accounting standards, updates, and regulations as of June 30, 2024 that will become effective in subsequent periods;
however, management does not believe that any of those updates would have significantly affected the Company&#8217;s financial accounting
measures or disclosures had they been in effect during 2024 or 2023, and it does not believe that any of those standards will have a significant
impact on the Company&#8217;s consolidated financial statements at the time they become effective.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845740292256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zJuoXdjIIoJ" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;NOTE 3 &#8211; <span id="xdx_82D_zXjOevyDt1Gc">ACCOUNTS RECEIVABLE, MEDICAL
RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long Term Accounts Receivable</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long term accounts receivable balances at June 30,
2024 and June 30, 2023 amounted to $<span id="xdx_907_ecustom--AccountsReceivableNetLongTerm_iI_c20240630_zk5RlgsJy513" title="Long term accounts receivable balances">829,473</span> and $<span id="xdx_90C_ecustom--AccountsReceivableNetLongTerm_iI_c20230630_zAPvrQOBno15" title="Long term accounts receivable balances">710,085</span>, respectively. The Company will generate revenue from long-term, non-cancellable
contracts to provide service and repair services. Future revenue to be recognized over the following four years at June 30, 2024 is as
follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zLQiGYyfu0bi" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
  <tr style="vertical-align: bottom">
    <td colspan="5" style="border-bottom: Black 1pt solid; text-align: left"><span id="xdx_8B3_zxULpWrUqVfg" style="display: none">Schedule of receivables -
    non current - net</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 76%; text-align: left; text-indent: -11pt">2026</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pp0p0_c20240630_z65xpqNEy7Og" style="width: 12%; text-align: right" title="2026">631,415</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pp0p0_c20240630_zkbrS17Eqe14" style="text-align: right" title="2027">369,429</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">2028</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pp0p0_c20240630_z8vnE3Dkn9V4" style="text-align: right" title="2028">87,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">2029</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ContractReceivableDueFiveYearsOrMore_iI_pp0p0_c20240630_zy0Txw28f7U8" style="border-bottom: Black 1pt solid; text-align: right" title="2029">87,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Total</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_pp0p0_c20240630_ztUVSFFardm4" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">1,174,844</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;The following represents a summary of allowance
for credit losses for the years ended June 30, 2024 and 2023, respectively:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zFFO6u20j805" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details)">
  <tr style="vertical-align: bottom">
    <td colspan="17" style="text-align: left"><span id="xdx_8B0_zD3XG0pfFJHc" style="display: none">Summary of allowance for credit losses</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Description</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Balance<br/> June 30, 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Additions(Recovery) (1)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Deductions</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Balance <br/> June 30, 2024</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 40%; text-align: left; text-indent: -11pt">Accounts receivable</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zBF6ClyECdHd" style="width: 10%; text-align: right" title="Beginning Balance">198,593</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zUMoQ2PipMO9" style="width: 10%; text-align: right" title="Additions (Included in provision for bad debts)">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_znx3PMN111dh" style="width: 10%; text-align: right" title="Deductions">32,544</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zIWDN5ZXQ1C7" style="width: 10%; text-align: right" title="Ending Balance">166,049</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Management and other fees receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zA1qbdfRARjj" style="text-align: right">12,608,567</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zZnbvQ3gXM91" style="text-align: right">(238,646</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zRQV4n4uybB1" style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zDMXfB5alEwb" style="text-align: right">12,369,921</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Management and other fees receivable - related medical practices</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zrNOpFQWEGs1" style="text-align: right">3,989,692</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zfG1pNXhkK4b" style="text-align: right">2,120,707</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_ztnXmPeg2XR4" style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zVHM9lvFsM9d" style="text-align: right">6,110,399</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Notes receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zxHpUcPE0KIf" style="text-align: right">777,354</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zVw03YpOdjX" style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zjb73ljDLr72" style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zObfmcnQMtFh" style="text-align: right">777,354</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Balance</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Balance</td></tr>
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Description</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2022</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Additions</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Deductions</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2023</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 11pt; width: 40%; text-align: left; text-indent: -11pt">Accounts receivable</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_986_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zkjZ0KCipFG6" style="width: 10%; text-align: right">204,597</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zfiFNBpauq5" style="width: 10%; text-align: right">55,000</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zmou41KxiL8j" style="width: 10%; text-align: right">61,004</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_znJjja0WDUR4" style="width: 10%; text-align: right">198,593</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Management and other fees receivable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zBpI8XxzF22a" style="text-align: right">16,627,917</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_ztRazgyEAwhk" style="text-align: right">4,007,382</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zGnS8dg6pbul" style="text-align: right">8,026,732</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_982_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zTVo2UAOtnW7" style="text-align: right">12,608,567</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Management and other fees receivable - related medical practices</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zuOWkhbmYtb8" style="text-align: right">4,686,893</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zkQHOCML4XN6" style="text-align: right">1,451,094</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zxDJ4eMv3sw3" style="text-align: right">2,148,295</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zuCIkEopmD" style="text-align: right">3,989,692</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Notes receivable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zhnpJ6qYQTca" style="text-align: right">777,354</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zyxGjMNrEsrj" style="text-align: right">&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zT3J173ma649" style="text-align: right">&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zEkAq0VH0ngb" style="text-align: right">777,354</td>
<td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4px; padding-left: 11pt; text-align: justify"><span id="xdx_F0C_zrCZXU1ui0Y7" style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(1)</span></td>
    <td style="padding-left: 11pt; text-align: justify"><span id="xdx_F1A_zsRxEBUXR3me" style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Included in provision for credit losses.</span></td></tr>
  </table>
<p id="xdx_8A8_ztKyRO3m0ZRd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>



















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Net revenues from management and other fees charged
to the related party medical practices accounted for approximately <span id="xdx_904_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20230701__20240630_zJwmpjKgEhIh" title="Percentage of consolidated net revenue from management fees">12</span>% and <span id="xdx_90E_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20220701__20230630_zrywzfceAFc3" title="Percentage of consolidated net revenue from management fees">12</span>%, of the consolidated net revenues for the years ended June
30, 2024 and 2023, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Tallahassee Magnetic Resonance Imaging, PA, Stand
Up MRI of Boca Raton, PA and Stand Up MRI &amp; Diagnostic Center, PA (all related party medical practices) entered into a guaranty agreement,
pursuant to which they cross guaranteed all management fees which are payable to the Company, which have arisen under each individual
management agreement.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth the number of our facilities
for the years ended June 30, 2024 and 2023.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">Total Facilities</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zfYGN6cu7R9l" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BA_zJnWAxBnUaec" style="display: none">Schedule of facilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20230701__20240630_zcfnQrId55si" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20220701__20230630_zoCB6mcCEOF8" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Year Ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_40C_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_zEHDaxHV6qma" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Total Facilities Owned or Managed (at Beginning of Year)</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">27</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">27</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Facilities Added by:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--ManagedFacilitiesAddedByInternalDevelopment_z0bbJ3tHn9Oj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Internal development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--ManagedFacilitiesClosedDuringYear_d0_zJpUq4cJUVHc" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Managed Facilities Closed</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_z2BaW7Ft6d7a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total Facilities Owned or Managed (at End of Year)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">28</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">27</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due to entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/310-10/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845740423360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--InventoryDisclosureTextBlock_zTrA76cWlrtj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 4 &#8211; <span id="xdx_82E_zu6ohMdAktFb">INVENTORIES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventories included in the accompanying consolidated
balance sheets consist of:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zwnAgOCuvp7d" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BF_zqv8kemkf119" style="display: none">Schedule of inventories</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20240630_z08defaRLD9e" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20230630_z4g7daxKJPD4" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">As of June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_40E_eus-gaap--OtherInventorySupplies_iI_maIFGAWzdt0_zBMZYvgXWDf8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Purchased parts and components</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,524,201</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,346,300</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_maIFGAWzdt0_zuttCjsifXc1" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Work-in-process</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">191,240</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">223,366</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--InventoryNet_iTI_mtIFGAWzdt0_zdvRqeSPTQ6b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Inventories</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,715,441</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,569,666</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845745825824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text"><p id="xdx_801_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zOzVAobHVl3k" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 5 - <span id="xdx_823_zo7KbIYIqZr7">PROPERTY AND EQUIPMENT</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment, at cost, less accumulated
depreciation and amortization, at June 30, 2024 and 2023, is comprised of:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--PropertyPlantAndEquipmentTextBlock_zeZShXzkNEya" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT - Property and equipment (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8B1_z0kZGrhTUiIk" style="display: none">Schedule of property and equipment, at cost, less accumulated
depreciation and amortization</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">As of June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Diagnostic equipment</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zbs7snyeOlNl" style="width: 12%; text-align: right" title="Property plant and equipment, gross">33,243,694</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zKk3jW2LEiCc" style="width: 12%; text-align: right" title="Property plant and equipment, gross">33,144,266</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Research, development and demonstration equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDevelopmentAndDemonstrationEquipmentMember_zxFK8qFrWdzc" style="text-align: right" title="Property plant and equipment, gross">6,199,941</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDevelopmentAndDemonstrationEquipmentMember_zuyNjcZHQj0d" style="text-align: right" title="Property plant and equipment, gross">6,199,941</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Machinery and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zIN3xebDOpg" style="text-align: right" title="Property plant and equipment, gross">2,069,055</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zoAqAHSXPpJc" style="text-align: right" title="Property plant and equipment, gross">2,069,055</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Furniture and fixtures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zHfP635UCEC1" style="text-align: right" title="Property plant and equipment, gross">3,742,169</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zv8nRRhPnyT5" style="text-align: right" title="Property plant and equipment, gross">3,714,499</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zocD8M52HM84" style="text-align: right" title="Property plant and equipment, gross">16,312,904</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zQKg145Wc3z2" style="text-align: right" title="Property plant and equipment, gross">15,650,041</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Building</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zAca8yQwTd9e" style="border-bottom: Black 1pt solid; text-align: right" title="Property plant and equipment, gross">939,614</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zxHktrqlZYw9" style="border-bottom: Black 1pt solid; text-align: right" title="Property plant and equipment, gross">939,614</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630_zv2RGMKNlZbi" style="text-align: right" title="Property plant and equipment, gross">62,507,377</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630_zBPrJZmZavl6" style="text-align: right" title="Property plant and equipment, gross">61,717,416</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Less: Accumulated depreciation and amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20240630_zYTlQhk0vYi8" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation and amortization">43,798,457</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20230630_zsRQ2IVkT9w9" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation and amortization">39,571,043</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20240630_zdZ6fHZ8gPT" style="border-bottom: Black 2.5pt double; text-align: right" title="Property plant and equipment, net">18,708,920</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20230630_zvEiv82swc5f" style="border-bottom: Black 2.5pt double; text-align: right" title="Property plant and equipment, net">22,146,373</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Depreciation and amortization of property and equipment
for the years ended June 30, 2024 and 2023 was $<span id="xdx_90C_eus-gaap--OtherDepreciationAndAmortization_pp0p0_c20230701__20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_ztWb38BZePDf" title="Depreciation and amortization of property and equipment">4,227,414</span> and $<span id="xdx_909_eus-gaap--OtherDepreciationAndAmortization_pp0p0_c20220701__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_zo0jkFNmHUOb" title="Depreciation and amortization of property and equipment">4,148,544</span>, respectively.</p>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845743951152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingFinancingLeasesAbstract', window );"><strong>Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">OPERATING &amp; FINANCING LEASES</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--LesseeOperatingLeasesTextBlock_ztqvZWXCtYpl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 6 &#8211; <span id="xdx_825_zYCZnDcxHQJl">OPERATING &amp; FINANCING LEASES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for its various operating leases
in accordance with Accounting Standards Codification (&#8216;ASC&#8217;) 842 &#8211; Lease, as updated by ASU 2016-02. At the inception
of a lease, the Company recognizes right-of-use lease assets and related lease liabilities measured at present value of future lease payments
on its balance sheet. Lease expense is recognized on a straight-line basis over the term of the lease. Our most common initial term varies
in length from 2 to 19 years. Including renewal options negotiated with the landlord, we have a total span of 2 to 16 years at the facilities
we lease. The Company reviewed its contracts with vendors and customers, determining that its right-to-use lease assets consisted of only
office space operating leases. In determining the right-to-use lease assets and liabilities, the Company did recognize lease extension
options which the Company feels would be reasonably exercised. Our incremental borrowing rate (&#8220;IBR&#8221;) used to discount the
stream of operating lease payments is closely related to the interest rates available to the Company. A reconciliation of operating and
financing lease payments undiscounted cash flows to lease liabilities recognized as of June 30, 2024 is as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



















<table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zxWPFt2jtes7" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Lease payments (Details)">
<tr style="vertical-align: bottom">
<td colspan="3" style="text-align: center"><span id="xdx_8B6_zuSTGREMEtnb" style="display: none">Schedule of reconciliation of operating and financing
lease payments</span></td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Year Ending June 30,</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Operating Lease Payments</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Financing Lease Payments</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 1%; text-align: left">&#160;</td>
<td style="padding: 0pt 0pt 0pt 11pt; width: 26%; text-align: center">2025</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zqSak3qkBvEl" style="width: 26%; text-align: right" title="2025">5,895,014</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_981_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zaetlJMqecnb" style="width: 26%; text-align: right" title="2025">244,343</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">&#160;</td>
<td style="padding: 0pt 0pt 0pt 11pt; text-align: center">2026</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zVAslA7beGhj" style="text-align: right" title="2026">5,561,968</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zGD3L8Yr9Fmf" style="text-align: right" title="2026">244,343</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">&#160;</td>
<td style="padding: 0pt 0pt 0pt 11pt; text-align: center">2027</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_znXbPoZA6cjj" style="text-align: right" title="2027">5,226,352</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_ziANxjpZgdki" style="text-align: right" title="2027">162,897</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">&#160;</td>
<td style="padding: 0pt 0pt 0pt 11pt; text-align: center">2028</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zixNMdUG7s6k" style="text-align: right" title="2028">5,194,655</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_d0_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_ztABDuAvvCRe" style="text-align: right" title="2028">&#8212;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">&#160;</td>
<td style="padding: 0pt 0pt 0pt 11pt; text-align: center">2029</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zZhQOIZmIFUj" style="text-align: right" title="2029">4,865,285</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_d0_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zftT6Aci8Xsc" style="text-align: right" title="2029">&#8212;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">&#160;</td>
<td style="padding: 0pt 0pt 0pt 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Thereafter</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zKAMGbtPidmj" style="text-align: right" title="Thereafter">29,295,110</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_d0_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z1vKArLZveq3" style="text-align: right" title="Thereafter">&#8212;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">&#160;</td>
<td style="padding: 0pt 0pt 0pt 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Present value discount</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_988_ecustom--PresentValueDiscount_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zI3jKE4AE5ag" style="border-bottom: Black 1pt solid; text-align: right" title="Present value discount">(15,096,964</td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_982_ecustom--PresentValueDiscountFinancingLease_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zpoBhrJkD4Si" style="border-bottom: Black 1pt solid; text-align: right" title="Present value discount">(31,074</td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">&#160;</td>
<td style="padding: 0pt 0pt 0pt 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Total lease liability</span></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98B_eus-gaap--OperatingLeaseLiability_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zxwBPf5hn9j5" style="border-bottom: Black 2.5pt double; text-align: right" title="Total lease liability">40,941,420</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_989_eus-gaap--FinanceLeaseLiability_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_ztaaIsy0HIh5" style="border-bottom: Black 2.5pt double; text-align: right" title="Total lease liability">620,509</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8A5_z63dNoSslRJ8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Weighted Average Remaining Lease Term</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_zygwCTE1sr35" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Weighted average remaining lease term (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8B4_zWFj85KW5wka" style="display: none">Schedule
    of weighted average remaining lease term</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 70%; text-align: left; text-indent: -11pt">Operating leases - years</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right"><span id="xdx_909_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240630_z4cUpqCdVwT1" title="Operating leases - years">11.0</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Finance lease - years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240630_zokYbdtNjWGi" title="Finance lease - years">2.6</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Weighted Average Discount Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Operating leases</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20240630_zGPIFz2bvSkj" title="Weighted average discount rate, operating leases">6.4</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Finance lease</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20240630_zk49Yn4GCN54" title="Weighted average discount rate, finance leases">3.6</span></td><td style="text-align: left">%</td></tr>
  </table>


<p id="xdx_8AA_z6bQkgs6xFBb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">The components of lease expense were as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--LeaseCostTableTextBlock_zChHtcRNhfh8" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Components of lease expense (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BC_z3vKzFFltW5e" style="display: none">Schedule of components
    of lease expense</span></td><td>&#160;</td>
    <td colspan="3" id="xdx_495_20230701__20240630_zRYYaviEFZCl" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_499_20220701__20230630_zyTFfjRrVyhh" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For Year Ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Operating lease cost</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">5,685,008</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">5,887,390</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--FinanceLeaseCostsAbstract_iB_zeM01tV7OYff" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Finance lease cost:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0_zXU0EuIp7Ta7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Depreciation of leased equipment</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">198,881</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">198,881</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Interest on lease liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">26,534</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">35,833</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--FinanceLeaseCost_i01_pp0p0_z7ekTXZ28Dqg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total finance lease cost</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">225,415</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">234,714</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8A6_zHeHskNhqtq6" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>



















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Supplemental cash flow information related to leases
was as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_zdQTVXAaEMC2" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BE_zKRrkpPwBYH5" style="display: none">Schedule
    of supplemental cash flow information related to leases</span></td><td>&#160;</td>
    <td colspan="3" id="xdx_492_20230701__20240630_z1ipsSFewXC1" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_497_20220701__20230630_ztGFuONv9TVf" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For Year Ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Cash paid for amounts included in the measurement of lease liabilities:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_40A_ecustom--OperatingCashFlowsFromOperatingLeases_zHCoVLOQMixl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Operating cash flows from operating leases</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">6,363,561</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">5,577,578</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--FinancingCashFlowsFromFinancingLeases_zAKnEkj1TkP3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Financing cash flows from financing leases</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">244,344</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">244,344</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB_zYcS5XR52d8l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Right-of-use and equipment assets obtained in exchange for lease obligations:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_z6SkehgmknMh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Operating leases</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,715,138</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,902,584</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8AA_zALHWBB9Y7mh" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845740376800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">OTHER INTANGIBLE ASSETS</a></td>
<td class="text"><p id="xdx_809_eus-gaap--IntangibleAssetsDisclosureTextBlock_z3Qx9sBrFId" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 7 - <span id="xdx_828_zgI2U6s9Rgfc">OTHER INTANGIBLE ASSETS</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Other intangible assets, net of accumulated amortization,
at June 30, 2024 and 2023, are comprised of:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zTZeAiPTZlPj" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BD_zRldzUPfbKR5" style="display: none">Schedule of other intangible assets, net of accumulated amortization</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">As of June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Capitalized software development costs</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zHo6lKBP5wYk" style="width: 12%; text-align: right" title="Gross other intangible assets">7,004,847</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_z450GDfCMzka" style="width: 12%; text-align: right" title="Gross other intangible assets">7,004,847</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Patents and copyrights</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zVQZvLqOXcMl" style="text-align: right" title="Gross other intangible assets">5,259,811</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zpu9ss2TXRt4" style="text-align: right" title="Gross other intangible assets">5,452,345</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Non-competition agreements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zWLQ1yIC7Ur" style="text-align: right" title="Gross other intangible assets">4,150,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zcSFlPvCTD52" style="text-align: right" title="Gross other intangible assets">4,150,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Customer relationships</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zGsg1YJ41Z6a" style="border-bottom: Black 1pt solid; text-align: right" title="Gross other intangible assets">3,900,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zUO0SAKgJ1j4" style="border-bottom: Black 1pt solid; text-align: right" title="Gross other intangible assets">3,900,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630_zkC0ARlF12Dk" style="text-align: right" title="Gross other intangible assets">20,314,658</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630_z6SexuNOt9df" style="text-align: right" title="Gross other intangible assets">20,507,192</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Less: Accumulated amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630_zmnZWQ2tYfRh" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization">17,444,334</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20230630_zd9g3M1lpcD6" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization">17,075,327</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630_zkfwcF55JAW2" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets-net">2,870,324</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230630_zL2qSjTom81a" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets-net">3,431,865</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A6_zOQE8wglUrRd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The estimated amortization of other intangible assets
for the five years ending June 30, 2029 and thereafter is as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zALUw94kCrH" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details)">
  <tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span id="xdx_8B0_zS5rMT1DnUo3">Schedule of other intangible assets</span> For the Years Ending June 30,</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Patents and Copyrights</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Customer Relationships</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; width: 20%; text-align: center">2025</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20240630_z2zhaLeG9YAh" style="width: 19%; text-align: right" title="2025">351,882</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zucE2paX80F8" style="width: 19%; text-align: right" title="2025">151,882</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zoyvb9MaEDCc" style="width: 19%; text-align: right" title="2025">200,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; text-align: center">2026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20240630_zvj8mnVqegOk" style="text-align: right" title="2026">339,179</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zVU2rNpDwL1b" style="text-align: right" title="2026">139,179</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zrJYijuNDFu2" style="text-align: right" title="2026">200,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; text-align: center">2027</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20240630_zAHlj2WdIAe5" style="text-align: right" title="2027">326,502</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zZniJvrzVxo" style="text-align: right" title="2027">126,502</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zqeH9Pk1dTml" style="text-align: right" title="2027">200,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; text-align: center">2028</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20240630_zXrZZsgNe8Yk" style="text-align: right" title="2028">320,232</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zjtKAMTleb85" style="text-align: right" title="2028">120,232</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyJWgNWYLOri" style="text-align: right" title="2028">200,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; text-align: center">2029</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20240630_zcvLXcvugUPh" style="text-align: right" title="2029">313,052</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zGLJ10r989x9" style="text-align: right" title="2029">113,052</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zUbrEh1xJHrg" style="text-align: right" title="2029">200,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Thereafter</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20240630_zbUh6zNdAbIg" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter">1,219,477</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zu3VCQTvoTQc" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter">505,310</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zeVa6aaccMXb" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter">714,167</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Other intangible assets - net</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20240630_z3zOxK7AmWli" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net">2,870,324</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zGttMuYsbUQ4" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net">1,156,157</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zvLJHoyziiAb" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net">1,714,167</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8A5_z1hZhXrbu854" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>



















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The weighted average amortization period for other
intangible assets is <span id="xdx_90A_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630_zIANwAAmTnoa" title="Weighted average amortization period for other intangible assets">9.9</span> years and they have no expected residual value.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Information related to the above intangible assets
for the years ended June 30, 2024 and 2023 is as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zFFQU4AQoQhe" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Intangle assets - (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8B0_z3TpVubR3Ppe" style="display: none">Schedule of other
    intangible assets</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Year-ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Balance &#8211; Beginning of Year</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20230701__20240630_zuRowUPpOm92" style="width: 12%; text-align: right" title="Balance - Beginning of Year">3,431,865</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20220701__20230630_zqsUC5ramWs5" style="width: 12%; text-align: right" title="Balance - Beginning of Year">3,703,885</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Amounts capitalized</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--AmountsCapitalized_pp0p0_c20230701__20240630_zh8mT33OD2Mk" style="text-align: right" title="Amounts capitalized">32,885</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--AmountsCapitalized_pp0p0_c20220701__20230630_zaeCIwycCfm5" style="text-align: right" title="Amounts capitalized">119,571</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Patents written off</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_c20230701__20240630_zynJp5KK9b49" style="text-align: right" title="Patents written off">(225,419</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_d0_c20220701__20230630_zCs18PKjwHuk" style="text-align: right" title="Patents written off">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AdjustmentForAmortization_pp0p0_c20230701__20240630_zzPIoTiTtdK1" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization">(369,007</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AdjustmentForAmortization_pp0p0_c20220701__20230630_zOPGATxicSzf" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization">(391,591</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Balance &#8211; End of Year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20230701__20240630_zpfOyF6P9aPh" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance - End of Year">2,870,324</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20220701__20230630_zaSgAbRZInOf" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance - End of Year">3,431,865</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8AA_z5RPc7GCOIZa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Amortization of patents and copyrights for the years
ended June 30, 2024 and 2023 amounted to $<span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zPlXpGxsdT0h" title="Amortization">169,007</span> and $<span id="xdx_902_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220701__20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_z7UJXbSpDTXc" title="Amortization of patents and copyrights">191,591</span>, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Amortization of customer relationships for the years
ended June 30, 2024 and 2023 amounted to $<span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zqboraOBnNTh" title="Amortization">200,000</span> and $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220701__20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zLpN060Jthb2" title="Amortization of customer relationships">200,000</span>, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845740694976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureCapitalStockAbstract', window );"><strong>Capital Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CapitalStockDisclosureTextblock', window );">CAPITAL STOCK</a></td>
<td class="text"><p id="xdx_80C_ecustom--CapitalStockDisclosureTextblock_zD1szU3WK4H2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 8 - <span id="xdx_828_zJhikIMjg9na">CAPITAL STOCK</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Common Stock</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_903_eus-gaap--DividendsPayableNature_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zLrVfGdLc9W4" title="Dividends payable, nature">Cash dividends payable on the common stock shall,
in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend payable on shares of Class B common stock
and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common stock.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Class B Common Stock</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_903_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zHXG2OEjuIi9" title="Conversuion of shares into one-for-one basis">Class B common stock is convertible into shares of
common stock on a one-for-one basis.</span> <span id="xdx_908_eus-gaap--CommonStockVotingRights_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_ztQ5eGUQqoi6" title="Common stock, voting rights">Class B common stock has 10 votes per share.</span> There were <span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zSjtFcfBpUNl" title="Common stock, shares outstanding"><span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z2t3VxrjBu" title="Common stock, shares outstanding">146</span></span> of such shares outstanding at June 30,
2024 and 2023.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>





















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Class C Common Stock</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_90A_eus-gaap--CommonStockVotingRights_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdw8lY2faNv8" title="Common stock, voting rights">The Class C common stock has 25 votes per share</span>, as
compared to 10 votes per share for the Class B common stock and <span id="xdx_90C_eus-gaap--CommonStockVotingRights_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zfDoUeFYeS9" title="Common stock, voting rights">one vote per share for the common stock.</span> <span id="xdx_902_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zL9aBo6vSOX8">The Class C common stock was
offered on a three-for-one basis to the holders of the Class B common stock.</span> Although having greater voting power, each share of Class
C common stock has only one-third of the rights of a share of Class B common stock to dividends and distributions. <span id="xdx_90C_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zAL9kWUwKp4i">Class C common stock
is convertible into shares of common stock on a three-for-one basis.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Class A Non-Voting Preferred Stock</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 3, 1995, the stockholders ratified a proposal
consisting of the creation of a new class of Class A non-voting preferred stock with special dividend rights and the declaration of a
stock dividend on the Company&#8217;s common stock consisting of <span id="xdx_907_eus-gaap--CommonStockVotingRights_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zbCGzX4Iq4Sk">one share of Class A non-voting preferred stock for every five shares
of common stock.</span> <span id="xdx_904_eus-gaap--DividendsPayableNature_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zo09MgJXnlRe">The stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued
pursuant to such stock dividend approximates 313,000 shares.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Class A non-voting preferred stock is entitled
to a special dividend equal to 3-1/4% of the first $10 million, 4-1/2% of the next $20 million and 5-1/2% on amounts in excess of $30
million of the amount of any cash awards or settlements received by the Company in connection with the enforcement of five of the Company&#8217;s
patents in its patent lawsuits, less the revised special dividend payable on the common stock with respect to one of the Company&#8217;s
patents.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Class A non-voting preferred stock participates
on an equal per share basis with the common stock in any dividends declared and ranks equally with the common stock on distribution rights,
liquidation rights and other rights and preferences (other than the voting rights).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock Bonus Plans</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 23, 2010, the Board approved the 2010 Stock
Bonus Plan. The plan entitles the Company to reserve <span id="xdx_903_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20100423__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zxlYUqSSnPd1" title="Common stock, capital shares reserved for future issuance">2,000,000</span> shares of common stock. On August 10, 2010, the Company filed Form S-8
to register the <span id="xdx_90A_ecustom--SharesRegistered_iI_c20100810__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zs0dmncvVWbe" title="Shares registered">2,000,000</span> shares. As of June 30, 2024, <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20240630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zewLkGWB5kL7" title="Number of shares available for future grant">450,177</span> shares of common stock of FONAR were available for future grant under this
plan. For the years ended June 30, 2024 and 2023, <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20230701__20240630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zUicNQ8RZAx5" title="Number of shares were issued"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20220701__20230630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zTieJANGutxj" title="Number of shares were issued">0</span></span> shares were issued.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Treasury Stock</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 13, 2022, the Company adopted a stock
repurchase plan. The plan has no expiration date and cannot determine the number of shares which will be repurchased. On September 26,
2022, the Board of Directors has approved up to $<span id="xdx_901_eus-gaap--PaymentsForRepurchaseOfEquity_pdn6_c20220925__20220926__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zd63ALfSTw93" title="Payments for repurchase of equity">9</span> million to be repurchased under the plan which will be purchased on the publicly traded
open market at prevailing prices.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company utilizes the cost method of accounting
to value the treasury stock when repurchasing stock. Under this method, the shares are valued at the price paid and recorded to treasury
stock. When the treasury stock is cancelled, the par value of the stock is reduced and the additional paid in capital is reduced for the
remaining value based upon the original stock sale. For the year ended June 30, 2024, the Company purchased <span id="xdx_901_eus-gaap--StockRepurchasedDuringPeriodShares_c20230701__20240630_zL2RInDExWQ9" title="Purchase of treasury shares">156,206</span> shares at a cost of
$<span id="xdx_90D_eus-gaap--StockRepurchasedDuringPeriodValue_pp0p0_c20230701__20240630_zh5RR7drRSFd" title="Purchase of treasury stock">2,505,832</span> and cancelled <span id="xdx_90F_ecustom--CancellationOfTreasuryShares_c20230701__20240630_z8qjbsWJnIjl" title="Cancellation of treasury shares">122,588</span> shares valued at $<span id="xdx_902_ecustom--CancellationOfTreasuryStock_c20230701__20240630_zxkEZOBtjq96" title="Cancellation of treasury stock">2,005,020</span>. For the year ended June 30, 2023, the Company purchased <span id="xdx_90A_eus-gaap--StockRepurchasedDuringPeriodShares_c20220701__20230630_zyt0He4RBsn9" title="Purchase of treasury shares">103,148</span> shares at
a cost of $<span id="xdx_907_eus-gaap--StockRepurchasedDuringPeriodValue_pp0p0_c20220701__20230630_ztYQ1MHrW7xl" title="Purchase of treasury stock">1,759,457</span> and cancelled <span id="xdx_900_ecustom--CancellationOfTreasuryShares_c20220701__20230630_zX8YjFScYHB9" title="Cancellation of treasury shares">103,328</span> shares valued at $<span id="xdx_903_ecustom--CancellationOfTreasuryStock_c20220701__20230630_z5yFAJ01Ftr9" title="Cancellation of treasury stock">1,919,027</span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CapitalStockDisclosureTextblock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CapitalStockDisclosureTextblock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureCapitalStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureCapitalStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845745825824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONTROLLING AND NONCONTROLLING INTERESTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">CONTROLLING AND NONCONTROLLING INTERESTS</a></td>
<td class="text"><p id="xdx_801_eus-gaap--MinorityInterestDisclosureTextBlock_zs3umEEjdeL7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;<b>NOTE 9 &#8211; <span id="xdx_82A_zn0ptgZX6le3">CONTROLLING AND NONCONTROLLING
INTERESTS</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 13, 2013, the Company entered into an
agreement with outside investors to acquire a 50.5% controlling interest in a newly formed limited liability company, Health Diagnostics
Management LLC (HDM). According to the February 13, 2013, LLC operating agreement of HDM there are two classes of members; Class A members
and one Class B member. The Class A members have an ownership interest of <span id="xdx_904_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_zmnAJQhrNIJ8" title="Ownership interest">49.5</span>% of HDM. The Class B member (HMCA) has an ownership of
<span id="xdx_90C_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember_zDQrufwjbrB1" title="Ownership percenatge">50.5</span>% of HDM. On all matters on which members may vote every member is entitled to cast the percentage of votes equal to their percentage
of ownership interest. Profits and losses on all items of income, gain or loss, deductions or other allocations of the Company will be
allocated among the members in the same proportions as their membership interests in the Company bear to all the Class A and Class B membership
interests of the Company in the aggregate outstanding. All of the depreciation and amortization of the assets of the Company will be allocated
solely to the Class A members, unless and until their interests have been redeemed by the Company in full pursuant to the provisions of
the operating agreement. The Company contributed $<span id="xdx_902_ecustom--ProceedsFromContributionsFromCompany_pp0p0_c20130212__20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember_zYW9Dqv6WFul" title="Company contribution">20,200,000</span> to HDM and the group of outside investors contributed $<span id="xdx_900_eus-gaap--ProceedsFromContributionsFromAffiliates_pp0p0_c20130212__20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_zb14mRksmjc5" title="Investors contribution">19,800,000</span> for its
non-controlling membership interest.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 5, 2013, HDM purchased from Health Diagnostics,
LLC (&#8220;HD&#8221;) and certain of its subsidiaries, a business managing twelve (<span id="xdx_909_ecustom--PurchaseOfStandupMriCenters_iI_uInteger_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zkIdegjdxrU9" title="Purchase of stand up MRI centers">12</span>) Stand-Up MRI Centers and two (<span id="xdx_90E_ecustom--PurchaseOfOtherMriCenters_iI_uInteger_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zP7e7nvsGKig" title="Purchase of other MRI centers">2</span>) other scanning
centers located in the States of New York and Florida for a total purchase price (including consideration of $<span id="xdx_903_ecustom--ConsiderationToOutsideInvestors_iI_pn5n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zUur4HS6hQ5k" title="HDM purchase price includes consideration to outside investors">1.5</span> million to outside investors)
aggregating $<span id="xdx_907_ecustom--TotalPurchasePrice_iI_pn5n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zfoEHPjghhfg" title="HDM purchase from Health Diagnostics (HD) ($)">35.9</span> million. Concurrently with the acquisition, HDM entered into several consulting and non-competition agreements for a
consideration of $<span id="xdx_900_ecustom--ConsiderationForNoncompetitionAndConsultingAgreements_iI_pn5n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zcwLY6zvZ4A7" title="HDM entered agreement for consulting and non-competition agreement ($)">4.1</span> million. The acquisition was accounted for using the purchase method in accordance with ASC 805, &#8220;Business
Combinations&#8221;. The Company recognized and measured goodwill as of the acquisition date, as the excess of the fair value of the consideration
paid over the fair value of the identified net assets acquired.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 8, 2015, the Company purchased <span id="xdx_907_ecustom--EquityMethodInvestmentsOwnershipPercentage_iI_dp_c20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zQyErlqKzwF" title="Purchase of interests from Class A,  percentage">20</span>%
of the Class A members ownership interest at a cost of $<span id="xdx_90C_ecustom--DirectPurchaseOfNoncontrollingInterests_c20150107__20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zlUWeSmllwA3" title="Purchase of interests from Class A">4,971,094</span>. The Company has a <span id="xdx_909_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zI5klHa894oj" title="Ownership interest in HDM">60.4</span>% ownership interest in HDM after this transaction.
During the year ended June 30, 2022, the Company purchased noncontrolling interests for $<span id="xdx_90A_ecustom--DirectPurchaseOfNoncontrollingInterests_c20220701__20230630__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_z4gbFFBihfKg" title="Purchase of interests from Class A">546,000</span> giving the Company a direct ownership
interest of <span id="xdx_908_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20230630__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_z2mseZiMkMp6" title="Ownership interest of company">70.8</span>% and the investors&#8217; a <span id="xdx_901_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20230630__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_zrOgXXUzdfLl" title="Ownership interest of investors">29.2</span>% ownership interest.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The amount of each class of HDM members&#8217; equity
as of June 30, 2024 and 2023 is as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zKcjhoIk1oE5" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"><span id="xdx_8B6_zPPYXjlVbfU6" style="display: none">Schedule of HDM members equity</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2023</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class A Members</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class B Member</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class A Members</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class B Member</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 40%; text-align: left; text-indent: -11pt">Opening Members&#8217; Equity</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">($</td><td id="xdx_98B_ecustom--OpeningMembersEquity_iI_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zBrXOeaQEJwc" style="width: 10%; text-align: right" title="Opening Members Equity">7,079,293</td><td style="width: 1%; text-align: left">)</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--OpeningMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_z4Zn1ILvbg73" style="width: 10%; text-align: right" title="Opening Members Equity">54,781,813</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">($</td><td id="xdx_98F_ecustom--OpeningMembersEquity_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zGlkxvIQK5Kg" style="width: 10%; text-align: right" title="Opening Members Equity">4,053,833</td><td style="width: 1%; text-align: left">)</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--OpeningMembersEquity_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zyBUIwmC4wYk" style="width: 10%; text-align: right" title="Opening Members Equity">50,292,073</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Share of Net Income</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_ecustom--ShareOfNetIncome_iI_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zYqKH0W5ebKf" style="text-align: right" title="Share of Net Income">3,530,021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_ecustom--ShareOfNetIncome_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zdz67QBQ0yl9" style="text-align: right" title="Share of Net Income">20,705,681</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_ecustom--ShareOfNetIncome_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zSlaohGV2h4c" style="text-align: right" title="Share of Net Income">2,750,740</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_ecustom--ShareOfNetIncome_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zlT3nROLK6m8" style="text-align: right" title="Share of Net Income">18,513,540</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Buyout of noncontrolling interests</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zwpPHKapcr12" style="text-align: right" title="Buyout of noncontrolling interests">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zX1yBm6E3Y2k" style="text-align: right" title="Buyout of noncontrolling interests">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z98PGEPUkOv5" style="text-align: right" title="Buyout of noncontrolling interests">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zlk1aGDOh0Oj" style="text-align: right" title="Buyout of noncontrolling interests">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Distributions</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">($</td><td id="xdx_984_ecustom--Distributions_iI_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z5zqKPDZWYsf" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions">5,630,336</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_985_ecustom--Distributions_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_z7b6UFqLQgo" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions">(13,669,664</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">($</td><td id="xdx_985_ecustom--Distributions_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zPHCdZMK2cBg" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions">5,776,200</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98F_ecustom--Distributions_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zdchjKdL0Ezl" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions">(14,023,800</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Ending Members&#8217; Equity</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">($</td><td id="xdx_98D_ecustom--EndingMembersEquity_iI_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zKBuYx21MFQ7" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity">9,179,608</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_ecustom--EndingMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zbZexYRUnqP2" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity">61,817,830</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">($</td><td id="xdx_984_ecustom--EndingMembersEquity_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zItXO6WH3voi" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity">7,079,293</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--EndingMembersEquity_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zf5BC2bLsAnl" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity">54,781,813</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845743546192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract', window );"><strong>Long-term Debt Notes Payable And Capital Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock', window );">LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES</a></td>
<td class="text"><p id="xdx_80A_ecustom--LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock_zQ0vH4QulR5j" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 10 - <span id="xdx_82F_zHnhBzj6k18h">LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL
LEASES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long-term debt, notes payable and capital leases consist
of the following:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfDebtTableTextBlock_zQd3FnJ62l5h" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 11pt; text-align: center; text-indent: -11pt"><span id="xdx_8B8_zTOADzhp4Yxf" style="display: none">Schedule of long-term debt, notes payable and capital leases</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Note payable requiring monthly payments of interest at a rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_909_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zCoNuW4lw4Rh" title="Interest rate">7</span>% until May 2009 followed by <span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_907_ecustom--MonthlyPaymentPeriod_dtM_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zEfEk1ny04yb" title="Monthly payment period">240</span> monthly payments of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90A_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zzqajwERB2m8" title="Debt instrument, periodic payment">4,472</span> through <span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_904_ecustom--MaturityDate_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zvmge24Fcs0b" title="Maturity date">October 2026</span>. The loan is collateralized by a building with a net book value of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_907_ecustom--BookValueOfBuilding_iI_pp0p0_c20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zzp5O41HW52k" title="Book value of building">310,827</span> as of June 30, 2024.</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--LongTermDebt_iI_pp0p0_c20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zbUgTaZIhN53" style="width: 12%; text-align: right" title="Long term debt current">113,940</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--LongTermDebt_iI_pp0p0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zDuORGkrKj52" style="width: 12%; text-align: right" title="Long term debt current">158,842</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">The revolving credit note was extended to November 14, 2024. The Company can borrow up to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_908_eus-gaap--ProceedsFromLinesOfCredit_pp0p0_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zdj4WL0iZapd" title="Proceeds from lines of credit">10,000,000</span> and prepay the loan in whole or part in multiples of $100,000 at any time without penalty. The note bears interest at a rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_901_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_z7tulAvfFHJh" title="Interest rate">8.5</span>% per annum and is payable monthly. The loan is collateralized by substantially all of the Company&#8217;s assets. The loan also contains certain financial covenants that must be met on a periodic basis. The Company still has the ability to draw down on the line.</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LongTermDebt_iI_pp0p0_d0_c20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zpXEHFFS9VQ2" style="border-bottom: Black 1pt solid; text-align: right" title="Long term debt current">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--LongTermDebt_iI_pp0p0_d0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zAKwtNt9oiD5" style="border-bottom: Black 1pt solid; text-align: right" title="Long term debt current">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--LongTermDebt_iI_pp0p0_c20240630_zcvkeYpicsM" style="text-align: right" title="Long term debt, notes payable and capital leases">113,940</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--LongTermDebt_iI_pp0p0_c20230630_zuxIcoMpqRM3" style="text-align: right" title="Long term debt, notes payable and capital leases">158,842</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Less: Current portion</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_iI_pp0p0_c20240630_znlIwV9UoGta" style="border-bottom: Black 1pt solid; text-align: right" title="Current portion of long term debt, notes payable and capital leases">47,002</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_iI_pp0p0_c20230630_zEnznTi3X4zd" style="border-bottom: Black 1pt solid; text-align: right" title="Current portion of long term debt, notes payable and capital leases">43,767</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--LongTermDebtAndCapitalLeaseObligations_iI_pp0p0_c20240630_ziLKPxsGuGtl" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term debt, notes payable and capital leases less current portion">66,938</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--LongTermDebtAndCapitalLeaseObligations_iI_pp0p0_c20230630_zdnuz2CUgs9l" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term debt, notes payable and capital leases less current portion">115,075</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8A4_zakCJzmO0Ri" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The maturities of debt over the next three years are
as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>



<p style="margin-top: 0pt; margin-bottom: 0pt"></p><table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zpq2vdDgH7uh" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities of long term debt over 5 years - (Details)"> <tr style="vertical-align: bottom">

    <td style="text-align: left"><span id="xdx_8B7_zTuYv98oVxkd" style="display: none">Schedule of maturities of long-term debt</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left">Years Ending June 30,</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 76%; text-align: left; text-indent: -11pt">2025</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_pp0p0_c20240630_zvpfG79G2mDa" style="width: 12%; text-align: right" title="2024">47,002</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_pp0p0_c20240630_z24gB1xe98dd" style="text-align: right" title="2025">50,448</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">2027</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_pp0p0_c20240630_zUrn8wDlhbU9" style="border-bottom: Black 1pt solid; text-align: right" title="2026">16,490</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; color: white; text-align: left; text-indent: -11pt"><span style="font: normal 11pt Times New Roman, Times, Serif; text-decoration: none; color: Black; vertical-align: baseline">Long-Term
    Debt Over Five Years and Thereafter</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--LongTermDebt_iI_c20240630_zGxdSee5wQ13" style="border-bottom: Black 2.5pt double; text-align: right" title="Total long term debt">113,940</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8A2_zVNQBoyGmDPf" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845745752288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--IncomeTaxDisclosureTextBlock_zGLmlguh1OA8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 11 - <span id="xdx_825_z8VWpc9FtsZk">INCOME TAXES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;The Company has recorded a deferred tax
asset of $<span id="xdx_906_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_c20240630_zbP3UzWjg9v5" title="Deferred tax asset">7,223,255</span>
and a deferred tax liability of $<span id="xdx_909_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_iI_pp0p0_c20240630_zj2S1M07nD99" title="Deferred tax liability">371,560</span>
as of June 30, 2024, primarily relating to its allowance for credit losses of $3,970,000 and tax credits of approximately $<span id="xdx_907_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20240630_zjNfDjOdaXIc" title="Allowance for doubtful accounts and tax credits">1,323,000</span>
available to offset future taxable income through 2043. During fiscal 2024, the Company utilized all Federal loss carryforwards. In
addition the Company has state operating loss carryforwards of approximately $<span id="xdx_90F_eus-gaap--OperatingIncomeLoss_pp0p0_c20230701__20240630_zPecr9kFqVu" title="State operating loss carryforwards">4,516,000</span>
and city operating loss carryforwards of approximately $<span id="xdx_906_eus-gaap--OtherOperatingIncome_pp0p0_c20230701__20240630_z3KFShJTBQRe" title="City operating loss carryforwards">618,000</span>.
The net operating losses begin to expire in 2026 for state income tax purposes. The Company has also recorded a valuation allowance
against $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwardsValuationAllowance_iI_pp0p0_c20240630_zRE0FmCB4E8c" title="Valuation allowance of state operating losses">2,746,000</span>
of the state operating losses since the Company doesn&#8217;t anticipate being able to utilize them.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company files corporate income tax returns in
the United States (federal) and in various state and local jurisdictions. In most instances, the Company is no longer subject to federal,
state and local income tax examinations by tax authorities for years prior to 2020.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Future ownership changes as determined under Section
382 of the Internal Revenue code could further limit the utilization of net operating loss carryforwards. As of June 30, 2024, no such
changes in ownership have occurred.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Inflation Reduction Act (&#8220;IRA&#8221;) was
enacted on August 16, 2022. The IRA includes provisions imposing a <span id="xdx_907_ecustom--PercentageOfExciseTax_dp_c20230701__20240630_zxikkdOY9Wj2" title="Percentage of excise tax">1</span>% excise tax on share repurchases that occur after December 31, 2022
and introduces a <span id="xdx_905_ecustom--CorporateAlternativeMinimumTaxPercentage_dp_c20230701__20240630_zL6GqyTjidY4" title="Corporate alternative minimum tax percentage">15</span>%&#160;corporate alternative minimum tax (&#8220;CAMT&#8221;) on adjusted financial statement income. The CAMT will
be effective for tax years beginning after December 31, 2022. Currently, the IRA did not have a material impact to the Company&#8217;s
financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The valuation allowance for deferred tax assets decreased
during the year ended June 30, 2024, by approximately $<span id="xdx_908_eus-gaap--DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_iI_pp0p0_c20240630_zIHvpFYikvCl" title="Valuation allowance for deferred tax assets">171,000</span>. The valuation allowance decreased by approximately $<span id="xdx_90D_eus-gaap--DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_iI_pp0p0_c20230630_zNi7bIeV7nYa" title="Valuation allowance for deferred tax assets">78,000</span> during the
year ended June 30, 2023.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Components of the provision for income taxes are as
follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z9sWZUCGaNVi" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Components of provision for income taxes (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BE_z1SNdi7WdLbh" style="display: none">Schedule of components
    of the provision for income taxes</span></td><td>&#160;</td>
    <td colspan="3" id="xdx_49B_20230701__20240630_zpKh9SmNlITi" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_492_20220701__20230630_zLdD00Lt5SIk" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">Years Ended June 30,</td></tr>
  <tr id="xdx_404_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_zsZixD2IhqMh" style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Current:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_401_eus-gaap--CurrentFederalTaxExpenseBenefit_d0_maCITEBzHyE_zBjL8rWRkwP2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; width: 56%; text-align: left; text-indent: -11pt">Federal</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">429,873</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCITEBzHyE_zW3qlNcMdLHg" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">State</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,943,588</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">652,521</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_maITEBzXA8_mtCITEBzHyE_znFk5QhjYvZi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,373,461</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">652,521</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_pp0p0_z6x46xBkG5Sd" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Deferred:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzROz_zpQoQ3jM4Tq2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Federal deferred taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,585,515</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,770,980</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzROz_zv38VAZL6vDj" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">State deferred taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">209,992</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">208,570</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DeferredIncomeTaxExpensesBenefit_iT_pp0p0_mtDITEBzROz_maITEBzXA8_zsNcthnIZjMd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,795,507</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,979,550</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzXA8_zMR6xz0x1AC" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Provision (Benefit) for Income Taxes - Net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,168,968</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,632,071</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8AD_zYtgKg9sCJFf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A reconciliation of the federal statutory income tax
rate to the Company&#8217;s effective tax rate as reported is as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zoscTUSQtz28" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8B8_ze4WkrOfrg1h" style="display: none">Schedule of
    reconciliation of federal statutory income tax rate to company&#8217;s effective tax rate</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">Years Ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Taxes at federal statutory rate</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_906_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_dp_c20230701__20240630_zCe5Cd2yv06f" title="Taxes at federal statutory rate">21.0</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_903_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_dp_c20220701__20230630_zneX5UxD0w05" title="Taxes at federal statutory rate">21.0</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">State and local income taxes (benefit), net of federal benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20230701__20240630_zUmPEuw7Kqsd" title="State and local income taxes (benefit), net of federal benefit">7.1</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20220701__20230630_zgoczKdnDywd" title="State and local income taxes (benefit), net of federal benefit">5.1</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Non-controlling interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20230701__20240630_zK78v0AH8uT3" title="Noncontrolling interest">(5.3</span></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20220701__20230630_zcxnrAndN7Eg" title="Noncontrolling interest">(4.6</span></td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Expiration of tax credits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_c20230701__20240630_zgbX50BtWvQa" title="Expiration of tax credits">2.2</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_c20220701__20230630_zGIokfHUIDUj" title="Expiration of tax credits">2.8</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Return to provision adjustments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp0_c20230701__20240630_zaG6vhJN5Pac" title="Return to provision adjustments">&#8212;</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_c20220701__20230630_zEkgoYvjVo0k" title="Return to provision adjustments">(2.3</span></td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Change in the valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20230701__20240630_z7RL2utqT1Wa" title="Change in the valuation allowance">(0.2</span></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20220701__20230630_z1H0ZT04BBbb" title="Change in the valuation allowance">(0.5</span></td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20230701__20240630_zap2RVYajSSa" title="Other">2.0</span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20220701__20230630_zsd62kktcE1d" title="Other">1.5</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Effective income tax rate</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20230701__20240630_z5nDSWn7b8x1" title="Effective income tax rate">26.8</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20220701__20230630_zcCDzM2z68u8" title="Effective income tax rate">23.0</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>


<p id="xdx_8AB_zh4LD6ASuwFa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>



















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2024, the Company utilized all Federal
net operating loss (&#8220;NOL&#8221;) carryforwards as compared to NOL&#8217;s of approximately $9,110,000 as of June 30, 2023. The utilization
of certain of the NOLs is limited by separate return limitation year rules pursuant to Section 1502 of the Internal Revenue Code.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has, for federal income tax purposes,
research and development tax credits and investments tax credits carryforwards aggregating $<span id="xdx_90F_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_iI_pp0p0_c20240630_zvulAavt8qd4" title="Tax credits carryforwards">1,323,000</span>. However, the realization of these
credits may be limited as a result of expiring prior to their utilization. These credits can only be applied after all net operating losses
have been used.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;Significant components of the Company&#8217;s
deferred tax assets and liabilities at June 30, 2024 and 2023 are as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zMqcrx20DgGf" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Deferred tax assets and liabilities - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BC_zMULfEhGAqE2" style="display: none">Schedule of company&#8217;s
deferred tax assets and liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20240630_zmuKQ9m5zlZd" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20230630_zdjeToFeSOIh" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzM4n_zibiFm5K9Qah" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Allowance for credit losses</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,969,819</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,360,809</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzM4n_zszFOdQf73S" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Non-deductible accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">758,700</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">707,400</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzM4n_ztlOIfuAk64e" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Net operating carryforwards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">396,092</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,768,844</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzM4n_zLQMYZfL8LK3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Tax credits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,323,018</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,981,214</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_i01I_pp0p0_maDTAGzM4n_z9dgsUKM8Mp" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Capitalized research and development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">747,407</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">369,675</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--DeferredTaxAssetsInRightUseAssetsAndLiabilities_i01I_pp0p0_maDTAGzM4n_zwpnzLQy2uyg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Right of use assets and lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">114,116</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">112,938</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzM4n_zuyGoIorZQdd" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Inventories</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">106,879</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">105,310</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzM4n_maDTANzJzu_z9l7g2nMCjca" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Deferred Tax Assets - gross</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,416,031</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,406,190</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzJzu_zdkzvBgmTDcl" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(192,776</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(364,230</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzJzu_maDTALNzFAZ_z8c8sM4QmDc4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,223,255</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,041,960</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_pp0p0_di_maDTLzImD_z0HSCRTtRFx3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Property and equipment and depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(267,124</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(151,007</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzImD_zAENllX4Dqi2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Intangibles</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(104,436</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(243,751</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_msDTALNzFAZ_mtDTLzImD_zNqihF02Jv1b" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total deferred tax liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(371,560</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(394,758</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzFAZ_zy4p6iK9IJuj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Net deferred tax asset</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,851,695</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,647,202</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8A9_zyTQ0sZfOKpk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845845504160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">OTHER CURRENT LIABILITIES</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_ztqTOz9sie16" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 12 - <span id="xdx_825_zEInyM7QGgQc">OTHER CURRENT LIABILITIES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Included in other current liabilities are the following:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zLPhW9v4htne" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8B7_zJqBC5NLE9O8" style="display: none">Schedule of other current liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20240630_zITTz9uZyXrl" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20230630_zVHCeNkN7jb9" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_40D_eus-gaap--AccruedSalariesCurrent_iI_maOLCzbf4_zNVOmqy10yI9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Accrued salaries, commissions and payroll taxes</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">4,677,690</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">4,413,044</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_maOLCzbf4_zQ7LK7x0eAb2" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Sales tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">197,317</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">193,041</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_maOLCzbf4_zEvlcDCGHTx" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">State income taxes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,461,336</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,353</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AccruedProfessionalFeesCurrent_iI_maOLCzbf4_zUdGxQjdaOdc" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Legal and other professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,207</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,207</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_maOLCzbf4_zESr0jVwOI9f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Accounting fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">119,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--SelfInsuranceReserve_iI_maOLCzbf4_zJPW3PvDhDM5" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Self-funded health insurance reserve</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">121,445</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,971</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_maOLCzbf4_zkT55C58U2e3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Accrued interest and penalty</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,534</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,534</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OtherSundryLiabilitiesCurrent_iI_maOLCzbf4_zxPXP6ULGWHh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,348,710</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">573,574</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--OtherLiabilitiesCurrent_iTI_mtOLCzbf4_zMLrUOLXO7Ye" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Other current liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,941,039</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,443,724</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845740424384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zZKbgkWCscSh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 13 - <span id="xdx_828_zQtsp1iuWmoe">COMMITMENTS AND CONTINGENCIES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Leases</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company rents its operating facilities and certain
equipment, pursuant to operating lease agreements expiring at various dates through November 2033. The leases for certain facilities contain
escalation clauses relating to increases in real property taxes as well as certain maintenance costs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Rent expense for operating leases approximated $<span id="xdx_903_ecustom--LeaseAndRentalExpenses_pp0p0_c20230701__20240630_zRAAc6o6VfKf" title="Rent expense for operating leases">5,685,000</span>
and $<span id="xdx_90C_ecustom--LeaseAndRentalExpenses_pp0p0_c20220701__20230630_zzakPXfsHYk5" title="Rent expense for operating leases">5,887,000</span>, for the years ended June 30, 2024 and 2023, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company received approval from the Suffolk County
Industrial Development Agency on February 29, 2016 of a <span id="xdx_90B_ecustom--PropertyTaxAbatementFromSuffolkCountyIda_dp_c20160228__20160229_ztie8PuWue76" title="Property tax abatement from suffolk county IDA">50</span>% property tax abatement, valued at $<span id="xdx_90E_ecustom--PropertyTaxAbatement_pp0p0_c20160228__20160229_zDQJRCzzWWTh" title="Property tax abatement">440,000</span>, over a 10 year period commencing
January 2017.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Employee Benefit Plans</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has a non-contributory 401(k) Plan (the
&#8220;401(k) Plan&#8221;). The 401(k) Plan covers all non-union employees who are at least 21 years of age with no minimum service requirements.
There were $<span id="xdx_90A_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_pp0p0_c20230701__20240630_zsDqLxzdTUNb" title="Employer contributions">0</span> and $<span id="xdx_90B_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_pp0p0_c20220701__20230630_zbGhCYkXGVO4" title="Employer contributions">36,523</span> employer contributions to the Plan for the years ended June 30, 2024 and 2023, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The stockholders of the Company approved the 2000
Employee Stock Purchase Plan (&#8220;ESPP&#8221;) at the Company&#8217;s annual stockholders&#8217; meeting in April 2000. The ESPP provides
for eligible employees to acquire common stock of the Company at a discount, not to exceed 15%. This plan has not been put into effect
as of June 30, 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Other Matters</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is subject to other legal proceedings
and claims arising from the ordinary course of its business, including personal injury, customer contract and employment claims besides
the claim above. In the opinion of management, and with consultation with legal counsel, the aggregate liability, if any, with respect
to such actions, will not have a material adverse effect on the consolidated financial position or results of operations of the Company.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company maintains a self-funded health insurance
program with a stop-loss umbrella policy with a third-party insurer to limit the maximum potential liability for individual claims to
$<span id="xdx_905_eus-gaap--ReinsurancePayable_iI_c20240630_zYqMrA883wj9" title="Liability for individual claims">110,000</span> per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company
considers historical and projected medical utilization data when estimating its health insurance program liability and related expense.
As of June 30, 2024 and 2023, the Company had approximately $<span id="xdx_906_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpense_iI_c20240630_zZv1oBgSkdPa" title="Reserve for self-funded">121,000</span> and $<span id="xdx_90A_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpense_iI_c20230630_zxuJypjvlCT2" title="Reserve for self-funded">101,000</span>, respectively, in reserve for its self-funded health
insurance programs. The reserves are included in &#8220;Other current liabilities&#8221; in the consolidated balance sheets.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company regularly analyzes its reserves for incurred
but not reported claims, and for reported but not paid claims related to its reinsurance and self-funded insurance programs. The Company
believes its reserves are adequate. However, significant judgment is involved in assessing these reserves such as assessing historical
paid claims, average lags between the claims&#8217; incurred date, reported dates and paid dates, and the frequency and severity of claims.
There may be differences between actual settlement amounts and recorded reserves and any resulting adjustments are included in expense
once a probable amount is known. There were no significant adjustments recorded in the years covered by this report.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845745872192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">SUPPLEMENTAL CASH FLOW INFORMATION</a></td>
<td class="text"><p id="xdx_805_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_zWJG6q65f5th" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 14 - <span id="xdx_82A_zkvg7ceUmV65">SUPPLEMENTAL CASH FLOW INFORMATION</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the years ended June 30, 2024 and 2023 the
Company paid $<span id="xdx_900_eus-gaap--InterestPaidNet_c20230701__20240630_zcyOH2kUY779" title="Interest paid">76,997</span> and $<span id="xdx_90E_eus-gaap--InterestPaidNet_c20220701__20230630_ztn0BYRDTbva" title="Interest paid">50,132</span> for interest, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the years ended June 30, 2024 and 2023 the
Company paid $<span id="xdx_902_eus-gaap--IncomeTaxesPaid_c20230701__20240630_zjTqW99SYPS1" title="Income taxes paid">507,139</span> and $<span id="xdx_907_eus-gaap--IncomeTaxesPaid_c20220701__20230630_zadEMEw0Uj22" title="Income taxes paid">1,439,507</span> for income taxes, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/230/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845740426816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p id="xdx_801_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zZC3AuLwFS1f" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 15 &#8211; <span id="xdx_82C_zM1GSWVc1qq5">RELATED PARTY TRANSACTIONS</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 31, 2023, the Company entered into an
agreement with Magnetic Resonance Management, LLC (&#8220;MRM&#8221;) for the sale of a MRI scanner. MRM is owned by the CEO and President
of the Company. The sales price of the equipment was $<span id="xdx_90D_eus-gaap--ConvertibleNotesPayable_iI_c20231231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zapqcbK7XOg1" title="Sale of price of the equipment">576,857</span> which is payable based upon a promissory note dated December 1, 2023. The
note bears interest at a rate of <span id="xdx_908_eus-gaap--DerivativeFixedInterestRate_iI_dp_c20231231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zgit3f9dZIO8" title="Bears interest rate">9</span>% and is payable in full at the maturity of the note in December 2028. The MRI scanner had zero basis,
which resulted in a gain of $<span id="xdx_901_eus-gaap--DeferredGainOnSaleOfProperty_iI_c20231231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zxBPl1xA3u9f" title="Gain on sale of equipments">576,857</span>. The Company has the option but not the obligation to re-take possession of the scanner in lieu of
payment upon maturity of the note.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_907_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20230701__20240630__dei--LegalEntityAxis__custom--BensonhurstMRILimitedPartnershipMember_zbgnOk3x02t7" title="Related party transaction, description">Bensonhurst
MRI Limited Partnership (&#8220;Bensonhurst&#8221;), in which the CEO and President of the Company holds an interest, is party to an
agreement with the Company for the service and maintenance of its Upright MRI Scanner for a price of $110,000 per annum. On February
1, 2024, Bensonhurst entered into a second contract with the Company for the service and maintenance of a High-Field MRI Scanner for
a price of $70,000 per annum. Also, during fiscal year ended June 30, 2024, the Company charged Bensonhurst MRI Limited Partnership
$190,362 for reimbursable salaries and marketing expenses.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The CEO and President of the Company was a minority
owner of a billing company, which performs billing and collection services with respect to No-Fault and Workers&#8217; Compensation claims
of the Company&#8217;s clients. The Company terminated this agreement on January 1, 2021. On June 1, 2017, the Company had also entered
into a one year renewable agreement to provide IT services to the billing company for a monthly fee of $<span id="xdx_903_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20170530__20170601_zjp8pwJkyf5k" title="Monthly fee">23,884</span>. The agreement was terminated
on May 31, 2023.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_90A_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20230701__20240630__dei--LegalEntityAxis__custom--RadianHealthcareManagementLLCMember_zC5YBQQHVWth" title="Related party transaction, description">Radian Healthcare Management, LLC (&#8220;Radian&#8221;),
which is owned by the son-in-law of the CEO and President of the Company provided the Company with personnel recruitment of 32 new employees
at a fee of approximately $200,000 during the fiscal year ended June 30, 2024.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845739753312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT AND RELATED INFORMATION</a></td>
<td class="text"><p id="xdx_803_eus-gaap--SegmentReportingDisclosureTextBlock_zcg6tWgYUPX8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 16 - <span id="xdx_820_zrgqTbZFfdA3">SEGMENT AND RELATED INFORMATION</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company provides segment data in accordance with
the provisions of ASC 280, &#8220;Disclosures about Segments of an Enterprise and Related Information&#8221;.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company operates in two industry segments - manufacturing
and the servicing of medical equipment and management of diagnostic imaging centers.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accounting policies of the segments are the same
as those described in the summary of significant accounting policies. All intersegment sales are market-based. The Company evaluates performance
based on income or loss from operations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Summarized financial information concerning the Company&#8217;s
reportable segments is shown in the following table:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_91F_eus-gaap--HealthCareMember_zrbbrh8Nq8gi"><b style="display: none">Manufacturing
and Servicing of Medical Equipment [Member] </b></span><b><span id="xdx_91A_eus-gaap--HealthCareOtherMember_zwfA1uFTuOY3" style="display: none">Management
of Diagnostic Imaging Center [Member]</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zA71g3xO3oA4" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"><span id="xdx_8BE_zwqIFlHSQafg" style="display: none">Schedule of summarized segment financial information</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">Manufacturing and Servicing of Medical</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">Management of Diagnostic Imaging</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Fiscal 2024:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Center</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Totals</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; width: 46%; text-align: left; text-indent: -11pt">Net revenues from external customers</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--Revenues_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zTMiA4oQGU86" style="width: 11%; text-align: right" title="Net revenues from external customers">8,329,106</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zP5FyMWHPOql" style="width: 11%; text-align: right" title="Net revenues from external customers">94,554,983</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_c20230701__20240630_zVnyRssIqxyj" style="width: 11%; text-align: right" title="Net revenues from external customers">102,884,089</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Intersegment net revenues *</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_ecustom--IntersegmentNetRevenues_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_fKg_____zsmgMH9E59ib" style="text-align: right" title="Inter-segment net revenues">1,073,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_ecustom--IntersegmentNetRevenues_d0_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_fKg_____zrUKfCDHutK8" style="text-align: right" title="Inter-segment net revenues">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_ecustom--IntersegmentNetRevenues_c20230701__20240630_fKg_____zUkVPQEM3tbd" style="text-align: right" title="Inter-segment net revenues">1,073,333</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">(Loss) Income from operations</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperations_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zmyXcXzbgiqd" style="text-align: right" title="(Loss) Income from operations">(6,958,012</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperations_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zzGA0IqxmlIe" style="text-align: right" title="(Loss) Income from operations">23,493,376</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20230701__20240630_zhW7fHRstad1" style="text-align: right" title="(Loss) Income from operations">16,535,364</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zKoTIcpgsPMg" style="text-align: right" title="Depreciation and amortization">238,802</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zwEQkny54BJa" style="text-align: right" title="Depreciation and amortization">4,357,619</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20230701__20240630_zz4PjQT86Uca" style="text-align: right" title="Depreciation and amortization">4,596,421</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Total identifiable assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsNet_iI_c20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_znTU5qLeEuEk" style="text-align: right" title="Total identifiable assets">30,360,188</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsNet_iI_c20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zfygfHXMgf2l" style="text-align: right" title="Total identifiable assets">183,885,781</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--AssetsNet_iI_c20240630_zULDki0ufAV8" style="text-align: right" title="Total identifiable assets">214,245,969</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Capital expenditures</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--PaymentsToAcquireProductiveAssets_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zSXFWTmaLcMa" style="text-align: right" title="Capital expenditures">32,885</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zEiSLrMAOXn6" style="text-align: right" title="Capital expenditures">789,961</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_c20230701__20240630_z36IwKzGEBJh" style="text-align: right" title="Capital expenditures">822,846</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Fiscal 2023:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Net revenues from external customers</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zaN9AzScedn8" style="text-align: right" title="Net revenues from external customers">8,260,711</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--Revenues_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zWF3Zns9v0Md" style="text-align: right" title="Net revenues from external customers">90,384,390</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20220701__20230630_zUOVGy35HEFd" style="text-align: right" title="Net revenues from external customers">98,645,101</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Intersegment net revenues *</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_ecustom--IntersegmentNetRevenues_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_fKg_____z6eheYM24d34" style="text-align: right" title="Inter-segment net revenues">985,833</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_ecustom--IntersegmentNetRevenues_d0_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_fKg_____z572vB3OXIGk" style="text-align: right" title="Inter-segment net revenues">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_ecustom--IntersegmentNetRevenues_c20220701__20230630_fKg_____zFchbOhMwL31" style="text-align: right" title="Inter-segment net revenues">985,833</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">(Loss) Income from operations</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zf4rqOpSeg4l" style="text-align: right" title="(Loss) Income from operations">(5,875,126</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zYgu0HNxD36c" style="text-align: right" title="(Loss) Income from operations">20,664,388</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230630_zQQ6ZmcIK5Ej" style="text-align: right" title="(Loss) Income from operations">14,789,262</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zCrhWL1BCx18" style="text-align: right" title="Depreciation and amortization">263,720</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_ztWMPkpsRrtb" style="text-align: right" title="Depreciation and amortization">4,276,415</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230630_zxZkR34GdXec" style="text-align: right" title="Depreciation and amortization">4,540,135</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Total identifiable assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsNet_iI_c20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zi9yx79H9G3a" style="text-align: right" title="Total identifiable assets">30,892,807</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsNet_iI_c20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zVczUvnXtAab" style="text-align: right" title="Total identifiable assets">170,153,612</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsNet_iI_c20230630_zYv2i4PPTnn7" style="text-align: right" title="Total identifiable assets">201,046,419</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Capital expenditures</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zqUwEC7PUS0f" style="text-align: right" title="Capital expenditures">119,571</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--PaymentsToAcquireProductiveAssets_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zRKM4MQOQHok" style="text-align: right" title="Capital expenditures">4,218,084</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--PaymentsToAcquireProductiveAssets_c20220701__20230630_z9foLkt23973" style="text-align: right" title="Capital expenditures">4,337,655</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4px; padding-left: 11pt; text-align: justify"><span id="xdx_F03_z2AsoMtRz1Kb" style="font-family: Times New Roman, Times, Serif; font-size: 11pt">*</span></td>
    <td style="padding-left: 11pt; text-align: justify"><span id="xdx_F13_zGOAjo82oomk" style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Amounts eliminated in consolidation</span></td></tr>
  </table>
<p id="xdx_8AB_zL5RHqsaxZ2a" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Export Product Sales</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s areas of operations are principally
in the United States. The Company had export sales of medical equipment amounting to <span id="xdx_906_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20230701__20240630_zzydAcmfkBY6" title="Export sales of medical equipment percentage">0.2</span>% and <span id="xdx_90A_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20220701__20230630_ztlb31XNbj8k" title="Export sales of medical equipment percentage">14.1</span>% of product sales revenues to third
parties for the years ended June 30, 2024 and 2023, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The foreign product sales, as a percentage of product
sales to unrelated parties, were made to customers in the following countries:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfExportProductSalesTableTextBlock_zPxvt0Md6uRd" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"><span id="xdx_8BA_zV8IvqceoLdk" style="display: none">Schedule of export product sales</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-indent: -11pt">Canada</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_909_ecustom--ForeignProductSales_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zY8o9O0ihNw6" title="Foreign product sales">0.2</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90B_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CA_z6VZMCBFzPJa" title="Foreign product sales">8.5</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Germany</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_ecustom--ForeignProductSales_dp0_c20230701__20240630__srt--StatementGeographicalAxis__country--DE_zmBAUyyf01rj" title="Foreign product sales">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DE_ziwtdxJ09DCg" title="Foreign product sales">4.9</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">United Arab Emirates</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecustom--ForeignProductSales_dp0_c20230701__20240630__srt--StatementGeographicalAxis__country--AE_zwJcDCMPuaIj" title="Foreign product sales">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AE_zCSOYTp2ycS7" title="Foreign product sales">0.7</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_ecustom--ForeignProductSales_dp_c20230701__20240630_zTYH7ZgvBT45" title="Foreign product sales">0.2</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_ecustom--ForeignProductSales_dp_c20220701__20230630_zgnSQ5SgksR5" title="Foreign product sales">14.1</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

<p id="xdx_8A2_zqabiH0gy4Ni" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>



















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Foreign Service and Repair Fees</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s areas of service and repair are
principally in the United States. The Company had foreign revenues of service and repair of medical equipment amounting to <span id="xdx_902_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20230701__20240630_zD7klvy2hoIl" title="Percentage of service and repair of medical equipment">7.4</span>% and <span id="xdx_90F_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20220701__20230630_zsReGTMvXxUi" title="Percentage of service and repair of medical equipment">6.4</span>%
of consolidated net service and repair fees for the years ended June 30, 2024 and 2023, respectively. Foreign service and repair fees,
as a percentage of total service and repair fees, were provided principally to the following countries:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;Foreign Service and Repair Fees</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfExportServiceRevenuesTableTextBlock_z7jiVO9m4v1j" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"><span id="xdx_8BA_z5mx20i5YrCa" style="display: none">Schedule of export service revenues</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Puerto Rico</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90E_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--PR_z4TR3fJLSEf9" title="Foreign service and repair fees">1.9</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_905_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--PR_z4pkxQDKv8vk" title="Foreign service and repair fees">1.5</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Switzerland</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CH_z5ThHoeCyosa" title="Foreign service and repair fees">0.3</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CH_z7Bm71O8iZY6" title="Foreign service and repair fees">0.3</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Germany</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--DE_zRYwYFliwQ83" title="Foreign service and repair fees">2.0</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DE_zsz2GlSfRBfh" title="Foreign service and repair fees">1.6</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">England</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--GB_z3K53JttbUh4" title="Foreign service and repair fees">0.7</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--GB_zV3kqEMVFlPj" title="Foreign service and repair fees">0.6</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">United Arab Emirates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--AE_zMbLBBGpuaFa" title="Foreign service and repair fees">0.3</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AE_zn3tqTDy40he" title="Foreign service and repair fees">0.1</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Dominican Republic</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--DO_zMCibsAKuY33" title="Foreign service and repair fees">1.2</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DO_zlhfPHoNaW0b" title="Foreign service and repair fees">0.5</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Canada</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_ecustom--ForeignServiceAndRepairFees_dp0_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zn8wMDBi7iYi" title="Foreign service and repair fees">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CA_zoyPr5HlQdOc" title="Foreign service and repair fees">0.6</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Greece</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--GR_z8xAcCJrq6Od" title="Foreign service and repair fees">0.3</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--GR_zE1T9oHhrLL2" title="Foreign service and repair fees">0.3</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 1pt 11pt; text-indent: -11pt">Australia</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--AU_zFcb35Wfn3Di" title="Foreign service and repair fees">0.7</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AU_zrFkQP17t7mb" title="Foreign service and repair fees">0.9</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 2.5pt 11pt; text-indent: -11pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630_zPsaKxpaO687" title="Foreign service and repair fees">7.4</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630_zok0Okk7tur9" title="Foreign service and repair fees">6.4</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>


<p id="xdx_8AB_zy8qXKfYo7ma" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;The Company does not have any material assets
outside of the United States.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845739752816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--SubsequentEventsTextBlock_zv0m0gtYAXd9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 17 &#8211; <span id="xdx_826_zDRw4DBAztga">SUBSEQUENT EVENTS</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates events that have occurred after
the balance sheet date, but before the consolidated financial statements are issued.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 18, 2024, the Company repurchased
<span id="xdx_90F_esrt--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_iI_c20240918__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSFLRoUFIB04" title="Number of shares repurchased, shares">19,914</span> shares at a cost of $<span id="xdx_908_eus-gaap--StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_iI_c20240918__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTfz2Td2y8e9" title="Number of shares repurchased, value">340,933</span> which was authorized under the stock repurchase plan adopted in September 2022.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845739784496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zwyUDgDQDNFi" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_869_z2pxossBaQ4j">Principles of Consolidation</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements include the
accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships. The operating activities of subsidiaries are
included in the accompanying consolidated statements from the date of acquisition. All significant intercompany accounts and transactions
have been eliminated in consolidation.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



















<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--UseOfEstimates_zqEKKHEfG9S9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_865_zDrffM0Rk6Ua">Use of Estimates</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the consolidated financial statements
in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities in the consolidated financial
statements and accompanying notes. The most significant estimates relate to receivable allowances, income taxes and related tax asset
valuation allowances, contingencies, and revenue recognition. In addition, healthcare industry reforms and reimbursement practices will
continue to impact the Company&#8217;s operations and the determination of contractual and other allowance estimates. Actual results could
differ from those estimates.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessPolicy', window );">Inventories</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--InventoryWorkInProcessPolicy_zJRpuO4jgf7e" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_860_zYX965COlutb">Inventories</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventories consist of purchased parts, components
and supplies, as well as work-in-process, and are stated at the lower of cost or net realizable value.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zDew3dopOlpd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_865_z84usRR4a1s">Property and Equipment</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment procured in the normal course
of business is stated at cost less accumulated depreciation. Property and equipment purchased in connection with an acquisition is stated
at its estimated fair value, generally based on an appraisal. Property and equipment is being depreciated for financial accounting purposes
using the straight-line method over their estimated useful lives. Leasehold improvements are being amortized over the shorter of the useful
life or the remaining lease term. Upon retirement or other disposition of these assets, the cost and related accumulated depreciation
of these assets are removed from the accounts and the resulting gains or losses are reflected in the results of operations. Expenses for
maintenance and repairs are charged to operations. Renewals and betterments are capitalized. Maintenance and repair expenses totaled approximately
$<span id="xdx_90A_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20230701__20240630_zvKqLaoduv4e" title="Maintenance and repair expenses">2,948,000</span> and $<span id="xdx_906_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20220701__20230630_zULLmiJZg0Ba" title="Maintenance and repair expenses">2,801,000</span> for the years ended June 30, 2024 and 2023 respectively. The estimated useful lives in years are generally as
follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88E_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_z1vIwy6ZISK9" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)">
<tr style="vertical-align: bottom">
<td colspan="3" style="border-bottom: Black 1pt solid; padding: 0pt; text-align: left; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_8BF_zs2gNJdAoczg" style="display: none">Schedule
of estimated useful life in years for property and equipment</span></span></td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: bottom; width: 87%; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Diagnostic equipment</span></td>
<td style="padding: 0pt; vertical-align: bottom; width: 12%; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zLKj6odAoCG5">5</span>&#8211;<span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_z15gqxQVKlt" title="Estimated useful lives">13</span></span></td>
<td style="padding: 0pt; width: 1%; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Research, development and demonstration equipment</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zD1kMI5H9Pfk">3</span>-<span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_z6eK5e3xFzCa">7</span></span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Machinery and equipment</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_za6eX1JyjcW7">2</span>-<span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zHXeZQTExWYd">7</span></span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Furniture and fixtures</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zPVJ7nKtC0lg">3</span>-<span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z2TR8Wlv23Fc">9</span></span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Leasehold improvements</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zy1haNsqvvPb">5</span>&#8211;<span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z3GQyurSiPwa">10</span></span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Building</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--WeightedAverageMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zP9U3mTibM8l" title="Estimated useful lives">28</span></span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



















<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text"><p id="xdx_842_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zhUDRnXmYAj4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_862_zAIQkiz1EDza">Long-Lived Assets</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company periodically assesses the recoverability
of long-lived assets, including property and equipment and intangibles, other than goodwill, when events or changes in circumstances indicate
that the carrying value of long-lived assets may not be recoverable. If indicators are present, the Company performs a recoverability
test by comparing the sum of the estimated undiscounted future cash flows attributable to the asset group in question to its carrying
amount. An impairment loss is recognized if it is determined that the long-lived asset group is not recoverable and is calculated by comparing
the discounted future cash flows with the carrying value of the related asset group. In performing this analysis, management considers
such factors as current results, trends, and future prospects, in addition to other economic factors.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Other Intangible Assets</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zpdPcnvzbad3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_860_zfvdavdczYO5">Other Intangible Assets</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">1) Patents and Copyrights</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Patent and copyrights are professional costs incurred
to acquire certain patent and copyrights. Amortization is calculated on the straight-line basis over <span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zAvQaEtly327" title="Finite-lived intangible asset, useful life">15</span> years.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">2) Non-Competition Agreements</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The non-competition agreements are agreements entered
into with past principal owners of entities that the Company had acquired. The non-competition agreements are being amortized on the straight-line
basis over the length of the agreement (<span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_z0tdVFCqcb8j" title="Finite-lived intangible asset, useful life">7</span> years).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">3) Customer Relationships</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Customer relationships represents customer lists acquired
in acquisition of prior entities. Amortization is calculated on the straight-line basis over <span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zhmAQeXD3XE8" title="Finite-lived intangible asset, useful life">20</span> years.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text"><p id="xdx_847_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_ztol9VfCLX07" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_866_ze2XHKlM2Ggl">Goodwill</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Goodwill represents the cost of a business acquisition
in excess of the fair value of the net assets acquired. Goodwill is not amortized and is reviewed for impairment annually, or more frequently
if facts and circumstances indicate that it is more likely than not that the fair value of the reporting unit is less than its carrying
amount including goodwill. If it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the
Company performs a quantitative test to identify and measure the amount of goodwill impairment loss. The Company compares the fair value
of the reporting unit with its carrying amount. If the carrying amount exceeds fair value, goodwill of the reporting unit is considered
impaired, and that excess is recognized as a goodwill impairment loss.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



















<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zjVfGdP4cLJl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_867_zdNR78TDJ4c4">Revenue Recognition</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue on sales contracts for scanners, included
in &#8220;product sales&#8221; in the accompanying consolidated statements of operations, is recognized under the percentage-of-completion
method in accordance with FASB ASC 606, &#8220;Revenue Recognition &#8211; Construction-Type and Production-Type Contracts&#8221;. The
Company manufactures its scanners under specific contracts that provide for progress payments. Production and installation take approximately
three to six months.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue on scanner service contracts is recognized
on the straight-line method over the related contract period, usually one year. As of June 30, 2023, the Company had unearned revenue
on service contracts of $3,832,184 of which all was recognized as revenue in the fiscal year ending June 30, 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue from product sales (upgrades and supplies)
is recognized upon shipment.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue under management contracts is recognized
based upon contractual agreements for management services rendered by the Company primarily under various long-term agreements with
various medical providers (the &#8220;PCs&#8221;). As of June 30, 2024, the Company has <span id="xdx_90E_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20240630_zXpwoYmmoGR3" title="Management agreements with company total medical practices">22</span>
management agreements of which <span id="xdx_90F_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20240630_zNWAb72g9LO9" title="Scanners with management agreements with company owned by related party">3</span>
were with PC&#8217;s owned by Timothy Damadian, Chairman of the Board, President, Chief Executive Officer and Treasurer (formerly
owned by Raymond V. Damadian, M.D., Chairman of the Board of FONAR until his unexpected death in August 2022)(&#8220;the Related
medical practices&#8221;) and <span id="xdx_901_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20240630_zaNpGoUYnkHe" title="Scanners with management with company located in new york state">19</span>
are with PC&#8217;s, which are all located in the state of New York (&#8220;the New York PC&#8217;s&#8221;), owned by two unrelated
radiologists. The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility
ranging from approximately $<span id="xdx_90E_ecustom--ContractualFeesForServicesRenderedMinimum_iI_pdp0_c20240630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zjiq4LJFqZza" title="Contractual fees for services rendered minimum">84,000</span>
to $<span id="xdx_905_ecustom--ContractualFeesForServicesRenderedMaximum_iI_c20240630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zHPpdazHDQgg" title="Contractual fees for services rendered maximum">447,000</span>.
All fees are re-negotiable at the anniversary of the agreements and each year thereafter. The Company records a credit loss expense for
estimated uncollectible fees, which is reflected in other operating expenses on the Consolidated Statement of Operations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company currently recognizes revenue in accordance
with the recognition accounting standard issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;) and codified in the ASC
as topic 606 (&#8220;ASC 606&#8221;). The revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing
revenue as performance obligations, defined in a contract with a customer as goods or services transferred to the customer in exchange
for consideration, are satisfied. The standard also requires expanded disclosures regarding the Company&#8217;s revenue recognition policies
and significant judgments employed in the determination of revenue.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s revenues generally relate to net
patient fees&#160;received from various payers and patients themselves under contracts in which our performance obligations are to provide
diagnostic services to the patients. Revenues are recorded during the period our obligations to provide diagnostic services are satisfied.
Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships
with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health plans and commercial insurance
companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent
upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the
third-party payers. The payment arrangements with third-party payers for the services we provide to the related patients typically specify
payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services
or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates
to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s patient fee revenues, net of contractual
allowances and discounts for the years ended June 30, 2024 and 2023 are summarized in the following table.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--DisaggregationOfRevenueTableTextBlock_zKieyjyUMs7l" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8B2_zibRPTtp76H6" style="display: none">Schedule of patient fee
    revenue - net</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Commercial Insurance/ Managed Care</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zQP7AjRvBfCb" style="width: 12%; text-align: right" title="Net Patient Fee Revenue">4,952,712</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zSWvqUvUpEb1" style="width: 12%; text-align: right" title="Net Patient Fee Revenue">4,124,646</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Medicare/Medicaid</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zgZLnk8r0RPj" style="text-align: right" title="Net Patient Fee Revenue">1,138,176</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zUubfFwT39r" style="text-align: right" title="Net Patient Fee Revenue">1,063,846</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Workers&#8217; Compensation/Personal Injury</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zPcuEffR23yd" style="text-align: right" title="Net Patient Fee Revenue">20,673,483</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zNq4J8jwHUGl" style="text-align: right" title="Net Patient Fee Revenue">18,670,019</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zVCGIZyggKpg" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue">7,051,425</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zdne1tGYBBZ2" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue">5,935,482</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Net Patient Fee Revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630_zpm5teBsyZ91" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue">33,815,796</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630_zT2g27BSSgz8" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue">29,793,993</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MedicalReceivableAndManagementAndOtherFeesReceivablePolicyTextBlock', window );">Medical Receivable and Management and Other Fees Receivable</a></td>
<td class="text"><p id="xdx_847_ecustom--MedicalReceivableAndManagementAndOtherFeesReceivablePolicyTextBlock_zQcxncB6FOvk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86A_z16itZ81ONV4">Medical Receivable and Management and Other Fees Receivable</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span>Medical Receivable</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management fees receivable is related to management fees outstanding
from the related and non related PCs under management agreements. The Company has established a current expected credit loss (&#8220;CECL&#8221;)
to address the risk that a portion of the contractually obligated management fees receivable from the PCs may not be paid. The PC&#8217;s
may be limited in their ability to pay the full management fee receivable if they do not collect sufficient expected fees from third-party
payers and patients. The Company&#8217;s management fees are collateralized, individually and collectively, by the assets of the PCs.
The CECL is determined based on the difference between the management fee receivable and the current amount of outstanding fees estimated
to be collected by the PCs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span>Management and Other Fees Receivable</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management fees receivable is related to management
fees outstanding from the related and non related PCs under management agreements. The Company has established a current expected credit
loss (&#8220;CECL&#8221;) to address the risk that a portion of the contractually obligated management fees receivable from the PCs may
not be paid. The PC&#8217;s may be limited in their ability to pay the full management fee receivable if they do not collect sufficient
expected fees from third-party payers and patients. The Company&#8217;s management fees are collateralized, individually and collectively,
by the assets of the PCs. The CECL is determined based on the difference between the management fee receivable and the current amount
of outstanding fees estimated to be collected by the PCs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s considerations into the estimate
of the PC&#8217;s fee collection is based on a combination of factors. As each management agreement specifies the Company&#8217;s ultimate
collateral for unpaid management fees are the patient fee receivables owned by each PC, the Company considers the historical loss rates
to pools of receivables with similar risks characteristics, aging of the patient fee receivables, and the financial condition of each
PC. In addition, the Company subjectively adjusts its estimated expected credit losses for current and forward-looking economic conditions
which would include trends seen within the industry and newly enacted regulation. The Company also incorporates qualitative factors, such
as changes in the nature and volume of receivables, regulatory changes, and other relevant factors. Specifically, insurance carriers covering
automobile no-fault and workers compensation claims incur longer payment cycles and rigorous informational requirements and certain other
disallowed claims. Approximately 67% of the PCs&#8217; 2024 and 2023 net revenues were derived from no-fault and personal injury protection
claims.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; background-color: white">The Company combines
an objective and subjective loss-rate methodology to estimate expected credit losses based on the collateral owned by each PC. This involves
objectively using historical loss rates to pools of receivables with similar risk characteristics (i.e., various insurance payors) and
then subjectively adjusting for current and forward-looking economic conditions which would include trends seen within the industry and
newly enacted regulation. The Company also incorporates qualitative factors, such as changes in the nature and volume of the receivables,
regulatory changes, and other relevant factors.</p>

<p style="font: 11pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify">The provision for credit losses for the year
ended June 30, 2024 was $<span id="xdx_902_ecustom--ProvisionForBadDebts_c20230701__20240630_zyJjWYtgVg0e">1,882,061</span>. This can be attributable to an increase in scan volume at all the PC&#8217;s and due to the nature
of the payor classes, where there is a longer expected payment term. Additionally, newly proposed legislation around credit reporting
on individual medical debts increasing the likelihood of non-payment of individual patient accounts. The management fee receivable for
unrelated and related parties as of July 1, 2022 was $<span id="xdx_906_ecustom--ManagementFeeReceivableForUnrelatedParties_iI_c20220702_zkNt4LsmZD46">33,419,219
</span>and $<span id="xdx_908_ecustom--ManagementFeeReceivableForRelatedParties_iI_c20220702_zPKWt8qGodgf">8,602,561</span>,
respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>




<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--ReceivablesPolicyTextBlock_zM7aYnXv6Xpd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86C_zkRXn4BeEfgg">Accounts Receivable</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Credit risk with respect to the Company&#8217;s
accounts receivable related to product sales and service and repair fees is limited due to the customer advances received prior to the
commencement of work performed and the billing of amounts to customers as sub-assemblies are completed. Service and repair fees are billed
on a monthly or quarterly basis and the Company does not continue providing these services if accounts receivable become past due. The
Company controls credit risk with respect to accounts receivable from service and repair fees through its credit evaluation process,
credit limits, monitoring procedures and reasonably short collection terms. The Company performs ongoing credit authorizations before
a product sales contract is entered into or service and repair fees are provided.&#160;The account receivable balance for scanner service
contracts as of July 1, 2022 was $<span id="xdx_905_ecustom--AccountsReceivableServiceContractsNet_iI_c20220702_zniw8wLrrNx4">4,335,956</span>.</p>















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text"><p id="xdx_840_eus-gaap--ResearchAndDevelopmentExpensePolicy_zQV6jIMjdrmd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_860_z7fpB9w5Lmb2">Research and Development Costs</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development costs are charged to expense
as incurred. The costs of equipment that are acquired or constructed for research and development activities, and have alternative future
uses (either in research and development, marketing or production), are classified as property and equipment and depreciated over their
estimated useful lives.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--AdvertisingCostsPolicyTextBlock_zQcdQH8wfeA5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_861_zAXOhmeiQA89">Advertising Costs</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Advertising costs are expensed as incurred. Advertising
expense approximated $<span id="xdx_90E_eus-gaap--AdvertisingExpense_c20230701__20240630_zxCMQfhbqrrj">731,000</span> and $<span id="xdx_905_eus-gaap--AdvertisingExpense_c20220701__20230630_z5aKmIyxUmni">570,000
</span>and for the years ended June 30, 2024 and 2023, respectively.<b>&#160;</b></p>



<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_zGk2PMILa6eh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_868_zqA8dJzcQkL8">Income Taxes</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Deferred tax assets and liabilities are determined
based on the difference between the financial statement carrying amounts and tax basis of assets and liabilities using enacted tax rates
in effect in the years in which the differences are expected to reverse.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The ultimate realization of deferred tax assets is
dependent on the generation of future taxable income during the periods in which temporary differences become deductible or when such
net operating losses can be utilized. The Company considers projected future taxable income, the regulatory environment of the industry,
and tax planning strategies in making this assessment. At present, the Company believes that it is more likely than not that the benefits
from certain deferred tax asset carryforwards, will not all be fully realized. In recognition of this inherent risk, a valuation allowance
was established for the partial value of the deferred tax asset, which principally related to certain state net operating losses. A valuation
allowance will be maintained until sufficient positive evidence exists to support the reversal of the remainder of the valuation.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with ASC 740, &#8220;Accounting for
Income Taxes&#8221;, prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement
of tax positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be
taken in a tax return and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits.
A liability is recognized (or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax
benefit because it represents an enterprise&#8217;s potential future obligation to the taxing authority for a tax position that was not
recognized as a result of applying the provisions of ASC 740. The Company believes there are no uncertain tax positions in prior year&#8217;s
tax filings and therefore it has not recorded a liability for unrecognized tax benefits.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with ASC 740, interest costs related
to unrecognized tax benefits are required to be calculated (if applicable) and would be classified as &#8220;Interest expense, net. Penalties
if incurred would be recognized as a component of &#8220;Selling, general and administrative&#8221; expenses. Penalties for the years
ended June 30, 2024 and June 30, 2023 were $<span id="xdx_905_eus-gaap--IncomeTaxExaminationPenaltiesExpense_c20230701__20240630_z9Q0Hn5aAaTh" title="Penalties">20,444</span> and $<span id="xdx_906_eus-gaap--IncomeTaxExaminationPenaltiesExpense_c20220701__20230630_z8bTkU63dY9" title="Penalties">31,122</span>, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



















<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CustomerAdvancesPolicyTextBlock', window );">Customer Advances</a></td>
<td class="text"><p id="xdx_849_ecustom--CustomerAdvancesPolicyTextBlock_zifYBNqOen18" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86A_zROga0l6TK7j">Customer Advances</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash advances and progress payments received on sales
orders are reflected as customer advances until such time as revenue recognition occurs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_zUPGfY2S3991" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_869_zkNcgjyuBKRe">Earnings Per Share</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic earnings per share (&#8220;EPS&#8221;) is computed
by dividing net income available to common stockholders by the weighted average number of shares of common stock outstanding during the
period. In accordance with ASC topic 260-10, &#8220;Participating Securities and the Two-Class Method&#8221;, the Company used the Two-Class
method for calculating basic earnings per share and applied the if converted method in calculating diluted earnings per share for the
years ended June 30, 2024 and 2023.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Diluted EPS reflects the potential dilution from the
exercise or conversion of all dilutive securities into common stock based on the average market price of common shares outstanding during
the period. For the years ended June 30, 2024 and 2023, diluted EPS for common shareholders includes <span id="xdx_900_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20230701__20240630_zXgmLFs4rzuc" title="Conversion of Class C Common Stock"><span id="xdx_904_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20220701__20230630_zMkTYZPbhp7k" title="Conversion of Class C Common Stock">127,504</span></span> shares upon conversion of
Class C Common.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zQOGX5QvAza3" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BF_zywvfBLj6VWf" style="display: none">Schedule of earnings per share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Basic</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class C Common Stock</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Numerator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 46%; text-align: left; text-indent: -11pt">Net income available to common stockholders</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630_z5Rcu2Wqc693" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders">10,567,396</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z7tmlgA6yw86" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders">9,908,920</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zS3OC7vju5ra" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders">167,700</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Weighted average shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630_zODObpn37tXd" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">6,350,862</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_983_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z1NzWS5YYt6j" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">6,350,862</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zsv8MvcuX5Jg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">382,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Basic income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630_za6Cya3uMO29" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.66</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zbT5oyjhJ3Ha" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.56</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zo2AdSpO5Nch" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">0.44</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Weighted average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z6Dsgme3pJZ9" style="text-align: right" title="Weighted average shares outstanding">6,350,862</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zJaoalYiGapd" style="text-align: right" title="Weighted average shares outstanding">382,513</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Class C Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zTUCK9K36mxc" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock">127,504</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zKDHmj3FQQP" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zo0pacwcLj68" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share">6,478,366</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_ztshFF2cGGVa" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share">382,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zvB8OZFZJUHb" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share">1.53</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zS00GW4GVGzg" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share">0.44</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>























<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2023</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Basic</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class C Common Stock</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Numerator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 46%; text-align: left; text-indent: -11pt">Net income available to common stockholders</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20220701__20230630_zxtZWKIKsiff" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders">9,375,776</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zwJEvY67Iumb" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders">8,801,974</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z3Qi4OsGnkJ3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders">146,136</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Weighted average shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630_zB7YdIopqgb6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">6,539,376</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zbeFLt3EWpwj" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">6,539,376</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z69RHhQSz9a5" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">382,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Basic income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630_zytNpUPMRTf3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.43</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zEsXKtKOJyIe" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.35</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zEWBFp7LRyXf" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">0.38</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Weighted average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zaiGOcIWQt49" style="text-align: right" title="Weighted average shares outstanding">6,539,376</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z14HKTw8KMnj" style="text-align: right" title="Weighted average shares outstanding">382,513</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Class C Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zaUCBatpgKp5" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock">127,504</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zZLCrPweHY4b" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zh3uUtS9SNpk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share">6,666,880</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zcsRabBp4lNh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share">382,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zvhfQ9yDrIPb" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share">1.32</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zuZoteG2VhO1" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share">0.38</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8A1_zOL0s9iyGBTk" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z33M7wt7oICl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_869_zhbMc3xQZmNe">Cash and Cash Equivalents</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash and cash equivalents includes cash on hand, cash
in banks, investments in certificates of deposit with original maturities of 90 days or less, and money market funds.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Short-Term Investments</a></td>
<td class="text"><p id="xdx_848_eus-gaap--InvestmentPolicyTextBlock_zNVmvzpue4E7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_860_zKPyc0dKGqci">Short-Term Investments</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Short-term investments include certificates of deposit
with original maturities of greater than 90 days. Interest is recorded as earned.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zjfBs4dogapf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_866_zTIqGj8fSFsd">Concentration of Credit Risk</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash: The Company maintains its cash and cash equivalents
with various financial institutions, which exceed federally insured limits throughout the year. At June 30, 2024, the Company had cash
on deposit of approximately $<span id="xdx_907_eus-gaap--Cash_iI_pp0p0_c20240630_zls9uqywcjkh" title="Cash deposit">53,883,000</span> in excess of federally insured limits of $<span id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20240630_zBSk8mx3ekc3" title="Federally insured limits">250,000</span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Related Parties: Net revenues from related parties
accounted for approximately <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zcUvQhEqKW3f" title="Concentration risk, percentage"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zSnnpyzSZ80h" title="Concentration risk, percentage">12</span></span>% of the consolidated net revenues for the years ended June 30, 2024 and 2023. Net management fee receivables
from the related party medical practices accounted for approximately <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMedicalPracticesMember_z9UgZHdapRv" title="Concentration risk, percentage">12</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMedicalPracticesMember_zrb3soJNEv93" title="Concentration risk, percentage">13</span>% of the consolidated accounts receivable as of June 30,
2024 and 2023, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">See Note 3 regarding the Company&#8217;s concentrations
in the healthcare industry.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



















<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_843_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zioSBMNADrJ2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_867_zrF5xqH8vBS8">Fair Value of Financial Instruments</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company measures fair value in accordance with
ASC 820-10, &#8220;Fair Value Measurements and Disclosures&#8221;. ASC 820-10 clarifies that fair value is an exit price, representing
the amount that would be received by selling an asset or paid to transfer a liability in an orderly transaction between market participants.
As such, fair value is a market-based measurement that should be determined based on assumptions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The standard establishes a three-tier fair value hierarchy,
which prioritizes the inputs used in measuring and revaluing fair value. These tiers include, Level 1, defined as observable inputs such
as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or
indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity
to develop its own assumptions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following methods and assumptions were used to
estimate the fair value of each class of financial instruments for which it is practicable to estimate that value:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash and cash equivalents: The carrying amount approximates
fair value because of the short-term maturity of those instruments.</p>







<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Short-term investments: The carrying amount approximates
fair value because of the short-term maturity of those instruments. Such amounts include Certificates of Deposits with original maturities
greater than 90 days. These securities are classified as Level 1.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Receivable and accounts payable: The carrying amounts
approximate fair value because of the short maturity of those instruments.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Notes receivable: The carrying amount approximates
fair value because the discounted present value of the cash flow generated by the parties approximates the carrying value of the amounts
due to the Company.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long-term debt and notes payable: The carrying amounts
of debt and notes payable approximate fair value due to the length of the maturities, the interest rates being tied to market indices
and/or due to the interest rates not being significantly different from the current market rates available to the Company.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All of the Company&#8217;s financial instruments are
held for purposes other than trading.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RecentAccountingStandardsPolicyTextBlock', window );">Recent Accounting Standards</a></td>
<td class="text"><p id="xdx_84B_ecustom--RecentAccountingStandardsPolicyTextBlock_zgf8tw78paHl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_863_zlONLM6d1tvh">Recent Accounting Standards</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2023, The Financial Accounting Standards
Board (&#8220;FASB&#8221;) issued ASU 2023-09, &#8220;Income Taxes (740) &#8220;Improvements to Income Tax Disclosures&#8221;, which requires
the annual financial statements to include consistent categories and great disaggregation of information in the rate reconciliation and
income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for the Company&#8217;s annual reporting beginning after December
15, 2024, with early adoption permitted, and should be applied on a prospective basis, with a retrospective option. The Company is currently
evaluating the effect that the adoption of ASU 2023-09 will have on our disclosures.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2023, FASB issued ASU 2023-07, &#8220;Segment
Reporting (Topic 280)&#8221;, which is intended to improve reportable segment disclosure requirements through enhanced disclosures about
significant segment expenses. The amendments require disclosure of significant segment expenses regularly provided to the chief operating
decision maker (CODM) as well as other segment items, extended certain annual disclosures to interim periods, clarify the applicability
to single reportable segment entities, permit more than one measure of profit or loss to be reported under certain conditions, and require
disclosure of the title and position of the CODM. The effective date for public entities is for fiscal years beginning after December
15, 2023 and interim periods with fiscal years beginning after December 15, 2024. The Company is expected to adopt the new disclosures
as required and are currently evaluating the impact on the related disclosures.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Standards</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zyzmnEIgfeC5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_866_zGeyNISx7NB9">Recently Adopted Accounting Standards</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company adopted ASU 2016-13, &#8220;Financial
Instruments &#8211; Credit Losses&#8221; (Topic 326) &#8220;Measurement of Credit Losses on Financial Instruments&#8221;, on July 1, 2023,
as amended which replaces the incurred loss methodology with an expected loss methodology that is referred to as the current expected
credit loss (CECL) methodology, The measurement of expected credit losses under the CECL methodology is applicable to financial assets
measured at amortized cost, including loan receivables and held-to-maturity debt securities. It also applies to off-balance sheet credit
exposures not accounted for as insurance (loan commitments, standby letters of credit, financial guarantees, and other similar instruments)
and net investments in leases recognized by a lessor in accordance with Topic 842 on leases. The Company used a modified retrospective
approach, which required a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting in which the standard
was effective. The adoption did not have a material effect on the Company&#8217;s consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FASB, the Emerging Issues Task Force and the SEC have
issued certain other accounting standards, updates, and regulations as of June 30, 2024 that will become effective in subsequent periods;
however, management does not believe that any of those updates would have significantly affected the Company&#8217;s financial accounting
measures or disclosures had they been in effect during 2024 or 2023, and it does not believe that any of those standards will have a significant
impact on the Company&#8217;s consolidated financial statements at the time they become effective.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CustomerAdvancesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CustomerAdvancesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MedicalReceivableAndManagementAndOtherFeesReceivablePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MedicalReceivableAndManagementAndOtherFeesReceivablePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RecentAccountingStandardsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RecentAccountingStandardsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 35<br> -Topic 720<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the basis and manner that goods are added and removed from inventory in the course of production (work in process). If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory and how cost is determined (such as FIFO, LIFO, average).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 12<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845740491264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock', window );">Schedule of estimated useful life in years for property and equipment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88E_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_z1vIwy6ZISK9" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)">
<tr style="vertical-align: bottom">
<td colspan="3" style="border-bottom: Black 1pt solid; padding: 0pt; text-align: left; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_8BF_zs2gNJdAoczg" style="display: none">Schedule
of estimated useful life in years for property and equipment</span></span></td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: bottom; width: 87%; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Diagnostic equipment</span></td>
<td style="padding: 0pt; vertical-align: bottom; width: 12%; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zLKj6odAoCG5">5</span>&#8211;<span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_z15gqxQVKlt" title="Estimated useful lives">13</span></span></td>
<td style="padding: 0pt; width: 1%; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Research, development and demonstration equipment</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zD1kMI5H9Pfk">3</span>-<span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_z6eK5e3xFzCa">7</span></span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Machinery and equipment</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_za6eX1JyjcW7">2</span>-<span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zHXeZQTExWYd">7</span></span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Furniture and fixtures</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zPVJ7nKtC0lg">3</span>-<span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z2TR8Wlv23Fc">9</span></span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Leasehold improvements</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zy1haNsqvvPb">5</span>&#8211;<span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z3GQyurSiPwa">10</span></span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr style="background-color: White">
<td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Building</span></td>
<td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--WeightedAverageMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zP9U3mTibM8l" title="Estimated useful lives">28</span></span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of patient fee revenue - net</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--DisaggregationOfRevenueTableTextBlock_zKieyjyUMs7l" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8B2_zibRPTtp76H6" style="display: none">Schedule of patient fee
    revenue - net</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Commercial Insurance/ Managed Care</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zQP7AjRvBfCb" style="width: 12%; text-align: right" title="Net Patient Fee Revenue">4,952,712</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zSWvqUvUpEb1" style="width: 12%; text-align: right" title="Net Patient Fee Revenue">4,124,646</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Medicare/Medicaid</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zgZLnk8r0RPj" style="text-align: right" title="Net Patient Fee Revenue">1,138,176</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zUubfFwT39r" style="text-align: right" title="Net Patient Fee Revenue">1,063,846</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Workers&#8217; Compensation/Personal Injury</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zPcuEffR23yd" style="text-align: right" title="Net Patient Fee Revenue">20,673,483</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zNq4J8jwHUGl" style="text-align: right" title="Net Patient Fee Revenue">18,670,019</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zVCGIZyggKpg" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue">7,051,425</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zdne1tGYBBZ2" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue">5,935,482</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Net Patient Fee Revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630_zpm5teBsyZ91" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue">33,815,796</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630_zT2g27BSSgz8" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue">29,793,993</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of earnings per share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zQOGX5QvAza3" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BF_zywvfBLj6VWf" style="display: none">Schedule of earnings per share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Basic</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class C Common Stock</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Numerator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 46%; text-align: left; text-indent: -11pt">Net income available to common stockholders</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630_z5Rcu2Wqc693" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders">10,567,396</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z7tmlgA6yw86" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders">9,908,920</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zS3OC7vju5ra" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders">167,700</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Weighted average shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630_zODObpn37tXd" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">6,350,862</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_983_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z1NzWS5YYt6j" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">6,350,862</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zsv8MvcuX5Jg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">382,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Basic income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630_za6Cya3uMO29" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.66</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zbT5oyjhJ3Ha" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.56</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zo2AdSpO5Nch" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">0.44</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Weighted average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z6Dsgme3pJZ9" style="text-align: right" title="Weighted average shares outstanding">6,350,862</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zJaoalYiGapd" style="text-align: right" title="Weighted average shares outstanding">382,513</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Class C Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zTUCK9K36mxc" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock">127,504</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zKDHmj3FQQP" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zo0pacwcLj68" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share">6,478,366</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_ztshFF2cGGVa" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share">382,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zvB8OZFZJUHb" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share">1.53</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zS00GW4GVGzg" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share">0.44</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>























<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2023</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Basic</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class C Common Stock</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Numerator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 46%; text-align: left; text-indent: -11pt">Net income available to common stockholders</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20220701__20230630_zxtZWKIKsiff" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders">9,375,776</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zwJEvY67Iumb" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders">8,801,974</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z3Qi4OsGnkJ3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders">146,136</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Weighted average shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630_zB7YdIopqgb6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">6,539,376</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zbeFLt3EWpwj" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">6,539,376</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z69RHhQSz9a5" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">382,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Basic income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630_zytNpUPMRTf3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.43</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zEsXKtKOJyIe" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.35</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zEWBFp7LRyXf" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">0.38</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Weighted average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zaiGOcIWQt49" style="text-align: right" title="Weighted average shares outstanding">6,539,376</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z14HKTw8KMnj" style="text-align: right" title="Weighted average shares outstanding">382,513</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Class C Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zaUCBatpgKp5" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock">127,504</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zZLCrPweHY4b" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zh3uUtS9SNpk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share">6,666,880</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zcsRabBp4lNh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share">382,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zvhfQ9yDrIPb" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share">1.32</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zuZoteG2VhO1" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share">0.38</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845744304864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock', window );">Schedule of receivables - non current - net</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zLQiGYyfu0bi" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
  <tr style="vertical-align: bottom">
    <td colspan="5" style="border-bottom: Black 1pt solid; text-align: left"><span id="xdx_8B3_zxULpWrUqVfg" style="display: none">Schedule of receivables -
    non current - net</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 76%; text-align: left; text-indent: -11pt">2026</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pp0p0_c20240630_z65xpqNEy7Og" style="width: 12%; text-align: right" title="2026">631,415</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pp0p0_c20240630_zkbrS17Eqe14" style="text-align: right" title="2027">369,429</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">2028</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pp0p0_c20240630_z8vnE3Dkn9V4" style="text-align: right" title="2028">87,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">2029</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ContractReceivableDueFiveYearsOrMore_iI_pp0p0_c20240630_zy0Txw28f7U8" style="border-bottom: Black 1pt solid; text-align: right" title="2029">87,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Total</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_pp0p0_c20240630_ztUVSFFardm4" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">1,174,844</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock', window );">Summary of allowance for credit losses</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zFFO6u20j805" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details)">
  <tr style="vertical-align: bottom">
    <td colspan="17" style="text-align: left"><span id="xdx_8B0_zD3XG0pfFJHc" style="display: none">Summary of allowance for credit losses</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Description</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Balance<br/> June 30, 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Additions(Recovery) (1)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Deductions</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Balance <br/> June 30, 2024</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 40%; text-align: left; text-indent: -11pt">Accounts receivable</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zBF6ClyECdHd" style="width: 10%; text-align: right" title="Beginning Balance">198,593</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zUMoQ2PipMO9" style="width: 10%; text-align: right" title="Additions (Included in provision for bad debts)">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_znx3PMN111dh" style="width: 10%; text-align: right" title="Deductions">32,544</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zIWDN5ZXQ1C7" style="width: 10%; text-align: right" title="Ending Balance">166,049</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Management and other fees receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zA1qbdfRARjj" style="text-align: right">12,608,567</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zZnbvQ3gXM91" style="text-align: right">(238,646</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zRQV4n4uybB1" style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zDMXfB5alEwb" style="text-align: right">12,369,921</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Management and other fees receivable - related medical practices</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zrNOpFQWEGs1" style="text-align: right">3,989,692</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zfG1pNXhkK4b" style="text-align: right">2,120,707</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_ztnXmPeg2XR4" style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zVHM9lvFsM9d" style="text-align: right">6,110,399</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Notes receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zxHpUcPE0KIf" style="text-align: right">777,354</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zVw03YpOdjX" style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zjb73ljDLr72" style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zObfmcnQMtFh" style="text-align: right">777,354</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Balance</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Balance</td></tr>
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Description</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2022</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Additions</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Deductions</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2023</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 11pt; width: 40%; text-align: left; text-indent: -11pt">Accounts receivable</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_986_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zkjZ0KCipFG6" style="width: 10%; text-align: right">204,597</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zfiFNBpauq5" style="width: 10%; text-align: right">55,000</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zmou41KxiL8j" style="width: 10%; text-align: right">61,004</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_znJjja0WDUR4" style="width: 10%; text-align: right">198,593</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Management and other fees receivable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zBpI8XxzF22a" style="text-align: right">16,627,917</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_ztRazgyEAwhk" style="text-align: right">4,007,382</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zGnS8dg6pbul" style="text-align: right">8,026,732</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_982_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zTVo2UAOtnW7" style="text-align: right">12,608,567</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Management and other fees receivable - related medical practices</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zuOWkhbmYtb8" style="text-align: right">4,686,893</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zkQHOCML4XN6" style="text-align: right">1,451,094</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zxDJ4eMv3sw3" style="text-align: right">2,148,295</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zuCIkEopmD" style="text-align: right">3,989,692</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Notes receivable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zhnpJ6qYQTca" style="text-align: right">777,354</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zyxGjMNrEsrj" style="text-align: right">&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zT3J173ma649" style="text-align: right">&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zEkAq0VH0ngb" style="text-align: right">777,354</td>
<td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4px; padding-left: 11pt; text-align: justify"><span id="xdx_F0C_zrCZXU1ui0Y7" style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(1)</span></td>
    <td style="padding-left: 11pt; text-align: justify"><span id="xdx_F1A_zsRxEBUXR3me" style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Included in provision for credit losses.</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalFacilitiesOwnedOrManagedTableTextBlock', window );">Schedule of facilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zfYGN6cu7R9l" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BA_zJnWAxBnUaec" style="display: none">Schedule of facilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20230701__20240630_zcfnQrId55si" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20220701__20230630_zoCB6mcCEOF8" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Year Ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_40C_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_zEHDaxHV6qma" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Total Facilities Owned or Managed (at Beginning of Year)</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">27</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">27</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Facilities Added by:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--ManagedFacilitiesAddedByInternalDevelopment_z0bbJ3tHn9Oj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Internal development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--ManagedFacilitiesClosedDuringYear_d0_zJpUq4cJUVHc" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Managed Facilities Closed</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_z2BaW7Ft6d7a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total Facilities Owned or Managed (at End of Year)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">28</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">27</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalFacilitiesOwnedOrManagedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalFacilitiesOwnedOrManagedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-11B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss of financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-11B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845743974496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventories</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zwnAgOCuvp7d" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BF_zqv8kemkf119" style="display: none">Schedule of inventories</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20240630_z08defaRLD9e" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20230630_z4g7daxKJPD4" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">As of June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_40E_eus-gaap--OtherInventorySupplies_iI_maIFGAWzdt0_zBMZYvgXWDf8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Purchased parts and components</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,524,201</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,346,300</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_maIFGAWzdt0_zuttCjsifXc1" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Work-in-process</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">191,240</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">223,366</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--InventoryNet_iTI_mtIFGAWzdt0_zdvRqeSPTQ6b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Inventories</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,715,441</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,569,666</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845843603616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment, at cost, less accumulated depreciation and amortization</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--PropertyPlantAndEquipmentTextBlock_zeZShXzkNEya" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT - Property and equipment (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8B1_z0kZGrhTUiIk" style="display: none">Schedule of property and equipment, at cost, less accumulated
depreciation and amortization</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">As of June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Diagnostic equipment</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zbs7snyeOlNl" style="width: 12%; text-align: right" title="Property plant and equipment, gross">33,243,694</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zKk3jW2LEiCc" style="width: 12%; text-align: right" title="Property plant and equipment, gross">33,144,266</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Research, development and demonstration equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDevelopmentAndDemonstrationEquipmentMember_zxFK8qFrWdzc" style="text-align: right" title="Property plant and equipment, gross">6,199,941</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDevelopmentAndDemonstrationEquipmentMember_zuyNjcZHQj0d" style="text-align: right" title="Property plant and equipment, gross">6,199,941</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Machinery and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zIN3xebDOpg" style="text-align: right" title="Property plant and equipment, gross">2,069,055</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zoAqAHSXPpJc" style="text-align: right" title="Property plant and equipment, gross">2,069,055</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Furniture and fixtures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zHfP635UCEC1" style="text-align: right" title="Property plant and equipment, gross">3,742,169</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zv8nRRhPnyT5" style="text-align: right" title="Property plant and equipment, gross">3,714,499</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zocD8M52HM84" style="text-align: right" title="Property plant and equipment, gross">16,312,904</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zQKg145Wc3z2" style="text-align: right" title="Property plant and equipment, gross">15,650,041</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Building</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zAca8yQwTd9e" style="border-bottom: Black 1pt solid; text-align: right" title="Property plant and equipment, gross">939,614</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zxHktrqlZYw9" style="border-bottom: Black 1pt solid; text-align: right" title="Property plant and equipment, gross">939,614</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630_zv2RGMKNlZbi" style="text-align: right" title="Property plant and equipment, gross">62,507,377</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630_zBPrJZmZavl6" style="text-align: right" title="Property plant and equipment, gross">61,717,416</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Less: Accumulated depreciation and amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20240630_zYTlQhk0vYi8" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation and amortization">43,798,457</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20230630_zsRQ2IVkT9w9" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation and amortization">39,571,043</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20240630_zdZ6fHZ8gPT" style="border-bottom: Black 2.5pt double; text-align: right" title="Property plant and equipment, net">18,708,920</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20230630_zvEiv82swc5f" style="border-bottom: Black 2.5pt double; text-align: right" title="Property plant and equipment, net">22,146,373</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845740238624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingFinancingLeasesAbstract', window );"><strong>Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of reconciliation of operating and financing lease payments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zxWPFt2jtes7" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Lease payments (Details)">
<tr style="vertical-align: bottom">
<td colspan="3" style="text-align: center"><span id="xdx_8B6_zuSTGREMEtnb" style="display: none">Schedule of reconciliation of operating and financing
lease payments</span></td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Year Ending June 30,</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Operating Lease Payments</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Financing Lease Payments</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 1%; text-align: left">&#160;</td>
<td style="padding: 0pt 0pt 0pt 11pt; width: 26%; text-align: center">2025</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zqSak3qkBvEl" style="width: 26%; text-align: right" title="2025">5,895,014</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_981_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zaetlJMqecnb" style="width: 26%; text-align: right" title="2025">244,343</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">&#160;</td>
<td style="padding: 0pt 0pt 0pt 11pt; text-align: center">2026</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zVAslA7beGhj" style="text-align: right" title="2026">5,561,968</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zGD3L8Yr9Fmf" style="text-align: right" title="2026">244,343</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">&#160;</td>
<td style="padding: 0pt 0pt 0pt 11pt; text-align: center">2027</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_znXbPoZA6cjj" style="text-align: right" title="2027">5,226,352</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_ziANxjpZgdki" style="text-align: right" title="2027">162,897</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">&#160;</td>
<td style="padding: 0pt 0pt 0pt 11pt; text-align: center">2028</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zixNMdUG7s6k" style="text-align: right" title="2028">5,194,655</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_d0_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_ztABDuAvvCRe" style="text-align: right" title="2028">&#8212;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">&#160;</td>
<td style="padding: 0pt 0pt 0pt 11pt; text-align: center">2029</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zZhQOIZmIFUj" style="text-align: right" title="2029">4,865,285</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_d0_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zftT6Aci8Xsc" style="text-align: right" title="2029">&#8212;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">&#160;</td>
<td style="padding: 0pt 0pt 0pt 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Thereafter</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zKAMGbtPidmj" style="text-align: right" title="Thereafter">29,295,110</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_d0_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z1vKArLZveq3" style="text-align: right" title="Thereafter">&#8212;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">&#160;</td>
<td style="padding: 0pt 0pt 0pt 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Present value discount</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_988_ecustom--PresentValueDiscount_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zI3jKE4AE5ag" style="border-bottom: Black 1pt solid; text-align: right" title="Present value discount">(15,096,964</td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_982_ecustom--PresentValueDiscountFinancingLease_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zpoBhrJkD4Si" style="border-bottom: Black 1pt solid; text-align: right" title="Present value discount">(31,074</td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">&#160;</td>
<td style="padding: 0pt 0pt 0pt 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Total lease liability</span></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98B_eus-gaap--OperatingLeaseLiability_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zxwBPf5hn9j5" style="border-bottom: Black 2.5pt double; text-align: right" title="Total lease liability">40,941,420</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_989_eus-gaap--FinanceLeaseLiability_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_ztaaIsy0HIh5" style="border-bottom: Black 2.5pt double; text-align: right" title="Total lease liability">620,509</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock', window );">Schedule of weighted average remaining lease term</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_zygwCTE1sr35" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Weighted average remaining lease term (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8B4_zWFj85KW5wka" style="display: none">Schedule
    of weighted average remaining lease term</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 70%; text-align: left; text-indent: -11pt">Operating leases - years</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right"><span id="xdx_909_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240630_z4cUpqCdVwT1" title="Operating leases - years">11.0</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Finance lease - years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240630_zokYbdtNjWGi" title="Finance lease - years">2.6</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Weighted Average Discount Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Operating leases</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20240630_zGPIFz2bvSkj" title="Weighted average discount rate, operating leases">6.4</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Finance lease</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20240630_zk49Yn4GCN54" title="Weighted average discount rate, finance leases">3.6</span></td><td style="text-align: left">%</td></tr>
  </table>


<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of components of lease expense</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--LeaseCostTableTextBlock_zChHtcRNhfh8" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Components of lease expense (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BC_z3vKzFFltW5e" style="display: none">Schedule of components
    of lease expense</span></td><td>&#160;</td>
    <td colspan="3" id="xdx_495_20230701__20240630_zRYYaviEFZCl" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_499_20220701__20230630_zyTFfjRrVyhh" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For Year Ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Operating lease cost</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">5,685,008</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">5,887,390</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--FinanceLeaseCostsAbstract_iB_zeM01tV7OYff" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Finance lease cost:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0_zXU0EuIp7Ta7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Depreciation of leased equipment</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">198,881</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">198,881</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Interest on lease liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">26,534</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">35,833</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--FinanceLeaseCost_i01_pp0p0_z7ekTXZ28Dqg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total finance lease cost</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">225,415</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">234,714</td><td style="text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock', window );">Schedule of supplemental cash flow information related to leases</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_zdQTVXAaEMC2" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BE_zKRrkpPwBYH5" style="display: none">Schedule
    of supplemental cash flow information related to leases</span></td><td>&#160;</td>
    <td colspan="3" id="xdx_492_20230701__20240630_z1ipsSFewXC1" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_497_20220701__20230630_ztGFuONv9TVf" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For Year Ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Cash paid for amounts included in the measurement of lease liabilities:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_40A_ecustom--OperatingCashFlowsFromOperatingLeases_zHCoVLOQMixl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Operating cash flows from operating leases</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">6,363,561</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">5,577,578</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--FinancingCashFlowsFromFinancingLeases_zAKnEkj1TkP3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Financing cash flows from financing leases</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">244,344</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">244,344</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB_zYcS5XR52d8l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Right-of-use and equipment assets obtained in exchange for lease obligations:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_z6SkehgmknMh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Operating leases</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,715,138</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,902,584</td><td style="text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845743547968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of other intangible assets, net of accumulated amortization</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zTZeAiPTZlPj" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BD_zRldzUPfbKR5" style="display: none">Schedule of other intangible assets, net of accumulated amortization</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">As of June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Capitalized software development costs</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zHo6lKBP5wYk" style="width: 12%; text-align: right" title="Gross other intangible assets">7,004,847</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_z450GDfCMzka" style="width: 12%; text-align: right" title="Gross other intangible assets">7,004,847</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Patents and copyrights</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zVQZvLqOXcMl" style="text-align: right" title="Gross other intangible assets">5,259,811</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zpu9ss2TXRt4" style="text-align: right" title="Gross other intangible assets">5,452,345</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Non-competition agreements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zWLQ1yIC7Ur" style="text-align: right" title="Gross other intangible assets">4,150,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zcSFlPvCTD52" style="text-align: right" title="Gross other intangible assets">4,150,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Customer relationships</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zGsg1YJ41Z6a" style="border-bottom: Black 1pt solid; text-align: right" title="Gross other intangible assets">3,900,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zUO0SAKgJ1j4" style="border-bottom: Black 1pt solid; text-align: right" title="Gross other intangible assets">3,900,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630_zkC0ARlF12Dk" style="text-align: right" title="Gross other intangible assets">20,314,658</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630_z6SexuNOt9df" style="text-align: right" title="Gross other intangible assets">20,507,192</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Less: Accumulated amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630_zmnZWQ2tYfRh" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization">17,444,334</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20230630_zd9g3M1lpcD6" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization">17,075,327</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630_zkfwcF55JAW2" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets-net">2,870,324</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230630_zL2qSjTom81a" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets-net">3,431,865</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of other intangible assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zALUw94kCrH" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details)">
  <tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span id="xdx_8B0_zS5rMT1DnUo3">Schedule of other intangible assets</span> For the Years Ending June 30,</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Patents and Copyrights</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Customer Relationships</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; width: 20%; text-align: center">2025</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20240630_z2zhaLeG9YAh" style="width: 19%; text-align: right" title="2025">351,882</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zucE2paX80F8" style="width: 19%; text-align: right" title="2025">151,882</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zoyvb9MaEDCc" style="width: 19%; text-align: right" title="2025">200,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; text-align: center">2026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20240630_zvj8mnVqegOk" style="text-align: right" title="2026">339,179</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zVU2rNpDwL1b" style="text-align: right" title="2026">139,179</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zrJYijuNDFu2" style="text-align: right" title="2026">200,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; text-align: center">2027</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20240630_zAHlj2WdIAe5" style="text-align: right" title="2027">326,502</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zZniJvrzVxo" style="text-align: right" title="2027">126,502</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zqeH9Pk1dTml" style="text-align: right" title="2027">200,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; text-align: center">2028</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20240630_zXrZZsgNe8Yk" style="text-align: right" title="2028">320,232</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zjtKAMTleb85" style="text-align: right" title="2028">120,232</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyJWgNWYLOri" style="text-align: right" title="2028">200,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; text-align: center">2029</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20240630_zcvLXcvugUPh" style="text-align: right" title="2029">313,052</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zGLJ10r989x9" style="text-align: right" title="2029">113,052</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zUbrEh1xJHrg" style="text-align: right" title="2029">200,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Thereafter</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20240630_zbUh6zNdAbIg" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter">1,219,477</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zu3VCQTvoTQc" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter">505,310</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zeVa6aaccMXb" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter">714,167</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="padding: 0pt 0pt 0pt 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Other intangible assets - net</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20240630_z3zOxK7AmWli" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net">2,870,324</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zGttMuYsbUQ4" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net">1,156,157</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zvLJHoyziiAb" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net">1,714,167</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of other intangible assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zFFQU4AQoQhe" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Intangle assets - (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8B0_z3TpVubR3Ppe" style="display: none">Schedule of other
    intangible assets</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Year-ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Balance &#8211; Beginning of Year</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20230701__20240630_zuRowUPpOm92" style="width: 12%; text-align: right" title="Balance - Beginning of Year">3,431,865</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20220701__20230630_zqsUC5ramWs5" style="width: 12%; text-align: right" title="Balance - Beginning of Year">3,703,885</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Amounts capitalized</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--AmountsCapitalized_pp0p0_c20230701__20240630_zh8mT33OD2Mk" style="text-align: right" title="Amounts capitalized">32,885</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--AmountsCapitalized_pp0p0_c20220701__20230630_zaeCIwycCfm5" style="text-align: right" title="Amounts capitalized">119,571</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Patents written off</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_c20230701__20240630_zynJp5KK9b49" style="text-align: right" title="Patents written off">(225,419</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_d0_c20220701__20230630_zCs18PKjwHuk" style="text-align: right" title="Patents written off">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AdjustmentForAmortization_pp0p0_c20230701__20240630_zzPIoTiTtdK1" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization">(369,007</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AdjustmentForAmortization_pp0p0_c20220701__20230630_zOPGATxicSzf" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization">(391,591</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Balance &#8211; End of Year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20230701__20240630_zpfOyF6P9aPh" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance - End of Year">2,870,324</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20220701__20230630_zaSgAbRZInOf" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance - End of Year">3,431,865</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845745856512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONTROLLING AND NONCONTROLLING INTERESTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock', window );">Schedule of HDM members equity</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zKcjhoIk1oE5" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"><span id="xdx_8B6_zPPYXjlVbfU6" style="display: none">Schedule of HDM members equity</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2023</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class A Members</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class B Member</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class A Members</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class B Member</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 40%; text-align: left; text-indent: -11pt">Opening Members&#8217; Equity</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">($</td><td id="xdx_98B_ecustom--OpeningMembersEquity_iI_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zBrXOeaQEJwc" style="width: 10%; text-align: right" title="Opening Members Equity">7,079,293</td><td style="width: 1%; text-align: left">)</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--OpeningMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_z4Zn1ILvbg73" style="width: 10%; text-align: right" title="Opening Members Equity">54,781,813</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">($</td><td id="xdx_98F_ecustom--OpeningMembersEquity_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zGlkxvIQK5Kg" style="width: 10%; text-align: right" title="Opening Members Equity">4,053,833</td><td style="width: 1%; text-align: left">)</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--OpeningMembersEquity_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zyBUIwmC4wYk" style="width: 10%; text-align: right" title="Opening Members Equity">50,292,073</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Share of Net Income</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_ecustom--ShareOfNetIncome_iI_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zYqKH0W5ebKf" style="text-align: right" title="Share of Net Income">3,530,021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_ecustom--ShareOfNetIncome_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zdz67QBQ0yl9" style="text-align: right" title="Share of Net Income">20,705,681</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_ecustom--ShareOfNetIncome_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zSlaohGV2h4c" style="text-align: right" title="Share of Net Income">2,750,740</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_ecustom--ShareOfNetIncome_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zlT3nROLK6m8" style="text-align: right" title="Share of Net Income">18,513,540</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Buyout of noncontrolling interests</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zwpPHKapcr12" style="text-align: right" title="Buyout of noncontrolling interests">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zX1yBm6E3Y2k" style="text-align: right" title="Buyout of noncontrolling interests">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z98PGEPUkOv5" style="text-align: right" title="Buyout of noncontrolling interests">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zlk1aGDOh0Oj" style="text-align: right" title="Buyout of noncontrolling interests">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Distributions</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">($</td><td id="xdx_984_ecustom--Distributions_iI_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z5zqKPDZWYsf" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions">5,630,336</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_985_ecustom--Distributions_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_z7b6UFqLQgo" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions">(13,669,664</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">($</td><td id="xdx_985_ecustom--Distributions_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zPHCdZMK2cBg" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions">5,776,200</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98F_ecustom--Distributions_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zdchjKdL0Ezl" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions">(14,023,800</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Ending Members&#8217; Equity</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">($</td><td id="xdx_98D_ecustom--EndingMembersEquity_iI_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zKBuYx21MFQ7" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity">9,179,608</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_ecustom--EndingMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zbZexYRUnqP2" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity">61,817,830</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">($</td><td id="xdx_984_ecustom--EndingMembersEquity_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zItXO6WH3voi" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity">7,079,293</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--EndingMembersEquity_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zf5BC2bLsAnl" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity">54,781,813</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845745850880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract', window );"><strong>Long-term Debt Notes Payable And Capital Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of long-term debt, notes payable and capital leases</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfDebtTableTextBlock_zQd3FnJ62l5h" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 11pt; text-align: center; text-indent: -11pt"><span id="xdx_8B8_zTOADzhp4Yxf" style="display: none">Schedule of long-term debt, notes payable and capital leases</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Note payable requiring monthly payments of interest at a rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_909_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zCoNuW4lw4Rh" title="Interest rate">7</span>% until May 2009 followed by <span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_907_ecustom--MonthlyPaymentPeriod_dtM_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zEfEk1ny04yb" title="Monthly payment period">240</span> monthly payments of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90A_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zzqajwERB2m8" title="Debt instrument, periodic payment">4,472</span> through <span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_904_ecustom--MaturityDate_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zvmge24Fcs0b" title="Maturity date">October 2026</span>. The loan is collateralized by a building with a net book value of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_907_ecustom--BookValueOfBuilding_iI_pp0p0_c20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zzp5O41HW52k" title="Book value of building">310,827</span> as of June 30, 2024.</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--LongTermDebt_iI_pp0p0_c20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zbUgTaZIhN53" style="width: 12%; text-align: right" title="Long term debt current">113,940</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--LongTermDebt_iI_pp0p0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zDuORGkrKj52" style="width: 12%; text-align: right" title="Long term debt current">158,842</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">The revolving credit note was extended to November 14, 2024. The Company can borrow up to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_908_eus-gaap--ProceedsFromLinesOfCredit_pp0p0_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zdj4WL0iZapd" title="Proceeds from lines of credit">10,000,000</span> and prepay the loan in whole or part in multiples of $100,000 at any time without penalty. The note bears interest at a rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_901_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_z7tulAvfFHJh" title="Interest rate">8.5</span>% per annum and is payable monthly. The loan is collateralized by substantially all of the Company&#8217;s assets. The loan also contains certain financial covenants that must be met on a periodic basis. The Company still has the ability to draw down on the line.</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LongTermDebt_iI_pp0p0_d0_c20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zpXEHFFS9VQ2" style="border-bottom: Black 1pt solid; text-align: right" title="Long term debt current">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--LongTermDebt_iI_pp0p0_d0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zAKwtNt9oiD5" style="border-bottom: Black 1pt solid; text-align: right" title="Long term debt current">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--LongTermDebt_iI_pp0p0_c20240630_zcvkeYpicsM" style="text-align: right" title="Long term debt, notes payable and capital leases">113,940</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--LongTermDebt_iI_pp0p0_c20230630_zuxIcoMpqRM3" style="text-align: right" title="Long term debt, notes payable and capital leases">158,842</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Less: Current portion</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_iI_pp0p0_c20240630_znlIwV9UoGta" style="border-bottom: Black 1pt solid; text-align: right" title="Current portion of long term debt, notes payable and capital leases">47,002</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_iI_pp0p0_c20230630_zEnznTi3X4zd" style="border-bottom: Black 1pt solid; text-align: right" title="Current portion of long term debt, notes payable and capital leases">43,767</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--LongTermDebtAndCapitalLeaseObligations_iI_pp0p0_c20240630_ziLKPxsGuGtl" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term debt, notes payable and capital leases less current portion">66,938</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--LongTermDebtAndCapitalLeaseObligations_iI_pp0p0_c20230630_zdnuz2CUgs9l" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term debt, notes payable and capital leases less current portion">115,075</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of maturities of long-term debt</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zpq2vdDgH7uh" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities of long term debt over 5 years - (Details)"> <tr style="vertical-align: bottom">

    <td style="text-align: left"><span id="xdx_8B7_zTuYv98oVxkd" style="display: none">Schedule of maturities of long-term debt</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left">Years Ending June 30,</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 76%; text-align: left; text-indent: -11pt">2025</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_pp0p0_c20240630_zvpfG79G2mDa" style="width: 12%; text-align: right" title="2024">47,002</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_pp0p0_c20240630_z24gB1xe98dd" style="text-align: right" title="2025">50,448</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">2027</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_pp0p0_c20240630_zUrn8wDlhbU9" style="border-bottom: Black 1pt solid; text-align: right" title="2026">16,490</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; color: white; text-align: left; text-indent: -11pt"><span style="font: normal 11pt Times New Roman, Times, Serif; text-decoration: none; color: Black; vertical-align: baseline">Long-Term
    Debt Over Five Years and Thereafter</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--LongTermDebt_iI_c20240630_zGxdSee5wQ13" style="border-bottom: Black 2.5pt double; text-align: right" title="Total long term debt">113,940</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845740488576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of components of the provision for income taxes</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z9sWZUCGaNVi" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Components of provision for income taxes (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BE_z1SNdi7WdLbh" style="display: none">Schedule of components
    of the provision for income taxes</span></td><td>&#160;</td>
    <td colspan="3" id="xdx_49B_20230701__20240630_zpKh9SmNlITi" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_492_20220701__20230630_zLdD00Lt5SIk" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">Years Ended June 30,</td></tr>
  <tr id="xdx_404_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_zsZixD2IhqMh" style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Current:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_401_eus-gaap--CurrentFederalTaxExpenseBenefit_d0_maCITEBzHyE_zBjL8rWRkwP2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; width: 56%; text-align: left; text-indent: -11pt">Federal</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">429,873</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCITEBzHyE_zW3qlNcMdLHg" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">State</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,943,588</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">652,521</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_maITEBzXA8_mtCITEBzHyE_znFk5QhjYvZi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,373,461</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">652,521</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_pp0p0_z6x46xBkG5Sd" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Deferred:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzROz_zpQoQ3jM4Tq2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Federal deferred taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,585,515</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,770,980</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzROz_zv38VAZL6vDj" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">State deferred taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">209,992</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">208,570</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DeferredIncomeTaxExpensesBenefit_iT_pp0p0_mtDITEBzROz_maITEBzXA8_zsNcthnIZjMd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,795,507</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,979,550</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzXA8_zMR6xz0x1AC" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Provision (Benefit) for Income Taxes - Net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,168,968</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,632,071</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of reconciliation of federal statutory income tax rate to company&#8217;s effective tax rate</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zoscTUSQtz28" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8B8_ze4WkrOfrg1h" style="display: none">Schedule of
    reconciliation of federal statutory income tax rate to company&#8217;s effective tax rate</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">Years Ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Taxes at federal statutory rate</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_906_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_dp_c20230701__20240630_zCe5Cd2yv06f" title="Taxes at federal statutory rate">21.0</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_903_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_dp_c20220701__20230630_zneX5UxD0w05" title="Taxes at federal statutory rate">21.0</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">State and local income taxes (benefit), net of federal benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20230701__20240630_zUmPEuw7Kqsd" title="State and local income taxes (benefit), net of federal benefit">7.1</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20220701__20230630_zgoczKdnDywd" title="State and local income taxes (benefit), net of federal benefit">5.1</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Non-controlling interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20230701__20240630_zK78v0AH8uT3" title="Noncontrolling interest">(5.3</span></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20220701__20230630_zcxnrAndN7Eg" title="Noncontrolling interest">(4.6</span></td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Expiration of tax credits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_c20230701__20240630_zgbX50BtWvQa" title="Expiration of tax credits">2.2</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_c20220701__20230630_zGIokfHUIDUj" title="Expiration of tax credits">2.8</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Return to provision adjustments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp0_c20230701__20240630_zaG6vhJN5Pac" title="Return to provision adjustments">&#8212;</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_c20220701__20230630_zEkgoYvjVo0k" title="Return to provision adjustments">(2.3</span></td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Change in the valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20230701__20240630_z7RL2utqT1Wa" title="Change in the valuation allowance">(0.2</span></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20220701__20230630_z1H0ZT04BBbb" title="Change in the valuation allowance">(0.5</span></td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20230701__20240630_zap2RVYajSSa" title="Other">2.0</span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20220701__20230630_zsd62kktcE1d" title="Other">1.5</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Effective income tax rate</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20230701__20240630_z5nDSWn7b8x1" title="Effective income tax rate">26.8</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20220701__20230630_zcCDzM2z68u8" title="Effective income tax rate">23.0</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>


<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of company&#8217;s deferred tax assets and liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zMqcrx20DgGf" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Deferred tax assets and liabilities - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8BC_zMULfEhGAqE2" style="display: none">Schedule of company&#8217;s
deferred tax assets and liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20240630_zmuKQ9m5zlZd" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20230630_zdjeToFeSOIh" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzM4n_zibiFm5K9Qah" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Allowance for credit losses</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,969,819</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,360,809</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzM4n_zszFOdQf73S" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Non-deductible accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">758,700</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">707,400</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzM4n_ztlOIfuAk64e" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Net operating carryforwards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">396,092</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,768,844</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzM4n_zLQMYZfL8LK3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Tax credits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,323,018</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,981,214</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_i01I_pp0p0_maDTAGzM4n_z9dgsUKM8Mp" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Capitalized research and development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">747,407</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">369,675</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--DeferredTaxAssetsInRightUseAssetsAndLiabilities_i01I_pp0p0_maDTAGzM4n_zwpnzLQy2uyg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Right of use assets and lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">114,116</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">112,938</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzM4n_zuyGoIorZQdd" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Inventories</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">106,879</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">105,310</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzM4n_maDTANzJzu_z9l7g2nMCjca" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Deferred Tax Assets - gross</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,416,031</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,406,190</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzJzu_zdkzvBgmTDcl" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(192,776</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(364,230</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzJzu_maDTALNzFAZ_z8c8sM4QmDc4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,223,255</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,041,960</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_pp0p0_di_maDTLzImD_z0HSCRTtRFx3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Property and equipment and depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(267,124</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(151,007</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzImD_zAENllX4Dqi2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Intangibles</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(104,436</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(243,751</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_msDTALNzFAZ_mtDTLzImD_zNqihF02Jv1b" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total deferred tax liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(371,560</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(394,758</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzFAZ_zy4p6iK9IJuj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Net deferred tax asset</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,851,695</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,647,202</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845845422720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of other current liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zLPhW9v4htne" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"><span id="xdx_8B7_zJqBC5NLE9O8" style="display: none">Schedule of other current liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20240630_zITTz9uZyXrl" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20230630_zVHCeNkN7jb9" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr id="xdx_40D_eus-gaap--AccruedSalariesCurrent_iI_maOLCzbf4_zNVOmqy10yI9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Accrued salaries, commissions and payroll taxes</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">4,677,690</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">4,413,044</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_maOLCzbf4_zQ7LK7x0eAb2" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Sales tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">197,317</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">193,041</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_maOLCzbf4_zEvlcDCGHTx" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">State income taxes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,461,336</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,353</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AccruedProfessionalFeesCurrent_iI_maOLCzbf4_zUdGxQjdaOdc" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Legal and other professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,207</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,207</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_maOLCzbf4_zESr0jVwOI9f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Accounting fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">119,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--SelfInsuranceReserve_iI_maOLCzbf4_zJPW3PvDhDM5" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Self-funded health insurance reserve</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">121,445</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,971</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_maOLCzbf4_zkT55C58U2e3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Accrued interest and penalty</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,534</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,534</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OtherSundryLiabilitiesCurrent_iI_maOLCzbf4_zxPXP6ULGWHh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,348,710</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">573,574</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--OtherLiabilitiesCurrent_iTI_mtOLCzbf4_zMLrUOLXO7Ye" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Other current liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,941,039</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,443,724</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845744304064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of summarized segment financial information</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zA71g3xO3oA4" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"><span id="xdx_8BE_zwqIFlHSQafg" style="display: none">Schedule of summarized segment financial information</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">Manufacturing and Servicing of Medical</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">Management of Diagnostic Imaging</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Fiscal 2024:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Center</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Totals</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; width: 46%; text-align: left; text-indent: -11pt">Net revenues from external customers</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--Revenues_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zTMiA4oQGU86" style="width: 11%; text-align: right" title="Net revenues from external customers">8,329,106</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zP5FyMWHPOql" style="width: 11%; text-align: right" title="Net revenues from external customers">94,554,983</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_c20230701__20240630_zVnyRssIqxyj" style="width: 11%; text-align: right" title="Net revenues from external customers">102,884,089</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Intersegment net revenues *</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_ecustom--IntersegmentNetRevenues_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_fKg_____zsmgMH9E59ib" style="text-align: right" title="Inter-segment net revenues">1,073,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_ecustom--IntersegmentNetRevenues_d0_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_fKg_____zrUKfCDHutK8" style="text-align: right" title="Inter-segment net revenues">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_ecustom--IntersegmentNetRevenues_c20230701__20240630_fKg_____zUkVPQEM3tbd" style="text-align: right" title="Inter-segment net revenues">1,073,333</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">(Loss) Income from operations</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperations_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zmyXcXzbgiqd" style="text-align: right" title="(Loss) Income from operations">(6,958,012</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperations_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zzGA0IqxmlIe" style="text-align: right" title="(Loss) Income from operations">23,493,376</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20230701__20240630_zhW7fHRstad1" style="text-align: right" title="(Loss) Income from operations">16,535,364</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zKoTIcpgsPMg" style="text-align: right" title="Depreciation and amortization">238,802</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zwEQkny54BJa" style="text-align: right" title="Depreciation and amortization">4,357,619</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20230701__20240630_zz4PjQT86Uca" style="text-align: right" title="Depreciation and amortization">4,596,421</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Total identifiable assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsNet_iI_c20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_znTU5qLeEuEk" style="text-align: right" title="Total identifiable assets">30,360,188</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsNet_iI_c20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zfygfHXMgf2l" style="text-align: right" title="Total identifiable assets">183,885,781</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--AssetsNet_iI_c20240630_zULDki0ufAV8" style="text-align: right" title="Total identifiable assets">214,245,969</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Capital expenditures</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--PaymentsToAcquireProductiveAssets_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zSXFWTmaLcMa" style="text-align: right" title="Capital expenditures">32,885</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zEiSLrMAOXn6" style="text-align: right" title="Capital expenditures">789,961</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_c20230701__20240630_z36IwKzGEBJh" style="text-align: right" title="Capital expenditures">822,846</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Fiscal 2023:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Net revenues from external customers</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zaN9AzScedn8" style="text-align: right" title="Net revenues from external customers">8,260,711</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--Revenues_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zWF3Zns9v0Md" style="text-align: right" title="Net revenues from external customers">90,384,390</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20220701__20230630_zUOVGy35HEFd" style="text-align: right" title="Net revenues from external customers">98,645,101</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Intersegment net revenues *</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_ecustom--IntersegmentNetRevenues_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_fKg_____z6eheYM24d34" style="text-align: right" title="Inter-segment net revenues">985,833</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_ecustom--IntersegmentNetRevenues_d0_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_fKg_____z572vB3OXIGk" style="text-align: right" title="Inter-segment net revenues">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_ecustom--IntersegmentNetRevenues_c20220701__20230630_fKg_____zFchbOhMwL31" style="text-align: right" title="Inter-segment net revenues">985,833</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">(Loss) Income from operations</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zf4rqOpSeg4l" style="text-align: right" title="(Loss) Income from operations">(5,875,126</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zYgu0HNxD36c" style="text-align: right" title="(Loss) Income from operations">20,664,388</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230630_zQQ6ZmcIK5Ej" style="text-align: right" title="(Loss) Income from operations">14,789,262</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zCrhWL1BCx18" style="text-align: right" title="Depreciation and amortization">263,720</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_ztWMPkpsRrtb" style="text-align: right" title="Depreciation and amortization">4,276,415</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230630_zxZkR34GdXec" style="text-align: right" title="Depreciation and amortization">4,540,135</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Total identifiable assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsNet_iI_c20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zi9yx79H9G3a" style="text-align: right" title="Total identifiable assets">30,892,807</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsNet_iI_c20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zVczUvnXtAab" style="text-align: right" title="Total identifiable assets">170,153,612</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsNet_iI_c20230630_zYv2i4PPTnn7" style="text-align: right" title="Total identifiable assets">201,046,419</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt">Capital expenditures</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zqUwEC7PUS0f" style="text-align: right" title="Capital expenditures">119,571</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--PaymentsToAcquireProductiveAssets_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zRKM4MQOQHok" style="text-align: right" title="Capital expenditures">4,218,084</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--PaymentsToAcquireProductiveAssets_c20220701__20230630_z9foLkt23973" style="text-align: right" title="Capital expenditures">4,337,655</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4px; padding-left: 11pt; text-align: justify"><span id="xdx_F03_z2AsoMtRz1Kb" style="font-family: Times New Roman, Times, Serif; font-size: 11pt">*</span></td>
    <td style="padding-left: 11pt; text-align: justify"><span id="xdx_F13_zGOAjo82oomk" style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Amounts eliminated in consolidation</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ScheduleOfExportProductSalesTableTextBlock', window );">Schedule of export product sales</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfExportProductSalesTableTextBlock_zPxvt0Md6uRd" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"><span id="xdx_8BA_zV8IvqceoLdk" style="display: none">Schedule of export product sales</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-indent: -11pt">Canada</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_909_ecustom--ForeignProductSales_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zY8o9O0ihNw6" title="Foreign product sales">0.2</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90B_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CA_z6VZMCBFzPJa" title="Foreign product sales">8.5</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Germany</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_ecustom--ForeignProductSales_dp0_c20230701__20240630__srt--StatementGeographicalAxis__country--DE_zmBAUyyf01rj" title="Foreign product sales">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DE_ziwtdxJ09DCg" title="Foreign product sales">4.9</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">United Arab Emirates</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecustom--ForeignProductSales_dp0_c20230701__20240630__srt--StatementGeographicalAxis__country--AE_zwJcDCMPuaIj" title="Foreign product sales">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AE_zCSOYTp2ycS7" title="Foreign product sales">0.7</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_ecustom--ForeignProductSales_dp_c20230701__20240630_zTYH7ZgvBT45" title="Foreign product sales">0.2</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_ecustom--ForeignProductSales_dp_c20220701__20230630_zgnSQ5SgksR5" title="Foreign product sales">14.1</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ScheduleOfExportServiceRevenuesTableTextBlock', window );">Schedule of export service revenues</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfExportServiceRevenuesTableTextBlock_z7jiVO9m4v1j" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"><span id="xdx_8BA_z5mx20i5YrCa" style="display: none">Schedule of export service revenues</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt">Puerto Rico</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90E_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--PR_z4TR3fJLSEf9" title="Foreign service and repair fees">1.9</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_905_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--PR_z4pkxQDKv8vk" title="Foreign service and repair fees">1.5</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Switzerland</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CH_z5ThHoeCyosa" title="Foreign service and repair fees">0.3</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CH_z7Bm71O8iZY6" title="Foreign service and repair fees">0.3</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Germany</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--DE_zRYwYFliwQ83" title="Foreign service and repair fees">2.0</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DE_zsz2GlSfRBfh" title="Foreign service and repair fees">1.6</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">England</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--GB_z3K53JttbUh4" title="Foreign service and repair fees">0.7</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--GB_zV3kqEMVFlPj" title="Foreign service and repair fees">0.6</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">United Arab Emirates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--AE_zMbLBBGpuaFa" title="Foreign service and repair fees">0.3</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AE_zn3tqTDy40he" title="Foreign service and repair fees">0.1</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Dominican Republic</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--DO_zMCibsAKuY33" title="Foreign service and repair fees">1.2</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DO_zlhfPHoNaW0b" title="Foreign service and repair fees">0.5</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Canada</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_ecustom--ForeignServiceAndRepairFees_dp0_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zn8wMDBi7iYi" title="Foreign service and repair fees">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CA_zoyPr5HlQdOc" title="Foreign service and repair fees">0.6</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Greece</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--GR_z8xAcCJrq6Od" title="Foreign service and repair fees">0.3</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--GR_zE1T9oHhrLL2" title="Foreign service and repair fees">0.3</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 1pt 11pt; text-indent: -11pt">Australia</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--AU_zFcb35Wfn3Di" title="Foreign service and repair fees">0.7</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AU_zrFkQP17t7mb" title="Foreign service and repair fees">0.9</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 2.5pt 11pt; text-indent: -11pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630_zPsaKxpaO687" title="Foreign service and repair fees">7.4</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630_zok0Okk7tur9" title="Foreign service and repair fees">6.4</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ScheduleOfExportProductSalesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ScheduleOfExportProductSalesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ScheduleOfExportServiceRevenuesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ScheduleOfExportServiceRevenuesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845743330512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative) - Nonconsolidated Investees, Other [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Interest received percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest percentage</a></td>
<td class="nump">70.80%<span></span>
</td>
<td class="nump">45.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsToMinorityShareholders', window );">Non-controlling interests from the minority shareholders</a></td>
<td class="nump">$ 546,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=us-gaap_OtherInvesteesMember', window );">Noncontrolling Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest percentage</a></td>
<td class="nump">29.20%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedPercentOfNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of investment owned to net assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedPercentOfNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=us-gaap_OtherInvesteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=us-gaap_OtherInvesteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845739921328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Diagnostic Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Research Deveopment And Demonstration Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Diagnostic Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">13 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Research Deveopment And Demonstration Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">9 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average [Member] | Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">28 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_ResearchDeveopmentAndDemonstrationEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_ResearchDeveopmentAndDemonstrationEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845743272528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">$ 33,815,796<span></span>
</td>
<td class="nump">$ 29,793,993<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember', window );">Commercial Insurance/ Managed Care [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">4,952,712<span></span>
</td>
<td class="nump">4,124,646<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember', window );">Medicare/Medicaid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">1,138,176<span></span>
</td>
<td class="nump">1,063,846<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember', window );">Workers? Compensation/Personal Injury [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">20,673,483<span></span>
</td>
<td class="nump">18,670,019<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">$ 7,051,425<span></span>
</td>
<td class="nump">$ 5,935,482<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetPatientFeeRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetPatientFeeRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845744734144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetIncomeLossAvailableToCommonStockholderBasic', window );">Net income available to common stockholders</a></td>
<td class="nump">$ 10,567,396<span></span>
</td>
<td class="nump">$ 9,375,776<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageSharesOutstandingBasic', window );">Weighted average shares outstanding basic</a></td>
<td class="nump">6,350,862<span></span>
</td>
<td class="nump">6,539,376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic income per common share</a></td>
<td class="nump">$ 1.66<span></span>
</td>
<td class="nump">$ 1.43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetIncomeLossAvailableToCommonStockholderBasic', window );">Net income available to common stockholders</a></td>
<td class="nump">$ 9,908,920<span></span>
</td>
<td class="nump">$ 8,801,974<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageSharesOutstandingBasic', window );">Weighted average shares outstanding basic</a></td>
<td class="nump">6,350,862<span></span>
</td>
<td class="nump">6,539,376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic income per common share</a></td>
<td class="nump">$ 1.56<span></span>
</td>
<td class="nump">$ 1.35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageBasicSharesOutstandingProForma', window );">Weighted average shares outstanding</a></td>
<td class="nump">6,350,862<span></span>
</td>
<td class="nump">6,539,376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock', window );">Class C Common Stock</a></td>
<td class="nump">127,504<span></span>
</td>
<td class="nump">127,504<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageNumberOfDilutedEarningsPerShare', window );">Total Denominator for diluted earnings per share</a></td>
<td class="nump">6,478,366<span></span>
</td>
<td class="nump">6,666,880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted income per common share</a></td>
<td class="nump">$ 1.53<span></span>
</td>
<td class="nump">$ 1.32<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetIncomeLossAvailableToCommonStockholderBasic', window );">Net income available to common stockholders</a></td>
<td class="nump">$ 167,700<span></span>
</td>
<td class="nump">$ 146,136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageSharesOutstandingBasic', window );">Weighted average shares outstanding basic</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic income per common share</a></td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageBasicSharesOutstandingProForma', window );">Weighted average shares outstanding</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Class C Common Stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageNumberOfDilutedEarningsPerShare', window );">Total Denominator for diluted earnings per share</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted income per common share</a></td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.38<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetIncomeLossAvailableToCommonStockholderBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetIncomeLossAvailableToCommonStockholderBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_WeightedAverageNumberOfDilutedEarningsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_WeightedAverageNumberOfDilutedEarningsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_WeightedAverageSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_WeightedAverageSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 17: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-42<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageBasicSharesOutstandingProForma">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of shares (units) outstanding in the calculation of pro forma basic earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageBasicSharesOutstandingProForma</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845743677488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 02, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfPropertyRepairsAndMaintenance', window );">Maintenance and repair expenses</a></td>
<td class="nump">$ 2,948,000<span></span>
</td>
<td class="nump">$ 2,801,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAgreementsWithCompanyTotalMedicalPractices', window );">Management agreements with company total medical practices</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty', window );">Scanners with management agreements with company owned by related party</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState', window );">Scanners with management with company located in new york state</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ProvisionForBadDebts', window );">[custom:ProvisionForBadDebts]</a></td>
<td class="nump">$ 1,882,061<span></span>
</td>
<td class="nump">5,513,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementFeeReceivableForUnrelatedParties', window );">[custom:ManagementFeeReceivableForUnrelatedParties-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,419,219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementFeeReceivableForRelatedParties', window );">[custom:ManagementFeeReceivableForRelatedParties-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,602,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableServiceContractsNet', window );">[custom:AccountsReceivableServiceContractsNet-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,335,956<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising Expense</a></td>
<td class="nump">731,000<span></span>
</td>
<td class="nump">570,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesExpense', window );">Penalties</a></td>
<td class="nump">$ 20,444<span></span>
</td>
<td class="nump">$ 31,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders', window );">Conversion of Class C Common Stock | shares</a></td>
<td class="nump">127,504<span></span>
</td>
<td class="nump">127,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash deposit</a></td>
<td class="nump">$ 53,883,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Federally insured limits</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Related Parties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Related Parties Medical Practices [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=FONR_DiagnosticImagingFacilityMember', window );">Diagnostic Imaging Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ContractualFeesForServicesRenderedMinimum', window );">Contractual fees for services rendered minimum</a></td>
<td class="nump">$ 84,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ContractualFeesForServicesRenderedMaximum', window );">Contractual fees for services rendered maximum</a></td>
<td class="nump">$ 447,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Intellectual Property [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableServiceContractsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableServiceContractsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ContractualFeesForServicesRenderedMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ContractualFeesForServicesRenderedMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ContractualFeesForServicesRenderedMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ContractualFeesForServicesRenderedMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAgreementsWithCompanyTotalMedicalPractices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAgreementsWithCompanyTotalMedicalPractices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementFeeReceivableForRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementFeeReceivableForRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementFeeReceivableForUnrelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementFeeReceivableForUnrelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProvisionForBadDebts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProvisionForBadDebts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483385/720-35-55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfPropertyRepairsAndMaintenance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs of keeping the property in good condition but that do not appreciably prolong the life or increase the value of the property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfPropertyRepairsAndMaintenance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=FONR_RelatedPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=FONR_RelatedPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=FONR_RelatedPartiesMedicalPracticesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=FONR_RelatedPartiesMedicalPracticesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=FONR_DiagnosticImagingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=FONR_DiagnosticImagingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845740660224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueTwoToThreeYears', window );">2026</a></td>
<td class="nump">$ 631,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueThreeToFourYears', window );">2027</a></td>
<td class="nump">369,429<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueFourToFiveYears', window );">2028</a></td>
<td class="nump">87,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueFiveYearsOrMore', window );">2029</a></td>
<td class="nump">87,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms', window );">Total</a></td>
<td class="nump">$ 1,174,844<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount billed to customers under long-term contracts or programs but not paid. Excludes amounts due that have been withheld because of retainage provisions in a contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueFiveYearsOrMore">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueFiveYearsOrMore</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueFourToFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueFourToFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueThreeToFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueThreeToFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueTwoToThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueTwoToThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845746796768">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 198,593<span></span>
</td>
<td class="nump">$ 204,597<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsAdditions', window );">Additions (Included in provision for bad debts)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">55,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsDeductions', window );">Deductions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">32,544<span></span>
</td>
<td class="nump">61,004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">166,049<span></span>
</td>
<td class="nump">198,593<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableMember', window );">Management And Other Fees Receivable [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,608,567<span></span>
</td>
<td class="nump">16,627,917<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsAdditions', window );">Additions (Included in provision for bad debts)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(238,646)<span></span>
</td>
<td class="nump">4,007,382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsDeductions', window );">Deductions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,026,732<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,369,921<span></span>
</td>
<td class="nump">12,608,567<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember', window );">Management And Other Fees Receivable Related Medical Practices [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,989,692<span></span>
</td>
<td class="nump">4,686,893<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsAdditions', window );">Additions (Included in provision for bad debts)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,120,707<span></span>
</td>
<td class="nump">1,451,094<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsDeductions', window );">Deductions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,148,295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,110,399<span></span>
</td>
<td class="nump">3,989,692<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_NotesReceivableMember', window );">Notes Receivable [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">777,354<span></span>
</td>
<td class="nump">777,354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsAdditions', window );">Additions (Included in provision for bad debts)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsDeductions', window );">Deductions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 777,354<span></span>
</td>
<td class="nump">$ 777,354<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Included in provision for credit losses.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AllowanceForDoubtfulAccountsAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AllowanceForDoubtfulAccountsAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AllowanceForDoubtfulAccountsDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AllowanceForDoubtfulAccountsDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 40<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481628/310-20-40-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_NotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_NotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845744733408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details) - Integer<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear', window );">Total Facilities Owned or Managed (at Beginning of Year)</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagedFacilitiesAddedByInternalDevelopment', window );">Internal development</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagedFacilitiesClosedDuringYear', window );">Managed Facilities Closed</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear', window );">Total Facilities Owned or Managed (at End of Year)</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagedFacilitiesAddedByInternalDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagedFacilitiesAddedByInternalDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagedFacilitiesClosedDuringYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagedFacilitiesClosedDuringYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845740369328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableNetLongTerm', window );">Long term accounts receivable balances</a></td>
<td class="nump">$ 829,473<span></span>
</td>
<td class="nump">$ 710,085<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PercentageOfConsolidatedNetRevenueFromManagementFees', window );">Percentage of consolidated net revenue from management fees</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableNetLongTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableNetLongTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PercentageOfConsolidatedNetRevenueFromManagementFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PercentageOfConsolidatedNetRevenueFromManagementFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845743206048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES - Inventories (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInventorySupplies', window );">Purchased parts and components</a></td>
<td class="nump">$ 2,524,201<span></span>
</td>
<td class="nump">$ 2,346,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-process</a></td>
<td class="nump">191,240<span></span>
</td>
<td class="nump">223,366<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 2,715,441<span></span>
</td>
<td class="nump">$ 2,569,666<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventorySupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventorySupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845739107584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT - Property and equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment, gross</a></td>
<td class="nump">$ 62,507,377<span></span>
</td>
<td class="nump">$ 61,717,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation and amortization</a></td>
<td class="nump">43,798,457<span></span>
</td>
<td class="nump">39,571,043<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property plant and equipment, net</a></td>
<td class="nump">18,708,920<span></span>
</td>
<td class="nump">22,146,373<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember', window );">Diagnostic Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment, gross</a></td>
<td class="nump">33,243,694<span></span>
</td>
<td class="nump">33,144,266<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_ResearchDevelopmentAndDemonstrationEquipmentMember', window );">Research, development and demonstration equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment, gross</a></td>
<td class="nump">6,199,941<span></span>
</td>
<td class="nump">6,199,941<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment, gross</a></td>
<td class="nump">2,069,055<span></span>
</td>
<td class="nump">2,069,055<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment, gross</a></td>
<td class="nump">3,742,169<span></span>
</td>
<td class="nump">3,714,499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment, gross</a></td>
<td class="nump">16,312,904<span></span>
</td>
<td class="nump">15,650,041<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment, gross</a></td>
<td class="nump">$ 939,614<span></span>
</td>
<td class="nump">$ 939,614<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_ResearchDevelopmentAndDemonstrationEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_ResearchDevelopmentAndDemonstrationEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845744169104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization of property and equipment</a></td>
<td class="nump">$ 4,227,414<span></span>
</td>
<td class="nump">$ 4,148,544<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845739920064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES - Lease payments (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=FONR_OperatingLeasePaymentsMember', window );">Operating Lease Payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 5,895,014<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">5,561,968<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">5,226,352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">5,194,655<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2029</a></td>
<td class="nump">4,865,285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">29,295,110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PresentValueDiscount', window );">Present value discount</a></td>
<td class="num">(15,096,964)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liability</a></td>
<td class="nump">40,941,420<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=FONR_FinancingLeasePaymentsMember', window );">Financing Lease Payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">244,343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">244,343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">162,897<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2029</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PresentValueDiscountFinancingLease', window );">Present value discount</a></td>
<td class="num">(31,074)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total lease liability</a></td>
<td class="nump">$ 620,509<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PresentValueDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PresentValueDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PresentValueDiscountFinancingLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PresentValueDiscountFinancingLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=FONR_OperatingLeasePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=FONR_OperatingLeasePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=FONR_FinancingLeasePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=FONR_FinancingLeasePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845740375328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES - Weighted average remaining lease term (Details)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingFinancingLeasesAbstract', window );"><strong>Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases - years</a></td>
<td class="text">11 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance lease - years</a></td>
<td class="text">2 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate, operating leases</a></td>
<td class="nump">6.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate, finance leases</a></td>
<td class="nump">3.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845735209296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES - Components of lease expense (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingFinancingLeasesAbstract', window );"><strong>Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 5,685,008<span></span>
</td>
<td class="nump">$ 5,887,390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_FinanceLeaseCostsAbstract', window );"><strong>Finance lease cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DepreciationOfLeasedEquipment', window );">Depreciation of leased equipment</a></td>
<td class="nump">198,881<span></span>
</td>
<td class="nump">198,881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">26,534<span></span>
</td>
<td class="nump">35,833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_FinanceLeaseCost', window );">Total finance lease cost</a></td>
<td class="nump">$ 225,415<span></span>
</td>
<td class="nump">$ 234,714<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DepreciationOfLeasedEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DepreciationOfLeasedEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_FinanceLeaseCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_FinanceLeaseCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845739814800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES - Related to leases (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingFinancingLeasesAbstract', window );"><strong>Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OperatingCashFlowsFromOperatingLeases', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 6,363,561<span></span>
</td>
<td class="nump">$ 5,577,578<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_FinancingCashFlowsFromFinancingLeases', window );">Financing cash flows from financing leases</a></td>
<td class="nump">244,344<span></span>
</td>
<td class="nump">244,344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract', window );"><strong>Right-of-use and equipment assets obtained in exchange for lease obligations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases', window );">Operating leases</a></td>
<td class="nump">$ 3,715,138<span></span>
</td>
<td class="nump">$ 2,902,584<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_FinancingCashFlowsFromFinancingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_FinancingCashFlowsFromFinancingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OperatingCashFlowsFromOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OperatingCashFlowsFromOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845744167504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">$ 20,314,658<span></span>
</td>
<td class="nump">$ 20,507,192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: Accumulated amortization</a></td>
<td class="nump">17,444,334<span></span>
</td>
<td class="nump">17,075,327<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Other intangible assets-net</a></td>
<td class="nump">2,870,324<span></span>
</td>
<td class="nump">3,431,865<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software and Software Development Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">7,004,847<span></span>
</td>
<td class="nump">7,004,847<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember', window );">Patents and copyrights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">5,259,811<span></span>
</td>
<td class="nump">5,452,345<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">4,150,000<span></span>
</td>
<td class="nump">4,150,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">$ 3,900,000<span></span>
</td>
<td class="nump">$ 3,900,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478859/928-340-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845739396000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 351,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2026</a></td>
<td class="nump">339,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2027</a></td>
<td class="nump">326,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2028</a></td>
<td class="nump">320,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2029</a></td>
<td class="nump">313,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">1,219,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets - net</a></td>
<td class="nump">2,870,324<span></span>
</td>
<td class="nump">$ 3,431,865<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2025</a></td>
<td class="nump">151,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2026</a></td>
<td class="nump">139,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2027</a></td>
<td class="nump">126,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2028</a></td>
<td class="nump">120,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2029</a></td>
<td class="nump">113,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">505,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets - net</a></td>
<td class="nump">1,156,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2025</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2026</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2027</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2028</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2029</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">714,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets - net</a></td>
<td class="nump">$ 1,714,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845746683408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS - Intangle assets - (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Balance - Beginning of Year</a></td>
<td class="nump">$ 3,431,865<span></span>
</td>
<td class="nump">$ 3,703,885<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AmountsCapitalized', window );">Amounts capitalized</a></td>
<td class="nump">32,885<span></span>
</td>
<td class="nump">119,571<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SoftwareOrPatentsWrittenOff', window );">Patents written off</a></td>
<td class="num">(225,419)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="num">(369,007)<span></span>
</td>
<td class="num">(391,591)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Balance - End of Year</a></td>
<td class="nump">$ 2,870,324<span></span>
</td>
<td class="nump">$ 3,431,865<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AmountsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AmountsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SoftwareOrPatentsWrittenOff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SoftwareOrPatentsWrittenOff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845746682928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period for other intangible assets</a></td>
<td class="text">9 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of customer relationships</a></td>
<td class="nump">$ 169,007<span></span>
</td>
<td class="nump">$ 191,591<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of customer relationships</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845748249680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2022</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Aug. 10, 2010</div></th>
<th class="th"><div>Apr. 23, 2010</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfEquity', window );">Payments for repurchase of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,505,832<span></span>
</td>
<td class="nump">$ 1,759,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Purchase of treasury shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,206<span></span>
</td>
<td class="nump">103,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,505,832<span></span>
</td>
<td class="nump">$ 1,759,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CancellationOfTreasuryShares', window );">Cancellation of treasury shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122,588<span></span>
</td>
<td class="nump">103,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CancellationOfTreasuryStock', window );">Cancellation of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,005,020<span></span>
</td>
<td class="nump">$ 1,919,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember', window );">Board of Directors Chairman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfEquity', window );">Payments for repurchase of equity</a></td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=FONR_N2010StockBonusPlanMember', window );">N 2010 Stock Bonus Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, capital shares reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SharesRegistered', window );">Shares registered</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for future grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450,177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Number of shares were issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableNature', window );">Dividends payable, nature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Cash dividends payable on the common stock shall,
in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend payable on shares of Class B common stock
and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare', window );">Conversuion of shares into one-for-one basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Class C common stock
is convertible into shares of common stock on a three-for-one basis.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common stock, voting rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one vote per share for the common stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,328,294<span></span>
</td>
<td class="nump">6,450,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare', window );">Conversuion of shares into one-for-one basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Class B common stock is convertible into shares of
common stock on a one-for-one basis.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common stock, voting rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Class B common stock has 10 votes per share.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare', window );">Conversuion of shares into one-for-one basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Class C common stock was
offered on a three-for-one basis to the holders of the Class B common stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common stock, voting rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Class C common stock has 25 votes per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember', window );">Preferred Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableNature', window );">Dividends payable, nature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued
pursuant to such stock dividend approximates 313,000 shares.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common stock, voting rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one share of Class A non-voting preferred stock for every five shares
of common stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CancellationOfTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CancellationOfTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CancellationOfTreasuryStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CancellationOfTreasuryStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SharesRegistered">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SharesRegistered</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableNature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes the declaration as being a special dividend (over and above the normal dividend); as the annual, semi-annual, quarterly dividend, or other normal periodic dividend; or as some other type of dividend.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableNature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of reason for including or excluding share issuable in conversion of contingently convertible security in calculation of diluted earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=FONR_N2010StockBonusPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=FONR_N2010StockBonusPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845743650192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details) - HDM Equity [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OpeningMembersEquity', window );">Opening Members Equity</a></td>
<td class="nump">$ 7,079,293<span></span>
</td>
<td class="nump">$ 4,053,833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ShareOfNetIncome', window );">Share of Net Income</a></td>
<td class="nump">3,530,021<span></span>
</td>
<td class="nump">2,750,740<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_BuyoutOfNoncontrollingInterestsValue', window );">Buyout of noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_Distributions', window );">Distributions</a></td>
<td class="nump">5,630,336<span></span>
</td>
<td class="nump">5,776,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EndingMembersEquity', window );">Ending Members Equity</a></td>
<td class="nump">9,179,608<span></span>
</td>
<td class="nump">7,079,293<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OpeningMembersEquity', window );">Opening Members Equity</a></td>
<td class="nump">54,781,813<span></span>
</td>
<td class="nump">50,292,073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ShareOfNetIncome', window );">Share of Net Income</a></td>
<td class="nump">20,705,681<span></span>
</td>
<td class="nump">18,513,540<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_BuyoutOfNoncontrollingInterestsValue', window );">Buyout of noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_Distributions', window );">Distributions</a></td>
<td class="num">(13,669,664)<span></span>
</td>
<td class="num">(14,023,800)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EndingMembersEquity', window );">Ending Members Equity</a></td>
<td class="nump">$ 61,817,830<span></span>
</td>
<td class="nump">$ 54,781,813<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_BuyoutOfNoncontrollingInterestsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_BuyoutOfNoncontrollingInterestsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_Distributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_Distributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EndingMembersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EndingMembersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OpeningMembersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OpeningMembersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ShareOfNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ShareOfNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=FONR_HDMEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=FONR_HDMEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845740127072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative) - HDM [Member]<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 08, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 13, 2013 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 05, 2013 </div>
<div>USD ($) </div>
<div>Integer</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PurchaseOfStandupMriCenters', window );">Purchase of stand up MRI centers | Integer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PurchaseOfOtherMriCenters', window );">Purchase of other MRI centers | Integer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ConsiderationToOutsideInvestors', window );">HDM purchase price includes consideration to outside investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalPurchasePrice', window );">HDM purchase from Health Diagnostics (HD) ($)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ConsiderationForNoncompetitionAndConsultingAgreements', window );">HDM entered agreement for consulting and non-competition agreement ($)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_HDMMember', window );">Class B Controlling Interests [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EquityMethodInvestmentOwnershipPercentages', window );">Ownership interest of company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ProceedsFromContributionsFromCompany', window );">Company contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_HDMMember', window );">Class A Controlling Interests [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EquityMethodInvestmentOwnershipPercentages', window );">Ownership interest of company</a></td>
<td class="nump">60.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EquityMethodInvestmentsOwnershipPercentage', window );">Purchase of interests from Class A, percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DirectPurchaseOfNoncontrollingInterests', window );">Purchase of interests from Class A</a></td>
<td class="nump">$ 4,971,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 546,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_HDMMember', window );">Class A Controlling Interests [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership interest of investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.50%<span></span>
</td>
<td class="nump">29.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromContributionsFromAffiliates', window );">Investors contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ConsiderationForNoncompetitionAndConsultingAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ConsiderationForNoncompetitionAndConsultingAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ConsiderationToOutsideInvestors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ConsiderationToOutsideInvestors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DirectPurchaseOfNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DirectPurchaseOfNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EquityMethodInvestmentOwnershipPercentages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EquityMethodInvestmentOwnershipPercentages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EquityMethodInvestmentsOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EquityMethodInvestmentsOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProceedsFromContributionsFromCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProceedsFromContributionsFromCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PurchaseOfOtherMriCenters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PurchaseOfOtherMriCenters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PurchaseOfStandupMriCenters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PurchaseOfStandupMriCenters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalPurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalPurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromContributionsFromAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromContributionsFromAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=FONR_HDMMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=FONR_HDMMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOwnershipInterestsByNameAxis=FONR_ClassBControllingInterestsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOwnershipInterestsByNameAxis=FONR_ClassBControllingInterestsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOwnershipInterestsByNameAxis=FONR_ClassAControllingInterestsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOwnershipInterestsByNameAxis=FONR_ClassAControllingInterestsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=FONR_ClassAControllingInterestsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=FONR_ClassAControllingInterestsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845829930048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt, notes payable and capital leases</a></td>
<td class="nump">$ 113,940<span></span>
</td>
<td class="nump">$ 158,842<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long term debt, notes payable and capital leases</a></td>
<td class="nump">47,002<span></span>
</td>
<td class="nump">43,767<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long term debt, notes payable and capital leases less current portion</a></td>
<td class="nump">66,938<span></span>
</td>
<td class="nump">115,075<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=FONR_NotePayable1Member', window );">Note Payable 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt, notes payable and capital leases</a></td>
<td class="nump">113,940<span></span>
</td>
<td class="nump">158,842<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=FONR_NotePayable2Member', window );">Note Payable 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt, notes payable and capital leases</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=FONR_NotePayable1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=FONR_NotePayable1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=FONR_NotePayable2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=FONR_NotePayable2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845740479072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities of long term debt over 5 years - (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract', window );"><strong>Long-term Debt Notes Payable And Capital Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 47,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2025</a></td>
<td class="nump">50,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree', window );">2026</a></td>
<td class="nump">16,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long term debt</a></td>
<td class="nump">$ 113,940<span></span>
</td>
<td class="nump">$ 158,842<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845743360032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=FONR_NotePayable1Member', window );">Note Payable 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MonthlyPaymentPeriod', window );">Monthly payment period</a></td>
<td class="text">240 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Debt instrument, periodic payment</a></td>
<td class="nump">$ 4,472<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MaturityDate', window );">Maturity date</a></td>
<td class="text">October 2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_BookValueOfBuilding', window );">Book value of building</a></td>
<td class="nump">$ 310,827<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=FONR_NotePayable2Member', window );">Note Payable 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="nump">8.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from lines of credit</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_BookValueOfBuilding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_BookValueOfBuilding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MonthlyPaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MonthlyPaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=FONR_NotePayable1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=FONR_NotePayable1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=FONR_NotePayable2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=FONR_NotePayable2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845740592608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Components of provision for income taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 429,873<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">1,943,588<span></span>
</td>
<td class="nump">652,521<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Subtotal</a></td>
<td class="nump">2,373,461<span></span>
</td>
<td class="nump">652,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal deferred taxes</a></td>
<td class="nump">2,585,515<span></span>
</td>
<td class="nump">2,770,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State deferred taxes</a></td>
<td class="nump">209,992<span></span>
</td>
<td class="nump">208,570<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DeferredIncomeTaxExpensesBenefit', window );">Subtotal</a></td>
<td class="nump">2,795,507<span></span>
</td>
<td class="nump">2,979,550<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision (Benefit) for Income Taxes - Net</a></td>
<td class="nump">$ 5,168,968<span></span>
</td>
<td class="nump">$ 3,632,071<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DeferredIncomeTaxExpensesBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DeferredIncomeTaxExpensesBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845739688208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates', window );">Taxes at federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and local income taxes (benefit), net of federal benefit</a></td>
<td class="nump">7.10%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense', window );">Noncontrolling interest</a></td>
<td class="num">(5.30%)<span></span>
</td>
<td class="num">(4.60%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes', window );">Expiration of tax credits</a></td>
<td class="nump">2.20%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Return to provision adjustments</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(2.30%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in the valuation allowance</a></td>
<td class="num">(0.20%)<span></span>
</td>
<td class="num">(0.50%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent', window );">Other</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">26.80%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of reported income tax benefit (expense) from difference to income tax expense (benefit) computed by applying statutory federal (national) income tax rate to pretax income (loss) from continuing operation, attributable to other reconciling items. Excludes state and local income tax expense (benefit), federal tax expense (benefit), statutory income tax expense (benefit) outside of country of domicile, tax credit, nondeductible expense, deduction, income tax settlement, income tax contingency, and cross-border tax law.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845744888944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - Deferred tax assets and liabilities - (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Allowance for credit losses</a></td>
<td class="nump">$ 3,969,819<span></span>
</td>
<td class="nump">$ 3,360,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Non-deductible accruals</a></td>
<td class="nump">758,700<span></span>
</td>
<td class="nump">707,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating carryforwards</a></td>
<td class="nump">396,092<span></span>
</td>
<td class="nump">2,768,844<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">1,323,018<span></span>
</td>
<td class="nump">2,981,214<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Capitalized research and development</a></td>
<td class="nump">747,407<span></span>
</td>
<td class="nump">369,675<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities', window );">Right of use assets and lease liabilities</a></td>
<td class="nump">114,116<span></span>
</td>
<td class="nump">112,938<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventories</a></td>
<td class="nump">106,879<span></span>
</td>
<td class="nump">105,310<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred Tax Assets - gross</a></td>
<td class="nump">7,416,031<span></span>
</td>
<td class="nump">10,406,190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(192,776)<span></span>
</td>
<td class="num">(364,230)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">7,223,255<span></span>
</td>
<td class="nump">10,041,960<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property and equipment and depreciation</a></td>
<td class="num">(267,124)<span></span>
</td>
<td class="num">(151,007)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets', window );">Intangibles</a></td>
<td class="num">(104,436)<span></span>
</td>
<td class="num">(243,751)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(371,560)<span></span>
</td>
<td class="num">(394,758)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax asset</a></td>
<td class="nump">$ 6,851,695<span></span>
</td>
<td class="nump">$ 9,647,202<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845744397504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax asset</a></td>
<td class="nump">$ 7,223,255<span></span>
</td>
<td class="nump">$ 10,041,960<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus', window );">Deferred tax liability</a></td>
<td class="nump">371,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Allowance for doubtful accounts and tax credits</a></td>
<td class="nump">1,323,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">State operating loss carryforwards</a></td>
<td class="nump">4,516,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingIncome', window );">City operating loss carryforwards</a></td>
<td class="nump">618,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsValuationAllowance', window );">Valuation allowance of state operating losses</a></td>
<td class="nump">$ 2,746,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PercentageOfExciseTax', window );">Percentage of excise tax</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CorporateAlternativeMinimumTaxPercentage', window );">Corporate alternative minimum tax percentage</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital', window );">Valuation allowance for deferred tax assets</a></td>
<td class="nump">$ 171,000<span></span>
</td>
<td class="nump">$ 78,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Tax credits carryforwards</a></td>
<td class="nump">$ 1,323,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CorporateAlternativeMinimumTaxPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CorporateAlternativeMinimumTaxPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PercentageOfExciseTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PercentageOfExciseTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to a policyholders' surplus.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 740<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation allowance for tax benefit to be credited to shareholders' equity if tax benefit subsequently becomes realizable. Includes, but is not limited to, adjustment to opening balance of retained earnings for change in accounting principle or correction of error, gain (loss) in comprehensive income (loss) but excluded from net income (loss), deductible expenditure for income tax purposes reported as reduction of shareholders' equity, and deductible temporary difference existing at date of quasi-reorganization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845746740640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued salaries, commissions and payroll taxes</a></td>
<td class="nump">$ 4,677,690<span></span>
</td>
<td class="nump">$ 4,413,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">Sales tax payable</a></td>
<td class="nump">197,317<span></span>
</td>
<td class="nump">193,041<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrentAndNoncurrent', window );">State income taxes payable</a></td>
<td class="nump">1,461,336<span></span>
</td>
<td class="nump">48,353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Legal and other professional fees</a></td>
<td class="nump">11,207<span></span>
</td>
<td class="nump">11,207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent', window );">Accounting fees</a></td>
<td class="nump">119,800<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self-funded health insurance reserve</a></td>
<td class="nump">121,445<span></span>
</td>
<td class="nump">100,971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Accrued interest and penalty</a></td>
<td class="nump">3,534<span></span>
</td>
<td class="nump">3,534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">1,348,710<span></span>
</td>
<td class="nump">573,574<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">$ 7,941,039<span></span>
</td>
<td class="nump">$ 5,443,724<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481573/470-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845743258208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 29, 2016</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_LeaseAndRentalExpenses', window );">Rent expense for operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,685,000<span></span>
</td>
<td class="nump">$ 5,887,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PropertyTaxAbatementFromSuffolkCountyIda', window );">Property tax abatement from suffolk county IDA</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PropertyTaxAbatement', window );">Property tax abatement</a></td>
<td class="nump">$ 440,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP', window );">Employer contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">36,523<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsurancePayable', window );">Liability for individual claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Reserve for self-funded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 121,000<span></span>
</td>
<td class="nump">$ 101,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_LeaseAndRentalExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_LeaseAndRentalExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PropertyTaxAbatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PropertyTaxAbatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PropertyTaxAbatementFromSuffolkCountyIda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PropertyTaxAbatementFromSuffolkCountyIda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the amount of cash contributions during the period made by the entity to the Employee Stock Ownership Plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480489/718-40-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-7<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 9E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-9E<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(13)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsurancePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date of the known and estimated amounts owed to insurers under reinsurance treaties or other arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsurancePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845745803456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">$ 76,997<span></span>
</td>
<td class="nump">$ 50,132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">$ 507,139<span></span>
</td>
<td class="nump">$ 1,439,507<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845740762544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 01, 2017</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Monthly fee</a></td>
<td class="nump">$ 23,884<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=FONR_BensonhurstMRILimitedPartnershipMember', window );">Bensonhurst MRI Limited Partnership [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionDescriptionOfTransaction', window );">Related party transaction, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Bensonhurst
MRI Limited Partnership (&#8220;Bensonhurst&#8221;), in which the CEO and President of the Company holds an interest, is party to an
agreement with the Company for the service and maintenance of its Upright MRI Scanner for a price of $110,000 per annum. On February
1, 2024, Bensonhurst entered into a second contract with the Company for the service and maintenance of a High-Field MRI Scanner for
a price of $70,000 per annum. Also, during fiscal year ended June 30, 2024, the Company charged Bensonhurst MRI Limited Partnership
$190,362 for reimbursable salaries and marketing expenses.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=FONR_RadianHealthcareManagementLLCMember', window );">Radian Healthcare Management LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionDescriptionOfTransaction', window );">Related party transaction, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Radian Healthcare Management, LLC (&#8220;Radian&#8221;),
which is owned by the son-in-law of the CEO and President of the Company provided the Company with personnel recruitment of 32 new employees
at a fee of approximately $200,000 during the fiscal year ended June 30, 2024.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=FONR_MagneticResonanceManagementMember', window );">Magnetic Resonance Management [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Sale of price of the equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 576,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Bears interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredGainOnSaleOfProperty', window );">Gain on sale of equipments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 576,857<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredGainOnSaleOfProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain on the sale of property that does not qualify for gain recognition as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredGainOnSaleOfProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionDescriptionOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481440/840-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479741/842-40-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionDescriptionOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=FONR_BensonhurstMRILimitedPartnershipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=FONR_BensonhurstMRILimitedPartnershipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=FONR_RadianHealthcareManagementLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=FONR_RadianHealthcareManagementLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=FONR_MagneticResonanceManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=FONR_MagneticResonanceManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845740124832">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION - Summarized segments - (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues from external customers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 102,884,089<span></span>
</td>
<td class="nump">$ 98,645,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Inter-segment net revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,073,333<span></span>
</td>
<td class="nump">985,833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,535,364<span></span>
</td>
<td class="nump">14,789,262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,596,421<span></span>
</td>
<td class="nump">4,540,135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Total identifiable assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">214,245,969<span></span>
</td>
<td class="nump">201,046,419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">822,846<span></span>
</td>
<td class="nump">4,337,655<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCareMember', window );">Manufacturing and Servicing of Medical Equipment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues from external customers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,329,106<span></span>
</td>
<td class="nump">8,260,711<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Inter-segment net revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,073,333<span></span>
</td>
<td class="nump">985,833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(6,958,012)<span></span>
</td>
<td class="num">(5,875,126)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">238,802<span></span>
</td>
<td class="nump">263,720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Total identifiable assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30,360,188<span></span>
</td>
<td class="nump">30,892,807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">32,885<span></span>
</td>
<td class="nump">119,571<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember', window );">Management of Diagnostic Imaging Center [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues from external customers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">94,554,983<span></span>
</td>
<td class="nump">90,384,390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Inter-segment net revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,493,376<span></span>
</td>
<td class="nump">20,664,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,357,619<span></span>
</td>
<td class="nump">4,276,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Total identifiable assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">183,885,781<span></span>
</td>
<td class="nump">170,153,612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 789,961<span></span>
</td>
<td class="nump">$ 4,218,084<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts eliminated in consolidation</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IntersegmentNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of intersegment net revenues during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IntersegmentNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net assets (liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 30<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479910/205-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845735209840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignProductSales', window );">Foreign product sales</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">14.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">CANADA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignProductSales', window );">Foreign product sales</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DE', window );">GERMANY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignProductSales', window );">Foreign product sales</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">4.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AE', window );">UNITED ARAB EMIRATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignProductSales', window );">Foreign product sales</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ForeignProductSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ForeignProductSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_AE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_AE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845743206176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign service and repair fees</a></td>
<td class="nump">7.40%<span></span>
</td>
<td class="nump">6.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_PR', window );">PUERTO RICO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign service and repair fees</a></td>
<td class="nump">1.90%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CH', window );">SWITZERLAND</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign service and repair fees</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DE', window );">GERMANY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign service and repair fees</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_GB', window );">UNITED KINGDOM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign service and repair fees</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AE', window );">UNITED ARAB EMIRATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign service and repair fees</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DO', window );">DOMINICAN REPUBLIC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign service and repair fees</a></td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">CANADA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign service and repair fees</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_GR', window );">GREECE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign service and repair fees</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AU', window );">AUSTRALIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign service and repair fees</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ForeignServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ForeignServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_PR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_PR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_AE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_AE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DO">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DO</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_AU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_AU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845744732208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ExportSalesOfMedicalEquipmentPercentage', window );">Export sales of medical equipment percentage</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">14.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage', window );">Percentage of service and repair of medical equipment</a></td>
<td class="nump">7.40%<span></span>
</td>
<td class="nump">6.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ExportSalesOfMedicalEquipmentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ExportSalesOfMedicalEquipmentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45845740106096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member]<br></strong></div></th>
<th class="th">
<div>Sep. 18, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Number of shares repurchased, shares | shares</a></td>
<td class="nump">19,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Number of shares repurchased, value | $</a></td>
<td class="nump">$ 340,933<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized to be purchased under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>90
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M](QF %-JY5L-5 :P80M?T)M&) S199K(CQ-M_]RC4W6I&"YK?-O!(;* K;*
M7>O"P55$^3P;S7Z7"F(ATU.T)+&VS>T1K+QF#-<UQG:(4&"K4&#7NH0P74C+
M <*"9:IA&37]IM3*L'9N_JEUT6"2/H:!AZY#1K0#/ZS2\)Q=HVJC0LW)U;*;
M"E<7V,)GG94.C/+Y-FS/=ZX-QR3V IG*\_6Q_+TKSO/5;3E1KN\5_)[=&_2/
MEMP/WAT$US5F=(@08*L08,.&?9CZ@9#$JJ+2GO)\-3O24C+J^4VIE2DISV_#
M3GU#Z3K@$;H9:4'!"OV!]@HQ7-68TB',OJW,O@U;\PVE;*4LZWM:3+#$F#ZC
M;XP_'2']<C5<WIC7(6R^K6R^#9ORW94M]/V69FN*^I'*I$UWC:J-3*F5&2K3
M;]<R_>5%PNF"R.]"=ZE(!(FSI3,M59/VW2W4>CMS7=^V!M:ILYWO"F"'\/F.
M\OG.GK7^-2DW)$F"+L%F!RLU!614;61*K4Q1!0"G5@#XD68'*S>FBO_7[+#3
M?]/D3'UE&9:R_4ZM%?QUDW/A)F?2P;M&U4:FU,H451YP:N6!'VIR1C-"H;;;
MY.R!U</VVU9WB,L!SL[# ;!_7S>W(1I+6E]8ON@XX71&93+P:\RYL'IC9F8?
M*3A$9G!49G!J73CXH99H,A6XA5JI)6+;L0=O6Z+1]-#9>8 J6P#*'T1+D)?=
M4;5^EFK[[O9AMV'^B%='[;Y^4D[&IWD0)RBD,UG:/3Z1!\K7#Y^M-P1;YH]C
M/3(A6)2_7%#B4Y[M(#^?,28V&]D7;!\!O/@/4$L#!!0    ( -2#.UF>V[U
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M,[:X=5!IDT%]YPI&,/<)M44 C1F1TJ(_ER6-1"RYK\J-7L!AP6 'L8WA+BN
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M +2@JRB?'U_NR.6F$%RKAK5J6/1SWN@WBR*RS3@3-V*$XQUZ3+!0EPG7D!5
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MK[Y21=N$W:'R"?:-@3(# Q]4VA\8)JW0V*F-)N9R_]K:IMX%17TA?-%?&;9
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M+^#]_:HMT*=0/(<JI_8$U.T)#%:;L?M;O$Q#P&'[1[DQ_RR!\ <KR\Z+:>/
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M36JJ;GCS$;I\1H:7<BKM+VI:W\#%**VEXF4GUA&4!6N_Y+ZKPYY@&!X1>)W
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MUDAW,!YA)-IYT!J*5[:E5ESI!K7+7(]0$,9!GZ\Y5SO#7- /Y>0W4$L#!!0
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M%]1:  *E5#?F7SK,INP:]57M%"]/F!1FJ9$76*6AQXS#"YQ?H6R )M^2J]N
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M+6(E[0-O% :IZ?:!T5GL<*$+"UJX]FCX752<C-1?1+&&#Q%0WLG V"MXFA%
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MZX!$QDEY=7KV7Y%&<TYU-XK@OCO)PSQH"LOKD#+J;''K/'##'CBLU;#"2!P
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M\]6>?7[+1L8>]!F2?NM\)S7O$!8_JO2)^ WWN]=]&7N;[?!A+SK .@5\J-]
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MC:]@H>P&U"^E-/<?UD'_KI[^ U!+ P04    " #4@SM9SZSJ)H$&   Z$
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M&O]NU8"-TH3E:3[>HV_4.3CR^J9/.<@;X;AD-TX7/W8Y&+:/=F^GFGAC&U[
M:1]);\$\0/_LY;-LFK[= V[<@1OOT_[[Z._?_OGJ]CT[8@=L0P^[U'6-A/<>
MLTMN*U:*!U&"*BUK^(+?26"X[BI@11"U7M167,JD)[!6I&0%<MTF[,[+<M:
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M!5E/D7JC16D[]TIHF@-VN:7!B]((T/U:4*T<-\; >90/_P=02P,$%     @
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M8Y$;^XD=)7YFGX&;1MW,KJI950O-H&HE%3>"55V H D(3*L:C2G'8,=O366
MX<Y@F6;#F2B%XO41XTV))>R!JTJVFFGZ;B=K6?":?6]5I<O*%KT>L>N&+:4V
MV(&%32&TR\P.G$JS1F)G,Q=$5=/O8 MF).NUN<Y+\3MXQ1-'17*KB$V?[1QO
MS4*JRE2 #,IDSX(KS5: JD@LLMH;L<^MH2R4CXU0>E&M6+'@ * 9PE *(Q3$
MPO(6-:787<=?3I@%% 4"?]U@30,PM^)!-*V .TOZ:>N2S5J%)8K5U;(R=G5K
MJKKZR\(D 0U%<P7C3-7,891&-+A2ST#[R%4)ETTTK4,EBDTENN0EW18+9PT5
M$=CB7_ 'F%,4+67-R,;[NIG5G<Y;4;8=!4_@V^$O/V5!X)U<WT[LR#\Y8H]<
M.Z)!.<)H6M;.07P,Z42Z@U[>[81\7[>E('_*ATI;OU?+E=1D"6<^\V.[]H'7
M;:>;U^@Z%'8;C-V\9C:OR=\%FID6I5,B<2"'7$918X(H[:4;$&:^@OJG"AU!
MU,^H"A^U0%F>=FE/F24;T1B]#M<&K06Q32 *.-( QL\DX=3'SAV:;MG6@K86
M&T'.#P4Y_[%Y=K4'V;FD>#3FV&*GG]#YW.4U8$=![F9IB!'%P0].'%MI*.D\
M"MTXRU@2!VX<^,Y=.S728%/@AFGH1HF_^?2I]^CQ1O"NCV$@EF4QJ"$F.D@]
M-\^\7L_+A5[NYGF 9^;&J;>K-,TAP4LQRM/<C6//^;9QQ/!"-&)6F2/KDBW;
M0^)'=H-4_\!BUT\R-T\RC$,W"0/72WTVL837%*B-36F0C_O"M[32&JF>=_SL
M6,9"&>\PB'5>>J*9F,V$/6)T7&99@U@5/$=Y7=GJ/A1HYS60]T"P-8CBAP .
M9\4V&3H_<7- GU42^"./_=P_^K =8D*BYVD?![<CF*T-_0>6CGS(BNG7N9'-
M1]AL%-Q!-5<1H0G4_# >A>SH9S:,1@F>SM73JE+;^, N5&M9H;:"44#01AG$
MW=K&03[95@@OOX-$EK8.^P3'^F%@Y3N7EL6(Q,P;?#'TH("0>*.8=GRUK!I8
MA_B8 K:-OU\&)T@(%@M"N_H@G>[VH(Z@J?/6->OKR#E TVOJO/GZSPUU[E$W
M99C-"EM6DO4+;78 P@OBREW?]RQE\5<(PXYT=UH'<5 AE.'5IE0@7E->VU8#
MC>!&+:"<7-#U\NY3YUK+J:JE[K]JE6YY8QMMW]Y W=[;_>T2_6WT\L3BVI)?
MI]E.#" >/0&=WJ$S$%?%PF9M"6&U7%%*[&52=YYX$.MLV?WVPKWSN1+S+B(?
M=LX^=]6\J6950285K^C_!5$XA[J0K:J*3^%N>W1 3>XEC%U <>D[QD$B><D(
M_X\FYP M?'J][=B9['72SC\V+8&6>#5/T$[\W([#Q',S+[=E7G;=?PJ$O"A4
MRVO-TCAS4^J87NI&GN?<[.7ZOL_#'&=(Z@MN"A;/HHA8:Q.?/@9^1LTA\]W
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MH>PF'P:@NT[:+:S:^^ZU499ZH9_2<96HG0/M5TK9T\(EZ']GLW\ 4$L#!!0
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M;\#SPJ%QNQLVL/M0/?L+4$L#!!0    ( -2#.UD DO)D; (  (L%   9
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M:1W,_D8(?3#L 4W_C7X!4$L#!!0    ( -2#.UF_X8MWP 0  !4+   9
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M1E6=,A!4LF[_\Z<N#SL*J?>&0M I!!9WZ\BBO.0-/S_5:LTT2<,:/=A0K3;
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M+W=O<FMS:&5E=',O<VAE970R-2YX;6S%/6EOVTB6W_DK"IGL( 9H1X?/3G<
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M[6D7GM>RF87)9J9@2L/ON;'SHK)M36B!!2'T./.>=P3R?O0D$?41G#&9EA6
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MK7=V+77S5@"4O)M&M;D@[O4=1I<\*=]*M)^3DI&?"YZK0<JA>A'*"K9-M:Y
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MD=JQI)OKUDT(FCG^R"MMQ=B5MA*.(DI WD9!3;-0??B>:6J=H8JM7)(8263
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M8\,1+HDK_Q2?1[N3ZZ6JQ(-%:=* $JJ@H.*[BCOLH[- *,?P 6DF$"Z=]_2
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M:<(RA@%)LYS$KJ9]T@\*TH\".X&C>1!XKYB0>*=UOM^["Q3W$%UCN 7KD&O
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M=@'.SZ4TVXX-L/L',O@34$L#!!0    ( -2#.UF)780&1P0  -@*   9
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M2;[&U@V9P"?E)BO_NG_*_8LSU1O4U1N\N<G-69+E&,+3U7H6YY_[V0&\@6,
M(.'P!V>J^H^JT\2V*[_*E:I97==J<+<5*(FZ5?!2:#$#([[(A,C$PKYA =N
MC9"&C2-%3$R4GCU?-FZ$X4H@;,HW.$>MR@1P85]]Z?%S8R093_;Q:;G0?J--
M$YM1M361->A4I#I'TT;!U:*<J324%5(-'O5I/;8-JVGE(%[-?%.FD 8-.9^C
MJG,18FM5U1Q5;8Q<E;/+3!J<A,KE$D=/KJP WL\EYNEN8Q^HA]G!WU!+ P04
M    " #4@SM9C\_YUWT"  !:!0  &0   'AL+W=O<FMS:&5E=',O<VAE970R
M."YX;6Q]E%UOVC 4AN_Y%58V39N4-HD3TH]!)&@[C4GM4.G:BVD7)CD0JXZ=
MV4YI__UL)Z1, FZ(/\[[^#T''X\V0CZK$D"CUXIQ-?9*K>O+(%!Y"151IZ(&
M;G960E9$FZE<!ZJ60 HGJEB PS -*D*YEXW<VEQF(]%H1CG,)5)-51'Y-@4F
M-F,O\K8+]W1=:KL09*.:K&$!^E<]EV86])2"5L 5%1Q)6(V]270Y36R\"WBD
ML%$[8V0S60KQ;">S8NR%UA PR+4E$/-Y@2M@S(*,C;\=T^N/M,+=\9;^S>5N
M<ED2!5>"/=%"EV/OW$,%K$C#]+W8?(<NGZ'EY8(I]XLV;6R,/90W2HNJ$QL'
M%>7ME[QV==@1G(<'!+@38.>[/<BYO"::9",I-DC::$.S Y>J4QMSE-L_9:&E
MV:5&I[/9W>/-W<//^]G- GU^($L&ZLLHT(9L]X.\HTQ;"CY B3"Z%5R7"MWP
M HK_ 8&QU/O"6U]3?)3XH^&G* Y]A$.<'.'%?9ZQXZ6'\N0OP+60;^B:JIP)
MU4A OR=+I:6Y&'_VI=P"X_U VRR7JB8YC#W3#0KD"WC9IP]1&GX]8C?I[2;'
MZ-G"-%_1,$!BA6AGG8+:9_,H:+_- _3!1-D54WJPI1_8TMOZQX-Y(_/2W/T"
MU41JA0@O4"ZJ6G"C5>@CPOX0)SX.(S>.D]2/PW#P9!KRA/*36HH<E$+11>3C
M)$08QWZ<IH/9^]E.=Q8-_21I&</TPD_3%.TK9K!SWRN0:]?5RCAJN&ZO?K_:
M/QR3ME_>P]M7YY;(->4*,5@9:7AZ-O20;#NYG6A1N^Y9"FUZT0U+\_B!M %F
M?R6$WD[L ?USFOT#4$L#!!0    ( -2#.UF8.9&3/ ,   ,'   9    >&PO
M=V]R:W-H965T<R]S:&5E=#(Y+GAM;*55;8_3.!#^GE\Q"NAT2-;F/=GLM95:
MMBM +)3N CJ=[H.;N(U%8@?;V2[\>L9)7Y93J9#N2SRV9YYYQGD\'FVE^J(K
MQ@P\-K708[<RIKWR/%U4K*'Z0K9,X,Y:JH8:G*J-IUO%:-D'-;47^G[J-90+
M=S+JUQ9J,I*=J;E@"P6Z:QJJOLU8+;=C-W#W"TN^J8Q=\":CEF[8'3,?VX7"
MF7= *7G#A.92@&+KL3L-KF:Q]>\=/G&VU4]LL)6LI/QB)Z_+L>M;0JQFA;$(
M%(<']I+5M05"&E]WF.XAI0U\:N_1;_K:L985U>REK#_STE1C]]*%DJUI5YNE
MW+YBNWH2BU?(6O=?V.Y\?1>*3AO9[(*10</%,-+'W3G\3D"X"PA[WD.BGN4U
M-70R4G(+RGHCFC7Z4OMH),>%_2EW1N$NQS@S62S?+^;+^[]A^NX:YA\^OE[<
MSM_=PY_W=%4S_6+D&4QB7;UB!S@; ,-?  8AW$IA*@US4;+R9P /V1THAGN*
ML_ LXIM.7$#D$PC],#Z#%QU*CGJ\]%<E*Y2T,M\(+&HJ#%!1POQKQUO4FH%_
MIBMM%(KEWU.U#\C1:61[@:YT2PLV=O&&:*8>F#OYXUF0^G^=X1T?>,?GT"=W
M>"'+KF8@U]#N:NC)LSUY M1 (34:^/,T2K[HFJZFAI6H5*14<#K<!8RBC52&
M?^\73I5ZELSI4O\70^<L0V>J+2IJ@5DM.%8+5A"1<\WI1B B+XYIX#E$$0GC
MB*1Y/$R"."9AFCI+)$M541$\D0?L28._35>R1@K[[WL"1ZR4!'E.\C@X6LXM
M+2H\$?6?\B D?IH3/TF.EG/3*<%-IUCON^:/UM80D2P.29#FU@IB$N>Y\Y9A
M@ZED70)O\  ?F 75$*0D"D*2^S$$"4D3G_C(8=;QNN1B WF4DS2(]Z.3AB3Q
M,Q)E&:0!8F<D#E+$UOH*IK\K"<##R_)+$B<9(&Z2!9@T<IY#<$DR_Y+DH8\'
M&V(%,;++(CBE<.])8VJ8VO3M5Z, .F&&'G58/73XZ=#8CN[#\W!+U88+C;)9
M8ZA_D24NJ*'E#A,CV[[-K:3!IMF;%;Y23%D'W%]+:?83F^#P[DU^ %!+ P04
M    " #4@SM9G:Z1]YH$  #Y"P  &0   'AL+W=O<FMS:&5E=',O<VAE970S
M,"YX;6R=5NMOHS@0_\Y?,6(?ZDHT ?,(I$FD]+77TVXO:GNWNH\.<1*T@%EL
MFO:_O[$AD*9IKMH/;>SQS&_>PXPVO/PIUHQ)>,K27(S-M93%L-\7\9IE5/1X
MP7)\6?(RHQ*OY:HOBI+1A1;*TCZQ[:"?T20W)R--FY63$:]DFN1L5H*HLHR6
MS^<LY9NQZ9A;PEVR6DM%Z$]&!5VQ>R;_+F8EWOHMRB+)6"X2GD/)EF-SZ@S/
M!XI?,_R3L(W8.8/R9,[Y3W6Y68Q-6QG$4A9+A4#QYY%=L#150&C&KP;3;%4J
MP=WS%OU:^XZ^S*E@%SS]D2SD>FR&)BS8DE:IO..;/UCCCZ_P8IX*_1\V-6\0
MF1!70O*L$48+LB2O?^E3$X<=@=!^0X T D3;72O25EY222>CDF^@5-R(I@[:
M52V-QB6Y2LJ]+/$U03DY^6MV=3=]N+G]"I]I5IS!]<WM]/9"W;]=3>^O[N'D
M@<Y3)KZ,^A+5*:%^W$"?U]#D#6B'P'>>R[6 JWS!%B\!^FAG:RS9&GM.CB+^
M6>4]<&T+B$V\(WANZ[RK\8*WG"]82662K^ ZR6D>J],WACD6A[RML=S#6*IY
MAJ*@,1N;V!V"E8_,G'S^X 3VV1%+O=92[QCZY!Z;<5&E#/@26R'F:&N:4%W7
M2.&M'S1?P++U)56^0$&?L8OD09^.:CWLTV^98KPTQ?B7T5*5A6+$K#*=U2X=
M.@DP:[CWL],^&%@'/GP$WPHCW[(=#\_$\RS7<]53@ ]^X%A1$.Z2!T@F)+!<
MGX 3$)0=*'*(9"?RK,#WX?.'D#CD3)$C\*PP0(FP(S^L&0[ I60ED,@BJ-MQ
M[/9UID*52WBD:<5@D8B85W@]<=#$*$!K//@")ZYCV0,\&0]<TK1)%09RCM&4
MS^B(9UN1YU@>L?$2$-OR[0B.E)+?EI+_[E+:Z*'%%D ?,?0KA@E5@[RK'70Q
M.U0W[U-AO%>%T:5>$P6<PC.6B #'Z=E&G7_6"&R?2"\P?FS1IPWZY3;<=U2R
MU[!!SX-/>WAN+X!/1P(;M($-WAW8F&<%SW7QXJW6PY[P2RK8H7 >!?[_-NRT
M&?O:#/QVP;;;,$[;9E.E[:DYZNX'"=&$U$T5A%BQ=E@W6#BPW&@_%8IU:%PR
M-"ON9H!^6P#[526%ZE,$<*(0(9SN9-SDF'B&FE#F9?$GF"=L3]_UP$7%KMNT
MR/*5:M7NQ+<\1PT!XGK6 $? D4P.VDP.WIU)415%RI0;:$),Q1J6N,A DM<+
M4;V;I%35H.1-F1U*\5&-QU-L_*89;^;^0LD7-,$!C1PT4PTC$"M.*\67Y"#7
M##($J4JMLROBG20-X5 -M;8)6)8\V_D@-"V(P\QR U=-9EU9_F" ?Z'1#?E]
MB+T/FFBG?#?O/4.ODZ=\>5JAE>K;TY4?%8*I1IQ+'#RU?^PI7M,<YX4*0.T9
MGZ?)2D=2#%\/CH_@8G7AH'=5/Q KLHGEAX>KK;^SCF6L7.FE4X">2_5FUE+;
MO79:KW,=>[T4?Z?E*LD%6K%$4;LWP,%;UHMF?9&\T,O=G$M<%?5QC;LY*Q4#
MOB\YE]N+4M!N^Y/_ %!+ P04    " #4@SM9"L(BSR,$  !6"@  &0   'AL
M+W=O<FMS:&5E=',O<VAE970S,2YX;6RU5FUOVS80_JY?<5"#(@&86*3>K,0V
M8*=9FZ%-@]C=, S[P$BT+502-9*.V_[Z'25'45#'*+KM@\VCCO?</;P[DJ.M
M5)_U6@@#7\JBTF-W;4Q]/ACH="U*KL]D+2K4+*4JN<&I6@UTK03/&J.R&##/
MBP8ESRMW,FJ^W:K)2&Y,D5?B5H'>E"577V>BD-NQ2]W'#W?Y:FWLA\%D5/.5
MF OSJ;Y5.!MT*%E>BDKGL@(EEF-W2L]GD5W?+/@M%UO=D\$RN9?RLYU<9V/7
MLP&)0J3&(G <'L2E* H+A&'\O<-T.Y?6L"\_HO_2<$<N]UR+2UG\GF=F/7:'
M+F1BR3>%N9/;=V+')[1XJ2QT\P_;=FV4N)!NM)'ESA@C*/.J'?F7W3[T#(;>
M"P9L9\":N%M'391ON.&3D9);4'8UHEFAH=I88W!Y99,R-PJU.=J9R<?%NZL[
MN+Y93&_>7L_>7\%T/K]:S.%XP>\+H4]& X->[-I!ND.<M8CL!43*X(.LS%K#
M596)[#G  ,/K8F2/,<[80<1?-]49^!X!YK'@ )[?<?8;O.@%O+=29MN\*(!7
M&5Q7AE>K',G"5&MA-+S)=5I(O5$"_IS>:Z.P<O[:MP^M%W^_%]M-Y[KFJ1B[
MV"Y:J ?A3EZ_HI%W<8!#T'$(#J%/YMB=V0:#EDN09BT4Y$]$>$.$0(5-C7J>
MIIMR4W C,N"E5";_QFU+[.-TT.M^3O]%*,Y46S5F6MA,.S;3-MV^<\GKW/ B
M_X866B[-EF->,O& QTF-AX.!5&I,VA'$Q/,",@SBONS<HJL*]3;5J:R_*MNE
M&D+"PH0,*44I"!GQ@]"YD=5I*LM:F+P],%9*B+*Q#@@-/<3TGB3GLFE.9*M$
MT7#0Z[S6X)/$:Y=V$K(A/@U(% Z1$PF]F-"$.>^%UN<P?6%'@,8D" +B^X$5
MO3@D/HN=(V!D&",>[L\1N@A\2H91" =**NQ**ORW);6O8@Z"_G3%P$)BUJ&?
MOLNG]'5[?]??>ULUH=V5$/=DR%"BG<2Z5+ (?#\A-$Z [L:>,@:?19@B!G0W
M]I1#5'J$^5;9CCUE C[UB1>B<C<^*A?(4/"EP7@I830A01Q#Z&%"J0<Q%@:-
M8N?C"_MPVK3.\[13+,((?W$C[Q .E4#4E4#T?Y3 0= ?+ 'G.T\.7KN *OA#
M<'4J[&6R[X"8\8)7J8#7KX:,T@N8B55>57FULM#6]%F?6#GV?*R*T)F6<F.+
M*^T=,3ZS*DQA0L*8=L?'5N4&)81<PC%C>&C0!$Y:G^S"(CTU[K$?)9CW&/7'
M?D))F% X^2Y,O!Q[ ?YX4P]Z=SUVP*IYT2 '2Z6]]KNOW:-IVKX5GI:W+ZX/
M7.%6:2C$$DV]LQA;6;6OF'9B9-V\'.ZEP79KQ#4^_(2R"U"_E-(\3JR#[BDY
M^0=02P,$%     @ U(,[6>FQV  / P  S@8  !D   !X;"]W;W)K<VAE971S
M+W-H965T,S(N>&UL?55M;]HP$/[.KSBET]1)4>.\D*0M($';;4PMK4JW?9CV
MP< !T9*8VLY8__W.3IHQB>8#V.>[>^XYOSP9[(7\I;:(&OX4>:F&SE;KW87G
MJ>46"Z[.Q Y+\JR%++@F4VX\M9/(5S:IR+V L=@K>%8ZHX%=>Y"C@:ATGI7X
M($%51<'ERP1SL1\ZOO.Z\)AMMMHL>*/!CF]PCOKK[D&2Y;4HJZS 4F6B!(GK
MH3/V+R:1B;<!WS+<JX,YF$X60OPRQG0U=)@AA#DNM4'@-/S&*\QS T0TGAM,
MIRUI$@_GK^@?;>_4RX(KO!+Y]VREMT,G=6"%:U[E^E'L/V/33]_@+46N[#_L
MZ]@^<V!9*2V*)ID8%%E9C_Q/LP\'">E;"4&3$%C>=2'+\IIK/AI(L0=IH@G-
M3&RK-IO(9:4YE+F6Y,TH3X^N[F=/C_>WM]/9)QC/KF%V/SM<FLZ>;AYOYD]S
M.'WBBQS5AX&GJ:Q)]I9-B4E=(GBCA!_ G2CU5L%-N<+5_P >\6U)!Z^D)T$G
MXI>J/(.0N1"P(.K "]M-""U>_ ;>3)1+8BA%3IX-3$N-$I6&'^.%TI(NSL]C
M7=>8X7%,\Y@NU(XO<>C0:U$H?Z,S>G_BQ^RR@W'4,HZZT$=S>IRK*D<0:_A\
M?0<%%@N4"O"YRO3+,;:=>,?9=A?IT2E@>PIP:(6]JYPK!6.X:U)J>]+8T.WN
MW9/DF(-HW.]/TL!/+N'&UH73=Y"X+#EW@_,0/L [Z$=NDOINZH?&%[FL'[II
MV/@8A044'O;F6RYM+S/2NBF=>($4$+I]8LT"G^8!<Q/6=^/4&FY"R4G$:.ZG
M;M^GR(CU)M4+:9N!*?^_-5ES:Q18OL'E6V/O.J-;E2TJ(TO*4*:2Q"$,8TOY
ME"K%\3G](K*M.TEBEV2V<5.' 75H[!X]J<Z=.G=]VJF8I38W-KN4T.:PSET\
M=D&] XTI4&ZLDBI8BJK4M=RTJZU8CVN-^A=>*_T=EYN,.L]Q3:GL+.D[(&OU
MK TM=E:Q%D*3_MGIECXX*$T ^=="Z%?#%&@_8:._4$L#!!0    ( -2#.UG_
M53 I>0,  -8'   9    >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;*55;8_:
M.!#^SJ\8I55UE5+RRLMN 0E8^G)B=]'"W:D?33) U,1.;0=V__V-'<AQ.I:K
M5&G9^&7F>>;QC#V#@Y#?U0Y1PW.1<S5T=EJ7MYZGDAT63+5%B9QV-D(63--4
M;CU52F2I=2IR+_3]KE>PC#NC@5U;R-% 5#K/."XDJ*HHF'R98"X.0R=P3@M/
MV7:GS8(W&I1LBTO4?Y0+23.O04FS KG*! >)FZ$S#FXG'6-O#?[,\*#.QF"4
MK(7X;B9?TZ'CFX PQT0;!$:?/4XQSPT0A?'CB.DTE,;Q?'Q"_V2UDY8U4S@5
M^5]9JG=#I^] BAM6Y?I)'+[@48\-,!&YLO_A4-MVB3&IE!;%T9GF1<;K+WL^
MGL.90]]_Q2$\.H0V[IK(1GG'-!L-I#B --:$9@96JO6FX#)NDK+4DG8S\M.C
M^>/#YP^KV=,]W,TF*Q<>'E>S)2S&W\:3^0S&#W<P'2^^KL9SF,_&2]KZ;<76
M.:KW T\3O0'QDB/5I*8*7Z$*0K@77.\4S'B*Z;\!/(J["3X\!3\)KR+^7O$V
M1+X+H1_&5_"BYC BB]=][3 $WW[0* NXP[6&!Z%1P8*]&,4PYBE,69EIEL,<
MJ1#4I2.H":++!.:&W:J2)3ATZ HIE'MT1N_>!%W_XY7PXR;\^!KZ:$DW-JTH
M5+&!O)&2DA07N-52'K4PTI(<M>2O:KG*=EG+KX30,EDTJ8Q:YN0;2XD_JDQF
M? N%*9_\Q>S0NZ"58<DX4:#2P.@/)-.6NP=A[$/LQKT0'A,MUB@-<A>BP'?[
M80_>0A!$[@T9T:C3=_MQV%KM#-E>Y'M#EDA,,VVCA@-3@,\:3=V"%E09>RP,
M9A#7Q=<&XSP51<GX"^GBL!;2I*\JC3UQ^*[OVQ_TVQUX]Z8?!N''T[=U"N84
MRAR5NH5I)27IA%)(^X3%/0(((8[<7K?7>@O=KGL3]:V6CNOW.G"EB#I-$75^
MNHCHT:MDIC-4_\WGI8*YBOS_!7.-KO4-F;0OA\D-77PT%]^43(?TUP?3LAGN
M^&X<]\VX!T'7C6_\EKW7*X)JV7O]N*?,?:)F #6H*45*'_6T#?&=E<:EX_3.
MWMH"Y=9V% 6)J+BNG]UFM6E:X_JM_L>\[GCW3&XSKJC\-^3JMWMT?K+N(O5$
MB]*^W&NAJ0_8X8X:+TIC0/L;0<5YG!B"II6/_@902P,$%     @ U(,[6<YC
MP\=5!0  LPP  !D   !X;"]W;W)K<VAE971S+W-H965T,S0N>&ULM5=;;]LV
M%'[7KR#<"QR M4E*U"5-#.16K .:!DG6;1CV0$NTK54679**D_WZ'5**XK:J
MESWLQ:3(<S_?.3P^VBK]V:RDM.A^7=7F>+2R=G,XG9I\)=?"3-1&UG"S4'HM
M+'SJY=1LM!2%9UI74T9(/%V+LA[-COS9E9X=J<9692VO-#+->BWTPZFLU/9X
M1$>/!]?E<F7=P71VM!%+>2/M+YLK#5_37DI1KF5M2E4C+1?'HQ-Z>!H[>D_P
MJ91;L[-'SI.Y4I_=Q_OB>$2<0;*2N742!"QW\DQ6E1,$9GSI9(YZE8YQ=_\H
M_9WW'7R9"R//5/5K6=C5\2@=H4(N1%/9:[7]27;^<"<O5Y7QOVC;T9(1RAMC
MU;IC!@O69=VNXKZ+PW,86,? O-VM(F_EN;!B=J35%FE'#=+<QKOJN<&XLG9)
MN;$:;DO@L[/WEV<?/UR@VY/?+F[0^%;,*VD.CJ861#N":=Z).6W%L!^(H0Q]
M4+5=&711%[+X6L 4;.H-8X^&G;*]$G]NZ@D*"4:,L&B/O+!W-/3RXA\Y6N=J
M+=&MN$?GI<DK91HMT1\G<V,U0.//(9];B>&P1%<NAV8C<GD\@GHP4M_)T>SU
M"QJ3MWOLC7I[HWW29S=0?D532:06""S?J%K6UK@ONY)HH]5=Z0L#ZA*5K6]6
MW$LSY,=>3<-^#*L/_E5]\+L4ND,!@AQ*E\/@K-$:^ ]],MU/&+R3A=2B0B]1
MQ#*<)B'L7K](&65O@QLKK$049U&(>9JBF#/,&0UNFKE5%I@8#I,01S'MK\[E
M0H*.XK 77'0GK5W PE...>6P2Q*"LY1T>KXE)!G.,@9KBGE"=I4F&4@@">RR
M),.<D^"J#\3X5-9R4=H#'Y(GM('$-^@2NNM+Q#&-4YS%*>Q#'(<,DX2B/5CA
M/5;XL[&B9:[JO*Q*X;L>G"RZ@!CPMK%*/^PD#&D7 :M\CD7]X#.0O#5(+A;2
M-\R>:@A8SS8K^-_,&@;<$\[:% @[H,\K871"T*MNZ1 AZ@)5*@?B76BC\;Q+
M,48U)'3'A^X")1,*LKC[#2Y5_09\MEI5$)@EB+(2RLNB,9^$Z. 5&D>3&-;@
MXGY3ZCXLSJ\<T%A"L;,)<Z9-4A!W+6VC:Q>3I^(3Q5_P0JQ]8^AJ!^C'S,L/
MSE:B7DK0ZTOV3E1-JT14\!*+.I=H3$"!LX1,N./X"(0:]+F 4#@"V_IX?YL<
M%CNS$ L=]1X,QSV&X__4[W:SOENA2!@CP5^?HU+, 5*V'&Y[>Q4^K^WM6!$\
MPXI@ (#GW[,=!B=]#ERW:/,-D(-;XYM#%D-/I)G?AS'!*<D\H #D#>0#7FF8
M9W+=B,J@A*<X(00E),$1(8%K-C"T.4@!['*A]0,HV0I=&!1F,2:NN>$$6E$:
M1:X^>KQ1'+(0$YJZ#I=2S&@4G(E-"=VO_!L\<&$2.E]YMPMY!R/=QJ$/)9%3
MG: 0S(X3'OC9SL6P,?*K4$D8H'8#ABB-,*4QK* R3(/W]1T(5-K?D1@>A@Q6
MCD-*GB+I;#YII;Y!2PUA0Z"?@FLA!6HP)<8T(\&G(<S3S#T 4'EH',819B%!
M!\&M[_!#&4XP@Y@PSIU@$L&C%/NV#P&V#]XI^:4IVS"T80$TY5V;&[,XP120
M ,HHIYA C [ 1PN5Z9((/862"$>A-X?!<Y=P.FS.;M#&84(QCXGW(8N *04F
ME_?O/0 (011!=YQQV$-^(%< S,%W9[HS2*ZE7OIQV4 E-+5M9\K^M)_(3]I!
M](F\'><_"+TL:P,I7P KF23P5NAV1&X_K-KXL72N+ RY?KN"?Q52.P*X7RAE
M'S^<@OY_RNP?4$L#!!0    ( -2#.UD\4*=7'0,  )(&   9    >&PO=V]R
M:W-H965T<R]S:&5E=#,U+GAM;(U5VV[C-A!]]U<0:E&T@!I1%UMQ:ANPTQ3K
M(ML-[&S[4/2!ED86L12IDM0Z^?L.*5E- <?HBW@[<^;,##E:G)3^8FH 2UX:
M(<TRJ*UM[Z+(%#4TS-RH%B2>5$HWS.)2'R/3:F"E-VI$E% ZBQK&9;!:^+TG
MO5JHS@HNX4D3TS4-TZ\;$.JT#.+@O+'CQ]JZC6BU:-D1]F _MT\:5]'(4O(&
MI.%*$@W5,EC'=YO,X3W@=PXG\V9.7"0'I;ZXQ;9<!M0) @&%=0P,AZ]P#T(X
M(I3Q]\ 9C"Z=X=OYF?T7'SO&<F &[I7X@Y>V7@:W 2FA8IVP.W7Z $,\4\=7
M*&'\EYQZ;(K@HC-6-8,Q*FBX[$?V,N3AC<$M?<<@&0P2K[MWY%7^S"Q;+;0Z
M$>W0R.8F/E1OC>*X=$796XVG'.WLZM/SAX<=N?^\VSW\]DP>M^O-]G'[O'W8
MD^^?V4& ^6$16?3CT%$Q<&YZSN0=SC@A'Y6TM2$/LH3ROP01"AQ5)F>5F^0J
MXZ^=O"$I#4E"D^P*7SI&G7J^V3M\3^S5!T>8+,FZ*'3'A"%_K@_&:KPG?UV*
MN6=,+S.ZMW-G6E; ,L#'84!_A6#UW3?QC/YT16\VZLVNL:_V^!;+3@!1%5&V
M!HU70VN0E@C.#EQPR\%<$GV5]K+H_^5K@A4!5Y&)JX@K2SKQ>822&":81DQ(
M"M4TW+CWVV>Z9:]:"4$L>\'<?TNR<);GX6Q._3R+TY!FV63/7&40X_"N3"2>
MYV$:YS@Z1#S96V:!<(G\,)"-T#";Q6&:SDAV&Z;3=/((1R:\]SZ85JL*O";<
MK@!-XSA,:#X,+@K52<OE\7PZ#V\I)3&E(:5TL@=1_5AU[F*3&IBP-0HQG6:R
M #(DD<0)ZLBFWFB>QV-JN+2 &-MG U""?25I.$VS_COYY#5B *@^CRF9YKB?
MG_<O% (SEX?S+ YI.L?Y%-VF88XEN73KHC=]H@%]]-W0$!]PWS+&W;'AKOL^
M\R^\[]8?F3YBW$1 A:;T)I\&1/<=L%]8U?JN<U 6>YB?8KI*T Z YY52]KQP
M#L;?T.H?4$L#!!0    ( -2#.UG](?PPZ 0  ($+   9    >&PO=V]R:W-H
M965T<R]S:&5E=#,V+GAM;*U6;6_;-A#^KE]!N&O1%(0M4A(EI8D!)W&Z#$T:
M).F&8=@'6J)MHA+IDE2<]M?O*-FJ.SA)A^Z#99&Z>^[NN1?R:*W-)[L4PJ&'
MNE+V>+!T;G4X&MEB*6INAWHE%'R9:U-S!TNS&-F5$;QLE>IJ1,.0C6HNU6!\
MU.Y=F_&1;EPEE;@VR#9US<V7$U'I]?& #+8;-W*Q='YC-#Y:\86X%>[CZMK
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MBA=]K)A(EN6MX(%)U5CR8:1:/W)MH/87C,GM1!]0_9GH_0%02P,$%     @
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MM3>)_=>(?4/Q3?X%X)$KQ>/\<@UT 2+KH)\O.5<OC>RC0O%-J/<#4$L#!!0
M   ( -2#.UFJ=QYXU ,  *T0   9    >&PO=V]R:W-H965T<R]S:&5E=#,Y
M+GAM;+58;8_B-A#^*U9ZJNZDWB;.*]D"U2Y[>Z4Z6+3<]E15_>!-!D@OL:EM
MX.[?G^-D X$0%2G[A=C.S..9QP]FAOZ.\:]B!2#1MRRE8F"LI%Q?FZ:(5I 1
M<<760-6;!>,9D6K*EZ98<R"Q=LI2T[8LW\Q(0HUA7Z_-^+#/-C)-*,PX$ILL
M(_S[+:1L-S"P\;+PF"Q7,E\PA_TU6<(<Y--ZQM7,K%#B) ,J$D81A\7 N,'7
M(^SG#MKBSP1VXF",\E2>&?N:3\;QP+#RB""%2.801#VV,((TS9%4'/^5H$:U
M9^YX.'Y!O]?)JV2>B8 12[\DL5P-C)Z!8EB032H?V>YW*!/R<KR(I4)_HEUI
M:QDHV@C)LM)919 EM'B2;R41!PXJT68'NW2PCQW<,PY.Z>#H1(O(=%IW1))A
MG[,=XKFU0LL'FAOMK;)):'Z,<\G5VT3YR>'\:3*Y>?P+/=RC^?CC='P_'MU,
M/Z.;T>CA:?IY//V(9@^?QJ/QASEZCV9$)D EN@= C[ %NLF?$5O21)_)>_3V
M#B1)4H'P.S5[FM^AMV_>]4VI(LWW,Z,RJMLB*OM,5-A&$T;E2J /-(:X#F"J
M%*L\[9<\;^U6Q#\V] HYUB_(MFRW(:#1_W=W6L)Q*MH=C>>?P;M+!%DN.2R)
M)HXM*C[__J1,T5A")OYI(J[ =9IQ\R_]M5B3" :&^E8+X%LPAC__A'WKUZ:D
M.P*K4>!6%+AMZ,.INJ,:!-64<P'D:J#\7MH.':>'O2#T^^;V,)]30SL,0B<,
MG<JP%JM7Q>JUQCIB608\2DB*QE1L.*$1F&A"J+KI8C0B7)W;!+)GX(UGU@I^
MZ9EU!%;CP:]X\%])MGZ7%'0$5J,@J"@(NI)M >0=J-$-/3O ]I%J&^RP[?JN
MWRS:7A5IKS72"<1)I*1I%H,D;M5H*]:E!]016"WML$H[?"6-AEU2T!%8C0)L
M[7_5K:Y46B(=R@]C=;T&QY=KDZ'E.[US.L4'-0ANC?:+JO2 B]^0NF=5?2KT
MR9DSM<2HOG+_W?#OK>IMW^#2L^L*K4Z'O:?#?B4%E\!=T= 16IV&?8F$6\N/
MBS3LG$C3MOS <7O.L8A/+7'/#RP+AV=4O*]G<'M!\R!7P-M5V@IP\?%TA%9/
M=U\28>^U5-II/=056IV&?46$6ZN-BU3JGY2G@>5AU_:.17IJZ(6.Y_;L(XV:
M!XV?*E"7NA\6*&(;*HO>J%JM>NX;W6D>K=_FO;AN*/<P12,_(7R94(%26"A(
MZRI0=/.B-RXFDJUU>_G,I&I6]7 %) :>&ZCW"\;DRR3?H/J'8O@#4$L#!!0
M   ( -2#.UF0R!YO4 0  "T2   9    >&PO=V]R:W-H965T<R]S:&5E=#0P
M+GAM;+58;7.C-A#^*QK:Z=S-M &)5Z>V9Q*27'W3O$R<]*;3Z0?%*#830#Y)
MCN_^?27 @(TL)TTN'V(0NP_/+KO[@(9KRI[X@A !ON59P4?60HCEL6WSV8+D
MF!_1)2GDE4?*<BSD*9O;?,D(3DJG/+.1XP1VCM/"&@_+M1LV'M*5R-*"W##
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MY_T#%8+FY>&"8#DYE8&\_DBIV)RH&S0[1./_ %!+ P04    " #4@SM9#8)
MRB0'  #]+   &0   'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6RU6FMOVS84
M_2N$-PPMT,82);^RQ$ B-9V')C7B9L-0] ,M7]M$)<HC::<&]N-'/6)9EDP_
MRGQ)))D\XCWD)<^A>/4<\^]B#B#1CRADXKHQEW)QV6R*8 X1$1?Q ICZ91KS
MB$AURV=-L>! )FFE*&QBRVHW(T)9HW^5/AOR_E6\E"%E,.1(+*.(\/4MA/'S
M=<-NO#QXI+.Y3!XT^U<+,H,1R*?%D*N[Y@9E0B-@@L8,<9A>-V[L2]]I)172
M$G]1>!9;UR@)91S'WY.;P>2Z824M@A "F4 0]6\%'H1A@J3:\6\.VMB\,ZFX
M??V"?I<&KX(9$P%>'/Y-)W)^W>@VT 2F9!G*Q_CY#\@#2AL8Q*%(_Z+GO*S5
M0,%2R#C**ZL61)1E_\F/G(BM"KBWIP+.*^!C*SAY!6>W MY3P<TKN"DS62@I
M#SZ1I'_%XV?$D](*+;E(R4QKJ_ I2_I])+GZE:IZLC]ZNK^_>?P'?;Y#H\''
MA\'=P+MY^()N/._ST\.7P<-'-/S\:> -/HS0&Q\DH:% #X1SDG37VZNF5&U(
MD)I!_K[;['UXS_MLC.YC)N<"?6 3F)0!FJKQFPCP2P2W6(OXYY)=(,=ZA["%
M7?0T\M&;7]\B,2<<1$W[O./1G,-H_B&T\ )9.$7#+VB:F)U-KSDI;GL/[I#'
MDV4@T8!EF9]DT-=/JA :2(C$M[I^R1"=>L1D>KD4"Q+ =4/-'P+X"AK]WWZQ
MV];O=22:!/,-@968=#=,NCKT_KV:&B4PP@) A$W45+8@E"/XH2964=OEMQF@
MFP(FT^JJCWMNU[*LJ^9JFZ.:<EW+KI3SM0T\,_S6)OS6@?"9FMW5/"X1F7%(
MKX2:@N0<!7&T(&R-9"Q)B"*8T$#]7_!DI@[JF<G>U=J.&.^0HFW.J0/'$%B)
MN?:&N;:6N5% & .>DQ4=YC%^9C!!X[4:8B&1ZG)!N%S7T=BNT.CLL*AMVJDL
M&@(KL=C9L-@YC\42=6$<I(Q1AIA2$FNE))"0ZE$=>YT*>W9OASYMFTZESQ!8
MB;[NAKZNEKZOF4*X5.O!BB923&FA6S+Q82SK%X%N94ZRNUULM>T=AKH5$ELM
MVW$[[9VY2]N\,X/O;8+O'15\,8?= 3Q" '1%QB$H*IY8GFM#E6H4Q'NKEA3M
M:TY=&4V"^;U*=SF.:_?PUH@N46=;A>RS?I*\QV.HT[_E5.Z,HODYVO8@[K8M
MW-H:[&7RMC2S?11Y-T$0+]5$7_ V4HU2JZ.G)&ZR4(H'D/N8T[[B9.9,HODY
MVO:X<QVGU6NU]S"'"^:PEKF;R0K4>!*4S="'3&/5DH,K7==QJM+)JRG7ZEA5
MB:5OU9GSE%VH=5LK8?M#)3##)(MJ8W6J.M%R77<WU&HQQ[9W]96O;\FYD19J
MVM;+:37P50>GFP+Q%'DA$0)YR(NC2#T9R3CXCO[;[Z9N<_32XHT[+:M"QG'E
M?'UKSV6C$->V7EU[1,S1!!:QH+(VW%:E3UM.M^O4#'2CNMD46IF60CG;>NE\
M!Q/@) S72M"))5?"+J01E?4CHEW-CE8UPSW]*T\FZ#4TL5V(8ENOBA]A!6P)
MZ!98,(^(4KM?[R$: _^FLL=+UQ[@*JN4:4W6F=3^/U)1*I8OWRA?OS<_U9)L
M4A![1M%\4VCEKB@$MMTUOM-B&U+%.9TFT7Q3:&4Z"\ENZS5[><QR-6;?H07P
MY)F2H;5D9H"VO34#6!?V[K["<<5\??/.#!\7JAOK5?=K)/9]OC,S?-F9T::Z
MOH&GCDVC:+XIM'+G%*H>V\93'1M5\4;1?%-H93H+J8_U4O_T5,\!#Z7ZGF([
M>V2^OGGGAE]H?JS7_#XE,Q8+E9%H$)%98GCN2$!#*M?Z!#6Z3V\4S3>%5J:T
M,!?8-9^@AAQ 3J=)--\46IG.PIW@ ^XDWZ18JL5C"FK=4*PBD6U@",2!*96N
MUIF(,AHMHUIRJ_ZEZU:UN;X=)[/V&N8%%^8%Z\W+L:R1'WM9JUH:U^W4T&;4
MTIA"*]-66!JLMS0#)B%,/O8O4ZD2JY7@T$1HU)081?--H97)+$P)-F]*L%%3
M8A3--X56IK,P)5AO2N[4#"?A?4A7Z3<F2=B,CD- 1 B0[]!2P'09HI!.ZU6+
M'MQNH3407G\4P>C' E-HY1,)A;=Q]-[F0>F].%J !'13? +59;@>\.0C"4:]
MB"FT,IF%%W',>Q''J!<QBN:;0BO367@11^]%?B[##X!W]B>XON;))+Z&HW&V
MSASI'<UF?R+=@5 C4LSIXD"&FSUT9/;4T6N8&:<P,XYY,^,8-3-&T7Q3:&4Z
M"S/CZ,W,3V:X'AQ;FA0W:FY,H64L-K?.A:K$G:7G:P5*/UIG!RPW3S=G>&_2
MDZL[SV_M2R\[B5O 9 >#[PF?4290"%,%:5UT5  \.VN;W<AXD9X^'<=2S1[I
MY1R(,DE) ?7[-([ERTWR@LV)Y_[_4$L#!!0    ( -2#.UG4O-]F9@(  .L%
M   9    >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;)647V_:,!3%OXJ535,G
M5<T?0D*[$"E NG8JM +:/4Q[,.$"5ITXLPUTWWZVDT91F[;:"_&U?<[OW 0[
M.C+^*'8 $CWEM!!#:R=E>6';(MM!CL49*Z%0*QO&<RQ5R;>V*#G@M1'EU/8<
M)[!S3 HKCLS<'8\CMI>4%'#'D=CG.>9_1T#9<6BYUO/$G&QW4D_8<53B+2Q
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MNJ$_\/T7/+MU=O4U.,5\2PJ!*&R4TCD+56!>72U5(5EICO.*274YF.%.W<;
M]0:UOF%,/A?ZAFCN]_@?4$L#!!0    ( -2#.UDN,K<".@4  #@9   9
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M)'9F.RW\^]E.B ($Q,->&E_[GN-S;G-ODAT7=[( 4.B^*IF<.(52]8GKRJR
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ML4AD?\$VO];S+3!;"\GBHE@EB&F2?^+GXD;L%2#44("* I3ESD%9RDLL\6C
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M,!4@KR\H%<\#]9I>?I;Q?P%02P,$%     @ U(,[6?04_;M0!   71@  !D
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M3Q23K-@H/L^'P9@K/5KRY4P/?Q#&0+^?<*XV&Q.@_#L1_P%02P,$%     @
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M[FXXVR.N1RLT_:*DJ[16%SC)=&0]2:Z^392=O%O</_[RY?Y7]/3EM\6_T;N
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MZEFA!>9T03:QO&?;S]0$E!&<L5ADOV!K;*$%9ALA66*<%8,D2O-_\LLDHN2
MW ,.CG%PCG7 Q@%G@>;,LK"&1))^E[,MX-I:H>F'+#>9MXHF2O5KG$BN5B/E
M)_N#V_'#_>WU]6C\"5R,AV!\.RY/C<8/5_=7DX<)> \^#V] 0I,IY0+0QTTD
MG\';(94DBL4[LWR53W^_R<Q^J-DODR%X^_I=UY:*K-[2GAEBESDQYP"Q?S?I
M&<#P'^! QVUP'QSOCJONMDI1D2>GR).3X>%#>6))HJIN$!,AP$4185-<K4#Z
MLSP7:S*C/4M]=X+R)VKUW[Q"/OS0%.6)P"HQXR)FG*'[!V(>LW3&4LE9K%:6
M8)1*JC:1X/NU,@0C21/1F !\R@2<"*R2 +=(@-OZTF^56.K(;TS5Y^7=%'*.
MXV8X6CF?^@$,.DY'E=Y3.9JZG0L]'.*=786H5Q#U6HE.5H13P!9@K(1_I-Y:
M0IM8YB!>:7?L80@=M,>R;N<$'@Q<V,S2+UCZK2PO-\^JD6B::;6R(E-9HHFT
M7R,#]^BV652(!@71H)7H,!*21].-;C2-G(+:CIZ/(<;^'K,&NR#P58MMYA<6
M_,)6?E?I_+BR#&O[=U#0\6&XQ[-NMU^^%9Z=@F?G>-&\;!7-5J#_JQDG JO$
MC."NH\*_(IL&]D0Y.!5:-0FE8P4ZD70:H,I'X@8A"M&^>#990J?CP.! G:)=
M=T?M[?U( 34H%66$ ?3\<%]"&RQ1Z"'L'1)1M.O*J+7G_:&,&M V'6TUJ9+=
M=5#4WD+_4TJ-?WG3]PC[?L?WW7U^3::N.M^%AP05[1HH:N^@1TNJP2FW<%_5
M:A#B6CKKEK7"SMG:I?.[OCS=$+Z,4@%BNE"N\"Q02#R_C^0#R=;9D7[*I+H@
M9(\K=8>C7!NH]05C\F6@;PG%K;#_&U!+ P04    " #4@SM9A.0;<88%  #Z
M(@  &0   'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6S5FEUOVS84AO\*X0U#
M"J31ARW'SAP#B:4N'A(G2-KUHM@%+=$648G42#IN@?WXD9(L6;',1!LOUES$
MDDP^AWR/= X/K<F6LJ\\1DB ;VE"^&4O%B*[L"P>QBB%_(QFB,AO5I2E4,A3
MMK9XQA",\DYI8KFV/;12B$EO.LFO/;#IA&Y$@@EZ8(!OTA2R[]<HH=O+GM/;
M77C$ZUBH"]9TDL$U>D+B4_; Y)E542*<(L(Q)8"AU67ORKD(W+Q#WN(/C+9\
M[QBHJ2PI_:I.YM%ESU8C0@D*A4) ^?&,9BA)%$F.XZ\2VJMLJH[[QSOZAWSR
M<C)+R-&,)I]Q).++WJ@'(K2"FT0\TNT-*B?D*5Y($Y[_!]NRK=T#X88+FI:=
MY0A23(I/^*T48J^#ZQ[IX)8=W+=VZ)<=^F_M,"@[#%YTZ!^;@U=VR*=N%7//
MA?.A@-,)HUO 5&M)4P>Y^GEOJ1<FZD9Y$DQ^BV4_,9W=+SX^WM_>SA>_@:N%
M#Q;WB_U+\\7'X#%X^O@$3GPD($XX6$#&H/+N._ >W/AWX,L=2I>(_3FQA!R0
MPEIA:=POC+M'C#LNN*-$Q!P$)$)1$V#)F533<7?3N7:UQ-\A.0/VZ!2XMN.!
M3T\^./GY7<O 9GK,![0\ TX_Q_0U&/^5T6SD:/JVPK@Z3*#'W$$F)^4U1P/F
M1* U8AK1^M4]T,_YPV/W "6<)CB"ZM$]!;>(<R!B2,#GF";)=W"_)2@"3YLE
MQQ&6T>04/$"&B,B_8#S&63X8AK@X!<%J)6, !W0%9I*Q1OP4+&3 ^W(KK8*Y
M0"EONU.NBR'VVX>HPN4%SV"(+GLR'G+$GE%O^LM/SM#^M<V[)F&^25A@"-;P
M\Z#R\T!'GSYL6!C+H*I\PP4D$=ADX.YQ#D*DW,?!W^TW5>$@+;NK@TS"?).P
MH(!Y.4QEV6<9I2;6<XOL7B6[]V;9J8@1>[OF6G!7S4W"?).PP#O0_(CDPTKR
MH59RE9:RG>P9PR$"F(3))D(<A#+:X0BQ/-H!08%</JD+LL6SC&"4\39/:.UU
M]81)F&\2%A2PP?[=[]GJK]T?YY4_SM_NCQ6C*;A!,!$Q\#%<$\H%#CDXN?'?
M'4F0UUI\5_E-PGR3L.#\X$'H>V.-_J-*_]&K^N?Q1N9QN&8(I2I]RS(C?QKD
MFAJ3-5 )@5#R/J1IA@0NUO%5XR..T=KMZAB3,-\D+!@=/!<#1^.7<>67L=8O
MLP3*M=8UD"LPP>1:2[EAMY3BNH7UM9;;57>3,-\D+# $:SC'L>O:R/[_+XS+
M,1IRM5&:;Y06F*(UO;U7"3O:A[%V&BZ=IGREHB$DWUL]H^5U]DQ9J-M[0<8^
M\VRO"C&EYB:M!J9H3<W=6G-7'P +=54:$@PO-^I!:Y5:B^DLM7L0SF6%WHSG
MI=@F[0:F:$VQZS+?T5:79;:Y^A?91@_N++_1\MPH+3!%:[JHKM"=P0^0<8R6
M^D9IOE%:8(K6]':],>#H=P:Z9QRO+4<,[4$S;,WT=CMKWFKUW!XUK0:FK#;5
MK&M^1U_T[^^SX"JLY=5F&?E.08:8VGB!:]0J;V' <1H3=5^*:[1\-TH+3-&:
M+JC+?$=?Y[_N@E;9SP^KJ_&Y8X\/;FNCE7N+66\P/%@#!*:L-C6M2W='7[O_
MAZQMM#@W2O.-T@)3M*:+ZBK>&?\ 6=OHEH!1FF^4%IBB-7]AK'<%7&T=>B1K
M:W>/]<2NOBEI+_+Q8/RR4FQOYXY?)+3 U.B:>M9UMZNON^<[Y5ZM O6@SC(Z
MAYO=XU%;%6C4;F"*5LAM[?WVGR*VSE^Z4%)NB"A> ZBN5B]V7.6O,UAU\^*M
MD#O(UIAPD*"5["I7>'(]QXH7+8H30;/\38(E%8*F^6&,8(28:B"_7U$J=B?*
M0/6ZR_0?4$L#!!0    ( -2#.UFK,8PP' ,  "\,   9    >&PO=V]R:W-H
M965T<R]S:&5E=#8P+GAM;+67;4_;,!#'OXJ531.3@#PG+6LC]6E;IU(J6C9-
M:"_<]MI&)'%FNRU\^]E)R!(($4CA#;'CN__YYYRO1^=(Z!W; 7!T'P81ZRH[
MSN,+566K'828G9,8(K&R(33$7$SI5F4Q!;Q.G,) -33-44/L1XK72=[-J-<A
M>Q[X$<PH8OLPQ/2A#P$Y=A5=>7QQ[6]W7+Y0O4Z,MS '?A//J)BIN<K:#R%B
M/HD0A4U7Z>D7 SUQ2"Q^^G!DA3&2*$M"[N1DO.XJFMP1!+#B4@*+QP$&$ 12
M2>SC;R:JY#&E8W'\J/XU@1<P2\Q@0()?_IKONDI+06O8X'W K\GQ.V1 MM1;
MD8 E?]$QM75%Q-6><1)FSF(>^E'ZQ/?9010<=.L%!R-S,%[K8&8.9@*:[BS!
M&F*.O0XE1T2EM5"3@^1L$F]!XT?R,\XY%:N^\./>Y&KZ[6PQNKY$PU%_<8JF
M5XO1',UZOWO]R0CUID,TZ,W&B]X$34:]N5@Z0R=#X-@/V&<QOID/T<G'SQV5
MB[U(1765Q>VG<8T7XO[81^?(U$Z1H1E6A?O@]>YFV5T5)Y ?@Y$?@Y'H.2_H
M#6')T3ABG.Y%CG)T.Q$&:,PA9'^JX%(ULUI-7KT+%N,5=!5QMQC0 RC>IP^Z
MHWVI0FU(K 1NYN!FG;HW(=$6<:"AR/TE/T41X<!0C!_P,@"$HS5:X=CG.$ !
MB-O"J@XCC6 E$639.'BZ;K8MK:,>BI@59G:K91FY60G R@&L6H#!GE+YQ6)"
MD[I -BAH@"D-:A<V:[F:9CQ!JK R7<>M)K)S(KO13R(>C(E:43J'*B;[V6X=
MIVVVGC ]M])U6W/M:B@GAW)JH:8" LTR!AW=7D*X!%IYMVJ%WGJW&A(K,;LY
ML]MH47&;!&](K 3>RL%;[UY46A5I6%%4*LQJBDH[!VB_/EN-VFRM%7KK1VM(
MK,2L:_]; :W1?,WD&F)O2JT,7^B#]'?/V2Q$\2?N:;[6FJ1;5PO=G&RE+S'=
M^I$L\QOAHYV[(MMIVIVF$T[BI,%;$B[:Q62X$QT]4&D@UC=$L&03V3/F_R-X
M_P!02P,$%     @ U(,[665ZFD^L @  ?@<  !D   !X;"]W;W)K<VAE971S
M+W-H965T-C$N>&ULK95K3]LP%(;_BI5-$Y. W$-A::3TLHVIE(J63?OHMJ>M
MA1-GMMO"OY_MA*Q 6A#:E\2.SWO\O"?Q2;QE_$ZL "2ZSV@NVM9*RN+"ML5L
M!1D6IZR 7*TL&,^P5%.^M$7! <^-**.VYSB1G6&26TELGHUX$K.UI"2'$4=B
MG668/W2 LFW;<JW'!S=DN9+Z@9W$!5["&.1M,>)J9M=9YB2#7!"6(PZ+MI6Z
M%]U(QYN GP2V8F>,M),I8W=Z<CEO6XX& @HSJ3-@==M %RC5B13&GRJG56^I
MA;OCQ^Q?C7?E98H%=!G]1>9RU;9:%IK# J^IO&';[U#Y"76^&:/"7-&VBG4L
M-%L+R;)*K @RDI=W?%_584?@!GL$7B7PWBKP*X%OC)9DQE8/2YS$G&T1U]$J
MFQZ8VABU<D-R_1;'DJM5HG0R&5P/OYU,^C=7J-?O3([1\'K2'Z-1^COM#/HH
M'?90-QU=3M(!&O33L5HZ05=8KCF1! 1B"T19OD02>*:*-Y6(;8"C$#T YD+%
M'O5 8D+%9S6^'??0T<?/L2T5M][=GE6,G9+1V\/X8YV?(M\Y1I[C!0WR[MOE
M_E.YK:I5E\RK2^:9?-&^DBG')\9Q3SL>,JDJ,<(/>$H!I?D<=7%!)*9H .K[
M$DU^RPW\Y@WTP;T0!9Y!VU(G4P#?@)5\^N!&SI<F]_\IV9-:^'4M_$/9DSUO
MI%.J J/2C623!&>.X\7V9I?\8.YWD@<U>? :>=A$7JK"'?+0"8+6,_*#N=])
M'M;DX6OD41-Y^(+<C8)SYQGYP=SO)(]J\N@@^83I8_&T8S0YB5Y\/:[KGP?/
MK32$A:U6\.\K*R'MG>ZH_TQ7F"])+A"%A1(ZIV>J)+SL]N5$LL(TS"F3JOV:
MX4K](('K +6^8.K(5Q/=@^M?;O(74$L#!!0    ( -2#.UEN1O)[0@,   @*
M   9    >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;+66;6_:,!#'O\HIFZ9-
MZIK$4* =($%A&Q.EJ'2;IFDO3'* M23.; ?*MY_MI"G=0E3M@1?$3_?W[\[V
MV=T=%]_E!E'!71PELN=LE$HO7%<&&XRI/.4I)KIGQ45,E:Z*M2M3@32T1G'D
M$L]KN3%EB=/OVK:YZ'=YIB*6X%R S.*8BOT0([[K.;YSWW##UAME&MQ^-Z5K
M7*#ZF,Z%KKFE2LAB3"3C"0A<]9R!?S'T&\; COC$<"</RF!<67+^W50F8<_Q
M#!%&&"@C0?5GBY<8149)<_PH1)UR3F-X6+Y7?VN=U\XLJ<1+'GUFH=KTG(X#
M(:YH%JD;OGN/A4-G1B_@D;3_L,O'MLX="#*I>%P8:X*8)?F7WA6!.# @Y(@!
M*0R(Y<XGLI0CJFB_*_@.A!FMU4S!NFJM-1Q+S*HLE-"]3-NI_O1Z]N[U[?CF
M"D;CX>T)S*YOQPN8#[X,AM,Q#&8CN!S,)[>#*4S'@X7N>CE"15DD84:%H":D
MK[JNTB1&SPV*68?YK.3(K#Z!*YZHC81Q$F+X6,#5+I1^D'L_AJ16\4.6G$+#
M.P'BD29\7(S@Y?-7-;J-,CX-J]LXHCOC"F%.]W09(?CP]0KC)8IO52[7"IG3
M=2%3&F#/T<='HMBBTW_QS&]Y;VHPFR5FTZJWCF".<*E@DD@E,GUD%'R=Z@$P
M41C+2M;F?V ]*UG/:D,Z211J505Z^V 57&[NYUO6I)5MWSOUVMZCG]]UMQ40
MK1*B50MAMU^TAY3N;<!2%(R'533U.J3I06RW<DUDVB54NU;,KB(K5_&DH&+!
M/6857R[9/ A6L]DFU='IE""=^NA0E0FF]A >6:)Z\^M <7U*S%ELU83EO*0Y
MKY4;ZIP.6QIE"'P%RXQ%(4O655CGO\6BX7L=TJZ.AN\])$GOZ5F U&:!>J4_
M/%K^03KW_VDB*.3^,2YYP"5_EPL*>Q/5PV30.7M*,O ?LKQ?G^;G@@>(H825
MX#&87FGV6B P9)6GKM [W&I^ ?,+BWMP.<<HUO8)(B'@6:+R>[IL+9\Y@_QR
M?QB>OY&NJ%CK]  1KK2I=]K6F5+DSXZ\HGAJK_HE5_KA8(L;_51#80;H_A77
M&[FHF G*QU__)U!+ P04    " #4@SM9)#\+*#(#  !;"@  &0   'AL+W=O
M<FMS:&5E=',O<VAE970V,RYX;6RM5FUOVC 0_BM6-DVMM#;O;PPB%6BU3FJ'
M2KOMJR$'1$WLS#;0_?O9#J00 JNF?@';N>?N>2X7WW77E#WS!8! +T5.>,]8
M"%%V3)-/%U!@?DE+(/+)C+(""[EE<Y.7#'"J045N.I85F 7.B)%T]=F()5VZ
M%'E&8,007Q8%9G_ZD--US["-[<%#-E\(=6 FW1+/80SBJ1PQN3-K+VE6 .$9
M)8C!K&=<V9V!K0':XD<&:[ZS1DK*A-)GM;E->X:E&$$.4Z%<8/FW@@'DN?(D
M>?S>.#7JF JXN]YZO]'BI9@)YC"@^<\L%8N>$1DHA1E>YN*!KK_"1I"O_$UI
MSO4O6E>V86"@Z9(+6FS DD&1D>H?OVP2L0.PCP&<#<!I KPC '<#<+70BIF6
M-<0")UU&UX@I:^E-+71N-%JJR8AZC6/!Y--,XD1R>S_X?G>-'J]^78_1!1K0
MHJ0$B."(SE#)Z"K3+TS6"\K(E!: !'X!CLZ&('"6\W,)>AH/T=G'\ZXI)"'E
MUIQN@O>KX,Z1X+:#[B@1"XZN20KIO@-3*JGE.%LY?>>DQV]+<HE<ZS-R+,=K
M(31X.]P]0<>ML^MJ?\$1?X,E8S*9G;;45$BW':F^W@XO\11ZAOP\.; 5&,FG
M#W9@?6F3]4[.]D1ZM4COE/?D!E)@.&_36 $]#507RBKQG#@*96I7N^P/S:S:
M8H^27U/R3U(:"RR@C5 %\W<BV;'G^E'48'1H%_B.[]CMM(*:5G":UG(BJ&A/
M57 0T7%#UPOL!K-#NU/,PII9>+)0AS #6:II:Z6&[UFI[^1L3V54JXS>4JGJ
MFM=JJ[NL37)T^#;\R/=MO_$V6NS"T(JC(_4;UT3C?]?O&VC&A^&M.(Z=!LLV
ML\@/CY"TK=?>8?UW/6^@^ZF)?=\*&^3:#&-M>83>3FNS3](;U>WKK \$9IDX
MUXWLMFIDC[J17:![$*T"[(-;R;>#* Z:=T6+H1NXCA4VOTESITT7P.9Z>N%H
M2I=$5"VN/JTGI"L]%S3.^VIRTNW_U4TU=MUA-L\(1SG,I$OK,I1I9=4D4VT$
M+?4P,*%"CA9ZN9#3'S!E()_/*!7;C0I0SY/)7U!+ P04    " #4@SM9CW#9
MV8 #  #W"@  &0   'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6RM5MMNXS80
M_15"10LOL+5NOB6U#21.BFZ![ ;)]@(4?:"ED<4N1;HD96?_OD/*5FR55OI0
M/UCBY1R>,QJ2,]]+]467 (:\5%SH15 :L[T.0YV54%$]E%L0.%)(55&#3;4)
M]58!S1VHXF$219.PHDP$R[GK>U3+N:P-9P(>%=%U55'U]1:XW"^".#AV/+%-
M:6Q'N)QOZ0:>P?RR?538"EN6G%4@-)."*"@6P4U\O8H=P,WXE<%>G[P3:V4M
MY1?;^) O@L@J @Z9L104'SM8 >>6"77\?2 -VC4M\/3]R/ZC,X]FUE3#2O+?
M6&[*13 +2 X%K;EYDON?X&!H;/DRR;7[)_MF[G0:D*S61E8',"JHF&B>].40
MB!- /+D 2 Z I L870"D!T#JC#;*G*T[:NARKN2>*#L;V>R+BXU#HQLF[&=\
M-@I'&>+,\L/'U:>'>_+YYO?[9_(]>8),BHQQ1EV094$*R$%13K2AIC92?25,
M9+("8N@+4=0 &=R!H8SK=_/0H"++&V:'U6^;U9,+J\<)>9#"E)K<BQSR<X(0
MK;1^DJ.?VZ27\>=:#$D:O2=)E(P\@E;_'9[VR$G;\*:.;W(IO$VL/F.L[IC.
MN-2U O+'S5H;A1G\IR]D#6/J9[3;^EIO:0:+ />M!K6#8/G=-_$D^L%G]W\B
M.S,_:LV/^MB7Z!HTH<:30S9Q?-X;PKC)5GL$[9;1,(GGX>[4U%NSSM2.6[7C
M7K7/QB8S%3GA,D.QKVF.)@9K$% P\^X]$7BVGNR+PX#/3+->')W)C*;1U=FO
MX\T/&E\P-VG-37K-?<1=C1M-28XC&_1F +^W5W4_T6 \3*-O?5M]]09P-)S\
M"WCF9=IZF?8RW;]LF6K/)WL,90IR9K3/S=0;SB3I1/W"M)D_ZK-6Z:Q7Z1.8
M6@EB)-DJN6/NZJ/Y7WBJXT7HUSOSI'9':_^:@\3S@<[47[7JKWJ95B45&\!<
M(:8$LJ.\;H)..=[]5&3>#=Q/.<!M>B%[W@2.^UW%T>N-%_5R?4([RGM71;YS
M)>KFRG%:)UGBL3]9XI.K..Y/[*( 5]5TKUBOV-BG(IG,NFIC[V&9=L2&)R5$
M!6KC*BM-,ED+T]R^;6];O=VXFJ73?VNK.E>:O-(T)>$#51LF-.%0(&4TG.)1
MIYHJJVD8N76%REH:+'O<:XF5*2@[ <<+*<VQ81=H:]WE/U!+ P04    " #4
M@SM9AZE29"4$  #C#0  &0   'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6RM
MEVV3FS80Q[^*AG8ZR4Q]Z $$7&W/7'S)]#J3]"9W2?M6!MEF@I$C9/NNG[XK
M\&$?")H7?6,CV%W]=I'V+Z9'I;]5&RD->MH6937S-L;LKGV_2C=R*ZHKM9,E
M/%DIO14&AGKM5SLM158[;0N?8LS]K<A+;SZM[]WK^53M39&7\EZC:K_="OW\
M3A;J./.(]W+C<[[>&'O#GT]W8BT?I/FRN]<P\MLH6;Z5996K$FFYFGDWY'I!
MN'6H+;[F\EA=7".;RE*I;W9PE\T\;(ED(5-C0PCX.\B%+ H;"3B^GX)Z[9S6
M\?+Z)?J'.GE(9BDJN5#%7WEF-C,O]E F5V)?F,_J^+L\)13:>*DJJOH7'1O;
MB'DHW5=&;4_.0+#-R^9?/)T*<>% @@$'>G*@/^K 3@ZL3K0AJ].Z%4;,IUH=
MD;;6$,U>U+6IO2&;O+2O\<%H>)J#GYG??5K\^?$]>KSY^_T#FJ!;N9):RPP9
M\81$54E3(5%FJ,C%,B]RD\L*K-[<2B/RHGH+UU\>;M&;G]].?0,T-J:?GF9^
MU\Q,!V;^8U]>(89_1133P.&^^'%W]MK=AQJTA:!M(6@=CP_$<V1^[4JJB<+<
M4>RFNZYV(I4S#W95)?5!>O-??B(<_^9*\7\*]BIAUB;,QJ+/;PK8PJ),)8)F
M@%)(/3>H4)!YY<J["1;4P6QO.,Q9PI.8)%/_<)F2PXYQ'..SW2O:H*4-1FD_
MJ7*2R6P/NWY92-C]J=Z+PDG:! HO"*(PCC#N@#K,<!1<F+WB#%O.<)P3.B_T
M6"U,7JY1*K1^AO(>A<Z<K&$/ JJ*$]IA[9O1B,=Q$+AA>0O+1V$?8:DW+]X)
MQWNS$D89)G&'KF]'86%0,D 7M731*-U"['(CBOP?V)1V^0N=;NIFE,D#R,\.
MQ,2XL*/^BPW@Q48=ZKX9XPF/0C=TW$+'H]"U#B*U0OM*OFJ@$K3FLHVZR.-^
MP4E ".^0N\QHPF(W>=*2)Z/D=^4!"JKT %O2GQ3S..IN?Y=9R,C KB+X+%-X
ME*YMSW;-WC1UG:"UAG[EE![L6 30.!GI\#H,"0XP)\D0\H6RDE'DKZ+8B^:L
M\M)JG:BD1S A"8VB[FMW&3(>P(X<(#U+'QD5FOFC@GUF#S]=!73RTGYI*64T
M#+N\?4."<4"@P0T GZ6+C&O7O;8]UCS76TM^W^=U,S@U!]#*-*\+[\1G_2I2
M'A$:=/$=AB2$#*(!^K.4D7$MNRN-*-=6Q]P%[BO3!-9DP'H+PF%( Q:%9(#P
M+&)D7,4<"^(_6A?I2]2$123D7=EU&B8!2/0 ]%G,R+B:6>GMKV$G+.\=4G@<
M$I[TEG#?,.%!!$?.#JQ_<0*WGS\?A5[G905M?P6>^"J"?'7S1=$,C-K5A_*E
M,G#$KR\W\!4FM36 YRNES,O GO/;[[KYOU!+ P04    " #4@SM98<[)*:8#
M   ?#0  &0   'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6RME^]OFS@8Q_\5
MBSN=-NFN8""0]A*D-.GI=E*W:NE^2-.]<.!)8LW8F6V:]K^?#9200MD:[4V"
MP<_7WX^Q'S],]D)^55L C>YSQM74V6J]NW!=E6XA)^I,[(";)VLA<Z)-4VY<
MM9- LC(H9Z[O>9&;$\J=9%+>NY')1!2:40XW$JDBSXE\N 0F]E,'.X\WWM/-
M5ML;;C+9D0TL07_8W4C3<AN5C.; %14<25A/G1F^F./ !I0]/E+8J]8ULB@K
M(;[:QIMLZGC6$3!(M94@YN\.YL"853(^OM6B3C.F#6Q?/ZK_4\(;F!51,!?L
M$\WT=NJ,'93!FA1,OQ?[?Z$&&EF]5#!5_J)]U3<TG=-":9'7P<9!3GGU3^[K
MB6@%X.B9 +\.\)\&A,\$!'5 .7-NY:S$6A!-DHD4>R1M;Z-F+\JY*:,-#>7V
M-2ZU-$^IB=/)F[?S=]=7Z';V^6J)7BU $\H4>DND)'9^7Z._T(?E KWZ_?7$
MU68\&^6FM?9EI>T_HXU]="VXWBITQ3/(C@5<8[1QZS^ZO?0'%?\K^!D*O#^1
M[_EACZ'YSX<' W:"9O*"4B]Z;O)X*G) M^0>+:A*F5"%!/1EME):FO7Y?]^4
M58I!OZ+=M!=J1U*8.F97*I!WX"1__(8C[^\^W%\D=@0?-O#AD'JR@#5("1G2
M!I\H!;H/M]((2PV;4NZ2V/<#?S2:N'=MDFX_['DA/H^\IN.1RU'C<O3S+ADE
M*\JH?NAS6NF,6@Z"&(]:XU=&!X<[<<JC!B8:A)DQDW4)3P&9_(TR4:STNF F
M%::BX%HAPBO.U !3K?HHHPXE#OS \YYB#AHY$3-N,.-!S*4F&I YJ6P.XAMD
M]I5"J4E)#P9[3V362Q9WR,*1,=0A&QS[1+)Q0S8>))N;M?=BL'$'+,+C+M?@
MR"=RG3=<YX-<'PDK2'4L-TM4K)'J>9'0RWC>V?Y^'/:\O$$;)T)B[W!6>H.8
M-R!3X-J4-Y8.[E.JP&ZXWJ.QDL*XQ>2=>?@)T/"(IQ*U3G\\O""%W EIWQ)A
M&B0O#WU;9]"\R,M<LFN8>REQ'R5^FMV'79Q*Z1\H_1<OSS*#=HZPWL59JQ\=
M3C'N+LZ>?O'11CVV?Z@R\. YGMP>4OJ/LT6M%?XPPP\/^M)WXK9*T!SDIJS,
MC5U[,%75:'.WJ?YG9<WK'KI7GP[71&XH5XC!VH1Z9[%)?;*JQJN&%KNRH%T)
M;<KC\G)KOF! V@[F^5H(_=BP S3?1,EW4$L#!!0    ( -2#.UGQ<;JT>0,
M 'X*   9    >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;*V6VV[C-A"&7X50
MBV(7V(W.DI7: A(GQ;I(NX&=M!=%+VAI9!-+B5Z2BI.W+TDY6ENFG5S4%Q8I
MS0R_?S@\C+>,?Q-K (F>:]J(B;.6<G/INJ)80XW%!=M H[Y4C-=8JBY?N6+#
M 9?&J:9NX'F)6V/2./G8O+OG^9BUDI(&[CD2;5UC_G(-E&TGCN^\OIB3U5KJ
M%VX^WN 5+$ ^;NZYZKE]E)+4T C"&L2AFCA7_N74-P[&XB\"6['71EK*DK%O
MNC,K)XZGB8!"(74(K!Y/, 5*=23%\7T7U.G'U([[[=?HOQGQ2LP2"Y@R^C<I
MY7KBC!Q40H5;*N=L^P5V@F(=KV!4F'^T[6S3Q$%%*R2K=\Z*H"9-]\3/NT3L
M.?C1"8=@YQ"\UR'<.81&:$=F9-U@B?,Q9UO$M;6*IALF-\9;J2&-GL:%Y.HK
M47XR__KPY7:.IH_S^>V?#^AN=G4]NYL]S&X7Z#/Z*M? T;3E'!J)[@A>$DHD
M :&^?;@!B0D5'U7[<7&#/OS\<>Q*!:3#NL5N\.MN\.#$X+^WS04*O4\H\(+(
MXCY]OWMXZ.ZJ-/2Y"/I<!"9><B+>/7[!2ZKDX:9$5T7!6TP%^N=J*217Y?:O
M36 7,;1'U&OP4FQP 1-'+3(!_ F<_)>?_,3[U2;W?PIV(#[LQ8?GHN=&+Y1(
M8(JYFN-/J&!U381>KUU&-OB%,TJ1Q,\@;+GH!HC, 'K[>,JC)$V3S!N[3_LR
M+7:1'WI1U-L=*(AZ!=%9!0NLYT[1:5(]D3;&+D2\-[:?I:&?#A!M9HK0MQ/&
M/6%\GE!B"8@T*K/0I?$<:GS,$"5^&"8#UF.[:!3&H1TUZ5&3LZAWL,+43#LS
MN\"&LPI,,:C7%=@+(#DF]@-OF-NWK YXTYXW?:M\6=M(TJQ.TJ66<;.1-ZQ.
MBYFG?W:^4<\W.C_U0*O/5=N4:HFM 5.Y5G4@6HZ; M!N-=N@1\<T@1]%\0#:
M8N9Y67JB7K,>.GO7GD :"8I1=ML J!*0+S;8[(A"U6$T0'W#Z #4]WX<8]Y9
M5'-664\@[S@U831*_>&\6PSC-(S34VA[)ZS_-IHZR[MCE/XX1JVX_M'FF&:1
M[X79$/?8,(ZB, V&O.[>Y4#?S/[ ?*5*#U&HE*=WD2K%O+OL=!W)-N:^L&12
MW3Y,4U5L"5P;J.\58_*UHZ\@_94S_P]02P,$%     @ U(,[6=]FW-J' P
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MHV<!C. (#?1^ N,(DP!-*%F=3:2) ^1S#H*CWQ.)@\8"8OZG3-5T4;=\4?7
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MKN7Q#)@*D/>7E(K]0"V0'_B\_U!+ P04    " #4@SM9RE?93[0$  #-'@
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MP@3H\PWGZK P!=J_3O('4$L#!!0    ( -2#.UDP?D G/@(  .$$   9
M>&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;*5446^;,!#^*Q:KIE;J @&:-1D@
M+4VJ55JCK"S=P[0'!XY@U6!J&^BD_?C9AJ!L2_JR%^,[WWWW?>;.0<OXD\@!
M)'HI:"E"*Y>RFMFV2'(HL!BQ"DIUDC%>8*E,OK-%Q0&G)JF@MNLX$[O I+2B
MP/C6/ I8+2DI8<V1J(L"\Y]SH*P-K;&U=SR072ZUPXZ""N\@!KFIUEQ9]H"2
MD@)*05B).&2A]7$\F_LZW@0\$FC%P1YI)5O&GK1QEX:6HPD!A41J!*P^#=P
MI1I(T7CN,:VAI$X\W._1;XUVI66+!=PP^HVD,@^M:PNED.&:R@?6?H)>SY7&
M2Q@59D5M%SN96"BIA61%GZP8%*3LOOBEOX>#!'=Z(L'M$US#NRMD6"ZPQ%'
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MI@T\L#@0Z=?6&L\V7B'[ZP#+Z;X*P6:*5R(V4WRM ?&O&W@DB3_;6!SPP+*
MU0[$]\>!FO+[1!%D%=.&[6 <21(,@5KTUV@<(ZL3P\>?'VR71%&2^!' _ JB
M"$-@-^((I@ T8$@45>?@SGD4-N=4N/X%;?0#4$L#!!0    ( -2#.UF7BKL<
MP    !,"   +    7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$
M^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8E
MCVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^
MKSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE
M?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @
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M4')O<',O8V]R92YX;6Q02P$"% ,4    " #4@SM9F5R<(Q &  "<)P  $P
M            @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M -2#.UG.6IB>! @   XX   8              " @0T(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    " #4@SM9GMN]0%<*  "%-0  &
M            @(%'$   >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#
M%     @ U(,[66-M>>SI!   8!D  !@              ("!U!H  'AL+W=O
M<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( -2#.UDN4KJZ,P@  &TI
M   8              " @?,?  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q0
M2P$"% ,4    " #4@SM9O$(.4%(&  !H*P  &               @(%<*
M>&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ U(,[628<UY;9
M!P  VQ\  !@              ("!Y"X  'AL+W=O<FMS:&5E=',O<VAE970V
M+GAM;%!+ 0(4 Q0    ( -2#.UEG$LJN3 (  * %   8              "
M@?,V  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " #4@SM9
M6B^V# L%   ^"P  &               @(%U.0  >&PO=V]R:W-H965T<R]S
M:&5E=#@N>&UL4$L! A0#%     @ U(,[63@MR4K<(0  O64  !@
M     ("!MCX  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    (
M -2#.UEA&-LVF 4  ' -   9              " @<A@  !X;"]W;W)K<VAE
M971S+W-H965T,3 N>&UL4$L! A0#%     @ U(,[60(3(%:L @  L04  !D
M             ("!EV8  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"
M% ,4    " #4@SM9/* = 'H#  #/!P  &0              @(%Z:0  >&PO
M=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( -2#.UF="<27E@8
M '$/   9              " @2MM  !X;"]W;W)K<VAE971S+W-H965T,3,N
M>&UL4$L! A0#%     @ U(,[62X5,?>G!   8PL  !D              ("!
M^',  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " #4@SM9
MSZSJ)H$&   Z$   &0              @('6>   >&PO=V]R:W-H965T<R]S
M:&5E=#$U+GAM;%!+ 0(4 Q0    ( -2#.UEA*.Y8F00   @*   9
M      " @8Y_  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%
M  @ U(,[6:']H,&< P  U@<  !D              ("!7H0  'AL+W=O<FMS
M:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " #4@SM9</<4EJ$'  !E$0
M&0              @($QB   >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+
M 0(4 Q0    ( -2#.UD^OW#2-0,  -H&   9              " @0F0  !X
M;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ U(,[63U8Z\[F
M!@  M X  !D              ("!=9,  'AL+W=O<FMS:&5E=',O<VAE970R
M,"YX;6Q02P$"% ,4    " #4@SM9 )+R9&P"  "+!0  &0
M@(&2F@  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( -2#
M.UF_X8MWP 0  !4+   9              " @36=  !X;"]W;W)K<VAE971S
M+W-H965T,C(N>&UL4$L! A0#%     @ U(,[6=V13*3)!@  \ \  !D
M         ("!+*(  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4
M    " #4@SM9%65R0I0"  "0!0  &0              @($LJ0  >&PO=V]R
M:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( -2#.UGMW&UC8",  -MQ
M   9              " @?>K  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL
M4$L! A0#%     @ U(,[63V4)UW/!   C0P  !D              ("!CL\
M 'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " #4@SM9B5V$
M!D<$  #8"@  &0              @(&4U   >&PO=V]R:W-H965T<R]S:&5E
M=#(W+GAM;%!+ 0(4 Q0    ( -2#.UF/S_G7?0(  %H%   9
M  " @1+9  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @
MU(,[69@YD9,\ P   P<  !D              ("!QML  'AL+W=O<FMS:&5E
M=',O<VAE970R.2YX;6Q02P$"% ,4    " #4@SM9G:Z1]YH$  #Y"P  &0
M            @($YWP  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4
M Q0    ( -2#.UD*PB+/(P0  %8*   9              " @0KD  !X;"]W
M;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ U(,[6>FQV  / P
MS@8  !D              ("!9.@  'AL+W=O<FMS:&5E=',O<VAE970S,BYX
M;6Q02P$"% ,4    " #4@SM9_U4P*7D#  #6!P  &0              @(&J
MZP  >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( -2#.UG.
M8\/'504  +,,   9              " @5KO  !X;"]W;W)K<VAE971S+W-H
M965T,S0N>&UL4$L! A0#%     @ U(,[63Q0IU<= P  D@8  !D
M     ("!YO0  'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -2#.UF0R!YO4 0  "T2   9              "
M@0X) 0!X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ U(,[
M60V"0,HD!P  _2P  !D              ("!E0T! 'AL+W=O<FMS:&5E=',O
M<VAE970T,2YX;6Q02P$"% ,4    " #4@SM9U+S?9F8"  #K!0  &0
M        @('P% $ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0
M   ( -2#.UDN,K<".@4  #@9   9              " @8T7 0!X;"]W;W)K
M<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ U(,[6>@TB,OD @  ] <
M !D              ("!_AP! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q0
M2P$"% ,4    " #4@SM9*; _1<@"  "T!@  &0              @($9( $
M>&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( -2#.UGGQLKP
M= (  $4&   9              " @1@C 0!X;"]W;W)K<VAE971S+W-H965T
M-#8N>&UL4$L! A0#%     @ U(,[61($7:I<!   1A<  !D
M ("!PR4! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    " #4
M@SM9"E8/A),"  #:!@  &0              @(%6*@$ >&PO=V]R:W-H965T
M<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( -2#.UF0&K^S3 ,  + +   9
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M970U,RYX;6Q02P$"% ,4    " #4@SM9]!3]NU $  !=&   &0
M    @(&T/0$ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    (
M -2#.UG0-[=K$ ,  %H(   9              " @3M" 0!X;"]W;W)K<VAE
M971S+W-H965T-34N>&UL4$L! A0#%     @ U(,[6?+N=^$L P  E@L  !D
M             ("!@D4! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"
M% ,4    " #4@SM9Z7N5,N\'  !%.@  &0              @('E2 $ >&PO
M=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( -2#.UDQN3KCJP,
M "$.   9              " @0M1 0!X;"]W;W)K<VAE971S+W-H965T-3@N
M>&UL4$L! A0#%     @ U(,[683D&W&&!0  ^B(  !D              ("!
M[50! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q02P$"% ,4    " #4@SM9
MJS&,,!P#   O#   &0              @(&J6@$ >&PO=V]R:W-H965T<R]S
M:&5E=#8P+GAM;%!+ 0(4 Q0    ( -2#.UEE>II/K (  'X'   9
M      " @?U= 0!X;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%
M  @ U(,[66Y&\GM" P  " H  !D              ("!X& ! 'AL+W=O<FMS
M:&5E=',O<VAE970V,BYX;6Q02P$"% ,4    " #4@SM9)#\+*#(#  !;"@
M&0              @(%99 $ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+
M 0(4 Q0    ( -2#.UF/<-G9@ ,  /<*   9              " @<)G 0!X
M;"]W;W)K<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @ U(,[68>I4F0E
M!   XPT  !D              ("!>6L! 'AL+W=O<FMS:&5E=',O<VAE970V
M-2YX;6Q02P$"% ,4    " #4@SM98<[)*:8#   ?#0  &0
M@('5;P$ >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( -2#
M.UGQ<;JT>0,  'X*   9              " @;)S 0!X;"]W;W)K<VAE971S
M+W-H965T-C<N>&UL4$L! A0#%     @ U(,[6=]FW-J' P  *PP  !D
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M=#<R+GAM;%!+ 0(4 Q0    ( -2#.UG*5]E/M 0  ,T>   9
M  " @=", 0!X;"]W;W)K<VAE971S+W-H965T-S,N>&UL4$L! A0#%     @
MU(,[6?O5> V6 @  @08  !D              ("!NY$! 'AL+W=O<FMS:&5E
M=',O<VAE970W-"YX;6Q02P$"% ,4    " #4@SM9,'Y )SX"  #A!   &0
M            @(&(E $ >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4
M Q0    ( -2#.UD7C"A<.0,  $X3   -              "  ?V6 0!X;"]S
M='EL97,N>&UL4$L! A0#%     @ U(,[69>*NQS     $P(   L
M     ( !89H! %]R96QS+RYR96QS4$L! A0#%     @ U(,[6;!P9ICM!0
M[3$   \              ( !2IL! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0
M   ( -2#.UEG_%)"3 (  &@L   :              "  62A 0!X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( -2#.UF&IF-(# (  &$K
M   3              "  >BC 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@
0  !3 %, O!8  "6F 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>203</ContextCount>
  <ElementCount>419</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>73</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedStatementsOfIncome</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995612 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995613 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995614 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995615 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Inventories</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995616 - Disclosure - PROPERTY AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/PropertyAndEquipment</Role>
      <ShortName>PROPERTY AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995617 - Disclosure - OPERATING &amp; FINANCING LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995618 - Disclosure - OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssets</Role>
      <ShortName>OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995619 - Disclosure - CAPITAL STOCK</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CapitalStock</Role>
      <ShortName>CAPITAL STOCK</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995620 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ControllingAndNoncontrollingInterests</Role>
      <ShortName>CONTROLLING AND NONCONTROLLING INTERESTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995621 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases</Role>
      <ShortName>LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995622 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995623 - Disclosure - OTHER CURRENT LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherCurrentLiabilities</Role>
      <ShortName>OTHER CURRENT LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995624 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995625 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SupplementalCashFlowInformation</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995626 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/RelatedPartyTransactions</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995627 - Disclosure - SEGMENT AND RELATED INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformation</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995628 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995629 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995630 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995631 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995632 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/InventoriesTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Inventories</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995633 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/PropertyAndEquipmentTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/PropertyAndEquipment</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995634 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeasesTables</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/OperatingFinancingLeases</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995635 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssetsTables</Role>
      <ShortName>OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherIntangibleAssets</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>995636 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ControllingAndNoncontrollingInterestsTables</Role>
      <ShortName>CONTROLLING AND NONCONTROLLING INTERESTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/ControllingAndNoncontrollingInterests</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995637 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables</Role>
      <ShortName>LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>995638 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxesTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/IncomeTaxes</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>995639 - Disclosure - OTHER CURRENT LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherCurrentLiabilitiesTables</Role>
      <ShortName>OTHER CURRENT LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherCurrentLiabilities</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995640 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformationTables</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/SegmentAndRelatedInformation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>995641 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>995642 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>995643 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>995644 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>995645 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>995646 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>995647 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>995648 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>995649 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>995650 - Disclosure - INVENTORIES - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Inventories-InventoriesDetails</Role>
      <ShortName>INVENTORIES - Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>995651 - Disclosure - PROPERTY AND EQUIPMENT - Property and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT - Property and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>995652 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/PropertyAndEquipmentDetailsNarrative</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/PropertyAndEquipmentTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>995653 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES - Lease payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>995654 - Disclosure - OPERATING &amp; FINANCING LEASES - Weighted average remaining lease term (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES - Weighted average remaining lease term (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>995655 - Disclosure - OPERATING &amp; FINANCING LEASES - Components of lease expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES - Components of lease expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>995656 - Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES - Related to leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>995657 - Disclosure - OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails</Role>
      <ShortName>OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>995658 - Disclosure - OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details</Role>
      <ShortName>OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>995659 - Disclosure - OTHER INTANGIBLE ASSETS - Intangle assets - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details</Role>
      <ShortName>OTHER INTANGIBLE ASSETS - Intangle assets - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>995660 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative</Role>
      <ShortName>OTHER INTANGIBLE ASSETS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherIntangibleAssetsTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>995661 - Disclosure - CAPITAL STOCK (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CapitalStockDetailsNarrative</Role>
      <ShortName>CAPITAL STOCK (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/CapitalStock</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>995662 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails</Role>
      <ShortName>CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>995663 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative</Role>
      <ShortName>CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/ControllingAndNoncontrollingInterestsTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>995664 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Details</Role>
      <ShortName>LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>995665 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities of long term debt over 5 years - (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLongTermDebtOver5Years-Details</Role>
      <ShortName>LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities of long term debt over 5 years - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>995666 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative</Role>
      <ShortName>LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>995667 - Disclosure - INCOME TAXES - Components of provision for income taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES - Components of provision for income taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>995668 - Disclosure - INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails</Role>
      <ShortName>INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>995669 - Disclosure - INCOME TAXES - Deferred tax assets and liabilities - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details</Role>
      <ShortName>INCOME TAXES - Deferred tax assets and liabilities - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>995670 - Disclosure - INCOME TAXES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>INCOME TAXES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/IncomeTaxesTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>995671 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details</Role>
      <ShortName>OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>995672 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>995673 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SupplementalCashFlowInformation</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>995674 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/RelatedPartyTransactions</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>995675 - Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>995676 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>995677 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>995678 - Disclosure - SEGMENT AND RELATED INFORMATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SegmentAndRelatedInformationTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>995679 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SubsequentEvents</ParentRole>
      <Position>75</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="fonar_10-k.htm">fonar_10-k.htm</File>
    <File>fonr-20240630.xsd</File>
    <File>fonr-20240630_cal.xml</File>
    <File>fonr-20240630_def.xml</File>
    <File>fonr-20240630_lab.xml</File>
    <File>fonr-20240630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>fonar-performance_graph.jpg</File>
    <File>fonar_logo.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2024</BaseTaxonomy>
    <BaseTaxonomy items="705">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="40">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>96
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "fonar_10-k.htm": {
   "nsprefix": "FONR",
   "nsuri": "http://fonar.com/20240630",
   "dts": {
    "inline": {
     "local": [
      "fonar_10-k.htm"
     ]
    },
    "schema": {
     "local": [
      "fonr-20240630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "fonr-20240630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "fonr-20240630_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "fonr-20240630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fonr-20240630_pre.xml"
     ]
    }
   },
   "keyStandard": 318,
   "keyCustom": 101,
   "axisStandard": 24,
   "axisCustom": 0,
   "memberStandard": 41,
   "memberCustom": 30,
   "hidden": {
    "total": 50,
    "http://fasb.org/us-gaap/2024": 45,
    "http://fonar.com/20240630": 1,
    "http://xbrl.sec.gov/dei/2024": 4
   },
   "contextCount": 203,
   "entityCount": 1,
   "segmentCount": 73,
   "elementCount": 716,
   "unitCount": 5,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 705,
    "http://xbrl.sec.gov/dei/2024": 40,
    "http://fasb.org/srt/2024": 1
   },
   "report": {
    "R1": {
     "role": "http://fonar.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://fonar.com/role/ConsolidatedBalanceSheets",
     "longName": "00000002 - Statement - CONSOLIDATED BALANCE SHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
     "longName": "00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://fonar.com/role/ConsolidatedStatementsOfIncome",
     "longName": "00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
     "longName": "00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "AsOf2022-06-30_custom_ClassANonVotingPreferredMember",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-06-30_custom_ClassANonVotingPreferredMember",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://fonar.com/role/ConsolidatedStatementsOfCashFlows",
     "longName": "00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:DepreciationAndAmortization",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R8": {
     "role": "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources",
     "longName": "995612 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES",
     "shortName": "DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPolicies",
     "longName": "995613 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable",
     "longName": "995614 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://fonar.com/role/Inventories",
     "longName": "995615 - Disclosure - INVENTORIES",
     "shortName": "INVENTORIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://fonar.com/role/PropertyAndEquipment",
     "longName": "995616 - Disclosure - PROPERTY AND EQUIPMENT",
     "shortName": "PROPERTY AND EQUIPMENT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://fonar.com/role/OperatingFinancingLeases",
     "longName": "995617 - Disclosure - OPERATING & FINANCING LEASES",
     "shortName": "OPERATING & FINANCING LEASES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://fonar.com/role/OtherIntangibleAssets",
     "longName": "995618 - Disclosure - OTHER INTANGIBLE ASSETS",
     "shortName": "OTHER INTANGIBLE ASSETS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://fonar.com/role/CapitalStock",
     "longName": "995619 - Disclosure - CAPITAL STOCK",
     "shortName": "CAPITAL STOCK",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:CapitalStockDisclosureTextblock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:CapitalStockDisclosureTextblock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://fonar.com/role/ControllingAndNoncontrollingInterests",
     "longName": "995620 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS",
     "shortName": "CONTROLLING AND NONCONTROLLING INTERESTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases",
     "longName": "995621 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES",
     "shortName": "LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://fonar.com/role/IncomeTaxes",
     "longName": "995622 - Disclosure - INCOME TAXES",
     "shortName": "INCOME TAXES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://fonar.com/role/OtherCurrentLiabilities",
     "longName": "995623 - Disclosure - OTHER CURRENT LIABILITIES",
     "shortName": "OTHER CURRENT LIABILITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://fonar.com/role/CommitmentsAndContingencies",
     "longName": "995624 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://fonar.com/role/SupplementalCashFlowInformation",
     "longName": "995625 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://fonar.com/role/RelatedPartyTransactions",
     "longName": "995626 - Disclosure - RELATED PARTY TRANSACTIONS",
     "shortName": "RELATED PARTY TRANSACTIONS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://fonar.com/role/SegmentAndRelatedInformation",
     "longName": "995627 - Disclosure - SEGMENT AND RELATED INFORMATION",
     "shortName": "SEGMENT AND RELATED INFORMATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://fonar.com/role/SubsequentEvents",
     "longName": "995628 - Disclosure - SUBSEQUENT EVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "995629 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "longName": "995630 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables",
     "longName": "995631 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://fonar.com/role/InventoriesTables",
     "longName": "995632 - Disclosure - INVENTORIES (Tables)",
     "shortName": "INVENTORIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://fonar.com/role/PropertyAndEquipmentTables",
     "longName": "995633 - Disclosure - PROPERTY AND EQUIPMENT (Tables)",
     "shortName": "PROPERTY AND EQUIPMENT (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://fonar.com/role/OperatingFinancingLeasesTables",
     "longName": "995634 - Disclosure - OPERATING & FINANCING LEASES (Tables)",
     "shortName": "OPERATING & FINANCING LEASES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://fonar.com/role/OtherIntangibleAssetsTables",
     "longName": "995635 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)",
     "shortName": "OTHER INTANGIBLE ASSETS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://fonar.com/role/ControllingAndNoncontrollingInterestsTables",
     "longName": "995636 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)",
     "shortName": "CONTROLLING AND NONCONTROLLING INTERESTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables",
     "longName": "995637 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)",
     "shortName": "LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "FONR:LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "FONR:LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://fonar.com/role/IncomeTaxesTables",
     "longName": "995638 - Disclosure - INCOME TAXES (Tables)",
     "shortName": "INCOME TAXES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://fonar.com/role/OtherCurrentLiabilitiesTables",
     "longName": "995639 - Disclosure - OTHER CURRENT LIABILITIES (Tables)",
     "shortName": "OTHER CURRENT LIABILITIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://fonar.com/role/SegmentAndRelatedInformationTables",
     "longName": "995640 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)",
     "shortName": "SEGMENT AND RELATED INFORMATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative",
     "longName": "995641 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)",
     "shortName": "DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "AsOf2015-07-01_us-gaap_OtherInvesteesMember",
      "name": "us-gaap:InvestmentOwnedPercentOfNetAssets",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2015-07-01_us-gaap_OtherInvesteesMember",
      "name": "us-gaap:InvestmentOwnedPercentOfNetAssets",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details",
     "longName": "995642 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30_srt_MinimumMember_custom_DiagnosticEquipmentMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30_srt_MinimumMember_custom_DiagnosticEquipmentMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1",
     "longName": "995643 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:NetPatientFeeRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:NetPatientFeeRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details",
     "longName": "995644 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:NetIncomeLossAvailableToCommonStockholderBasic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:NetIncomeLossAvailableToCommonStockholderBasic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "longName": "995645 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:CostOfPropertyRepairsAndMaintenance",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:CostOfPropertyRepairsAndMaintenance",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails",
     "longName": "995646 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:ContractReceivableDueTwoToThreeYears",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:ContractReceivableDueTwoToThreeYears",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails",
     "longName": "995647 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details)",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30_us-gaap_AccountsReceivableMember",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-06-30_us-gaap_AccountsReceivableMember",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails",
     "longName": "995648 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear",
      "unitRef": "Integer",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "FONR:TotalFacilitiesOwnedOrManagedTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear",
      "unitRef": "Integer",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "FONR:TotalFacilitiesOwnedOrManagedTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative",
     "longName": "995649 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "FONR:AccountsReceivableNetLongTerm",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:PercentageOfConsolidatedNetRevenueFromManagementFees",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://fonar.com/role/Inventories-InventoriesDetails",
     "longName": "995650 - Disclosure - INVENTORIES - Inventories (Details)",
     "shortName": "INVENTORIES - Inventories (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:OtherInventorySupplies",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:OtherInventorySupplies",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
     "longName": "995651 - Disclosure - PROPERTY AND EQUIPMENT - Property and equipment (Details)",
     "shortName": "PROPERTY AND EQUIPMENT - Property and equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative",
     "longName": "995652 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)",
     "shortName": "PROPERTY AND EQUIPMENT (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "From2023-07-012024-06-30_us-gaap_PropertyPlantAndEquipmentMember",
      "name": "us-gaap:OtherDepreciationAndAmortization",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012024-06-30_us-gaap_PropertyPlantAndEquipmentMember",
      "name": "us-gaap:OtherDepreciationAndAmortization",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
     "longName": "995653 - Disclosure - OPERATING & FINANCING LEASES - Lease payments (Details)",
     "shortName": "OPERATING & FINANCING LEASES - Lease payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30_custom_OperatingLeasePaymentsMember",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30_custom_OperatingLeasePaymentsMember",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails",
     "longName": "995654 - Disclosure - OPERATING & FINANCING LEASES - Weighted average remaining lease term (Details)",
     "shortName": "OPERATING & FINANCING LEASES - Weighted average remaining lease term (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails",
     "longName": "995655 - Disclosure - OPERATING & FINANCING LEASES - Components of lease expense (Details)",
     "shortName": "OPERATING & FINANCING LEASES - Components of lease expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails",
     "longName": "995656 - Disclosure - OPERATING & FINANCING LEASES - Related to leases (Details)",
     "shortName": "OPERATING & FINANCING LEASES - Related to leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:OperatingCashFlowsFromOperatingLeases",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:OperatingCashFlowsFromOperatingLeases",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails",
     "longName": "995657 - Disclosure - OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)",
     "shortName": "OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details",
     "longName": "995658 - Disclosure - OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details)",
     "shortName": "OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details",
     "longName": "995659 - Disclosure - OTHER INTANGIBLE ASSETS - Intangle assets - (Details)",
     "shortName": "OTHER INTANGIBLE ASSETS - Intangle assets - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:OtherIntangibleAssetsNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-06-30",
      "name": "us-gaap:OtherIntangibleAssetsNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative",
     "longName": "995660 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)",
     "shortName": "OTHER INTANGIBLE ASSETS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://fonar.com/role/CapitalStockDetailsNarrative",
     "longName": "995661 - Disclosure - CAPITAL STOCK (Details Narrative)",
     "shortName": "CAPITAL STOCK (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:PaymentsForRepurchaseOfEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "FONR:CapitalStockDisclosureTextblock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
     "longName": "995662 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)",
     "shortName": "CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember",
      "name": "FONR:OpeningMembersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember",
      "name": "FONR:OpeningMembersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative",
     "longName": "995663 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)",
     "shortName": "CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "AsOf2013-03-05_custom_HDMMember",
      "name": "FONR:PurchaseOfStandupMriCenters",
      "unitRef": "Integer",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2013-03-05_custom_HDMMember",
      "name": "FONR:PurchaseOfStandupMriCenters",
      "unitRef": "Integer",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Details",
     "longName": "995664 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - (Details)",
     "shortName": "LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:LongTermDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "FONR:LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "FONR:LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLongTermDebtOver5Years-Details",
     "longName": "995665 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities of long term debt over 5 years - (Details)",
     "shortName": "LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities of long term debt over 5 years - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "FONR:LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "FONR:LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative",
     "longName": "995666 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Details Narrative)",
     "shortName": "LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "From2023-07-012024-06-30_custom_NotePayable1Member",
      "name": "us-gaap:DebtInstrumentInterestRateDuringPeriod",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "FONR:LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012024-06-30_custom_NotePayable1Member",
      "name": "us-gaap:DebtInstrumentInterestRateDuringPeriod",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "FONR:LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails",
     "longName": "995667 - Disclosure - INCOME TAXES - Components of provision for income taxes (Details)",
     "shortName": "INCOME TAXES - Components of provision for income taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails",
     "longName": "995668 - Disclosure - INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)",
     "shortName": "INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details",
     "longName": "995669 - Disclosure - INCOME TAXES - Deferred tax assets and liabilities - (Details)",
     "shortName": "INCOME TAXES - Deferred tax assets and liabilities - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://fonar.com/role/IncomeTaxesDetailsNarrative",
     "longName": "995670 - Disclosure - INCOME TAXES (Details Narrative)",
     "shortName": "INCOME TAXES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:DeferredTaxAssetsNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details",
     "longName": "995671 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)",
     "shortName": "OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:AccruedSalariesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:AccruedSalariesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "longName": "995672 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:LeaseAndRentalExpenses",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:LeaseAndRentalExpenses",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative",
     "longName": "995673 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:InterestPaidNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:InterestPaidNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative",
     "longName": "995674 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)",
     "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "From2017-05-302017-06-01",
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2017-05-302017-06-01",
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details",
     "longName": "995675 - Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)",
     "shortName": "SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:IntersegmentNetRevenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
     "longName": "995676 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)",
     "shortName": "SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:ForeignProductSales",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfExportProductSalesTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:ForeignProductSales",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfExportProductSalesTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details",
     "longName": "995677 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)",
     "shortName": "SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:ForeignServiceAndRepairFees",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfExportServiceRevenuesTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:ForeignServiceAndRepairFees",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfExportServiceRevenuesTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative",
     "longName": "995678 - Disclosure - SEGMENT AND RELATED INFORMATION (Details Narrative)",
     "shortName": "SEGMENT AND RELATED INFORMATION (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:ExportSalesOfMedicalEquipmentPercentage",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FONR:ExportSalesOfMedicalEquipmentPercentage",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://fonar.com/role/SubsequentEventsDetailsNarrative",
     "longName": "995679 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
     "shortName": "SUBSEQUENT EVENTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-18_us-gaap_SubsequentEventMember",
      "name": "srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-18_us-gaap_SubsequentEventMember",
      "name": "srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "country_AE": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "AE",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED ARAB EMIRATES"
       }
      }
     },
     "auth_ref": []
    },
    "country_AU": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "AU",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AUSTRALIA"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_AbandonedPatents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "AbandonedPatents",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Abandoned patents"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r282",
      "r910"
     ]
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivable Type [Axis]",
        "documentation": "Information by type of receivable."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r79"
     ]
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER CURRENT LIABILITIES",
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r392"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r746"
     ]
    },
    "FONR_AccountsPayableRelatedPartyNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "AccountsPayableRelatedPartyNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due to related party medical practices"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableBilledForLongTermContractsOrPrograms",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total",
        "documentation": "Amount billed to customers under long-term contracts or programs but not paid. Excludes amounts due that have been withheld because of retainage provisions in a contract."
       }
      }
     },
     "auth_ref": [
      "r1004"
     ]
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable [Member]",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable \u2013 net of allowances for credit losses of $166,049 and $198,593 at June 30, 2024 and 2023, respectively",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r907"
     ]
    },
    "FONR_AccountsReceivableNetLongTerm": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "AccountsReceivableNetLongTerm",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable \u2013 long term",
        "verboseLabel": "Long term accounts receivable balances"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_AccountsReceivableServiceContractsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "AccountsReceivableServiceContractsNet",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:AccountsReceivableServiceContractsNet-0]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedFeesAndOtherRevenueReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedFeesAndOtherRevenueReceivable",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable \u2013 net of allowances for credit losses of $12,369,921 and $12,608,567 as of June 30, 2024 and 2023, respectively",
        "documentation": "For an unclassified balance sheet, the amount of fees and other revenue, excluding investment income receivable, earned but not yet received, which were recognized in conformity with revenue recognition criteria based on estimates or specific contractual terms."
       }
      }
     },
     "auth_ref": [
      "r876"
     ]
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal and other professional fees",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedProfessionalFeesCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting fees",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "us-gaap_AccruedSalariesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedSalariesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued salaries, commissions and payroll taxes",
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r700"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less: Accumulated depreciation and amortization",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r191",
      "r541"
     ]
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average amortization period for other intangible assets",
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r307",
      "r694"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Paid-in capital in excess of par value",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r746",
      "r1047"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r585",
      "r894",
      "r895",
      "r896",
      "r897",
      "r988",
      "r1048"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "us-gaap_AdjustmentForAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentForAmortization",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization",
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdvertisingCostsPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advertising Costs",
        "documentation": "Disclosure of accounting policy for advertising cost."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "us-gaap_AdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdvertisingExpense",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advertising Expense",
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line."
       }
      }
     },
     "auth_ref": [
      "r393",
      "r734"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r793",
      "r804",
      "r814",
      "r840"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r796",
      "r807",
      "r817",
      "r843"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r828"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r835"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r797",
      "r808",
      "r818",
      "r835",
      "r844",
      "r848",
      "r856"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "auth_ref": [
      "r854"
     ]
    },
    "us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of allowance for credit losses",
        "documentation": "Tabular disclosure of allowance for credit loss on financing receivable."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r913"
     ]
    },
    "FONR_AllowanceForDoubtfulAccountsAdditions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "AllowanceForDoubtfulAccountsAdditions",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions (Included in provision for bad debts)"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_AllowanceForDoubtfulAccountsDeductions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "AllowanceForDoubtfulAccountsDeductions",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deductions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable - net of allowances for credit losses",
        "documentation": "The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet."
       }
      }
     },
     "auth_ref": [
      "r909"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning Balance",
        "periodEndLabel": "Ending Balance",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r286",
      "r294",
      "r295",
      "r296",
      "r1011"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of customer relationships",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r304",
      "r311",
      "r717"
     ]
    },
    "FONR_AmountsCapitalized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "AmountsCapitalized",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amounts capitalized"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r137",
      "r195",
      "r221",
      "r252",
      "r260",
      "r270",
      "r273",
      "r291",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r435",
      "r439",
      "r454",
      "r530",
      "r626",
      "r710",
      "r711",
      "r746",
      "r774",
      "r937",
      "r938",
      "r996"
     ]
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r204",
      "r221",
      "r291",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r435",
      "r439",
      "r454",
      "r746",
      "r937",
      "r938",
      "r996"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total identifiable assets",
        "documentation": "Amount of net assets (liabilities)."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r786",
      "r788",
      "r800"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r786",
      "r788",
      "r800"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r786",
      "r788",
      "r800"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "auth_ref": [
      "r847"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r850"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r849"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r848"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r848"
     ]
    },
    "FONR_BensonhurstMRILimitedPartnershipMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "BensonhurstMRILimitedPartnershipMember",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bensonhurst MRI Limited Partnership [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "BoardOfDirectorsChairmanMember",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board of Directors Chairman [Member]",
        "documentation": "Leader of board of directors."
       }
      }
     },
     "auth_ref": [
      "r906"
     ]
    },
    "FONR_BookValueOfBuilding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "BookValueOfBuilding",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Book value of building"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BuildingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BuildingMember",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Building [Member]",
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r430",
      "r731",
      "r732"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r45",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r430",
      "r731",
      "r732"
     ]
    },
    "us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessDescriptionAndAccountingPoliciesTextBlock",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES",
        "documentation": "The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r106"
     ]
    },
    "FONR_BuyoutOfNoncontrollingInterestsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "BuyoutOfNoncontrollingInterestsValue",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Buyout of noncontrolling interests"
       }
      }
     },
     "auth_ref": []
    },
    "country_CA": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "CA",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA"
       }
      }
     },
     "auth_ref": []
    },
    "country_CH": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "CH",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SWITZERLAND"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CancellationOfTreasuryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "CancellationOfTreasuryShares",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancellation of treasury shares"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CancellationOfTreasuryStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "CancellationOfTreasuryStock",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancellation of treasury stock"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CapitalStockDisclosureTextblock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "CapitalStockDisclosureTextblock",
     "presentation": [
      "http://fonar.com/role/CapitalStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CAPITAL STOCK"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Cash",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash deposit",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r534",
      "r596",
      "r621",
      "r746",
      "r774",
      "r873"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r189",
      "r698"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR",
        "periodEndLabel": "CASH AND CASH EQUIVALENTS - END OF YEAR",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r101",
      "r219"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET INCREASE IN CASH AND CASH EQUIVALENTS",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r101"
     ]
    },
    "us-gaap_CashFDICInsuredAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFDICInsuredAmount",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federally insured limits",
        "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUPPLEMENTAL CASH FLOW INFORMATION",
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r826"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ClassAControllingInterestsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ClassAControllingInterestsMember",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Controlling Interests [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ClassANonVotingPreferredMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ClassANonVotingPreferredMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Non Voting Preferred [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ClassANonVotingPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ClassANonVotingPreferredStockMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Non Voting Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ClassANonVotingPreferredStockholdersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ClassANonVotingPreferredStockholdersMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Non Voting Preferred Stockholders [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ClassBControllingInterestsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ClassBControllingInterestsMember",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class B Controlling Interests [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ClassCCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ClassCCommonStockMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class C Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r199",
      "r200",
      "r201",
      "r221",
      "r241",
      "r242",
      "r247",
      "r249",
      "r254",
      "r255",
      "r291",
      "r328",
      "r330",
      "r331",
      "r332",
      "r335",
      "r336",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r454",
      "r574",
      "r575",
      "r576",
      "r577",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r597",
      "r613",
      "r635",
      "r655",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r864",
      "r889",
      "r898"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "FONR_CommercialInsuranceManagedCareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "CommercialInsuranceManagedCareMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commercial Insurance/ Managed Care [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r126",
      "r533",
      "r612"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMITMENTS AND CONTINGENCIES",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r322",
      "r323",
      "r681",
      "r929",
      "r934"
     ]
    },
    "us-gaap_CommonClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonClassAMember",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class A [Member]",
        "documentation": "Classification of common stock representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r1048"
     ]
    },
    "us-gaap_CommonClassBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonClassBMember",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class B [Member]",
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r1048"
     ]
    },
    "us-gaap_CommonClassCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonClassCMember",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class C [Member]",
        "documentation": "Classification of common stock that has different rights than provided to Class A or B shares, representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, capital shares reserved for future issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r764",
      "r765",
      "r766",
      "r768",
      "r769",
      "r770",
      "r771",
      "r894",
      "r895",
      "r897",
      "r988",
      "r1044",
      "r1048"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, par value",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r613"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r72",
      "r613",
      "r632",
      "r1048",
      "r1049"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock value",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r536",
      "r746"
     ]
    },
    "us-gaap_CommonStockVotingRights": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockVotingRights",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, voting rights",
        "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "FONR_CommonStockholdersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "CommonStockholdersMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stockholders [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r832"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r833"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r830"
     ]
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r56",
      "r57",
      "r280",
      "r680"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r56",
      "r57",
      "r280",
      "r568",
      "r680"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r56",
      "r57",
      "r280",
      "r680",
      "r869"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration of Credit Risk",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r147"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration risk, percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r56",
      "r57",
      "r280"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r56",
      "r57",
      "r280",
      "r680"
     ]
    },
    "FONR_ConsiderationForNoncompetitionAndConsultingAgreements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ConsiderationForNoncompetitionAndConsultingAgreements",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "HDM entered agreement for consulting and non-competition agreement ($)"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ConsiderationToOutsideInvestors": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ConsiderationToOutsideInvestors",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "HDM purchase price includes consideration to outside investors"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Less-than-Wholly-Owned Subsidiary, Parent Ownership Interest, Effect of Change [Table]",
        "documentation": "Disclosure of information about effect of change in parent's ownership interest in subsidiary on equity attributable to parent. Excludes change from deconsolidation of subsidiary."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r55"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principles of Consolidation",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r702"
     ]
    },
    "us-gaap_ContractReceivableDueFiveYearsOrMore": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractReceivableDueFiveYearsOrMore",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2029",
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1005"
     ]
    },
    "us-gaap_ContractReceivableDueFourToFiveYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractReceivableDueFourToFiveYears",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2028",
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1005"
     ]
    },
    "us-gaap_ContractReceivableDueThreeToFourYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractReceivableDueThreeToFourYears",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2027",
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1005"
     ]
    },
    "us-gaap_ContractReceivableDueTwoToThreeYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractReceivableDueTwoToThreeYears",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2026",
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1005"
     ]
    },
    "FONR_ContractualFeesForServicesRenderedMaximum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ContractualFeesForServicesRenderedMaximum",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contractual fees for services rendered maximum"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ContractualFeesForServicesRenderedMinimum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ContractualFeesForServicesRenderedMinimum",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contractual fees for services rendered minimum"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleNotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of price of the equipment",
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r125",
      "r1009"
     ]
    },
    "FONR_CorporateAlternativeMinimumTaxPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "CorporateAlternativeMinimumTaxPercentage",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate alternative minimum tax percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfPropertyRepairsAndMaintenance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfPropertyRepairsAndMaintenance",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maintenance and repair expenses",
        "documentation": "The aggregate costs of keeping the property in good condition but that do not appreciably prolong the life or increase the value of the property."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Costs and Expenses",
        "label": "Costs and Expenses [Default Label]",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostsAndExpensesAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CostsRelatedToManagementAndOtherFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "CostsRelatedToManagementAndOtherFees",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to management and other fees"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to management and other fees \u2013 related party medical practices"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CostsRelatedToProductSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "CostsRelatedToProductSales",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to product sales"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CostsRelatedToServiceAndRepairFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "CostsRelatedToServiceAndRepairFees",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to service and repair fees"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CostsRelatedToServiceAndRepairFeesRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "CostsRelatedToServiceAndRepairFeesRelatedParties",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to service and repair fees \u2013 related parties"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r871",
      "r892",
      "r979"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Subtotal",
        "label": "Current Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r416",
      "r892"
     ]
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r871",
      "r892",
      "r979"
     ]
    },
    "FONR_CustomerAdvancesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "CustomerAdvancesPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Advances"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r280"
     ]
    },
    "FONR_CustomerDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "CustomerDeposits",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer deposits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerRelationshipsMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails",
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Relationships [Member]",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r924",
      "r927",
      "r928"
     ]
    },
    "country_DE": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "DE",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GERMANY"
       }
      }
     },
     "auth_ref": []
    },
    "country_DO": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "DO",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "DOMINICAN REPUBLIC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate",
        "documentation": "The average effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r349",
      "r991"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Details",
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r744",
      "r890",
      "r991",
      "r992"
     ]
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentPeriodicPayment",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt instrument, periodic payment",
        "documentation": "Amount of the required periodic payments including both interest and principal payments."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r60"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Details",
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r38",
      "r39",
      "r59",
      "r112",
      "r113",
      "r223",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r744",
      "r890",
      "r991",
      "r992"
     ]
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "parentTag": "FONR_DeferredIncomeTaxExpensesBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal deferred taxes",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r892",
      "r978",
      "r979"
     ]
    },
    "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredGainOnSaleOfProperty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredGainOnSaleOfProperty",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain on sale of equipments",
        "documentation": "Amount of gain on the sale of property that does not qualify for gain recognition as of the balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred income tax - net",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r153",
      "r892"
     ]
    },
    "FONR_DeferredIncomeTaxExpensesBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "DeferredIncomeTaxExpensesBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Subtotal",
        "label": "DeferredIncomeTaxExpensesBenefit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred income tax liability",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other liabilities expected to be paid after one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredRevenueCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRevenueCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unearned revenue on service contracts",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRevenueNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unearned revenue on service contracts",
        "label": "Deferred Revenue, Noncurrent",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "parentTag": "FONR_DeferredIncomeTaxExpensesBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State deferred taxes",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r892",
      "r978",
      "r979"
     ]
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsDeferredIncome",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred income tax asset",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income."
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred Tax Assets - gross",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r409"
     ]
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized research and development",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both."
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "DeferredTaxAssetsInRightUseAssetsAndLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right of use assets and lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsInventory",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventories",
        "label": "Deferred Tax Assets, Inventory",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory."
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax asset",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r972"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details",
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax assets",
        "label": "Deferred tax asset",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r972"
     ]
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNetAbstract",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net operating carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-deductible accruals",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax credits",
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax credits carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allowance for credit losses",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r410"
     ]
    },
    "us-gaap_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r972"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Intangibles",
        "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill."
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Property and equipment and depreciation",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax liability",
        "documentation": "Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to a policyholders' surplus."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation allowance for deferred tax assets",
        "documentation": "Amount of valuation allowance for tax benefit to be credited to shareholders' equity if tax benefit subsequently becomes realizable. Includes, but is not limited to, adjustment to opening balance of retained earnings for change in accounting principle or correction of error, gain (loss) in comprehensive income (loss) but excluded from net income (loss), deductible expenditure for income tax purposes reported as reduction of shareholders' equity, and deductible temporary difference existing at date of quasi-reorganization."
       }
      }
     },
     "auth_ref": [
      "r414",
      "r980"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation and amortization",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r34"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r252",
      "r264",
      "r273",
      "r710",
      "r711"
     ]
    },
    "FONR_DepreciationOfLeasedEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "DepreciationOfLeasedEquipment",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation of leased equipment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeFixedInterestRate",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bears interest rate",
        "documentation": "Fixed interest rate related to the interest rate derivative."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_DiagnosticEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "DiagnosticEquipmentMember",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diagnostic Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_DiagnosticImagingFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "DiagnosticImagingFacilityMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diagnostic Imaging Facility [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_DirectPurchaseOfNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "DirectPurchaseOfNoncontrollingInterests",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of interests from Class A"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r362",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r362",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of patient fee revenue - net",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "FONR_DisclosureCapitalStockAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "DisclosureCapitalStockAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term Debt Notes Payable And Capital Leases",
        "verboseLabel": "Long-term Debt Notes Payable And Capital Leases - Maturities Of Long Term Debt Over 5 Years -"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_DisclosureOperatingFinancingLeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "DisclosureOperatingFinancingLeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Financing Leases",
        "verboseLabel": "Operating Financing Leases - Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Financing Leases - Components Of Lease Expense"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_Distributions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "Distributions",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsPayableNature": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DividendsPayableNature",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends payable, nature",
        "documentation": "Describes the declaration as being a special dividend (over and above the normal dividend); as the annual, semi-annual, quarterly dividend, or other normal periodic dividend; or as some other type of dividend."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r19",
      "r20"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r788"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r786",
      "r788",
      "r800"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r786",
      "r788",
      "r800",
      "r836"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r787"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r788"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r788"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r778"
     ]
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic Net Income Per Common Share Available to Common Stockholders",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r212",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r238",
      "r241",
      "r247",
      "r248",
      "r249",
      "r251",
      "r428",
      "r432",
      "r448",
      "r449",
      "r526",
      "r548",
      "r704"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted Net Income Per Common Share Available to Common Stockholders",
        "verboseLabel": "Diluted income per common share",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r212",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r241",
      "r247",
      "r248",
      "r249",
      "r251",
      "r428",
      "r432",
      "r448",
      "r449",
      "r526",
      "r548",
      "r704"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r22",
      "r250"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective income tax rate",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r400",
      "r735"
     ]
    },
    "FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes at federal statutory rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in the valuation allowance",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r403",
      "r735",
      "r893",
      "r969"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling interest",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes."
       }
      }
     },
     "auth_ref": [
      "r893",
      "r969",
      "r970"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return to provision adjustments",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r735",
      "r893",
      "r969",
      "r970"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other",
        "documentation": "Percentage of reported income tax benefit (expense) from difference to income tax expense (benefit) computed by applying statutory federal (national) income tax rate to pretax income (loss) from continuing operation, attributable to other reconciling items. Excludes state and local income tax expense (benefit), federal tax expense (benefit), statutory income tax expense (benefit) outside of country of domicile, tax credit, nondeductible expense, deduction, income tax settlement, income tax contingency, and cross-border tax law."
       }
      }
     },
     "auth_ref": [
      "r970"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration of tax credits",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense."
       }
      }
     },
     "auth_ref": [
      "r893",
      "r969",
      "r970"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and local income taxes (benefit), net of federal benefit",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r402",
      "r735",
      "r893",
      "r969"
     ]
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOwnershipPlanESOPCashContributionsToESOP",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employer contributions",
        "documentation": "This item represents the amount of cash contributions during the period made by the entity to the Employee Stock Ownership Plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "FONR_EndingMembersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "EndingMembersEquity",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ending Members Equity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r781"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r777"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r777"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r777"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r777"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r777"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r777"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r777"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from External Customer [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r184",
      "r208",
      "r209",
      "r210",
      "r224",
      "r225",
      "r226",
      "r228",
      "r233",
      "r235",
      "r237",
      "r253",
      "r292",
      "r293",
      "r318",
      "r361",
      "r417",
      "r418",
      "r425",
      "r426",
      "r427",
      "r429",
      "r431",
      "r432",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r463",
      "r466",
      "r479",
      "r547",
      "r562",
      "r563",
      "r564",
      "r585",
      "r655"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r289",
      "r290",
      "r424",
      "r865",
      "r866",
      "r867",
      "r981",
      "r982",
      "r983",
      "r984"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership interest percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r288"
     ]
    },
    "FONR_EquityMethodInvestmentOwnershipPercentages": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "EquityMethodInvestmentOwnershipPercentages",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership interest of company"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_EquityMethodInvestmentsOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "EquityMethodInvestmentsOwnershipPercentage",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of interests from Class A, percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r829"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r793",
      "r804",
      "r814",
      "r840"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r790",
      "r801",
      "r811",
      "r837"
     ]
    },
    "FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of estimated useful life in years for property and equipment"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r835"
     ]
    },
    "FONR_ExportSalesOfMedicalEquipmentPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ExportSalesOfMedicalEquipmentPercentage",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Export sales of medical equipment percentage"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Financial Instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "FONR_FinanceLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "FinanceLeaseCost",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total finance lease cost"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_FinanceLeaseCostsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "FinanceLeaseCostsAbstract",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance lease cost:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest on lease liabilities",
        "documentation": "Amount of interest expense on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r469",
      "r470",
      "r745"
     ]
    },
    "us-gaap_FinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total lease liability",
        "label": "Finance Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease."
       }
      }
     },
     "auth_ref": [
      "r468",
      "r474"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing lease liability \u2013 current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r468"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing lease liability \u2013 net of current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r468"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Thereafter",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2025",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2029",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2028",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2027",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2026",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use-asset \u2013 financing lease",
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average discount rate, finance leases",
        "documentation": "Weighted average discount rate for finance lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r473",
      "r745"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance lease - years",
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r745"
     ]
    },
    "FONR_FinancingCashFlowsFromFinancingLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "FinancingCashFlowsFromFinancingLeases",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing cash flows from financing leases"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_FinancingLeasePaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "FinancingLeasePaymentsMember",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Lease Payments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-lived intangible asset, useful life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less: Accumulated amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r298",
      "r310",
      "r717"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Thereafter",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r925",
      "r1050"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2025",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r694",
      "r717"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2029",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r694",
      "r717"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2028",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r694",
      "r717"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2027",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r694",
      "r717"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2026",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r694",
      "r717"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails",
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r303",
      "r305",
      "r306",
      "r307",
      "r309",
      "r310",
      "r313",
      "r314",
      "r493",
      "r494",
      "r694"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross other intangible assets",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r298",
      "r310",
      "r494",
      "r717"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails",
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r303",
      "r310",
      "r313",
      "r314",
      "r316",
      "r493",
      "r694",
      "r717"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails",
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r303",
      "r305",
      "r306",
      "r307",
      "r309",
      "r310",
      "r313",
      "r314",
      "r694"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other intangible assets-net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r493",
      "r924"
     ]
    },
    "FONR_ForeignProductSales": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ForeignProductSales",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign product sales"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of service and repair of medical equipment"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ForeignServiceAndRepairFees": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ForeignServiceAndRepairFees",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign service and repair fees"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r797",
      "r808",
      "r818",
      "r844"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r797",
      "r808",
      "r818",
      "r844"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r797",
      "r808",
      "r818",
      "r844"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r797",
      "r808",
      "r818",
      "r844"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r797",
      "r808",
      "r818",
      "r844"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "country_GB": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "GB",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED KINGDOM"
       }
      }
     },
     "auth_ref": []
    },
    "country_GR": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "GR",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GREECE"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_GainOnSaleOfEquipmentRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "GainOnSaleOfEquipmentRelatedParty",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gain on sale of equipment \u2013 related party",
        "label": "GainOnSaleOfEquipmentRelatedParty"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_GainlossOnDispositionOfFixedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "GainlossOnDispositionOfFixedAssets",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "(Gain)Loss on disposition of fixed assets",
        "label": "GainlossOnDispositionOfFixedAssets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r300",
      "r525",
      "r711",
      "r716",
      "r738",
      "r746",
      "r915",
      "r916"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Goodwill",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined."
       }
      }
     },
     "auth_ref": [
      "r299",
      "r301",
      "r716"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Intangible Assets",
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r914",
      "r917"
     ]
    },
    "FONR_HDMEquityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "HDMEquityMember",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "HDM Equity [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_HDMMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "HDMMember",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "HDM [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HealthCareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HealthCareMember",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Manufacturing and Servicing of Medical Equipment [Member]",
        "documentation": "Service provided for prevention, maintenance, diagnosis or treatment of physical and mental health."
       }
      }
     },
     "auth_ref": [
      "r942"
     ]
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HealthCareOrganizationRevenueSourcesAxis",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Health Care Organization, Revenue Sources [Axis]",
        "documentation": "Information by major payor source of revenue for health care organizations."
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HealthCareOrganizationRevenueSourcesDomain",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Major payor source of revenue for health care organizations."
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "us-gaap_HealthCareOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HealthCareOtherMember",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management of Diagnostic Imaging Center [Member]",
        "documentation": "Service provided for maintenance, diagnosis and treatment of physical and mental health, classified as other."
       }
      }
     },
     "auth_ref": [
      "r942"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Assets",
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperations",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "(Loss) Income from operations",
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r85",
      "r104",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r245",
      "r249",
      "r432"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income before provision for income taxes and noncontrolling interests",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r131",
      "r136",
      "r527",
      "r543",
      "r706",
      "r710",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income from Operations",
        "label": "Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net",
        "documentation": "Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic income per common share",
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r132",
      "r212",
      "r227",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r241",
      "r247",
      "r248",
      "r428",
      "r432",
      "r449",
      "r526",
      "r1012"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r319",
      "r320",
      "r321",
      "r451",
      "r452",
      "r453",
      "r559",
      "r561",
      "r640",
      "r694",
      "r739",
      "r1014"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r320",
      "r321",
      "r451",
      "r452",
      "r453",
      "r559",
      "r561",
      "r640",
      "r694",
      "r739",
      "r1014"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INCOME TAXES",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r396",
      "r400",
      "r404",
      "r405",
      "r406",
      "r407",
      "r412",
      "r419",
      "r421",
      "r422",
      "r423",
      "r579",
      "r735"
     ]
    },
    "us-gaap_IncomeTaxExaminationPenaltiesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExaminationPenaltiesExpense",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Penalties",
        "documentation": "The amount of estimated penalties recognized in the period arising from income tax examinations."
       }
      }
     },
     "auth_ref": [
      "r971"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Provision for Income Taxes",
        "totalLabel": "Provision (Benefit) for Income Taxes - Net",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r154",
      "r236",
      "r237",
      "r252",
      "r265",
      "r273",
      "r399",
      "r400",
      "r420",
      "r550",
      "r735"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r397",
      "r398",
      "r407",
      "r408",
      "r411",
      "r415",
      "r573"
     ]
    },
    "us-gaap_IncomeTaxesPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesPaid",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes paid",
        "documentation": "Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r103",
      "r888",
      "r974",
      "r975"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts, medical and management fee receivables",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "FONR_IncreaseDecreaseInCustomerAdvance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "IncreaseDecreaseInCustomerAdvance",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer advances"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventories",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "FONR_IncreaseDecreaseInNotesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "IncreaseDecreaseInNotesReceivable",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in assets and liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liabilities",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r870",
      "r885"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other liabilities",
        "label": "Increase (Decrease) in Other Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in other expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other current liabilities",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "documentation": "Amount of increase (decrease) in current liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r885"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other assets",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r885"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidExpensesOther",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expenses, Other",
        "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_IncreaseDecreaseInTradingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInTradingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing lease liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of trading liabilities from the reporting entity's trading activities. This include liabilities resulting from sales of assets that the reporting entity does not own and revaluation losses."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "IncrementalCommonSharesAttributableToConversionOfCommonStock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class C Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Class C Common Stock",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r244",
      "r249"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r797",
      "r808",
      "r818",
      "r835",
      "r844",
      "r848",
      "r856"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "auth_ref": [
      "r854"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r789",
      "r859"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r789",
      "r859"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r789",
      "r859"
     ]
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER INTANGIBLE ASSETS",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r302",
      "r315",
      "r317",
      "r693",
      "r694"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other intangible assets \u2013 net",
        "verboseLabel": "Other intangible assets - net",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r303",
      "r924",
      "r926"
     ]
    },
    "us-gaap_IntellectualPropertyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntellectualPropertyMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intellectual Property [Member]",
        "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r924",
      "r927",
      "r928"
     ]
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r263",
      "r882"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest paid",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r217",
      "r218"
     ]
    },
    "FONR_IntersegmentNetRevenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "IntersegmentNetRevenues",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inter-segment net revenues",
        "documentation": "This represents the amount of intersegment net revenues during period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/Inventories"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INVENTORIES",
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory."
       }
      }
     },
     "auth_ref": [
      "r297"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 7.0
      },
      "http://fonar.com/role/Inventories-InventoriesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/Inventories-InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories",
        "totalLabel": "Inventories",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r699",
      "r746"
     ]
    },
    "us-gaap_InventoryWorkInProcess": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryWorkInProcess",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/Inventories-InventoriesDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/Inventories-InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Work-in-process",
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "us-gaap_InventoryWorkInProcessPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryWorkInProcessPolicy",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventories",
        "label": "Inventory Work in Process, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the basis and manner that goods are added and removed from inventory in the course of production (work in process). If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory and how cost is determined (such as FIFO, LIFO, average)."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_InvestmentIncomeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentIncomeNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment income",
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r92",
      "r93"
     ]
    },
    "FONR_InvestmentIncomeRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "InvestmentIncomeRelatedParty",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment income \u2013 related party"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentOwnedPercentOfNetAssets": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentOwnedPercentOfNetAssets",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest received percentage",
        "documentation": "Percentage of investment owned to net assets."
       }
      }
     },
     "auth_ref": [
      "r599",
      "r601",
      "r602",
      "r661",
      "r668",
      "r669",
      "r670",
      "r672",
      "r766",
      "r1045"
     ]
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Investments",
        "documentation": "Disclosure of accounting policy for investment in financial asset."
       }
      }
     },
     "auth_ref": [
      "r549",
      "r569",
      "r570",
      "r571",
      "r572",
      "r662",
      "r663"
     ]
    },
    "FONR_LeaseAndRentalExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "LeaseAndRentalExpenses",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rent expense for operating leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of components of lease expense",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r993"
     ]
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r476"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of reconciliation of operating and financing lease payments",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r994"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Thereafter",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2025",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2029",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OPERATING &amp; FINANCING LEASES",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r465"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r63",
      "r64",
      "r65",
      "r67",
      "r68",
      "r69",
      "r70",
      "r221",
      "r291",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r436",
      "r439",
      "r440",
      "r454",
      "r611",
      "r705",
      "r774",
      "r937",
      "r996",
      "r997"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities and Stockholders\u2019 Equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r128",
      "r539",
      "r746",
      "r891",
      "r912",
      "r990"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 Equity:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r188",
      "r221",
      "r291",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r436",
      "r439",
      "r440",
      "r454",
      "r746",
      "r937",
      "r996",
      "r997"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Long-Term Liabilities",
        "label": "Liabilities, Noncurrent",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r67",
      "r68",
      "r69",
      "r70",
      "r221",
      "r291",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r436",
      "r439",
      "r440",
      "r454",
      "r937",
      "r996",
      "r997"
     ]
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reserve for self-funded",
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date."
       }
      }
     },
     "auth_ref": [
      "r758",
      "r762",
      "r1007",
      "r1015"
     ]
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
        "documentation": "The entire disclosure for claims held for amounts due to entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses."
       }
      }
     },
     "auth_ref": [
      "r462",
      "r905"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Details",
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLongTermDebtOver5Years-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long term debt, notes payable and capital leases",
        "verboseLabel": "Total long term debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r125",
      "r344",
      "r354",
      "r719",
      "r720",
      "r744",
      "r1009"
     ]
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long term debt, notes payable and capital leases less current portion",
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r532"
     ]
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current portion of long term debt, notes payable and capital leases",
        "documentation": "Amount of long-term debt and lease obligation, classified as current."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLongTermDebtOver5Years-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2026",
        "label": "Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Three",
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLongTermDebtOver5Years-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2025",
        "label": "Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two",
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLongTermDebtOver5Years-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2024",
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current portion of long-term debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term debt and capital leases, less current portion",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r197"
     ]
    },
    "FONR_LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Details",
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r930",
      "r931",
      "r932"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Details",
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r37",
      "r930",
      "r931",
      "r932"
     ]
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MachineryAndEquipmentMember",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Machinery and Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_MagneticResonanceManagementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "MagneticResonanceManagementMember",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Magnetic Resonance Management [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "documentation": "Information by name or description of a single external customer or a group of external customers."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r726",
      "r756",
      "r761",
      "r941",
      "r1013",
      "r1016",
      "r1017",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043"
     ]
    },
    "FONR_ManagedFacilitiesAddedByInternalDevelopment": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ManagedFacilitiesAddedByInternalDevelopment",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Internal development"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagedFacilitiesClosedDuringYear": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ManagedFacilitiesClosedDuringYear",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Managed Facilities Closed"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAgreementsWithCompanyTotalMedicalPractices": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ManagementAgreementsWithCompanyTotalMedicalPractices",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management agreements with company total medical practices"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAndOtherFeesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ManagementAndOtherFeesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAndOtherFeesReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ManagementAndOtherFeesReceivableMember",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management And Other Fees Receivable [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management And Other Fees Receivable Related Medical Practices [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ManagementAndOtherFeesRelatedMedicalPracticesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees \u2013 related party medical practices"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ManagementAndOtherReceivableAllowancesForDoubtfulAccounts",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable - net of allowances for credit losses"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementFeeReceivableForRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ManagementFeeReceivableForRelatedParties",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ManagementFeeReceivableForRelatedParties-0]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementFeeReceivableForUnrelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ManagementFeeReceivableForUnrelatedParties",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ManagementFeeReceivableForUnrelatedParties-0]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable \u2013 related party medical practices \u2013 net of allowances for credit losses of $6,110,399 and $3,989,692 as of June 30, 2024 and 2023, respectively"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_MaturityDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "MaturityDate",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity date"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r158",
      "r160",
      "r161",
      "r163",
      "r182",
      "r183",
      "r324",
      "r325",
      "r326",
      "r327",
      "r364",
      "r391",
      "r450",
      "r491",
      "r558",
      "r560",
      "r567",
      "r603",
      "r604",
      "r660",
      "r664",
      "r666",
      "r667",
      "r671",
      "r691",
      "r692",
      "r715",
      "r723",
      "r733",
      "r740",
      "r741",
      "r742",
      "r743",
      "r757",
      "r939",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "FONR_MedicalReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "MedicalReceivable",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical receivables \u2013 net"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_MedicalReceivableAndManagementAndOtherFeesReceivablePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "MedicalReceivableAndManagementAndOtherFeesReceivablePolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical Receivable and Management and Other Fees Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_MedicareMedicaidMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "MedicareMedicaidMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medicare/Medicaid [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r158",
      "r160",
      "r161",
      "r163",
      "r182",
      "r183",
      "r324",
      "r325",
      "r326",
      "r327",
      "r364",
      "r391",
      "r450",
      "r491",
      "r558",
      "r560",
      "r567",
      "r603",
      "r604",
      "r660",
      "r664",
      "r666",
      "r667",
      "r671",
      "r691",
      "r692",
      "r715",
      "r723",
      "r733",
      "r740",
      "r741",
      "r742",
      "r757",
      "r939",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003"
     ]
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling interests",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r127",
      "r221",
      "r291",
      "r328",
      "r330",
      "r331",
      "r332",
      "r335",
      "r336",
      "r454",
      "r538",
      "r615"
     ]
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Distributions to noncontrolling interests",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterestDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONTROLLING AND NONCONTROLLING INTERESTS",
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock."
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "us-gaap_MinorityInterestLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterestLineItems",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership interest of investors",
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterestTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterestTable",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Table]",
        "documentation": "Disclosure of information about noncontrolling interest, including, but not limited to, name of subsidiary, ownership percentage held by parent, ownership percentage held by noncontrolling owner, amount of noncontrolling interest and its location in statement of financial position, explanation of increase (decrease) in noncontrolling interest, noncontrolling interest share of net income (loss) of subsidiary and its location in statement of income, amount of noncontrolling interest represented by preferred stock, description and dividend requirement of preferred stock, and nature of noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r52",
      "r77",
      "r86"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    },
    "FONR_MonthlyPaymentPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "MonthlyPaymentPeriod",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Monthly payment period"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "FONR_N2010StockBonusPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "N2010StockBonusPlanMember",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "N 2010 Stock Bonus Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r726",
      "r756",
      "r761",
      "r941",
      "r1013",
      "r1016",
      "r1017",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET CASH USED IN FINANCING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r216"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET CASH USED IN INVESTING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r216"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM INVESTING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET CASH PROVIDED BY OPERATING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r104"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM OPERATING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Income \u2013 Attributable to FONAR",
        "label": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r104",
      "r133",
      "r186",
      "r205",
      "r206",
      "r210",
      "r221",
      "r227",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r236",
      "r237",
      "r245",
      "r291",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r428",
      "r432",
      "r449",
      "r454",
      "r546",
      "r634",
      "r653",
      "r654",
      "r772",
      "r937"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net Income \u2013 Noncontrolling Interests",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r119",
      "r205",
      "r206",
      "r233",
      "r236",
      "r237",
      "r545",
      "r881"
     ]
    },
    "FONR_NetIncomeLossAvailableToCommonStockholderBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "NetIncomeLossAvailableToCommonStockholderBasic",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net income available to common stockholders"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income Available to Common Stockholders",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r229",
      "r230",
      "r231",
      "r232",
      "r238",
      "r239",
      "r246",
      "r249",
      "r432"
     ]
    },
    "FONR_NetPatientFeeRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "NetPatientFeeRevenue",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Patient Fee Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recently Adopted Accounting Standards",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r825"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncompeteAgreementsMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncompete Agreements [Member]",
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r924",
      "r927",
      "r928"
     ]
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncontrollingInterestAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Member]",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r361",
      "r894",
      "r895",
      "r896",
      "r897",
      "r1048"
     ]
    },
    "FONR_NotePayable1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "NotePayable1Member",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Details",
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Payable 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_NotePayable2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "NotePayable2Member",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Details",
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Payable 2 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_NoteReceivableRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "NoteReceivableRelatedParty",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note receivable \u2013 related party"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesReceivableMember",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Receivable [Member]",
        "documentation": "An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) within one year of the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Class C Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_OpeningMembersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "OpeningMembersEquity",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Opening Members Equity"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_OperatingCashFlowsFromOperatingLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "OperatingCashFlowsFromOperatingLeases",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating cash flows from operating leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State operating loss carryforwards",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r706",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r471",
      "r745"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total lease liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r468"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liabilities \u2013 current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r468"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liabilities \u2013 net of current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r468"
     ]
    },
    "FONR_OperatingLeasePaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "OperatingLeasePaymentsMember",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Payments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use-assets \u2013 operating leases",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization on right-of-use assets",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average discount rate, operating leases",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r473",
      "r745"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating leases - years",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r745"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allowance for doubtful accounts and tax credits",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r413"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwardsValuationAllowance",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation allowance of state operating losses",
        "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r973"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued interest and penalty",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_OtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other assets",
        "documentation": "Amount of assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r194",
      "r529",
      "r711",
      "r774"
     ]
    },
    "us-gaap_OtherCostOfOperatingRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCostOfOperatingRevenue",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to patient fee revenue",
        "documentation": "Other costs incurred during the reporting period related to other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherDepreciationAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation and amortization of property and equipment",
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r34",
      "r89"
     ]
    },
    "FONR_OtherIncomeRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "OtherIncomeRelatedParty",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income \u2013 related party"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherIntangibleAssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance - Beginning of Year",
        "periodEndLabel": "Balance - End of Year",
        "label": "Other Intangible Assets, Net",
        "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherInventorySupplies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherInventorySupplies",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/Inventories-InventoriesDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/Inventories-InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchased parts and components",
        "documentation": "Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "us-gaap_OtherInvesteesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherInvesteesMember",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonconsolidated Investees, Other [Member]",
        "documentation": "Investment in group of nonconsolidated investees classified as other."
       }
      }
     },
     "auth_ref": [
      "r911"
     ]
    },
    "us-gaap_OtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other liabilities",
        "documentation": "Amount of liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r531",
      "r607",
      "r608",
      "r774",
      "r1010",
      "r1046"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other current liabilities",
        "totalLabel": "Other current liabilities",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r746"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income (expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and (Expenses):"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherOperatingIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherOperatingIncome",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City operating loss carryforwards",
        "documentation": "The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_OtherOwnershipInterestsByNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherOwnershipInterestsByNameAxis",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Ownership Interests Name [Axis]",
        "documentation": "Information by ownership interests about other units or shares or classes of ownership in a partnership. Excludes limited or general partners' ownership interests."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "us-gaap_OtherOwnershipInterestsNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherOwnershipInterestsNameDomain",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the ownership interest, which details special or unusual rights. Does not include limited or general partners' ownership interests."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r788"
     ]
    },
    "FONR_OtherRevenueSourceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "OtherRevenueSourceMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherSundryLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Other Sundry Liabilities, Current",
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r64"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r795",
      "r806",
      "r816",
      "r842"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r798",
      "r809",
      "r819",
      "r845"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r798",
      "r809",
      "r819",
      "r845"
     ]
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "auth_ref": []
    },
    "country_PR": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "PR",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PUERTO RICO"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_PatentsAndCopyrightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "PatentsAndCopyrightsMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patents and copyrights [Member]",
        "documentation": "Patents and copyrights - Member - Custom elements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PatentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PatentsMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patents [Member]",
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r924",
      "r927",
      "r928"
     ]
    },
    "FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patient fee revenue, net of contractual allowances and discounts"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "auth_ref": [
      "r823"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForProceedsFromShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForProceedsFromShortTermInvestments",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of Short-term investment",
        "label": "Payments for (Proceeds from) Short-Term Investments",
        "documentation": "The net amount paid (received) by the reporting entity through acquisition or sale and maturities of short-term investments with an original maturity that is three months or less which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term."
       }
      }
     },
     "auth_ref": [
      "r883",
      "r884",
      "r887"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForRepurchaseOfEquity",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of treasury stock",
        "label": "Payments for repurchase of equity",
        "documentation": "The cash outflow to reacquire common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r577"
     ]
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfDividendsMinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Distributions to noncontrolling interests",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cost of patents",
        "label": "Payments to Acquire Intangible Assets",
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireProductiveAssets",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital expenditures",
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r985",
      "r986",
      "r987"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r826"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r826"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r825"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "FONR_PercentageOfConsolidatedNetRevenueFromManagementFees": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "PercentageOfConsolidatedNetRevenueFromManagementFees",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of consolidated net revenue from management fees"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_PercentageOfExciseTax": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "PercentageOfExciseTax",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of excise tax"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r825"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r782"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r784"
     ]
    },
    "us-gaap_PreferredClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredClassAMember",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Class A [Member]",
        "documentation": "Outstanding nonredeemable preferred class A stock or outstanding convertible preferred class A stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock [Member]",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r764",
      "r765",
      "r768",
      "r769",
      "r770",
      "r771",
      "r1044",
      "r1048"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, par value",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r355"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r613"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r355"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r613",
      "r632",
      "r1048",
      "r1049"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock value",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r535",
      "r746"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "FONR_PresentValueDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "PresentValueDiscount",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Present value discount"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_PresentValueDiscountFinancingLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "PresentValueDiscountFinancingLease",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Present value discount",
        "label": "PresentValueDiscountFinancingLease"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromContributionsFromAffiliates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromContributionsFromAffiliates",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investors contribution",
        "documentation": "The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "FONR_ProceedsFromContributionsFromCompany": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ProceedsFromContributionsFromCompany",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company contribution"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromLinesOfCredit",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from lines of credit",
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r890"
     ]
    },
    "us-gaap_ProceedsFromPaymentsToMinorityShareholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromPaymentsToMinorityShareholders",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-controlling interests from the minority shareholders",
        "documentation": "Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale of equipment",
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "us-gaap_ProductInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProductInformationLineItems",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r181",
      "r276",
      "r492",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r696",
      "r724",
      "r755",
      "r757",
      "r759",
      "r762",
      "r763",
      "r872",
      "r935",
      "r936",
      "r941",
      "r1013",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043"
     ]
    },
    "FONR_ProductSalesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ProductSalesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product sales"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r181",
      "r276",
      "r492",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r696",
      "r724",
      "r755",
      "r757",
      "r759",
      "r762",
      "r763",
      "r872",
      "r935",
      "r936",
      "r941",
      "r1013",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows",
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Income",
        "label": "Net income",
        "verboseLabel": "Net Income",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r205",
      "r206",
      "r215",
      "r221",
      "r227",
      "r233",
      "r236",
      "r237",
      "r291",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r428",
      "r432",
      "r434",
      "r437",
      "r438",
      "r449",
      "r454",
      "r527",
      "r544",
      "r584",
      "r634",
      "r653",
      "r654",
      "r736",
      "r737",
      "r773",
      "r881",
      "r937"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r476"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PROPERTY AND EQUIPMENT",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r148",
      "r151",
      "r152"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property plant and equipment, gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r190",
      "r542"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r476"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentMember",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Member]",
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment \u2013 net",
        "verboseLabel": "Property plant and equipment, net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r476",
      "r528",
      "r542",
      "r746"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r148",
      "r151",
      "r540"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of property and equipment, at cost, less accumulated depreciation and amortization",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r476"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Estimated useful lives",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_PropertyTaxAbatement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "PropertyTaxAbatement",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property tax abatement"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_PropertyTaxAbatementFromSuffolkCountyIda": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "PropertyTaxAbatementFromSuffolkCountyIda",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property tax abatement from suffolk county IDA"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ProvisionForBadDebts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ProvisionForBadDebts",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows",
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for credit losses",
        "verboseLabel": "[custom:ProvisionForBadDebts]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_PurchaseOfOtherMriCenters": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "PurchaseOfOtherMriCenters",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of other MRI centers"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_PurchaseOfStandupMriCenters": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "PurchaseOfStandupMriCenters",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of stand up MRI centers"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "FONR_RadianHealthcareManagementLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "RadianHealthcareManagementLLCMember",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Radian Healthcare Management LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r158",
      "r160",
      "r161",
      "r163",
      "r182",
      "r183",
      "r324",
      "r325",
      "r326",
      "r327",
      "r363",
      "r364",
      "r387",
      "r388",
      "r389",
      "r391",
      "r450",
      "r489",
      "r490",
      "r491",
      "r558",
      "r560",
      "r567",
      "r603",
      "r604",
      "r660",
      "r664",
      "r666",
      "r667",
      "r671",
      "r691",
      "r692",
      "r715",
      "r723",
      "r733",
      "r740",
      "r741",
      "r742",
      "r743",
      "r757",
      "r766",
      "r933",
      "r939",
      "r989",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r158",
      "r160",
      "r161",
      "r163",
      "r182",
      "r183",
      "r324",
      "r325",
      "r326",
      "r327",
      "r363",
      "r364",
      "r387",
      "r388",
      "r389",
      "r391",
      "r450",
      "r489",
      "r490",
      "r491",
      "r558",
      "r560",
      "r567",
      "r603",
      "r604",
      "r660",
      "r664",
      "r666",
      "r667",
      "r671",
      "r691",
      "r692",
      "r715",
      "r723",
      "r733",
      "r740",
      "r741",
      "r742",
      "r743",
      "r757",
      "r766",
      "r933",
      "r939",
      "r989",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003"
     ]
    },
    "us-gaap_ReceivableTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivableTypeDomain",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r79"
     ]
    },
    "us-gaap_ReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivablesPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable",
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable."
       }
      }
     },
     "auth_ref": [
      "r283",
      "r284",
      "r285",
      "r287",
      "r908"
     ]
    },
    "FONR_RecentAccountingStandardsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "RecentAccountingStandardsPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recent Accounting Standards"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "auth_ref": [
      "r790",
      "r801",
      "r811",
      "r837"
     ]
    },
    "us-gaap_RedeemableNoncontrollingInterestTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RedeemableNoncontrollingInterestTableTextBlock",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of HDM members equity",
        "documentation": "Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReinsurancePayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReinsurancePayable",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for individual claims",
        "documentation": "The carrying amount as of the balance sheet date of the known and estimated amounts owed to insurers under reinsurance treaties or other arrangements."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_RelatedPartiesMedicalPracticesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "RelatedPartiesMedicalPracticesMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties Medical Practices [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_RelatedPartiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "RelatedPartiesMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "RelatedPartyReceivableAllowancesForDoubtfulAccounts",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable - related party medical practices - net of allowances for credit losses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Monthly fee",
        "documentation": "Amount of transactions with related party during the financial reporting period."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r483"
     ]
    },
    "us-gaap_RelatedPartyTransactionDescriptionOfTransaction": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionDescriptionOfTransaction",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party transaction, description",
        "documentation": "A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r198",
      "r475",
      "r477",
      "r478",
      "r482"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RELATED PARTY TRANSACTIONS",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r480",
      "r481",
      "r482",
      "r484",
      "r485",
      "r580",
      "r581",
      "r582",
      "r638",
      "r639",
      "r640",
      "r658",
      "r659"
     ]
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of borrowings and capital lease obligations",
        "label": "Repayments of Notes Payable",
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r395",
      "r694",
      "r710",
      "r1006"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Costs",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r394"
     ]
    },
    "FONR_ResearchDevelopmentAndDemonstrationEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ResearchDevelopmentAndDemonstrationEquipmentMember",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research, development and demonstration equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ResearchDeveopmentAndDemonstrationEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ResearchDeveopmentAndDemonstrationEquipmentMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research Deveopment And Demonstration Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r791",
      "r802",
      "r812",
      "r838"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r792",
      "r803",
      "r813",
      "r839"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r799",
      "r810",
      "r820",
      "r846"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r114",
      "r537",
      "r565",
      "r566",
      "r578",
      "r614",
      "r746"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r224",
      "r225",
      "r226",
      "r228",
      "r233",
      "r235",
      "r237",
      "r292",
      "r293",
      "r318",
      "r417",
      "r418",
      "r425",
      "r426",
      "r427",
      "r429",
      "r431",
      "r432",
      "r441",
      "r443",
      "r444",
      "r446",
      "r447",
      "r463",
      "r466",
      "r562",
      "r564",
      "r585",
      "r1048"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r636",
      "r695",
      "r703"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Revenues \u2013 Net",
        "label": "Net revenues from external customers",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r135",
      "r211",
      "r221",
      "r252",
      "r261",
      "r262",
      "r269",
      "r273",
      "r276",
      "r278",
      "r280",
      "r291",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r454",
      "r527",
      "r710",
      "r937"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating leases"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use and equipment assets obtained in exchange for lease obligations:"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "us-gaap_SalesAndExciseTaxPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesAndExciseTaxPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales tax payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r868"
     ]
    },
    "FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scanners with management agreements with company owned by related party"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ScannersWithManagementWithCompanyLocatedInNewYorkState",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scanners with management with company located in new york state"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts and Financing Receivables [Table]",
        "documentation": "Disclosure of information about accounts and financing receivables. Includes, but is not limited to, amount of receivable and allowance for credit loss."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r79",
      "r282",
      "r910"
     ]
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of other current liabilities",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of components of the provision for income taxes",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r977"
     ]
    },
    "us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of receivables - non current - net",
        "documentation": "Tabular disclosure of allowance for credit loss of financing receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r913"
     ]
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDebtTableTextBlock",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of long-term debt, notes payable and capital leases",
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of company\u2019s deferred tax assets and liabilities",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r972"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of earnings per share",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r899"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of reconciliation of federal statutory income tax rate to company\u2019s effective tax rate",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r401",
      "r735",
      "r969"
     ]
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Revenue from External Customer, Product and Service [Table]",
        "documentation": "Disclosure of information about revenue from external customer by product and service when not provided as part of reportable operating segment information."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r289",
      "r290",
      "r424",
      "r865",
      "r866",
      "r867",
      "r981",
      "r982",
      "r983",
      "r984"
     ]
    },
    "FONR_ScheduleOfExportProductSalesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ScheduleOfExportProductSalesTableTextBlock",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of export product sales"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ScheduleOfExportServiceRevenuesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ScheduleOfExportServiceRevenuesTableTextBlock",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of export service revenues"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails",
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Asset, Finite-Lived [Table]",
        "documentation": "Disclosure of information about finite-lived intangible asset. Excludes indefinite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r303",
      "r310",
      "r313",
      "r314",
      "r316",
      "r493",
      "r694",
      "r717"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of other intangible assets",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r717",
      "r923"
     ]
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of other intangible assets, net of accumulated amortization",
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class."
       }
      }
     },
     "auth_ref": [
      "r914",
      "r917"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://fonar.com/role/InventoriesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of inventories",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r80",
      "r81",
      "r82"
     ]
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of maturities of long-term debt",
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfProductInformationTable",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nature of Operation, Product Information, Concentration of Risk [Table]",
        "documentation": "Disclosure of information about concentration risk of product within nature of operation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r476"
     ]
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "documentation": "Disclosure of information about revenue from external customer and long-lived asset by geographical area. Long-lived asset excludes financial instrument, customer relationship with financial institution, mortgage and other servicing right, deferred policy acquisition cost, and deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r83"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of summarized segment financial information",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r30"
     ]
    },
    "FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of weighted average remaining lease term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of other intangible assets",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r717",
      "r925"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r776"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r780"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r779"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r785"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r159",
      "r162",
      "r164",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r278",
      "r279",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r598",
      "r600",
      "r602",
      "r661",
      "r665",
      "r669",
      "r672",
      "r679",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r697",
      "r725",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r760",
      "r766",
      "r941",
      "r1013",
      "r1016",
      "r1017",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEGMENT AND RELATED INFORMATION",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r252",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r266",
      "r267",
      "r268",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r280",
      "r707",
      "r708",
      "r709",
      "r710",
      "r712",
      "r713",
      "r714"
     ]
    },
    "us-gaap_SelfInsuranceReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SelfInsuranceReserve",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Self-funded health insurance reserve",
        "documentation": "Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling, general and administrative expenses",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "FONR_ServiceAndRepairFeesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ServiceAndRepairFeesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Service and repair fees"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ServiceAndRepairFeesRelatedPartiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ServiceAndRepairFeesRelatedPartiesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Service and repair fees \u2013 related parties"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares available for future grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares were issued",
        "documentation": "Number of shares issued under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390"
     ]
    },
    "FONR_ShareOfNetIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "ShareOfNetIncome",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share of Net Income"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance, shares",
        "periodEndLabel": "Ending balance, shares",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_SharesRegistered": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "SharesRegistered",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares registered"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term investments",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r130",
      "r879"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r220"
     ]
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software and Software Development Costs [Member]",
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_SoftwareOrPatentsWrittenOff": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "SoftwareOrPatentsWrittenOff",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patents written off"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r783"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r199",
      "r200",
      "r201",
      "r221",
      "r241",
      "r242",
      "r247",
      "r249",
      "r254",
      "r255",
      "r291",
      "r328",
      "r330",
      "r331",
      "r332",
      "r335",
      "r336",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r454",
      "r574",
      "r575",
      "r576",
      "r577",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r597",
      "r613",
      "r635",
      "r655",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r864",
      "r889",
      "r898"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r72",
      "r76",
      "r77",
      "r184",
      "r208",
      "r209",
      "r210",
      "r224",
      "r225",
      "r226",
      "r228",
      "r233",
      "r235",
      "r237",
      "r253",
      "r292",
      "r293",
      "r318",
      "r361",
      "r417",
      "r418",
      "r425",
      "r426",
      "r427",
      "r429",
      "r431",
      "r432",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r463",
      "r466",
      "r479",
      "r547",
      "r562",
      "r563",
      "r564",
      "r585",
      "r655"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r159",
      "r162",
      "r164",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r278",
      "r279",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r598",
      "r600",
      "r602",
      "r661",
      "r665",
      "r669",
      "r672",
      "r679",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r697",
      "r725",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r760",
      "r766",
      "r941",
      "r1013",
      "r1016",
      "r1017",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative",
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r225",
      "r226",
      "r253",
      "r466",
      "r492",
      "r569",
      "r597",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r613",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r622",
      "r623",
      "r624",
      "r625",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r633",
      "r636",
      "r637",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r655",
      "r767"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative",
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r225",
      "r226",
      "r253",
      "r281",
      "r466",
      "r492",
      "r569",
      "r597",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r613",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r622",
      "r623",
      "r624",
      "r625",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r633",
      "r636",
      "r637",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r655",
      "r767"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r794",
      "r805",
      "r815",
      "r841"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancellation of shares, shares",
        "documentation": "Number of shares (or other type of equity) forfeited during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensationForfeited",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancellation of shares",
        "documentation": "Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares repurchased, shares",
        "documentation": "Number of shares authorized to be purchased under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares repurchased, value",
        "documentation": "Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchasedDuringPeriodShares",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of treasury shares",
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r71",
      "r72",
      "r114",
      "r577",
      "r655",
      "r676"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchasedDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of treasury shares",
        "label": "Purchase of treasury stock",
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r71",
      "r72",
      "r114",
      "r585",
      "r655",
      "r676",
      "r773"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Fonar Corporation\u2019s Stockholders\u2019 Equity",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r76",
      "r77",
      "r108",
      "r615",
      "r632",
      "r656",
      "r657",
      "r746",
      "r774",
      "r891",
      "r912",
      "r990",
      "r1048"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Stockholders\u2019 Equity",
        "periodStartLabel": "Beginning balance, value",
        "periodEndLabel": "Ending balance, value",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r49",
      "r53",
      "r184",
      "r185",
      "r209",
      "r224",
      "r225",
      "r226",
      "r228",
      "r233",
      "r235",
      "r292",
      "r293",
      "r318",
      "r361",
      "r417",
      "r418",
      "r425",
      "r426",
      "r427",
      "r429",
      "r431",
      "r432",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r455",
      "r456",
      "r460",
      "r464",
      "r479",
      "r563",
      "r564",
      "r583",
      "r615",
      "r632",
      "r656",
      "r657",
      "r678",
      "r773",
      "r891",
      "r912",
      "r990",
      "r1048"
     ]
    },
    "us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversuion of shares into one-for-one basis",
        "documentation": "Description of reason for including or excluding share issuable in conversion of contingently convertible security in calculation of diluted earnings per share."
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r461",
      "r487"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r461",
      "r487"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r461",
      "r487"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r461",
      "r487"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r461",
      "r487"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://fonar.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENTS",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r486",
      "r488"
     ]
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowElementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "SupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of supplemental cash flow information related to leases"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "us-gaap_TaxesPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxesPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State income taxes payable",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r122",
      "r1008"
     ]
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]",
        "documentation": "Information by title and position of individual or group within organization."
       }
      }
     },
     "auth_ref": [
      "r906",
      "r995"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title and position of individual or group within organization."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "TotalFacilitiesOwnedOrManagedAtBeginningOfYear",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Facilities Owned or Managed (at Beginning of Year)"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "TotalFacilitiesOwnedOrManagedAtEndOfYear",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Facilities Owned or Managed (at End of Year)"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_TotalFacilitiesOwnedOrManagedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "TotalFacilitiesOwnedOrManagedTableTextBlock",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of facilities"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_TotalPurchasePrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "TotalPurchasePrice",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "HDM purchase from Health Diagnostics (HD) ($)"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r826"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r833"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransactionDomain",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement between buyer and seller for the exchange of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r701"
     ]
    },
    "us-gaap_TransactionTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransactionTypeAxis",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Type [Axis]",
        "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r701"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r857"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title"
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r857"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury stock, shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_TreasuryStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockValue",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury stock, at cost \u2013 45,081 and 11,463 shares of common stock at June 30, 2024 and 2023, respectively",
        "label": "Treasury Stock, Value",
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r41",
      "r72",
      "r76"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r27",
      "r145",
      "r146",
      "r149",
      "r150"
     ]
    },
    "us-gaap_WeightedAverageBasicSharesOutstandingProForma": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageBasicSharesOutstandingProForma",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average shares outstanding",
        "documentation": "The weighted average number of shares (units) outstanding in the calculation of pro forma basic earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering."
       }
      }
     },
     "auth_ref": []
    },
    "srt_WeightedAverageMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "WeightedAverageMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average [Member]",
        "documentation": "Average of a range of values, calculated with consideration of proportional relevance."
       }
      }
     },
     "auth_ref": [
      "r450",
      "r490",
      "r691",
      "r692",
      "r740",
      "r998",
      "r1000",
      "r1003"
     ]
    },
    "FONR_WeightedAverageNumberOfDilutedEarningsPerShare": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "WeightedAverageNumberOfDilutedEarningsPerShare",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Denominator for diluted earnings per share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Diluted Shares Outstanding - Common Stockholders",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r249"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Basic Shares Outstanding - Common Stockholders",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r249"
     ]
    },
    "FONR_WeightedAverageSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "WeightedAverageSharesOutstandingBasic",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average shares outstanding basic"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_WorkersCompensationPersonalInjuryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20240630",
     "localname": "WorkersCompensationPersonalInjuryMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Workers? Compensation/Personal Injury [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "30",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479910/205-30-50-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "740",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "44",
   "SubTopic": "20",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-44"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "330",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-10"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480489/718-40-50-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-18"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4M"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/230/tableOfContent"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 4.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-5"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481440/840-10-50-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-20"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "35",
   "Topic": "720",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column C",
   "Footnote": "5",
   "Publisher": "SEC"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column C",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(a)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column C",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column F",
   "Footnote": "7",
   "Publisher": "SEC"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column A",
   "Publisher": "SEC"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "L",
   "Publisher": "SEC"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 4",
   "Publisher": "SEC"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-42"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/330/tableOfContent"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-4"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-9"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-4"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479741/842-40-50-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-21"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "12",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-12"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-19"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483385/720-35-55-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-7"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r868": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r869": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r870": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r871": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r872": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r873": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-9"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/310-10/tableOfContent"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "40",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481628/310-20-40-7"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-11"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480060/805-50-25-1"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-1"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-2"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(13)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(cc)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>97
<FILENAME>0000355019-24-000038-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000355019-24-000038-xbrl.zip
M4$L#!!0    ( -2#.UDJ)S(D09H! +(! @ ;    9F]N87(M<&5R9F]R;6%N
M8V5?9W)A<&@N:G!G[+QW0%/1LRZZ:88>Z5*C=*5)5RE1D28B(@("0E1 FH"
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M18MY8]T;B+.-E5/+>0?-OF.J!MS=$HJ4/;Y8_\"\?2Y[,^^&.6*/&=XT1RJ
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MCV/FUQ&\% LK*>1-_Q@[,0A%1@"L,S"6'18.&99G/G/B\Z&NK2*YSML0Y:N
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M+S;;&4<Y64\'"#\9,2\99.1FHSF&$<0@?SK0/5[_G[O"_K.A3)E_ ?H+T%^
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M,WA:TX+QH-KSU]9K*,'6)QPN0+OJ/L\T%"#GMMG<&G5:LS_S7-1PL&*:R??
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M:R6ZQ067RE5K:^?G$NNE;N0F9QO "IM\$L!,S\!)"-8].#.0W1,@=]KV95>
M]W=KWZ]:/!T6ITZ<]7^K&&]M??:'AA^&6[&C(N;ZE239M(GYH%J9T3PKE>+Z
M_$\C]H7U<+$EA9<+!,.D5^!C\F)-(UI<;L70SHZ4];O/4<FG5@P^&(()'% C
M=Y1(U?"F2]3TC_E3>7SW##LCP;?O52K%^NZ5%3]X?&?XW=T7RMJR$V_\M7[
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MOB-U=D(@@$2C!X1@OS4U/M"K]2!4O1<>D#M_-1A#V:' 60ZA.$B/"=.B==>
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M3Z" I';7C7S5!(EA>?L')A<F5T,\(J8*#KBI_-.H!'IE_.D-SH<2"^.A?J9
MB#(8VOF1W;YG1D[K9(U>W)\*;\?D](?56$G+EK>GET\\0IMMEHO5U!OFWDQ4
MZQW3N\-S;07$<^59Q=I!;0&[VRUIR?E[?\K>OFD$)VCR??;3"Y90^X_+I/U5
M'F#@IG\?R[W(WO)X$!G"+C$R_\EP,.*:"/O?>>[4MX74>OBC3>-VTN%H!NO
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MEUOLD:Y08)6S*FJV?UD')DN4+2=T4@*3*6%I\0>1#X\P57=*A;C%"YD?+YN
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M">W*6FBR6GJ<8<K#(/Y-/)9!8BK7JN^YKJ7-%\'Y1;J-GE/ 8P25]#QFW?8
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M_95OIM%;=$\<_1CQ%X2C\#>G/YU:@J@,BH"OB/QWGDD\3" SYIY80VE>272
M7K!^UF9E51OQ\39\-M[8(0_$TMXHWH 3)$R(7%0@7_!9K\RWN$\?%L)*:7]?
M]QBQ)1)<Y:(J!;/NI2CTO5)(7G=R?=1&^,8-+#%)-]WFNX3^MN]?)M?J4ASN
M)&V&]+B$T*+@:]<_X.LKV(]F*KI$[;_%@V5X53>1VV+!9 .U2/DPEO5)N\ZM
MZD]%U0/-R(>/V,Z;MMKV6O;2"%)W>2W[\E"0LUN8IGQ.$00@%-]S_CX[=/9C
M+;IO!#A2T?)DT.TE0E,XU0MMTM5M[-;)YW,&-L1M*14T2Z:;^D.Y&4X!&22O
M4P##IMXIX"7EZ<S)\VS_0("YC]"+K 35]<[@L.@HW+).^="LRO3+6AH88YQ3
M8!'EX4]. >[;<9R*_&<_)3S<>))[=YC_MQ;2<8-(YMXVQ:VK(/%<+NOBQPY'
MC7IQ;V\'Y!7(ZZ,GNM<I[:#RCW&0"][N0OB[" A.X8"&DK["5%PV<K&18DW,
MZ8D'7,NS#TSIQA"EX11J21./D^A&4!.8.HKQ'[<MT^1\'H0+,YOO^Y1A!>P'
M^L]T2!T]*?G)!N'K71I4U5KZ$6Q7=C$KQ<._<S8[1)ZOI)_KLT7[@ XJKEAT
MMGOSK]\-.I3_TRIUF%@PS@Q%&;-,WA>^XGGB?P\_J'N0+#!P\9A32O#5AP\T
M^YM."WP_<U^&'4\.8G"F)@0)MYA3@&\IZ\W:\>HFPYN-N(T1 ^^G[G&7EEX!
MUOI^ NOSV+1H@'9'C36JM@]$!1^^\\!85;L?0Z<A7YT?73YWKRC 1.?P'2@!
M/E\'K]R.5@G/Z+ KJZ#3?I1O%'T*0#^3Z6]T/@70\1+51E7*$N:1/)Y)UZK+
M^)G<9S B/Q?)U'::?R;A@INY/#R1TW/B^)R2=KXI1>4^S.N'E-H=7W.B*+#G
M4N0A32Y)D\A+X^(.G.('!7Y2#T!3<SQ[J#KS^356SVH0ZXXF=4:B@D!]P"D
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MP1].Z M\"S3P6FI*1\R4V-AJ W)GC:D\LAMHRN^__:3WL_L PU#SP OKIY3
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M"6#V)>7>-@W4P7\6\](PW5.;/AK>]SYO7Q[GS!D9;BWIZ]JV=^2S-]5_<KU
M44V&K;7&KOZJX[0C3<?.TQ&)^V#%-VOR.#+Z8Y$Y1]YU&UP*,3=A'4FQG>0+
MO8.>OZ>H:[R?*1KG@W9ZCW[)SR[GTF<M/P9>0>+76CDR.8V'%)U0*I?>+QT>
M;I;&[N[[ZH=@(!6RH3\,E0J6M&< [D9D?WEXFEPDH3[3 2E]Y)J\ABE7$OMJ
M[9S"B0*1GP/CZR%U$YFY_,T:=P^MZS,]:6U :LN]XL:/-E=!/;]V,.:-M_10
MC4*DG@]T[ .Y NQK7/+GX SSDIYMQ,9UPBVTE]O>*[5.GO%Y$E&JN[J9Q.!;
M,SFZ!;L@;NU0O2"6%[?Q7J10F@^.Z<%J8F;>RFL*%7K3(>L"Y4H3B54(<BEV
MJR=H#N>8*2HNO;I7#+? $XI#96>F$-L.Z/==QLU;RW.=''_JP#8CKL/E]#OA
M39=5J:MDRD-22GKRRP.V0)CM'((VJ(U9>P-[-."V^P(L63%S&4G6QHKM->>8
M;FUX\Q1=4KA\@0OM?TZ1\XF(D'Y^MO*^^/SA?-C+X!K<G!35>B]6:[X95*A^
M&/3.VF8'HE"$T\1W>E%PM#=30 Q; /A*A"-\>O<^Y&=Y9?JDB)$>?@2Z-WHB
M37$85=V8<G2F8&,Y!+L-\01>XH[DU'!,N.&TMS5=7S+<;E9/85*=T*$,3 X/
MH@RJ?;_:UB:,E?3$B+GT@P9=)8]EE]7W"\@I7+/']Y/@\UAJ#&*;NR8+*X6Z
MAOP]G^P)&O5[\NWWE&UBFL:<7S'*\CU=)FR++7@2K(STDR"-][";P5KF14.#
M DXN]COW4F*3GOW6XEZA*=J;2Q=&C9NZ4D &X3/?25)3D#"=:!"7[X.+H;?U
M_31>&C>7<@25JMDVWH^B?5=:O>N\#2PK(X\&<?+7E@,JD<L+4.#^ZB]$XN/>
M520'-X![UV"^UM;&@Z#./6^[SYY>'?AIP4TF^6&AEQL1B3M:/B#5FNI2YL!W
MKQ!"V.N7A'N+*-N'\X^?G,5<YM0V((XA*J_V/T[ ):#Z.!?+RU?UUV"$J#&%
M',+D.8U$7"V4CL1-![,]@# OA(3-<.D7S59;-U+*K$TBG33W(&O5XPL0.Z/=
MB+IAO8K?V0/V7+H"?T\ $A_BF#=TT[DU&)*,'+OA\4&5?$*;+>#?26XW$='R
MYYSYX([M-M#:/!^XC!P[ V.<AY/-32$76S KAI@H1\-A 7MNL561RZJXX>'Q
M>' 1>@'!FN1(+B]-&@1;V)A_PIBM7\KMCCGJA*,X>9<G+4Y,WR10;]"*6_GV
M0@0JO'"(DXS$K8LU_>-8Y+&,CE(0&U2$OM:&;WKSR;VS_P:@M$\3?YI35,97
MI5_ FB"8,@87.V/.6<SP[ 0-_'Q;0=$AVD;8- Q:.1B+.C3S#<^V?,N#5-WH
M# .TWRH?9-!'7Z=S/\(7$#;'0W;,U67Z+=[J!$5IS3@\8[JNKJ7CHB2>O:1^
MH0<4I>20UG@0B*\O1&XPWXS28>K(2I/C$KY.Q24::&LR^<"Q^BIH/A449!V8
MRH/T(3<Y8^O#T0J[N#Q(=*VY3#O^D84"WK96_1P%%"U@]%_>2H0Q[WG)'?>G
M'F'Q(!>USU=LU29[_\JCA8G97C_'SN!"WYL$*E>.]703#_>0J-7X+;_+)EV!
M[!^EG9V7\Y0I&K'O?B&H%8B-OQN>Z4:Z#-WX3,FU^<''*>?[N+?B%@FUO^+N
M*Y[0++O![EI.N7X.([A(>%:$H/)3#,%0"(GIJ&,<:_XL[R)A,;FJB$3-)PD&
MZM%;(R)^@QQMM467JH1L5@:[:] V:>$HY\A[+-5B352.!SF:*Q08Y*:VOK9K
M"HKZ[@Q';M.!0%<F!SEUQ7[(H>"Q/2P1]"E&'&*T;R=RHI?[29^5/IK\/FBO
M R)ZNQ /$@A?/.$D$;G_UHME@D$9]RVHX!O-56AUDWS_N6YAV2^X,P_JJ@>3
M1ZL5;/^)2C1]FGJWG+7W\]+LA3<?7]IUE)X#?)LY7;UT[UG+VLGB:Z9TI<.3
M3Y=%+ZR=%G-.O%B9@G%]:LO9XK#_3:#B52%&1^14S;ZW=+N[<6L_.CE;SB7^
ML&7F<9?/^\T5\""'3DC)7VPQ%\>O]!TYDP>D+V;EGCO1:F>AJ'P/UI*NTGO6
MX;N=6;"IX']TI;#<X=]"/8J+'1A1;#W?%U,?(:762Q\AMU<A<=CR_I(U?$,'
MMH6HT,\Q9Q33PYRKCE2QU1_HB7JKR+V_6P6OR%8U.TJ7N'YNJJ-ZQ:.EIG)-
MZ%ZH%=O34DNC:")3]<;IBK?2$&ITE'F)WR(9"1Q -"*!?;8<28\Q0I(.20:X
M )>RI%-B4X$\8ZN?L;/&GVSEO,U^ZU>''7YM,;O+$1TM'SMLKB,P0V%80@$-
M2B,.4(<V?B3]<OJ-WL]4:;2#<U1'Q7L5N-K6ET_J=.D)O0SP7 V[(V<IT">Z
M+[!T]>R1S_-DDBKVVGRLLB+W%98ZB93F7 'DE)ZC]1F.=Y]; M$TI9V;NPU,
M:$>_)OCG/$.$ZC3H53XZ%W/GMAD\[K+ME#YGAQ6K()JUAQL+[D.??Y;:R<#<
M/=$19;%Y</[%ENNTG:S;SW;93$Y,V6X4G)@']C[E06()?"M. WLIE6<:Y^0-
MX_+K&5[U%8];AC35)7VO)V$X-RE?Y)QOD#ZJ3.Q,F>6'P$Y %5I' 0Y(3J7#
M9 P0Q;XUZ;&7,X8L:\L'"!K/;2TM?/1./0K?]+3(LZ+E*[I2;J> "XEQ&C%H
MAOQ! (4G&15C8%8R<6=I5^I9IN#G5(V:JB'=ONE;".WM03J)J=_Z[.H@(E@Y
M++4$"T%XP<F_>ZAQ.$[D52I!@>)3YIO666RR)S-=]6;Z]KRABUNDACPN:T,L
MR,+7-2$8MRG8)L/]V/HR;#6N801AS.S_1)\?5*![Q;LS^EJ>%[[W0>O?OO'#
M\<![TY?&AU=+W\;38SU1O47^R)KI[Z&SH\2-W.J)];6N:IIC _(>#R)6E0B5
M!P+K,(@>=#B=(#FUF,MZD$V>GM4VS8LL4&B_/5O@>6I;RU?FJ3V/C'+:%PW9
M;D;_3CGRZ8S1D1&5<+D=I:?JM8RF!'9ZS9C_>^7(CW!">W61.]!'GH!*J+7.
M7Q@URSXMS;GH$>RK2X1TY<'.SD7IQFT'\QZA#&/QE;'Y.3!&H>$>/#N$CW-^
M9J3^VU.,ZS5;NH_E<25(\7A V(L'^:RSOI,"OW0:W(NE[L'S(*H#!79&RJ[K
M&RG>8KO4@6<\R)TT+"=U?5\&WUY/$6A>X 9G'F3!^J\E8/Y)[I_D_L^3P_^-
M'/:OY/Z1ON[?ZB7_ZUZZ_DT'?VJ/>?V]%^1?>X'_+[+QCP/1G0GA]_LWYM:W
M)_WIM_O?C.0_X-<"Z\T]PX-T'/C+%J;U >:9"GA\0;+N]UY<9.30+!'+XW]Z
M;N%FP2^B*<)$51C[9OFZP2_'=OK:1)INOIDG5&M'(Q.:M^AFF4[6XY4O1@]T
M]%QW1;RL+S&YQ*B^BSYM2>2^J#4.<2U(;USS@W5^TUTB'LW;1\^(V_*IVTOI
M>N$F1^!Q#OS\,V;F1[8&1X4IF(9GW6!67J<LS@4&0F KS63:^T^W0>%EQG/G
MSW'4ZN8Y@TR\5X:$S'3-U "EXS/M#J+3I07E D?EM#7=<#-WI3?PTW,!"T[G
M (*:-KKET];K:!7F1//0FRL]K^T .6.N7U(_B9HJJ4?/<^*<-^&H!V4YZT]<
M6%QSG)53O-T]U^K[Q3E B9O:T(1R;70(:]PS1>;:MCP( X6MF?+?4_.\B7L_
MGDB+U)+%VMWH2_3A0392 &[V(;9,]'+;#=3!$=7U\I8TDM^/RTL3+\S,<]T7
M,J!^!+-P*;1\V]5B0U2$)9A'O_"$K07V*TL*_I)&;-.HHV^;/<Y/@DE]69DJ
MW%)0_@44<+:NJ'!Y8(1YNTKXH?O B5,G[T=NH=3E,5Z7OR=$W41J/P-,1+"_
MW\]\YP/1$LQ);&,3UA<*H?KFG#=ZH<^*BSN%Q;?5]I?P-6 3 2"-T0KSO4&Y
M#X(%&5]03N!N(\1IKL?M+:JRWAZ&XZ:>OB2Q$"7T]MNO?:I=:U;?M:URZE]=
M]B/$%J[RU>EA[7&:R+&Q"CZO0U]XD(+5YBQL?42M2>#= D#0^D/KA>K>47A7
M3N#DI3=Q_-Y^?7]S0!>ZP9=%Q3W+JDV^&'E8!I$;&58"MO @H@:G7>=  <:3
M1OT+_EI;P=O!%VT^\*>0!.PB'-?)W-CSRCUBJ$-'=NWZ%4X^2[;W]UNUF6BN
M&_T+K+ZUP8_=53T5KK?.40^ 5#7I[#+PD%3.<FYH7%PL-(,"6K"&_68*MLP$
MR0&]0U!NL<OH3C[ .,21[1?VUIGSL/48%3MM@F//A@:YS'.VX<:6R=4L;#S'
MX5IK5IK3-3L@_#)8B50F/<'AFXZ)CN7:,W@0E<KUMUY8D="!(7\_VL4E[HS+
M22'ZGCHILC>,80<31>4%LJY%TT071C;*N+BFKKK)K^(N\3O=;/;JN0T0O^^$
M@U?W74&F,R(W*(+"V9;8>FN(5,'Q&/M(LC4<16FO!KXNI#LVVS+W&EBWZEPJ
M'&>FOTY?Q4>X@'VI;EKN0#!SLP-B)*$Y#GS<.\VV'DUM;83%"X$C1:35O:03
MU['41!Y$4>>D82,-+^(J->7>!U?A0;[[-_N3^8#]" _BBQ4R0U1@=K9 0 6D
MQ"C!]MI]D3[W64)"^G!8-[UH392;IY[!EXKMDB$35EGR>L10AG,:8>6* "WS
M^)[%UPOT"6SBA_B =8>!%#%GI+-&&(+85W['TK(+>1 [A>,/&L&A1:YW.NL>
MMPHM,E.=J=A;M<E-7 >5)\1,P,U!)^ZEMXT:[KWI$U_GB.-^"(D<X#LBV%LO
MT-*KB<39^ <^0.=VO?7"Q^ E$0R)3A[DD=^8/5_$AMS7!C(Q_42YEAE\./[4
MI_OX HEMB /?_RQ58U2[\K;/XL4\S)&?QF<D3@WR(*$TL)('J9Q:YCRK-7!L
MF_<=9F!NI+ &.#JQ^8WKU*'<FC_N59"5T@?A=^/,U.8["@T>9'4OT3P.%!W)
M44".H@0=G$DU<+HZO@21ZSE#8K@Y>]JSH+'=%;<6J_QS>!"E^SU@=^,0MIZ/
M>&HY]F.]E464U_Q$<+"5];!/^ ]9^-_(1K,M9CRQGS7^>-@_4RAFS>?L*4"@
M:>G8QDK_) VO:I603CFHY;^!<W:8L_*8U[%,3<"7$3#N H>Z*1_C0112[+EY
M)K]&UE0RW=0]YT\?*D!86($"*T>X.<N'>!"=BK\'$B%62F\ZH8$2[P&._(4K
M*1Q]8*Z8-LF#F#)^YUZ#*DXQ3-8^+Q<HU".KX4F']W[JO>X1@)]V"=F)I<!.
M(.;$4^X1Z6HT][3'!]=?] 2X+AN.(RK[LX006PU5<>S0/]+RX>;-[PAFM-,.
M*K-82#Y/HGP7(8WYH;S/?R73X&.5VMO/M*-TV./3YIAE$SN^+9S'="NK3/ @
MK>13JS,5?FO14*Y$L'G_S*<"4N8]*UQ%.%90/9]["?>Q!.$G777N*A!&GTKO
MHY79K8U<V,Q/$39M9@S$/>1^;"2J5 BOU+)?'CZ(.%X#^$Z"6_!,_'D>!$?:
M#IP,HGSMU?K9.AGHN,1W)C!<R1:V5V*MMG\F\;SV9]P;(_#)\R8:X7</Q]80
M[=.<VIU\8: H9?D6/SW>% 1<S891R+-&T-5Q0[P^>/>FWX9 0+.S88LES),9
MO'W: \J#*!/D^2&=&B635,A/W^\'P157C]DAOIV>7@H$=N;%[5*9 X_UEQC-
M_B2;"W.MSM^^CGX7A=36S0Q:1HY17T&=L?7'G1'4#X@M/;^GB8<#V3?XKA+G
MH-X):.4U3$7+AMC*?E 2=#F9Q9]BETLJX!8/!O%[=% 1JH:1_&I^MQ%V_FE,
MZ#$USG8\M22CKN/US$#1)_2<C1MV]X'T 3)[WVN.21%IO!<!6S1H=^1/^A)P
M87-S>I3N+-Y$L\D.^KTJ6+Z5(_/M4AX;,=:I]NJYHR@G6W>)Q5?,C26 S.L8
M!"/:^8M][8#]9WR^EFFHO.,O*4:8J>!G('3,)#DSX.4.4J&@>5FK57CN%(FZ
MH0T%$IB'>NG3,$"H/F.2(^/7&G;\ >X>^JCO[?">]H-<D0MBDQSI8+K-!]B:
M]+.QH9N4Q4:;EVUK 0\'IEM2V/HH42/!7VY0QDC):.:%ER(>"RY3OPRD7D_?
M$;UT[ L$\6$#86$#KH#FMHP<ALWH2_6!AKX#K_U!\Y\UV'HSA ]%'@:D:V6#
M7L9>8R,_,4'5Q7JV291W\ =/YW"T X4W#3YM=8$3A+X@)Y$$T;RZZ VR<9S-
MKUTMTE][(Z@Z6*\.CH.G[ACF"F(EJ;OHDP*R %@-8E2P&I@GY50#XV.04>)%
M[D*@X,36"WJY;'E,K_*NAU43.+IKU,B9FE(T-U@3\^WIDX@#]!_GLN2F]H%?
MWH#[JQ?5P9V_Q0. I$L^:VV<,WA0F,"<O( > 1 NCR53)RZJ\R#ZNH37V/H#
M&+6+211O0Y5*M?R$AOU!2]RU@5\LH2JM0^8L4RBB=CJ/VG^R"F_PR;.S[8$:
M*'RH^#T/8E,)Q)Y XZ#D=XCC79?T<'RYO>J^;,=]]1KM_4&)\T#-YC[^V_CL
M\HGGFQ\&\R"SQ=+.<4C/I7V =>/!T1BN*[9@M2J7'Q0.&L*<B0$&PLP9Q@J%
M^X*O;I3#T9?,UNFM M:Y4HL84<[E3^H#WS(485^F'"ECD4?>/&GV+3TOW84,
MFCW+6(SS01]Q0O?Q(-JT3^HL$^!$[L&KW)<&D>K)"_=?"S'\&M3SNXE0].$N
MR#9,A_+.ZR&'O2-"[F$T;_C-='Q8YA08D]6]O^<J91/I?3D-@R?@T6+6V*%"
M#BZS,AX-S]K'AM5!I5S\%<-=]KYXS\DKB6VE+4S[;B+54^YON]MS[:5[%O9G
M\VVY;SXW#G5XOY(J/R$?'B"1^7C:-$(U_!CX7::P9PS1=&6I_(^KB@"_D_F6
M8,=48?SEP;+#+I^PZ+GS(6_/NJJT"\TI%(CC18A[H.S@/Q\C 1\Q>S >^??(
MM'RHI\0[JTOU?Q6V;UWH!'R4_I#H_"L)Y#\^^',EU?KI+1.^]_X7>C!&M_Q?
MX;W0W^"]M$$%*(^P1RR>_LO!US_X'D;6_\L3[%\>#+RU,RK"[4=4VF2/8'9P
M+!&LR3^H/8X5V[L>C_C<\R"0HO6 \,FI=$?@#HGIUK)Q(584\01&$FV!8(U?
M7?]Z/\"]9=[!>$[CPX9J!3AH27 V6&K>I1JV0_*7SW*"012=?C'=9 6_A;BK
M#>IQQ1/+HE7\)NX<1&*+@?WT^*.=G;E.L%;04'VH;OCH1!3DQ(&+]H?2!,4T
MJ<2?:'9X^%BQ.<(;V$3[?/-FF'=&T.?EB8A6(B/P3NC654H%YN,A-35L7$AC
M*M"!//.D\[3#QEL%(?0^^/O)3*L[Z<UF<' $^1/]ZC;#8RQF;;O:KT[:)HU@
M]B<A&[[B&K^XH+ORJYZ!.S>LRGV.OO9J];BF)C]2?P]HCGQHJ^0C"^HJ-SQG
MJ_\VUWCOL2^].7;]O9SC*FS["*8%*52R(/1KGKE=X'<)_W&@G]I9;A1Q&R6@
MM8Z4N&VSXFIP$^+E>.1/A C4)2XZ>WD<&=1J'U6^?_Y>'+B!U,99)O)];1#G
M0(V[.V#)?-NK_%SMW9&5U1)K3R3?V Z!2A?W+]0*,B<H!N@X6_[,$G-UUTR2
MOA\^%FQ)O<&#M"4?!<(;*RBBT$=EJRFA?",L95R_2^P<P^*"T'D*U.X?7@/Q
MFS$O9W>S06'3U^W\,$0V;T'Q_4%:AEDF'0%(5*V]0,UHGWX=<2%0JQ%1&M39
M,"J7.B!"7 &]?O9U<B1</, W0[22H#8LU&F9'[BLBPH[ =76^RT&B7 8WF[O
M73]<]P+)[:G7[/+KP2@A>WOND]AI6!,=?P^MJY:[F30WC7T&4$+_5&>Y<R<2
M?YIYAOAJ"<4': ')?GOG06$D,T CW%"F?^+ST1%_B<BCDO+</#FEH%5:NO(R
M=/^KR947%0R_.+>N1TNI" E)4/@9D]QX([$^HYPSN&FO:>?//E\8H$:9D_3!
MJS> >VR"%Y!OZ3P(3(KM9!@8(2+^/I>;:IZ##?_&D?F,:3Z="(XB9#41[A1R
MM'5G2@Z*O!/[H? .=LG?QYA]#!R0OW;J$-K\/NQ3]46552MD6>[MA)-"H;G<
M%/'4]%%SCG'M)RS?NR!8*QQ!Y@(BEO)N;T)N(^=,RXTPW]' Z0G)59&'0"JK
MY?MA+.WG(=O'/$AV?"L8%;PLM<9Q=P2E. 5OR(<XZOA<1];5=R^(3&S3WB!0
M^HHS=JCUYP&P&_9.^=[<A E3X(F,T%?&EW(<FHO'?\OD:UO>G$/69O9Y%\;"
M';%)P,.'@PU17Z8ZMY@?RANWOKW%<D(6UV=JS@KI[W-&,$479?F07/?MIP >
MQ'Y!"4M]BZVT2=1J?QR3D'R*O-U^F2YU<P 456=^M!;L[ F1NY5\)N-Z._Z+
M,;(8^L:5M'E4DH\_I5PF&S+\)]"S"I:'#RV>REMS,!##/$$N+\IP3(@[<8S%
M"+P.#_*54\SW25%T]/G*-.W0+-1)TXUHHFG3=7J>4,<1SH/(048PJ[D/5.$<
M[-+];"B--I+P32LXRM:1[A2W #>'=R5DYAP0WT+[Y!88JZSTR*CSE<_APR^B
M^O.#5A.&*^/]B_MU3!](QCC(0AQMY&-\L8J_([U$&&!@>E_JUZ"26I>N(^31
ML$.&R@"9WNJBDYXN+UX]-F!YYB3E?++JLSLB87<5WI.#DS]\R3SF]>JB1X)=
M=\(OPZE_+/OD=].O'N&+!/:&U4.'-HP*&_@P!NJJURHC6IX7$HOAL;^T=(6)
MG[&!J/YYG=(*'9D-@ANG>1#-71GGVT8R5LC[!.'U&.$NHA+*=\", ::^\8XP
M35B]U7\L\JW+D"M\Y9R.P/G;D /X)GQ,IBS0.D;YA91!!1LS+^ F&\-82AZV
M"6M#W^*;4BS'OQ1][.IS=I6[ (G:4A*5 +GN_R%<MCF<#WQA@_ QY)RN;C3'
M O!BL&FB/E=BGC'A<=>7/;P5YL,QZ,!29790QA(_,JC78T2ZB,I_'XS+7P=3
M=*N_?P81HV(D95X*N5 PLR]K>8? &*F4![%-I+#.+>.YK]S&W138T"7@$P]R
M%<Z/*62IW^<%_NU^+0*<FXW]&0SP3=@C"CN]:2XBYK^F;.M_4=MU]K:(^5W8
MVX*UA- =$K3,I"BK?1?'LI.X%_)],[=U+]^75R\4=;W__*V!\6-P<Y7LUD5C
MV6G+URN'TN23EEY(+EN,!2"NS4,Z0R<_4SNW&GSXQNK9J;DZ5SRB,D:,SA)@
M*:G85/XR2/2T00BXDG0WOKC<]25))>V*^[R\'3OE@N8!\J&F[=!LD6?^5XR;
M?'@0=$**X6-:T)GI!R)^WJ_B)00:]G'V#QG]VF_<L4/^=5K]W76%%+K<\M]=
MW>Q?*IS])VWKM:3_<&8OSC<3$H[)U,W'C.YA$A("2>4<;2IW[ZQKW[S!,S6V
MTLM*N,[":E"A!=O#[+B=<_)!@2,[!+KL+%[N]_ZSF82O<&<C$B ,RO_VD:E\
MQW];^? _9>.?[7_>Y(??*RXB[Y$DB%HH+"B")&#KSTC2Q7ZND1(07ES!I@QL
M(VG3Z&B-#Q%6WC.GNZ6E4"S[??+M=Q^BY)3#)'3.?+]W]8(+EXRI]6+,(E/P
MC!OK!>U[&O'R&$6.%?<-J @\8H]5-U%$ =MSO;5GWR7/7J4K'1MM0%;6[TN*
M3?;1M,L>UE8L7+"("THQ,DS[CJ"^M&++\T&/$5$2(%!?C!Y@X!M($F*.%DQ2
ME,[0T+-:;<4<VXS;"DN5&EW.*1J&=IY;8C*E!*P.IM[GAR 0,T@11PM020*8
M3HP!D,*#B/18 "N1>_(2=6=#;WWH1NMOD*G=/I=P]M&E]\D=\J<\-_@\C5*Y
M<K&:(^$(BH;2D7PJE0I@.ZG**_HW1@G357/^^KNPS9L26IL3%:WW7Q5^VGWA
M@5QODXM<5%E200.L$K$./*!UV*%SOT8X]H U%2L_0_*4CYA)7W,7LU&_\;5=
MXM*;H7M&W\9/OJ^_I;(Q P*(LC;Q(-&>?,>)$T>?8L!:>)!8K(0!EFEES9C(
ME2Y[73NZNSO46II%VSP">\ZZO4-SO$WJG?".6"/94*%>/H+_!*N&)8)R?K"-
M)"]H#''G1T9>DRW9L8GA+0'$=MRI8?0_](H5??X4-VKY]-LKQ9O2^[_,W2@R
M/(=C'5N_J6^$ *A7U[L2[JW-WX?S(%ZV9&13*0!W8(PLU[\,*3:;<$@8"9.,
M72 [_4RX\)5XT3Y'>F/%$H5Q_DJ0/D<IC"W?C-4IG8H?N^]9==6H<0[ITV\%
MG4<W^]]5NR-N'@%9Q@('L+^,7V'KM; >>[E9I&LOCV$W<2P![="K;WU3FT,-
MYN@=NGG)HD.1'L$3P.'/D\^N[C4]=,C\9-/ %.S7 [;9% ]2-?FKG@I+D!<Q
M.(9,7CI^Z=H^I>H3!1D'.T5A\V;C#^E)KUJE:"3&Q0^_YO@</416FK@U=3>,
M"A--!8\Z.Q]2".V4V($PGG:+Y$$V?RE>6#_NB-F(]0Y<!#L*'X\:[X;-%9M\
MGA[Z,HB[?E:(])^67'V'U$FIZY#0>'3@T=N.RD,M1FHO@I-O8!X+3)#^,29F
M&!X%*#3KSGA049=R9\G*>3?SV&?O1!I2?TZ"F_!KRV?VD<&%M..E/X:2@E.F
M$IE"M/>*:'W&M%(9K1.<R(+:K]<HDH8VX];V@DH\2 .!!_F0SX/$1#,]P'A2
M')91R(/\]H7\I>;198X3'UD&CE$X!W@0=@8.<$)((Z:> V'KY;K6J=G]D]H_
MJ?VW42L%=W,B@11&>X-^Q$0!@W**+9;<J?^9:3.Y.G+V<N3S3">,7!;4/[NV
M"K.3X]3*2<6*\R!CCCS(<"^)48K1P';I,^9!*2RWXZ\EMS1@B; E:\YQ?O_\
MK#?8CI^]"-%:N9+_\KN_%-UJJ ?*>)!3E$82X,"#K.C"_DGMG]3^VZ@]FL%+
M@ONG;^G+V/,]-0_RQ%_2X@?3S49(#;ST2<B&XP 71 <"S^@\R*;I8[_Q#,I)
MMGB9C]0<Z1FMF##>=G= Y=>PXG8CY<[_;TS'/ZG]_X&:+K@3[4C%QX+*G=P'
M^'5R>:8H?",!1Y$P5$/I=5[L)BI,82]_&MV]B+:O(EK*:[<.DFKS&,6D_Q<'
MK']2^R>U?T4-V@1-^/4#(<8YL6X?L#5K)^)V@,V$M43$?O2[RD<TB[4(3,@L
M2;OYB+)WPGX4XMI/_R='U[X+O>MR<S'<^=>1S/]E)-',OU@6%#OF_!?#.N]X
M@L%V9HI7O;:$Q^NX:HIPKQYXZ.H+\S?#^3YL9NT5WA-[Z(?B8JL1/BRS$E+Y
M#RLMNO$;N>H+V/57JU'5WOR_#%L$N6(,WFH92HF#2<^%P)6FY%4Q>[]/=/L;
M('U4(Z*F;SK9N+N&GTF;#Y3/]U\X_%N@.@!1Y-"!=@<<7W%" 7M:H""0V5$%
M%4.U6W[\ONSG\&Q,7R_]8*UDZZ<M(2,*I</W#GXSWGP'<0C41@7:\OLE8NL]
ML=<Z[R.$0V9G*;'(BMZPB('[1-7<I#1RP$<-W-:T#(<G30FDZS^8TL'24UU:
MN:O5-R+IK&?\WRYS5+B)B(!"2A1%9@FIA-KPW=EUQ,=0YV.W,MVX/\/ID8GB
M7J5%I2+0#JN1_^BHU#N('/&GS>-* 7Z,30@1Y>>0/,C<(498TUI@W/(L/(HB
M6&N$]O,G^$5XKETD:@ZHQ-/*DUO(-)VGY*'T\,SQK@OFVS5<6U;<M$'1,K8<
MJKHE<S\@Q3[-T?X^S[&E$P8KFL_ZR9#%GRNSY[=-!1K PS>*' U_>.ITR['7
M%73-*M<EFP0(YQM_Y.68/GDX9P>%M>\#(,S6]>N';3?<B7;_6-8#1Y2W6T*C
MEOK>)]-^3SI=1M"0[XZ<,;2N<Q[,/9!2L4%H%%:>_FOQ->8SML+QKJ&<MU;W
MM*'@]SD=J_!G&TX,I$CDG*D+"9?5KD:$=T2('393*/L6E %A0O_U4MA^[A.B
M@A]27*@).U<(+\,&HB;M^S6PD8J9D46CCNEJ;:T!MZJ__+B2;$2XD+45*@=L
M;F^IR8P.O=43;W B7^QTK]F8\6-35:3^QB=#ZHPMDU(?91M"$0^._=<L'JH+
MT1SO:&#VH8XMGNRM97I$CJ^^D=-#?-[==O#&[?RY'MU/IA ]Q$>@)_^_9H'J
MP SYIF^_OG3YY)</\=EH/7'9RW0*[(D]0^V>OX$ ]9/ZR=)%P\8<%U./P F]
MR06Z4>+[E2.":OU5^?^W3Q3_JY;SY";%[IR=D2Q2K%;0@]%8GQ:A_'R2F]!&
M2I\T7#4,\Q&W$;IUHL:]VON_:$&./B&$:RFMW<4 6^M=DC^&>DVN$G?UBN>&
M3AB.33S-OC^W=*E,3?G#<O':/@&97,T_96'^Y\TZZ%O$K3P[(]@]&,,.":CA
MZY6T07$D-\T =I5!JJ\)B^:$95L7H**-*WI4WO7HNC[%5KZVW//.2,6]8^OM
MV&'#KWIFP6O+5#PYD2K4B%28IFQ&'V=*4G]'TZR54LU*&7K/"=/]Z?T:\8\K
M$VT>-+8X'#,K2Q*H:\;<PM9;G"5QE&S94G>$51JJ?[+%,JIN41C.EP[W0P%-
M6XYD[*KF7#>+WN2V-\JYR:,C[0BMY_2N@-SSGW=!7FSX=3L#PNYI)KV+JZ=
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MN2ZT&^!%BY$?^+_:&S+!P'3=WD*W:)?/[#/X^/21L,E.S__GYC;5\R_F5N7
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MNOLM;E2)\(/.^L6T><F.Y%AP'X.:OGIDR@.TRAMC&F$+\$9=ISQ0UMO>?VO
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MEC?W/]A[SZBFOF]M-$COTJ6&)B#%"%(4(5&1+D9$0&I$0)J0GP(2-"04Z4U
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M$ CR.>T:,6C&PNO6F+W(S;"0-RIZQ[)*;@]I36CT[7NAMR)!#SD&PY=#,T#
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M'#LRC,TX-#5]!\,<0X"P77V(.G@/+ =,/8=30M7WJ0A0%_$4DFAMD=A]O&-
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M<1B%MZ/!<]%@"I('\&1XCOV""0.5Y\>T$RD"P]6MF^//WY?5CM?IB98M\_.
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M%E3M%+34,EX4[3KF.=)K;GWGYEQ9BEMSH97)^US3F[&N@5?O/RRV7K0_F(X
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MMWUS>R$:T3H3IN_]:$?%'+@_W(JH[K2AZ O1M4<R#7KLE%X&K TCH]AR5DY
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MS3B/V&ZT4)PDTHK*)- ,)7XNZ(T5,\1ZIU)D*0FESTS3S;7[+C8=312/C[B
M-99=)=0ATC#D-YZ^CT/HY7V^NP!SE;L1K_(AA[^&2GT-:W*6^:HL%"0][[TV
M[W;GB,81'_*M\T%L^7W,0P")44'>!GW )/!<+UH,**>JXCI)4DM%6LT,N1)J
MAEP?Z9)<=6VT5A5"[OLOU900S6#76_8"OV_RK1;Q.$K\'4(0*7D;)(6*I6Z#
M9)HR4'Z5J'/T?V.1%ZBJ5Y;O5B^0PZ;V>S@/"OPNG%/4=*=Z!&1:C*J\H<,
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M)G*_5ZO+[VO]5SV7(JV=?Y4_.H#BQC^ N3HRF\85X5& W6D^=F1L-VP/Z@A
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M@_E:!BN6.X$39'NP+@'CY\?1NT-#7BV9$^WB4?JY2NF&D5'2[50?@PEH[NZ
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M)'5?0Q@OXTSDR=S!]H^SE=L>99EH/GK[3M/Q)GY=@,A[0U4E;(-X>+)1(U0
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MU8UZM;YC#%*-12<W$/Q[O1=>WSO.7G6SIL:9.)S\3O%QVXDUQ%TQ!FXU)SR
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M>]0\?/\]$H-A)&*[6IUSS,WF=P3 =[WQ[VKC\X^Q5<>/-C=V-VJ/^'I[_[L
M1(4=P/\V!B)PX?\GQ[[3^]YU_%@\8*2Z,=)AV$EI("_N./X?PHF.X9>8%OB
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MC2W=G9X9JV&L>LE=,(NX,'N/OM48__?Q,T@#YT'+\<5Y]^BOU!MB[,FE\!T
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MAAK$8&;#8=5I1HD(RXT(STX1)B-U41P;BD0T>I%8%?OVH[C%;%"\%61H$G7
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M^.!0M).QAC"3&WTU2\=RQ77.B/,N\6)E9)P'T(#Z6SGK>DD#[K4NE31@=>2
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M=OST7HO^7%CUVEC]G >L8CHD*6!*,/UT^W]TS_\XO+Q(@\='U>9.-V?3RBV
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MYQT71DJU:;';F9*MO4-R]"-V.<W8D#,/3IF,<UUA^S(;?6(SD7!^5-L")&J
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M^3O\:7\]/_\5_]VZ:EP=G7+EVO:GQ5.99]ZSQAGES#8ZL9$00H(W\+%&$*1
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MUETR5O"#K',.MJ4$?$2%/Q*B2NQ"#01ON1QD0_V_F54,P@0I-LIT\K6$K2=
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M'[^@%$&58\^T#A)IQF*AV#\G,874\@"CH]'XY;C7 " 9=0T+FT((E!V,8>>
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M=<Y=>Z>5"";5#0W#_EBCUC$#'ON>1QP\/^!*.>03AQE[5%O\QF$O"O 30=D
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M4ZVS!%)EJ<OL=A/1/?GXNRLRR6<#PP/LY-ZA.KI=C&;%F"-I^(A$E0>FENW
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MP'N(WAO\[!_[&^M;^B>TPM.TN(3-=;OEW4IKJ&6,FRV9VT_?R)1:6A>V-/"
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MVY(+Y1W'V@RUR%=@FS.],"'VP*"'8:^$:CW;$3IB P76%5T/A5$TU>'/D96
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MN0>-+R=N5("=B5*(@+NAL_K8=@-Z4FR#>4<;;68$?O2[DTO//_9%M04R*%9
M300_,@Q\VSHS1A$&;*A9W5C@W=[EW1[W_[44_M%LML'CQ,V\?[9[Z+>V&O[)
M_NFO_M[6]MG1B=KHW7GN\*Y^X7D^!FR,5-TLI8@5P@7*@.MXJE:,%Z&7Q\47
MEC\@C+6U\-2*,^P Q60TPGN]3R3'C[4\J(BUI[;D& (YZ?F_EII+^#,$V.7G
M._?A,NZ70_719O-5Q7V?=M[5%):Y/.("4K#JMI5>JR\MO57=[,L'N.7FTH]O
MIW_;0=^ZI0:O[-M_KAV'$Q:X/''(MT\PV^D?LLXHS+*.%R%+I7K!"V'$PC7
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M:8)8 2<I@K*N\8"(]ZWZ'P[F2PT+)1:Y$:TH;YVRR@827\YQ_E1;F'\S-9L
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MH 1%/$BQL$0XNT5#@9_#T_A0F:AQ K2ZLG4(BX<,0ERJ3QW()ZG1Z?NH#B4
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M4K#6\/_O251$^474__^?+,< J"J45B;GR;-\M)KN,*\#%\3'K?>[H%ZA"2"
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MVH'(,BCF^RI(BS;B$YV8^5V FOB\5F/]E3<=!6*7C\S.UD9C\Y46PZEMRO0
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M<EXPG!/-&F6[T(Z'2S4&Q3UESB8#_$CKYW%X984JZP1DX)+D-==C<@?R6_F
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MH +A+;KLU'!8:] GFOJ>Q.@!J:KZC'<7^+!H>\,]OVQU(.T+HE7]GFT([5/
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M0QP5"Y#I^AZKXV@<IY0>(X;!FE3:L\A[Z\+)21_SH(C Z+%X.%9FVQG%;IA
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MBUT"+[(B*3)'5A\2&W$1XL9B1X%%EH9=%UG4AT@+ 0->ZKO>U8!6:6IC1;>
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MB>$K1N>%Q^M*@7FI5&^EG.TSU'?8(!I_0S:*0;E_/[6U[JG^>3K050#-WP3
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MEG5#6A*)#8).@/]#+'!J]DZGMD8H\'"'K?!.BG=,8<;.;W,D2].D*.!T#N1
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M'"^M(A-3_A*4SZZP# ,%,+JN,E>69WS,1<G<BLT^URQ35>S!5I3Y%V*VXP6
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MLS4>/O9R>LWZ;:U#>)(]7K3)+X1PG&,*\.Z)"=B 1P/'-H_[ 3)%;I0X)_!
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M[24KNVX([;D]*IGOK[9=?,G39$G_#-#D!JK',C_ \YRY*5UEK$^4H5OI;G;
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M)A2BK V5#\72@,SX#R.)CX'>'1 ?"MQ+[OT!6 ;@/9?3X8R@19*@95'Z13B
M@"=I1A\H;Q7N,8>06)JM*59W0 );[%T;FJ@ECX3S&=2I8S<ZFZJM-PTR_ D@
M@+?"&LBD84#KQ._D]."9PBD/8PN I(^'SL"'&Z5OP(N6 $:E"<T6C:B.E#[\
M^E_NH6^:5>_(T&9$X*G:1%N H>K@*::MVQ",P130 _S*AL%Z^Q=1!9\!=B#Z
M,+"4@-V@O\/'6^!<QE1SNT_10W4+/-1O1 7O#1[!_3S$%;!,3:*O&9J#5?0
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MN!/X.WT$I!3^Y%-EC%PM<+"^97Y,!LLZ@$"8T/H0J\?+Q'5/14(SB.;))3:
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M.22%[Q]VW>Z:( I.G'T+6\Z*6J?":>?PG=N^LX "]2J[9'"P#%<U&,IP9NN
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M[7FK8L"OB?QN>_[ZT#M7&USW^G*X(^I67!>Q/5=K35%JE2^Y+@?G23B3FP/
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M!'PJ[,"GM+R1495U/B4]L\A""W>""'$,.W=!)KQFX4F((/7]7RZ>Y]&=7 C
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M.<E9Q8>K%RC.A=E859FM!^>6&DE.W-XR!P6H1QPM^.XJ-MK2"RU\W7@W 2'
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M.U><3\.\Z^^IL[/5+1B!4?<NRKNIA+N]!2UEUE1WR<R&UT,3\5V?Z%X,?J#
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M@A,DR>HM@/RO\-^ EYS];T</8ZH>%3'FJ'WCOG7Y3-W/2P8+"\S.)H";2S3
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M/-HDZW"?V83[D2J QU5,!QO+W@0_ =/ [\#W,5'#5)@&P\,HI(:L38'_,IN
M63D=%!E6IS&S?CJB]EY1!1Z<S."GP#;P9DYN>*MOO W+6IY71NPTP5)V:S<"
MW3=ZC8_+M^*P6]=X6._'0QI<;Y,T#-)V]ML!'AN_L-Y8@ $$,!4HJD59!_\#
M>T*WSHRP8\7<$7-6%969A@W!MI Y$6P-\"+03V<HL3.++<8B!U[[Y 0 _J$
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MV  C33$2Z3N8+<A6Q L$"Z>;R$ 2!$U(!KO2LXHP-FOQA3<]NZK@"B8L()C
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MLQ)ZYP,7X#3S2CIZZSLB!I;2$LVX:-9,^@$*L20 -51% 4KSJUG/A$<S%GQ
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MY.OMEJN768G8[V4D$XZ601XZ6>_][35W4Q&G]<O50B>'SLHC8F7EY<D$?.<
MGQ2SQG,>&1N;\90HXO+Q S[' YL=S!'KS?*4G7GJT!XC-9YPK*1X]SGR"03O
M*6I].8!3A%U$?TYH=OP1A=Q$F>7QFT_QMOB6,N2V6.9[8RZ!X#6- \RM,;%.
M$7-QKK/53@-W\O7;&YM[JCYX8H3G=6DMGT!@>N.EM3B(VT,9M:,P1\EV#[4I
MHW@T5J7P2:J;NV;PE:>-XO.G42<(]BA.+F+_#+Y\(8DK(5F:*&09/(+^N14F
M2>!KCU3W$X&6I6GJ'=88+6NEQ?C]X#&<U:-^'Y@E$ 3/@V._D"6+:Y+6#HZR
MN&GN)P0SXU+N%OD1/1W,I,.'>9)%6 +!YV(V1]#9 GDJ""-.5'/<%66]1X5X
M*+5T^6F/\J#'O1-&)7%U<LN=L,@P.88S\X!)[DEMGSBQTU-2,[>DS,U:3^_C
MP>1%'^Q1$O5PVN<.*7-4 A<P\UFZ2&>+4<RVOSII AGN[_=7K<K=;?ZY29^/
MJKH+)A/(#L"S>0K/YI@(SJN#8#*B$_XD-=@MPO&S>IT7[N:DM@@/=9^F8KL+
M'I.(&F7Q/% #F#4U] ^.1_S,]=UM!W:E\5Y3II/J.2C!NT QB4K[FV^D'4(U
M3L.U&IK<GM1VV;=D2.J!A36Y@6-Y>DU_O-SWN..Z37?(#:02B%MMS T\N*PM
M[979?B3H6+KF\O/R[:ZIUC0U1HV9U*+N46"48C6ZL_%_'A="1H^\Q@ODA*7S
MS"EHAKN@)\4+C0='S[[W&8\%G]I[Z2/W>)631\>IVA$'-PD$7Y(YO"SM["AY
M[=X\]F">^\XT>)+7-R2Y;ZO7KBO3U0N5=M;H]-/)D[Z C/P5HGBZ+7M])=SK
MN4K?4"NOSP_X3,R]%'P3C-VW!%7Z=JNYK[D(NC.M>*EO:)W/6OGAN4-.A&1H
MA=MOJ"BZ#':'N1>L?Z#]  3_YT3Z);%P^07YXJ'[[=_UE7!]]>Q_HAU@?_K?
MT/+V-KQ7>G%[.EZ7BGU#OUEV6N0D]]KA8T!PUXX2ZWK8WQG-T253?AKVQBE0
ML:V)^O^YN,#JHB#QO[ VL$=_@^]^S 0@&7]A-/$;>V2E&?B1P"XN+,#QXMQ#
M/\#YX_B#^*#SI=&C*Y##N\JX.>,FU1=@_X%A(%"M7]@OT A#8;*II(JLE,6N
M!&DNP+T,& $.F N+&ZNYZ/ZQ<B%CY>!8<.Z8EQDV&WYC\&CZ!<9E!R+W&VN"
M<\1D55.!3*$)[UO_M5^#?_+VC =<"^5?H6\P9'F:4U]H0O$TLE(%]OUB( #X
M@]&F:&%VY)D##&^:OY\4+^&( 8#H35CQ K?:-ZYON%EU/A_?/Z:Z>Z)25.L;
M3_SD^;'UP=3(07(DV7<:@.I9ZF"55J?=ZI1ZC583-2OI/I2[C6JCU&G4NKM0
MF^L;;Y3(3NM<JVTPR5/;;/5J7:S7 @0WNZW;1K74JU6Q>J-9:E8:I5NLVP._
M@"U7=J(:"$WYK75=R+VSZOM;\E1?/S1KJTV =J&0Z!OWW*BU+ VH^T<A>0IW
MQR40D67\X_IE>G5W5TF09ZZ('Z#5QD@,61CX[ZC-=S+1&S #%/4:S8=:%:@@
M@ZV'2F!;WLGYMU[S\O7N,:7IVXL23ED**FY3T.T>Z)K997VR-O#.C<''!#ZC
M*ZCGE1UZG[*JOEP-P-OMC, 34/=AIT 7^@3F@2Y(2\RON3$Y3_RH+:@0HH"&
MUK "K%]XSL)Q *4=DU!H ;M.9^AL[O/3T#O*QO5B,GV[&=7&#;<8O#L [#C$
M>8: 3:;]+><]S( LV&C,QR%\TZ5U?T\NKQE&1\U0:C3KCB%V07@LL?9,%6 :
M28@5AM30?]#:!U>IELPJ!0UN0UTNC"$GE.H<>3ZKM.* \:]1(6KF0?PURD+.
MP)VXCCOK^]-EMO2G^WF@_G0I?+_' I-YS (32\#NV)$,E6NL(VB*C!HJ-28L
M>'V4Q=HE\$D=3#_S,,7N.@W(S++"L5B'U149_AWQ!CV"68_\/W8R_8U51?!9
M18/?K:##%#W\'8R[32;^P-#SR#8$4I3%1C-6967P*#M2!82W;&8Z4[49^"4P
MZK'%6.3&< 67P'@$9J/]@@ ^ <<+(-]ZGE4%0,$2.2PL85U1)@ SRZSUQ)B=
M"^ Q41-D #A@X6 ""WXMRD"G%OD9*V6\QX!-VSFCPM?JT?3E:(*.=HB..(R!
M'3H C  P4&;@Q&,Y41)U4= RT9L\GCR#+.-QU70,UQ%1AU6L[K B\>FM*J,I
M-*TLD-^\)P":E#NGUD(6^)9J2GQ^WP:5WOJC.PS4-X8OETV:FQ4ZC'3H=I3!
M53Z9_I.'+!X7;%U9 LJC_%3Z+,L/K+"^=24W%OB9A'24H6>;^%HR)U+ )\\4
M^F$:+C>4[]4&3U&:&+6@QZ%K#^49NA^F]BF5,CWA*K56/3SM=!_2(]<:B8<C
MVR6WI2#,+D4K5AI(%C8[(;<4KJA;AQ;L[X[5?&>6W\=\UCS:K[@'X733/"H-
MY,J".#LG5XEXG)1TISED:PC7O&_4KJKLY]4C_3%QDV,.VR.4HB/7*UDY@]#T
M, !B:X) O]8QMP$FD+=PEBL=8ZV1BWOT(-O8W PG=KXDO]NZQ?,(%*)F%2%K
MTS$Q&V"D$4+A]E+9\7GVQ19CF^$?]9[X 9;B%*OT>O9XB8?'TF#Y*Q%U8WT*
MQ1%TGV2)"3T:/!5(+/RZK$6<+2\AJ%29E:K"7)"4*;3A^T9N,+@F]2N9:;T=
M[EP@<M$18E,-]HI#=LJ+LD%B[,#;F+([:E+-&H&Q;[>;<V3J-AF\DX,\>9:&
M[M?2AOU: ?:]P%=G*M@X2'OC8?!B^O"1YZX?'J^X&!LUW8Z6O%=7,ZF/K4G'
MT)XW(7&7[\1 :G"IXFWZ8H3:PFO &;6N< C_HS/QC!9O4WO&>*NW1;H4HU[@
M,T,[8K#)X@YB)N(:_M@@=LC(%F1-YFW;D2BS3X6Z3O.%@]N.2=J+-1C 7F,I
M!EE+_*3B8!R]AO'*;" )>\)\_:?VMFN<I8TIK:+>RUIGTQ1W1CIB1GQY]0>O
MYC;IE;ZK(-9:!G)>@RFOZ4355E)N,JNYMDF'HXJ%;X$D_H8\![)-49=NI,<;
M@O(D^^:\EQTVO=8W>FJI0'-/DJJGF:J5=U*U @$4HM8W9K0RON-+[WI] *RZ
MYF.MV6N9Z856?,3A^8&6-H5A[$6 9Y#HR?R&OG>8 87"[M!CZ4W2R S,NNB8
M-A9@$!K^3=1T<%;].E $.7%0,T%0VZ&QUM#!:66FJN"GO6.LWCJ848?I&PNY
M-&I59O-I@=\88?4 %?[+L[[G&Q?U)(W;OT&G4.!WZVY<1 ^;UOO&Q[SX+DS>
MASC.1 F;BBZ#TXF;YCS1TER1%X9LY[;*"*<;+2UX8J3Y48%G/V^NV]7PWHI_
M8Z1[Q-Y*&@3@W[#H^85%O6H0*CGA"/_N;#J5@"SIBXW^A&W4+TM/!J^#G52^
M>WV9CYZ?JL/BZ8=#VS.5&[.:E4FHH00SJ$L Z2GK6G!Q$HBS_2>1$)M]]H<O
MR:;V2GYM@MFA;%>P$ U%@%7*;7>M'">>>30^A]J"S ZEJ()\)O-TEEQ7L7_/
M8&7X1G<F^J2H[PVYK2J<H*UN])FN5]XT<?C,X2?D-H<T@]]=3$VJS]C?NAF2
MX8NTP];?H010L+@ZG@5ZWE^_>-+K%"XZ=JAC$Q =!)DE:3J-=0H5(<4P$=(4
M]+[8 Y)#]T@.?M[Y$+KMWCT].$VO=\-K*QW% ;IR?B7I^US!)EBE'23'#@7H
M@X=9 :>R^?SN\9C3]%*?QB*%BXT=*HBL:'8TDZ5C"(YDW,\'<U)NN&A=R5/+
MQ@?W<$F(Z?ATH]R)W51H@=Q>:('N&^/GRON,:3ZU[_*;C<2O66B!W*O00JEO
MW.J?LCQJ"G<?;D?WTR^T4.X;;].GLE&3VN\OW#'N3V\H 3%]+$T[]<;KZU,Q
M.<K2*;A0ZQOYF_L>69^4[Q@V>6K3*;@ J)8>K]G[MG);N4FAG,'^!1<J?:/:
M4>N3/*'/6BGP=7W!A90CCGB.#@9G@+H_!8KMLBVQJ&QK[6,FHFR[[1%(;VG=
M73[3-UK&8TD97#U*Y'N*$4D*NUB)19)]0RG<#!HOC8]7M0!D=Z?5KG5Z+V@?
MUNX?&FV(YZ\4EK17!NT$P5Z6+,;J $\:^$$"UAX,4,XF,W1E.<,+4Q5H7RQ2
M]>!;[$0!IH^!?H%>#+_SFL5$#?DFX6UB_GQ#F'BN&'F7[!.\)*/L'\^N$5Z[
MXV?CO5E;LAO#EN&8AG\(A<(9!S.3N^2)]XW<^^NE.NX]B(WW*-'*:;+[*LF(
MYU>__W#>(;F_D<H_*5)YZO%%3PD31XBE&NWRM0K9?OY=PF(G,++CENG-!XKS
MKGVWO%SMM^#.UWG,+L,[T J:O!1:4E-RBP_94GX*/QZ4]2-(W$H7VU@!O,T,
MV.3[M+LOK)V97[G!$^@Z1I)9(D]FZ75=9TXHN.K"C8H)MV MZ*3@=O-.OCT1
MMS6QPIT%W,AX<$N@QQ& &YX'$C&"Q_>L+\1V!$U@56Z<]=YW1"#@A8DB:[IJ
MZHXK@CJ1=#,FFD&2M$"V)^VYZ =>J7HGO+)U/NLWQ8^Z^L0;\;;.$:3S[M,,
M[*,$&N+069QALDR$Z-9!\AO];>P/)I+C &ZV;+YQKU?W;SG^9 %')@RX!+K<
M)P6XH^G3T>3V'<N-15E0 [Z A#=+X9#2V7G:F9OW27M;-)KDIS"HMJ:CD]T5
M^4!OBPWS"> _@0X71#9',]D<M:89WN$%;OV0 C<:AI321^FJ^]R>7I_N61YL
MD!(91$0"QE92(#I%C;<^4\%<H=L:KO$0L C\K"4,^MI1!*<S-=0IR)R8C?FK
M89LFJ8=*K8*?+.:#@G/]? *03\+@RQ;R1!:GF5.1F[FCR,U-$)H7Y4YGW):7
M/>ID(104FY$AE$CSSP*>S^:9?2%TXJKGK<!JPEB1 %@GL,40JLZ<M  ]J%_
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M^@9-\DVEJTF=ZS0NGZ1=B<9W0*$G .,5LR':+WC/55#A]>]O_SX)$#<"CY7
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M5DD+2^9H"BV8HCE#H>1,SH;]T^T]OFQ4"@_J2:(^J+2NGTH ]K%#U_DL3N6
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M,@L4 ;BV@JRAXZ*D@G-GA/2-\M)]!.C.\%<EJ-( W1-,$U@ :.32G!4EJ#4
M3%R"=_5UB5<[KZNPN'V_?"I3[[<%9UW-L3VID*P]O'>'CR =V[9W6O/?F/RT
M(WB(O<"3IW)9/+1=Z"89 /]M!ME1_MUZ!H,!>;3M1:#RH=.E'KG8]"HT<TE
MTYQY ]E9#;F-2J!OL6MWAN6#R#7OBYW7TB>U'I:(=::]MQH;K*<ZU?57Q7:>
M:D\4KDO-RYG^^19UJNELN;#)1KP8N...RZ>8=)C^]%<OR^TX?7JOZ8>=4IMS
M%E<Q=+R,1+QOS)[PU\%'+2_!]HDGE9%8C)21^-[2BC)SO7Q<X']B1F)QKXQ$
M!J@<ZO3NFC+RVB-Y1AF)E;[!SKI/"^%C-"<2[(048M9&)8GJ&W>?/;Y2;,K7
M^01KD:29!5CK&T.:)7NO'Y<%(<'<L'2S ('4>IAPL_G38$I^GF068+YOU,O+
M^?7SX(KPU(,\;A;@8MKD[O+&@FRG(NG3R ($>RJ?OQHUWO7G5B&EEE*';\D$
MI*LV4Y=?(/[;%:8ZTJDP''GG",+O.F%Y98K:-5DY JHPG:G<&"A[V-3OG(-9
M)V8#(]$*T_*L+IBU8UA95G2@B0'H3T1@6J$8QHI./A:Y,09;@L++NNY /'+P
MN(02-+H/0GC=B. K55$5.%T!-ARDQ/$KSJ:A%4IPCSEC::T:L 0[SJBMH9E]
MT9_R,FW9* Q!(1L%_D3W^YJJ7USTH(4!RT(@C_B,E4Q#!?T-T=8:.I15QJP(
M]%3'5.%ILG0[[/86#.FI1FL2@RQ7#[?!# 5$T#:%?>-LUBG@S 5!.3_1D/K^
M9N)]*C@P3W<N5D$'BU6$U1@V]6T[:@76T0\,QYBW(.A'D/N8%1J:S@:2R$E+
M3%=98.5G%&#.P#WR+NCPLM%4%:#;P(R9B)QP]K$@:PO/=!$6,M>L2(RF8Q-!
M'RMHT[ <!T. 8,[0*XI:C:''=%O"67&TL2"[C(<<LCRO#XXWQ?JHE4)B^;F
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M._18VH'.OFY*;H>0^RJ=XRQ/,R%Z-QS6'2GI50I%%1M-A<^.8L)D&5LG]&<
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MU"0= 10]Q>*[:>FM!"-3;%!DE_< R]\^IS)P^<= 0]AJFRWE3(&VZ5_X]GM
M 36\8ZBV=0+WUMCQHL._\=$K'OZ&MI@B3,+#:W"0=2X;.F!,,>D8P1[QDMO!
M!*H'E;SHL6N\@_49T7N#/ES5X!)7NTXIT_$8R&>VIK*?&7Z<7I3%WN#E:BYS
M=7G'UK2!37N('C-(73@2!UD*+^&4;I(1A+?L!+/PK]I(()) /Q)OAGQEB0,9
MDFY,TO/2 9.#%D1859''Z-<Q!$,L5#!7\@/?!?O:-GF  M2Z/%(P#053N-KU
M_-[7E]:29 7*E7NB6M 0:F?+N,_*&L)/?VR8%KJJ9<C-(2^T"U,<\+=[6G7
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M8NOY!5?/_W_)\_\_BI"46*#MM;5E?->&JRF=!4Z[&79<;(ZKKXN[M;XZVZ
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M[2"0_$=G'""O7# 8CW?=7/YV;-VE+@<,@=**7ZD"@6H<233[&\& 8\#<WV<
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M93QOCE*4W>G-4F?4,VN5G@O>C=O>'[QAMA:I+(OO75\-RE&*V4> 1<V@LE^
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M<SADJ5FH4.EK*G>;N;\I-*@2V7:^U,C<U ND\1_U7&K>4IE<KOIXW\R@7\2
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MWNV\!L\TN U3X[8-BK/TT7[=,.S7<ZOS9H*=&%==$?'[V<]M&\.?-96Y3.B
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MCD, F:Z7V":P:(<+MJU@^Z#D?.,%:VDP!ZA&*O,#, G$BNK0)^TBI>'0*3T
M\C"8$AP _6_,IMAX)L=$X) U '.WV#'MFT [*_:G/M/N8*'5&XX>88HP+"6P
MKP.0XYABCH1K0;=G3@,:X/+1*F@D %? 17*\%&6Y7X^_20VW'G25\U@"T3FP
M$Q:6#X8]4A<B=L7%[4 47G1Z=79@'41/)(7T-'+_J:30[O.DO^X2NZ<3"Q38
M*.CBN_>M 4*K!4'2:#!MG5B=ZVO"=24[H6Y>T+#F(S4ZC@](#Y;=V^V* ;2A
M,Q0V W8>@P; 2MBJY7#OLX9F$II#5V)+_4"-#^%PJY]@D%:Q;94$J5ADD*HA
MI_F;(U<M2X*(0(L" J0-51]9WOP4 JA,'\ 2R2D8K<P$OYZL=FVQM'2'>KHU
MJ*F80]C0"C4 (6-2VD_(NCF%F [U_P.[FA(92*!5HL8<:WM5)^$J<E)E/8@!
M4&VVTJUH)RFTT-6A0:T*0AR6WG)0">N##^ GL#-*]0JM&EJ2%DE386G%H5:K
M785%)$TWG ,_,!!H6SUR:D,D+"%@;*8,T"U4K8XQPZ&L"K@E\>Z7]YU$K71:
M]4:*>N;J9M3'85ZX=U,8K*F&59S29F<278)"3HP.&G^A0%%RHZ6]V[(C& !%
MJZB&NRS-?AUYOSJ5E!,7$GUI5"/B1S7LJ$;$CVK\L+9*GJY>HW3BRI/&#T+:
M[G__B/RQSIT[AM#.(<?Z$E:%H#7('+L5_S#V4#\R1/%O)A:* EG:5R'GR;EX
MVB1HVHL@YU@J50&;^0NKV[9K4A9/^_B\,>U\"W$OB3(7SJR_4SP<AE&[#B[R
MUQNP>]3R015.NE8SF)SF#B]EF;^&B)>6RL7?LM13$U+L@&5:0.[;[O=A@7O;
MAK]G@/!> G[O@MY!WU]"TW >RY3^9JX0:<]9(A:LL?SLK?8,D1?01)#1CUU^
M=6/Q/@,=6N9SB!+XGC3#_]B51WQ6>;NNP<HFAR9.\#WCE"QZEHQ>',GN'<A\
M GR- $DQK&?)S)?3GRNG[1K<G]VWQX]\6)&/(RMS/_+A1S[\R(>'C0$_\N%'
M/OS(AQ_Y\"UJ/_+A1S[\R,>W)D _\O$S5_[%D8]3I%EMCO!(;HSPX$*NH1W9
M>K61K[5(WLNQ!G?L!^PSIGG<VL/MT6* INXFW7OZ/07L[E [6TVM>?-!)Z,>
M*;JP]NZ-RLH=(YTD?36TEE2/]&&JD_4.79 %;4FK7%3%A$'2SLU6(W_:V*.]
M?R',RPLADPH4U=4!'_.:[LPG=OHNP(4 )#Q: Y,M>(*,.K4:.FE6*WM(R58
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MN&>>198/C _,9S+8)RBZ'0.5?T0XQ -VDP_".T#PHK[:61G[,^(=?"08BWD
M#M\?<^&"3P4C;]T4CZNI-LS ,35:O/PS0AVQ2)!]JU?ML]8W"W6<2F7Y@0T?
MF.\-S&;7G2,4R7')K8*X<RU#3(1XO)872A%=M8CU3KO53M=RI=H5D[_IE-H]
M)GV;;N9:3+K-%$JM;+K"]/+IYF6^EEOA?A?B7UW)9^#VM-5Z1ZG&>Y&==M1$
MN=]LUSQ9;8/KT'-Y8&JTST,'NO3(2PAM=Q2T0-J S/JM6SUX?OVOWU#H#U<!
M]\< @[[:?BNBLQ7=-6&'BHQ]+\POII)&:[IR@H'.PIH]K= \?C\S4H3FB3J:
M$ZSMY$5K=@^$G<T&26'9YUN)CK#_2&%.</T$^J5N(9NXM;X?.U4-#[=9<73\
MRHP? /M.0/80<BV</@O9NY'[%]S7!2W(O)1MP7SY ?&)O>&OA^/DQ'8JWWK'
MD<KNYHE8-[G#6@00GZ"\05".]W(DOW&+5(@O>906)P>TBHKYK:+L5E&Q']@J
M:L.Q]KM">2T<L[LK%)41I5+)D72Y4C.?;=>;:WVA7HZY'%]H'8V6:!_550-
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M4RQJ/6\.CUH^%L9?BOHAY8=3-ZW\4/L!4$L#!!0    ( -2#.UE.I8&PJP(
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MJNLFC.?_?#;WNSH>#^IM?5=;;L."V#&VS4NV;8^0U9G2'CV_ %!+ P04
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ML'STFGB?7XS'-^7\0OTO4$L#!!0    ( -2#.UGOQ2]\W0,  +46   4
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M8FSF2K_M\\WSLWEV;MZAS7/U5U!+ P04    " #4@SM9#\3$$+88  !HP@
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M,\%[@W'M@)B!(BOA.J /P'H77K $%+IU8CZ<W04X'QZU#"RI!^O.)>H1L\U
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M.;C_/Q^L&D" $[93SK;G!+!78 ^;P!Y6 X  @#W[_QW>'N"_CCU[V?;M9^>
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MCFL>_^UCK2?VJ^EV?,YDXHB^4>O9QU:Q)?K8#*OG-C;EL;E'-W'U:_#:U7J
MWFE2#3OO$IVFVB6.E^"33[^=-XT7NOU,"7L957:HO*KB0BHC O]^0A+\3?[&
M @9MIUB ;K%CT_ME![XTX2N9L:,X%Z_F@*[FR(O@2_*3J#^DPH(,46,MLEGQ
MZ)JWG=2B"2V$!3 .\T-1[+%PFA]E 4T86L@6X_#!5.Q+6W464+:+#E)@Q&G<
M<VBT YQC5&]!+IM(QE5%?G#>XBH<5)E+"?"Y>A=B!#HQ%&_&P69(A3K!.*0'
M<:<40+T[Q5NUJ&&.6]]-CGZJZHCVW\>S+R@&V$L.[]!J$'G EY<P.#!E[Q$H
MV"QYAN8V=4EIDB/4_\DW%4_)385O"H20?/&7C_A"-!$WC1[/C!I^()!]\FRS
M<B6_5"QL+)8CU!JK#SQT>/K&LNY.X5O29G*E[!59K1]V#L-E55D5?K^8FG6W
MIK]([->NY(&XEN@>M*O4+IJ0VU2*X4O"P/)>6UJ*@?F[TE]L:WL&G)@SR$CW
MK09_GT1D-KHM$J<GI*OBIMED,,\"+FW<QDG$WU=Y>'3PHD6NC(A,%Z[G:XCE
MIX%I/..P!\2=04=!G<@2_FBT8+ B.2+%X]."[Y62-Z-N7'(%\W$I\L8F*CM=
MJ.=XDG59#(ITLU/2A993 D]N"1=*J>GH-V-!A1?S1HT;9\T]\$Y4,'-5)\&'
MX^A _>RMX[;<,5EO)[,2S"-*0OSO3S"T60#$S34QR?<:7(4+5U^:%,3C1@=1
MB]02-<1!95_Q@?-9SUQ-8T)K)#?)*_:D"4:,)6*3+@Q%R&T8/!E_-(L'%6&4
M_< ,LZLWX<\T,'+V4P775Q ] 6%K]WN#U7,6U7AY2X\<;#G/1DL^9[)D6QP.
M@[7. 2FH]C$+V#GK\1CO'U%HTH*8M;B6J"_=59CE<HW^AZ.W.Y[#EKPV$DE-
M^PO>ZQR:<Z!5?#7&NI<6GYOO[U;5[@G<%CBV.9>P?$#'O9=$<;;,_'FW8*CG
M6<W=C1O^\I)'Q/MD]77/^"<\-ES3/@]'4CY8:X>617?B)04)F.7._(57VM%>
M8@U; :J&#[7_+GXK5+@.?'UC-_9]<* M#.*)VRUGS8S7Y?R0X (+:+1J=5 D
MWZ^:ZA1:=% EZS"2;-_A0L[.;#;DOXNW$:\XKSV=W(%K_#ZJDWS7QS>/^T>,
M79?,#[@A7#YU KWK^#A:U@V.:EER)P9]CYI-_9CRMC2AHG\@2"'J]PX=0L3]
M5_$<N<P"ZD*0M*^[6= (C_I9>K7J7[@6?-F]N,VK=VIL5G6$N9)[..QCI^W,
MD_&'I3C%2NI !%H2OYWX%\YO5^9+N!G<O-8T&*3?"NRQI:G0+R\.!Z<?/QA2
M]$]9<;&=?]DKW9/1KC+RE6I_L09,]M@^FB6'9 3^ QB&/!*,(LE-YH21?6M*
M<R3,_^G-K"A1WT:Y;<=%^CNWQHV>Q\W74WUI$T3^81G":A@YH5;M\K)*NX9Z
M@V/8T9--)\-?0B?OW&+*4= "';GO';.O_,29B8ZMPK JLX/XC;X4&!!)E)]]
MY_RN^V;=I/),U(_PZ]E^[UKTG[:U&WX?,_WG&$79:A#[3-QDA6MR#%6#8F,X
M3V'Y6E]]GH=$JJN^/Y$:S9._J9DA5?9;W&J*&_;R(5Q6/Q[CI4U=T0+_[D$V
MX>_B/3#;JHHO)ZC2[N]90(V^W';9[:DX"JZS;  16VN5*2HD;FY4H>F/_%K]
M.EBN/OCJNUG!/Z2W2V7&R=&IM[XE)[BA?FTN@;4^2,)'F=S7?G#P/(17471W
M2>IV(2D]7;.+@UDC!5_;/A0ST !ZN2 H HJ54#P+>.E"W&)R?P8)/_]E2?7P
M\Z$"85/M@G DP P@%D%B*-).(YC\R3(0Y[\6> LEC+5_AK. <AW%E=$1*%1Z
MZSO8H 2G2+@?DF2K#:=6)!'F-2Q@/K@+2;J,H'7!AO\=" OXN_4))(0BR;@W
M6XI;D7.&;X)N%OV9V+6!V65:$_]A6EV;S%*&L!S$O<?[6%RE(W'[''HY'7$;
MT1+^U&J9R0(X> +[ZZ"1Z\PLM-#0A,UW'NU\8K]KMC&:_*K%C..C(RJYU\J(
M3ZKC\RTSBY3U(%S#AB^24^MB^[GU3'.%7)[-T.EXB@_3JQ*SX$1 -K. %RS@
M)Z:>CGPUP5'IZ/'-3>T:[@-/+.GZ^?(S-QE=9;];"SG>! G85U,@$F.)Q %Q
M/:<[!V*INLQ,2JZG@RD1)>"@XS1II)YUXI25YRMM#?8K0YTY.NCM>O^S#6>T
M#J[JW?Q=G['OGBC3)'+CO4N@\5-;GV[#38<;D"39JGX1$I];XLU:O/DU]4OK
M\,@W9^]B25S!Z]:YC7"Z\R%\<6?#<@ M[!NX\*!X=OGZ-:G^*BEJ<S-#9:"!
MI M.$A9A2+([^Z2FJ19KRW 2@;;-&68P>_\ O2(M>D22DE@ ]A8+H+Q,;X=7
ME$3"1 0_I3\(OD@"8RB:GB:&O5JZWQT&'70ES_S-3/O&;_I&;HL;09-A <MW
MAU"T^QC.AYH+<JAP;.%6(XH]F(^9K\5%]I@46BX9/A5>D-^?J7QD12[+\>B]
M$^NC<36X@>MX0CF29'+QA]TD7YDO9CMQ%4]+IA?P-\S<>FAN_>6R88JQAT._
M/>2R(8/YI28^JV4:\27>%*?A'F4R=*:XO?/2=M 0+FX9)*UU#C;G,I3TPE@
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MB7)Q7BM*+-T.0VM"OIR#LM+,68#^/=SL+%X-!M6M9 01_, ,H=C":6'I FF
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MI-G_^;#P]J0_[LT267[XM1C_A[[<2-IA>!6DF @"KY?/>Y(#AU"R(O55CW&
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M2&D^Q4X9$.7!8\KP@THEOCNIU2$7%>@-E3@?\AZI:JS#Z1@I76)#98VMB-"
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M^=!*_N2>^'@6?C$7_OP_4$L#!!0    ( -2#.UG=("A#/AL  %Q> 0 5
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M[18%KQ1E=^V[*[J&_*B[7)+8C^AI.Z627;IJ)HJ-4@'9Z>#A#"^Q^XR>//R
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M=[7BG./@V5VRYY]G[#EH_LHZ+%:@M>7BE5$-*J3UBSF32>(6%7JN;PLA$/,
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M?4U',4 :B[P"(1W!FCB%/I2R-R$TI&5]2 )D0Z=DDU9G"P(,FEB1XLQ9%SB
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M"B3MAA\IU&[8X<2<LTB/3<N?"P48UE>:Q1:IJ+6PH@%;1Q2)G',:&( 3CV5
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M !O@1/&)_[>\.$W+SML06K&S-^MXA>E7"D+<R;%;Q^>),9=_K,V(9.LEMIO
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MWLR3"8+@D X=M['7R".8W5S+C<<X^S.N1VQ8&;?,U!R,B[1."$9+4AT0G!L
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M@42DZHCI V9C4\]RZ-MI:X+@(^^*$2$;-?B,Y+!RE\3P541? 4S+5<4F)>]
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M5>>DDSBCY5Q/#S;EQ& %C/L#4,95R!?)0RRM]&*FZIYQ8F?TC.OJ 6><$*R
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M,V#"KL))X[ KL &&O".!<Z?*JU&$5XXBJGDJ(M;Q%8I[8=DYLQ6-UIS70XT
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MO,0W#L,J"VZ)IG5-S3ZI.F!*ZC!S/*7;DI42VK0UX'&5_*$X5#F*IS)MUV,
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MP74;(N6+X*?V":1]Q(;()W#'@7P$&M^<;X=-.>).D+=JB,RIS1Z%R<P5AF8
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M=E^(B.W/TYKRZB?'W<!3*8.N7%4=[C/$(+* 4[2W%6$2TF1%&<4N9(IJ!$;
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MTWR(0/-25QU9/3.4ZY/L_ 4U%*"!</C5+?O$OFZ_8O\\115EW_P/4$L#!!0
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M\GFPZE$8Y80C+PW%'G=KJ]/VS. /@]B+7_EK 9-$X@YFQ:JEH&#C;F=EVJ&
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MASZK32E =2A1=N2$ N.!EBJ$]:-M/ Q#&@XH&]SI:UGRT A(/2A#=F2+TB.
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M:,22  )TJ@I[>/.U"E09VYT!ILP "IMH@R]1RDK8SWW4H<G:Q:DBHVYEDE;
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MFSX-=NB3X9SARS[_Q#V;; ;PZ8YKD&NOV@DIJT%I[.ZXRFQ"!*& SM6"I(G
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ME0S']+67SLTT".P0A2RQO,_R%%7WVUJ#P=#9JU2JX3" X'SH-J+2V DHZ@T
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MXK$Z5A-4L?F@!VCPO).]<<C%//P5^74P*&2G@^Q$@W9?,M0C.WPAJX1- V3
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M<XX.?D5QW,.K)C,..@E[\Q>0N$=2%/?HJ<:T(U$6!?CAR\X+0;B72^*>0]6
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MQ(JBXW^X^/$+#3^/@C112)1-;J^JLSA5+7#N'5NX@8!@34+.5F]H@*=&> M
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M=S>\7?YG;S)=#A>]6?_7_NUXF,;S[A_\&P_[BR'/^= LP8/VI3^N)T1-\"N
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MR*@V8&^PFYCV!3CA%D43J55ORNK2IB4BZ[ %+<W6_G)%*-D6Q1 !P7@3]PL
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M87)?97AH:6)I="TR,2YH=&U02P$"% ,4    " #4@SM93J6!L*L"  "!#@
M%               @ $NY@, 9F]N87)?97AH:6)I="TR,RYH=&U02P$"% ,4
M    " #4@SM9V*5]*PP&  !7'P  %               @ $+Z0, 9F]N87)?
M97AH:6)I="TS,2YH=&U02P$"% ,4    " #4@SM9[\4O?-T#  "U%@  %
M            @ %)[P, 9F]N87)?97AH:6)I="TS,BYH=&U02P$"% ,4
M" #4@SM9#\3$$+88  !HP@  %               @ %8\P, 9F]N87)?97AH
M:6)I="TY-RYH=&U02P$"% ,4    " #4@SM9C5V:</<U  !H.   #@
M        @ % # 0 9F]N87)?;&]G;RYJ<&=02P$"% ,4    " #4@SM9,*2=
M[O$7   "#@$ $0              @ %C0@0 9F]N<BTR,#(T,#8S,"YX<V10
M2P$"% ,4    " #4@SM9W2 H0SX;  !<7@$ %0              @ &#6@0
M9F]N<BTR,#(T,#8S,%]C86PN>&UL4$L! A0#%     @ U(,[62&5J-^X0@
MQ1X$ !4              ( !]'4$ &9O;G(M,C R-# V,S!?9&5F+GAM;%!+
M 0(4 Q0    ( -2#.UGN3<VQJ($  /(Z!P 5              "  =^X! !F
M;VYR+3(P,C0P-C,P7VQA8BYX;6Q02P$"% ,4    " #4@SM99ZO^:(UA  "!
M*08 %0              @ &Z.@4 9F]N<BTR,#(T,#8S,%]P<F4N>&UL4$L%
3!@     -  T 5@,  'J<!0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>fonar_10-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:FONR="http://fonar.com/20240630"
  xmlns:country="http://xbrl.sec.gov/country/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="fonr-20240630.xsd" xlink:type="simple"/>
    <context id="From2023-07-01to2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2023-12-29</instant>
        </period>
    </context>
    <context id="AsOf2024-09-18_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-18</instant>
        </period>
    </context>
    <context id="AsOf2024-09-18_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-18</instant>
        </period>
    </context>
    <context id="AsOf2024-09-18_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-18</instant>
        </period>
    </context>
    <context id="AsOf2024-09-18_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-18</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_CommonStockholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:CommonStockholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_CommonStockholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:CommonStockholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ClassANonVotingPreferredStockholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ClassANonVotingPreferredStockholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ClassANonVotingPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ClassANonVotingPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonStockMember958664140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ClassANonVotingPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ClassANonVotingPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ClassANonVotingPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonStockMember958664218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2015-07-01_us-gaap_OtherInvesteesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_OtherInvesteesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_OtherInvesteesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_IntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_DiagnosticImagingFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">FONR:DiagnosticImagingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-07-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2022-07-02</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FONR:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FONR:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FONR:RelatedPartiesMedicalPracticesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FONR:RelatedPartiesMedicalPracticesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_srt_MinimumMember_custom_DiagnosticEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_srt_MaximumMember_custom_DiagnosticEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_srt_MinimumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDeveopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_srt_MaximumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDeveopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_srt_MinimumMember_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_srt_MaximumMember_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_srt_MinimumMember_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_srt_MaximumMember_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_srt_MinimumMember_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_srt_MaximumMember_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_srt_WeightedAverageMember_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_CommercialInsuranceManagedCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_CommercialInsuranceManagedCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_MedicareMedicaidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_MedicareMedicaidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_WorkersCompensationPersonalInjuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_WorkersCompensationPersonalInjuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_OtherRevenueSourceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_OtherRevenueSourceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_CommonStockMember958666312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_CommonStockMember958666343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_NotesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_NotesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_NotesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_NotesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_NotesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_DiagnosticEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_DiagnosticEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ResearchDevelopmentAndDemonstrationEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDevelopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ResearchDevelopmentAndDemonstrationEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDevelopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_PropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_PropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_OperatingLeasePaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:OperatingLeasePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_FinancingLeasePaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:FinancingLeasePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_PreferredClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2010-04-23_custom_N2010StockBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2010-04-23</instant>
        </period>
    </context>
    <context id="AsOf2010-08-10_custom_N2010StockBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2010-08-10</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_N2010StockBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_N2010StockBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_N2010StockBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-09-252022-09-26_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-09-26</endDate>
        </period>
    </context>
    <context id="AsOf2013-02-13_custom_HDMMember_custom_ClassAControllingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-02-13</instant>
        </period>
    </context>
    <context id="AsOf2013-02-13_custom_HDMMember_custom_ClassBControllingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassBControllingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-02-13</instant>
        </period>
    </context>
    <context id="From2013-02-122013-02-13_custom_HDMMember_custom_ClassBControllingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassBControllingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-02-12</startDate>
            <endDate>2013-02-13</endDate>
        </period>
    </context>
    <context id="From2013-02-122013-02-13_custom_HDMMember_custom_ClassAControllingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-02-12</startDate>
            <endDate>2013-02-13</endDate>
        </period>
    </context>
    <context id="AsOf2013-03-05_custom_HDMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-03-05</instant>
        </period>
    </context>
    <context id="AsOf2015-01-08_custom_ClassAControllingInterestsMember_custom_HDMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-01-08</instant>
        </period>
    </context>
    <context id="From2015-01-072015-01-08_custom_ClassAControllingInterestsMember_custom_HDMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-01-07</startDate>
            <endDate>2015-01-08</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ClassAControllingInterestsMember_custom_HDMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ClassAControllingInterestsMember_custom_HDMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_HDMMember_custom_ClassAControllingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_NotePayable1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_NotePayable1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_NotePayable2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_NotePayable1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_NotePayable2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_NotePayable2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2016-02-282016-02-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2016-02-28</startDate>
            <endDate>2016-02-29</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_MagneticResonanceManagementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">FONR:MagneticResonanceManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_BensonhurstMRILimitedPartnershipMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:BensonhurstMRILimitedPartnershipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2017-05-302017-06-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2017-05-30</startDate>
            <endDate>2017-06-01</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_RadianHealthcareManagementLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:RadianHealthcareManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_HealthCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_HealthCareOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_HealthCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_HealthCareOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_HealthCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_HealthCareOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_HealthCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_HealthCareOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_country_CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_country_CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_country_DE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_country_DE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_country_AE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_country_AE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_country_PR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_country_PR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_country_CH">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_country_CH">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_country_GB">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_country_GB">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_country_DO">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DO</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_country_DO">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DO</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_country_GR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_country_GR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_country_AU">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_country_AU">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-18_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-18</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Integer">
        <measure>FONR:Integer</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2023-07-01to2024-06-30" id="Fact000003">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="From2023-07-01to2024-06-30" id="Fact000004">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2023-07-01to2024-06-30" id="Fact000005">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2023-07-01to2024-06-30" id="Fact000006">0000355019</dei:EntityCentralIndexKey>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-06-30"
      id="xdx2ixbrl0195"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30_custom_ClassANonVotingPreferredMember"
      id="xdx2ixbrl0465"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0466"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0467"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012023-06-30_custom_ClassANonVotingPreferredMember"
      id="xdx2ixbrl0469"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0470"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012023-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0471"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2022-07-012023-06-30_custom_ClassANonVotingPreferredMember"
      id="xdx2ixbrl0473"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2022-07-012023-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0475"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012023-06-30_custom_ClassANonVotingPreferredMember"
      id="xdx2ixbrl0479"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0480"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012023-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0481"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012024-06-30_custom_ClassANonVotingPreferredMember"
      id="xdx2ixbrl0489"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0490"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0491"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012024-06-30_custom_ClassANonVotingPreferredMember"
      id="xdx2ixbrl0493"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0494"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0495"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-07-012024-06-30_custom_ClassANonVotingPreferredMember"
      id="xdx2ixbrl0497"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0499"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012024-06-30_custom_ClassANonVotingPreferredMember"
      id="xdx2ixbrl0503"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0504"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0505"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0516"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0519"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0520"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0523"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0525"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0526"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0531"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0534"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0535"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0538"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0540"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0541"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0550"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012023-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0555"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2022-07-012023-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0559"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0560"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012023-06-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0562"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0570"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012024-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0575"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-07-012024-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0579"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0580"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0582"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:GainOnSaleOfEquipmentRelatedParty
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0612"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2023-07-01to2024-06-30" id="Fact000013">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2023-07-01to2024-06-30" id="Fact000014">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2023-07-01to2024-06-30" id="Fact000015">2024-06-30</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2023-07-01to2024-06-30" id="Fact000016">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="From2023-07-01to2024-06-30" id="Fact000017">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2023-07-01to2024-06-30" id="Fact000018">0-10248</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2023-07-01to2024-06-30" id="Fact000019">FONAR CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-07-01to2024-06-30" id="Fact000021">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-07-01to2024-06-30" id="Fact000023">11-2464137</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-07-01to2024-06-30" id="Fact000025">110 Marcus Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2023-07-01to2024-06-30" id="Fact000027">Melville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-07-01to2024-06-30" id="Fact000029">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-07-01to2024-06-30" id="Fact000031">11747</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-07-01to2024-06-30" id="Fact000033">631</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-07-01to2024-06-30" id="Fact000035">694-2929</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2023-07-01to2024-06-30" id="Fact000036">Common Stock, $.0001 par     value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-07-01to2024-06-30" id="Fact000037">FONR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-07-01to2024-06-30" id="Fact000038">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2023-07-01to2024-06-30" id="Fact000040">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2023-07-01to2024-06-30" id="Fact000042">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2023-07-01to2024-06-30" id="Fact000043">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2023-07-01to2024-06-30" id="Fact000044">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2023-07-01to2024-06-30" id="Fact000045">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2023-07-01to2024-06-30" id="Fact000046">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-07-01to2024-06-30" id="Fact000047">false</dei:EntityEmergingGrowthCompany>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="From2023-07-01to2024-06-30" id="Fact000048">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="From2023-07-01to2024-06-30" id="Fact000049">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="AsOf2023-12-29"
      decimals="-5"
      id="Fact000051"
      unitRef="USD">121000000.0</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2024-09-18_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000053"
      unitRef="Shares">6328294</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2024-09-18_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000055"
      unitRef="Shares">146</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2024-09-18_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000057"
      unitRef="Shares">382513</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2024-09-18_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      id="Fact000059"
      unitRef="Shares">313438</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="From2023-07-01to2024-06-30" id="Fact000060">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:AuditorName contextRef="From2023-07-01to2024-06-30" id="Fact000061">Marcum</dei:AuditorName>
    <dei:AuditorFirmId contextRef="From2023-07-01to2024-06-30" id="Fact000062">688</dei:AuditorFirmId>
    <dei:AuditorLocation contextRef="From2023-07-01to2024-06-30" id="Fact000063">New York, NY</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000068"
      unitRef="USD">56341193</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000069"
      unitRef="USD">51279707</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000071"
      unitRef="USD">136102</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000072"
      unitRef="USD">32799</us-gaap:ShortTermInvestments>
    <us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000077"
      unitRef="USD">166049</us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables>
    <us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000079"
      unitRef="USD">198593</us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000074"
      unitRef="USD">4035336</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000075"
      unitRef="USD">3861512</us-gaap:AccountsReceivableNetCurrent>
    <FONR:MedicalReceivable
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000081"
      unitRef="USD">23991533</FONR:MedicalReceivable>
    <FONR:MedicalReceivable
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000082"
      unitRef="USD">21259262</FONR:MedicalReceivable>
    <FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000087"
      unitRef="USD">12369921</FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts>
    <FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000089"
      unitRef="USD">12608567</FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts>
    <us-gaap:AccruedFeesAndOtherRevenueReceivable
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000084"
      unitRef="USD">41953657</us-gaap:AccruedFeesAndOtherRevenueReceivable>
    <us-gaap:AccruedFeesAndOtherRevenueReceivable
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000085"
      unitRef="USD">35888253</us-gaap:AccruedFeesAndOtherRevenueReceivable>
    <FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000094"
      unitRef="USD">6110399</FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts>
    <FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000096"
      unitRef="USD">3989692</FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000091"
      unitRef="USD">9865061</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000092"
      unitRef="USD">9161870</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <us-gaap:InventoryNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000098"
      unitRef="USD">2715441</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000099"
      unitRef="USD">2569666</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000101"
      unitRef="USD">1285962</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000102"
      unitRef="USD">1607768</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000104"
      unitRef="USD">140324285</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000105"
      unitRef="USD">125660837</us-gaap:AssetsCurrent>
    <FONR:AccountsReceivableNetLongTerm
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000107"
      unitRef="USD">829473</FONR:AccountsReceivableNetLongTerm>
    <FONR:AccountsReceivableNetLongTerm
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000108"
      unitRef="USD">710085</FONR:AccountsReceivableNetLongTerm>
    <FONR:NoteReceivableRelatedParty
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000110"
      unitRef="USD">581183</FONR:NoteReceivableRelatedParty>
    <FONR:NoteReceivableRelatedParty
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000111"
      unitRef="USD">0</FONR:NoteReceivableRelatedParty>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000113"
      unitRef="USD">7223255</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000114"
      unitRef="USD">10041960</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000116"
      unitRef="USD">18708920</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000117"
      unitRef="USD">22146373</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000119"
      unitRef="USD">38427757</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000120"
      unitRef="USD">33068755</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000122"
      unitRef="USD">530348</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000123"
      unitRef="USD">729229</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000125"
      unitRef="USD">4269277</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000126"
      unitRef="USD">4269277</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000128"
      unitRef="USD">2870324</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000129"
      unitRef="USD">3431865</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssets
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000131"
      unitRef="USD">481147</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000132"
      unitRef="USD">523506</us-gaap:OtherAssets>
    <us-gaap:Assets
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000134"
      unitRef="USD">214245969</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000135"
      unitRef="USD">200581887</us-gaap:Assets>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000140"
      unitRef="USD">47002</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000141"
      unitRef="USD">43767</us-gaap:LongTermDebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000143"
      unitRef="USD">1855879</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000144"
      unitRef="USD">1579240</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000146"
      unitRef="USD">7941039</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000147"
      unitRef="USD">5443724</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000149"
      unitRef="USD">3473674</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000150"
      unitRef="USD">3905484</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000152"
      unitRef="USD">225786</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000153"
      unitRef="USD">217597</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000155"
      unitRef="USD">3870229</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000156"
      unitRef="USD">3832184</us-gaap:DeferredRevenueCurrent>
    <FONR:CustomerDeposits
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000158"
      unitRef="USD">443471</FONR:CustomerDeposits>
    <FONR:CustomerDeposits
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000159"
      unitRef="USD">602377</FONR:CustomerDeposits>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000161"
      unitRef="USD">17857080</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000162"
      unitRef="USD">15624373</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000167"
      unitRef="USD">1174844</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000168"
      unitRef="USD">760242</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000170"
      unitRef="USD">371560</us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000171"
      unitRef="USD">394758</us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent>
    <FONR:AccountsPayableRelatedPartyNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000173"
      unitRef="USD">92663</FONR:AccountsPayableRelatedPartyNoncurrent>
    <FONR:AccountsPayableRelatedPartyNoncurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000174"
      unitRef="USD">92663</FONR:AccountsPayableRelatedPartyNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000176"
      unitRef="USD">37467746</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000177"
      unitRef="USD">32105405</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000179"
      unitRef="USD">394723</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000180"
      unitRef="USD">620481</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000182"
      unitRef="USD">66938</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000183"
      unitRef="USD">115075</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000185"
      unitRef="USD">32026</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000186"
      unitRef="USD">41750</us-gaap:OtherLiabilities>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000188"
      unitRef="USD">39600500</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000189"
      unitRef="USD">34130374</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000191"
      unitRef="USD">57457580</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000192"
      unitRef="USD">49754747</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      id="Fact000200"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      id="Fact000202"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      id="Fact000204"
      unitRef="Shares">453000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      id="Fact000206"
      unitRef="Shares">453000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      id="Fact000208"
      unitRef="Shares">313438</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      id="Fact000210"
      unitRef="Shares">313438</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      id="Fact000212"
      unitRef="Shares">313438</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      id="Fact000214"
      unitRef="Shares">313438</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="0"
      id="Fact000216"
      unitRef="USD">31</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="0"
      id="Fact000218"
      unitRef="USD">31</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000220"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000222"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000224"
      unitRef="Shares">567000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000226"
      unitRef="Shares">567000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000228"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000230"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000232"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000234"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000236"
      unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000238"
      unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000240"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000242"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000244"
      unitRef="Shares">8500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000246"
      unitRef="Shares">8500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000248"
      unitRef="Shares">6373375</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000250"
      unitRef="Shares">6462345</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000252"
      unitRef="Shares">6328294</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000254"
      unitRef="Shares">6450882</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000256"
      unitRef="USD">635</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000258"
      unitRef="USD">647</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000260"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000262"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000264"
      unitRef="Shares">227000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000266"
      unitRef="Shares">227000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000268"
      unitRef="Shares">146</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000270"
      unitRef="Shares">146</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000272"
      unitRef="Shares">146</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000274"
      unitRef="Shares">146</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember"
      decimals="0"
      id="Fact000276"
      unitRef="USD">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember"
      decimals="0"
      id="Fact000278"
      unitRef="USD">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000280"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000282"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000284"
      unitRef="Shares">567000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000286"
      unitRef="Shares">567000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000288"
      unitRef="Shares">382513</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000290"
      unitRef="Shares">382513</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000292"
      unitRef="Shares">382513</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000294"
      unitRef="Shares">382513</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      id="Fact000296"
      unitRef="USD">38</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      id="Fact000298"
      unitRef="USD">38</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000300"
      unitRef="USD">180607510</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000301"
      unitRef="USD">182612518</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000303"
      unitRef="USD">-13623585</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000304"
      unitRef="USD">-24190981</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockCommonShares
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000309"
      unitRef="Shares">45081</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="Fact000311"
      unitRef="Shares">11463</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000306"
      unitRef="USD">1016632</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000307"
      unitRef="USD">515820</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000313"
      unitRef="USD">165967997</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000314"
      unitRef="USD">157906433</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000316"
      unitRef="USD">-9179608</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000317"
      unitRef="USD">-7079293</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000319"
      unitRef="USD">156788389</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000320"
      unitRef="USD">150827140</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000322"
      unitRef="USD">214245969</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000323"
      unitRef="USD">200581887</us-gaap:LiabilitiesAndStockholdersEquity>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000328"
      unitRef="USD">33815796</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000329"
      unitRef="USD">29793993</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts>
    <FONR:ProductSalesNet
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000331"
      unitRef="USD">737727</FONR:ProductSalesNet>
    <FONR:ProductSalesNet
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000332"
      unitRef="USD">731607</FONR:ProductSalesNet>
    <FONR:ServiceAndRepairFeesNet
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000334"
      unitRef="USD">7452212</FONR:ServiceAndRepairFeesNet>
    <FONR:ServiceAndRepairFeesNet
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000335"
      unitRef="USD">7419104</FONR:ServiceAndRepairFeesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000337"
      unitRef="USD">139167</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000338"
      unitRef="USD">110000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ManagementAndOtherFeesNet
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000340"
      unitRef="USD">48789287</FONR:ManagementAndOtherFeesNet>
    <FONR:ManagementAndOtherFeesNet
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000341"
      unitRef="USD">48640497</FONR:ManagementAndOtherFeesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000343"
      unitRef="USD">11949900</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000344"
      unitRef="USD">11949900</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <us-gaap:Revenues
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000346"
      unitRef="USD">102884089</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000347"
      unitRef="USD">98645101</us-gaap:Revenues>
    <FONR:CostsRelatedToProductSales
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000352"
      unitRef="USD">1052159</FONR:CostsRelatedToProductSales>
    <FONR:CostsRelatedToProductSales
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000353"
      unitRef="USD">852025</FONR:CostsRelatedToProductSales>
    <FONR:CostsRelatedToServiceAndRepairFees
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000355"
      unitRef="USD">3577570</FONR:CostsRelatedToServiceAndRepairFees>
    <FONR:CostsRelatedToServiceAndRepairFees
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000356"
      unitRef="USD">3033967</FONR:CostsRelatedToServiceAndRepairFees>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000358"
      unitRef="USD">144413</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000359"
      unitRef="USD">44983</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000361"
      unitRef="USD">18199579</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000362"
      unitRef="USD">16183166</us-gaap:OtherCostOfOperatingRevenue>
    <FONR:CostsRelatedToManagementAndOtherFees
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000364"
      unitRef="USD">28626595</FONR:CostsRelatedToManagementAndOtherFees>
    <FONR:CostsRelatedToManagementAndOtherFees
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000365"
      unitRef="USD">26975563</FONR:CostsRelatedToManagementAndOtherFees>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000367"
      unitRef="USD">6143728</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000368"
      unitRef="USD">5807454</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000370"
      unitRef="USD">1735949</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000371"
      unitRef="USD">1567749</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000373"
      unitRef="USD">26868732</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000374"
      unitRef="USD">29390932</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000376"
      unitRef="USD">86348725</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000377"
      unitRef="USD">83855839</us-gaap:CostsAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000379"
      unitRef="USD">16535364</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000380"
      unitRef="USD">14789262</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000385"
      unitRef="USD">76997</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000386"
      unitRef="USD">50131</us-gaap:InterestExpenseNonoperating>
    <FONR:InvestmentIncomeRelatedParty
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000388"
      unitRef="USD">25959</FONR:InvestmentIncomeRelatedParty>
    <FONR:InvestmentIncomeRelatedParty
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000389"
      unitRef="USD">0</FONR:InvestmentIncomeRelatedParty>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000391"
      unitRef="USD">2126439</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000392"
      unitRef="USD">1222176</us-gaap:InvestmentIncomeNet>
    <FONR:OtherIncomeRelatedParty
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000394"
      unitRef="USD">576857</FONR:OtherIncomeRelatedParty>
    <FONR:OtherIncomeRelatedParty
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000395"
      unitRef="USD">0</FONR:OtherIncomeRelatedParty>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000397"
      unitRef="USD">78763</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000398"
      unitRef="USD">-202720</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000400"
      unitRef="USD">19266385</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000401"
      unitRef="USD">15758587</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000403"
      unitRef="USD">5168968</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000404"
      unitRef="USD">3632071</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000406"
      unitRef="USD">14097417</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000407"
      unitRef="USD">12126516</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000409"
      unitRef="USD">3530021</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000410"
      unitRef="USD">2750740</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000412"
      unitRef="USD">10567396</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000413"
      unitRef="USD">9375776</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-07-012024-06-30_custom_CommonStockholdersMember"
      decimals="0"
      id="Fact000415"
      unitRef="USD">9908920</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2022-07-012023-06-30_custom_CommonStockholdersMember"
      decimals="0"
      id="Fact000417"
      unitRef="USD">8801974</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-07-012024-06-30_custom_ClassANonVotingPreferredStockholdersMember"
      decimals="0"
      id="Fact000419"
      unitRef="USD">490776</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2022-07-012023-06-30_custom_ClassANonVotingPreferredStockholdersMember"
      decimals="0"
      id="Fact000421"
      unitRef="USD">427666</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      id="Fact000423"
      unitRef="USD">167700</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      id="Fact000425"
      unitRef="USD">146136</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-07-012024-06-30_custom_CommonStockholdersMember"
      decimals="INF"
      id="Fact000427"
      unitRef="USDPShares">1.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-07-012023-06-30_custom_CommonStockholdersMember"
      decimals="INF"
      id="Fact000429"
      unitRef="USDPShares">1.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012024-06-30_custom_CommonStockholdersMember"
      decimals="INF"
      id="Fact000431"
      unitRef="USDPShares">1.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-07-012023-06-30_custom_CommonStockholdersMember"
      decimals="INF"
      id="Fact000433"
      unitRef="USDPShares">1.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000435"
      unitRef="USDPShares">0.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000437"
      unitRef="USDPShares">0.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000439"
      unitRef="USDPShares">0.38</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000441"
      unitRef="USDPShares">0.38</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-012024-06-30_custom_CommonStockholdersMember"
      decimals="INF"
      id="Fact000443"
      unitRef="Shares">6350862</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-012023-06-30_custom_CommonStockholdersMember"
      decimals="INF"
      id="Fact000445"
      unitRef="Shares">6539376</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-07-012024-06-30_custom_CommonStockholdersMember"
      decimals="INF"
      id="Fact000447"
      unitRef="Shares">6478366</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-07-012023-06-30_custom_CommonStockholdersMember"
      decimals="INF"
      id="Fact000449"
      unitRef="Shares">6666880</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000451"
      unitRef="Shares">382513</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000453"
      unitRef="Shares">382513</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000455"
      unitRef="Shares">382513</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000457"
      unitRef="Shares">382513</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredMember"
      decimals="0"
      id="Fact000459"
      unitRef="USD">31</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000463"
      unitRef="Shares">6554210</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000460"
      unitRef="USD">657</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_custom_ClassCCommonStockMember"
      decimals="0"
      id="Fact000461"
      unitRef="USD">38</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000477"
      unitRef="Shares">-103328</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000474"
      unitRef="USD">-10</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredMember"
      decimals="0"
      id="Fact000483"
      unitRef="USD">31</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember958664140"
      decimals="INF"
      id="Fact000487"
      unitRef="Shares">6450882</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember958664140"
      decimals="0"
      id="Fact000484"
      unitRef="USD">647</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_custom_ClassCCommonStockMember"
      decimals="0"
      id="Fact000485"
      unitRef="USD">38</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000501"
      unitRef="Shares">-122588</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000498"
      unitRef="USD">-12</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredMember"
      decimals="0"
      id="Fact000507"
      unitRef="USD">31</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember958664218"
      decimals="INF"
      id="Fact000511"
      unitRef="Shares">6328294</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember958664218"
      decimals="0"
      id="Fact000508"
      unitRef="USD">635</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_custom_ClassCCommonStockMember"
      decimals="0"
      id="Fact000509"
      unitRef="USD">38</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000513"
      unitRef="USD">184531535</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000514"
      unitRef="USD">-33566757</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000517"
      unitRef="USD">9375776</us-gaap:ProfitLoss>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000522"
      unitRef="USD">-1919017</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000528"
      unitRef="USD">182612518</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000529"
      unitRef="USD">-24190981</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000532"
      unitRef="USD">10567396</us-gaap:ProfitLoss>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000537"
      unitRef="USD">-2005008</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000543"
      unitRef="USD">180607510</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000544"
      unitRef="USD">-13623585</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      id="Fact000546"
      unitRef="USD">-675390</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000547"
      unitRef="USD">-4053833</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30"
      decimals="0"
      id="Fact000548"
      unitRef="USD">146236281</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000551"
      unitRef="USD">2750740</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000552"
      unitRef="USD">12126516</us-gaap:ProfitLoss>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012023-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      id="Fact000554"
      unitRef="USD">1759457</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000556"
      unitRef="USD">1759457</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2022-07-012023-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      id="Fact000558"
      unitRef="USD">1919027</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012023-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000563"
      unitRef="USD">5776200</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000564"
      unitRef="USD">5776200</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      id="Fact000566"
      unitRef="USD">-515820</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000567"
      unitRef="USD">-7079293</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000568"
      unitRef="USD">150827140</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012024-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000571"
      unitRef="USD">3530021</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000572"
      unitRef="USD">14097417</us-gaap:ProfitLoss>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      id="Fact000574"
      unitRef="USD">2505832</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000576"
      unitRef="USD">2505832</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      id="Fact000578"
      unitRef="USD">2005020</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012024-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000583"
      unitRef="USD">5630336</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000584"
      unitRef="USD">5630336</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      id="Fact000586"
      unitRef="USD">-1016632</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000587"
      unitRef="USD">-9179608</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000588"
      unitRef="USD">156788389</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000593"
      unitRef="USD">14097417</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000594"
      unitRef="USD">12126516</us-gaap:ProfitLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000599"
      unitRef="USD">4596421</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000600"
      unitRef="USD">4540135</us-gaap:DepreciationAndAmortization>
    <FONR:ProvisionForBadDebts
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000602"
      unitRef="USD">1882061</FONR:ProvisionForBadDebts>
    <FONR:ProvisionForBadDebts
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000603"
      unitRef="USD">5513476</FONR:ProvisionForBadDebts>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000605"
      unitRef="USD">2795507</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000606"
      unitRef="USD">2979550</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000608"
      unitRef="USD">4311762</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000609"
      unitRef="USD">4264818</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <FONR:GainOnSaleOfEquipmentRelatedParty
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000611"
      unitRef="USD">581183</FONR:GainOnSaleOfEquipmentRelatedParty>
    <FONR:GainlossOnDispositionOfFixedAssets
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000614"
      unitRef="USD">75411</FONR:GainlossOnDispositionOfFixedAssets>
    <FONR:GainlossOnDispositionOfFixedAssets
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000615"
      unitRef="USD">-213244</FONR:GainlossOnDispositionOfFixedAssets>
    <FONR:AbandonedPatents
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000617"
      unitRef="USD">225419</FONR:AbandonedPatents>
    <FONR:AbandonedPatents
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000618"
      unitRef="USD">0</FONR:AbandonedPatents>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000623"
      unitRef="USD">11676139</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000624"
      unitRef="USD">8055843</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <FONR:IncreaseDecreaseInNotesReceivable
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000626"
      unitRef="USD">55200</FONR:IncreaseDecreaseInNotesReceivable>
    <FONR:IncreaseDecreaseInNotesReceivable
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000627"
      unitRef="USD">-64532</FONR:IncreaseDecreaseInNotesReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000629"
      unitRef="USD">145775</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000630"
      unitRef="USD">209845</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000632"
      unitRef="USD">-266606</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000633"
      unitRef="USD">438911</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000635"
      unitRef="USD">-42359</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000636"
      unitRef="USD">-2763</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000638"
      unitRef="USD">276639</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000639"
      unitRef="USD">19685</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000641"
      unitRef="USD">2949962</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000642"
      unitRef="USD">-2527100</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <FONR:IncreaseDecreaseInCustomerAdvance
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000644"
      unitRef="USD">-158906</FONR:IncreaseDecreaseInCustomerAdvance>
    <FONR:IncreaseDecreaseInCustomerAdvance
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000645"
      unitRef="USD">241132</FONR:IncreaseDecreaseInCustomerAdvance>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000647"
      unitRef="USD">-4541352</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000648"
      unitRef="USD">-3862814</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInTradingLiabilities
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000650"
      unitRef="USD">-217569</us-gaap:IncreaseDecreaseInTradingLiabilities>
    <us-gaap:IncreaseDecreaseInTradingLiabilities
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000651"
      unitRef="USD">-210353</us-gaap:IncreaseDecreaseInTradingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000653"
      unitRef="USD">-9724</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000654"
      unitRef="USD">-64791</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000656"
      unitRef="USD">14093294</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000657"
      unitRef="USD">14467130</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000662"
      unitRef="USD">789961</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000663"
      unitRef="USD">4218084</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromShortTermInvestments
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000665"
      unitRef="USD">103303</us-gaap:PaymentsForProceedsFromShortTermInvestments>
    <us-gaap:PaymentsForProceedsFromShortTermInvestments
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000666"
      unitRef="USD">473</us-gaap:PaymentsForProceedsFromShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000668"
      unitRef="USD">75411</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000669"
      unitRef="USD">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000671"
      unitRef="USD">32885</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000672"
      unitRef="USD">119571</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000674"
      unitRef="USD">-850738</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000675"
      unitRef="USD">-4338128</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000680"
      unitRef="USD">44902</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000681"
      unitRef="USD">36615</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:PaymentsForRepurchaseOfEquity
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000683"
      unitRef="USD">2505832</us-gaap:PaymentsForRepurchaseOfEquity>
    <us-gaap:PaymentsForRepurchaseOfEquity
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000684"
      unitRef="USD">1759457</us-gaap:PaymentsForRepurchaseOfEquity>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000686"
      unitRef="USD">5630336</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000687"
      unitRef="USD">5776200</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000689"
      unitRef="USD">-8181070</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000690"
      unitRef="USD">-7572272</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000692"
      unitRef="USD">5061486</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000693"
      unitRef="USD">2556730</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000695"
      unitRef="USD">51279707</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2022-06-30"
      decimals="0"
      id="Fact000696"
      unitRef="USD">48722977</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000698"
      unitRef="USD">56341193</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000699"
      unitRef="USD">51279707</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000701">&lt;p id="xdx_808_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_z6rKFXjrXCi9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;NOTE 1 - &lt;span id="xdx_822_z4fTfDmZVo21"&gt;DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;Description of Business&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;FONAR Corporation (the &#x201c;Company&#x201d; or &#x201c;FONAR&#x201d;)
is a Delaware corporation, which was incorporated on July 17, 1978. FONAR is engaged in the research, development, production and marketing
of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (&#x201c;MRI&#x201d;) for the detection and diagnosis
of human diseases. In addition to deriving revenues from the direct sale of MRI equipment, revenue is also generated from our installed-base
of customers through our service and upgrade programs.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;FONAR, through its wholly-owned subsidiary Health
Management Corporation of America (&#x201c;HMCA&#x201d;) provides comprehensive management services to diagnostic imaging facilities. The
services provided by the Company include development, administration, leasing of office space, facilities and medical equipment, provision
of supplies, staffing and supervision of non-medical personnel, legal services, accounting, billing and collection and the development
and implementation of practice growth and marketing strategies.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On July 1, 2015, the Company restructured the corporate
organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely
integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized
in the business of Health Management Corporation of America) to HDM and received a &lt;span id="xdx_907_eus-gaap--InvestmentOwnedPercentOfNetAssets_iI_dp_c20150701__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_z9afFNvkf4n3" title="Interest received percentage"&gt;24.2&lt;/span&gt;% interest in HDM. Health Management Corporation
of America retained a direct ownership interest of &lt;span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20150701__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zb83N4OFrGSk" title="Ownership interest percentage"&gt;45.8&lt;/span&gt;% in HDM, and the original investors in HDM retained a &lt;span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20150701__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zABV9QRzTqZj" title="Ownership interest percentage"&gt;30.0&lt;/span&gt;% ownership interest
in the newly expanded HDM. During the year ended June 30, 2022, the Company purchased noncontrolling interests for $&lt;span id="xdx_904_eus-gaap--ProceedsFromPaymentsToMinorityShareholders_c20210701__20220630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zed18GeiCmL7" title="Non-controlling interests from the minority shareholders"&gt;546,000&lt;/span&gt; giving the
Company a direct ownership interest of &lt;span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20220630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zycUAw1DDfJc" title="Ownership interest percentage"&gt;70.8&lt;/span&gt;% and the investors&#x2019; a &lt;span id="xdx_901_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zeEsYG8cPVpe" title="Ownership interest percentage"&gt;29.2&lt;/span&gt;% ownership interest. The entire management of diagnostic
imaging centers business segment is now being conducted by HDM.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="AsOf2015-07-01_us-gaap_OtherInvesteesMember"
      decimals="INF"
      id="Fact000703"
      unitRef="Pure">0.242</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2015-07-01_us-gaap_OtherInvesteesMember"
      decimals="INF"
      id="Fact000705"
      unitRef="Pure">0.458</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember"
      decimals="INF"
      id="Fact000707"
      unitRef="Pure">0.300</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ProceedsFromPaymentsToMinorityShareholders
      contextRef="From2021-07-012022-06-30_us-gaap_OtherInvesteesMember"
      decimals="0"
      id="Fact000709"
      unitRef="USD">546000</us-gaap:ProceedsFromPaymentsToMinorityShareholders>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2022-06-30_us-gaap_OtherInvesteesMember"
      decimals="INF"
      id="Fact000711"
      unitRef="Pure">0.708</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember"
      decimals="INF"
      id="Fact000713"
      unitRef="Pure">0.292</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000715">&lt;p id="xdx_80A_eus-gaap--SignificantAccountingPoliciesTextBlock_zHYHmiqo2pn8" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;NOTE 2 - &lt;span id="xdx_82D_z5LNp253d4Kb"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zwyUDgDQDNFi" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_869_z2pxossBaQ4j"&gt;Principles of Consolidation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The consolidated financial statements include the
accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships. The operating activities of subsidiaries are
included in the accompanying consolidated statements from the date of acquisition. All significant intercompany accounts and transactions
have been eliminated in consolidation.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



















&lt;p id="xdx_84E_eus-gaap--UseOfEstimates_zqEKKHEfG9S9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_865_zDrffM0Rk6Ua"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The preparation of the consolidated financial statements
in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities in the consolidated financial
statements and accompanying notes. The most significant estimates relate to receivable allowances, income taxes and related tax asset
valuation allowances, contingencies, and revenue recognition. In addition, healthcare industry reforms and reimbursement practices will
continue to impact the Company&#x2019;s operations and the determination of contractual and other allowance estimates. Actual results could
differ from those estimates.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--InventoryWorkInProcessPolicy_zJRpuO4jgf7e" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_860_zYX965COlutb"&gt;Inventories&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Inventories consist of purchased parts, components
and supplies, as well as work-in-process, and are stated at the lower of cost or net realizable value.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zDew3dopOlpd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_865_z84usRR4a1s"&gt;Property and Equipment&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Property and equipment procured in the normal course
of business is stated at cost less accumulated depreciation. Property and equipment purchased in connection with an acquisition is stated
at its estimated fair value, generally based on an appraisal. Property and equipment is being depreciated for financial accounting purposes
using the straight-line method over their estimated useful lives. Leasehold improvements are being amortized over the shorter of the useful
life or the remaining lease term. Upon retirement or other disposition of these assets, the cost and related accumulated depreciation
of these assets are removed from the accounts and the resulting gains or losses are reflected in the results of operations. Expenses for
maintenance and repairs are charged to operations. Renewals and betterments are capitalized. Maintenance and repair expenses totaled approximately
$&lt;span id="xdx_90A_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20230701__20240630_zvKqLaoduv4e" title="Maintenance and repair expenses"&gt;2,948,000&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20220701__20230630_zULLmiJZg0Ba" title="Maintenance and repair expenses"&gt;2,801,000&lt;/span&gt; for the years ended June 30, 2024 and 2023 respectively. The estimated useful lives in years are generally as
follows:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_z1vIwy6ZISK9" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; padding: 0pt; text-align: left; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_8BF_zs2gNJdAoczg" style="display: none"&gt;Schedule
of estimated useful life in years for property and equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; width: 87%; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Diagnostic equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; width: 12%; text-align: right; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zLKj6odAoCG5"&gt;5&lt;/span&gt;&#x2013;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_z15gqxQVKlt" title="Estimated useful lives"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; width: 1%; line-height: 115%; text-indent: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Research, development and demonstration equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zD1kMI5H9Pfk"&gt;3&lt;/span&gt;-&lt;span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_z6eK5e3xFzCa"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; line-height: 115%; text-indent: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_za6eX1JyjcW7"&gt;2&lt;/span&gt;-&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zHXeZQTExWYd"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; line-height: 115%; text-indent: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zPVJ7nKtC0lg"&gt;3&lt;/span&gt;-&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z2TR8Wlv23Fc"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; line-height: 115%; text-indent: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zy1haNsqvvPb"&gt;5&lt;/span&gt;&#x2013;&lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z3GQyurSiPwa"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; line-height: 115%; text-indent: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Building&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--WeightedAverageMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zP9U3mTibM8l" title="Estimated useful lives"&gt;28&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; line-height: 115%; text-indent: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



















&lt;p id="xdx_842_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zhUDRnXmYAj4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_862_zAIQkiz1EDza"&gt;Long-Lived Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company periodically assesses the recoverability
of long-lived assets, including property and equipment and intangibles, other than goodwill, when events or changes in circumstances indicate
that the carrying value of long-lived assets may not be recoverable. If indicators are present, the Company performs a recoverability
test by comparing the sum of the estimated undiscounted future cash flows attributable to the asset group in question to its carrying
amount. An impairment loss is recognized if it is determined that the long-lived asset group is not recoverable and is calculated by comparing
the discounted future cash flows with the carrying value of the related asset group. In performing this analysis, management considers
such factors as current results, trends, and future prospects, in addition to other economic factors.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zpdPcnvzbad3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_860_zfvdavdczYO5"&gt;Other Intangible Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;1) Patents and Copyrights&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Patent and copyrights are professional costs incurred
to acquire certain patent and copyrights. Amortization is calculated on the straight-line basis over &lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zAvQaEtly327" title="Finite-lived intangible asset, useful life"&gt;15&lt;/span&gt; years.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;2) Non-Competition Agreements&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The non-competition agreements are agreements entered
into with past principal owners of entities that the Company had acquired. The non-competition agreements are being amortized on the straight-line
basis over the length of the agreement (&lt;span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_z0tdVFCqcb8j" title="Finite-lived intangible asset, useful life"&gt;7&lt;/span&gt; years).&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;3) Customer Relationships&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Customer relationships represents customer lists acquired
in acquisition of prior entities. Amortization is calculated on the straight-line basis over &lt;span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zhmAQeXD3XE8" title="Finite-lived intangible asset, useful life"&gt;20&lt;/span&gt; years.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_ztol9VfCLX07" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_866_ze2XHKlM2Ggl"&gt;Goodwill&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Goodwill represents the cost of a business acquisition
in excess of the fair value of the net assets acquired. Goodwill is not amortized and is reviewed for impairment annually, or more frequently
if facts and circumstances indicate that it is more likely than not that the fair value of the reporting unit is less than its carrying
amount including goodwill. If it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the
Company performs a quantitative test to identify and measure the amount of goodwill impairment loss. The Company compares the fair value
of the reporting unit with its carrying amount. If the carrying amount exceeds fair value, goodwill of the reporting unit is considered
impaired, and that excess is recognized as a goodwill impairment loss.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



















&lt;p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zjVfGdP4cLJl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span id="xdx_867_zdNR78TDJ4c4"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Revenue on sales contracts for scanners, included
in &#x201c;product sales&#x201d; in the accompanying consolidated statements of operations, is recognized under the percentage-of-completion
method in accordance with FASB ASC 606, &#x201c;Revenue Recognition &#x2013; Construction-Type and Production-Type Contracts&#x201d;. The
Company manufactures its scanners under specific contracts that provide for progress payments. Production and installation take approximately
three to six months.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Revenue on scanner service contracts is recognized
on the straight-line method over the related contract period, usually one year. As of June 30, 2023, the Company had unearned revenue
on service contracts of $3,832,184 of which all was recognized as revenue in the fiscal year ending June 30, 2024.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Revenue from product sales (upgrades and supplies)
is recognized upon shipment.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Revenue under management contracts is recognized
based upon contractual agreements for management services rendered by the Company primarily under various long-term agreements with
various medical providers (the &#x201c;PCs&#x201d;). As of June 30, 2024, the Company has &lt;span id="xdx_90E_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20240630_zXpwoYmmoGR3" title="Management agreements with company total medical practices"&gt;22&lt;/span&gt;
management agreements of which &lt;span id="xdx_90F_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20240630_zNWAb72g9LO9" title="Scanners with management agreements with company owned by related party"&gt;3&lt;/span&gt;
were with PC&#x2019;s owned by Timothy Damadian, Chairman of the Board, President, Chief Executive Officer and Treasurer (formerly
owned by Raymond V. Damadian, M.D., Chairman of the Board of FONAR until his unexpected death in August 2022)(&#x201c;the Related
medical practices&#x201d;) and &lt;span id="xdx_901_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20240630_zaNpGoUYnkHe" title="Scanners with management with company located in new york state"&gt;19&lt;/span&gt;
are with PC&#x2019;s, which are all located in the state of New York (&#x201c;the New York PC&#x2019;s&#x201d;), owned by two unrelated
radiologists. The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility
ranging from approximately $&lt;span id="xdx_90E_ecustom--ContractualFeesForServicesRenderedMinimum_iI_pdp0_c20240630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zjiq4LJFqZza" title="Contractual fees for services rendered minimum"&gt;84,000&lt;/span&gt;
to $&lt;span id="xdx_905_ecustom--ContractualFeesForServicesRenderedMaximum_iI_c20240630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zHPpdazHDQgg" title="Contractual fees for services rendered maximum"&gt;447,000&lt;/span&gt;.
All fees are re-negotiable at the anniversary of the agreements and each year thereafter. The Company records a credit loss expense for
estimated uncollectible fees, which is reflected in other operating expenses on the Consolidated Statement of Operations.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company currently recognizes revenue in accordance
with the recognition accounting standard issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) and codified in the ASC
as topic 606 (&#x201c;ASC 606&#x201d;). The revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing
revenue as performance obligations, defined in a contract with a customer as goods or services transferred to the customer in exchange
for consideration, are satisfied. The standard also requires expanded disclosures regarding the Company&#x2019;s revenue recognition policies
and significant judgments employed in the determination of revenue.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s revenues generally relate to net
patient fees&#160;received from various payers and patients themselves under contracts in which our performance obligations are to provide
diagnostic services to the patients. Revenues are recorded during the period our obligations to provide diagnostic services are satisfied.
Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships
with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health plans and commercial insurance
companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent
upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the
third-party payers. The payment arrangements with third-party payers for the services we provide to the related patients typically specify
payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services
or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates
to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s patient fee revenues, net of contractual
allowances and discounts for the years ended June 30, 2024 and 2023 are summarized in the following table.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--DisaggregationOfRevenueTableTextBlock_zKieyjyUMs7l" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8B2_zibRPTtp76H6" style="display: none"&gt;Schedule of patient fee
    revenue - net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Years Ended June 30&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Commercial Insurance/ Managed Care&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zQP7AjRvBfCb" style="width: 12%; text-align: right" title="Net Patient Fee Revenue"&gt;4,952,712&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zSWvqUvUpEb1" style="width: 12%; text-align: right" title="Net Patient Fee Revenue"&gt;4,124,646&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Medicare/Medicaid&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zgZLnk8r0RPj" style="text-align: right" title="Net Patient Fee Revenue"&gt;1,138,176&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zUubfFwT39r" style="text-align: right" title="Net Patient Fee Revenue"&gt;1,063,846&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Workers&#x2019; Compensation/Personal Injury&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zPcuEffR23yd" style="text-align: right" title="Net Patient Fee Revenue"&gt;20,673,483&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zNq4J8jwHUGl" style="text-align: right" title="Net Patient Fee Revenue"&gt;18,670,019&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zVCGIZyggKpg" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue"&gt;7,051,425&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zdne1tGYBBZ2" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue"&gt;5,935,482&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Net Patient Fee Revenue&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630_zpm5teBsyZ91" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue"&gt;33,815,796&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630_zT2g27BSSgz8" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue"&gt;29,793,993&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_847_ecustom--MedicalReceivableAndManagementAndOtherFeesReceivablePolicyTextBlock_zQcxncB6FOvk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86A_z16itZ81ONV4"&gt;Medical Receivable and Management and Other Fees Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span&gt;Medical Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Management fees receivable is related to management fees outstanding
from the related and non related PCs under management agreements. The Company has established a current expected credit loss (&#x201c;CECL&#x201d;)
to address the risk that a portion of the contractually obligated management fees receivable from the PCs may not be paid. The PC&#x2019;s
may be limited in their ability to pay the full management fee receivable if they do not collect sufficient expected fees from third-party
payers and patients. The Company&#x2019;s management fees are collateralized, individually and collectively, by the assets of the PCs.
The CECL is determined based on the difference between the management fee receivable and the current amount of outstanding fees estimated
to be collected by the PCs.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span&gt;Management and Other Fees Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Management fees receivable is related to management
fees outstanding from the related and non related PCs under management agreements. The Company has established a current expected credit
loss (&#x201c;CECL&#x201d;) to address the risk that a portion of the contractually obligated management fees receivable from the PCs may
not be paid. The PC&#x2019;s may be limited in their ability to pay the full management fee receivable if they do not collect sufficient
expected fees from third-party payers and patients. The Company&#x2019;s management fees are collateralized, individually and collectively,
by the assets of the PCs. The CECL is determined based on the difference between the management fee receivable and the current amount
of outstanding fees estimated to be collected by the PCs.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s considerations into the estimate
of the PC&#x2019;s fee collection is based on a combination of factors. As each management agreement specifies the Company&#x2019;s ultimate
collateral for unpaid management fees are the patient fee receivables owned by each PC, the Company considers the historical loss rates
to pools of receivables with similar risks characteristics, aging of the patient fee receivables, and the financial condition of each
PC. In addition, the Company subjectively adjusts its estimated expected credit losses for current and forward-looking economic conditions
which would include trends seen within the industry and newly enacted regulation. The Company also incorporates qualitative factors, such
as changes in the nature and volume of receivables, regulatory changes, and other relevant factors. Specifically, insurance carriers covering
automobile no-fault and workers compensation claims incur longer payment cycles and rigorous informational requirements and certain other
disallowed claims. Approximately 67% of the PCs&#x2019; 2024 and 2023 net revenues were derived from no-fault and personal injury protection
claims.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; background-color: white"&gt;The Company combines
an objective and subjective loss-rate methodology to estimate expected credit losses based on the collateral owned by each PC. This involves
objectively using historical loss rates to pools of receivables with similar risk characteristics (i.e., various insurance payors) and
then subjectively adjusting for current and forward-looking economic conditions which would include trends seen within the industry and
newly enacted regulation. The Company also incorporates qualitative factors, such as changes in the nature and volume of the receivables,
regulatory changes, and other relevant factors.&lt;/p&gt;

&lt;p style="font: 11pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The provision for credit losses for the year
ended June 30, 2024 was $&lt;span id="xdx_902_ecustom--ProvisionForBadDebts_c20230701__20240630_zyJjWYtgVg0e"&gt;1,882,061&lt;/span&gt;. This can be attributable to an increase in scan volume at all the PC&#x2019;s and due to the nature
of the payor classes, where there is a longer expected payment term. Additionally, newly proposed legislation around credit reporting
on individual medical debts increasing the likelihood of non-payment of individual patient accounts. The management fee receivable for
unrelated and related parties as of July 1, 2022 was $&lt;span id="xdx_906_ecustom--ManagementFeeReceivableForUnrelatedParties_iI_c20220702_zkNt4LsmZD46"&gt;33,419,219
&lt;/span&gt;and $&lt;span id="xdx_908_ecustom--ManagementFeeReceivableForRelatedParties_iI_c20220702_zPKWt8qGodgf"&gt;8,602,561&lt;/span&gt;,
respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;




&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--ReceivablesPolicyTextBlock_zM7aYnXv6Xpd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86C_zkRXn4BeEfgg"&gt;Accounts Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"&gt;Credit risk with respect to the Company&#x2019;s
accounts receivable related to product sales and service and repair fees is limited due to the customer advances received prior to the
commencement of work performed and the billing of amounts to customers as sub-assemblies are completed. Service and repair fees are billed
on a monthly or quarterly basis and the Company does not continue providing these services if accounts receivable become past due. The
Company controls credit risk with respect to accounts receivable from service and repair fees through its credit evaluation process,
credit limits, monitoring procedures and reasonably short collection terms. The Company performs ongoing credit authorizations before
a product sales contract is entered into or service and repair fees are provided.&#160;The account receivable balance for scanner service
contracts as of July 1, 2022 was $&lt;span id="xdx_905_ecustom--AccountsReceivableServiceContractsNet_iI_c20220702_zniw8wLrrNx4"&gt;4,335,956&lt;/span&gt;.&lt;/p&gt;















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--ResearchAndDevelopmentExpensePolicy_zQV6jIMjdrmd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_860_z7fpB9w5Lmb2"&gt;Research and Development Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Research and development costs are charged to expense
as incurred. The costs of equipment that are acquired or constructed for research and development activities, and have alternative future
uses (either in research and development, marketing or production), are classified as property and equipment and depreciated over their
estimated useful lives.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--AdvertisingCostsPolicyTextBlock_zQcdQH8wfeA5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_861_zAXOhmeiQA89"&gt;Advertising Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Advertising costs are expensed as incurred. Advertising
expense approximated $&lt;span id="xdx_90E_eus-gaap--AdvertisingExpense_c20230701__20240630_zxCMQfhbqrrj"&gt;731,000&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--AdvertisingExpense_c20220701__20230630_z5aKmIyxUmni"&gt;570,000
&lt;/span&gt;and for the years ended June 30, 2024 and 2023, respectively.&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;



&lt;p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_zGk2PMILa6eh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_868_zqA8dJzcQkL8"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Deferred tax assets and liabilities are determined
based on the difference between the financial statement carrying amounts and tax basis of assets and liabilities using enacted tax rates
in effect in the years in which the differences are expected to reverse.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The ultimate realization of deferred tax assets is
dependent on the generation of future taxable income during the periods in which temporary differences become deductible or when such
net operating losses can be utilized. The Company considers projected future taxable income, the regulatory environment of the industry,
and tax planning strategies in making this assessment. At present, the Company believes that it is more likely than not that the benefits
from certain deferred tax asset carryforwards, will not all be fully realized. In recognition of this inherent risk, a valuation allowance
was established for the partial value of the deferred tax asset, which principally related to certain state net operating losses. A valuation
allowance will be maintained until sufficient positive evidence exists to support the reversal of the remainder of the valuation.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In accordance with ASC 740, &#x201c;Accounting for
Income Taxes&#x201d;, prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement
of tax positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be
taken in a tax return and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits.
A liability is recognized (or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax
benefit because it represents an enterprise&#x2019;s potential future obligation to the taxing authority for a tax position that was not
recognized as a result of applying the provisions of ASC 740. The Company believes there are no uncertain tax positions in prior year&#x2019;s
tax filings and therefore it has not recorded a liability for unrecognized tax benefits.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In accordance with ASC 740, interest costs related
to unrecognized tax benefits are required to be calculated (if applicable) and would be classified as &#x201c;Interest expense, net. Penalties
if incurred would be recognized as a component of &#x201c;Selling, general and administrative&#x201d; expenses. Penalties for the years
ended June 30, 2024 and June 30, 2023 were $&lt;span id="xdx_905_eus-gaap--IncomeTaxExaminationPenaltiesExpense_c20230701__20240630_z9Q0Hn5aAaTh" title="Penalties"&gt;20,444&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--IncomeTaxExaminationPenaltiesExpense_c20220701__20230630_z8bTkU63dY9" title="Penalties"&gt;31,122&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



















&lt;p id="xdx_849_ecustom--CustomerAdvancesPolicyTextBlock_zifYBNqOen18" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86A_zROga0l6TK7j"&gt;Customer Advances&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cash advances and progress payments received on sales
orders are reflected as customer advances until such time as revenue recognition occurs.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_zUPGfY2S3991" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_869_zkNcgjyuBKRe"&gt;Earnings Per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Basic earnings per share (&#x201c;EPS&#x201d;) is computed
by dividing net income available to common stockholders by the weighted average number of shares of common stock outstanding during the
period. In accordance with ASC topic 260-10, &#x201c;Participating Securities and the Two-Class Method&#x201d;, the Company used the Two-Class
method for calculating basic earnings per share and applied the if converted method in calculating diluted earnings per share for the
years ended June 30, 2024 and 2023.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Diluted EPS reflects the potential dilution from the
exercise or conversion of all dilutive securities into common stock based on the average market price of common shares outstanding during
the period. For the years ended June 30, 2024 and 2023, diluted EPS for common shareholders includes &lt;span id="xdx_900_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20230701__20240630_zXgmLFs4rzuc" title="Conversion of Class C Common Stock"&gt;&lt;span id="xdx_904_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20220701__20230630_zMkTYZPbhp7k" title="Conversion of Class C Common Stock"&gt;127,504&lt;/span&gt;&lt;/span&gt; shares upon conversion of
Class C Common.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zQOGX5QvAza3" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8BF_zywvfBLj6VWf" style="display: none"&gt;Schedule of earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Basic&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class C Common Stock&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 46%; text-align: left; text-indent: -11pt"&gt;Net income available to common stockholders&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630_z5Rcu2Wqc693" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders"&gt;10,567,396&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z7tmlgA6yw86" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders"&gt;9,908,920&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zS3OC7vju5ra" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders"&gt;167,700&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630_zODObpn37tXd" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;6,350,862&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z1NzWS5YYt6j" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;6,350,862&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zsv8MvcuX5Jg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630_za6Cya3uMO29" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.66&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zbT5oyjhJ3Ha" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.56&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zo2AdSpO5Nch" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;0.44&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt"&gt;Diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z6Dsgme3pJZ9" style="text-align: right" title="Weighted average shares outstanding"&gt;6,350,862&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zJaoalYiGapd" style="text-align: right" title="Weighted average shares outstanding"&gt;382,513&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zTUCK9K36mxc" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock"&gt;127,504&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zKDHmj3FQQP" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock"&gt;&#x2014;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Total Denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zo0pacwcLj68" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;6,478,366&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_ztshFF2cGGVa" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zvB8OZFZJUHb" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;1.53&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zS00GW4GVGzg" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;0.44&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;























&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Basic&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class C Common Stock&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 46%; text-align: left; text-indent: -11pt"&gt;Net income available to common stockholders&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20220701__20230630_zxtZWKIKsiff" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders"&gt;9,375,776&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zwJEvY67Iumb" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders"&gt;8,801,974&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z3Qi4OsGnkJ3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders"&gt;146,136&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630_zB7YdIopqgb6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;6,539,376&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zbeFLt3EWpwj" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;6,539,376&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z69RHhQSz9a5" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630_zytNpUPMRTf3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.43&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zEsXKtKOJyIe" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.35&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zEWBFp7LRyXf" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;0.38&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt"&gt;Diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zaiGOcIWQt49" style="text-align: right" title="Weighted average shares outstanding"&gt;6,539,376&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z14HKTw8KMnj" style="text-align: right" title="Weighted average shares outstanding"&gt;382,513&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zaUCBatpgKp5" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock"&gt;127,504&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zZLCrPweHY4b" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock"&gt;&#x2014;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Total Denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zh3uUtS9SNpk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;6,666,880&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zcsRabBp4lNh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zvhfQ9yDrIPb" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;1.32&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zuZoteG2VhO1" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;0.38&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A1_zOL0s9iyGBTk" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z33M7wt7oICl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span id="xdx_869_zhbMc3xQZmNe"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cash and cash equivalents includes cash on hand, cash
in banks, investments in certificates of deposit with original maturities of 90 days or less, and money market funds.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--InvestmentPolicyTextBlock_zNVmvzpue4E7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_860_zKPyc0dKGqci"&gt;Short-Term Investments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Short-term investments include certificates of deposit
with original maturities of greater than 90 days. Interest is recorded as earned.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zjfBs4dogapf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_866_zTIqGj8fSFsd"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cash: The Company maintains its cash and cash equivalents
with various financial institutions, which exceed federally insured limits throughout the year. At June 30, 2024, the Company had cash
on deposit of approximately $&lt;span id="xdx_907_eus-gaap--Cash_iI_pp0p0_c20240630_zls9uqywcjkh" title="Cash deposit"&gt;53,883,000&lt;/span&gt; in excess of federally insured limits of $&lt;span id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20240630_zBSk8mx3ekc3" title="Federally insured limits"&gt;250,000&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Related Parties: Net revenues from related parties
accounted for approximately &lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zcUvQhEqKW3f" title="Concentration risk, percentage"&gt;&lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zSnnpyzSZ80h" title="Concentration risk, percentage"&gt;12&lt;/span&gt;&lt;/span&gt;% of the consolidated net revenues for the years ended June 30, 2024 and 2023. Net management fee receivables
from the related party medical practices accounted for approximately &lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMedicalPracticesMember_z9UgZHdapRv" title="Concentration risk, percentage"&gt;12&lt;/span&gt;% and &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMedicalPracticesMember_zrb3soJNEv93" title="Concentration risk, percentage"&gt;13&lt;/span&gt;% of the consolidated accounts receivable as of June 30,
2024 and 2023, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;See Note 3 regarding the Company&#x2019;s concentrations
in the healthcare industry.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



















&lt;p id="xdx_843_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zioSBMNADrJ2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_867_zrF5xqH8vBS8"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company measures fair value in accordance with
ASC 820-10, &#x201c;Fair Value Measurements and Disclosures&#x201d;. ASC 820-10 clarifies that fair value is an exit price, representing
the amount that would be received by selling an asset or paid to transfer a liability in an orderly transaction between market participants.
As such, fair value is a market-based measurement that should be determined based on assumptions.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The standard establishes a three-tier fair value hierarchy,
which prioritizes the inputs used in measuring and revaluing fair value. These tiers include, Level 1, defined as observable inputs such
as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or
indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity
to develop its own assumptions.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following methods and assumptions were used to
estimate the fair value of each class of financial instruments for which it is practicable to estimate that value:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cash and cash equivalents: The carrying amount approximates
fair value because of the short-term maturity of those instruments.&lt;/p&gt;







&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Short-term investments: The carrying amount approximates
fair value because of the short-term maturity of those instruments. Such amounts include Certificates of Deposits with original maturities
greater than 90 days. These securities are classified as Level 1.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Receivable and accounts payable: The carrying amounts
approximate fair value because of the short maturity of those instruments.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Notes receivable: The carrying amount approximates
fair value because the discounted present value of the cash flow generated by the parties approximates the carrying value of the amounts
due to the Company.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Long-term debt and notes payable: The carrying amounts
of debt and notes payable approximate fair value due to the length of the maturities, the interest rates being tied to market indices
and/or due to the interest rates not being significantly different from the current market rates available to the Company.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;All of the Company&#x2019;s financial instruments are
held for purposes other than trading.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84B_ecustom--RecentAccountingStandardsPolicyTextBlock_zgf8tw78paHl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_863_zlONLM6d1tvh"&gt;Recent Accounting Standards&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In December 2023, The Financial Accounting Standards
Board (&#x201c;FASB&#x201d;) issued ASU 2023-09, &#x201c;Income Taxes (740) &#x201c;Improvements to Income Tax Disclosures&#x201d;, which requires
the annual financial statements to include consistent categories and great disaggregation of information in the rate reconciliation and
income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for the Company&#x2019;s annual reporting beginning after December
15, 2024, with early adoption permitted, and should be applied on a prospective basis, with a retrospective option. The Company is currently
evaluating the effect that the adoption of ASU 2023-09 will have on our disclosures.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In November 2023, FASB issued ASU 2023-07, &#x201c;Segment
Reporting (Topic 280)&#x201d;, which is intended to improve reportable segment disclosure requirements through enhanced disclosures about
significant segment expenses. The amendments require disclosure of significant segment expenses regularly provided to the chief operating
decision maker (CODM) as well as other segment items, extended certain annual disclosures to interim periods, clarify the applicability
to single reportable segment entities, permit more than one measure of profit or loss to be reported under certain conditions, and require
disclosure of the title and position of the CODM. The effective date for public entities is for fiscal years beginning after December
15, 2023 and interim periods with fiscal years beginning after December 15, 2024. The Company is expected to adopt the new disclosures
as required and are currently evaluating the impact on the related disclosures.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zyzmnEIgfeC5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_866_zGeyNISx7NB9"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company adopted ASU 2016-13, &#x201c;Financial
Instruments &#x2013; Credit Losses&#x201d; (Topic 326) &#x201c;Measurement of Credit Losses on Financial Instruments&#x201d;, on July 1, 2023,
as amended which replaces the incurred loss methodology with an expected loss methodology that is referred to as the current expected
credit loss (CECL) methodology, The measurement of expected credit losses under the CECL methodology is applicable to financial assets
measured at amortized cost, including loan receivables and held-to-maturity debt securities. It also applies to off-balance sheet credit
exposures not accounted for as insurance (loan commitments, standby letters of credit, financial guarantees, and other similar instruments)
and net investments in leases recognized by a lessor in accordance with Topic 842 on leases. The Company used a modified retrospective
approach, which required a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting in which the standard
was effective. The adoption did not have a material effect on the Company&#x2019;s consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;FASB, the Emerging Issues Task Force and the SEC have
issued certain other accounting standards, updates, and regulations as of June 30, 2024 that will become effective in subsequent periods;
however, management does not believe that any of those updates would have significantly affected the Company&#x2019;s financial accounting
measures or disclosures had they been in effect during 2024 or 2023, and it does not believe that any of those standards will have a significant
impact on the Company&#x2019;s consolidated financial statements at the time they become effective.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;















</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000717">&lt;p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zwyUDgDQDNFi" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_869_z2pxossBaQ4j"&gt;Principles of Consolidation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The consolidated financial statements include the
accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships. The operating activities of subsidiaries are
included in the accompanying consolidated statements from the date of acquisition. All significant intercompany accounts and transactions
have been eliminated in consolidation.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



















</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2023-07-01to2024-06-30" id="Fact000727">&lt;p id="xdx_84E_eus-gaap--UseOfEstimates_zqEKKHEfG9S9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_865_zDrffM0Rk6Ua"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The preparation of the consolidated financial statements
in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities in the consolidated financial
statements and accompanying notes. The most significant estimates relate to receivable allowances, income taxes and related tax asset
valuation allowances, contingencies, and revenue recognition. In addition, healthcare industry reforms and reimbursement practices will
continue to impact the Company&#x2019;s operations and the determination of contractual and other allowance estimates. Actual results could
differ from those estimates.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:InventoryWorkInProcessPolicy contextRef="From2023-07-01to2024-06-30" id="Fact000729">&lt;p id="xdx_84E_eus-gaap--InventoryWorkInProcessPolicy_zJRpuO4jgf7e" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_860_zYX965COlutb"&gt;Inventories&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Inventories consist of purchased parts, components
and supplies, as well as work-in-process, and are stated at the lower of cost or net realizable value.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:InventoryWorkInProcessPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000731">&lt;p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zDew3dopOlpd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_865_z84usRR4a1s"&gt;Property and Equipment&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Property and equipment procured in the normal course
of business is stated at cost less accumulated depreciation. Property and equipment purchased in connection with an acquisition is stated
at its estimated fair value, generally based on an appraisal. Property and equipment is being depreciated for financial accounting purposes
using the straight-line method over their estimated useful lives. Leasehold improvements are being amortized over the shorter of the useful
life or the remaining lease term. Upon retirement or other disposition of these assets, the cost and related accumulated depreciation
of these assets are removed from the accounts and the resulting gains or losses are reflected in the results of operations. Expenses for
maintenance and repairs are charged to operations. Renewals and betterments are capitalized. Maintenance and repair expenses totaled approximately
$&lt;span id="xdx_90A_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20230701__20240630_zvKqLaoduv4e" title="Maintenance and repair expenses"&gt;2,948,000&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20220701__20230630_zULLmiJZg0Ba" title="Maintenance and repair expenses"&gt;2,801,000&lt;/span&gt; for the years ended June 30, 2024 and 2023 respectively. The estimated useful lives in years are generally as
follows:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_z1vIwy6ZISK9" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; padding: 0pt; text-align: left; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_8BF_zs2gNJdAoczg" style="display: none"&gt;Schedule
of estimated useful life in years for property and equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; width: 87%; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Diagnostic equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; width: 12%; text-align: right; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zLKj6odAoCG5"&gt;5&lt;/span&gt;&#x2013;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_z15gqxQVKlt" title="Estimated useful lives"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; width: 1%; line-height: 115%; text-indent: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Research, development and demonstration equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zD1kMI5H9Pfk"&gt;3&lt;/span&gt;-&lt;span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_z6eK5e3xFzCa"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; line-height: 115%; text-indent: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_za6eX1JyjcW7"&gt;2&lt;/span&gt;-&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zHXeZQTExWYd"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; line-height: 115%; text-indent: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zPVJ7nKtC0lg"&gt;3&lt;/span&gt;-&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z2TR8Wlv23Fc"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; line-height: 115%; text-indent: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zy1haNsqvvPb"&gt;5&lt;/span&gt;&#x2013;&lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z3GQyurSiPwa"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; line-height: 115%; text-indent: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Building&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--WeightedAverageMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zP9U3mTibM8l" title="Estimated useful lives"&gt;28&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; line-height: 115%; text-indent: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



















</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:CostOfPropertyRepairsAndMaintenance
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000733"
      unitRef="USD">2948000</us-gaap:CostOfPropertyRepairsAndMaintenance>
    <us-gaap:CostOfPropertyRepairsAndMaintenance
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000735"
      unitRef="USD">2801000</us-gaap:CostOfPropertyRepairsAndMaintenance>
    <FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000737">&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_z1vIwy6ZISK9" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; padding: 0pt; text-align: left; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_8BF_zs2gNJdAoczg" style="display: none"&gt;Schedule
of estimated useful life in years for property and equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; width: 87%; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Diagnostic equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; width: 12%; text-align: right; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zLKj6odAoCG5"&gt;5&lt;/span&gt;&#x2013;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_z15gqxQVKlt" title="Estimated useful lives"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; width: 1%; line-height: 115%; text-indent: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Research, development and demonstration equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zD1kMI5H9Pfk"&gt;3&lt;/span&gt;-&lt;span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_z6eK5e3xFzCa"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; line-height: 115%; text-indent: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_za6eX1JyjcW7"&gt;2&lt;/span&gt;-&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zHXeZQTExWYd"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; line-height: 115%; text-indent: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zPVJ7nKtC0lg"&gt;3&lt;/span&gt;-&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z2TR8Wlv23Fc"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; line-height: 115%; text-indent: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zy1haNsqvvPb"&gt;5&lt;/span&gt;&#x2013;&lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z3GQyurSiPwa"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; line-height: 115%; text-indent: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Building&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; vertical-align: bottom; text-align: right; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__srt--RangeAxis__srt--WeightedAverageMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zP9U3mTibM8l" title="Estimated useful lives"&gt;28&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0pt; line-height: 115%; text-indent: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-06-30_srt_MinimumMember_custom_DiagnosticEquipmentMember"
      id="Fact000738">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-06-30_srt_MaximumMember_custom_DiagnosticEquipmentMember"
      id="Fact000740">P13Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-06-30_srt_MinimumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember"
      id="Fact000741">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-06-30_srt_MaximumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember"
      id="Fact000742">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-06-30_srt_MinimumMember_us-gaap_MachineryAndEquipmentMember"
      id="Fact000743">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-06-30_srt_MaximumMember_us-gaap_MachineryAndEquipmentMember"
      id="Fact000744">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-06-30_srt_MinimumMember_us-gaap_FurnitureAndFixturesMember"
      id="Fact000745">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-06-30_srt_MaximumMember_us-gaap_FurnitureAndFixturesMember"
      id="Fact000746">P9Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-06-30_srt_MinimumMember_us-gaap_LeaseholdImprovementsMember"
      id="Fact000747">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-06-30_srt_MaximumMember_us-gaap_LeaseholdImprovementsMember"
      id="Fact000748">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-06-30_srt_WeightedAverageMember_us-gaap_BuildingMember"
      id="Fact000750">P28Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000760">&lt;p id="xdx_842_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zhUDRnXmYAj4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_862_zAIQkiz1EDza"&gt;Long-Lived Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company periodically assesses the recoverability
of long-lived assets, including property and equipment and intangibles, other than goodwill, when events or changes in circumstances indicate
that the carrying value of long-lived assets may not be recoverable. If indicators are present, the Company performs a recoverability
test by comparing the sum of the estimated undiscounted future cash flows attributable to the asset group in question to its carrying
amount. An impairment loss is recognized if it is determined that the long-lived asset group is not recoverable and is calculated by comparing
the discounted future cash flows with the carrying value of the related asset group. In performing this analysis, management considers
such factors as current results, trends, and future prospects, in addition to other economic factors.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000762">&lt;p id="xdx_84C_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zpdPcnvzbad3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_860_zfvdavdczYO5"&gt;Other Intangible Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;1) Patents and Copyrights&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Patent and copyrights are professional costs incurred
to acquire certain patent and copyrights. Amortization is calculated on the straight-line basis over &lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zAvQaEtly327" title="Finite-lived intangible asset, useful life"&gt;15&lt;/span&gt; years.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;2) Non-Competition Agreements&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The non-competition agreements are agreements entered
into with past principal owners of entities that the Company had acquired. The non-competition agreements are being amortized on the straight-line
basis over the length of the agreement (&lt;span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_z0tdVFCqcb8j" title="Finite-lived intangible asset, useful life"&gt;7&lt;/span&gt; years).&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;3) Customer Relationships&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Customer relationships represents customer lists acquired
in acquisition of prior entities. Amortization is calculated on the straight-line basis over &lt;span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zhmAQeXD3XE8" title="Finite-lived intangible asset, useful life"&gt;20&lt;/span&gt; years.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2024-06-30_us-gaap_IntellectualPropertyMember"
      id="Fact000764">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2024-06-30_us-gaap_NoncompeteAgreementsMember"
      id="Fact000766">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember"
      id="Fact000768">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="From2023-07-01to2024-06-30" id="Fact000770">&lt;p id="xdx_847_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_ztol9VfCLX07" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_866_ze2XHKlM2Ggl"&gt;Goodwill&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Goodwill represents the cost of a business acquisition
in excess of the fair value of the net assets acquired. Goodwill is not amortized and is reviewed for impairment annually, or more frequently
if facts and circumstances indicate that it is more likely than not that the fair value of the reporting unit is less than its carrying
amount including goodwill. If it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the
Company performs a quantitative test to identify and measure the amount of goodwill impairment loss. The Company compares the fair value
of the reporting unit with its carrying amount. If the carrying amount exceeds fair value, goodwill of the reporting unit is considered
impaired, and that excess is recognized as a goodwill impairment loss.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



















</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000780">&lt;p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zjVfGdP4cLJl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span id="xdx_867_zdNR78TDJ4c4"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Revenue on sales contracts for scanners, included
in &#x201c;product sales&#x201d; in the accompanying consolidated statements of operations, is recognized under the percentage-of-completion
method in accordance with FASB ASC 606, &#x201c;Revenue Recognition &#x2013; Construction-Type and Production-Type Contracts&#x201d;. The
Company manufactures its scanners under specific contracts that provide for progress payments. Production and installation take approximately
three to six months.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Revenue on scanner service contracts is recognized
on the straight-line method over the related contract period, usually one year. As of June 30, 2023, the Company had unearned revenue
on service contracts of $3,832,184 of which all was recognized as revenue in the fiscal year ending June 30, 2024.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Revenue from product sales (upgrades and supplies)
is recognized upon shipment.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Revenue under management contracts is recognized
based upon contractual agreements for management services rendered by the Company primarily under various long-term agreements with
various medical providers (the &#x201c;PCs&#x201d;). As of June 30, 2024, the Company has &lt;span id="xdx_90E_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20240630_zXpwoYmmoGR3" title="Management agreements with company total medical practices"&gt;22&lt;/span&gt;
management agreements of which &lt;span id="xdx_90F_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20240630_zNWAb72g9LO9" title="Scanners with management agreements with company owned by related party"&gt;3&lt;/span&gt;
were with PC&#x2019;s owned by Timothy Damadian, Chairman of the Board, President, Chief Executive Officer and Treasurer (formerly
owned by Raymond V. Damadian, M.D., Chairman of the Board of FONAR until his unexpected death in August 2022)(&#x201c;the Related
medical practices&#x201d;) and &lt;span id="xdx_901_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20240630_zaNpGoUYnkHe" title="Scanners with management with company located in new york state"&gt;19&lt;/span&gt;
are with PC&#x2019;s, which are all located in the state of New York (&#x201c;the New York PC&#x2019;s&#x201d;), owned by two unrelated
radiologists. The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility
ranging from approximately $&lt;span id="xdx_90E_ecustom--ContractualFeesForServicesRenderedMinimum_iI_pdp0_c20240630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zjiq4LJFqZza" title="Contractual fees for services rendered minimum"&gt;84,000&lt;/span&gt;
to $&lt;span id="xdx_905_ecustom--ContractualFeesForServicesRenderedMaximum_iI_c20240630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zHPpdazHDQgg" title="Contractual fees for services rendered maximum"&gt;447,000&lt;/span&gt;.
All fees are re-negotiable at the anniversary of the agreements and each year thereafter. The Company records a credit loss expense for
estimated uncollectible fees, which is reflected in other operating expenses on the Consolidated Statement of Operations.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company currently recognizes revenue in accordance
with the recognition accounting standard issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) and codified in the ASC
as topic 606 (&#x201c;ASC 606&#x201d;). The revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing
revenue as performance obligations, defined in a contract with a customer as goods or services transferred to the customer in exchange
for consideration, are satisfied. The standard also requires expanded disclosures regarding the Company&#x2019;s revenue recognition policies
and significant judgments employed in the determination of revenue.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s revenues generally relate to net
patient fees&#160;received from various payers and patients themselves under contracts in which our performance obligations are to provide
diagnostic services to the patients. Revenues are recorded during the period our obligations to provide diagnostic services are satisfied.
Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships
with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health plans and commercial insurance
companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent
upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the
third-party payers. The payment arrangements with third-party payers for the services we provide to the related patients typically specify
payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services
or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates
to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s patient fee revenues, net of contractual
allowances and discounts for the years ended June 30, 2024 and 2023 are summarized in the following table.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--DisaggregationOfRevenueTableTextBlock_zKieyjyUMs7l" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8B2_zibRPTtp76H6" style="display: none"&gt;Schedule of patient fee
    revenue - net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Years Ended June 30&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Commercial Insurance/ Managed Care&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zQP7AjRvBfCb" style="width: 12%; text-align: right" title="Net Patient Fee Revenue"&gt;4,952,712&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zSWvqUvUpEb1" style="width: 12%; text-align: right" title="Net Patient Fee Revenue"&gt;4,124,646&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Medicare/Medicaid&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zgZLnk8r0RPj" style="text-align: right" title="Net Patient Fee Revenue"&gt;1,138,176&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zUubfFwT39r" style="text-align: right" title="Net Patient Fee Revenue"&gt;1,063,846&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Workers&#x2019; Compensation/Personal Injury&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zPcuEffR23yd" style="text-align: right" title="Net Patient Fee Revenue"&gt;20,673,483&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zNq4J8jwHUGl" style="text-align: right" title="Net Patient Fee Revenue"&gt;18,670,019&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zVCGIZyggKpg" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue"&gt;7,051,425&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zdne1tGYBBZ2" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue"&gt;5,935,482&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Net Patient Fee Revenue&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630_zpm5teBsyZ91" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue"&gt;33,815,796&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630_zT2g27BSSgz8" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue"&gt;29,793,993&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <FONR:ManagementAgreementsWithCompanyTotalMedicalPractices
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000782"
      unitRef="Pure">22</FONR:ManagementAgreementsWithCompanyTotalMedicalPractices>
    <FONR:ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000784"
      unitRef="Pure">3</FONR:ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty>
    <FONR:ScannersWithManagementWithCompanyLocatedInNewYorkState
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000786"
      unitRef="Pure">19</FONR:ScannersWithManagementWithCompanyLocatedInNewYorkState>
    <FONR:ContractualFeesForServicesRenderedMinimum
      contextRef="AsOf2024-06-30_custom_DiagnosticImagingFacilityMember"
      decimals="0"
      id="Fact000788"
      unitRef="USD">84000</FONR:ContractualFeesForServicesRenderedMinimum>
    <FONR:ContractualFeesForServicesRenderedMaximum
      contextRef="AsOf2024-06-30_custom_DiagnosticImagingFacilityMember"
      decimals="0"
      id="Fact000790"
      unitRef="USD">447000</FONR:ContractualFeesForServicesRenderedMaximum>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000802">&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--DisaggregationOfRevenueTableTextBlock_zKieyjyUMs7l" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8B2_zibRPTtp76H6" style="display: none"&gt;Schedule of patient fee
    revenue - net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Years Ended June 30&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Commercial Insurance/ Managed Care&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zQP7AjRvBfCb" style="width: 12%; text-align: right" title="Net Patient Fee Revenue"&gt;4,952,712&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zSWvqUvUpEb1" style="width: 12%; text-align: right" title="Net Patient Fee Revenue"&gt;4,124,646&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Medicare/Medicaid&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zgZLnk8r0RPj" style="text-align: right" title="Net Patient Fee Revenue"&gt;1,138,176&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zUubfFwT39r" style="text-align: right" title="Net Patient Fee Revenue"&gt;1,063,846&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Workers&#x2019; Compensation/Personal Injury&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zPcuEffR23yd" style="text-align: right" title="Net Patient Fee Revenue"&gt;20,673,483&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zNq4J8jwHUGl" style="text-align: right" title="Net Patient Fee Revenue"&gt;18,670,019&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zVCGIZyggKpg" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue"&gt;7,051,425&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zdne1tGYBBZ2" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue"&gt;5,935,482&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Net Patient Fee Revenue&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630_zpm5teBsyZ91" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue"&gt;33,815,796&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630_zT2g27BSSgz8" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue"&gt;29,793,993&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <FONR:NetPatientFeeRevenue
      contextRef="From2023-07-012024-06-30_custom_CommercialInsuranceManagedCareMember"
      decimals="0"
      id="Fact000804"
      unitRef="USD">4952712</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2022-07-012023-06-30_custom_CommercialInsuranceManagedCareMember"
      decimals="0"
      id="Fact000806"
      unitRef="USD">4124646</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2023-07-012024-06-30_custom_MedicareMedicaidMember"
      decimals="0"
      id="Fact000808"
      unitRef="USD">1138176</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2022-07-012023-06-30_custom_MedicareMedicaidMember"
      decimals="0"
      id="Fact000810"
      unitRef="USD">1063846</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2023-07-012024-06-30_custom_WorkersCompensationPersonalInjuryMember"
      decimals="0"
      id="Fact000812"
      unitRef="USD">20673483</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2022-07-012023-06-30_custom_WorkersCompensationPersonalInjuryMember"
      decimals="0"
      id="Fact000814"
      unitRef="USD">18670019</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2023-07-012024-06-30_custom_OtherRevenueSourceMember"
      decimals="0"
      id="Fact000816"
      unitRef="USD">7051425</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2022-07-012023-06-30_custom_OtherRevenueSourceMember"
      decimals="0"
      id="Fact000818"
      unitRef="USD">5935482</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000820"
      unitRef="USD">33815796</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000822"
      unitRef="USD">29793993</FONR:NetPatientFeeRevenue>
    <FONR:MedicalReceivableAndManagementAndOtherFeesReceivablePolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000824">&lt;p id="xdx_847_ecustom--MedicalReceivableAndManagementAndOtherFeesReceivablePolicyTextBlock_zQcxncB6FOvk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86A_z16itZ81ONV4"&gt;Medical Receivable and Management and Other Fees Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span&gt;Medical Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Management fees receivable is related to management fees outstanding
from the related and non related PCs under management agreements. The Company has established a current expected credit loss (&#x201c;CECL&#x201d;)
to address the risk that a portion of the contractually obligated management fees receivable from the PCs may not be paid. The PC&#x2019;s
may be limited in their ability to pay the full management fee receivable if they do not collect sufficient expected fees from third-party
payers and patients. The Company&#x2019;s management fees are collateralized, individually and collectively, by the assets of the PCs.
The CECL is determined based on the difference between the management fee receivable and the current amount of outstanding fees estimated
to be collected by the PCs.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span&gt;Management and Other Fees Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Management fees receivable is related to management
fees outstanding from the related and non related PCs under management agreements. The Company has established a current expected credit
loss (&#x201c;CECL&#x201d;) to address the risk that a portion of the contractually obligated management fees receivable from the PCs may
not be paid. The PC&#x2019;s may be limited in their ability to pay the full management fee receivable if they do not collect sufficient
expected fees from third-party payers and patients. The Company&#x2019;s management fees are collateralized, individually and collectively,
by the assets of the PCs. The CECL is determined based on the difference between the management fee receivable and the current amount
of outstanding fees estimated to be collected by the PCs.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s considerations into the estimate
of the PC&#x2019;s fee collection is based on a combination of factors. As each management agreement specifies the Company&#x2019;s ultimate
collateral for unpaid management fees are the patient fee receivables owned by each PC, the Company considers the historical loss rates
to pools of receivables with similar risks characteristics, aging of the patient fee receivables, and the financial condition of each
PC. In addition, the Company subjectively adjusts its estimated expected credit losses for current and forward-looking economic conditions
which would include trends seen within the industry and newly enacted regulation. The Company also incorporates qualitative factors, such
as changes in the nature and volume of receivables, regulatory changes, and other relevant factors. Specifically, insurance carriers covering
automobile no-fault and workers compensation claims incur longer payment cycles and rigorous informational requirements and certain other
disallowed claims. Approximately 67% of the PCs&#x2019; 2024 and 2023 net revenues were derived from no-fault and personal injury protection
claims.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; background-color: white"&gt;The Company combines
an objective and subjective loss-rate methodology to estimate expected credit losses based on the collateral owned by each PC. This involves
objectively using historical loss rates to pools of receivables with similar risk characteristics (i.e., various insurance payors) and
then subjectively adjusting for current and forward-looking economic conditions which would include trends seen within the industry and
newly enacted regulation. The Company also incorporates qualitative factors, such as changes in the nature and volume of the receivables,
regulatory changes, and other relevant factors.&lt;/p&gt;

&lt;p style="font: 11pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The provision for credit losses for the year
ended June 30, 2024 was $&lt;span id="xdx_902_ecustom--ProvisionForBadDebts_c20230701__20240630_zyJjWYtgVg0e"&gt;1,882,061&lt;/span&gt;. This can be attributable to an increase in scan volume at all the PC&#x2019;s and due to the nature
of the payor classes, where there is a longer expected payment term. Additionally, newly proposed legislation around credit reporting
on individual medical debts increasing the likelihood of non-payment of individual patient accounts. The management fee receivable for
unrelated and related parties as of July 1, 2022 was $&lt;span id="xdx_906_ecustom--ManagementFeeReceivableForUnrelatedParties_iI_c20220702_zkNt4LsmZD46"&gt;33,419,219
&lt;/span&gt;and $&lt;span id="xdx_908_ecustom--ManagementFeeReceivableForRelatedParties_iI_c20220702_zPKWt8qGodgf"&gt;8,602,561&lt;/span&gt;,
respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;




&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</FONR:MedicalReceivableAndManagementAndOtherFeesReceivablePolicyTextBlock>
    <FONR:ProvisionForBadDebts
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000833"
      unitRef="USD">1882061</FONR:ProvisionForBadDebts>
    <FONR:ManagementFeeReceivableForUnrelatedParties
      contextRef="AsOf2022-07-02"
      decimals="0"
      id="Fact000834"
      unitRef="USD">33419219</FONR:ManagementFeeReceivableForUnrelatedParties>
    <FONR:ManagementFeeReceivableForRelatedParties
      contextRef="AsOf2022-07-02"
      decimals="0"
      id="Fact000835"
      unitRef="USD">8602561</FONR:ManagementFeeReceivableForRelatedParties>
    <us-gaap:ReceivablesPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000837">&lt;p id="xdx_84F_eus-gaap--ReceivablesPolicyTextBlock_zM7aYnXv6Xpd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86C_zkRXn4BeEfgg"&gt;Accounts Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"&gt;Credit risk with respect to the Company&#x2019;s
accounts receivable related to product sales and service and repair fees is limited due to the customer advances received prior to the
commencement of work performed and the billing of amounts to customers as sub-assemblies are completed. Service and repair fees are billed
on a monthly or quarterly basis and the Company does not continue providing these services if accounts receivable become past due. The
Company controls credit risk with respect to accounts receivable from service and repair fees through its credit evaluation process,
credit limits, monitoring procedures and reasonably short collection terms. The Company performs ongoing credit authorizations before
a product sales contract is entered into or service and repair fees are provided.&#160;The account receivable balance for scanner service
contracts as of July 1, 2022 was $&lt;span id="xdx_905_ecustom--AccountsReceivableServiceContractsNet_iI_c20220702_zniw8wLrrNx4"&gt;4,335,956&lt;/span&gt;.&lt;/p&gt;















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ReceivablesPolicyTextBlock>
    <FONR:AccountsReceivableServiceContractsNet
      contextRef="AsOf2022-07-02"
      decimals="0"
      id="Fact000838"
      unitRef="USD">4335956</FONR:AccountsReceivableServiceContractsNet>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2023-07-01to2024-06-30" id="Fact000846">&lt;p id="xdx_840_eus-gaap--ResearchAndDevelopmentExpensePolicy_zQV6jIMjdrmd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_860_z7fpB9w5Lmb2"&gt;Research and Development Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Research and development costs are charged to expense
as incurred. The costs of equipment that are acquired or constructed for research and development activities, and have alternative future
uses (either in research and development, marketing or production), are classified as property and equipment and depreciated over their
estimated useful lives.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000848">&lt;p id="xdx_84F_eus-gaap--AdvertisingCostsPolicyTextBlock_zQcdQH8wfeA5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_861_zAXOhmeiQA89"&gt;Advertising Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Advertising costs are expensed as incurred. Advertising
expense approximated $&lt;span id="xdx_90E_eus-gaap--AdvertisingExpense_c20230701__20240630_zxCMQfhbqrrj"&gt;731,000&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--AdvertisingExpense_c20220701__20230630_z5aKmIyxUmni"&gt;570,000
&lt;/span&gt;and for the years ended June 30, 2024 and 2023, respectively.&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;



</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000849"
      unitRef="USD">731000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000850"
      unitRef="USD">570000</us-gaap:AdvertisingExpense>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000853">&lt;p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_zGk2PMILa6eh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_868_zqA8dJzcQkL8"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Deferred tax assets and liabilities are determined
based on the difference between the financial statement carrying amounts and tax basis of assets and liabilities using enacted tax rates
in effect in the years in which the differences are expected to reverse.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The ultimate realization of deferred tax assets is
dependent on the generation of future taxable income during the periods in which temporary differences become deductible or when such
net operating losses can be utilized. The Company considers projected future taxable income, the regulatory environment of the industry,
and tax planning strategies in making this assessment. At present, the Company believes that it is more likely than not that the benefits
from certain deferred tax asset carryforwards, will not all be fully realized. In recognition of this inherent risk, a valuation allowance
was established for the partial value of the deferred tax asset, which principally related to certain state net operating losses. A valuation
allowance will be maintained until sufficient positive evidence exists to support the reversal of the remainder of the valuation.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In accordance with ASC 740, &#x201c;Accounting for
Income Taxes&#x201d;, prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement
of tax positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be
taken in a tax return and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits.
A liability is recognized (or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax
benefit because it represents an enterprise&#x2019;s potential future obligation to the taxing authority for a tax position that was not
recognized as a result of applying the provisions of ASC 740. The Company believes there are no uncertain tax positions in prior year&#x2019;s
tax filings and therefore it has not recorded a liability for unrecognized tax benefits.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In accordance with ASC 740, interest costs related
to unrecognized tax benefits are required to be calculated (if applicable) and would be classified as &#x201c;Interest expense, net. Penalties
if incurred would be recognized as a component of &#x201c;Selling, general and administrative&#x201d; expenses. Penalties for the years
ended June 30, 2024 and June 30, 2023 were $&lt;span id="xdx_905_eus-gaap--IncomeTaxExaminationPenaltiesExpense_c20230701__20240630_z9Q0Hn5aAaTh" title="Penalties"&gt;20,444&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--IncomeTaxExaminationPenaltiesExpense_c20220701__20230630_z8bTkU63dY9" title="Penalties"&gt;31,122&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



















</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:IncomeTaxExaminationPenaltiesExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000855"
      unitRef="USD">20444</us-gaap:IncomeTaxExaminationPenaltiesExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesExpense
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000857"
      unitRef="USD">31122</us-gaap:IncomeTaxExaminationPenaltiesExpense>
    <FONR:CustomerAdvancesPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000867">&lt;p id="xdx_849_ecustom--CustomerAdvancesPolicyTextBlock_zifYBNqOen18" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86A_zROga0l6TK7j"&gt;Customer Advances&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cash advances and progress payments received on sales
orders are reflected as customer advances until such time as revenue recognition occurs.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</FONR:CustomerAdvancesPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000869">&lt;p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_zUPGfY2S3991" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_869_zkNcgjyuBKRe"&gt;Earnings Per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Basic earnings per share (&#x201c;EPS&#x201d;) is computed
by dividing net income available to common stockholders by the weighted average number of shares of common stock outstanding during the
period. In accordance with ASC topic 260-10, &#x201c;Participating Securities and the Two-Class Method&#x201d;, the Company used the Two-Class
method for calculating basic earnings per share and applied the if converted method in calculating diluted earnings per share for the
years ended June 30, 2024 and 2023.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Diluted EPS reflects the potential dilution from the
exercise or conversion of all dilutive securities into common stock based on the average market price of common shares outstanding during
the period. For the years ended June 30, 2024 and 2023, diluted EPS for common shareholders includes &lt;span id="xdx_900_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20230701__20240630_zXgmLFs4rzuc" title="Conversion of Class C Common Stock"&gt;&lt;span id="xdx_904_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20220701__20230630_zMkTYZPbhp7k" title="Conversion of Class C Common Stock"&gt;127,504&lt;/span&gt;&lt;/span&gt; shares upon conversion of
Class C Common.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zQOGX5QvAza3" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8BF_zywvfBLj6VWf" style="display: none"&gt;Schedule of earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Basic&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class C Common Stock&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 46%; text-align: left; text-indent: -11pt"&gt;Net income available to common stockholders&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630_z5Rcu2Wqc693" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders"&gt;10,567,396&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z7tmlgA6yw86" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders"&gt;9,908,920&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zS3OC7vju5ra" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders"&gt;167,700&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630_zODObpn37tXd" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;6,350,862&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z1NzWS5YYt6j" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;6,350,862&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zsv8MvcuX5Jg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630_za6Cya3uMO29" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.66&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zbT5oyjhJ3Ha" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.56&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zo2AdSpO5Nch" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;0.44&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt"&gt;Diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z6Dsgme3pJZ9" style="text-align: right" title="Weighted average shares outstanding"&gt;6,350,862&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zJaoalYiGapd" style="text-align: right" title="Weighted average shares outstanding"&gt;382,513&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zTUCK9K36mxc" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock"&gt;127,504&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zKDHmj3FQQP" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock"&gt;&#x2014;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Total Denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zo0pacwcLj68" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;6,478,366&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_ztshFF2cGGVa" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zvB8OZFZJUHb" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;1.53&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zS00GW4GVGzg" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;0.44&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;























&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Basic&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class C Common Stock&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 46%; text-align: left; text-indent: -11pt"&gt;Net income available to common stockholders&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20220701__20230630_zxtZWKIKsiff" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders"&gt;9,375,776&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zwJEvY67Iumb" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders"&gt;8,801,974&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z3Qi4OsGnkJ3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders"&gt;146,136&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630_zB7YdIopqgb6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;6,539,376&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zbeFLt3EWpwj" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;6,539,376&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z69RHhQSz9a5" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630_zytNpUPMRTf3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.43&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zEsXKtKOJyIe" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.35&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zEWBFp7LRyXf" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;0.38&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt"&gt;Diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zaiGOcIWQt49" style="text-align: right" title="Weighted average shares outstanding"&gt;6,539,376&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z14HKTw8KMnj" style="text-align: right" title="Weighted average shares outstanding"&gt;382,513&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zaUCBatpgKp5" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock"&gt;127,504&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zZLCrPweHY4b" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock"&gt;&#x2014;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Total Denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zh3uUtS9SNpk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;6,666,880&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zcsRabBp4lNh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zvhfQ9yDrIPb" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;1.32&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zuZoteG2VhO1" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;0.38&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A1_zOL0s9iyGBTk" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <FONR:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact000871"
      unitRef="Shares">127504</FONR:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders>
    <FONR:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact000873"
      unitRef="Shares">127504</FONR:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000875">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zQOGX5QvAza3" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8BF_zywvfBLj6VWf" style="display: none"&gt;Schedule of earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Basic&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class C Common Stock&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 46%; text-align: left; text-indent: -11pt"&gt;Net income available to common stockholders&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630_z5Rcu2Wqc693" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders"&gt;10,567,396&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z7tmlgA6yw86" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders"&gt;9,908,920&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zS3OC7vju5ra" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders"&gt;167,700&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630_zODObpn37tXd" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;6,350,862&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z1NzWS5YYt6j" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;6,350,862&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zsv8MvcuX5Jg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630_za6Cya3uMO29" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.66&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zbT5oyjhJ3Ha" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.56&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zo2AdSpO5Nch" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;0.44&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt"&gt;Diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z6Dsgme3pJZ9" style="text-align: right" title="Weighted average shares outstanding"&gt;6,350,862&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zJaoalYiGapd" style="text-align: right" title="Weighted average shares outstanding"&gt;382,513&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zTUCK9K36mxc" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock"&gt;127,504&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zKDHmj3FQQP" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock"&gt;&#x2014;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Total Denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zo0pacwcLj68" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;6,478,366&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_ztshFF2cGGVa" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zvB8OZFZJUHb" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;1.53&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zS00GW4GVGzg" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;0.44&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;























&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Basic&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class C Common Stock&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 46%; text-align: left; text-indent: -11pt"&gt;Net income available to common stockholders&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20220701__20230630_zxtZWKIKsiff" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders"&gt;9,375,776&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zwJEvY67Iumb" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders"&gt;8,801,974&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z3Qi4OsGnkJ3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Net income available to common stockholders"&gt;146,136&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630_zB7YdIopqgb6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;6,539,376&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zbeFLt3EWpwj" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;6,539,376&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z69RHhQSz9a5" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630_zytNpUPMRTf3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.43&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zEsXKtKOJyIe" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.35&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zEWBFp7LRyXf" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;0.38&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt"&gt;Diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-decoration: underline; text-align: left; text-indent: -11pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zaiGOcIWQt49" style="text-align: right" title="Weighted average shares outstanding"&gt;6,539,376&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z14HKTw8KMnj" style="text-align: right" title="Weighted average shares outstanding"&gt;382,513&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zaUCBatpgKp5" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock"&gt;127,504&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zZLCrPweHY4b" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock"&gt;&#x2014;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Total Denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zh3uUtS9SNpk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;6,666,880&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zcsRabBp4lNh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zvhfQ9yDrIPb" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;1.32&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zuZoteG2VhO1" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;0.38&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000877"
      unitRef="USD">10567396</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember958666312"
      decimals="0"
      id="Fact000879"
      unitRef="USD">9908920</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      id="Fact000881"
      unitRef="USD">167700</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact000883"
      unitRef="Shares">6350862</FONR:WeightedAverageSharesOutstandingBasic>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember958666312"
      decimals="INF"
      id="Fact000885"
      unitRef="Shares">6350862</FONR:WeightedAverageSharesOutstandingBasic>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000887"
      unitRef="Shares">382513</FONR:WeightedAverageSharesOutstandingBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact000889"
      unitRef="USDPShares">1.66</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember958666312"
      decimals="INF"
      id="Fact000891"
      unitRef="USDPShares">1.56</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000893"
      unitRef="USDPShares">0.44</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember958666312"
      decimals="INF"
      id="Fact000895"
      unitRef="Shares">6350862</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma
      contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000897"
      unitRef="Shares">382513</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <FONR:IncrementalCommonSharesAttributableToConversionOfCommonStock
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember958666312"
      decimals="INF"
      id="Fact000899"
      unitRef="Shares">127504</FONR:IncrementalCommonSharesAttributableToConversionOfCommonStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000901"
      unitRef="Shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember958666312"
      decimals="INF"
      id="Fact000903"
      unitRef="Shares">6478366</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000905"
      unitRef="Shares">382513</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember958666312"
      decimals="INF"
      id="Fact000907"
      unitRef="USDPShares">1.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000909"
      unitRef="USDPShares">0.44</us-gaap:EarningsPerShareDiluted>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000921"
      unitRef="USD">9375776</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember958666343"
      decimals="0"
      id="Fact000923"
      unitRef="USD">8801974</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      id="Fact000925"
      unitRef="USD">146136</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact000927"
      unitRef="Shares">6539376</FONR:WeightedAverageSharesOutstandingBasic>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember958666343"
      decimals="INF"
      id="Fact000929"
      unitRef="Shares">6539376</FONR:WeightedAverageSharesOutstandingBasic>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000931"
      unitRef="Shares">382513</FONR:WeightedAverageSharesOutstandingBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact000933"
      unitRef="USDPShares">1.43</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember958666343"
      decimals="INF"
      id="Fact000935"
      unitRef="USDPShares">1.35</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000937"
      unitRef="USDPShares">0.38</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember958666343"
      decimals="INF"
      id="Fact000939"
      unitRef="Shares">6539376</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma
      contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000941"
      unitRef="Shares">382513</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <FONR:IncrementalCommonSharesAttributableToConversionOfCommonStock
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember958666343"
      decimals="INF"
      id="Fact000943"
      unitRef="Shares">127504</FONR:IncrementalCommonSharesAttributableToConversionOfCommonStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000945"
      unitRef="Shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember958666343"
      decimals="INF"
      id="Fact000947"
      unitRef="Shares">6666880</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000949"
      unitRef="Shares">382513</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember958666343"
      decimals="INF"
      id="Fact000951"
      unitRef="USDPShares">1.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000953"
      unitRef="USDPShares">0.38</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000955">&lt;p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z33M7wt7oICl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span id="xdx_869_zhbMc3xQZmNe"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cash and cash equivalents includes cash on hand, cash
in banks, investments in certificates of deposit with original maturities of 90 days or less, and money market funds.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000957">&lt;p id="xdx_848_eus-gaap--InvestmentPolicyTextBlock_zNVmvzpue4E7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_860_zKPyc0dKGqci"&gt;Short-Term Investments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Short-term investments include certificates of deposit
with original maturities of greater than 90 days. Interest is recorded as earned.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2023-07-01to2024-06-30" id="Fact000959">&lt;p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zjfBs4dogapf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_866_zTIqGj8fSFsd"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cash: The Company maintains its cash and cash equivalents
with various financial institutions, which exceed federally insured limits throughout the year. At June 30, 2024, the Company had cash
on deposit of approximately $&lt;span id="xdx_907_eus-gaap--Cash_iI_pp0p0_c20240630_zls9uqywcjkh" title="Cash deposit"&gt;53,883,000&lt;/span&gt; in excess of federally insured limits of $&lt;span id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20240630_zBSk8mx3ekc3" title="Federally insured limits"&gt;250,000&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Related Parties: Net revenues from related parties
accounted for approximately &lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zcUvQhEqKW3f" title="Concentration risk, percentage"&gt;&lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zSnnpyzSZ80h" title="Concentration risk, percentage"&gt;12&lt;/span&gt;&lt;/span&gt;% of the consolidated net revenues for the years ended June 30, 2024 and 2023. Net management fee receivables
from the related party medical practices accounted for approximately &lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMedicalPracticesMember_z9UgZHdapRv" title="Concentration risk, percentage"&gt;12&lt;/span&gt;% and &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMedicalPracticesMember_zrb3soJNEv93" title="Concentration risk, percentage"&gt;13&lt;/span&gt;% of the consolidated accounts receivable as of June 30,
2024 and 2023, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;See Note 3 regarding the Company&#x2019;s concentrations
in the healthcare industry.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



















</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:Cash
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000961"
      unitRef="USD">53883000</us-gaap:Cash>
    <us-gaap:CashFDICInsuredAmount
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000963"
      unitRef="USD">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-07-012024-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMember"
      decimals="INF"
      id="Fact000965"
      unitRef="Pure">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-07-012023-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMember"
      decimals="INF"
      id="Fact000967"
      unitRef="Pure">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-07-012024-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMedicalPracticesMember"
      decimals="INF"
      id="Fact000969"
      unitRef="Pure">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-07-012023-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMedicalPracticesMember"
      decimals="INF"
      id="Fact000971"
      unitRef="Pure">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2023-07-01to2024-06-30" id="Fact000981">&lt;p id="xdx_843_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zioSBMNADrJ2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_867_zrF5xqH8vBS8"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company measures fair value in accordance with
ASC 820-10, &#x201c;Fair Value Measurements and Disclosures&#x201d;. ASC 820-10 clarifies that fair value is an exit price, representing
the amount that would be received by selling an asset or paid to transfer a liability in an orderly transaction between market participants.
As such, fair value is a market-based measurement that should be determined based on assumptions.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The standard establishes a three-tier fair value hierarchy,
which prioritizes the inputs used in measuring and revaluing fair value. These tiers include, Level 1, defined as observable inputs such
as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or
indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity
to develop its own assumptions.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following methods and assumptions were used to
estimate the fair value of each class of financial instruments for which it is practicable to estimate that value:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cash and cash equivalents: The carrying amount approximates
fair value because of the short-term maturity of those instruments.&lt;/p&gt;







&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Short-term investments: The carrying amount approximates
fair value because of the short-term maturity of those instruments. Such amounts include Certificates of Deposits with original maturities
greater than 90 days. These securities are classified as Level 1.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Receivable and accounts payable: The carrying amounts
approximate fair value because of the short maturity of those instruments.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Notes receivable: The carrying amount approximates
fair value because the discounted present value of the cash flow generated by the parties approximates the carrying value of the amounts
due to the Company.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Long-term debt and notes payable: The carrying amounts
of debt and notes payable approximate fair value due to the length of the maturities, the interest rates being tied to market indices
and/or due to the interest rates not being significantly different from the current market rates available to the Company.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;All of the Company&#x2019;s financial instruments are
held for purposes other than trading.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <FONR:RecentAccountingStandardsPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000986">&lt;p id="xdx_84B_ecustom--RecentAccountingStandardsPolicyTextBlock_zgf8tw78paHl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_863_zlONLM6d1tvh"&gt;Recent Accounting Standards&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In December 2023, The Financial Accounting Standards
Board (&#x201c;FASB&#x201d;) issued ASU 2023-09, &#x201c;Income Taxes (740) &#x201c;Improvements to Income Tax Disclosures&#x201d;, which requires
the annual financial statements to include consistent categories and great disaggregation of information in the rate reconciliation and
income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for the Company&#x2019;s annual reporting beginning after December
15, 2024, with early adoption permitted, and should be applied on a prospective basis, with a retrospective option. The Company is currently
evaluating the effect that the adoption of ASU 2023-09 will have on our disclosures.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In November 2023, FASB issued ASU 2023-07, &#x201c;Segment
Reporting (Topic 280)&#x201d;, which is intended to improve reportable segment disclosure requirements through enhanced disclosures about
significant segment expenses. The amendments require disclosure of significant segment expenses regularly provided to the chief operating
decision maker (CODM) as well as other segment items, extended certain annual disclosures to interim periods, clarify the applicability
to single reportable segment entities, permit more than one measure of profit or loss to be reported under certain conditions, and require
disclosure of the title and position of the CODM. The effective date for public entities is for fiscal years beginning after December
15, 2023 and interim periods with fiscal years beginning after December 15, 2024. The Company is expected to adopt the new disclosures
as required and are currently evaluating the impact on the related disclosures.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</FONR:RecentAccountingStandardsPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000996">&lt;p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zyzmnEIgfeC5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_866_zGeyNISx7NB9"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company adopted ASU 2016-13, &#x201c;Financial
Instruments &#x2013; Credit Losses&#x201d; (Topic 326) &#x201c;Measurement of Credit Losses on Financial Instruments&#x201d;, on July 1, 2023,
as amended which replaces the incurred loss methodology with an expected loss methodology that is referred to as the current expected
credit loss (CECL) methodology, The measurement of expected credit losses under the CECL methodology is applicable to financial assets
measured at amortized cost, including loan receivables and held-to-maturity debt securities. It also applies to off-balance sheet credit
exposures not accounted for as insurance (loan commitments, standby letters of credit, financial guarantees, and other similar instruments)
and net investments in leases recognized by a lessor in accordance with Topic 842 on leases. The Company used a modified retrospective
approach, which required a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting in which the standard
was effective. The adoption did not have a material effect on the Company&#x2019;s consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;FASB, the Emerging Issues Task Force and the SEC have
issued certain other accounting standards, updates, and regulations as of June 30, 2024 that will become effective in subsequent periods;
however, management does not believe that any of those updates would have significantly affected the Company&#x2019;s financial accounting
measures or disclosures had they been in effect during 2024 or 2023, and it does not believe that any of those standards will have a significant
impact on the Company&#x2019;s consolidated financial statements at the time they become effective.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;















</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001004">&lt;p id="xdx_80B_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zJuoXdjIIoJ" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;NOTE 3 &#x2013; &lt;span id="xdx_82D_zXjOevyDt1Gc"&gt;ACCOUNTS RECEIVABLE, MEDICAL
RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Long Term Accounts Receivable&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Long term accounts receivable balances at June 30,
2024 and June 30, 2023 amounted to $&lt;span id="xdx_907_ecustom--AccountsReceivableNetLongTerm_iI_c20240630_zk5RlgsJy513" title="Long term accounts receivable balances"&gt;829,473&lt;/span&gt; and $&lt;span id="xdx_90C_ecustom--AccountsReceivableNetLongTerm_iI_c20230630_zAPvrQOBno15" title="Long term accounts receivable balances"&gt;710,085&lt;/span&gt;, respectively. The Company will generate revenue from long-term, non-cancellable
contracts to provide service and repair services. Future revenue to be recognized over the following four years at June 30, 2024 is as
follows:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zLQiGYyfu0bi" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="5" style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span id="xdx_8B3_zxULpWrUqVfg" style="display: none"&gt;Schedule of receivables -
    non current - net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 76%; text-align: left; text-indent: -11pt"&gt;2026&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pp0p0_c20240630_z65xpqNEy7Og" style="width: 12%; text-align: right" title="2026"&gt;631,415&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;2027&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pp0p0_c20240630_zkbrS17Eqe14" style="text-align: right" title="2027"&gt;369,429&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;2028&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pp0p0_c20240630_z8vnE3Dkn9V4" style="text-align: right" title="2028"&gt;87,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;2029&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ContractReceivableDueFiveYearsOrMore_iI_pp0p0_c20240630_zy0Txw28f7U8" style="border-bottom: Black 1pt solid; text-align: right" title="2029"&gt;87,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_pp0p0_c20240630_ztUVSFFardm4" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;1,174,844&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;The following represents a summary of allowance
for credit losses for the years ended June 30, 2024 and 2023, respectively:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zFFO6u20j805" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="17" style="text-align: left"&gt;&lt;span id="xdx_8B0_zD3XG0pfFJHc" style="display: none"&gt;Summary of allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Description&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Balance&lt;br/&gt; June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Additions(Recovery) (1)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Deductions&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Balance &lt;br/&gt; June 30, 2024&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 40%; text-align: left; text-indent: -11pt"&gt;Accounts receivable&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zBF6ClyECdHd" style="width: 10%; text-align: right" title="Beginning Balance"&gt;198,593&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zUMoQ2PipMO9" style="width: 10%; text-align: right" title="Additions (Included in provision for bad debts)"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_znx3PMN111dh" style="width: 10%; text-align: right" title="Deductions"&gt;32,544&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zIWDN5ZXQ1C7" style="width: 10%; text-align: right" title="Ending Balance"&gt;166,049&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Management and other fees receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zA1qbdfRARjj" style="text-align: right"&gt;12,608,567&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zZnbvQ3gXM91" style="text-align: right"&gt;(238,646&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zRQV4n4uybB1" style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zDMXfB5alEwb" style="text-align: right"&gt;12,369,921&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Management and other fees receivable - related medical practices&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zrNOpFQWEGs1" style="text-align: right"&gt;3,989,692&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zfG1pNXhkK4b" style="text-align: right"&gt;2,120,707&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_ztnXmPeg2XR4" style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zVHM9lvFsM9d" style="text-align: right"&gt;6,110,399&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Notes receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zxHpUcPE0KIf" style="text-align: right"&gt;777,354&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zVw03YpOdjX" style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zjb73ljDLr72" style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zObfmcnQMtFh" style="text-align: right"&gt;777,354&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;Balance&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;Balance&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Description&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2022&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Additions&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Deductions&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; width: 40%; text-align: left; text-indent: -11pt"&gt;Accounts receivable&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_986_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zkjZ0KCipFG6" style="width: 10%; text-align: right"&gt;204,597&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zfiFNBpauq5" style="width: 10%; text-align: right"&gt;55,000&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zmou41KxiL8j" style="width: 10%; text-align: right"&gt;61,004&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_znJjja0WDUR4" style="width: 10%; text-align: right"&gt;198,593&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Management and other fees receivable&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zBpI8XxzF22a" style="text-align: right"&gt;16,627,917&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_ztRazgyEAwhk" style="text-align: right"&gt;4,007,382&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zGnS8dg6pbul" style="text-align: right"&gt;8,026,732&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_982_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zTVo2UAOtnW7" style="text-align: right"&gt;12,608,567&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Management and other fees receivable - related medical practices&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zuOWkhbmYtb8" style="text-align: right"&gt;4,686,893&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zkQHOCML4XN6" style="text-align: right"&gt;1,451,094&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zxDJ4eMv3sw3" style="text-align: right"&gt;2,148,295&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zuCIkEopmD" style="text-align: right"&gt;3,989,692&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Notes receivable&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zhnpJ6qYQTca" style="text-align: right"&gt;777,354&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zyxGjMNrEsrj" style="text-align: right"&gt;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zT3J173ma649" style="text-align: right"&gt;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zEkAq0VH0ngb" style="text-align: right"&gt;777,354&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 4px; padding-left: 11pt; text-align: justify"&gt;&lt;span id="xdx_F0C_zrCZXU1ui0Y7" style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-left: 11pt; text-align: justify"&gt;&lt;span id="xdx_F1A_zsRxEBUXR3me" style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Included in provision for credit losses.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A8_ztKyRO3m0ZRd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;



















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Net revenues from management and other fees charged
to the related party medical practices accounted for approximately &lt;span id="xdx_904_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20230701__20240630_zJwmpjKgEhIh" title="Percentage of consolidated net revenue from management fees"&gt;12&lt;/span&gt;% and &lt;span id="xdx_90E_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20220701__20230630_zrywzfceAFc3" title="Percentage of consolidated net revenue from management fees"&gt;12&lt;/span&gt;%, of the consolidated net revenues for the years ended June
30, 2024 and 2023, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Tallahassee Magnetic Resonance Imaging, PA, Stand
Up MRI of Boca Raton, PA and Stand Up MRI &amp;amp; Diagnostic Center, PA (all related party medical practices) entered into a guaranty agreement,
pursuant to which they cross guaranteed all management fees which are payable to the Company, which have arisen under each individual
management agreement.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table sets forth the number of our facilities
for the years ended June 30, 2024 and 2023.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;Total Facilities&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zfYGN6cu7R9l" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8BA_zJnWAxBnUaec" style="display: none"&gt;Schedule of facilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20230701__20240630_zcfnQrId55si" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20220701__20230630_zoCB6mcCEOF8" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Year Ended June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_zEHDaxHV6qma" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Total Facilities Owned or Managed (at Beginning of Year)&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;27&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;27&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Facilities Added by:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ManagedFacilitiesAddedByInternalDevelopment_z0bbJ3tHn9Oj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;Internal development&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ManagedFacilitiesClosedDuringYear_d0_zJpUq4cJUVHc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Managed Facilities Closed&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_z2BaW7Ft6d7a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Total Facilities Owned or Managed (at End of Year)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;28&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;27&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <FONR:AccountsReceivableNetLongTerm
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001006"
      unitRef="USD">829473</FONR:AccountsReceivableNetLongTerm>
    <FONR:AccountsReceivableNetLongTerm
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001008"
      unitRef="USD">710085</FONR:AccountsReceivableNetLongTerm>
    <us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001010">&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zLQiGYyfu0bi" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="5" style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span id="xdx_8B3_zxULpWrUqVfg" style="display: none"&gt;Schedule of receivables -
    non current - net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 76%; text-align: left; text-indent: -11pt"&gt;2026&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pp0p0_c20240630_z65xpqNEy7Og" style="width: 12%; text-align: right" title="2026"&gt;631,415&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;2027&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pp0p0_c20240630_zkbrS17Eqe14" style="text-align: right" title="2027"&gt;369,429&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;2028&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pp0p0_c20240630_z8vnE3Dkn9V4" style="text-align: right" title="2028"&gt;87,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;2029&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ContractReceivableDueFiveYearsOrMore_iI_pp0p0_c20240630_zy0Txw28f7U8" style="border-bottom: Black 1pt solid; text-align: right" title="2029"&gt;87,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_pp0p0_c20240630_ztUVSFFardm4" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;1,174,844&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock>
    <us-gaap:ContractReceivableDueTwoToThreeYears
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001012"
      unitRef="USD">631415</us-gaap:ContractReceivableDueTwoToThreeYears>
    <us-gaap:ContractReceivableDueThreeToFourYears
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001014"
      unitRef="USD">369429</us-gaap:ContractReceivableDueThreeToFourYears>
    <us-gaap:ContractReceivableDueFourToFiveYears
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001016"
      unitRef="USD">87000</us-gaap:ContractReceivableDueFourToFiveYears>
    <us-gaap:ContractReceivableDueFiveYearsOrMore
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001018"
      unitRef="USD">87000</us-gaap:ContractReceivableDueFiveYearsOrMore>
    <us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001020"
      unitRef="USD">1174844</us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms>
    <us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001022">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zFFO6u20j805" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="17" style="text-align: left"&gt;&lt;span id="xdx_8B0_zD3XG0pfFJHc" style="display: none"&gt;Summary of allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Description&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Balance&lt;br/&gt; June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Additions(Recovery) (1)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Deductions&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Balance &lt;br/&gt; June 30, 2024&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 40%; text-align: left; text-indent: -11pt"&gt;Accounts receivable&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zBF6ClyECdHd" style="width: 10%; text-align: right" title="Beginning Balance"&gt;198,593&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zUMoQ2PipMO9" style="width: 10%; text-align: right" title="Additions (Included in provision for bad debts)"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_znx3PMN111dh" style="width: 10%; text-align: right" title="Deductions"&gt;32,544&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zIWDN5ZXQ1C7" style="width: 10%; text-align: right" title="Ending Balance"&gt;166,049&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Management and other fees receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zA1qbdfRARjj" style="text-align: right"&gt;12,608,567&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zZnbvQ3gXM91" style="text-align: right"&gt;(238,646&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zRQV4n4uybB1" style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zDMXfB5alEwb" style="text-align: right"&gt;12,369,921&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Management and other fees receivable - related medical practices&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zrNOpFQWEGs1" style="text-align: right"&gt;3,989,692&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zfG1pNXhkK4b" style="text-align: right"&gt;2,120,707&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_ztnXmPeg2XR4" style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zVHM9lvFsM9d" style="text-align: right"&gt;6,110,399&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Notes receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zxHpUcPE0KIf" style="text-align: right"&gt;777,354&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zVw03YpOdjX" style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zjb73ljDLr72" style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zObfmcnQMtFh" style="text-align: right"&gt;777,354&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;Balance&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;Balance&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Description&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2022&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Additions&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Deductions&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; width: 40%; text-align: left; text-indent: -11pt"&gt;Accounts receivable&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_986_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zkjZ0KCipFG6" style="width: 10%; text-align: right"&gt;204,597&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zfiFNBpauq5" style="width: 10%; text-align: right"&gt;55,000&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zmou41KxiL8j" style="width: 10%; text-align: right"&gt;61,004&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_znJjja0WDUR4" style="width: 10%; text-align: right"&gt;198,593&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Management and other fees receivable&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zBpI8XxzF22a" style="text-align: right"&gt;16,627,917&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_ztRazgyEAwhk" style="text-align: right"&gt;4,007,382&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zGnS8dg6pbul" style="text-align: right"&gt;8,026,732&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_982_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zTVo2UAOtnW7" style="text-align: right"&gt;12,608,567&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Management and other fees receivable - related medical practices&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zuOWkhbmYtb8" style="text-align: right"&gt;4,686,893&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zkQHOCML4XN6" style="text-align: right"&gt;1,451,094&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zxDJ4eMv3sw3" style="text-align: right"&gt;2,148,295&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zuCIkEopmD" style="text-align: right"&gt;3,989,692&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Notes receivable&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zhnpJ6qYQTca" style="text-align: right"&gt;777,354&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zyxGjMNrEsrj" style="text-align: right"&gt;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zT3J173ma649" style="text-align: right"&gt;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zEkAq0VH0ngb" style="text-align: right"&gt;777,354&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 4px; padding-left: 11pt; text-align: justify"&gt;&lt;span id="xdx_F0C_zrCZXU1ui0Y7" style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-left: 11pt; text-align: justify"&gt;&lt;span id="xdx_F1A_zsRxEBUXR3me" style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Included in provision for credit losses.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2023-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      id="Fact001024"
      unitRef="USD">198593</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2023-07-012024-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      id="Fact001026"
      unitRef="USD">0</FONR:AllowanceForDoubtfulAccountsAdditions>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2023-07-012024-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      id="Fact001028"
      unitRef="USD">32544</FONR:AllowanceForDoubtfulAccountsDeductions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2024-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      id="Fact001030"
      unitRef="USD">166049</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      id="Fact001031"
      unitRef="USD">12608567</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2023-07-012024-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      id="Fact001032"
      unitRef="USD">-238646</FONR:AllowanceForDoubtfulAccountsAdditions>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2023-07-012024-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      id="Fact001033"
      unitRef="USD">0</FONR:AllowanceForDoubtfulAccountsDeductions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2024-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      id="Fact001034"
      unitRef="USD">12369921</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      id="Fact001035"
      unitRef="USD">3989692</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2023-07-012024-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      id="Fact001036"
      unitRef="USD">2120707</FONR:AllowanceForDoubtfulAccountsAdditions>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2023-07-012024-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      id="Fact001037"
      unitRef="USD">0</FONR:AllowanceForDoubtfulAccountsDeductions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2024-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      id="Fact001038"
      unitRef="USD">6110399</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2023-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      id="Fact001039"
      unitRef="USD">777354</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2023-07-012024-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      id="Fact001040"
      unitRef="USD">0</FONR:AllowanceForDoubtfulAccountsAdditions>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2023-07-012024-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      id="Fact001041"
      unitRef="USD">0</FONR:AllowanceForDoubtfulAccountsDeductions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2024-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      id="Fact001042"
      unitRef="USD">777354</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2022-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      id="Fact001043"
      unitRef="USD">204597</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2022-07-012023-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      id="Fact001044"
      unitRef="USD">55000</FONR:AllowanceForDoubtfulAccountsAdditions>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2022-07-012023-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      id="Fact001045"
      unitRef="USD">61004</FONR:AllowanceForDoubtfulAccountsDeductions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2023-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      id="Fact001046"
      unitRef="USD">198593</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      id="Fact001047"
      unitRef="USD">16627917</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2022-07-012023-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      id="Fact001048"
      unitRef="USD">4007382</FONR:AllowanceForDoubtfulAccountsAdditions>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2022-07-012023-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      id="Fact001049"
      unitRef="USD">8026732</FONR:AllowanceForDoubtfulAccountsDeductions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      id="Fact001050"
      unitRef="USD">12608567</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      id="Fact001051"
      unitRef="USD">4686893</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2022-07-012023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      id="Fact001052"
      unitRef="USD">1451094</FONR:AllowanceForDoubtfulAccountsAdditions>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2022-07-012023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      id="Fact001053"
      unitRef="USD">2148295</FONR:AllowanceForDoubtfulAccountsDeductions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      id="Fact001054"
      unitRef="USD">3989692</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2022-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      id="Fact001055"
      unitRef="USD">777354</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2022-07-012023-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      id="Fact001056"
      unitRef="USD">0</FONR:AllowanceForDoubtfulAccountsAdditions>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2022-07-012023-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      id="Fact001057"
      unitRef="USD">0</FONR:AllowanceForDoubtfulAccountsDeductions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2023-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      id="Fact001058"
      unitRef="USD">777354</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001069"
      unitRef="Pure">0.12</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001071"
      unitRef="Pure">0.12</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:TotalFacilitiesOwnedOrManagedTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001073">&lt;table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zfYGN6cu7R9l" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8BA_zJnWAxBnUaec" style="display: none"&gt;Schedule of facilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20230701__20240630_zcfnQrId55si" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20220701__20230630_zoCB6mcCEOF8" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Year Ended June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_zEHDaxHV6qma" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Total Facilities Owned or Managed (at Beginning of Year)&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;27&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;27&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Facilities Added by:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ManagedFacilitiesAddedByInternalDevelopment_z0bbJ3tHn9Oj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;Internal development&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ManagedFacilitiesClosedDuringYear_d0_zJpUq4cJUVHc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Managed Facilities Closed&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_z2BaW7Ft6d7a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Total Facilities Owned or Managed (at End of Year)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;28&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;27&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</FONR:TotalFacilitiesOwnedOrManagedTableTextBlock>
    <FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001075"
      unitRef="Integer">27</FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear>
    <FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001076"
      unitRef="Integer">27</FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear>
    <FONR:ManagedFacilitiesAddedByInternalDevelopment
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001078"
      unitRef="Integer">1</FONR:ManagedFacilitiesAddedByInternalDevelopment>
    <FONR:ManagedFacilitiesAddedByInternalDevelopment
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001079"
      unitRef="Integer">1</FONR:ManagedFacilitiesAddedByInternalDevelopment>
    <FONR:ManagedFacilitiesClosedDuringYear
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001081"
      unitRef="Integer">0</FONR:ManagedFacilitiesClosedDuringYear>
    <FONR:ManagedFacilitiesClosedDuringYear
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001082"
      unitRef="Integer">-1</FONR:ManagedFacilitiesClosedDuringYear>
    <FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001084"
      unitRef="Integer">28</FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear>
    <FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001085"
      unitRef="Integer">27</FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001087">&lt;p id="xdx_80E_eus-gaap--InventoryDisclosureTextBlock_zTrA76cWlrtj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 4 &#x2013; &lt;span id="xdx_82E_zu6ohMdAktFb"&gt;INVENTORIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Inventories included in the accompanying consolidated
balance sheets consist of:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zwnAgOCuvp7d" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8BF_zqv8kemkf119" style="display: none"&gt;Schedule of inventories&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20240630_z08defaRLD9e" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20230630_z4g7daxKJPD4" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OtherInventorySupplies_iI_maIFGAWzdt0_zBMZYvgXWDf8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Purchased parts and components&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,524,201&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,346,300&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_maIFGAWzdt0_zuttCjsifXc1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Work-in-process&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;191,240&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;223,366&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--InventoryNet_iTI_mtIFGAWzdt0_zdvRqeSPTQ6b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Inventories&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,715,441&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,569,666&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;















</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001089">&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zwnAgOCuvp7d" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8BF_zqv8kemkf119" style="display: none"&gt;Schedule of inventories&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20240630_z08defaRLD9e" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20230630_z4g7daxKJPD4" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OtherInventorySupplies_iI_maIFGAWzdt0_zBMZYvgXWDf8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Purchased parts and components&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,524,201&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,346,300&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_maIFGAWzdt0_zuttCjsifXc1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Work-in-process&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;191,240&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;223,366&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--InventoryNet_iTI_mtIFGAWzdt0_zdvRqeSPTQ6b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Inventories&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,715,441&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,569,666&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:OtherInventorySupplies
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001091"
      unitRef="USD">2524201</us-gaap:OtherInventorySupplies>
    <us-gaap:OtherInventorySupplies
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001092"
      unitRef="USD">2346300</us-gaap:OtherInventorySupplies>
    <us-gaap:InventoryWorkInProcess
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001094"
      unitRef="USD">191240</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001095"
      unitRef="USD">223366</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001097"
      unitRef="USD">2715441</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001098"
      unitRef="USD">2569666</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001106">&lt;p id="xdx_801_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zOzVAobHVl3k" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 5 - &lt;span id="xdx_823_zo7KbIYIqZr7"&gt;PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Property and equipment, at cost, less accumulated
depreciation and amortization, at June 30, 2024 and 2023, is comprised of:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--PropertyPlantAndEquipmentTextBlock_zeZShXzkNEya" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT - Property and equipment (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8B1_z0kZGrhTUiIk" style="display: none"&gt;Schedule of property and equipment, at cost, less accumulated
depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Diagnostic equipment&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zbs7snyeOlNl" style="width: 12%; text-align: right" title="Property plant and equipment, gross"&gt;33,243,694&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zKk3jW2LEiCc" style="width: 12%; text-align: right" title="Property plant and equipment, gross"&gt;33,144,266&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Research, development and demonstration equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDevelopmentAndDemonstrationEquipmentMember_zxFK8qFrWdzc" style="text-align: right" title="Property plant and equipment, gross"&gt;6,199,941&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDevelopmentAndDemonstrationEquipmentMember_zuyNjcZHQj0d" style="text-align: right" title="Property plant and equipment, gross"&gt;6,199,941&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Machinery and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zIN3xebDOpg" style="text-align: right" title="Property plant and equipment, gross"&gt;2,069,055&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zoAqAHSXPpJc" style="text-align: right" title="Property plant and equipment, gross"&gt;2,069,055&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Furniture and fixtures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zHfP635UCEC1" style="text-align: right" title="Property plant and equipment, gross"&gt;3,742,169&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zv8nRRhPnyT5" style="text-align: right" title="Property plant and equipment, gross"&gt;3,714,499&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zocD8M52HM84" style="text-align: right" title="Property plant and equipment, gross"&gt;16,312,904&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zQKg145Wc3z2" style="text-align: right" title="Property plant and equipment, gross"&gt;15,650,041&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Building&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zAca8yQwTd9e" style="border-bottom: Black 1pt solid; text-align: right" title="Property plant and equipment, gross"&gt;939,614&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zxHktrqlZYw9" style="border-bottom: Black 1pt solid; text-align: right" title="Property plant and equipment, gross"&gt;939,614&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630_zv2RGMKNlZbi" style="text-align: right" title="Property plant and equipment, gross"&gt;62,507,377&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630_zBPrJZmZavl6" style="text-align: right" title="Property plant and equipment, gross"&gt;61,717,416&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Less: Accumulated depreciation and amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20240630_zYTlQhk0vYi8" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation and amortization"&gt;43,798,457&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20230630_zsRQ2IVkT9w9" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation and amortization"&gt;39,571,043&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20240630_zdZ6fHZ8gPT" style="border-bottom: Black 2.5pt double; text-align: right" title="Property plant and equipment, net"&gt;18,708,920&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20230630_zvEiv82swc5f" style="border-bottom: Black 2.5pt double; text-align: right" title="Property plant and equipment, net"&gt;22,146,373&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Depreciation and amortization of property and equipment
for the years ended June 30, 2024 and 2023 was $&lt;span id="xdx_90C_eus-gaap--OtherDepreciationAndAmortization_pp0p0_c20230701__20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_ztWb38BZePDf" title="Depreciation and amortization of property and equipment"&gt;4,227,414&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--OtherDepreciationAndAmortization_pp0p0_c20220701__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_zo0jkFNmHUOb" title="Depreciation and amortization of property and equipment"&gt;4,148,544&lt;/span&gt;, respectively.&lt;/p&gt;
&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001108">&lt;table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--PropertyPlantAndEquipmentTextBlock_zeZShXzkNEya" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT - Property and equipment (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8B1_z0kZGrhTUiIk" style="display: none"&gt;Schedule of property and equipment, at cost, less accumulated
depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Diagnostic equipment&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zbs7snyeOlNl" style="width: 12%; text-align: right" title="Property plant and equipment, gross"&gt;33,243,694&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zKk3jW2LEiCc" style="width: 12%; text-align: right" title="Property plant and equipment, gross"&gt;33,144,266&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Research, development and demonstration equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDevelopmentAndDemonstrationEquipmentMember_zxFK8qFrWdzc" style="text-align: right" title="Property plant and equipment, gross"&gt;6,199,941&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDevelopmentAndDemonstrationEquipmentMember_zuyNjcZHQj0d" style="text-align: right" title="Property plant and equipment, gross"&gt;6,199,941&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Machinery and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zIN3xebDOpg" style="text-align: right" title="Property plant and equipment, gross"&gt;2,069,055&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zoAqAHSXPpJc" style="text-align: right" title="Property plant and equipment, gross"&gt;2,069,055&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Furniture and fixtures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zHfP635UCEC1" style="text-align: right" title="Property plant and equipment, gross"&gt;3,742,169&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zv8nRRhPnyT5" style="text-align: right" title="Property plant and equipment, gross"&gt;3,714,499&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zocD8M52HM84" style="text-align: right" title="Property plant and equipment, gross"&gt;16,312,904&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zQKg145Wc3z2" style="text-align: right" title="Property plant and equipment, gross"&gt;15,650,041&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Building&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zAca8yQwTd9e" style="border-bottom: Black 1pt solid; text-align: right" title="Property plant and equipment, gross"&gt;939,614&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zxHktrqlZYw9" style="border-bottom: Black 1pt solid; text-align: right" title="Property plant and equipment, gross"&gt;939,614&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630_zv2RGMKNlZbi" style="text-align: right" title="Property plant and equipment, gross"&gt;62,507,377&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630_zBPrJZmZavl6" style="text-align: right" title="Property plant and equipment, gross"&gt;61,717,416&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Less: Accumulated depreciation and amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20240630_zYTlQhk0vYi8" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation and amortization"&gt;43,798,457&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20230630_zsRQ2IVkT9w9" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation and amortization"&gt;39,571,043&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20240630_zdZ6fHZ8gPT" style="border-bottom: Black 2.5pt double; text-align: right" title="Property plant and equipment, net"&gt;18,708,920&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20230630_zvEiv82swc5f" style="border-bottom: Black 2.5pt double; text-align: right" title="Property plant and equipment, net"&gt;22,146,373&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-06-30_custom_DiagnosticEquipmentMember"
      decimals="0"
      id="Fact001110"
      unitRef="USD">33243694</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-06-30_custom_DiagnosticEquipmentMember"
      decimals="0"
      id="Fact001112"
      unitRef="USD">33144266</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-06-30_custom_ResearchDevelopmentAndDemonstrationEquipmentMember"
      decimals="0"
      id="Fact001114"
      unitRef="USD">6199941</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-06-30_custom_ResearchDevelopmentAndDemonstrationEquipmentMember"
      decimals="0"
      id="Fact001116"
      unitRef="USD">6199941</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-06-30_us-gaap_MachineryAndEquipmentMember"
      decimals="0"
      id="Fact001118"
      unitRef="USD">2069055</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-06-30_us-gaap_MachineryAndEquipmentMember"
      decimals="0"
      id="Fact001120"
      unitRef="USD">2069055</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-06-30_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      id="Fact001122"
      unitRef="USD">3742169</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-06-30_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      id="Fact001124"
      unitRef="USD">3714499</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-06-30_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      id="Fact001126"
      unitRef="USD">16312904</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-06-30_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      id="Fact001128"
      unitRef="USD">15650041</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-06-30_us-gaap_BuildingMember"
      decimals="0"
      id="Fact001130"
      unitRef="USD">939614</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-06-30_us-gaap_BuildingMember"
      decimals="0"
      id="Fact001132"
      unitRef="USD">939614</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001134"
      unitRef="USD">62507377</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001136"
      unitRef="USD">61717416</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001138"
      unitRef="USD">43798457</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001140"
      unitRef="USD">39571043</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001142"
      unitRef="USD">18708920</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001144"
      unitRef="USD">22146373</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2023-07-012024-06-30_us-gaap_PropertyPlantAndEquipmentMember"
      decimals="0"
      id="Fact001146"
      unitRef="USD">4227414</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2022-07-012023-06-30_us-gaap_PropertyPlantAndEquipmentMember"
      decimals="0"
      id="Fact001148"
      unitRef="USD">4148544</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001150">&lt;p id="xdx_80B_eus-gaap--LesseeOperatingLeasesTextBlock_ztqvZWXCtYpl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 6 &#x2013; &lt;span id="xdx_825_zYCZnDcxHQJl"&gt;OPERATING &amp;amp; FINANCING LEASES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounts for its various operating leases
in accordance with Accounting Standards Codification (&#x2018;ASC&#x2019;) 842 &#x2013; Lease, as updated by ASU 2016-02. At the inception
of a lease, the Company recognizes right-of-use lease assets and related lease liabilities measured at present value of future lease payments
on its balance sheet. Lease expense is recognized on a straight-line basis over the term of the lease. Our most common initial term varies
in length from 2 to 19 years. Including renewal options negotiated with the landlord, we have a total span of 2 to 16 years at the facilities
we lease. The Company reviewed its contracts with vendors and customers, determining that its right-to-use lease assets consisted of only
office space operating leases. In determining the right-to-use lease assets and liabilities, the Company did recognize lease extension
options which the Company feels would be reasonably exercised. Our incremental borrowing rate (&#x201c;IBR&#x201d;) used to discount the
stream of operating lease payments is closely related to the interest rates available to the Company. A reconciliation of operating and
financing lease payments undiscounted cash flows to lease liabilities recognized as of June 30, 2024 is as follows:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



















&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zxWPFt2jtes7" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Lease payments (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="3" style="text-align: center"&gt;&lt;span id="xdx_8B6_zuSTGREMEtnb" style="display: none"&gt;Schedule of reconciliation of operating and financing
lease payments&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Year Ending June 30,&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Operating Lease Payments&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Financing Lease Payments&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; width: 26%; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zqSak3qkBvEl" style="width: 26%; text-align: right" title="2025"&gt;5,895,014&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zaetlJMqecnb" style="width: 26%; text-align: right" title="2025"&gt;244,343&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;2026&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zVAslA7beGhj" style="text-align: right" title="2026"&gt;5,561,968&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zGD3L8Yr9Fmf" style="text-align: right" title="2026"&gt;244,343&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;2027&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_znXbPoZA6cjj" style="text-align: right" title="2027"&gt;5,226,352&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_ziANxjpZgdki" style="text-align: right" title="2027"&gt;162,897&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;2028&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zixNMdUG7s6k" style="text-align: right" title="2028"&gt;5,194,655&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_d0_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_ztABDuAvvCRe" style="text-align: right" title="2028"&gt;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;2029&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zZhQOIZmIFUj" style="text-align: right" title="2029"&gt;4,865,285&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_d0_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zftT6Aci8Xsc" style="text-align: right" title="2029"&gt;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zKAMGbtPidmj" style="text-align: right" title="Thereafter"&gt;29,295,110&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_d0_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z1vKArLZveq3" style="text-align: right" title="Thereafter"&gt;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Present value discount&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_ecustom--PresentValueDiscount_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zI3jKE4AE5ag" style="border-bottom: Black 1pt solid; text-align: right" title="Present value discount"&gt;(15,096,964&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_982_ecustom--PresentValueDiscountFinancingLease_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zpoBhrJkD4Si" style="border-bottom: Black 1pt solid; text-align: right" title="Present value discount"&gt;(31,074&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Total lease liability&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--OperatingLeaseLiability_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zxwBPf5hn9j5" style="border-bottom: Black 2.5pt double; text-align: right" title="Total lease liability"&gt;40,941,420&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--FinanceLeaseLiability_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_ztaaIsy0HIh5" style="border-bottom: Black 2.5pt double; text-align: right" title="Total lease liability"&gt;620,509&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A5_z63dNoSslRJ8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_zygwCTE1sr35" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Weighted average remaining lease term (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8B4_zWFj85KW5wka" style="display: none"&gt;Schedule
    of weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 70%; text-align: left; text-indent: -11pt"&gt;Operating leases - years&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240630_z4cUpqCdVwT1" title="Operating leases - years"&gt;11.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Finance lease - years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240630_zokYbdtNjWGi" title="Finance lease - years"&gt;2.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Weighted Average Discount Rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Operating leases&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20240630_zGPIFz2bvSkj" title="Weighted average discount rate, operating leases"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Finance lease&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20240630_zk49Yn4GCN54" title="Weighted average discount rate, finance leases"&gt;3.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AA_z6bQkgs6xFBb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--LeaseCostTableTextBlock_zChHtcRNhfh8" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Components of lease expense (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8BC_z3vKzFFltW5e" style="display: none"&gt;Schedule of components
    of lease expense&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_495_20230701__20240630_zRYYaviEFZCl" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_499_20220701__20230630_zyTFfjRrVyhh" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For Year Ended June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Operating lease cost&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;5,685,008&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;5,887,390&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--FinanceLeaseCostsAbstract_iB_zeM01tV7OYff" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Finance lease cost:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0_zXU0EuIp7Ta7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Depreciation of leased equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;198,881&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;198,881&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Interest on lease liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;26,534&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;35,833&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--FinanceLeaseCost_i01_pp0p0_z7ekTXZ28Dqg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Total finance lease cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;225,415&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;234,714&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A6_zHeHskNhqtq6" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Supplemental cash flow information related to leases
was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_zdQTVXAaEMC2" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Related to leases (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8BE_zKRrkpPwBYH5" style="display: none"&gt;Schedule
    of supplemental cash flow information related to leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_492_20230701__20240630_z1ipsSFewXC1" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_497_20220701__20230630_ztGFuONv9TVf" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For Year Ended June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--OperatingCashFlowsFromOperatingLeases_zHCoVLOQMixl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Operating cash flows from operating leases&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;6,363,561&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;5,577,578&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--FinancingCashFlowsFromFinancingLeases_zAKnEkj1TkP3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Financing cash flows from financing leases&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;244,344&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;244,344&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB_zYcS5XR52d8l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Right-of-use and equipment assets obtained in exchange for lease obligations:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_z6SkehgmknMh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Operating leases&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,715,138&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,902,584&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AA_zALHWBB9Y7mh" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001160">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zxWPFt2jtes7" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Lease payments (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="3" style="text-align: center"&gt;&lt;span id="xdx_8B6_zuSTGREMEtnb" style="display: none"&gt;Schedule of reconciliation of operating and financing
lease payments&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Year Ending June 30,&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Operating Lease Payments&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Financing Lease Payments&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; width: 26%; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zqSak3qkBvEl" style="width: 26%; text-align: right" title="2025"&gt;5,895,014&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zaetlJMqecnb" style="width: 26%; text-align: right" title="2025"&gt;244,343&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;2026&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zVAslA7beGhj" style="text-align: right" title="2026"&gt;5,561,968&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zGD3L8Yr9Fmf" style="text-align: right" title="2026"&gt;244,343&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;2027&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_znXbPoZA6cjj" style="text-align: right" title="2027"&gt;5,226,352&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_ziANxjpZgdki" style="text-align: right" title="2027"&gt;162,897&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;2028&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zixNMdUG7s6k" style="text-align: right" title="2028"&gt;5,194,655&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_d0_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_ztABDuAvvCRe" style="text-align: right" title="2028"&gt;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;2029&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zZhQOIZmIFUj" style="text-align: right" title="2029"&gt;4,865,285&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_d0_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zftT6Aci8Xsc" style="text-align: right" title="2029"&gt;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zKAMGbtPidmj" style="text-align: right" title="Thereafter"&gt;29,295,110&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_d0_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z1vKArLZveq3" style="text-align: right" title="Thereafter"&gt;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Present value discount&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_ecustom--PresentValueDiscount_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zI3jKE4AE5ag" style="border-bottom: Black 1pt solid; text-align: right" title="Present value discount"&gt;(15,096,964&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_982_ecustom--PresentValueDiscountFinancingLease_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zpoBhrJkD4Si" style="border-bottom: Black 1pt solid; text-align: right" title="Present value discount"&gt;(31,074&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Total lease liability&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--OperatingLeaseLiability_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zxwBPf5hn9j5" style="border-bottom: Black 2.5pt double; text-align: right" title="Total lease liability"&gt;40,941,420&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--FinanceLeaseLiability_iI_c20240630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_ztaaIsy0HIh5" style="border-bottom: Black 2.5pt double; text-align: right" title="Total lease liability"&gt;620,509&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2024-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      id="Fact001162"
      unitRef="USD">5895014</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2024-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      id="Fact001164"
      unitRef="USD">244343</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2024-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      id="Fact001166"
      unitRef="USD">5561968</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2024-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      id="Fact001168"
      unitRef="USD">244343</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2024-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      id="Fact001170"
      unitRef="USD">5226352</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2024-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      id="Fact001172"
      unitRef="USD">162897</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="AsOf2024-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      id="Fact001174"
      unitRef="USD">5194655</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="AsOf2024-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      id="Fact001176"
      unitRef="USD">0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="AsOf2024-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      id="Fact001178"
      unitRef="USD">4865285</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="AsOf2024-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      id="Fact001180"
      unitRef="USD">0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="AsOf2024-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      id="Fact001182"
      unitRef="USD">29295110</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="AsOf2024-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      id="Fact001184"
      unitRef="USD">0</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <FONR:PresentValueDiscount
      contextRef="AsOf2024-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      id="Fact001186"
      unitRef="USD">-15096964</FONR:PresentValueDiscount>
    <FONR:PresentValueDiscountFinancingLease
      contextRef="AsOf2024-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      id="Fact001188"
      unitRef="USD">-31074</FONR:PresentValueDiscountFinancingLease>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2024-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      id="Fact001190"
      unitRef="USD">40941420</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="AsOf2024-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      id="Fact001192"
      unitRef="USD">620509</us-gaap:FinanceLeaseLiability>
    <FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001194">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_zygwCTE1sr35" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Weighted average remaining lease term (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8B4_zWFj85KW5wka" style="display: none"&gt;Schedule
    of weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 70%; text-align: left; text-indent: -11pt"&gt;Operating leases - years&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240630_z4cUpqCdVwT1" title="Operating leases - years"&gt;11.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Finance lease - years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240630_zokYbdtNjWGi" title="Finance lease - years"&gt;2.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Weighted Average Discount Rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Operating leases&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20240630_zGPIFz2bvSkj" title="Weighted average discount rate, operating leases"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Finance lease&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20240630_zk49Yn4GCN54" title="Weighted average discount rate, finance leases"&gt;3.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2024-06-30" id="Fact001196">P11Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2024-06-30" id="Fact001198">P2Y7M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact001200"
      unitRef="Pure">0.064</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact001202"
      unitRef="Pure">0.036</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001204">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--LeaseCostTableTextBlock_zChHtcRNhfh8" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Components of lease expense (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8BC_z3vKzFFltW5e" style="display: none"&gt;Schedule of components
    of lease expense&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_495_20230701__20240630_zRYYaviEFZCl" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_499_20220701__20230630_zyTFfjRrVyhh" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For Year Ended June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Operating lease cost&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;5,685,008&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;5,887,390&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--FinanceLeaseCostsAbstract_iB_zeM01tV7OYff" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Finance lease cost:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0_zXU0EuIp7Ta7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Depreciation of leased equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;198,881&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;198,881&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Interest on lease liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;26,534&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;35,833&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--FinanceLeaseCost_i01_pp0p0_z7ekTXZ28Dqg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Total finance lease cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;225,415&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;234,714&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001206"
      unitRef="USD">5685008</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001207"
      unitRef="USD">5887390</us-gaap:OperatingLeaseCost>
    <FONR:DepreciationOfLeasedEquipment
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001212"
      unitRef="USD">198881</FONR:DepreciationOfLeasedEquipment>
    <FONR:DepreciationOfLeasedEquipment
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001213"
      unitRef="USD">198881</FONR:DepreciationOfLeasedEquipment>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001215"
      unitRef="USD">26534</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001216"
      unitRef="USD">35833</us-gaap:FinanceLeaseInterestExpense>
    <FONR:FinanceLeaseCost
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001218"
      unitRef="USD">225415</FONR:FinanceLeaseCost>
    <FONR:FinanceLeaseCost
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001219"
      unitRef="USD">234714</FONR:FinanceLeaseCost>
    <FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001229">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_zdQTVXAaEMC2" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Related to leases (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8BE_zKRrkpPwBYH5" style="display: none"&gt;Schedule
    of supplemental cash flow information related to leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_492_20230701__20240630_z1ipsSFewXC1" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_497_20220701__20230630_ztGFuONv9TVf" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For Year Ended June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--OperatingCashFlowsFromOperatingLeases_zHCoVLOQMixl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Operating cash flows from operating leases&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;6,363,561&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;5,577,578&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--FinancingCashFlowsFromFinancingLeases_zAKnEkj1TkP3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Financing cash flows from financing leases&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;244,344&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;244,344&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB_zYcS5XR52d8l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Right-of-use and equipment assets obtained in exchange for lease obligations:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_z6SkehgmknMh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Operating leases&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,715,138&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,902,584&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock>
    <FONR:OperatingCashFlowsFromOperatingLeases
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001231"
      unitRef="USD">6363561</FONR:OperatingCashFlowsFromOperatingLeases>
    <FONR:OperatingCashFlowsFromOperatingLeases
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001232"
      unitRef="USD">5577578</FONR:OperatingCashFlowsFromOperatingLeases>
    <FONR:FinancingCashFlowsFromFinancingLeases
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001234"
      unitRef="USD">244344</FONR:FinancingCashFlowsFromFinancingLeases>
    <FONR:FinancingCashFlowsFromFinancingLeases
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001235"
      unitRef="USD">244344</FONR:FinancingCashFlowsFromFinancingLeases>
    <FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001240"
      unitRef="USD">3715138</FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases>
    <FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001241"
      unitRef="USD">2902584</FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001243">&lt;p id="xdx_809_eus-gaap--IntangibleAssetsDisclosureTextBlock_z3Qx9sBrFId" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 7 - &lt;span id="xdx_828_zgI2U6s9Rgfc"&gt;OTHER INTANGIBLE ASSETS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Other intangible assets, net of accumulated amortization,
at June 30, 2024 and 2023, are comprised of:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zTZeAiPTZlPj" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8BD_zRldzUPfbKR5" style="display: none"&gt;Schedule of other intangible assets, net of accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Capitalized software development costs&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zHo6lKBP5wYk" style="width: 12%; text-align: right" title="Gross other intangible assets"&gt;7,004,847&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_z450GDfCMzka" style="width: 12%; text-align: right" title="Gross other intangible assets"&gt;7,004,847&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Patents and copyrights&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zVQZvLqOXcMl" style="text-align: right" title="Gross other intangible assets"&gt;5,259,811&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zpu9ss2TXRt4" style="text-align: right" title="Gross other intangible assets"&gt;5,452,345&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Non-competition agreements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zWLQ1yIC7Ur" style="text-align: right" title="Gross other intangible assets"&gt;4,150,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zcSFlPvCTD52" style="text-align: right" title="Gross other intangible assets"&gt;4,150,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Customer relationships&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zGsg1YJ41Z6a" style="border-bottom: Black 1pt solid; text-align: right" title="Gross other intangible assets"&gt;3,900,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zUO0SAKgJ1j4" style="border-bottom: Black 1pt solid; text-align: right" title="Gross other intangible assets"&gt;3,900,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630_zkC0ARlF12Dk" style="text-align: right" title="Gross other intangible assets"&gt;20,314,658&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630_z6SexuNOt9df" style="text-align: right" title="Gross other intangible assets"&gt;20,507,192&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Less: Accumulated amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630_zmnZWQ2tYfRh" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization"&gt;17,444,334&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20230630_zd9g3M1lpcD6" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization"&gt;17,075,327&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630_zkfwcF55JAW2" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets-net"&gt;2,870,324&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230630_zL2qSjTom81a" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets-net"&gt;3,431,865&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zOQE8wglUrRd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The estimated amortization of other intangible assets
for the five years ending June 30, 2029 and thereafter is as follows:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zALUw94kCrH" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span id="xdx_8B0_zS5rMT1DnUo3"&gt;Schedule of other intangible assets&lt;/span&gt; For the Years Ending June 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Patents and Copyrights&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Customer Relationships&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 0pt 11pt; width: 20%; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20240630_z2zhaLeG9YAh" style="width: 19%; text-align: right" title="2025"&gt;351,882&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zucE2paX80F8" style="width: 19%; text-align: right" title="2025"&gt;151,882&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zoyvb9MaEDCc" style="width: 19%; text-align: right" title="2025"&gt;200,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;2026&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20240630_zvj8mnVqegOk" style="text-align: right" title="2026"&gt;339,179&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zVU2rNpDwL1b" style="text-align: right" title="2026"&gt;139,179&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zrJYijuNDFu2" style="text-align: right" title="2026"&gt;200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;2027&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20240630_zAHlj2WdIAe5" style="text-align: right" title="2027"&gt;326,502&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zZniJvrzVxo" style="text-align: right" title="2027"&gt;126,502&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zqeH9Pk1dTml" style="text-align: right" title="2027"&gt;200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;2028&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20240630_zXrZZsgNe8Yk" style="text-align: right" title="2028"&gt;320,232&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zjtKAMTleb85" style="text-align: right" title="2028"&gt;120,232&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyJWgNWYLOri" style="text-align: right" title="2028"&gt;200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;2029&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20240630_zcvLXcvugUPh" style="text-align: right" title="2029"&gt;313,052&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zGLJ10r989x9" style="text-align: right" title="2029"&gt;113,052&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zUbrEh1xJHrg" style="text-align: right" title="2029"&gt;200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20240630_zbUh6zNdAbIg" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"&gt;1,219,477&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zu3VCQTvoTQc" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"&gt;505,310&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zeVa6aaccMXb" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"&gt;714,167&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Other intangible assets - net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20240630_z3zOxK7AmWli" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net"&gt;2,870,324&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zGttMuYsbUQ4" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net"&gt;1,156,157&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zvLJHoyziiAb" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net"&gt;1,714,167&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A5_z1hZhXrbu854" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&#160;&lt;/p&gt;



















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The weighted average amortization period for other
intangible assets is &lt;span id="xdx_90A_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630_zIANwAAmTnoa" title="Weighted average amortization period for other intangible assets"&gt;9.9&lt;/span&gt; years and they have no expected residual value.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Information related to the above intangible assets
for the years ended June 30, 2024 and 2023 is as follows:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zFFQU4AQoQhe" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Intangle assets - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8B0_z3TpVubR3Ppe" style="display: none"&gt;Schedule of other
    intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Year-ended June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Balance &#x2013; Beginning of Year&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20230701__20240630_zuRowUPpOm92" style="width: 12%; text-align: right" title="Balance - Beginning of Year"&gt;3,431,865&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20220701__20230630_zqsUC5ramWs5" style="width: 12%; text-align: right" title="Balance - Beginning of Year"&gt;3,703,885&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Amounts capitalized&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AmountsCapitalized_pp0p0_c20230701__20240630_zh8mT33OD2Mk" style="text-align: right" title="Amounts capitalized"&gt;32,885&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--AmountsCapitalized_pp0p0_c20220701__20230630_zaeCIwycCfm5" style="text-align: right" title="Amounts capitalized"&gt;119,571&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Patents written off&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_c20230701__20240630_zynJp5KK9b49" style="text-align: right" title="Patents written off"&gt;(225,419&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_d0_c20220701__20230630_zCs18PKjwHuk" style="text-align: right" title="Patents written off"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AdjustmentForAmortization_pp0p0_c20230701__20240630_zzPIoTiTtdK1" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;(369,007&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AdjustmentForAmortization_pp0p0_c20220701__20230630_zOPGATxicSzf" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;(391,591&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Balance &#x2013; End of Year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20230701__20240630_zpfOyF6P9aPh" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance - End of Year"&gt;2,870,324&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20220701__20230630_zaSgAbRZInOf" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance - End of Year"&gt;3,431,865&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AA_z5RPc7GCOIZa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Amortization of patents and copyrights for the years
ended June 30, 2024 and 2023 amounted to $&lt;span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zPlXpGxsdT0h" title="Amortization"&gt;169,007&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220701__20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_z7UJXbSpDTXc" title="Amortization of patents and copyrights"&gt;191,591&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Amortization of customer relationships for the years
ended June 30, 2024 and 2023 amounted to $&lt;span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zqboraOBnNTh" title="Amortization"&gt;200,000&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220701__20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zLpN060Jthb2" title="Amortization of customer relationships"&gt;200,000&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001245">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zTZeAiPTZlPj" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8BD_zRldzUPfbKR5" style="display: none"&gt;Schedule of other intangible assets, net of accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Capitalized software development costs&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zHo6lKBP5wYk" style="width: 12%; text-align: right" title="Gross other intangible assets"&gt;7,004,847&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_z450GDfCMzka" style="width: 12%; text-align: right" title="Gross other intangible assets"&gt;7,004,847&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Patents and copyrights&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zVQZvLqOXcMl" style="text-align: right" title="Gross other intangible assets"&gt;5,259,811&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zpu9ss2TXRt4" style="text-align: right" title="Gross other intangible assets"&gt;5,452,345&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Non-competition agreements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zWLQ1yIC7Ur" style="text-align: right" title="Gross other intangible assets"&gt;4,150,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zcSFlPvCTD52" style="text-align: right" title="Gross other intangible assets"&gt;4,150,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Customer relationships&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zGsg1YJ41Z6a" style="border-bottom: Black 1pt solid; text-align: right" title="Gross other intangible assets"&gt;3,900,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zUO0SAKgJ1j4" style="border-bottom: Black 1pt solid; text-align: right" title="Gross other intangible assets"&gt;3,900,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630_zkC0ARlF12Dk" style="text-align: right" title="Gross other intangible assets"&gt;20,314,658&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20230630_z6SexuNOt9df" style="text-align: right" title="Gross other intangible assets"&gt;20,507,192&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Less: Accumulated amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630_zmnZWQ2tYfRh" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization"&gt;17,444,334&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20230630_zd9g3M1lpcD6" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization"&gt;17,075,327&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630_zkfwcF55JAW2" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets-net"&gt;2,870,324&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230630_zL2qSjTom81a" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets-net"&gt;3,431,865&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="0"
      id="Fact001247"
      unitRef="USD">7004847</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="0"
      id="Fact001249"
      unitRef="USD">7004847</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-06-30_custom_PatentsAndCopyrightsMember"
      decimals="0"
      id="Fact001251"
      unitRef="USD">5259811</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-06-30_custom_PatentsAndCopyrightsMember"
      decimals="0"
      id="Fact001253"
      unitRef="USD">5452345</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="0"
      id="Fact001255"
      unitRef="USD">4150000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="0"
      id="Fact001257"
      unitRef="USD">4150000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001259"
      unitRef="USD">3900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001261"
      unitRef="USD">3900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001263"
      unitRef="USD">20314658</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001265"
      unitRef="USD">20507192</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001267"
      unitRef="USD">17444334</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001269"
      unitRef="USD">17075327</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001271"
      unitRef="USD">2870324</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001273"
      unitRef="USD">3431865</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001275">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zALUw94kCrH" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span id="xdx_8B0_zS5rMT1DnUo3"&gt;Schedule of other intangible assets&lt;/span&gt; For the Years Ending June 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Patents and Copyrights&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Customer Relationships&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 0pt 11pt; width: 20%; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20240630_z2zhaLeG9YAh" style="width: 19%; text-align: right" title="2025"&gt;351,882&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zucE2paX80F8" style="width: 19%; text-align: right" title="2025"&gt;151,882&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zoyvb9MaEDCc" style="width: 19%; text-align: right" title="2025"&gt;200,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;2026&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20240630_zvj8mnVqegOk" style="text-align: right" title="2026"&gt;339,179&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zVU2rNpDwL1b" style="text-align: right" title="2026"&gt;139,179&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zrJYijuNDFu2" style="text-align: right" title="2026"&gt;200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;2027&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20240630_zAHlj2WdIAe5" style="text-align: right" title="2027"&gt;326,502&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zZniJvrzVxo" style="text-align: right" title="2027"&gt;126,502&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zqeH9Pk1dTml" style="text-align: right" title="2027"&gt;200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;2028&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20240630_zXrZZsgNe8Yk" style="text-align: right" title="2028"&gt;320,232&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zjtKAMTleb85" style="text-align: right" title="2028"&gt;120,232&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyJWgNWYLOri" style="text-align: right" title="2028"&gt;200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;2029&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20240630_zcvLXcvugUPh" style="text-align: right" title="2029"&gt;313,052&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zGLJ10r989x9" style="text-align: right" title="2029"&gt;113,052&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zUbrEh1xJHrg" style="text-align: right" title="2029"&gt;200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20240630_zbUh6zNdAbIg" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"&gt;1,219,477&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zu3VCQTvoTQc" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"&gt;505,310&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zeVa6aaccMXb" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"&gt;714,167&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Other intangible assets - net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20240630_z3zOxK7AmWli" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net"&gt;2,870,324&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zGttMuYsbUQ4" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net"&gt;1,156,157&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zvLJHoyziiAb" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net"&gt;1,714,167&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001277"
      unitRef="USD">351882</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2024-06-30_us-gaap_PatentsMember"
      decimals="0"
      id="Fact001279"
      unitRef="USD">151882</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001281"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001283"
      unitRef="USD">339179</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2024-06-30_us-gaap_PatentsMember"
      decimals="0"
      id="Fact001285"
      unitRef="USD">139179</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001287"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001289"
      unitRef="USD">326502</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2024-06-30_us-gaap_PatentsMember"
      decimals="0"
      id="Fact001291"
      unitRef="USD">126502</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001293"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001295"
      unitRef="USD">320232</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2024-06-30_us-gaap_PatentsMember"
      decimals="0"
      id="Fact001297"
      unitRef="USD">120232</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001299"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001301"
      unitRef="USD">313052</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2024-06-30_us-gaap_PatentsMember"
      decimals="0"
      id="Fact001303"
      unitRef="USD">113052</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001305"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001307"
      unitRef="USD">1219477</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="AsOf2024-06-30_us-gaap_PatentsMember"
      decimals="0"
      id="Fact001309"
      unitRef="USD">505310</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001311"
      unitRef="USD">714167</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001313"
      unitRef="USD">2870324</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2024-06-30_us-gaap_PatentsMember"
      decimals="0"
      id="Fact001315"
      unitRef="USD">1156157</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001317"
      unitRef="USD">1714167</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="From2023-07-01to2024-06-30" id="Fact001327">P9Y10M24D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001329">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zFFQU4AQoQhe" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Intangle assets - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8B0_z3TpVubR3Ppe" style="display: none"&gt;Schedule of other
    intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Year-ended June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Balance &#x2013; Beginning of Year&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20230701__20240630_zuRowUPpOm92" style="width: 12%; text-align: right" title="Balance - Beginning of Year"&gt;3,431,865&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20220701__20230630_zqsUC5ramWs5" style="width: 12%; text-align: right" title="Balance - Beginning of Year"&gt;3,703,885&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Amounts capitalized&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AmountsCapitalized_pp0p0_c20230701__20240630_zh8mT33OD2Mk" style="text-align: right" title="Amounts capitalized"&gt;32,885&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--AmountsCapitalized_pp0p0_c20220701__20230630_zaeCIwycCfm5" style="text-align: right" title="Amounts capitalized"&gt;119,571&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Patents written off&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_c20230701__20240630_zynJp5KK9b49" style="text-align: right" title="Patents written off"&gt;(225,419&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_d0_c20220701__20230630_zCs18PKjwHuk" style="text-align: right" title="Patents written off"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AdjustmentForAmortization_pp0p0_c20230701__20240630_zzPIoTiTtdK1" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;(369,007&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AdjustmentForAmortization_pp0p0_c20220701__20230630_zOPGATxicSzf" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;(391,591&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Balance &#x2013; End of Year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20230701__20240630_zpfOyF6P9aPh" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance - End of Year"&gt;2,870,324&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20220701__20230630_zaSgAbRZInOf" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance - End of Year"&gt;3,431,865&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001331"
      unitRef="USD">3431865</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="AsOf2022-06-30"
      decimals="0"
      id="Fact001333"
      unitRef="USD">3703885</us-gaap:OtherIntangibleAssetsNet>
    <FONR:AmountsCapitalized
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001335"
      unitRef="USD">32885</FONR:AmountsCapitalized>
    <FONR:AmountsCapitalized
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001337"
      unitRef="USD">119571</FONR:AmountsCapitalized>
    <FONR:SoftwareOrPatentsWrittenOff
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001339"
      unitRef="USD">-225419</FONR:SoftwareOrPatentsWrittenOff>
    <FONR:SoftwareOrPatentsWrittenOff
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001341"
      unitRef="USD">0</FONR:SoftwareOrPatentsWrittenOff>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001343"
      unitRef="USD">-369007</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001345"
      unitRef="USD">-391591</us-gaap:AdjustmentForAmortization>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001347"
      unitRef="USD">2870324</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001349"
      unitRef="USD">3431865</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-07-012024-06-30_us-gaap_PatentsMember"
      decimals="0"
      id="Fact001351"
      unitRef="USD">169007</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-07-012023-06-30_us-gaap_PatentsMember"
      decimals="0"
      id="Fact001353"
      unitRef="USD">191591</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-07-012024-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001355"
      unitRef="USD">200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-07-012023-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001357"
      unitRef="USD">200000</us-gaap:AmortizationOfIntangibleAssets>
    <FONR:CapitalStockDisclosureTextblock contextRef="From2023-07-01to2024-06-30" id="Fact001359">&lt;p id="xdx_80C_ecustom--CapitalStockDisclosureTextblock_zD1szU3WK4H2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 8 - &lt;span id="xdx_828_zJhikIMjg9na"&gt;CAPITAL STOCK&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Common Stock&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_903_eus-gaap--DividendsPayableNature_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zLrVfGdLc9W4" title="Dividends payable, nature"&gt;Cash dividends payable on the common stock shall,
in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend payable on shares of Class B common stock
and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Class B Common Stock&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_903_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zHXG2OEjuIi9" title="Conversuion of shares into one-for-one basis"&gt;Class B common stock is convertible into shares of
common stock on a one-for-one basis.&lt;/span&gt; &lt;span id="xdx_908_eus-gaap--CommonStockVotingRights_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_ztQ5eGUQqoi6" title="Common stock, voting rights"&gt;Class B common stock has 10 votes per share.&lt;/span&gt; There were &lt;span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zSjtFcfBpUNl" title="Common stock, shares outstanding"&gt;&lt;span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z2t3VxrjBu" title="Common stock, shares outstanding"&gt;146&lt;/span&gt;&lt;/span&gt; of such shares outstanding at June 30,
2024 and 2023.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;





















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Class C Common Stock&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_90A_eus-gaap--CommonStockVotingRights_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdw8lY2faNv8" title="Common stock, voting rights"&gt;The Class C common stock has 25 votes per share&lt;/span&gt;, as
compared to 10 votes per share for the Class B common stock and &lt;span id="xdx_90C_eus-gaap--CommonStockVotingRights_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zfDoUeFYeS9" title="Common stock, voting rights"&gt;one vote per share for the common stock.&lt;/span&gt; &lt;span id="xdx_902_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zL9aBo6vSOX8"&gt;The Class C common stock was
offered on a three-for-one basis to the holders of the Class B common stock.&lt;/span&gt; Although having greater voting power, each share of Class
C common stock has only one-third of the rights of a share of Class B common stock to dividends and distributions. &lt;span id="xdx_90C_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zAL9kWUwKp4i"&gt;Class C common stock
is convertible into shares of common stock on a three-for-one basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Class A Non-Voting Preferred Stock&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 3, 1995, the stockholders ratified a proposal
consisting of the creation of a new class of Class A non-voting preferred stock with special dividend rights and the declaration of a
stock dividend on the Company&#x2019;s common stock consisting of &lt;span id="xdx_907_eus-gaap--CommonStockVotingRights_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zbCGzX4Iq4Sk"&gt;one share of Class A non-voting preferred stock for every five shares
of common stock.&lt;/span&gt; &lt;span id="xdx_904_eus-gaap--DividendsPayableNature_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zo09MgJXnlRe"&gt;The stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued
pursuant to such stock dividend approximates 313,000 shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Class A non-voting preferred stock is entitled
to a special dividend equal to 3-1/4% of the first $10 million, 4-1/2% of the next $20 million and 5-1/2% on amounts in excess of $30
million of the amount of any cash awards or settlements received by the Company in connection with the enforcement of five of the Company&#x2019;s
patents in its patent lawsuits, less the revised special dividend payable on the common stock with respect to one of the Company&#x2019;s
patents.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Class A non-voting preferred stock participates
on an equal per share basis with the common stock in any dividends declared and ranks equally with the common stock on distribution rights,
liquidation rights and other rights and preferences (other than the voting rights).&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Stock Bonus Plans&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 23, 2010, the Board approved the 2010 Stock
Bonus Plan. The plan entitles the Company to reserve &lt;span id="xdx_903_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20100423__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zxlYUqSSnPd1" title="Common stock, capital shares reserved for future issuance"&gt;2,000,000&lt;/span&gt; shares of common stock. On August 10, 2010, the Company filed Form S-8
to register the &lt;span id="xdx_90A_ecustom--SharesRegistered_iI_c20100810__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zs0dmncvVWbe" title="Shares registered"&gt;2,000,000&lt;/span&gt; shares. As of June 30, 2024, &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20240630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zewLkGWB5kL7" title="Number of shares available for future grant"&gt;450,177&lt;/span&gt; shares of common stock of FONAR were available for future grant under this
plan. For the years ended June 30, 2024 and 2023, &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20230701__20240630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zUicNQ8RZAx5" title="Number of shares were issued"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20220701__20230630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zTieJANGutxj" title="Number of shares were issued"&gt;0&lt;/span&gt;&lt;/span&gt; shares were issued.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Treasury Stock&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On September 13, 2022, the Company adopted a stock
repurchase plan. The plan has no expiration date and cannot determine the number of shares which will be repurchased. On September 26,
2022, the Board of Directors has approved up to $&lt;span id="xdx_901_eus-gaap--PaymentsForRepurchaseOfEquity_pdn6_c20220925__20220926__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zd63ALfSTw93" title="Payments for repurchase of equity"&gt;9&lt;/span&gt; million to be repurchased under the plan which will be purchased on the publicly traded
open market at prevailing prices.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company utilizes the cost method of accounting
to value the treasury stock when repurchasing stock. Under this method, the shares are valued at the price paid and recorded to treasury
stock. When the treasury stock is cancelled, the par value of the stock is reduced and the additional paid in capital is reduced for the
remaining value based upon the original stock sale. For the year ended June 30, 2024, the Company purchased &lt;span id="xdx_901_eus-gaap--StockRepurchasedDuringPeriodShares_c20230701__20240630_zL2RInDExWQ9" title="Purchase of treasury shares"&gt;156,206&lt;/span&gt; shares at a cost of
$&lt;span id="xdx_90D_eus-gaap--StockRepurchasedDuringPeriodValue_pp0p0_c20230701__20240630_zh5RR7drRSFd" title="Purchase of treasury stock"&gt;2,505,832&lt;/span&gt; and cancelled &lt;span id="xdx_90F_ecustom--CancellationOfTreasuryShares_c20230701__20240630_z8qjbsWJnIjl" title="Cancellation of treasury shares"&gt;122,588&lt;/span&gt; shares valued at $&lt;span id="xdx_902_ecustom--CancellationOfTreasuryStock_c20230701__20240630_zxkEZOBtjq96" title="Cancellation of treasury stock"&gt;2,005,020&lt;/span&gt;. For the year ended June 30, 2023, the Company purchased &lt;span id="xdx_90A_eus-gaap--StockRepurchasedDuringPeriodShares_c20220701__20230630_zyt0He4RBsn9" title="Purchase of treasury shares"&gt;103,148&lt;/span&gt; shares at
a cost of $&lt;span id="xdx_907_eus-gaap--StockRepurchasedDuringPeriodValue_pp0p0_c20220701__20230630_ztYQ1MHrW7xl" title="Purchase of treasury stock"&gt;1,759,457&lt;/span&gt; and cancelled &lt;span id="xdx_900_ecustom--CancellationOfTreasuryShares_c20220701__20230630_zX8YjFScYHB9" title="Cancellation of treasury shares"&gt;103,328&lt;/span&gt; shares valued at $&lt;span id="xdx_903_ecustom--CancellationOfTreasuryStock_c20220701__20230630_z5yFAJ01Ftr9" title="Cancellation of treasury stock"&gt;1,919,027&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;















</FONR:CapitalStockDisclosureTextblock>
    <us-gaap:DividendsPayableNature
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember958666312"
      id="Fact001361">Cash dividends payable on the common stock shall,
in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend payable on shares of Class B common stock
and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common stock.</us-gaap:DividendsPayableNature>
    <us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare
      contextRef="From2023-07-012024-06-30_us-gaap_CommonClassBMember"
      id="Fact001363">Class B common stock is convertible into shares of
common stock on a one-for-one basis.</us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare>
    <us-gaap:CommonStockVotingRights
      contextRef="From2023-07-012024-06-30_us-gaap_CommonClassBMember"
      id="Fact001365">Class B common stock has 10 votes per share.</us-gaap:CommonStockVotingRights>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact001367"
      unitRef="Shares">146</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact001369"
      unitRef="Shares">146</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockVotingRights
      contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember"
      id="Fact001380">The Class C common stock has 25 votes per share</us-gaap:CommonStockVotingRights>
    <us-gaap:CommonStockVotingRights
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember958666312"
      id="Fact001382">one vote per share for the common stock.</us-gaap:CommonStockVotingRights>
    <us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare
      contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember"
      id="Fact001383">The Class C common stock was
offered on a three-for-one basis to the holders of the Class B common stock.</us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare>
    <us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember958666312"
      id="Fact001384">Class C common stock
is convertible into shares of common stock on a three-for-one basis.</us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare>
    <us-gaap:CommonStockVotingRights
      contextRef="From2023-07-012024-06-30_us-gaap_PreferredClassAMember"
      id="Fact001385">one share of Class A non-voting preferred stock for every five shares
of common stock.</us-gaap:CommonStockVotingRights>
    <us-gaap:DividendsPayableNature
      contextRef="From2023-07-012024-06-30_us-gaap_PreferredClassAMember"
      id="Fact001386">The stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued
pursuant to such stock dividend approximates 313,000 shares.</us-gaap:DividendsPayableNature>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2010-04-23_custom_N2010StockBonusPlanMember"
      decimals="INF"
      id="Fact001388"
      unitRef="Shares">2000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <FONR:SharesRegistered
      contextRef="AsOf2010-08-10_custom_N2010StockBonusPlanMember"
      decimals="INF"
      id="Fact001390"
      unitRef="Shares">2000000</FONR:SharesRegistered>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2024-06-30_custom_N2010StockBonusPlanMember"
      decimals="INF"
      id="Fact001392"
      unitRef="Shares">450177</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="From2023-07-012024-06-30_custom_N2010StockBonusPlanMember"
      decimals="INF"
      id="Fact001394"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="From2022-07-012023-06-30_custom_N2010StockBonusPlanMember"
      decimals="INF"
      id="Fact001396"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:PaymentsForRepurchaseOfEquity
      contextRef="From2022-09-252022-09-26_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="Fact001406"
      unitRef="USD">9000000</us-gaap:PaymentsForRepurchaseOfEquity>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001408"
      unitRef="Shares">156206</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001410"
      unitRef="USD">2505832</us-gaap:StockRepurchasedDuringPeriodValue>
    <FONR:CancellationOfTreasuryShares
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001412"
      unitRef="Shares">122588</FONR:CancellationOfTreasuryShares>
    <FONR:CancellationOfTreasuryStock
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001414"
      unitRef="USD">2005020</FONR:CancellationOfTreasuryStock>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001416"
      unitRef="Shares">103148</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001418"
      unitRef="USD">1759457</us-gaap:StockRepurchasedDuringPeriodValue>
    <FONR:CancellationOfTreasuryShares
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001420"
      unitRef="Shares">103328</FONR:CancellationOfTreasuryShares>
    <FONR:CancellationOfTreasuryStock
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001422"
      unitRef="USD">1919027</FONR:CancellationOfTreasuryStock>
    <us-gaap:MinorityInterestDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001430">&lt;p id="xdx_801_eus-gaap--MinorityInterestDisclosureTextBlock_zs3umEEjdeL7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;b&gt;NOTE 9 &#x2013; &lt;span id="xdx_82A_zn0ptgZX6le3"&gt;CONTROLLING AND NONCONTROLLING
INTERESTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On February 13, 2013, the Company entered into an
agreement with outside investors to acquire a 50.5% controlling interest in a newly formed limited liability company, Health Diagnostics
Management LLC (HDM). According to the February 13, 2013, LLC operating agreement of HDM there are two classes of members; Class A members
and one Class B member. The Class A members have an ownership interest of &lt;span id="xdx_904_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_zmnAJQhrNIJ8" title="Ownership interest"&gt;49.5&lt;/span&gt;% of HDM. The Class B member (HMCA) has an ownership of
&lt;span id="xdx_90C_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember_zDQrufwjbrB1" title="Ownership percenatge"&gt;50.5&lt;/span&gt;% of HDM. On all matters on which members may vote every member is entitled to cast the percentage of votes equal to their percentage
of ownership interest. Profits and losses on all items of income, gain or loss, deductions or other allocations of the Company will be
allocated among the members in the same proportions as their membership interests in the Company bear to all the Class A and Class B membership
interests of the Company in the aggregate outstanding. All of the depreciation and amortization of the assets of the Company will be allocated
solely to the Class A members, unless and until their interests have been redeemed by the Company in full pursuant to the provisions of
the operating agreement. The Company contributed $&lt;span id="xdx_902_ecustom--ProceedsFromContributionsFromCompany_pp0p0_c20130212__20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember_zYW9Dqv6WFul" title="Company contribution"&gt;20,200,000&lt;/span&gt; to HDM and the group of outside investors contributed $&lt;span id="xdx_900_eus-gaap--ProceedsFromContributionsFromAffiliates_pp0p0_c20130212__20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_zb14mRksmjc5" title="Investors contribution"&gt;19,800,000&lt;/span&gt; for its
non-controlling membership interest.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 5, 2013, HDM purchased from Health Diagnostics,
LLC (&#x201c;HD&#x201d;) and certain of its subsidiaries, a business managing twelve (&lt;span id="xdx_909_ecustom--PurchaseOfStandupMriCenters_iI_uInteger_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zkIdegjdxrU9" title="Purchase of stand up MRI centers"&gt;12&lt;/span&gt;) Stand-Up MRI Centers and two (&lt;span id="xdx_90E_ecustom--PurchaseOfOtherMriCenters_iI_uInteger_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zP7e7nvsGKig" title="Purchase of other MRI centers"&gt;2&lt;/span&gt;) other scanning
centers located in the States of New York and Florida for a total purchase price (including consideration of $&lt;span id="xdx_903_ecustom--ConsiderationToOutsideInvestors_iI_pn5n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zUur4HS6hQ5k" title="HDM purchase price includes consideration to outside investors"&gt;1.5&lt;/span&gt; million to outside investors)
aggregating $&lt;span id="xdx_907_ecustom--TotalPurchasePrice_iI_pn5n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zfoEHPjghhfg" title="HDM purchase from Health Diagnostics (HD) ($)"&gt;35.9&lt;/span&gt; million. Concurrently with the acquisition, HDM entered into several consulting and non-competition agreements for a
consideration of $&lt;span id="xdx_900_ecustom--ConsiderationForNoncompetitionAndConsultingAgreements_iI_pn5n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zcwLY6zvZ4A7" title="HDM entered agreement for consulting and non-competition agreement ($)"&gt;4.1&lt;/span&gt; million. The acquisition was accounted for using the purchase method in accordance with ASC 805, &#x201c;Business
Combinations&#x201d;. The Company recognized and measured goodwill as of the acquisition date, as the excess of the fair value of the consideration
paid over the fair value of the identified net assets acquired.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On January 8, 2015, the Company purchased &lt;span id="xdx_907_ecustom--EquityMethodInvestmentsOwnershipPercentage_iI_dp_c20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zQyErlqKzwF" title="Purchase of interests from Class A,  percentage"&gt;20&lt;/span&gt;%
of the Class A members ownership interest at a cost of $&lt;span id="xdx_90C_ecustom--DirectPurchaseOfNoncontrollingInterests_c20150107__20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zlUWeSmllwA3" title="Purchase of interests from Class A"&gt;4,971,094&lt;/span&gt;. The Company has a &lt;span id="xdx_909_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zI5klHa894oj" title="Ownership interest in HDM"&gt;60.4&lt;/span&gt;% ownership interest in HDM after this transaction.
During the year ended June 30, 2022, the Company purchased noncontrolling interests for $&lt;span id="xdx_90A_ecustom--DirectPurchaseOfNoncontrollingInterests_c20220701__20230630__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_z4gbFFBihfKg" title="Purchase of interests from Class A"&gt;546,000&lt;/span&gt; giving the Company a direct ownership
interest of &lt;span id="xdx_908_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20230630__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_z2mseZiMkMp6" title="Ownership interest of company"&gt;70.8&lt;/span&gt;% and the investors&#x2019; a &lt;span id="xdx_901_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20230630__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_zrOgXXUzdfLl" title="Ownership interest of investors"&gt;29.2&lt;/span&gt;% ownership interest.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The amount of each class of HDM members&#x2019; equity
as of June 30, 2024 and 2023 is as follows:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zKcjhoIk1oE5" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;&lt;span id="xdx_8B6_zPPYXjlVbfU6" style="display: none"&gt;Schedule of HDM members equity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class A Members&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class B Member&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class A Members&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class B Member&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 40%; text-align: left; text-indent: -11pt"&gt;Opening Members&#x2019; Equity&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;($&lt;/td&gt;&lt;td id="xdx_98B_ecustom--OpeningMembersEquity_iI_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zBrXOeaQEJwc" style="width: 10%; text-align: right" title="Opening Members Equity"&gt;7,079,293&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--OpeningMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_z4Zn1ILvbg73" style="width: 10%; text-align: right" title="Opening Members Equity"&gt;54,781,813&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;($&lt;/td&gt;&lt;td id="xdx_98F_ecustom--OpeningMembersEquity_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zGlkxvIQK5Kg" style="width: 10%; text-align: right" title="Opening Members Equity"&gt;4,053,833&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--OpeningMembersEquity_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zyBUIwmC4wYk" style="width: 10%; text-align: right" title="Opening Members Equity"&gt;50,292,073&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Share of Net Income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShareOfNetIncome_iI_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zYqKH0W5ebKf" style="text-align: right" title="Share of Net Income"&gt;3,530,021&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareOfNetIncome_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zdz67QBQ0yl9" style="text-align: right" title="Share of Net Income"&gt;20,705,681&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareOfNetIncome_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zSlaohGV2h4c" style="text-align: right" title="Share of Net Income"&gt;2,750,740&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareOfNetIncome_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zlT3nROLK6m8" style="text-align: right" title="Share of Net Income"&gt;18,513,540&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Buyout of noncontrolling interests&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zwpPHKapcr12" style="text-align: right" title="Buyout of noncontrolling interests"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zX1yBm6E3Y2k" style="text-align: right" title="Buyout of noncontrolling interests"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z98PGEPUkOv5" style="text-align: right" title="Buyout of noncontrolling interests"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zlk1aGDOh0Oj" style="text-align: right" title="Buyout of noncontrolling interests"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Distributions&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;($&lt;/td&gt;&lt;td id="xdx_984_ecustom--Distributions_iI_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z5zqKPDZWYsf" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"&gt;5,630,336&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--Distributions_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_z7b6UFqLQgo" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"&gt;(13,669,664&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;($&lt;/td&gt;&lt;td id="xdx_985_ecustom--Distributions_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zPHCdZMK2cBg" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"&gt;5,776,200&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--Distributions_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zdchjKdL0Ezl" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"&gt;(14,023,800&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Ending Members&#x2019; Equity&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;($&lt;/td&gt;&lt;td id="xdx_98D_ecustom--EndingMembersEquity_iI_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zKBuYx21MFQ7" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"&gt;9,179,608&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--EndingMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zbZexYRUnqP2" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"&gt;61,817,830&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;($&lt;/td&gt;&lt;td id="xdx_984_ecustom--EndingMembersEquity_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zItXO6WH3voi" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"&gt;7,079,293&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--EndingMembersEquity_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zf5BC2bLsAnl" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"&gt;54,781,813&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;/p&gt;















</us-gaap:MinorityInterestDisclosureTextBlock>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="AsOf2013-02-13_custom_HDMMember_custom_ClassAControllingInterestsMember"
      decimals="INF"
      id="Fact001432"
      unitRef="Pure">0.495</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <FONR:EquityMethodInvestmentOwnershipPercentages
      contextRef="AsOf2013-02-13_custom_HDMMember_custom_ClassBControllingInterestsMember"
      decimals="INF"
      id="Fact001434"
      unitRef="Pure">0.505</FONR:EquityMethodInvestmentOwnershipPercentages>
    <FONR:ProceedsFromContributionsFromCompany
      contextRef="From2013-02-122013-02-13_custom_HDMMember_custom_ClassBControllingInterestsMember"
      decimals="0"
      id="Fact001436"
      unitRef="USD">20200000</FONR:ProceedsFromContributionsFromCompany>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="From2013-02-122013-02-13_custom_HDMMember_custom_ClassAControllingInterestsMember"
      decimals="0"
      id="Fact001438"
      unitRef="USD">19800000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <FONR:PurchaseOfStandupMriCenters
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="INF"
      id="Fact001440"
      unitRef="Integer">12</FONR:PurchaseOfStandupMriCenters>
    <FONR:PurchaseOfOtherMriCenters
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="INF"
      id="Fact001442"
      unitRef="Integer">2</FONR:PurchaseOfOtherMriCenters>
    <FONR:ConsiderationToOutsideInvestors
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="-5"
      id="Fact001444"
      unitRef="USD">1500000</FONR:ConsiderationToOutsideInvestors>
    <FONR:TotalPurchasePrice
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="-5"
      id="Fact001446"
      unitRef="USD">35900000</FONR:TotalPurchasePrice>
    <FONR:ConsiderationForNoncompetitionAndConsultingAgreements
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="-5"
      id="Fact001448"
      unitRef="USD">4100000</FONR:ConsiderationForNoncompetitionAndConsultingAgreements>
    <FONR:EquityMethodInvestmentsOwnershipPercentage
      contextRef="AsOf2015-01-08_custom_ClassAControllingInterestsMember_custom_HDMMember"
      decimals="INF"
      id="Fact001450"
      unitRef="Pure">0.20</FONR:EquityMethodInvestmentsOwnershipPercentage>
    <FONR:DirectPurchaseOfNoncontrollingInterests
      contextRef="From2015-01-072015-01-08_custom_ClassAControllingInterestsMember_custom_HDMMember"
      decimals="0"
      id="Fact001452"
      unitRef="USD">4971094</FONR:DirectPurchaseOfNoncontrollingInterests>
    <FONR:EquityMethodInvestmentOwnershipPercentages
      contextRef="AsOf2015-01-08_custom_ClassAControllingInterestsMember_custom_HDMMember"
      decimals="INF"
      id="Fact001454"
      unitRef="Pure">0.604</FONR:EquityMethodInvestmentOwnershipPercentages>
    <FONR:DirectPurchaseOfNoncontrollingInterests
      contextRef="From2022-07-012023-06-30_custom_ClassAControllingInterestsMember_custom_HDMMember"
      decimals="0"
      id="Fact001456"
      unitRef="USD">546000</FONR:DirectPurchaseOfNoncontrollingInterests>
    <FONR:EquityMethodInvestmentOwnershipPercentages
      contextRef="AsOf2023-06-30_custom_ClassAControllingInterestsMember_custom_HDMMember"
      decimals="INF"
      id="Fact001458"
      unitRef="Pure">0.708</FONR:EquityMethodInvestmentOwnershipPercentages>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="AsOf2023-06-30_custom_HDMMember_custom_ClassAControllingInterestsMember"
      decimals="INF"
      id="Fact001460"
      unitRef="Pure">0.292</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:RedeemableNoncontrollingInterestTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001462">&lt;table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zKcjhoIk1oE5" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;&lt;span id="xdx_8B6_zPPYXjlVbfU6" style="display: none"&gt;Schedule of HDM members equity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class A Members&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class B Member&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class A Members&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class B Member&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 40%; text-align: left; text-indent: -11pt"&gt;Opening Members&#x2019; Equity&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;($&lt;/td&gt;&lt;td id="xdx_98B_ecustom--OpeningMembersEquity_iI_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zBrXOeaQEJwc" style="width: 10%; text-align: right" title="Opening Members Equity"&gt;7,079,293&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--OpeningMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_z4Zn1ILvbg73" style="width: 10%; text-align: right" title="Opening Members Equity"&gt;54,781,813&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;($&lt;/td&gt;&lt;td id="xdx_98F_ecustom--OpeningMembersEquity_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zGlkxvIQK5Kg" style="width: 10%; text-align: right" title="Opening Members Equity"&gt;4,053,833&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--OpeningMembersEquity_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zyBUIwmC4wYk" style="width: 10%; text-align: right" title="Opening Members Equity"&gt;50,292,073&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Share of Net Income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShareOfNetIncome_iI_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zYqKH0W5ebKf" style="text-align: right" title="Share of Net Income"&gt;3,530,021&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareOfNetIncome_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zdz67QBQ0yl9" style="text-align: right" title="Share of Net Income"&gt;20,705,681&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareOfNetIncome_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zSlaohGV2h4c" style="text-align: right" title="Share of Net Income"&gt;2,750,740&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareOfNetIncome_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zlT3nROLK6m8" style="text-align: right" title="Share of Net Income"&gt;18,513,540&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Buyout of noncontrolling interests&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zwpPHKapcr12" style="text-align: right" title="Buyout of noncontrolling interests"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zX1yBm6E3Y2k" style="text-align: right" title="Buyout of noncontrolling interests"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z98PGEPUkOv5" style="text-align: right" title="Buyout of noncontrolling interests"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zlk1aGDOh0Oj" style="text-align: right" title="Buyout of noncontrolling interests"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Distributions&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;($&lt;/td&gt;&lt;td id="xdx_984_ecustom--Distributions_iI_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z5zqKPDZWYsf" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"&gt;5,630,336&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--Distributions_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_z7b6UFqLQgo" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"&gt;(13,669,664&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;($&lt;/td&gt;&lt;td id="xdx_985_ecustom--Distributions_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zPHCdZMK2cBg" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"&gt;5,776,200&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--Distributions_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zdchjKdL0Ezl" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"&gt;(14,023,800&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Ending Members&#x2019; Equity&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;($&lt;/td&gt;&lt;td id="xdx_98D_ecustom--EndingMembersEquity_iI_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zKBuYx21MFQ7" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"&gt;9,179,608&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--EndingMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zbZexYRUnqP2" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"&gt;61,817,830&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;($&lt;/td&gt;&lt;td id="xdx_984_ecustom--EndingMembersEquity_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zItXO6WH3voi" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"&gt;7,079,293&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--EndingMembersEquity_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zf5BC2bLsAnl" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"&gt;54,781,813&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:RedeemableNoncontrollingInterestTableTextBlock>
    <FONR:OpeningMembersEquity
      contextRef="AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001464"
      unitRef="USD">7079293</FONR:OpeningMembersEquity>
    <FONR:OpeningMembersEquity
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001466"
      unitRef="USD">54781813</FONR:OpeningMembersEquity>
    <FONR:OpeningMembersEquity
      contextRef="AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001468"
      unitRef="USD">4053833</FONR:OpeningMembersEquity>
    <FONR:OpeningMembersEquity
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001470"
      unitRef="USD">50292073</FONR:OpeningMembersEquity>
    <FONR:ShareOfNetIncome
      contextRef="AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001472"
      unitRef="USD">3530021</FONR:ShareOfNetIncome>
    <FONR:ShareOfNetIncome
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001474"
      unitRef="USD">20705681</FONR:ShareOfNetIncome>
    <FONR:ShareOfNetIncome
      contextRef="AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001476"
      unitRef="USD">2750740</FONR:ShareOfNetIncome>
    <FONR:ShareOfNetIncome
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001478"
      unitRef="USD">18513540</FONR:ShareOfNetIncome>
    <FONR:BuyoutOfNoncontrollingInterestsValue
      contextRef="AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001480"
      unitRef="USD">0</FONR:BuyoutOfNoncontrollingInterestsValue>
    <FONR:BuyoutOfNoncontrollingInterestsValue
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001482"
      unitRef="USD">0</FONR:BuyoutOfNoncontrollingInterestsValue>
    <FONR:BuyoutOfNoncontrollingInterestsValue
      contextRef="AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001484"
      unitRef="USD">0</FONR:BuyoutOfNoncontrollingInterestsValue>
    <FONR:BuyoutOfNoncontrollingInterestsValue
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001486"
      unitRef="USD">0</FONR:BuyoutOfNoncontrollingInterestsValue>
    <FONR:Distributions
      contextRef="AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001488"
      unitRef="USD">5630336</FONR:Distributions>
    <FONR:Distributions
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001490"
      unitRef="USD">-13669664</FONR:Distributions>
    <FONR:Distributions
      contextRef="AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001492"
      unitRef="USD">5776200</FONR:Distributions>
    <FONR:Distributions
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001494"
      unitRef="USD">-14023800</FONR:Distributions>
    <FONR:EndingMembersEquity
      contextRef="AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001496"
      unitRef="USD">9179608</FONR:EndingMembersEquity>
    <FONR:EndingMembersEquity
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001498"
      unitRef="USD">61817830</FONR:EndingMembersEquity>
    <FONR:EndingMembersEquity
      contextRef="AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001500"
      unitRef="USD">7079293</FONR:EndingMembersEquity>
    <FONR:EndingMembersEquity
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001502"
      unitRef="USD">54781813</FONR:EndingMembersEquity>
    <FONR:LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001510">&lt;p id="xdx_80A_ecustom--LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock_zQ0vH4QulR5j" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 10 - &lt;span id="xdx_82F_zHnhBzj6k18h"&gt;LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL
LEASES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Long-term debt, notes payable and capital leases consist
of the following:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfDebtTableTextBlock_zQd3FnJ62l5h" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 11pt; text-align: center; text-indent: -11pt"&gt;&lt;span id="xdx_8B8_zTOADzhp4Yxf" style="display: none"&gt;Schedule of long-term debt, notes payable and capital leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Note payable requiring monthly payments of interest at a rate of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_909_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zCoNuW4lw4Rh" title="Interest rate"&gt;7&lt;/span&gt;% until May 2009 followed by &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_907_ecustom--MonthlyPaymentPeriod_dtM_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zEfEk1ny04yb" title="Monthly payment period"&gt;240&lt;/span&gt; monthly payments of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90A_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zzqajwERB2m8" title="Debt instrument, periodic payment"&gt;4,472&lt;/span&gt; through &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_904_ecustom--MaturityDate_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zvmge24Fcs0b" title="Maturity date"&gt;October 2026&lt;/span&gt;. The loan is collateralized by a building with a net book value of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_907_ecustom--BookValueOfBuilding_iI_pp0p0_c20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zzp5O41HW52k" title="Book value of building"&gt;310,827&lt;/span&gt; as of June 30, 2024.&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LongTermDebt_iI_pp0p0_c20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zbUgTaZIhN53" style="width: 12%; text-align: right" title="Long term debt current"&gt;113,940&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--LongTermDebt_iI_pp0p0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zDuORGkrKj52" style="width: 12%; text-align: right" title="Long term debt current"&gt;158,842&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;The revolving credit note was extended to November 14, 2024. The Company can borrow up to $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_908_eus-gaap--ProceedsFromLinesOfCredit_pp0p0_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zdj4WL0iZapd" title="Proceeds from lines of credit"&gt;10,000,000&lt;/span&gt; and prepay the loan in whole or part in multiples of $100,000 at any time without penalty. The note bears interest at a rate of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_901_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_z7tulAvfFHJh" title="Interest rate"&gt;8.5&lt;/span&gt;% per annum and is payable monthly. The loan is collateralized by substantially all of the Company&#x2019;s assets. The loan also contains certain financial covenants that must be met on a periodic basis. The Company still has the ability to draw down on the line.&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LongTermDebt_iI_pp0p0_d0_c20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zpXEHFFS9VQ2" style="border-bottom: Black 1pt solid; text-align: right" title="Long term debt current"&gt;&#x2014;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--LongTermDebt_iI_pp0p0_d0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zAKwtNt9oiD5" style="border-bottom: Black 1pt solid; text-align: right" title="Long term debt current"&gt;&#x2014;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LongTermDebt_iI_pp0p0_c20240630_zcvkeYpicsM" style="text-align: right" title="Long term debt, notes payable and capital leases"&gt;113,940&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LongTermDebt_iI_pp0p0_c20230630_zuxIcoMpqRM3" style="text-align: right" title="Long term debt, notes payable and capital leases"&gt;158,842&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Less: Current portion&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_iI_pp0p0_c20240630_znlIwV9UoGta" style="border-bottom: Black 1pt solid; text-align: right" title="Current portion of long term debt, notes payable and capital leases"&gt;47,002&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_iI_pp0p0_c20230630_zEnznTi3X4zd" style="border-bottom: Black 1pt solid; text-align: right" title="Current portion of long term debt, notes payable and capital leases"&gt;43,767&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LongTermDebtAndCapitalLeaseObligations_iI_pp0p0_c20240630_ziLKPxsGuGtl" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term debt, notes payable and capital leases less current portion"&gt;66,938&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LongTermDebtAndCapitalLeaseObligations_iI_pp0p0_c20230630_zdnuz2CUgs9l" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term debt, notes payable and capital leases less current portion"&gt;115,075&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A4_zakCJzmO0Ri" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The maturities of debt over the next three years are
as follows:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zpq2vdDgH7uh" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities of long term debt over 5 years - (Details)"&gt; &lt;tr style="vertical-align: bottom"&gt;

    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B7_zTuYv98oVxkd" style="display: none"&gt;Schedule of maturities of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Years Ending June 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 76%; text-align: left; text-indent: -11pt"&gt;2025&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_pp0p0_c20240630_zvpfG79G2mDa" style="width: 12%; text-align: right" title="2024"&gt;47,002&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_pp0p0_c20240630_z24gB1xe98dd" style="text-align: right" title="2025"&gt;50,448&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;2027&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_pp0p0_c20240630_zUrn8wDlhbU9" style="border-bottom: Black 1pt solid; text-align: right" title="2026"&gt;16,490&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; color: white; text-align: left; text-indent: -11pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif; text-decoration: none; color: Black; vertical-align: baseline"&gt;Long-Term
    Debt Over Five Years and Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LongTermDebt_iI_c20240630_zGxdSee5wQ13" style="border-bottom: Black 2.5pt double; text-align: right" title="Total long term debt"&gt;113,940&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A2_zVNQBoyGmDPf" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;















</FONR:LongTermDebtNotesPayableAndCapitalLeasesDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001512">&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfDebtTableTextBlock_zQd3FnJ62l5h" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 11pt; text-align: center; text-indent: -11pt"&gt;&lt;span id="xdx_8B8_zTOADzhp4Yxf" style="display: none"&gt;Schedule of long-term debt, notes payable and capital leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Note payable requiring monthly payments of interest at a rate of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_909_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zCoNuW4lw4Rh" title="Interest rate"&gt;7&lt;/span&gt;% until May 2009 followed by &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_907_ecustom--MonthlyPaymentPeriod_dtM_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zEfEk1ny04yb" title="Monthly payment period"&gt;240&lt;/span&gt; monthly payments of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90A_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zzqajwERB2m8" title="Debt instrument, periodic payment"&gt;4,472&lt;/span&gt; through &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_904_ecustom--MaturityDate_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zvmge24Fcs0b" title="Maturity date"&gt;October 2026&lt;/span&gt;. The loan is collateralized by a building with a net book value of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_907_ecustom--BookValueOfBuilding_iI_pp0p0_c20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zzp5O41HW52k" title="Book value of building"&gt;310,827&lt;/span&gt; as of June 30, 2024.&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LongTermDebt_iI_pp0p0_c20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zbUgTaZIhN53" style="width: 12%; text-align: right" title="Long term debt current"&gt;113,940&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--LongTermDebt_iI_pp0p0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zDuORGkrKj52" style="width: 12%; text-align: right" title="Long term debt current"&gt;158,842&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;The revolving credit note was extended to November 14, 2024. The Company can borrow up to $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_908_eus-gaap--ProceedsFromLinesOfCredit_pp0p0_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zdj4WL0iZapd" title="Proceeds from lines of credit"&gt;10,000,000&lt;/span&gt; and prepay the loan in whole or part in multiples of $100,000 at any time without penalty. The note bears interest at a rate of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIExPTkctVEVSTSBERUJULCBOT1RFUyBQQVlBQkxFIEFORCBDQVBJVEFMIExFQVNFUyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_901_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20230701__20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_z7tulAvfFHJh" title="Interest rate"&gt;8.5&lt;/span&gt;% per annum and is payable monthly. The loan is collateralized by substantially all of the Company&#x2019;s assets. The loan also contains certain financial covenants that must be met on a periodic basis. The Company still has the ability to draw down on the line.&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LongTermDebt_iI_pp0p0_d0_c20240630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zpXEHFFS9VQ2" style="border-bottom: Black 1pt solid; text-align: right" title="Long term debt current"&gt;&#x2014;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--LongTermDebt_iI_pp0p0_d0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zAKwtNt9oiD5" style="border-bottom: Black 1pt solid; text-align: right" title="Long term debt current"&gt;&#x2014;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LongTermDebt_iI_pp0p0_c20240630_zcvkeYpicsM" style="text-align: right" title="Long term debt, notes payable and capital leases"&gt;113,940&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LongTermDebt_iI_pp0p0_c20230630_zuxIcoMpqRM3" style="text-align: right" title="Long term debt, notes payable and capital leases"&gt;158,842&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Less: Current portion&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_iI_pp0p0_c20240630_znlIwV9UoGta" style="border-bottom: Black 1pt solid; text-align: right" title="Current portion of long term debt, notes payable and capital leases"&gt;47,002&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_iI_pp0p0_c20230630_zEnznTi3X4zd" style="border-bottom: Black 1pt solid; text-align: right" title="Current portion of long term debt, notes payable and capital leases"&gt;43,767&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LongTermDebtAndCapitalLeaseObligations_iI_pp0p0_c20240630_ziLKPxsGuGtl" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term debt, notes payable and capital leases less current portion"&gt;66,938&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LongTermDebtAndCapitalLeaseObligations_iI_pp0p0_c20230630_zdnuz2CUgs9l" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term debt, notes payable and capital leases less current portion"&gt;115,075&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2023-07-012024-06-30_custom_NotePayable1Member"
      decimals="INF"
      id="Fact001514"
      unitRef="Pure">0.07</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <FONR:MonthlyPaymentPeriod
      contextRef="From2023-07-012024-06-30_custom_NotePayable1Member"
      id="Fact001516">P240M</FONR:MonthlyPaymentPeriod>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2023-07-012024-06-30_custom_NotePayable1Member"
      decimals="0"
      id="Fact001518"
      unitRef="USD">4472</us-gaap:DebtInstrumentPeriodicPayment>
    <FONR:MaturityDate
      contextRef="From2023-07-012024-06-30_custom_NotePayable1Member"
      id="Fact001520">October 2026</FONR:MaturityDate>
    <FONR:BookValueOfBuilding
      contextRef="AsOf2024-06-30_custom_NotePayable1Member"
      decimals="0"
      id="Fact001522"
      unitRef="USD">310827</FONR:BookValueOfBuilding>
    <us-gaap:LongTermDebt
      contextRef="AsOf2024-06-30_custom_NotePayable1Member"
      decimals="0"
      id="Fact001524"
      unitRef="USD">113940</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2023-06-30_custom_NotePayable1Member"
      decimals="0"
      id="Fact001526"
      unitRef="USD">158842</us-gaap:LongTermDebt>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="From2023-07-012024-06-30_custom_NotePayable2Member"
      decimals="0"
      id="Fact001528"
      unitRef="USD">10000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2023-07-012024-06-30_custom_NotePayable2Member"
      decimals="INF"
      id="Fact001530"
      unitRef="Pure">0.085</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LongTermDebt
      contextRef="AsOf2024-06-30_custom_NotePayable2Member"
      decimals="0"
      id="Fact001532"
      unitRef="USD">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2023-06-30_custom_NotePayable2Member"
      decimals="0"
      id="Fact001534"
      unitRef="USD">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001536"
      unitRef="USD">113940</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001538"
      unitRef="USD">158842</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001540"
      unitRef="USD">47002</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001542"
      unitRef="USD">43767</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001544"
      unitRef="USD">66938</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001546"
      unitRef="USD">115075</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001548">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zpq2vdDgH7uh" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities of long term debt over 5 years - (Details)"&gt; &lt;tr style="vertical-align: bottom"&gt;

    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B7_zTuYv98oVxkd" style="display: none"&gt;Schedule of maturities of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Years Ending June 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 76%; text-align: left; text-indent: -11pt"&gt;2025&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_pp0p0_c20240630_zvpfG79G2mDa" style="width: 12%; text-align: right" title="2024"&gt;47,002&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_pp0p0_c20240630_z24gB1xe98dd" style="text-align: right" title="2025"&gt;50,448&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;2027&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_pp0p0_c20240630_zUrn8wDlhbU9" style="border-bottom: Black 1pt solid; text-align: right" title="2026"&gt;16,490&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; color: white; text-align: left; text-indent: -11pt"&gt;&lt;span style="font: normal 11pt Times New Roman, Times, Serif; text-decoration: none; color: Black; vertical-align: baseline"&gt;Long-Term
    Debt Over Five Years and Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LongTermDebt_iI_c20240630_zGxdSee5wQ13" style="border-bottom: Black 2.5pt double; text-align: right" title="Total long term debt"&gt;113,940&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001550"
      unitRef="USD">47002</us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001552"
      unitRef="USD">50448</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001554"
      unitRef="USD">16490</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebt
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001556"
      unitRef="USD">113940</us-gaap:LongTermDebt>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001564">&lt;p id="xdx_80A_eus-gaap--IncomeTaxDisclosureTextBlock_zGLmlguh1OA8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 11 - &lt;span id="xdx_825_z8VWpc9FtsZk"&gt;INCOME TAXES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;The Company has recorded a deferred tax
asset of $&lt;span id="xdx_906_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_c20240630_zbP3UzWjg9v5" title="Deferred tax asset"&gt;7,223,255&lt;/span&gt;
and a deferred tax liability of $&lt;span id="xdx_909_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_iI_pp0p0_c20240630_zj2S1M07nD99" title="Deferred tax liability"&gt;371,560&lt;/span&gt;
as of June 30, 2024, primarily relating to its allowance for credit losses of $3,970,000 and tax credits of approximately $&lt;span id="xdx_907_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20240630_zjNfDjOdaXIc" title="Allowance for doubtful accounts and tax credits"&gt;1,323,000&lt;/span&gt;
available to offset future taxable income through 2043. During fiscal 2024, the Company utilized all Federal loss carryforwards. In
addition the Company has state operating loss carryforwards of approximately $&lt;span id="xdx_90F_eus-gaap--OperatingIncomeLoss_pp0p0_c20230701__20240630_zPecr9kFqVu" title="State operating loss carryforwards"&gt;4,516,000&lt;/span&gt;
and city operating loss carryforwards of approximately $&lt;span id="xdx_906_eus-gaap--OtherOperatingIncome_pp0p0_c20230701__20240630_z3KFShJTBQRe" title="City operating loss carryforwards"&gt;618,000&lt;/span&gt;.
The net operating losses begin to expire in 2026 for state income tax purposes. The Company has also recorded a valuation allowance
against $&lt;span id="xdx_90E_eus-gaap--OperatingLossCarryforwardsValuationAllowance_iI_pp0p0_c20240630_zRE0FmCB4E8c" title="Valuation allowance of state operating losses"&gt;2,746,000&lt;/span&gt;
of the state operating losses since the Company doesn&#x2019;t anticipate being able to utilize them.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company files corporate income tax returns in
the United States (federal) and in various state and local jurisdictions. In most instances, the Company is no longer subject to federal,
state and local income tax examinations by tax authorities for years prior to 2020.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Future ownership changes as determined under Section
382 of the Internal Revenue code could further limit the utilization of net operating loss carryforwards. As of June 30, 2024, no such
changes in ownership have occurred.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Inflation Reduction Act (&#x201c;IRA&#x201d;) was
enacted on August 16, 2022. The IRA includes provisions imposing a &lt;span id="xdx_907_ecustom--PercentageOfExciseTax_dp_c20230701__20240630_zxikkdOY9Wj2" title="Percentage of excise tax"&gt;1&lt;/span&gt;% excise tax on share repurchases that occur after December 31, 2022
and introduces a &lt;span id="xdx_905_ecustom--CorporateAlternativeMinimumTaxPercentage_dp_c20230701__20240630_zL6GqyTjidY4" title="Corporate alternative minimum tax percentage"&gt;15&lt;/span&gt;%&#160;corporate alternative minimum tax (&#x201c;CAMT&#x201d;) on adjusted financial statement income. The CAMT will
be effective for tax years beginning after December 31, 2022. Currently, the IRA did not have a material impact to the Company&#x2019;s
financial statements.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The valuation allowance for deferred tax assets decreased
during the year ended June 30, 2024, by approximately $&lt;span id="xdx_908_eus-gaap--DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_iI_pp0p0_c20240630_zIHvpFYikvCl" title="Valuation allowance for deferred tax assets"&gt;171,000&lt;/span&gt;. The valuation allowance decreased by approximately $&lt;span id="xdx_90D_eus-gaap--DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_iI_pp0p0_c20230630_zNi7bIeV7nYa" title="Valuation allowance for deferred tax assets"&gt;78,000&lt;/span&gt; during the
year ended June 30, 2023.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Components of the provision for income taxes are as
follows:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z9sWZUCGaNVi" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Components of provision for income taxes (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8BE_z1SNdi7WdLbh" style="display: none"&gt;Schedule of components
    of the provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49B_20230701__20240630_zpKh9SmNlITi" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_492_20220701__20230630_zLdD00Lt5SIk" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;Years Ended June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_zsZixD2IhqMh" style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Current:&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CurrentFederalTaxExpenseBenefit_d0_maCITEBzHyE_zBjL8rWRkwP2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Federal&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;429,873&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCITEBzHyE_zW3qlNcMdLHg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;State&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,943,588&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;652,521&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_maITEBzXA8_mtCITEBzHyE_znFk5QhjYvZi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Subtotal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,373,461&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;652,521&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_pp0p0_z6x46xBkG5Sd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Deferred:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzROz_zpQoQ3jM4Tq2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;Federal deferred taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,585,515&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,770,980&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzROz_zv38VAZL6vDj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;State deferred taxes&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;209,992&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;208,570&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredIncomeTaxExpensesBenefit_iT_pp0p0_mtDITEBzROz_maITEBzXA8_zsNcthnIZjMd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,795,507&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,979,550&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzXA8_zMR6xz0x1AC" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Provision (Benefit) for Income Taxes - Net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,168,968&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,632,071&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AD_zYtgKg9sCJFf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;A reconciliation of the federal statutory income tax
rate to the Company&#x2019;s effective tax rate as reported is as follows:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zoscTUSQtz28" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8B8_ze4WkrOfrg1h" style="display: none"&gt;Schedule of
    reconciliation of federal statutory income tax rate to company&#x2019;s effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;Years Ended June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Taxes at federal statutory rate&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_906_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_dp_c20230701__20240630_zCe5Cd2yv06f" title="Taxes at federal statutory rate"&gt;21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_903_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_dp_c20220701__20230630_zneX5UxD0w05" title="Taxes at federal statutory rate"&gt;21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;State and local income taxes (benefit), net of federal benefit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20230701__20240630_zUmPEuw7Kqsd" title="State and local income taxes (benefit), net of federal benefit"&gt;7.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20220701__20230630_zgoczKdnDywd" title="State and local income taxes (benefit), net of federal benefit"&gt;5.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Non-controlling interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20230701__20240630_zK78v0AH8uT3" title="Noncontrolling interest"&gt;(5.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20220701__20230630_zcxnrAndN7Eg" title="Noncontrolling interest"&gt;(4.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Expiration of tax credits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_c20230701__20240630_zgbX50BtWvQa" title="Expiration of tax credits"&gt;2.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_c20220701__20230630_zGIokfHUIDUj" title="Expiration of tax credits"&gt;2.8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Return to provision adjustments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp0_c20230701__20240630_zaG6vhJN5Pac" title="Return to provision adjustments"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_c20220701__20230630_zEkgoYvjVo0k" title="Return to provision adjustments"&gt;(2.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Change in the valuation allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20230701__20240630_z7RL2utqT1Wa" title="Change in the valuation allowance"&gt;(0.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20220701__20230630_z1H0ZT04BBbb" title="Change in the valuation allowance"&gt;(0.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20230701__20240630_zap2RVYajSSa" title="Other"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20220701__20230630_zsd62kktcE1d" title="Other"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Effective income tax rate&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20230701__20240630_z5nDSWn7b8x1" title="Effective income tax rate"&gt;26.8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20220701__20230630_zcCDzM2z68u8" title="Effective income tax rate"&gt;23.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AB_zh4LD6ASuwFa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;



















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of June 30, 2024, the Company utilized all Federal
net operating loss (&#x201c;NOL&#x201d;) carryforwards as compared to NOL&#x2019;s of approximately $9,110,000 as of June 30, 2023. The utilization
of certain of the NOLs is limited by separate return limitation year rules pursuant to Section 1502 of the Internal Revenue Code.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has, for federal income tax purposes,
research and development tax credits and investments tax credits carryforwards aggregating $&lt;span id="xdx_90F_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_iI_pp0p0_c20240630_zvulAavt8qd4" title="Tax credits carryforwards"&gt;1,323,000&lt;/span&gt;. However, the realization of these
credits may be limited as a result of expiring prior to their utilization. These credits can only be applied after all net operating losses
have been used.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;Significant components of the Company&#x2019;s
deferred tax assets and liabilities at June 30, 2024 and 2023 are as follows:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zMqcrx20DgGf" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Deferred tax assets and liabilities - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8BC_zMULfEhGAqE2" style="display: none"&gt;Schedule of company&#x2019;s
deferred tax assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20240630_zmuKQ9m5zlZd" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20230630_zdjeToFeSOIh" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Deferred tax assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzM4n_zibiFm5K9Qah" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Allowance for credit losses&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;3,969,819&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;3,360,809&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzM4n_zszFOdQf73S" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Non-deductible accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;758,700&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;707,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzM4n_ztlOIfuAk64e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Net operating carryforwards&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;396,092&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,768,844&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzM4n_zLQMYZfL8LK3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Tax credits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,323,018&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,981,214&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_i01I_pp0p0_maDTAGzM4n_z9dgsUKM8Mp" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Capitalized research and development&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;747,407&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;369,675&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--DeferredTaxAssetsInRightUseAssetsAndLiabilities_i01I_pp0p0_maDTAGzM4n_zwpnzLQy2uyg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Right of use assets and lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;114,116&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;112,938&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzM4n_zuyGoIorZQdd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Inventories&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;106,879&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;105,310&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzM4n_maDTANzJzu_z9l7g2nMCjca" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Deferred Tax Assets - gross&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,416,031&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,406,190&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzJzu_zdkzvBgmTDcl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(192,776&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(364,230&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzJzu_maDTALNzFAZ_z8c8sM4QmDc4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Total deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,223,255&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,041,960&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_pp0p0_di_maDTLzImD_z0HSCRTtRFx3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Property and equipment and depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(267,124&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(151,007&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzImD_zAENllX4Dqi2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Intangibles&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(104,436&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(243,751&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_msDTALNzFAZ_mtDTLzImD_zNqihF02Jv1b" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Total deferred tax liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(371,560&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(394,758&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzFAZ_zy4p6iK9IJuj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Net deferred tax asset&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,851,695&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;9,647,202&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A9_zyTQ0sZfOKpk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;















</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001566"
      unitRef="USD">7223255</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001568"
      unitRef="USD">371560</us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001570"
      unitRef="USD">1323000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001572"
      unitRef="USD">4516000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherOperatingIncome
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001574"
      unitRef="USD">618000</us-gaap:OtherOperatingIncome>
    <us-gaap:OperatingLossCarryforwardsValuationAllowance
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001576"
      unitRef="USD">2746000</us-gaap:OperatingLossCarryforwardsValuationAllowance>
    <FONR:PercentageOfExciseTax
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001578"
      unitRef="Pure">0.01</FONR:PercentageOfExciseTax>
    <FONR:CorporateAlternativeMinimumTaxPercentage
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001580"
      unitRef="Pure">0.15</FONR:CorporateAlternativeMinimumTaxPercentage>
    <us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001582"
      unitRef="USD">171000</us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital>
    <us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001584"
      unitRef="USD">78000</us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001594">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z9sWZUCGaNVi" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Components of provision for income taxes (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8BE_z1SNdi7WdLbh" style="display: none"&gt;Schedule of components
    of the provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49B_20230701__20240630_zpKh9SmNlITi" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_492_20220701__20230630_zLdD00Lt5SIk" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;Years Ended June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_zsZixD2IhqMh" style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Current:&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CurrentFederalTaxExpenseBenefit_d0_maCITEBzHyE_zBjL8rWRkwP2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Federal&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;429,873&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCITEBzHyE_zW3qlNcMdLHg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;State&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,943,588&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;652,521&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_maITEBzXA8_mtCITEBzHyE_znFk5QhjYvZi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Subtotal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,373,461&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;652,521&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_pp0p0_z6x46xBkG5Sd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Deferred:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzROz_zpQoQ3jM4Tq2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;Federal deferred taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,585,515&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,770,980&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzROz_zv38VAZL6vDj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;State deferred taxes&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;209,992&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;208,570&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredIncomeTaxExpensesBenefit_iT_pp0p0_mtDITEBzROz_maITEBzXA8_zsNcthnIZjMd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,795,507&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,979,550&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzXA8_zMR6xz0x1AC" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Provision (Benefit) for Income Taxes - Net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,168,968&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,632,071&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001599"
      unitRef="USD">429873</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001600"
      unitRef="USD">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001602"
      unitRef="USD">1943588</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001603"
      unitRef="USD">652521</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001605"
      unitRef="USD">2373461</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001606"
      unitRef="USD">652521</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001611"
      unitRef="USD">2585515</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001612"
      unitRef="USD">2770980</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001614"
      unitRef="USD">209992</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001615"
      unitRef="USD">208570</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <FONR:DeferredIncomeTaxExpensesBenefit
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001617"
      unitRef="USD">2795507</FONR:DeferredIncomeTaxExpensesBenefit>
    <FONR:DeferredIncomeTaxExpensesBenefit
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001618"
      unitRef="USD">2979550</FONR:DeferredIncomeTaxExpensesBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001620"
      unitRef="USD">5168968</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001621"
      unitRef="USD">3632071</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001623">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zoscTUSQtz28" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8B8_ze4WkrOfrg1h" style="display: none"&gt;Schedule of
    reconciliation of federal statutory income tax rate to company&#x2019;s effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;Years Ended June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Taxes at federal statutory rate&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_906_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_dp_c20230701__20240630_zCe5Cd2yv06f" title="Taxes at federal statutory rate"&gt;21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_903_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_dp_c20220701__20230630_zneX5UxD0w05" title="Taxes at federal statutory rate"&gt;21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;State and local income taxes (benefit), net of federal benefit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20230701__20240630_zUmPEuw7Kqsd" title="State and local income taxes (benefit), net of federal benefit"&gt;7.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20220701__20230630_zgoczKdnDywd" title="State and local income taxes (benefit), net of federal benefit"&gt;5.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Non-controlling interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20230701__20240630_zK78v0AH8uT3" title="Noncontrolling interest"&gt;(5.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20220701__20230630_zcxnrAndN7Eg" title="Noncontrolling interest"&gt;(4.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Expiration of tax credits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_c20230701__20240630_zgbX50BtWvQa" title="Expiration of tax credits"&gt;2.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_c20220701__20230630_zGIokfHUIDUj" title="Expiration of tax credits"&gt;2.8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Return to provision adjustments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp0_c20230701__20240630_zaG6vhJN5Pac" title="Return to provision adjustments"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_c20220701__20230630_zEkgoYvjVo0k" title="Return to provision adjustments"&gt;(2.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Change in the valuation allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20230701__20240630_z7RL2utqT1Wa" title="Change in the valuation allowance"&gt;(0.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20220701__20230630_z1H0ZT04BBbb" title="Change in the valuation allowance"&gt;(0.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20230701__20240630_zap2RVYajSSa" title="Other"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20220701__20230630_zsd62kktcE1d" title="Other"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Effective income tax rate&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20230701__20240630_z5nDSWn7b8x1" title="Effective income tax rate"&gt;26.8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20220701__20230630_zcCDzM2z68u8" title="Effective income tax rate"&gt;23.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <FONR:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001625"
      unitRef="Pure">0.210</FONR:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates>
    <FONR:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001627"
      unitRef="Pure">0.210</FONR:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001629"
      unitRef="Pure">0.071</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001631"
      unitRef="Pure">0.051</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001633"
      unitRef="Pure">-0.053</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001635"
      unitRef="Pure">-0.046</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001637"
      unitRef="Pure">0.022</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001639"
      unitRef="Pure">0.028</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001641"
      unitRef="Pure">0</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001643"
      unitRef="Pure">-0.023</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001645"
      unitRef="Pure">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001647"
      unitRef="Pure">-0.005</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001649"
      unitRef="Pure">0.020</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001651"
      unitRef="Pure">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001653"
      unitRef="Pure">0.268</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001655"
      unitRef="Pure">0.230</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001665"
      unitRef="USD">1323000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001667">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zMqcrx20DgGf" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Deferred tax assets and liabilities - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8BC_zMULfEhGAqE2" style="display: none"&gt;Schedule of company&#x2019;s
deferred tax assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20240630_zmuKQ9m5zlZd" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20230630_zdjeToFeSOIh" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Deferred tax assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzM4n_zibiFm5K9Qah" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Allowance for credit losses&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;3,969,819&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;3,360,809&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzM4n_zszFOdQf73S" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Non-deductible accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;758,700&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;707,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzM4n_ztlOIfuAk64e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Net operating carryforwards&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;396,092&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,768,844&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzM4n_zLQMYZfL8LK3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Tax credits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,323,018&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,981,214&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_i01I_pp0p0_maDTAGzM4n_z9dgsUKM8Mp" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Capitalized research and development&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;747,407&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;369,675&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--DeferredTaxAssetsInRightUseAssetsAndLiabilities_i01I_pp0p0_maDTAGzM4n_zwpnzLQy2uyg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Right of use assets and lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;114,116&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;112,938&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzM4n_zuyGoIorZQdd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Inventories&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;106,879&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;105,310&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzM4n_maDTANzJzu_z9l7g2nMCjca" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Deferred Tax Assets - gross&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,416,031&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,406,190&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzJzu_zdkzvBgmTDcl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(192,776&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(364,230&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzJzu_maDTALNzFAZ_z8c8sM4QmDc4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Total deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,223,255&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,041,960&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_pp0p0_di_maDTLzImD_z0HSCRTtRFx3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Property and equipment and depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(267,124&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(151,007&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzImD_zAENllX4Dqi2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Intangibles&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(104,436&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(243,751&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_msDTALNzFAZ_mtDTLzImD_zNqihF02Jv1b" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Total deferred tax liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(371,560&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(394,758&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzFAZ_zy4p6iK9IJuj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Net deferred tax asset&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,851,695&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;9,647,202&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001672"
      unitRef="USD">3969819</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001673"
      unitRef="USD">3360809</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001675"
      unitRef="USD">758700</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001676"
      unitRef="USD">707400</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001678"
      unitRef="USD">396092</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001679"
      unitRef="USD">2768844</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001681"
      unitRef="USD">1323018</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001682"
      unitRef="USD">2981214</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001684"
      unitRef="USD">747407</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001685"
      unitRef="USD">369675</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <FONR:DeferredTaxAssetsInRightUseAssetsAndLiabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001687"
      unitRef="USD">114116</FONR:DeferredTaxAssetsInRightUseAssetsAndLiabilities>
    <FONR:DeferredTaxAssetsInRightUseAssetsAndLiabilities
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001688"
      unitRef="USD">112938</FONR:DeferredTaxAssetsInRightUseAssetsAndLiabilities>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001690"
      unitRef="USD">106879</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001691"
      unitRef="USD">105310</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001693"
      unitRef="USD">7416031</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001694"
      unitRef="USD">10406190</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001696"
      unitRef="USD">192776</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001697"
      unitRef="USD">364230</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001699"
      unitRef="USD">7223255</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001700"
      unitRef="USD">10041960</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001702"
      unitRef="USD">267124</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001703"
      unitRef="USD">151007</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001705"
      unitRef="USD">104436</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001706"
      unitRef="USD">243751</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001708"
      unitRef="USD">371560</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001709"
      unitRef="USD">394758</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001711"
      unitRef="USD">6851695</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001712"
      unitRef="USD">9647202</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001720">&lt;p id="xdx_80C_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_ztqTOz9sie16" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 12 - &lt;span id="xdx_825_zEInyM7QGgQc"&gt;OTHER CURRENT LIABILITIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Included in other current liabilities are the following:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zLPhW9v4htne" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8B7_zJqBC5NLE9O8" style="display: none"&gt;Schedule of other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20240630_zITTz9uZyXrl" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20230630_zVHCeNkN7jb9" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AccruedSalariesCurrent_iI_maOLCzbf4_zNVOmqy10yI9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Accrued salaries, commissions and payroll taxes&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;4,677,690&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;4,413,044&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_maOLCzbf4_zQ7LK7x0eAb2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Sales tax payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;197,317&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;193,041&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_maOLCzbf4_zEvlcDCGHTx" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;State income taxes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,461,336&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48,353&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccruedProfessionalFeesCurrent_iI_maOLCzbf4_zUdGxQjdaOdc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Legal and other professional fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_maOLCzbf4_zESr0jVwOI9f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Accounting fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;119,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--SelfInsuranceReserve_iI_maOLCzbf4_zJPW3PvDhDM5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Self-funded health insurance reserve&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;121,445&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,971&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_maOLCzbf4_zkT55C58U2e3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Accrued interest and penalty&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,534&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,534&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OtherSundryLiabilitiesCurrent_iI_maOLCzbf4_zxPXP6ULGWHh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,348,710&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;573,574&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OtherLiabilitiesCurrent_iTI_mtOLCzbf4_zMLrUOLXO7Ye" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Other current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;7,941,039&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,443,724&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001722">&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zLPhW9v4htne" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8B7_zJqBC5NLE9O8" style="display: none"&gt;Schedule of other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20240630_zITTz9uZyXrl" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20230630_zVHCeNkN7jb9" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AccruedSalariesCurrent_iI_maOLCzbf4_zNVOmqy10yI9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Accrued salaries, commissions and payroll taxes&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;4,677,690&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;4,413,044&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_maOLCzbf4_zQ7LK7x0eAb2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Sales tax payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;197,317&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;193,041&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_maOLCzbf4_zEvlcDCGHTx" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;State income taxes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,461,336&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48,353&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccruedProfessionalFeesCurrent_iI_maOLCzbf4_zUdGxQjdaOdc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Legal and other professional fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_maOLCzbf4_zESr0jVwOI9f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Accounting fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;119,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--SelfInsuranceReserve_iI_maOLCzbf4_zJPW3PvDhDM5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Self-funded health insurance reserve&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;121,445&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,971&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_maOLCzbf4_zkT55C58U2e3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Accrued interest and penalty&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,534&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,534&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OtherSundryLiabilitiesCurrent_iI_maOLCzbf4_zxPXP6ULGWHh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,348,710&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;573,574&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OtherLiabilitiesCurrent_iTI_mtOLCzbf4_zMLrUOLXO7Ye" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Other current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;7,941,039&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,443,724&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedSalariesCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001724"
      unitRef="USD">4677690</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001725"
      unitRef="USD">4413044</us-gaap:AccruedSalariesCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001727"
      unitRef="USD">197317</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001728"
      unitRef="USD">193041</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001730"
      unitRef="USD">1461336</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001731"
      unitRef="USD">48353</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001733"
      unitRef="USD">11207</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001734"
      unitRef="USD">11207</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001736"
      unitRef="USD">119800</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001737"
      unitRef="USD">100000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:SelfInsuranceReserve
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001739"
      unitRef="USD">121445</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001740"
      unitRef="USD">100971</us-gaap:SelfInsuranceReserve>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001742"
      unitRef="USD">3534</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001743"
      unitRef="USD">3534</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001745"
      unitRef="USD">1348710</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001746"
      unitRef="USD">573574</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001748"
      unitRef="USD">7941039</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001749"
      unitRef="USD">5443724</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001751">&lt;p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zZKbgkWCscSh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 13 - &lt;span id="xdx_828_zQtsp1iuWmoe"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Leases&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company rents its operating facilities and certain
equipment, pursuant to operating lease agreements expiring at various dates through November 2033. The leases for certain facilities contain
escalation clauses relating to increases in real property taxes as well as certain maintenance costs.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Rent expense for operating leases approximated $&lt;span id="xdx_903_ecustom--LeaseAndRentalExpenses_pp0p0_c20230701__20240630_zRAAc6o6VfKf" title="Rent expense for operating leases"&gt;5,685,000&lt;/span&gt;
and $&lt;span id="xdx_90C_ecustom--LeaseAndRentalExpenses_pp0p0_c20220701__20230630_zzakPXfsHYk5" title="Rent expense for operating leases"&gt;5,887,000&lt;/span&gt;, for the years ended June 30, 2024 and 2023, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company received approval from the Suffolk County
Industrial Development Agency on February 29, 2016 of a &lt;span id="xdx_90B_ecustom--PropertyTaxAbatementFromSuffolkCountyIda_dp_c20160228__20160229_ztie8PuWue76" title="Property tax abatement from suffolk county IDA"&gt;50&lt;/span&gt;% property tax abatement, valued at $&lt;span id="xdx_90E_ecustom--PropertyTaxAbatement_pp0p0_c20160228__20160229_zDQJRCzzWWTh" title="Property tax abatement"&gt;440,000&lt;/span&gt;, over a 10 year period commencing
January 2017.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Employee Benefit Plans&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has a non-contributory 401(k) Plan (the
&#x201c;401(k) Plan&#x201d;). The 401(k) Plan covers all non-union employees who are at least 21 years of age with no minimum service requirements.
There were $&lt;span id="xdx_90A_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_pp0p0_c20230701__20240630_zsDqLxzdTUNb" title="Employer contributions"&gt;0&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_pp0p0_c20220701__20230630_zbGhCYkXGVO4" title="Employer contributions"&gt;36,523&lt;/span&gt; employer contributions to the Plan for the years ended June 30, 2024 and 2023, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The stockholders of the Company approved the 2000
Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;) at the Company&#x2019;s annual stockholders&#x2019; meeting in April 2000. The ESPP provides
for eligible employees to acquire common stock of the Company at a discount, not to exceed 15%. This plan has not been put into effect
as of June 30, 2024.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Other Matters&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company is subject to other legal proceedings
and claims arising from the ordinary course of its business, including personal injury, customer contract and employment claims besides
the claim above. In the opinion of management, and with consultation with legal counsel, the aggregate liability, if any, with respect
to such actions, will not have a material adverse effect on the consolidated financial position or results of operations of the Company.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company maintains a self-funded health insurance
program with a stop-loss umbrella policy with a third-party insurer to limit the maximum potential liability for individual claims to
$&lt;span id="xdx_905_eus-gaap--ReinsurancePayable_iI_c20240630_zYqMrA883wj9" title="Liability for individual claims"&gt;110,000&lt;/span&gt; per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company
considers historical and projected medical utilization data when estimating its health insurance program liability and related expense.
As of June 30, 2024 and 2023, the Company had approximately $&lt;span id="xdx_906_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpense_iI_c20240630_zZv1oBgSkdPa" title="Reserve for self-funded"&gt;121,000&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpense_iI_c20230630_zxuJypjvlCT2" title="Reserve for self-funded"&gt;101,000&lt;/span&gt;, respectively, in reserve for its self-funded health
insurance programs. The reserves are included in &#x201c;Other current liabilities&#x201d; in the consolidated balance sheets.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company regularly analyzes its reserves for incurred
but not reported claims, and for reported but not paid claims related to its reinsurance and self-funded insurance programs. The Company
believes its reserves are adequate. However, significant judgment is involved in assessing these reserves such as assessing historical
paid claims, average lags between the claims&#x2019; incurred date, reported dates and paid dates, and the frequency and severity of claims.
There may be differences between actual settlement amounts and recorded reserves and any resulting adjustments are included in expense
once a probable amount is known. There were no significant adjustments recorded in the years covered by this report.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <FONR:LeaseAndRentalExpenses
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001753"
      unitRef="USD">5685000</FONR:LeaseAndRentalExpenses>
    <FONR:LeaseAndRentalExpenses
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001755"
      unitRef="USD">5887000</FONR:LeaseAndRentalExpenses>
    <FONR:PropertyTaxAbatementFromSuffolkCountyIda
      contextRef="From2016-02-282016-02-29"
      decimals="INF"
      id="Fact001757"
      unitRef="Pure">0.50</FONR:PropertyTaxAbatementFromSuffolkCountyIda>
    <FONR:PropertyTaxAbatement
      contextRef="From2016-02-282016-02-29"
      decimals="0"
      id="Fact001759"
      unitRef="USD">440000</FONR:PropertyTaxAbatement>
    <us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001761"
      unitRef="USD">0</us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP>
    <us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001763"
      unitRef="USD">36523</us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP>
    <us-gaap:ReinsurancePayable
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001773"
      unitRef="USD">110000</us-gaap:ReinsurancePayable>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001775"
      unitRef="USD">121000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001777"
      unitRef="USD">101000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001779">&lt;p id="xdx_805_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_zWJG6q65f5th" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 14 - &lt;span id="xdx_82A_zkvg7ceUmV65"&gt;SUPPLEMENTAL CASH FLOW INFORMATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the years ended June 30, 2024 and 2023 the
Company paid $&lt;span id="xdx_900_eus-gaap--InterestPaidNet_c20230701__20240630_zcyOH2kUY779" title="Interest paid"&gt;76,997&lt;/span&gt; and $&lt;span id="xdx_90E_eus-gaap--InterestPaidNet_c20220701__20230630_ztn0BYRDTbva" title="Interest paid"&gt;50,132&lt;/span&gt; for interest, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the years ended June 30, 2024 and 2023 the
Company paid $&lt;span id="xdx_902_eus-gaap--IncomeTaxesPaid_c20230701__20240630_zjTqW99SYPS1" title="Income taxes paid"&gt;507,139&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--IncomeTaxesPaid_c20220701__20230630_zadEMEw0Uj22" title="Income taxes paid"&gt;1,439,507&lt;/span&gt; for income taxes, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;















</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:InterestPaidNet
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001781"
      unitRef="USD">76997</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001783"
      unitRef="USD">50132</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001785"
      unitRef="USD">507139</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001787"
      unitRef="USD">1439507</us-gaap:IncomeTaxesPaid>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001795">&lt;p id="xdx_801_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zZC3AuLwFS1f" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 15 &#x2013; &lt;span id="xdx_82C_zM1GSWVc1qq5"&gt;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On December 31, 2023, the Company entered into an
agreement with Magnetic Resonance Management, LLC (&#x201c;MRM&#x201d;) for the sale of a MRI scanner. MRM is owned by the CEO and President
of the Company. The sales price of the equipment was $&lt;span id="xdx_90D_eus-gaap--ConvertibleNotesPayable_iI_c20231231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zapqcbK7XOg1" title="Sale of price of the equipment"&gt;576,857&lt;/span&gt; which is payable based upon a promissory note dated December 1, 2023. The
note bears interest at a rate of &lt;span id="xdx_908_eus-gaap--DerivativeFixedInterestRate_iI_dp_c20231231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zgit3f9dZIO8" title="Bears interest rate"&gt;9&lt;/span&gt;% and is payable in full at the maturity of the note in December 2028. The MRI scanner had zero basis,
which resulted in a gain of $&lt;span id="xdx_901_eus-gaap--DeferredGainOnSaleOfProperty_iI_c20231231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zxBPl1xA3u9f" title="Gain on sale of equipments"&gt;576,857&lt;/span&gt;. The Company has the option but not the obligation to re-take possession of the scanner in lieu of
payment upon maturity of the note.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_907_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20230701__20240630__dei--LegalEntityAxis__custom--BensonhurstMRILimitedPartnershipMember_zbgnOk3x02t7" title="Related party transaction, description"&gt;Bensonhurst
MRI Limited Partnership (&#x201c;Bensonhurst&#x201d;), in which the CEO and President of the Company holds an interest, is party to an
agreement with the Company for the service and maintenance of its Upright MRI Scanner for a price of $110,000 per annum. On February
1, 2024, Bensonhurst entered into a second contract with the Company for the service and maintenance of a High-Field MRI Scanner for
a price of $70,000 per annum. Also, during fiscal year ended June 30, 2024, the Company charged Bensonhurst MRI Limited Partnership
$190,362 for reimbursable salaries and marketing expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The CEO and President of the Company was a minority
owner of a billing company, which performs billing and collection services with respect to No-Fault and Workers&#x2019; Compensation claims
of the Company&#x2019;s clients. The Company terminated this agreement on January 1, 2021. On June 1, 2017, the Company had also entered
into a one year renewable agreement to provide IT services to the billing company for a monthly fee of $&lt;span id="xdx_903_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20170530__20170601_zjp8pwJkyf5k" title="Monthly fee"&gt;23,884&lt;/span&gt;. The agreement was terminated
on May 31, 2023.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_90A_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20230701__20240630__dei--LegalEntityAxis__custom--RadianHealthcareManagementLLCMember_zC5YBQQHVWth" title="Related party transaction, description"&gt;Radian Healthcare Management, LLC (&#x201c;Radian&#x201d;),
which is owned by the son-in-law of the CEO and President of the Company provided the Company with personnel recruitment of 32 new employees
at a fee of approximately $200,000 during the fiscal year ended June 30, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2023-12-31_custom_MagneticResonanceManagementMember"
      decimals="0"
      id="Fact001797"
      unitRef="USD">576857</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="AsOf2023-12-31_custom_MagneticResonanceManagementMember"
      decimals="INF"
      id="Fact001799"
      unitRef="Pure">0.09</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DeferredGainOnSaleOfProperty
      contextRef="AsOf2023-12-31_custom_MagneticResonanceManagementMember"
      decimals="0"
      id="Fact001801"
      unitRef="USD">576857</us-gaap:DeferredGainOnSaleOfProperty>
    <us-gaap:RelatedPartyTransactionDescriptionOfTransaction
      contextRef="From2023-07-012024-06-30_custom_BensonhurstMRILimitedPartnershipMember"
      id="Fact001803">Bensonhurst
MRI Limited Partnership (&#x201c;Bensonhurst&#x201d;), in which the CEO and President of the Company holds an interest, is party to an
agreement with the Company for the service and maintenance of its Upright MRI Scanner for a price of $110,000 per annum. On February
1, 2024, Bensonhurst entered into a second contract with the Company for the service and maintenance of a High-Field MRI Scanner for
a price of $70,000 per annum. Also, during fiscal year ended June 30, 2024, the Company charged Bensonhurst MRI Limited Partnership
$190,362 for reimbursable salaries and marketing expenses.</us-gaap:RelatedPartyTransactionDescriptionOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="From2017-05-302017-06-01"
      decimals="0"
      id="Fact001805"
      unitRef="USD">23884</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionDescriptionOfTransaction
      contextRef="From2023-07-012024-06-30_custom_RadianHealthcareManagementLLCMember"
      id="Fact001807">Radian Healthcare Management, LLC (&#x201c;Radian&#x201d;),
which is owned by the son-in-law of the CEO and President of the Company provided the Company with personnel recruitment of 32 new employees
at a fee of approximately $200,000 during the fiscal year ended June 30, 2024.</us-gaap:RelatedPartyTransactionDescriptionOfTransaction>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001809">&lt;p id="xdx_803_eus-gaap--SegmentReportingDisclosureTextBlock_zcg6tWgYUPX8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 16 - &lt;span id="xdx_820_zrgqTbZFfdA3"&gt;SEGMENT AND RELATED INFORMATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company provides segment data in accordance with
the provisions of ASC 280, &#x201c;Disclosures about Segments of an Enterprise and Related Information&#x201d;.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company operates in two industry segments - manufacturing
and the servicing of medical equipment and management of diagnostic imaging centers.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The accounting policies of the segments are the same
as those described in the summary of significant accounting policies. All intersegment sales are market-based. The Company evaluates performance
based on income or loss from operations.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Summarized financial information concerning the Company&#x2019;s
reportable segments is shown in the following table:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_91F_eus-gaap--HealthCareMember_zrbbrh8Nq8gi"&gt;&lt;b style="display: none"&gt;Manufacturing
and Servicing of Medical Equipment [Member] &lt;/b&gt;&lt;/span&gt;&lt;b&gt;&lt;span id="xdx_91A_eus-gaap--HealthCareOtherMember_zwfA1uFTuOY3" style="display: none"&gt;Management
of Diagnostic Imaging Center [Member]&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zA71g3xO3oA4" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8BE_zwqIFlHSQafg" style="display: none"&gt;Schedule of summarized segment financial information&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;Manufacturing and Servicing of Medical&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;Management of Diagnostic Imaging&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Fiscal 2024:&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Equipment&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Center&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Totals&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; width: 46%; text-align: left; text-indent: -11pt"&gt;Net revenues from external customers&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zTMiA4oQGU86" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;8,329,106&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zP5FyMWHPOql" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;94,554,983&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20230701__20240630_zVnyRssIqxyj" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;102,884,089&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;Intersegment net revenues *&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--IntersegmentNetRevenues_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_fKg_____zsmgMH9E59ib" style="text-align: right" title="Inter-segment net revenues"&gt;1,073,333&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--IntersegmentNetRevenues_d0_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_fKg_____zrUKfCDHutK8" style="text-align: right" title="Inter-segment net revenues"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--IntersegmentNetRevenues_c20230701__20240630_fKg_____zUkVPQEM3tbd" style="text-align: right" title="Inter-segment net revenues"&gt;1,073,333&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;(Loss) Income from operations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperations_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zmyXcXzbgiqd" style="text-align: right" title="(Loss) Income from operations"&gt;(6,958,012&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperations_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zzGA0IqxmlIe" style="text-align: right" title="(Loss) Income from operations"&gt;23,493,376&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20230701__20240630_zhW7fHRstad1" style="text-align: right" title="(Loss) Income from operations"&gt;16,535,364&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zKoTIcpgsPMg" style="text-align: right" title="Depreciation and amortization"&gt;238,802&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zwEQkny54BJa" style="text-align: right" title="Depreciation and amortization"&gt;4,357,619&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20230701__20240630_zz4PjQT86Uca" style="text-align: right" title="Depreciation and amortization"&gt;4,596,421&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;Total identifiable assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsNet_iI_c20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_znTU5qLeEuEk" style="text-align: right" title="Total identifiable assets"&gt;30,360,188&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AssetsNet_iI_c20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zfygfHXMgf2l" style="text-align: right" title="Total identifiable assets"&gt;183,885,781&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AssetsNet_iI_c20240630_zULDki0ufAV8" style="text-align: right" title="Total identifiable assets"&gt;214,245,969&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;Capital expenditures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PaymentsToAcquireProductiveAssets_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zSXFWTmaLcMa" style="text-align: right" title="Capital expenditures"&gt;32,885&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zEiSLrMAOXn6" style="text-align: right" title="Capital expenditures"&gt;789,961&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_c20230701__20240630_z36IwKzGEBJh" style="text-align: right" title="Capital expenditures"&gt;822,846&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Fiscal 2023:&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;Net revenues from external customers&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zaN9AzScedn8" style="text-align: right" title="Net revenues from external customers"&gt;8,260,711&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zWF3Zns9v0Md" style="text-align: right" title="Net revenues from external customers"&gt;90,384,390&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_c20220701__20230630_zUOVGy35HEFd" style="text-align: right" title="Net revenues from external customers"&gt;98,645,101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;Intersegment net revenues *&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--IntersegmentNetRevenues_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_fKg_____z6eheYM24d34" style="text-align: right" title="Inter-segment net revenues"&gt;985,833&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--IntersegmentNetRevenues_d0_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_fKg_____z572vB3OXIGk" style="text-align: right" title="Inter-segment net revenues"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--IntersegmentNetRevenues_c20220701__20230630_fKg_____zFchbOhMwL31" style="text-align: right" title="Inter-segment net revenues"&gt;985,833&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;(Loss) Income from operations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zf4rqOpSeg4l" style="text-align: right" title="(Loss) Income from operations"&gt;(5,875,126&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zYgu0HNxD36c" style="text-align: right" title="(Loss) Income from operations"&gt;20,664,388&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230630_zQQ6ZmcIK5Ej" style="text-align: right" title="(Loss) Income from operations"&gt;14,789,262&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zCrhWL1BCx18" style="text-align: right" title="Depreciation and amortization"&gt;263,720&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_ztWMPkpsRrtb" style="text-align: right" title="Depreciation and amortization"&gt;4,276,415&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230630_zxZkR34GdXec" style="text-align: right" title="Depreciation and amortization"&gt;4,540,135&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;Total identifiable assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsNet_iI_c20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zi9yx79H9G3a" style="text-align: right" title="Total identifiable assets"&gt;30,892,807&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsNet_iI_c20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zVczUvnXtAab" style="text-align: right" title="Total identifiable assets"&gt;170,153,612&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsNet_iI_c20230630_zYv2i4PPTnn7" style="text-align: right" title="Total identifiable assets"&gt;201,046,419&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;Capital expenditures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zqUwEC7PUS0f" style="text-align: right" title="Capital expenditures"&gt;119,571&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PaymentsToAcquireProductiveAssets_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zRKM4MQOQHok" style="text-align: right" title="Capital expenditures"&gt;4,218,084&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PaymentsToAcquireProductiveAssets_c20220701__20230630_z9foLkt23973" style="text-align: right" title="Capital expenditures"&gt;4,337,655&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 4px; padding-left: 11pt; text-align: justify"&gt;&lt;span id="xdx_F03_z2AsoMtRz1Kb" style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-left: 11pt; text-align: justify"&gt;&lt;span id="xdx_F13_zGOAjo82oomk" style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Amounts eliminated in consolidation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AB_zL5RHqsaxZ2a" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Export Product Sales&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s areas of operations are principally
in the United States. The Company had export sales of medical equipment amounting to &lt;span id="xdx_906_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20230701__20240630_zzydAcmfkBY6" title="Export sales of medical equipment percentage"&gt;0.2&lt;/span&gt;% and &lt;span id="xdx_90A_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20220701__20230630_ztlb31XNbj8k" title="Export sales of medical equipment percentage"&gt;14.1&lt;/span&gt;% of product sales revenues to third
parties for the years ended June 30, 2024 and 2023, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The foreign product sales, as a percentage of product
sales to unrelated parties, were made to customers in the following countries:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfExportProductSalesTableTextBlock_zPxvt0Md6uRd" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;&lt;span id="xdx_8BA_zV8IvqceoLdk" style="display: none"&gt;Schedule of export product sales&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Years Ended June 30&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-indent: -11pt"&gt;Canada&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ForeignProductSales_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zY8o9O0ihNw6" title="Foreign product sales"&gt;0.2&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CA_z6VZMCBFzPJa" title="Foreign product sales"&gt;8.5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Germany&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--ForeignProductSales_dp0_c20230701__20240630__srt--StatementGeographicalAxis__country--DE_zmBAUyyf01rj" title="Foreign product sales"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DE_ziwtdxJ09DCg" title="Foreign product sales"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;United Arab Emirates&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignProductSales_dp0_c20230701__20240630__srt--StatementGeographicalAxis__country--AE_zwJcDCMPuaIj" title="Foreign product sales"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AE_zCSOYTp2ycS7" title="Foreign product sales"&gt;0.7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ForeignProductSales_dp_c20230701__20240630_zTYH7ZgvBT45" title="Foreign product sales"&gt;0.2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignProductSales_dp_c20220701__20230630_zgnSQ5SgksR5" title="Foreign product sales"&gt;14.1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zqabiH0gy4Ni" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Foreign Service and Repair Fees&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s areas of service and repair are
principally in the United States. The Company had foreign revenues of service and repair of medical equipment amounting to &lt;span id="xdx_902_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20230701__20240630_zD7klvy2hoIl" title="Percentage of service and repair of medical equipment"&gt;7.4&lt;/span&gt;% and &lt;span id="xdx_90F_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20220701__20230630_zsReGTMvXxUi" title="Percentage of service and repair of medical equipment"&gt;6.4&lt;/span&gt;%
of consolidated net service and repair fees for the years ended June 30, 2024 and 2023, respectively. Foreign service and repair fees,
as a percentage of total service and repair fees, were provided principally to the following countries:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;Foreign Service and Repair Fees&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfExportServiceRevenuesTableTextBlock_z7jiVO9m4v1j" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;&lt;span id="xdx_8BA_z5mx20i5YrCa" style="display: none"&gt;Schedule of export service revenues&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Years Ended June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Puerto Rico&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--PR_z4TR3fJLSEf9" title="Foreign service and repair fees"&gt;1.9&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--PR_z4pkxQDKv8vk" title="Foreign service and repair fees"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Switzerland&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CH_z5ThHoeCyosa" title="Foreign service and repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CH_z7Bm71O8iZY6" title="Foreign service and repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Germany&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--DE_zRYwYFliwQ83" title="Foreign service and repair fees"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DE_zsz2GlSfRBfh" title="Foreign service and repair fees"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;England&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--GB_z3K53JttbUh4" title="Foreign service and repair fees"&gt;0.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--GB_zV3kqEMVFlPj" title="Foreign service and repair fees"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;United Arab Emirates&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--AE_zMbLBBGpuaFa" title="Foreign service and repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AE_zn3tqTDy40he" title="Foreign service and repair fees"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Dominican Republic&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--DO_zMCibsAKuY33" title="Foreign service and repair fees"&gt;1.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DO_zlhfPHoNaW0b" title="Foreign service and repair fees"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Canada&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ForeignServiceAndRepairFees_dp0_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zn8wMDBi7iYi" title="Foreign service and repair fees"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CA_zoyPr5HlQdOc" title="Foreign service and repair fees"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Greece&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--GR_z8xAcCJrq6Od" title="Foreign service and repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--GR_zE1T9oHhrLL2" title="Foreign service and repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 1pt 11pt; text-indent: -11pt"&gt;Australia&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--AU_zFcb35Wfn3Di" title="Foreign service and repair fees"&gt;0.7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AU_zrFkQP17t7mb" title="Foreign service and repair fees"&gt;0.9&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 2.5pt 11pt; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630_zPsaKxpaO687" title="Foreign service and repair fees"&gt;7.4&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630_zok0Okk7tur9" title="Foreign service and repair fees"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AB_zy8qXKfYo7ma" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;The Company does not have any material assets
outside of the United States.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001821">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zA71g3xO3oA4" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;&lt;span id="xdx_8BE_zwqIFlHSQafg" style="display: none"&gt;Schedule of summarized segment financial information&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;Manufacturing and Servicing of Medical&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;Management of Diagnostic Imaging&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Fiscal 2024:&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Equipment&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Center&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Totals&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; width: 46%; text-align: left; text-indent: -11pt"&gt;Net revenues from external customers&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zTMiA4oQGU86" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;8,329,106&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zP5FyMWHPOql" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;94,554,983&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20230701__20240630_zVnyRssIqxyj" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;102,884,089&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;Intersegment net revenues *&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--IntersegmentNetRevenues_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_fKg_____zsmgMH9E59ib" style="text-align: right" title="Inter-segment net revenues"&gt;1,073,333&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--IntersegmentNetRevenues_d0_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_fKg_____zrUKfCDHutK8" style="text-align: right" title="Inter-segment net revenues"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--IntersegmentNetRevenues_c20230701__20240630_fKg_____zUkVPQEM3tbd" style="text-align: right" title="Inter-segment net revenues"&gt;1,073,333&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;(Loss) Income from operations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperations_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zmyXcXzbgiqd" style="text-align: right" title="(Loss) Income from operations"&gt;(6,958,012&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperations_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zzGA0IqxmlIe" style="text-align: right" title="(Loss) Income from operations"&gt;23,493,376&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20230701__20240630_zhW7fHRstad1" style="text-align: right" title="(Loss) Income from operations"&gt;16,535,364&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zKoTIcpgsPMg" style="text-align: right" title="Depreciation and amortization"&gt;238,802&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zwEQkny54BJa" style="text-align: right" title="Depreciation and amortization"&gt;4,357,619&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20230701__20240630_zz4PjQT86Uca" style="text-align: right" title="Depreciation and amortization"&gt;4,596,421&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;Total identifiable assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsNet_iI_c20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_znTU5qLeEuEk" style="text-align: right" title="Total identifiable assets"&gt;30,360,188&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AssetsNet_iI_c20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zfygfHXMgf2l" style="text-align: right" title="Total identifiable assets"&gt;183,885,781&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AssetsNet_iI_c20240630_zULDki0ufAV8" style="text-align: right" title="Total identifiable assets"&gt;214,245,969&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;Capital expenditures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PaymentsToAcquireProductiveAssets_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zSXFWTmaLcMa" style="text-align: right" title="Capital expenditures"&gt;32,885&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_c20230701__20240630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zEiSLrMAOXn6" style="text-align: right" title="Capital expenditures"&gt;789,961&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_c20230701__20240630_z36IwKzGEBJh" style="text-align: right" title="Capital expenditures"&gt;822,846&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Fiscal 2023:&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;Net revenues from external customers&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zaN9AzScedn8" style="text-align: right" title="Net revenues from external customers"&gt;8,260,711&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zWF3Zns9v0Md" style="text-align: right" title="Net revenues from external customers"&gt;90,384,390&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_c20220701__20230630_zUOVGy35HEFd" style="text-align: right" title="Net revenues from external customers"&gt;98,645,101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;Intersegment net revenues *&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--IntersegmentNetRevenues_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_fKg_____z6eheYM24d34" style="text-align: right" title="Inter-segment net revenues"&gt;985,833&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--IntersegmentNetRevenues_d0_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_fKg_____z572vB3OXIGk" style="text-align: right" title="Inter-segment net revenues"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--IntersegmentNetRevenues_c20220701__20230630_fKg_____zFchbOhMwL31" style="text-align: right" title="Inter-segment net revenues"&gt;985,833&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;(Loss) Income from operations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zf4rqOpSeg4l" style="text-align: right" title="(Loss) Income from operations"&gt;(5,875,126&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zYgu0HNxD36c" style="text-align: right" title="(Loss) Income from operations"&gt;20,664,388&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230630_zQQ6ZmcIK5Ej" style="text-align: right" title="(Loss) Income from operations"&gt;14,789,262&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zCrhWL1BCx18" style="text-align: right" title="Depreciation and amortization"&gt;263,720&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_ztWMPkpsRrtb" style="text-align: right" title="Depreciation and amortization"&gt;4,276,415&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230630_zxZkR34GdXec" style="text-align: right" title="Depreciation and amortization"&gt;4,540,135&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;Total identifiable assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsNet_iI_c20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zi9yx79H9G3a" style="text-align: right" title="Total identifiable assets"&gt;30,892,807&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsNet_iI_c20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zVczUvnXtAab" style="text-align: right" title="Total identifiable assets"&gt;170,153,612&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsNet_iI_c20230630_zYv2i4PPTnn7" style="text-align: right" title="Total identifiable assets"&gt;201,046,419&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -11pt"&gt;Capital expenditures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareMember_zqUwEC7PUS0f" style="text-align: right" title="Capital expenditures"&gt;119,571&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PaymentsToAcquireProductiveAssets_c20220701__20230630__srt--ProductOrServiceAxis__us-gaap--HealthCareOtherMember_zRKM4MQOQHok" style="text-align: right" title="Capital expenditures"&gt;4,218,084&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PaymentsToAcquireProductiveAssets_c20220701__20230630_z9foLkt23973" style="text-align: right" title="Capital expenditures"&gt;4,337,655&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 4px; padding-left: 11pt; text-align: justify"&gt;&lt;span id="xdx_F03_z2AsoMtRz1Kb" style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-left: 11pt; text-align: justify"&gt;&lt;span id="xdx_F13_zGOAjo82oomk" style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Amounts eliminated in consolidation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="From2023-07-012024-06-30_us-gaap_HealthCareMember"
      decimals="0"
      id="Fact001823"
      unitRef="USD">8329106</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-07-012024-06-30_us-gaap_HealthCareOtherMember"
      decimals="0"
      id="Fact001825"
      unitRef="USD">94554983</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001827"
      unitRef="USD">102884089</us-gaap:Revenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2023-07-012024-06-30_us-gaap_HealthCareMember"
      decimals="0"
      id="Fact001829"
      unitRef="USD">1073333</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2023-07-012024-06-30_us-gaap_HealthCareOtherMember"
      decimals="0"
      id="Fact001831"
      unitRef="USD">0</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001833"
      unitRef="USD">1073333</FONR:IntersegmentNetRevenues>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-07-012024-06-30_us-gaap_HealthCareMember"
      decimals="0"
      id="Fact001835"
      unitRef="USD">-6958012</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-07-012024-06-30_us-gaap_HealthCareOtherMember"
      decimals="0"
      id="Fact001837"
      unitRef="USD">23493376</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001839"
      unitRef="USD">16535364</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-07-012024-06-30_us-gaap_HealthCareMember"
      decimals="0"
      id="Fact001841"
      unitRef="USD">238802</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-07-012024-06-30_us-gaap_HealthCareOtherMember"
      decimals="0"
      id="Fact001843"
      unitRef="USD">4357619</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001845"
      unitRef="USD">4596421</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AssetsNet
      contextRef="AsOf2024-06-30_us-gaap_HealthCareMember"
      decimals="0"
      id="Fact001847"
      unitRef="USD">30360188</us-gaap:AssetsNet>
    <us-gaap:AssetsNet
      contextRef="AsOf2024-06-30_us-gaap_HealthCareOtherMember"
      decimals="0"
      id="Fact001849"
      unitRef="USD">183885781</us-gaap:AssetsNet>
    <us-gaap:AssetsNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001851"
      unitRef="USD">214245969</us-gaap:AssetsNet>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2023-07-012024-06-30_us-gaap_HealthCareMember"
      decimals="0"
      id="Fact001853"
      unitRef="USD">32885</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2023-07-012024-06-30_us-gaap_HealthCareOtherMember"
      decimals="0"
      id="Fact001855"
      unitRef="USD">789961</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact001857"
      unitRef="USD">822846</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:Revenues
      contextRef="From2022-07-012023-06-30_us-gaap_HealthCareMember"
      decimals="0"
      id="Fact001859"
      unitRef="USD">8260711</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-07-012023-06-30_us-gaap_HealthCareOtherMember"
      decimals="0"
      id="Fact001861"
      unitRef="USD">90384390</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001863"
      unitRef="USD">98645101</us-gaap:Revenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2022-07-012023-06-30_us-gaap_HealthCareMember"
      decimals="0"
      id="Fact001865"
      unitRef="USD">985833</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2022-07-012023-06-30_us-gaap_HealthCareOtherMember"
      decimals="0"
      id="Fact001867"
      unitRef="USD">0</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001869"
      unitRef="USD">985833</FONR:IntersegmentNetRevenues>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-07-012023-06-30_us-gaap_HealthCareMember"
      decimals="0"
      id="Fact001871"
      unitRef="USD">-5875126</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-07-012023-06-30_us-gaap_HealthCareOtherMember"
      decimals="0"
      id="Fact001873"
      unitRef="USD">20664388</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001875"
      unitRef="USD">14789262</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-07-012023-06-30_us-gaap_HealthCareMember"
      decimals="0"
      id="Fact001877"
      unitRef="USD">263720</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-07-012023-06-30_us-gaap_HealthCareOtherMember"
      decimals="0"
      id="Fact001879"
      unitRef="USD">4276415</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001881"
      unitRef="USD">4540135</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AssetsNet
      contextRef="AsOf2023-06-30_us-gaap_HealthCareMember"
      decimals="0"
      id="Fact001883"
      unitRef="USD">30892807</us-gaap:AssetsNet>
    <us-gaap:AssetsNet
      contextRef="AsOf2023-06-30_us-gaap_HealthCareOtherMember"
      decimals="0"
      id="Fact001885"
      unitRef="USD">170153612</us-gaap:AssetsNet>
    <us-gaap:AssetsNet
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001887"
      unitRef="USD">201046419</us-gaap:AssetsNet>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2022-07-012023-06-30_us-gaap_HealthCareMember"
      decimals="0"
      id="Fact001889"
      unitRef="USD">119571</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2022-07-012023-06-30_us-gaap_HealthCareOtherMember"
      decimals="0"
      id="Fact001891"
      unitRef="USD">4218084</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact001893"
      unitRef="USD">4337655</us-gaap:PaymentsToAcquireProductiveAssets>
    <FONR:ExportSalesOfMedicalEquipmentPercentage
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001896"
      unitRef="Pure">0.002</FONR:ExportSalesOfMedicalEquipmentPercentage>
    <FONR:ExportSalesOfMedicalEquipmentPercentage
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001898"
      unitRef="Pure">0.141</FONR:ExportSalesOfMedicalEquipmentPercentage>
    <FONR:ScheduleOfExportProductSalesTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001900">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfExportProductSalesTableTextBlock_zPxvt0Md6uRd" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;&lt;span id="xdx_8BA_zV8IvqceoLdk" style="display: none"&gt;Schedule of export product sales&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Years Ended June 30&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-indent: -11pt"&gt;Canada&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ForeignProductSales_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zY8o9O0ihNw6" title="Foreign product sales"&gt;0.2&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CA_z6VZMCBFzPJa" title="Foreign product sales"&gt;8.5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Germany&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--ForeignProductSales_dp0_c20230701__20240630__srt--StatementGeographicalAxis__country--DE_zmBAUyyf01rj" title="Foreign product sales"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DE_ziwtdxJ09DCg" title="Foreign product sales"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;United Arab Emirates&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignProductSales_dp0_c20230701__20240630__srt--StatementGeographicalAxis__country--AE_zwJcDCMPuaIj" title="Foreign product sales"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AE_zCSOYTp2ycS7" title="Foreign product sales"&gt;0.7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ForeignProductSales_dp_c20230701__20240630_zTYH7ZgvBT45" title="Foreign product sales"&gt;0.2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignProductSales_dp_c20220701__20230630_zgnSQ5SgksR5" title="Foreign product sales"&gt;14.1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</FONR:ScheduleOfExportProductSalesTableTextBlock>
    <FONR:ForeignProductSales
      contextRef="From2023-07-012024-06-30_country_CA"
      decimals="INF"
      id="Fact001902"
      unitRef="Pure">0.002</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2022-07-012023-06-30_country_CA"
      decimals="INF"
      id="Fact001904"
      unitRef="Pure">0.085</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2023-07-012024-06-30_country_DE"
      decimals="INF"
      id="Fact001906"
      unitRef="Pure">0</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2022-07-012023-06-30_country_DE"
      decimals="INF"
      id="Fact001908"
      unitRef="Pure">0.049</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2023-07-012024-06-30_country_AE"
      decimals="INF"
      id="Fact001910"
      unitRef="Pure">0</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2022-07-012023-06-30_country_AE"
      decimals="INF"
      id="Fact001912"
      unitRef="Pure">0.007</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001914"
      unitRef="Pure">0.002</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001916"
      unitRef="Pure">0.141</FONR:ForeignProductSales>
    <FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001926"
      unitRef="Pure">0.074</FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage>
    <FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001928"
      unitRef="Pure">0.064</FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage>
    <FONR:ScheduleOfExportServiceRevenuesTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001930">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfExportServiceRevenuesTableTextBlock_z7jiVO9m4v1j" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;&lt;span id="xdx_8BA_z5mx20i5YrCa" style="display: none"&gt;Schedule of export service revenues&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Years Ended June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 56%; text-align: left; text-indent: -11pt"&gt;Puerto Rico&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--PR_z4TR3fJLSEf9" title="Foreign service and repair fees"&gt;1.9&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--PR_z4pkxQDKv8vk" title="Foreign service and repair fees"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Switzerland&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CH_z5ThHoeCyosa" title="Foreign service and repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CH_z7Bm71O8iZY6" title="Foreign service and repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Germany&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--DE_zRYwYFliwQ83" title="Foreign service and repair fees"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DE_zsz2GlSfRBfh" title="Foreign service and repair fees"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;England&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--GB_z3K53JttbUh4" title="Foreign service and repair fees"&gt;0.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--GB_zV3kqEMVFlPj" title="Foreign service and repair fees"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;United Arab Emirates&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--AE_zMbLBBGpuaFa" title="Foreign service and repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AE_zn3tqTDy40he" title="Foreign service and repair fees"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Dominican Republic&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--DO_zMCibsAKuY33" title="Foreign service and repair fees"&gt;1.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DO_zlhfPHoNaW0b" title="Foreign service and repair fees"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Canada&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ForeignServiceAndRepairFees_dp0_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zn8wMDBi7iYi" title="Foreign service and repair fees"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CA_zoyPr5HlQdOc" title="Foreign service and repair fees"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Greece&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--GR_z8xAcCJrq6Od" title="Foreign service and repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--GR_zE1T9oHhrLL2" title="Foreign service and repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 1pt 11pt; text-indent: -11pt"&gt;Australia&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--AU_zFcb35Wfn3Di" title="Foreign service and repair fees"&gt;0.7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AU_zrFkQP17t7mb" title="Foreign service and repair fees"&gt;0.9&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 2.5pt 11pt; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630_zPsaKxpaO687" title="Foreign service and repair fees"&gt;7.4&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630_zok0Okk7tur9" title="Foreign service and repair fees"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</FONR:ScheduleOfExportServiceRevenuesTableTextBlock>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2023-07-012024-06-30_country_PR"
      decimals="INF"
      id="Fact001932"
      unitRef="Pure">0.019</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2022-07-012023-06-30_country_PR"
      decimals="INF"
      id="Fact001934"
      unitRef="Pure">0.015</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2023-07-012024-06-30_country_CH"
      decimals="INF"
      id="Fact001936"
      unitRef="Pure">0.003</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2022-07-012023-06-30_country_CH"
      decimals="INF"
      id="Fact001938"
      unitRef="Pure">0.003</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2023-07-012024-06-30_country_DE"
      decimals="INF"
      id="Fact001940"
      unitRef="Pure">0.020</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2022-07-012023-06-30_country_DE"
      decimals="INF"
      id="Fact001942"
      unitRef="Pure">0.016</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2023-07-012024-06-30_country_GB"
      decimals="INF"
      id="Fact001944"
      unitRef="Pure">0.007</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2022-07-012023-06-30_country_GB"
      decimals="INF"
      id="Fact001946"
      unitRef="Pure">0.006</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2023-07-012024-06-30_country_AE"
      decimals="INF"
      id="Fact001948"
      unitRef="Pure">0.003</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2022-07-012023-06-30_country_AE"
      decimals="INF"
      id="Fact001950"
      unitRef="Pure">0.001</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2023-07-012024-06-30_country_DO"
      decimals="INF"
      id="Fact001952"
      unitRef="Pure">0.012</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2022-07-012023-06-30_country_DO"
      decimals="INF"
      id="Fact001954"
      unitRef="Pure">0.005</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2023-07-012024-06-30_country_CA"
      decimals="INF"
      id="Fact001956"
      unitRef="Pure">0</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2022-07-012023-06-30_country_CA"
      decimals="INF"
      id="Fact001958"
      unitRef="Pure">0.006</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2023-07-012024-06-30_country_GR"
      decimals="INF"
      id="Fact001960"
      unitRef="Pure">0.003</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2022-07-012023-06-30_country_GR"
      decimals="INF"
      id="Fact001962"
      unitRef="Pure">0.003</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2023-07-012024-06-30_country_AU"
      decimals="INF"
      id="Fact001964"
      unitRef="Pure">0.007</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2022-07-012023-06-30_country_AU"
      decimals="INF"
      id="Fact001966"
      unitRef="Pure">0.009</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact001968"
      unitRef="Pure">0.074</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001970"
      unitRef="Pure">0.064</FONR:ForeignServiceAndRepairFees>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact001972">&lt;p id="xdx_80A_eus-gaap--SubsequentEventsTextBlock_zv0m0gtYAXd9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 17 &#x2013; &lt;span id="xdx_826_zDRw4DBAztga"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company evaluates events that have occurred after
the balance sheet date, but before the consolidated financial statements are issued.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of September 18, 2024, the Company repurchased
&lt;span id="xdx_90F_esrt--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_iI_c20240918__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSFLRoUFIB04" title="Number of shares repurchased, shares"&gt;19,914&lt;/span&gt; shares at a cost of $&lt;span id="xdx_908_eus-gaap--StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_iI_c20240918__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTfz2Td2y8e9" title="Number of shares repurchased, value"&gt;340,933&lt;/span&gt; which was authorized under the stock repurchase plan adopted in September 2022.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="AsOf2024-09-18_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001974"
      unitRef="Shares">19914</srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="AsOf2024-09-18_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact001976"
      unitRef="USD">340933</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact001026"
          xlink:label="Fact001026"
          xlink:type="locator"/>
        <link:footnote id="Footnote001059" xlink:label="Footnote001059" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Included in provision for credit losses.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001026"
          xlink:to="Footnote001059"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001032"
          xlink:label="Fact001032"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001032"
          xlink:to="Footnote001059"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001036"
          xlink:label="Fact001036"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001036"
          xlink:to="Footnote001059"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001040"
          xlink:label="Fact001040"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001040"
          xlink:to="Footnote001059"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001044"
          xlink:label="Fact001044"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001044"
          xlink:to="Footnote001059"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001048"
          xlink:label="Fact001048"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001048"
          xlink:to="Footnote001059"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001052"
          xlink:label="Fact001052"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001052"
          xlink:to="Footnote001059"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001056"
          xlink:label="Fact001056"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001056"
          xlink:to="Footnote001059"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001829"
          xlink:label="Fact001829"
          xlink:type="locator"/>
        <link:footnote id="Footnote001894" xlink:label="Footnote001894" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts eliminated in consolidation</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001829"
          xlink:to="Footnote001894"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001831"
          xlink:label="Fact001831"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001831"
          xlink:to="Footnote001894"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001833"
          xlink:label="Fact001833"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001833"
          xlink:to="Footnote001894"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001865"
          xlink:label="Fact001865"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001865"
          xlink:to="Footnote001894"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001867"
          xlink:label="Fact001867"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001867"
          xlink:to="Footnote001894"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001869"
          xlink:label="Fact001869"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001869"
          xlink:to="Footnote001894"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
